7,521 Unfiltered Template Results

(You need to login as owner of this project to build models)
ModelsNameDescriptionGMQEQSQESeq IdCoverageRangeMethodResolutionOligo-stateLigandsFound bySeq Similarity
7cwn.1.A
Spike glycoprotein
P17-H014 Fab cocktail in complex with SARS-CoV-2 spike protein
0.690.89100.001.00 1-1273EM0.00homo-trimer16 x NAG, 15 x NAG-NAGHHblits0.62
7cwn.1.B
Spike glycoprotein
P17-H014 Fab cocktail in complex with SARS-CoV-2 spike protein
0.690.89100.001.00 1-1273EM0.00homo-trimer16 x NAG, 15 x NAG-NAGHHblits0.62
7cwn.1.C
Spike glycoprotein
P17-H014 Fab cocktail in complex with SARS-CoV-2 spike protein
0.690.89100.001.00 1-1273EM0.00homo-trimer16 x NAG, 15 x NAG-NAGHHblits0.62
7cwo.1.A
Spike glycoprotein
SARS-CoV-2 spike protein RBD and P17 fab complex
0.020.00100.001.00 1-1273EM0.00monomerHHblits0.62
7cwm.1.B
Spike glycoprotein
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state
0.690.87100.001.00 1-1273EM0.00homo-trimer16 x NAG, 14 x NAG-NAGHHblits0.62
7cwl.1.B
Spike glycoprotein
SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state
0.680.88100.001.00 1-1273EM0.00homo-trimer27 x NAGHHblits0.62
7cwm.1.C
Spike glycoprotein
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state
0.690.87100.001.00 1-1273EM0.00homo-trimer16 x NAG, 14 x NAG-NAGHHblits0.62
7cwm.1.A
Spike glycoprotein
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state
0.680.86100.001.00 1-1273EM0.00homo-trimer16 x NAG, 14 x NAG-NAGHHblits0.62
7cwu.1.G
Spike glycoprotein
SARS-CoV-2 spike proteins trimer in complex with P17 and FC05 Fabs cocktail
0.69100.001.00 1-1273EM0.00hetero-3-3-3-3-3-mer16 x NAG, 15 x NAG-NAGHHblits0.62
7cwu.1.H
Spike glycoprotein
SARS-CoV-2 spike proteins trimer in complex with P17 and FC05 Fabs cocktail
0.68100.001.00 1-1273EM0.00hetero-3-3-3-3-3-mer16 x NAG, 15 x NAG-NAGHHblits0.62
7cwu.1.I
Spike glycoprotein
SARS-CoV-2 spike proteins trimer in complex with P17 and FC05 Fabs cocktail
0.69100.001.00 1-1273EM0.00hetero-3-3-3-3-3-mer16 x NAG, 15 x NAG-NAGHHblits0.62
7cwl.1.C
Spike glycoprotein
SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state
0.69100.001.00 1-1273EM0.00hetero-3-3-3-mer27 x NAGHHblits0.62
7cwl.1.A
Spike glycoprotein
SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state
0.69100.001.00 1-1273EM0.00hetero-3-3-3-mer27 x NAGHHblits0.62
7n64.1.B
Spike glycoprotein
SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction)
0.04100.001.00 1-1273EM0.00hetero-2-1-1-mer2 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.62
7n62.1.A
Spike glycoprotein
SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction)
0.07100.001.00 1-1273EM0.00hetero-1-1-1-mer5 x NAGHHblits0.62
7n64.1.A
Spike glycoprotein
SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction)
0.07100.001.00 1-1273EM0.00hetero-2-1-1-mer2 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.62
7fg3.1.A
Spike glycoprotein
Major cryo-EM structure of S protein trimer of SARS-CoV2 with K-874, composite map
0.57100.001.00 1-1273EM0.00hetero-1-1-merHHblits0.62
7fg7.1.A
Spike glycoprotein
Cryo-EM structure of S protein trimer of SARS-CoV2
0.60100.001.00 1-1273EM0.00monomerHHblits0.62
7fg2.1.A
Spike glycoprotein
Minor cryo-EM structure of S protein trimer of SARS-CoV2 with K-874A VHH, composite map
0.60100.001.00 1-1273EM0.00hetero-1-1-merHHblits0.62
7f3q.1.A
Spike glycoprotein
SARS-CoV-2 RBD in complex with A5-10 Fab and A34-2 Fab
0.03100.001.00 1-1273EM0.00hetero-1-1-1-1-1-mer1 x NAG, 1 x MESHHblits0.62
8dt3.1.A
Spike glycoprotein
Cryo-EM structure of spike binding to Fab of neutralizing antibody (locally refined)
0.07100.001.00 1-1273EM0.00hetero-1-1-1-merHHblits0.62
6xra.1.A
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
0.10100.001.00 1-1273EM0.00homo-trimer9 x NAG, 6 x NAG-NAG, 6 x NAG-NAG-MAN-MAN, 3 x NAG-NAG-MANHHblits0.62
6xra.1.B
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
0.10100.001.00 1-1273EM0.00homo-trimer9 x NAG, 6 x NAG-NAG, 6 x NAG-NAG-MAN-MAN, 3 x NAG-NAG-MANHHblits0.62
6xra.1.C
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
0.10100.001.00 1-1273EM0.00homo-trimer9 x NAG, 6 x NAG-NAG, 6 x NAG-NAG-MAN-MAN, 3 x NAG-NAG-MANHHblits0.62

6xr8.1.A
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
0.720.85100.001.00 1-1273EM0.00homo-trimer21 x NAG, 21 x NAG-NAG-MAN, 9 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MAN-MANHHblits0.62
6xr8.1.B
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
0.72100.001.00 1-1273EM0.00homo-trimer21 x NAG, 21 x NAG-NAG-MAN, 9 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MAN-MANHHblits0.62
6xr8.1.C
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
0.72100.001.00 1-1273EM0.00homo-trimer21 x NAG, 21 x NAG-NAG-MAN, 9 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MAN-MANHHblits0.62
6zwv.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: 3 Closed RBDs
0.6699.921.00 1-1273EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
6zwv.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: 3 Closed RBDs
0.6699.921.00 1-1273EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
6zwv.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: 3 Closed RBDs
0.6699.921.00 1-1273EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7krq.1.A
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
0.7199.921.00 1-1273EM3.44homo-trimer24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUCHHblits0.62
7krq.1.B
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
0.7199.921.00 1-1273EM3.44homo-trimer24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUCHHblits0.62
7krq.1.C
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
0.7199.921.00 1-1273EM3.44homo-trimer24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUCHHblits0.62
7krr.1.B
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
0.7299.921.00 1-1273EM3.50homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.62
7krs.1.C
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
0.7199.921.00 1-1273EM3.20homo-trimer21 x NAG, 30 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MANHHblits0.62
7krr.1.A
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
0.7299.921.00 1-1273EM3.50homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.62
7krs.1.B
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
0.7299.921.00 1-1273EM3.20homo-trimer21 x NAG, 30 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MANHHblits0.62
7krr.1.C
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
0.7199.921.00 1-1273EM3.50homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.62
7krs.1.A
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
0.7199.921.00 1-1273EM3.20homo-trimer21 x NAG, 30 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MANHHblits0.62
7upy.1.C
Spike glycoprotein
One RBD-up state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab fragment
0.7299.921.00 1-1273EM3.10hetero-3-3-3-mer23 x NAG, 16 x NAG-NAG, 12 x NAG-NAG-MAN, 6 x NAG-NAG-FUCHHblits0.62
7upy.1.A
Spike glycoprotein
One RBD-up state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab fragment
0.7299.921.00 1-1273EM3.10hetero-3-3-3-mer23 x NAG, 16 x NAG-NAG, 12 x NAG-NAG-MAN, 6 x NAG-NAG-FUCHHblits0.62
7upy.1.B
Spike glycoprotein
One RBD-up state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab fragment
0.7399.921.00 1-1273EM3.10hetero-3-3-3-mer23 x NAG, 16 x NAG-NAG, 12 x NAG-NAG-MAN, 6 x NAG-NAG-FUCHHblits0.62
8gjm.1.A
Spike glycoprotein
17b10 fab in complex with full-length SARS-CoV-2 Spike G614 trimer
0.7299.921.00 1-1273EM0.00hetero-3-1-1-mer25 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 5 x NAG-NAG-MANHHblits0.62
8gjm.1.C
Spike glycoprotein
17b10 fab in complex with full-length SARS-CoV-2 Spike G614 trimer
0.7099.921.00 1-1273EM0.00hetero-3-1-1-mer25 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 5 x NAG-NAG-MANHHblits0.62
8gjm.1.B
Spike glycoprotein
17b10 fab in complex with full-length SARS-CoV-2 Spike G614 trimer
0.7299.921.00 1-1273EM0.00hetero-3-1-1-mer25 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 5 x NAG-NAG-MANHHblits0.62
7d0d.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer26 x NAG, 22 x NAG-NAGHHblits0.62
7d00.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-1B8
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGHHblits0.62
7czp.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A1
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 23 x NAG-NAGHHblits0.62
7czr.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B8_2B
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer28 x NAG, 20 x NAG-NAGHHblits0.62
7czw.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G7
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGHHblits0.62
7czy.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2F11_2B
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAG, 2 x NAG-NAG-NAGHHblits0.62
7czq.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A10
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGHHblits0.62
7czu.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B6_2B
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGHHblits0.62
7d0c.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3A1
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer26 x NAG, 22 x NAG-NAGHHblits0.62
7czt.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G9
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGHHblits0.62
7ct5.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with T-ACE2
0.6899.841.00 1-1273EM0.00hetero-3-3-mer31 x NAG, 35 x NAG-NAGHHblits0.62
7c2l.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with 4A8
0.6699.841.00 1-1273EM0.00hetero-3-3-3-mer25 x NAG, 6 x NAG-NAG-NAG, 23 x NAG-NAGHHblits0.62
7c2l.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with 4A8
0.7099.841.00 1-1273EM0.00hetero-3-3-3-mer25 x NAG, 6 x NAG-NAG-NAG, 23 x NAG-NAGHHblits0.62
7c2l.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with 4A8
0.6999.841.00 1-1273EM0.00hetero-3-3-3-mer25 x NAG, 6 x NAG-NAG-NAG, 23 x NAG-NAGHHblits0.62
7ct5.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with T-ACE2
0.6899.841.00 1-1273EM0.00hetero-3-3-mer31 x NAG, 35 x NAG-NAGHHblits0.62
7czt.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G9
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGHHblits0.62
7czy.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2F11_2B
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAG, 2 x NAG-NAG-NAGHHblits0.62
7dx5.1.A
Spike glycoprotein
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound)
0.6999.841.00 1-1273EM0.00hetero-3-1-mer29 x NAG, 26 x NAG-NAGHHblits0.62
7dx9.1.A
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and 2 PD bound)
0.6999.841.00 1-1273EM0.00hetero-3-2-mer28 x NAG, 32 x NAG-NAGHHblits0.62
7dx6.1.A
Spike glycoprotein
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (2 up RBD and 1 PD bound)
0.6999.841.00 1-1273EM0.00hetero-3-1-mer27 x NAG, 27 x NAG-NAGHHblits0.62
7dx8.1.A
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and 2 PD bound)
0.6999.841.00 1-1273EM0.00hetero-3-2-mer28 x NAG, 32 x NAG-NAGHHblits0.62
7d0b.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B
0.6999.841.00 1-1273EM0.00hetero-3-1-1-mer27 x NAG, 21 x NAG-NAGHHblits0.62
7d03.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-2G7
0.6999.841.00 1-1273EM0.00hetero-3-1-1-mer28 x NAG, 20 x NAG-NAGHHblits0.62
7dx9.1.C
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and 2 PD bound)
0.6999.841.00 1-1273EM0.00hetero-3-2-mer28 x NAG, 32 x NAG-NAGHHblits0.62
7dx3.1.A
Spike glycoprotein
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and no PD bound)
0.6799.841.00 1-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGHHblits0.62
7dx0.1.A
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2
0.6799.841.00 1-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGHHblits0.62
7dwz.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in the active conformation
0.6999.841.00 1-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGHHblits0.62
7d00.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-1B8
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGHHblits0.62
7czz.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2F11_3B
0.6999.841.00 1-1273EM0.00hetero-3-3-3-mer26 x NAG, 22 x NAG-NAG, 3 x NAG-NAG-NAGHHblits0.62
7czv.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B
0.6999.841.00 1-1273EM0.00hetero-3-3-3-mer28 x NAG, 20 x NAG-NAGHHblits0.62
7czu.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B6_2B
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGHHblits0.62
7czr.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B8_2B
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer28 x NAG, 20 x NAG-NAGHHblits0.62
7czx.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B9
0.6999.841.00 1-1273EM0.00hetero-3-3-3-mer29 x NAG, 19 x NAG-NAGHHblits0.62
7dx6.1.B
Spike glycoprotein
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (2 up RBD and 1 PD bound)
0.6799.841.00 1-1273EM0.00hetero-3-1-mer27 x NAG, 27 x NAG-NAGHHblits0.62
7dx3.1.B
Spike glycoprotein
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and no PD bound)
0.6799.841.00 1-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGHHblits0.62
7dx5.1.B
Spike glycoprotein
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound)
0.6899.841.00 1-1273EM0.00hetero-3-1-mer29 x NAG, 26 x NAG-NAGHHblits0.62
7dx0.1.B
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2
0.6799.841.00 1-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGHHblits0.62
7dx8.1.B
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and 2 PD bound)
0.6799.841.00 1-1273EM0.00hetero-3-2-mer28 x NAG, 32 x NAG-NAGHHblits0.62
7dx7.1.B
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound)
0.6799.841.00 1-1273EM0.00hetero-3-1-mer27 x NAG, 27 x NAG-NAGHHblits0.62
7d0d.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer26 x NAG, 22 x NAG-NAGHHblits0.62
7czr.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B8_2B
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer28 x NAG, 20 x NAG-NAGHHblits0.62
7czt.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G9
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGHHblits0.62
7czq.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A10
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGHHblits0.62
7czv.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B
0.6999.841.00 1-1273EM0.00hetero-3-3-3-mer28 x NAG, 20 x NAG-NAGHHblits0.62
7czz.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2F11_3B
0.6999.841.00 1-1273EM0.00hetero-3-3-3-mer26 x NAG, 22 x NAG-NAG, 3 x NAG-NAG-NAGHHblits0.62
7czs.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B
0.6999.841.00 1-1273EM0.00hetero-3-3-3-mer28 x NAG, 20 x NAG-NAGHHblits0.62
7ct5.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with T-ACE2
0.6899.841.00 1-1273EM0.00hetero-3-3-mer31 x NAG, 35 x NAG-NAGHHblits0.62
7czw.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G7
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGHHblits0.62
7d0c.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3A1
0.6899.841.00 1-1273EM0.00hetero-3-2-2-mer26 x NAG, 22 x NAG-NAGHHblits0.62
7czs.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B
0.6999.841.00 1-1273EM0.00hetero-3-3-3-mer28 x NAG, 20 x NAG-NAGHHblits0.62
7czv.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B
0.6999.841.00 1-1273EM0.00hetero-3-3-3-mer28 x NAG, 20 x NAG-NAGHHblits0.62
7czz.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2F11_3B
0.6999.841.00 1-1273EM0.00hetero-3-3-3-mer26 x NAG, 22 x NAG-NAG, 3 x NAG-NAG-NAGHHblits0.62
7czp.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A1
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 23 x NAG-NAGHHblits0.62
7czq.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A10
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGHHblits0.62
7czw.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G7
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGHHblits0.62
7d0b.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B
0.6999.841.00 1-1273EM0.00hetero-3-1-1-mer27 x NAG, 21 x NAG-NAGHHblits0.62
7d03.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-2G7
0.6999.841.00 1-1273EM0.00hetero-3-1-1-mer28 x NAG, 20 x NAG-NAGHHblits0.62
7czp.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A1
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 23 x NAG-NAGHHblits0.62
7d0c.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3A1
0.6899.841.00 1-1273EM0.00hetero-3-2-2-mer26 x NAG, 22 x NAG-NAGHHblits0.62
7czs.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B
0.6999.841.00 1-1273EM0.00hetero-3-3-3-mer28 x NAG, 20 x NAG-NAGHHblits0.62
7d03.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-2G7
0.6999.841.00 1-1273EM0.00hetero-3-1-1-mer28 x NAG, 20 x NAG-NAGHHblits0.62
7d0b.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B
0.6999.841.00 1-1273EM0.00hetero-3-1-1-mer27 x NAG, 21 x NAG-NAGHHblits0.62
7czx.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B9
0.6999.841.00 1-1273EM0.00hetero-3-3-3-mer29 x NAG, 19 x NAG-NAGHHblits0.62
7d0d.1.G
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer26 x NAG, 22 x NAG-NAGHHblits0.62
7d00.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-1B8
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGHHblits0.62
7czu.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B6_2B
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGHHblits0.62
7czy.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2F11_2B
0.6999.841.00 1-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAG, 2 x NAG-NAG-NAGHHblits0.62
7czx.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B9
0.6999.841.00 1-1273EM0.00hetero-3-3-3-mer29 x NAG, 19 x NAG-NAGHHblits0.62
7dwx.1.H
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
0.6999.841.00 1-1273EM0.00hetero-2-2-6-mer62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAGHHblits0.62
7dwy.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in the locked conformation
0.7299.841.00 1-1273EM0.00homo-trimer47 x NAG, 3 x EIC, 11 x NAG-NAGHHblits0.62
7dwy.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in the locked conformation
0.7299.841.00 1-1273EM0.00homo-trimer47 x NAG, 3 x EIC, 11 x NAG-NAGHHblits0.62
7dwy.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in the locked conformation
0.7299.841.00 1-1273EM0.00homo-trimer47 x NAG, 3 x EIC, 11 x NAG-NAGHHblits0.62
7dwz.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in the active conformation
0.6999.841.00 1-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGHHblits0.62
7dwx.1.J
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
0.6999.841.00 1-1273EM0.00hetero-2-2-6-mer62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAGHHblits0.62
7dx3.1.C
Spike glycoprotein
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and no PD bound)
0.6799.841.00 1-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGHHblits0.62
7dwx.1.G
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
0.6999.841.00 1-1273EM0.00hetero-2-2-6-mer62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAGHHblits0.62
7dx5.1.C
Spike glycoprotein
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound)
0.6799.841.00 1-1273EM0.00hetero-3-1-mer29 x NAG, 26 x NAG-NAGHHblits0.62
7dx7.1.A
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound)
0.6999.841.00 1-1273EM0.00hetero-3-1-mer27 x NAG, 27 x NAG-NAGHHblits0.62
7dx6.1.C
Spike glycoprotein
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (2 up RBD and 1 PD bound)
0.6799.841.00 1-1273EM0.00hetero-3-1-mer27 x NAG, 27 x NAG-NAGHHblits0.62
7dx8.1.C
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and 2 PD bound)
0.6999.841.00 1-1273EM0.00hetero-3-2-mer28 x NAG, 32 x NAG-NAGHHblits0.62
7dwx.1.E
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
0.6999.841.00 1-1273EM0.00hetero-2-2-6-mer62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAGHHblits0.62
7dx7.1.C
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound)
0.6799.841.00 1-1273EM0.00hetero-3-1-mer27 x NAG, 27 x NAG-NAGHHblits0.62
7dx0.1.C
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2
0.6799.841.00 1-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGHHblits0.62
7dwx.1.F
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
0.6999.841.00 1-1273EM0.00hetero-2-2-6-mer62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAGHHblits0.62
7dwx.1.I
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
0.6999.841.00 1-1273EM0.00hetero-2-2-6-mer62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAGHHblits0.62
7dwz.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in the active conformation
0.6999.841.00 1-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGHHblits0.62
7dx9.1.B
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and 2 PD bound)
0.6999.841.00 1-1273EM0.00hetero-3-2-mer28 x NAG, 32 x NAG-NAGHHblits0.62
8cya.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67
0.6499.841.00 1-1273EM0.00hetero-3-3-mer32 x NAG, 14 x NAG-NAG-BMA, 4 x NAG-NAG, 2 x NAG-NAG-FUCHHblits0.62
8cya.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67
0.6499.841.00 1-1273EM0.00hetero-3-3-mer32 x NAG, 14 x NAG-NAG-BMA, 4 x NAG-NAG, 2 x NAG-NAG-FUCHHblits0.62
8cya.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67
0.6499.841.00 1-1273EM0.00hetero-3-3-mer32 x NAG, 14 x NAG-NAG-BMA, 4 x NAG-NAG, 2 x NAG-NAG-FUCHHblits0.62
7l7k.1.A
Spike glycoprotein
Cryo-EM structure of protein encoded by vaccine candidate BNT162b2
0.6899.841.00 1-1273EM0.00homo-trimerHHblits0.62
7l7k.1.C
Spike glycoprotein
Cryo-EM structure of protein encoded by vaccine candidate BNT162b2
0.6899.841.00 1-1273EM0.00homo-trimerHHblits0.62
8cxq.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-22
0.6799.841.00 1-1273EM0.00hetero-3-3-merHHblits0.62
8cy7.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
0.6199.841.00 1-1273EM0.00hetero-3-3-mer31 x NAG, 12 x NAG-NAGHHblits0.62
8cyc.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
0.6599.841.00 1-1273EM0.00hetero-3-3-merHHblits0.62
8cxn.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57
0.6399.841.00 1-1273EM0.00hetero-3-3-mer28 x NAGHHblits0.62
8cy6.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-65
0.6899.841.00 1-1273EM0.00hetero-3-3-merHHblits0.62
7l7k.1.B
Spike glycoprotein
Cryo-EM structure of protein encoded by vaccine candidate BNT162b2
0.6899.841.00 1-1273EM0.00homo-trimerHHblits0.62
8cyb.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8
0.6799.841.00 1-1273EM0.00hetero-3-1-mer32 x NAG, 4 x NAG-NAG, 7 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-FUC-GAL-FUC-NAG-BMA, 7 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN, 1 x NAG-FUC-NAGHHblits0.62
8cyb.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8
0.6799.841.00 1-1273EM0.00hetero-3-1-mer32 x NAG, 4 x NAG-NAG, 7 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-FUC-GAL-FUC-NAG-BMA, 7 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN, 1 x NAG-FUC-NAGHHblits0.62
8cy9.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-23
0.6699.841.00 1-1273EM0.00hetero-3-3-merHHblits0.62
8cy6.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-65
0.6899.841.00 1-1273EM0.00hetero-3-3-merHHblits0.62
8cy7.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
0.6199.841.00 1-1273EM0.00hetero-3-3-mer31 x NAG, 12 x NAG-NAGHHblits0.62
8cxq.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-22
0.6899.841.00 1-1273EM0.00hetero-3-3-merHHblits0.62
8cy6.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-65
0.6899.841.00 1-1273EM0.00hetero-3-3-merHHblits0.62
8cyc.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
0.6499.841.00 1-1273EM0.00hetero-3-3-merHHblits0.62
8cxn.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57
0.6399.841.00 1-1273EM0.00hetero-3-3-mer28 x NAGHHblits0.62
8cyb.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8
0.6799.841.00 1-1273EM0.00hetero-3-1-mer32 x NAG, 4 x NAG-NAG, 7 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-FUC-GAL-FUC-NAG-BMA, 7 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN, 1 x NAG-FUC-NAGHHblits0.62
8cxq.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-22
0.6799.841.00 1-1273EM0.00hetero-3-3-merHHblits0.62
8cyj.1.E
Spike glycoprotein
RBD of SARS-CoV-2 Spike protein in complex with pan-sarbecovirus nanobodies 2-10, 2-67, 2-62 and 1-25
0.0299.841.00 1-1273EM0.00hetero-1-1-1-1-1-merHHblits0.62
8cy7.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
0.6199.841.00 1-1273EM0.00hetero-3-3-mer31 x NAG, 12 x NAG-NAGHHblits0.62
8cy9.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-23
0.6699.841.00 1-1273EM0.00hetero-3-3-merHHblits0.62
8cyc.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
0.6699.841.00 1-1273EM0.00hetero-3-3-merHHblits0.62
8cxn.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57
0.6599.841.00 1-1273EM0.00hetero-3-3-mer28 x NAGHHblits0.62
8cy9.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-23
0.6499.841.00 1-1273EM0.00hetero-3-3-merHHblits0.62
7dx1.1.A
Spike glycoprotein
S protein of SARS-CoV-2 D614G mutant
0.6799.761.00 1-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGHHblits0.62
7dx2.1.A
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 D614G mutant
0.6799.761.00 1-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGHHblits0.62
7dx1.1.B
Spike glycoprotein
S protein of SARS-CoV-2 D614G mutant
0.6799.761.00 1-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGHHblits0.62
7dx2.1.B
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 D614G mutant
0.6799.761.00 1-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGHHblits0.62
7dx1.1.C
Spike glycoprotein
S protein of SARS-CoV-2 D614G mutant
0.6799.761.00 1-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGHHblits0.62
7dx2.1.C
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 D614G mutant
0.6799.761.00 1-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGHHblits0.62
7jji.1.A
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length prefusion spike trimer (C3 symmetry)
0.6999.611.00 1-1273EM0.00homo-trimer3 x NAG, 3 x VCG, 3 x EIC, 45 x NAG-NAGHHblits0.62
7jji.1.B
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length prefusion spike trimer (C3 symmetry)
0.6999.611.00 1-1273EM0.00homo-trimer3 x NAG, 3 x VCG, 3 x EIC, 45 x NAG-NAGHHblits0.62
7jji.1.C
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length prefusion spike trimer (C3 symmetry)
0.6999.611.00 1-1273EM0.00homo-trimer3 x NAG, 3 x VCG, 3 x EIC, 45 x NAG-NAGHHblits0.62
7jjj.1.A
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length dimers of spike trimers
0.6799.611.00 1-1273EM0.00homo-hexamer16 x NAG, 76 x NAG-NAG, 2 x NAG-NAG-FUC, 2 x NAG-NAG-BMA-FUCHHblits0.62
7jjj.1.B
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length dimers of spike trimers
0.6799.611.00 1-1273EM0.00homo-hexamer16 x NAG, 76 x NAG-NAG, 2 x NAG-NAG-FUC, 2 x NAG-NAG-BMA-FUCHHblits0.62
7jjj.1.C
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length dimers of spike trimers
0.6799.611.00 1-1273EM0.00homo-hexamer16 x NAG, 76 x NAG-NAG, 2 x NAG-NAG-FUC, 2 x NAG-NAG-BMA-FUCHHblits0.62
7jjj.1.D
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length dimers of spike trimers
0.6799.611.00 1-1273EM0.00homo-hexamer16 x NAG, 76 x NAG-NAG, 2 x NAG-NAG-FUC, 2 x NAG-NAG-BMA-FUCHHblits0.62
7jjj.1.E
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length dimers of spike trimers
0.6799.611.00 1-1273EM0.00homo-hexamer16 x NAG, 76 x NAG-NAG, 2 x NAG-NAG-FUC, 2 x NAG-NAG-BMA-FUCHHblits0.62
7jjj.1.F
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length dimers of spike trimers
0.6799.611.00 1-1273EM0.00homo-hexamer16 x NAG, 76 x NAG-NAG, 2 x NAG-NAG-FUC, 2 x NAG-NAG-BMA-FUCHHblits0.62
7x08.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex with 2G1
0.7299.531.00 1-1273EM0.00hetero-3-3-3-mer30 x NAG, 3 x EIC, 24 x NAG-NAGHHblits0.62
7epx.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex with GW01
0.6999.531.00 1-1273EM0.00hetero-3-2-2-mer25 x NAG, 23 x NAG-NAGHHblits0.62
7epx.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex with GW01
0.6999.531.00 1-1273EM0.00hetero-3-2-2-mer25 x NAG, 23 x NAG-NAGHHblits0.62
7epx.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex with GW01
0.6799.531.00 1-1273EM0.00hetero-3-2-2-mer25 x NAG, 23 x NAG-NAGHHblits0.62
7sbp.1.A
Spike glycoprotein
Closed state of pre-fusion SARS-CoV-2 Kappa variant spike protein
0.7299.371.00 1-1273EM3.44homo-trimer21 x NAG, 6 x NAG-NAG, 27 x NAG-NAG-MAN, 3 x NAG-NAG-FUCHHblits0.62
7sbp.1.B
Spike glycoprotein
Closed state of pre-fusion SARS-CoV-2 Kappa variant spike protein
0.7299.371.00 1-1273EM3.44homo-trimer21 x NAG, 6 x NAG-NAG, 27 x NAG-NAG-MAN, 3 x NAG-NAG-FUCHHblits0.62
7sbp.1.C
Spike glycoprotein
Closed state of pre-fusion SARS-CoV-2 Kappa variant spike protein
0.7299.371.00 1-1273EM3.44homo-trimer21 x NAG, 6 x NAG-NAG, 27 x NAG-NAG-MAN, 3 x NAG-NAG-FUCHHblits0.62
7sbq.1.A
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Kappa variant spike protein
0.7199.371.00 1-1273EM3.50homo-trimer24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MANHHblits0.62
7sbq.1.B
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Kappa variant spike protein
0.7399.371.00 1-1273EM3.50homo-trimer24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MANHHblits0.62
7sbq.1.C
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Kappa variant spike protein
0.7299.371.00 1-1273EM3.50homo-trimer24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MANHHblits0.62
7sbr.1.A
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Kappa variant spike protein
0.7299.371.00 1-1273EM3.50homo-trimer24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MANHHblits0.62
7sbr.1.B
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Kappa variant spike protein
0.7399.371.00 1-1273EM3.50homo-trimer24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MANHHblits0.62
7sbr.1.C
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Kappa variant spike protein
0.7299.371.00 1-1273EM3.50homo-trimer24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MANHHblits0.62
7sbs.1.A
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Gamma variant spike protein
0.6999.061.00 1-1273EM3.50homo-trimer29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7sbs.1.B
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Gamma variant spike protein
0.7099.061.00 1-1273EM3.50homo-trimer29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7sbs.1.C
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Gamma variant spike protein
0.6999.061.00 1-1273EM3.50homo-trimer29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7sbt.1.A
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Gamma variant spike protein
0.6999.061.00 1-1273EM3.50homo-trimer28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 9 x NAG-NAG-MANHHblits0.61
7sbt.1.B
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Gamma variant spike protein
0.7099.061.00 1-1273EM3.50homo-trimer28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 9 x NAG-NAG-MANHHblits0.61
7sbt.1.C
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Gamma variant spike protein
0.7099.061.00 1-1273EM3.50homo-trimer28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 9 x NAG-NAG-MANHHblits0.61
7sbk.1.A
Spike glycoprotein
Closed state of pre-fusion SARS-CoV-2 Delta variant spike protein
0.7199.291.00 1-1273EM3.44homo-trimer21 x NAG, 27 x NAG-NAG-MAN, 3 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.62
7sbk.1.B
Spike glycoprotein
Closed state of pre-fusion SARS-CoV-2 Delta variant spike protein
0.7199.291.00 1-1273EM3.44homo-trimer21 x NAG, 27 x NAG-NAG-MAN, 3 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.62
7sbk.1.C
Spike glycoprotein
Closed state of pre-fusion SARS-CoV-2 Delta variant spike protein
0.7199.291.00 1-1273EM3.44homo-trimer21 x NAG, 27 x NAG-NAG-MAN, 3 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.62
7sbl.1.A
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Delta variant spike protein
0.7099.291.00 1-1273EM3.44homo-trimer25 x NAG, 10 x NAG-NAG-MAN, 16 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.62
7sbl.1.B
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Delta variant spike protein
0.7299.291.00 1-1273EM3.44homo-trimer25 x NAG, 10 x NAG-NAG-MAN, 16 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.62
7sbl.1.C
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Delta variant spike protein
0.7199.291.00 1-1273EM3.44homo-trimer25 x NAG, 10 x NAG-NAG-MAN, 16 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.62
7sbo.1.A
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Delta variant spike protein
0.7099.291.00 1-1273EM3.44homo-trimer24 x NAG, 10 x NAG-NAG-MAN, 17 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.62
7sbo.1.B
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Delta variant spike protein
0.7199.291.00 1-1273EM3.44homo-trimer24 x NAG, 10 x NAG-NAG-MAN, 17 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.62
7sbo.1.C
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Delta variant spike protein
0.7199.291.00 1-1273EM3.44homo-trimer24 x NAG, 10 x NAG-NAG-MAN, 17 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.62
7n1t.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7199.291.00 1-1273EM3.44homo-trimer24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUCHHblits0.62
7n1t.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7199.291.00 1-1273EM3.44homo-trimer24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUCHHblits0.62
7n1t.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7199.291.00 1-1273EM3.44homo-trimer24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUCHHblits0.62
7n1q.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7499.291.00 1-1273EM3.44homo-trimer29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.62
7n1q.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7299.291.00 1-1273EM3.44homo-trimer29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.62
7n1q.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7299.291.00 1-1273EM3.44homo-trimer29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.62
7wg9.1.A
Spike glycoprotein
Delta Spike Trimer(1 RBD Up)
0.6899.211.00 1-1273EM0.00homo-trimer35 x NAG, 13 x NAG-NAGHHblits0.62
7wg9.1.B
Spike glycoprotein
Delta Spike Trimer(1 RBD Up)
0.6999.211.00 1-1273EM0.00homo-trimer35 x NAG, 13 x NAG-NAGHHblits0.62
7wg9.1.C
Spike glycoprotein
Delta Spike Trimer(1 RBD Up)
0.6899.211.00 1-1273EM0.00homo-trimer35 x NAG, 13 x NAG-NAGHHblits0.62
7wwl.1.A
Spike glycoprotein
S protein of Delta variant in complex with ZWD12
0.6898.821.00 1-1273EM0.00hetero-3-3-3-mer25 x NAG, 23 x NAG-NAGHHblits0.61
7wwl.1.C
Spike glycoprotein
S protein of Delta variant in complex with ZWD12
0.6998.821.00 1-1273EM0.00hetero-3-3-3-mer25 x NAG, 23 x NAG-NAGHHblits0.61
7wwl.1.B
Spike glycoprotein
S protein of Delta variant in complex with ZWD12
0.6898.821.00 1-1273EM0.00hetero-3-3-3-mer25 x NAG, 23 x NAG-NAGHHblits0.61
7wwm.1.A
Spike glycoprotein
S protein of Delta variant in complex with ZWC6
0.6898.821.00 1-1273EM0.00hetero-3-3-3-mer25 x NAG, 23 x NAG-NAGHHblits0.61
7wwm.1.B
Spike glycoprotein
S protein of Delta variant in complex with ZWC6
0.6898.821.00 1-1273EM0.00hetero-3-3-3-mer25 x NAG, 23 x NAG-NAGHHblits0.61
7wwm.1.C
Spike glycoprotein
S protein of Delta variant in complex with ZWC6
0.6898.821.00 1-1273EM0.00hetero-3-3-3-mer25 x NAG, 23 x NAG-NAGHHblits0.61
7n1u.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7398.981.00 1-1273EM0.00homo-trimer24 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7n1u.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7398.981.00 1-1273EM0.00homo-trimer24 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7n1u.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7398.981.00 1-1273EM0.00homo-trimer24 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7n1v.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7298.981.00 1-1273EM3.50homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7n1v.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7398.981.00 1-1273EM3.50homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7n1v.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7298.981.00 1-1273EM3.50homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7n1w.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7298.981.00 1-1273EM0.00homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7n1w.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7398.981.00 1-1273EM0.00homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7n1w.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7298.981.00 1-1273EM0.00homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7n1x.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7098.981.00 1-1273EM0.00homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7n1x.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7198.981.00 1-1273EM0.00homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7n1x.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7098.981.00 1-1273EM0.00homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7n1y.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.6998.981.00 1-1273EM0.00homo-trimer32 x NAG, 16 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7n1y.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7098.981.00 1-1273EM0.00homo-trimer32 x NAG, 16 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7n1y.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.6998.981.00 1-1273EM0.00homo-trimer32 x NAG, 16 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
8dt3.1.A
Spike glycoprotein
Cryo-EM structure of spike binding to Fab of neutralizing antibody (locally refined)
0.06100.000.99 12-1273EM0.00hetero-1-1-1-merBLAST0.62
6xra.1.A
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
0.10100.000.99 12-1273EM0.00homo-trimer9 x NAG, 6 x NAG-NAG, 6 x NAG-NAG-MAN-MAN, 3 x NAG-NAG-MANBLAST0.62
6xr8.1.A
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
0.72100.000.99 12-1273EM0.00homo-trimer21 x NAG, 21 x NAG-NAG-MAN, 9 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MAN-MANBLAST0.62
7cwn.1.A
Spike glycoprotein
P17-H014 Fab cocktail in complex with SARS-CoV-2 spike protein
0.69100.000.99 12-1273EM0.00hetero-3-3-3-3-3-mer16 x NAG, 15 x NAG-NAGBLAST0.62
7cwm.1.B
Spike glycoprotein
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state
0.69100.000.99 12-1273EM0.00hetero-3-3-3-mer16 x NAG, 14 x NAG-NAGBLAST0.62
7cwm.1.C
Spike glycoprotein
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state
0.69100.000.99 12-1273EM0.00hetero-3-3-3-mer16 x NAG, 14 x NAG-NAGBLAST0.62
7cwm.1.A
Spike glycoprotein
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state
0.68100.000.99 12-1273EM0.00hetero-3-3-3-mer16 x NAG, 14 x NAG-NAGBLAST0.62
7cwu.1.G
Spike glycoprotein
SARS-CoV-2 spike proteins trimer in complex with P17 and FC05 Fabs cocktail
0.69100.000.99 12-1273EM0.00hetero-3-3-3-3-3-mer16 x NAG, 15 x NAG-NAGBLAST0.62
7cwl.1.C
Spike glycoprotein
SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state
0.69100.000.99 12-1273EM0.00hetero-3-3-3-mer27 x NAGBLAST0.62
7cwl.1.A
Spike glycoprotein
SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state
0.69100.000.99 12-1273EM0.00hetero-3-3-3-mer27 x NAGBLAST0.62
7n64.1.B
Spike glycoprotein
SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction)
0.04100.000.99 12-1273EM0.00hetero-2-1-1-mer2 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.62
7n62.1.A
Spike glycoprotein
SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction)
0.07100.000.99 12-1273EM0.00hetero-1-1-1-mer5 x NAGBLAST0.62
7n64.1.A
Spike glycoprotein
SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction)
0.07100.000.99 12-1273EM0.00hetero-2-1-1-mer2 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.62
7fg3.1.A
Spike glycoprotein
Major cryo-EM structure of S protein trimer of SARS-CoV2 with K-874, composite map
0.56100.000.99 12-1273EM0.00hetero-1-1-merBLAST0.62
7fg7.1.A
Spike glycoprotein
Cryo-EM structure of S protein trimer of SARS-CoV2
0.60100.000.99 12-1273EM0.00monomerBLAST0.62
7fg2.1.A
Spike glycoprotein
Minor cryo-EM structure of S protein trimer of SARS-CoV2 with K-874A VHH, composite map
0.60100.000.99 12-1273EM0.00hetero-1-1-merBLAST0.62
7f3q.1.A
Spike glycoprotein
SARS-CoV-2 RBD in complex with A5-10 Fab and A34-2 Fab
0.03100.000.99 12-1273EM0.00hetero-1-1-1-1-1-mer1 x NAG, 1 x MESBLAST0.62
7krq.1.A
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
0.7199.920.99 12-1273EM3.44homo-trimer24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUCBLAST0.62
7krr.1.A
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
0.7299.920.99 12-1273EM3.50homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7krr.1.C
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
0.7199.920.99 12-1273EM3.50homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7krs.1.A
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
0.7199.920.99 12-1273EM3.20homo-trimer21 x NAG, 30 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MANBLAST0.62
7upy.1.C
Spike glycoprotein
One RBD-up state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab fragment
0.7299.920.99 12-1273EM3.10hetero-3-3-3-mer23 x NAG, 16 x NAG-NAG, 12 x NAG-NAG-MAN, 6 x NAG-NAG-FUCBLAST0.62
7upy.1.A
Spike glycoprotein
One RBD-up state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab fragment
0.7299.920.99 12-1273EM3.10hetero-3-3-3-mer23 x NAG, 16 x NAG-NAG, 12 x NAG-NAG-MAN, 6 x NAG-NAG-FUCBLAST0.62
7upy.1.B
Spike glycoprotein
One RBD-up state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab fragment
0.7399.920.99 12-1273EM3.10hetero-3-3-3-mer23 x NAG, 16 x NAG-NAG, 12 x NAG-NAG-MAN, 6 x NAG-NAG-FUCBLAST0.62
8gjm.1.A
Spike glycoprotein
17b10 fab in complex with full-length SARS-CoV-2 Spike G614 trimer
0.7299.920.99 12-1273EM0.00hetero-3-1-1-mer25 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 5 x NAG-NAG-MANBLAST0.62
8gjm.1.C
Spike glycoprotein
17b10 fab in complex with full-length SARS-CoV-2 Spike G614 trimer
0.7099.920.99 12-1273EM0.00hetero-3-1-1-mer25 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 5 x NAG-NAG-MANBLAST0.62
8gjm.1.B
Spike glycoprotein
17b10 fab in complex with full-length SARS-CoV-2 Spike G614 trimer
0.7299.920.99 12-1273EM0.00hetero-3-1-1-mer25 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 5 x NAG-NAG-MANBLAST0.62
6zwv.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: 3 Closed RBDs
0.6799.920.99 12-1273EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7d0d.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B
0.6999.840.99 12-1273EM0.00hetero-3-2-2-mer26 x NAG, 22 x NAG-NAGBLAST0.62
7ct5.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with T-ACE2
0.6899.840.99 12-1273EM0.00hetero-3-3-mer31 x NAG, 35 x NAG-NAGBLAST0.62
7c2l.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with 4A8
0.6699.840.99 12-1273EM0.00hetero-3-3-3-mer25 x NAG, 6 x NAG-NAG-NAG, 23 x NAG-NAGBLAST0.62
7c2l.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with 4A8
0.7099.840.99 12-1273EM0.00hetero-3-3-3-mer25 x NAG, 6 x NAG-NAG-NAG, 23 x NAG-NAGBLAST0.62
7c2l.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with 4A8
0.6999.840.99 12-1273EM0.00hetero-3-3-3-mer25 x NAG, 6 x NAG-NAG-NAG, 23 x NAG-NAGBLAST0.62
7ct5.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with T-ACE2
0.6899.840.99 12-1273EM0.00hetero-3-3-mer31 x NAG, 35 x NAG-NAGBLAST0.62
7czt.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G9
0.6999.840.99 12-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGBLAST0.62
7d0b.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B
0.6999.840.99 12-1273EM0.00hetero-3-1-1-mer27 x NAG, 21 x NAG-NAGBLAST0.62
7d00.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-1B8
0.6999.840.99 12-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGBLAST0.62
7czx.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B9
0.6999.840.99 12-1273EM0.00hetero-3-3-3-mer29 x NAG, 19 x NAG-NAGBLAST0.62
7d0d.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B
0.6999.840.99 12-1273EM0.00hetero-3-2-2-mer26 x NAG, 22 x NAG-NAGBLAST0.62
7czv.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B
0.6999.840.99 12-1273EM0.00hetero-3-3-3-mer28 x NAG, 20 x NAG-NAGBLAST0.62
7ct5.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with T-ACE2
0.6899.840.99 12-1273EM0.00hetero-3-3-mer31 x NAG, 35 x NAG-NAGBLAST0.62
7czw.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G7
0.6999.840.99 12-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGBLAST0.62
7czs.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B
0.6999.840.99 12-1273EM0.00hetero-3-3-3-mer28 x NAG, 20 x NAG-NAGBLAST0.62
7czp.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A1
0.6999.840.99 12-1273EM0.00hetero-3-2-2-mer27 x NAG, 23 x NAG-NAGBLAST0.62
7czw.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G7
0.6999.840.99 12-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGBLAST0.62
7d0b.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B
0.6999.840.99 12-1273EM0.00hetero-3-1-1-mer27 x NAG, 21 x NAG-NAGBLAST0.62
7czp.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A1
0.6999.840.99 12-1273EM0.00hetero-3-2-2-mer27 x NAG, 23 x NAG-NAGBLAST0.62
7d0c.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3A1
0.6899.840.99 12-1273EM0.00hetero-3-2-2-mer26 x NAG, 22 x NAG-NAGBLAST0.62
7d03.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-2G7
0.6999.840.99 12-1273EM0.00hetero-3-1-1-mer28 x NAG, 20 x NAG-NAGBLAST0.62
7czx.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B9
0.6999.840.99 12-1273EM0.00hetero-3-3-3-mer29 x NAG, 19 x NAG-NAGBLAST0.62
7d0d.1.G
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B
0.6999.840.99 12-1273EM0.00hetero-3-2-2-mer26 x NAG, 22 x NAG-NAGBLAST0.62
7d00.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-1B8
0.6999.840.99 12-1273EM0.00hetero-3-2-2-mer27 x NAG, 21 x NAG-NAGBLAST0.62
7czx.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B9
0.6999.840.99 12-1273EM0.00hetero-3-3-3-mer29 x NAG, 19 x NAG-NAGBLAST0.62
7dwx.1.H
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
0.6999.840.99 12-1273EM0.00hetero-2-2-6-mer62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAGBLAST0.62
7dwy.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in the locked conformation
0.7299.840.99 12-1273EM0.00homo-trimer47 x NAG, 3 x EIC, 11 x NAG-NAGBLAST0.62
7dwz.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in the active conformation
0.6999.840.99 12-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGBLAST0.62
7dx7.1.A
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound)
0.6999.840.99 12-1273EM0.00hetero-3-1-mer27 x NAG, 27 x NAG-NAGBLAST0.62
7dwx.1.E
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
0.6999.840.99 12-1273EM0.00hetero-2-2-6-mer62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAGBLAST0.62
7dx7.1.C
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound)
0.6799.840.99 12-1273EM0.00hetero-3-1-mer27 x NAG, 27 x NAG-NAGBLAST0.62
7dwx.1.F
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
0.6999.840.99 12-1273EM0.00hetero-2-2-6-mer62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAGBLAST0.62
7dx9.1.B
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and 2 PD bound)
0.6999.840.99 12-1273EM0.00hetero-3-2-mer28 x NAG, 32 x NAG-NAGBLAST0.62
8cya.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67
0.6499.840.99 12-1273EM0.00hetero-3-3-mer32 x NAG, 14 x NAG-NAG-BMA, 4 x NAG-NAG, 2 x NAG-NAG-FUCBLAST0.62
7l7k.1.A
Spike glycoprotein
Cryo-EM structure of protein encoded by vaccine candidate BNT162b2
0.6899.840.99 12-1273EM0.00homo-trimerBLAST0.62
8cxq.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-22
0.6799.840.99 12-1273EM0.00hetero-3-3-merBLAST0.62
8cy7.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
0.6199.840.99 12-1273EM0.00hetero-3-3-mer31 x NAG, 12 x NAG-NAGBLAST0.62
8cyc.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
0.6599.840.99 12-1273EM0.00hetero-3-3-merBLAST0.62
8cxn.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57
0.6399.840.99 12-1273EM0.00hetero-3-3-mer28 x NAGBLAST0.62
8cy6.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-65
0.6899.840.99 12-1273EM0.00hetero-3-3-merBLAST0.62
7l7k.1.B
Spike glycoprotein
Cryo-EM structure of protein encoded by vaccine candidate BNT162b2
0.6899.840.99 12-1273EM0.00homo-trimerBLAST0.62
8cyb.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8
0.6799.840.99 12-1273EM0.00hetero-3-1-mer32 x NAG, 4 x NAG-NAG, 7 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-FUC-GAL-FUC-NAG-BMA, 7 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN, 1 x NAG-FUC-NAGBLAST0.62
8cyb.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8
0.6799.840.99 12-1273EM0.00hetero-3-1-mer32 x NAG, 4 x NAG-NAG, 7 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-FUC-GAL-FUC-NAG-BMA, 7 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN, 1 x NAG-FUC-NAGBLAST0.62
8cy9.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-23
0.6699.840.99 12-1273EM0.00hetero-3-3-merBLAST0.62
8cy6.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-65
0.6899.840.99 12-1273EM0.00hetero-3-3-merBLAST0.62
8cy7.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
0.6199.840.99 12-1273EM0.00hetero-3-3-mer31 x NAG, 12 x NAG-NAGBLAST0.62
8cxq.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-22
0.6899.840.99 12-1273EM0.00hetero-3-3-merBLAST0.62
8cy6.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-65
0.6899.840.99 12-1273EM0.00hetero-3-3-merBLAST0.62
8cyc.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
0.6499.840.99 12-1273EM0.00hetero-3-3-merBLAST0.62
8cxn.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57
0.6399.840.99 12-1273EM0.00hetero-3-3-mer28 x NAGBLAST0.62
8cyb.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8
0.6799.840.99 12-1273EM0.00hetero-3-1-mer32 x NAG, 4 x NAG-NAG, 7 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-FUC-GAL-FUC-NAG-BMA, 7 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN, 1 x NAG-FUC-NAGBLAST0.62
8cxq.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-22
0.6799.840.99 12-1273EM0.00hetero-3-3-merBLAST0.62
8cyj.1.E
Spike glycoprotein
RBD of SARS-CoV-2 Spike protein in complex with pan-sarbecovirus nanobodies 2-10, 2-67, 2-62 and 1-25
0.0299.840.99 12-1273EM0.00hetero-1-1-1-1-1-merBLAST0.62
8cy7.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
0.6199.840.99 12-1273EM0.00hetero-3-3-mer31 x NAG, 12 x NAG-NAGBLAST0.62
8cy9.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-23
0.6699.840.99 12-1273EM0.00hetero-3-3-merBLAST0.62
8cyc.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
0.6699.840.99 12-1273EM0.00hetero-3-3-merBLAST0.62
8cxn.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57
0.6599.840.99 12-1273EM0.00hetero-3-3-mer28 x NAGBLAST0.62
8cy9.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-23
0.6499.840.99 12-1273EM0.00hetero-3-3-merBLAST0.62
7dx1.1.A
Spike glycoprotein
S protein of SARS-CoV-2 D614G mutant
0.6899.760.99 12-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGBLAST0.62
7dx1.1.B
Spike glycoprotein
S protein of SARS-CoV-2 D614G mutant
0.6799.760.99 12-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGBLAST0.62
7dx1.1.C
Spike glycoprotein
S protein of SARS-CoV-2 D614G mutant
0.6799.760.99 12-1273EM0.00homo-trimer26 x NAG, 22 x NAG-NAGBLAST0.62
7jji.1.A
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length prefusion spike trimer (C3 symmetry)
0.6999.600.99 12-1273EM0.00homo-trimer3 x NAG, 3 x VCG, 3 x EIC, 45 x NAG-NAGBLAST0.62
7x08.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex with 2G1
0.7299.520.99 12-1273EM0.00hetero-3-3-3-mer30 x NAG, 3 x EIC, 24 x NAG-NAGBLAST0.62
7epx.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex with GW01
0.6999.520.99 12-1273EM0.00hetero-3-2-2-mer25 x NAG, 23 x NAG-NAGBLAST0.62
7epx.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex with GW01
0.6999.520.99 12-1273EM0.00hetero-3-2-2-mer25 x NAG, 23 x NAG-NAGBLAST0.62
7epx.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex with GW01
0.6799.520.99 12-1273EM0.00hetero-3-2-2-mer25 x NAG, 23 x NAG-NAGBLAST0.62
7sbp.1.A
Spike glycoprotein
Closed state of pre-fusion SARS-CoV-2 Kappa variant spike protein
0.7299.370.99 12-1273EM3.44homo-trimer21 x NAG, 6 x NAG-NAG, 27 x NAG-NAG-MAN, 3 x NAG-NAG-FUCBLAST0.62
7sbq.1.A
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Kappa variant spike protein
0.7199.370.99 12-1273EM3.50homo-trimer24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MANBLAST0.62
7sbq.1.B
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Kappa variant spike protein
0.7299.370.99 12-1273EM3.50homo-trimer24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MANBLAST0.62
7sbq.1.C
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Kappa variant spike protein
0.7199.370.99 12-1273EM3.50homo-trimer24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MANBLAST0.62
7sbr.1.A
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Kappa variant spike protein
0.7199.370.99 12-1273EM3.50homo-trimer24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MANBLAST0.62
7sbr.1.B
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Kappa variant spike protein
0.7299.370.99 12-1273EM3.50homo-trimer24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MANBLAST0.62
7sbr.1.C
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Kappa variant spike protein
0.7199.370.99 12-1273EM3.50homo-trimer24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MANBLAST0.62
7sbs.1.A
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Gamma variant spike protein
0.6999.050.99 12-1273EM3.50homo-trimer29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7sbs.1.B
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Gamma variant spike protein
0.7099.050.99 12-1273EM3.50homo-trimer29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7sbs.1.C
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Gamma variant spike protein
0.6999.050.99 12-1273EM3.50homo-trimer29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7sbt.1.A
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Gamma variant spike protein
0.6999.050.99 12-1273EM3.50homo-trimer28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 9 x NAG-NAG-MANBLAST0.62
7sbt.1.B
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Gamma variant spike protein
0.7099.050.99 12-1273EM3.50homo-trimer28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 9 x NAG-NAG-MANBLAST0.62
7sbt.1.C
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Gamma variant spike protein
0.7099.050.99 12-1273EM3.50homo-trimer28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 9 x NAG-NAG-MANBLAST0.62
7sbk.1.A
Spike glycoprotein
Closed state of pre-fusion SARS-CoV-2 Delta variant spike protein
0.7199.370.99 12-1273EM3.44homo-trimer21 x NAG, 27 x NAG-NAG-MAN, 3 x NAG-NAG, 3 x NAG-NAG-FUCBLAST0.62
7sbl.1.A
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Delta variant spike protein
0.7099.370.99 12-1273EM3.44homo-trimer25 x NAG, 10 x NAG-NAG-MAN, 16 x NAG-NAG, 3 x NAG-NAG-FUCBLAST0.62
7sbl.1.B
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Delta variant spike protein
0.7299.370.99 12-1273EM3.44homo-trimer25 x NAG, 10 x NAG-NAG-MAN, 16 x NAG-NAG, 3 x NAG-NAG-FUCBLAST0.62
7sbl.1.C
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Delta variant spike protein
0.7199.370.99 12-1273EM3.44homo-trimer25 x NAG, 10 x NAG-NAG-MAN, 16 x NAG-NAG, 3 x NAG-NAG-FUCBLAST0.62
7sbo.1.A
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Delta variant spike protein
0.7099.370.99 12-1273EM3.44homo-trimer24 x NAG, 10 x NAG-NAG-MAN, 17 x NAG-NAG, 3 x NAG-NAG-FUCBLAST0.62
7sbo.1.B
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Delta variant spike protein
0.7199.370.99 12-1273EM3.44homo-trimer24 x NAG, 10 x NAG-NAG-MAN, 17 x NAG-NAG, 3 x NAG-NAG-FUCBLAST0.62
7sbo.1.C
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Delta variant spike protein
0.7199.370.99 12-1273EM3.44homo-trimer24 x NAG, 10 x NAG-NAG-MAN, 17 x NAG-NAG, 3 x NAG-NAG-FUCBLAST0.62
7n1t.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7199.360.99 12-1273EM3.44homo-trimer24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUCBLAST0.62
7n1q.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7499.360.99 12-1273EM3.44homo-trimer29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7n1q.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7299.360.99 12-1273EM3.44homo-trimer29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7n1q.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7299.360.99 12-1273EM3.44homo-trimer29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7wg9.1.A
Spike glycoprotein
Delta Spike Trimer(1 RBD Up)
0.6899.290.99 12-1273EM0.00homo-trimer35 x NAG, 13 x NAG-NAGBLAST0.62
7wg9.1.B
Spike glycoprotein
Delta Spike Trimer(1 RBD Up)
0.6999.290.99 12-1273EM0.00homo-trimer35 x NAG, 13 x NAG-NAGBLAST0.62
7wg9.1.C
Spike glycoprotein
Delta Spike Trimer(1 RBD Up)
0.6999.290.99 12-1273EM0.00homo-trimer35 x NAG, 13 x NAG-NAGBLAST0.62
7n1u.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7399.440.99 12-1273EM0.00homo-trimer24 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7n1v.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7299.440.99 12-1273EM3.50homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7n1v.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7399.440.99 12-1273EM3.50homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7n1v.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7299.440.99 12-1273EM3.50homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7n1w.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7299.440.99 12-1273EM0.00homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7n1w.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7399.440.99 12-1273EM0.00homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7n1w.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7299.440.99 12-1273EM0.00homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7n1x.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7099.440.99 12-1273EM0.00homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7n1x.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7199.440.99 12-1273EM0.00homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7n1x.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7099.440.99 12-1273EM0.00homo-trimer28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7n1y.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.6999.440.99 12-1273EM0.00homo-trimer32 x NAG, 16 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7n1y.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.7099.440.99 12-1273EM0.00homo-trimer32 x NAG, 16 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7n1y.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
0.6999.440.99 12-1273EM0.00homo-trimer32 x NAG, 16 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.62
7wwl.1.A
Spike glycoprotein
S protein of Delta variant in complex with ZWD12
0.6898.890.99 12-1273EM0.00hetero-3-3-3-mer25 x NAG, 23 x NAG-NAGBLAST0.61
7wwl.1.B
Spike glycoprotein
S protein of Delta variant in complex with ZWD12
0.6998.890.99 12-1273EM0.00hetero-3-3-3-mer25 x NAG, 23 x NAG-NAGBLAST0.61
7wwm.1.A
Spike glycoprotein
S protein of Delta variant in complex with ZWC6
0.6898.890.99 12-1273EM0.00hetero-3-3-3-mer25 x NAG, 23 x NAG-NAGBLAST0.61
7wwm.1.B
Spike glycoprotein
S protein of Delta variant in complex with ZWC6
0.6898.890.99 12-1273EM0.00hetero-3-3-3-mer25 x NAG, 23 x NAG-NAGBLAST0.61
7wwm.1.C
Spike glycoprotein
S protein of Delta variant in complex with ZWC6
0.6898.890.99 12-1273EM0.00hetero-3-3-3-mer25 x NAG, 23 x NAG-NAGBLAST0.61
7x6a.1.A
Spike glycoprotein
SARS-CoV-2 BA.2 variant spike protein in complex with Fab BD55-5840
0.6597.091.00 1-1273EM0.00hetero-3-3-3-merHHblits0.61
7x6a.1.B
Spike glycoprotein
SARS-CoV-2 BA.2 variant spike protein in complex with Fab BD55-5840
0.6597.091.00 1-1273EM0.00hetero-3-3-3-merHHblits0.61
7xiw.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 variant spike (state 1)
0.6597.091.00 1-1273EM3.62homo-trimer29 x NAG, 13 x NAG-NAGHHblits0.61
7x6a.1.C
Spike glycoprotein
SARS-CoV-2 BA.2 variant spike protein in complex with Fab BD55-5840
0.6397.091.00 1-1273EM0.00hetero-3-3-3-merHHblits0.61
7xiw.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 variant spike (state 1)
0.6397.091.00 1-1273EM3.62homo-trimer29 x NAG, 13 x NAG-NAGHHblits0.61
7xiw.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 variant spike (state 1)
0.6597.091.00 1-1273EM3.62homo-trimer29 x NAG, 13 x NAG-NAGHHblits0.61
7xix.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 variant spike (state 2)
0.6797.091.00 1-1273EM0.00homo-trimer30 x NAG, 18 x NAG-NAGHHblits0.61
7xix.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 variant spike (state 2)
0.6797.091.00 1-1273EM0.00homo-trimer30 x NAG, 18 x NAG-NAGHHblits0.61
7xix.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 variant spike (state 2)
0.6797.091.00 1-1273EM0.00homo-trimer30 x NAG, 18 x NAG-NAGHHblits0.61
7xnr.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2.13 variant spike
0.6497.011.00 1-1273EM0.00homo-trimer27 x NAG, 15 x NAG-NAGHHblits0.61
7xnr.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2.13 variant spike
0.6497.011.00 1-1273EM0.00homo-trimer27 x NAG, 15 x NAG-NAGHHblits0.61
7xnr.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.2.13 variant spike
0.6597.011.00 1-1273EM0.00homo-trimer27 x NAG, 15 x NAG-NAGHHblits0.61
7xo7.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
0.6796.931.00 1-1273EM0.00hetero-3-2-mer39 x NAG, 2 x ZNHHblits0.61
7xoa.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with one mouse ACE2 Bound
0.6696.931.00 1-1273EM0.00hetero-3-1-mer34 x NAG, 1 x ZNHHblits0.61
7xoa.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with one mouse ACE2 Bound
0.6796.931.00 1-1273EM0.00hetero-3-1-mer34 x NAG, 1 x ZNHHblits0.61
7xob.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two mouse ACE2 Bound
0.6796.931.00 1-1273EM0.00hetero-3-2-mer37 x NAG, 2 x ZNHHblits0.61
7xo7.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
0.6896.931.00 1-1273EM0.00hetero-3-2-mer39 x NAG, 2 x ZNHHblits0.61
7xo8.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three human ACE2 Bound
0.6896.931.00 1-1273EM0.00hetero-3-3-mer39 x NAG, 3 x ZNHHblits0.61
7xo9.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant RBD complexed with human ACE2
0.0296.931.00 1-1273EM0.00hetero-1-1-mer1 x ZN, 3 x NAGHHblits0.61
7xo7.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
0.6796.931.00 1-1273EM0.00hetero-3-2-mer39 x NAG, 2 x ZNHHblits0.61
7xo8.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three human ACE2 Bound
0.6896.931.00 1-1273EM0.00hetero-3-3-mer39 x NAG, 3 x ZNHHblits0.61
7xo8.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three human ACE2 Bound
0.6896.931.00 1-1273EM0.00hetero-3-3-mer39 x NAG, 3 x ZNHHblits0.61
7xoa.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with one mouse ACE2 Bound
0.6996.931.00 1-1273EM0.00hetero-3-1-mer34 x NAG, 1 x ZNHHblits0.61
7xob.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two mouse ACE2 Bound
0.6996.931.00 1-1273EM0.00hetero-3-2-mer37 x NAG, 2 x ZNHHblits0.61
7xob.1.D
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two mouse ACE2 Bound
0.6996.931.00 1-1273EM0.00hetero-3-2-mer37 x NAG, 2 x ZNHHblits0.61
7xoc.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant RBD complexed with mouse ACE2
0.0296.931.00 1-1273EM0.00hetero-1-1-mer1 x ZN, 2 x NAG, 1 x NAG-NAGHHblits0.61
7xod.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three JMB2002 Fab Bound
0.6896.931.00 1-1273EM0.00hetero-3-3-3-3-mer35 x NAG, 2 x NAG-NAGHHblits0.61
7xod.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three JMB2002 Fab Bound
0.6796.931.00 1-1273EM0.00hetero-3-3-3-3-mer35 x NAG, 2 x NAG-NAGHHblits0.61
7xod.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three JMB2002 Fab Bound
0.7096.931.00 1-1273EM0.00hetero-3-3-3-3-mer35 x NAG, 2 x NAG-NAGHHblits0.61
7xns.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.4 variant spike
0.6496.851.00 1-1273EM0.00homo-trimer30 x NAG, 18 x NAG-NAGHHblits0.61
7xns.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.4 variant spike
0.6496.851.00 1-1273EM0.00homo-trimer30 x NAG, 18 x NAG-NAGHHblits0.61
7xns.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.4 variant spike
0.6496.851.00 1-1273EM0.00homo-trimer30 x NAG, 18 x NAG-NAGHHblits0.61
7we7.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv282
0.6996.851.00 1-1273EM0.00hetero-3-3-3-mer27 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7we7.1.D
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv282
0.6996.851.00 1-1273EM0.00hetero-3-3-3-mer27 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7we7.1.E
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv282
0.6796.851.00 1-1273EM0.00hetero-3-3-3-mer27 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7we8.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265
0.6696.851.00 1-1273EM0.00hetero-3-1-1-mer26 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7we8.1.B
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265
0.6496.851.00 1-1273EM0.00hetero-3-1-1-mer26 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7we8.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265
0.6596.851.00 1-1273EM0.00hetero-3-1-1-mer26 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7we9.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv289
0.6196.851.00 1-1273EM0.00hetero-3-3-3-mer27 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7we9.1.B
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv289
0.6396.851.00 1-1273EM0.00hetero-3-3-3-mer27 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7we9.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv289
0.6196.851.00 1-1273EM0.00hetero-3-3-3-mer27 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7wea.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with two XGv347 binding to one close state RBD and one open state RBD
0.6796.851.00 1-1273EM0.00hetero-3-2-2-mer29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7wea.1.B
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with two XGv347 binding to one close state RBD and one open state RBD
0.6596.851.00 1-1273EM0.00hetero-3-2-2-mer29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7wea.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with two XGv347 binding to one close state RBD and one open state RBD
0.6896.851.00 1-1273EM0.00hetero-3-2-2-mer29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7web.1.E
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with two XGv347 binding to two open state RBDs
0.6596.851.00 1-1273EM0.00hetero-2-2-3-mer29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7web.1.F
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with two XGv347 binding to two open state RBDs
0.6796.851.00 1-1273EM0.00hetero-2-2-3-mer29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7web.1.G
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with two XGv347 binding to two open state RBDs
0.6896.851.00 1-1273EM0.00hetero-2-2-3-mer29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7wec.1.G
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with three XGv347 Fabs binding to three closed state RBDs
0.6996.851.00 1-1273EM0.00hetero-3-3-3-mer31 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7wec.1.H
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with three XGv347 Fabs binding to three closed state RBDs
0.6796.851.00 1-1273EM0.00hetero-3-3-3-mer31 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7wec.1.I
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with three XGv347 Fabs binding to three closed state RBDs
0.6896.851.00 1-1273EM0.00hetero-3-3-3-mer31 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7wee.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv265
0.0596.851.00 1-1273EM0.00hetero-1-1-1-merHHblits0.61
7tnw.1.A
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
0.7196.771.00 1-1273EM0.00homo-trimer21 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUCHHblits0.61
7tnw.1.B
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
0.7196.771.00 1-1273EM0.00homo-trimer21 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUCHHblits0.61
7tnw.1.C
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
0.7196.771.00 1-1273EM0.00homo-trimer21 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUCHHblits0.61
7to4.1.A
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
0.7196.771.00 1-1273EM0.00homo-trimer25 x NAG, 11 x NAG-NAG, 3 x NAG-NAG-FUC, 15 x NAG-NAG-MANHHblits0.61
7to4.1.B
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
0.7196.771.00 1-1273EM0.00homo-trimer25 x NAG, 11 x NAG-NAG, 3 x NAG-NAG-FUC, 15 x NAG-NAG-MANHHblits0.61
7to4.1.C
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
0.7196.771.00 1-1273EM0.00homo-trimer25 x NAG, 11 x NAG-NAG, 3 x NAG-NAG-FUC, 15 x NAG-NAG-MANHHblits0.61
7xnq.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.4 variant spike
0.6396.691.00 1-1273EM0.00homo-trimer33 x NAG, 18 x NAG-NAGHHblits0.61
7xnq.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.4 variant spike
0.6396.691.00 1-1273EM0.00homo-trimer33 x NAG, 18 x NAG-NAGHHblits0.61
7xnq.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.4 variant spike
0.6396.691.00 1-1273EM0.00homo-trimer33 x NAG, 18 x NAG-NAGHHblits0.61
7wgb.1.A
Spike glycoprotein
Neutral Omicron Spike Trimer in complex with ACE2
0.6796.691.00 1-1273EM0.00hetero-3-2-mer33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7wgb.1.B
Spike glycoprotein
Neutral Omicron Spike Trimer in complex with ACE2
0.6896.691.00 1-1273EM0.00hetero-3-2-mer33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7wgb.1.C
Spike glycoprotein
Neutral Omicron Spike Trimer in complex with ACE2
0.6696.691.00 1-1273EM0.00hetero-3-2-mer33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7wg7.1.A
Spike glycoprotein
Acidic Omicron Spike Trimer
0.6296.451.00 1-1273EM0.00homo-trimer28 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.60
7wg7.1.B
Spike glycoprotein
Acidic Omicron Spike Trimer
0.6496.451.00 1-1273EM0.00homo-trimer28 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.60
7wg7.1.C
Spike glycoprotein
Acidic Omicron Spike Trimer
0.6196.451.00 1-1273EM0.00homo-trimer28 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.60
7wgc.1.B
Spike glycoprotein
Neutral Omicron Spike Trimer in complex with ACE2.
0.0396.451.00 1-1273EM0.00hetero-1-1-mer5 x NAGHHblits0.60
7xiy.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.3 variant spike
0.6696.611.00 1-1273EM0.00homo-trimer23 x NAG, 12 x NAG-NAGHHblits0.60
7xiy.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.3 variant spike
0.6696.611.00 1-1273EM0.00homo-trimer23 x NAG, 12 x NAG-NAGHHblits0.60
7xiy.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.3 variant spike
0.6696.611.00 1-1273EM0.00homo-trimer23 x NAG, 12 x NAG-NAGHHblits0.60
7yqw.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down)
0.6796.291.00 1-1273EM3.51homo-trimer33 x NAG, 6 x NAG-NAG-BMA, 9 x NAG-NAGHHblits0.60
7yqw.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down)
0.6796.291.00 1-1273EM3.51homo-trimer33 x NAG, 6 x NAG-NAG-BMA, 9 x NAG-NAGHHblits0.60
7yqw.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down)
0.6796.291.00 1-1273EM3.51homo-trimer33 x NAG, 6 x NAG-NAG-BMA, 9 x NAG-NAGHHblits0.60
7yqt.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
0.6496.291.00 1-1273EM0.00homo-trimer45 x NAG, 9 x NAG-NAGHHblits0.60
7yqt.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
0.6596.291.00 1-1273EM0.00homo-trimer45 x NAG, 9 x NAG-NAGHHblits0.60
7yqv.1.A
Spike glycoprotein
pH 5.5 SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
0.6296.291.00 1-1273EM0.00homo-trimer44 x NAG, 9 x NAG-NAGHHblits0.60
7yqv.1.B
Spike glycoprotein
pH 5.5 SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
0.6496.291.00 1-1273EM0.00homo-trimer44 x NAG, 9 x NAG-NAGHHblits0.60
7yqv.1.C
Spike glycoprotein
pH 5.5 SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
0.6496.291.00 1-1273EM0.00homo-trimer44 x NAG, 9 x NAG-NAGHHblits0.60
7yqt.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
0.6496.291.00 1-1273EM0.00homo-trimer45 x NAG, 9 x NAG-NAGHHblits0.60
7yqx.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1)
0.6396.291.00 1-1273EM3.72hetero-3-2-2-mer45 x NAG, 9 x NAG-NAG, 2 x NAG-NAG-BMA-FUCHHblits0.60
7yqx.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1)
0.6396.291.00 1-1273EM3.72hetero-3-2-2-mer45 x NAG, 9 x NAG-NAG, 2 x NAG-NAG-BMA-FUCHHblits0.60
7yqx.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1)
0.6496.291.00 1-1273EM3.72hetero-3-2-2-mer45 x NAG, 9 x NAG-NAG, 2 x NAG-NAG-BMA-FUCHHblits0.60
7yqy.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2)
0.6496.291.00 1-1273EM3.74hetero-3-3-3-mer44 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMA-FUCHHblits0.60
7yqy.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2)
0.6296.291.00 1-1273EM3.74hetero-3-3-3-mer44 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMA-FUCHHblits0.60
7yqy.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2)
0.6496.291.00 1-1273EM3.74hetero-3-3-3-mer44 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMA-FUCHHblits0.60
7yqz.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3)
0.6596.291.00 1-1273EM3.84hetero-3-2-2-mer45 x NAG, 2 x NAG-NAG-BMA-FUCHHblits0.60
7yqz.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3)
0.6596.291.00 1-1273EM3.84hetero-3-2-2-mer45 x NAG, 2 x NAG-NAG-BMA-FUCHHblits0.60
7yqz.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3)
0.6696.291.00 1-1273EM3.84hetero-3-2-2-mer45 x NAG, 2 x NAG-NAG-BMA-FUCHHblits0.60
7yr1.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024
0.6696.291.00 1-1273EM0.00hetero-3-3-3-mer24 x NAG, 15 x NAG-NAG, 9 x NAG-NAG-BMAHHblits0.60
7yr1.1.D
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024
0.6696.291.00 1-1273EM0.00hetero-3-3-3-mer24 x NAG, 15 x NAG-NAG, 9 x NAG-NAG-BMAHHblits0.60
7yr1.1.G
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024
0.6696.291.00 1-1273EM0.00hetero-3-3-3-mer24 x NAG, 15 x NAG-NAG, 9 x NAG-NAG-BMAHHblits0.60
7yr2.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
0.6496.291.00 1-1273EM3.30hetero-1-3-mer1 x ZN, 48 x NAG, 9 x NAG-NAGHHblits0.60
7yr2.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
0.6596.291.00 1-1273EM3.30hetero-1-3-mer1 x ZN, 48 x NAG, 9 x NAG-NAGHHblits0.60
7yr2.1.D
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
0.6796.291.00 1-1273EM3.30hetero-1-3-mer1 x ZN, 48 x NAG, 9 x NAG-NAGHHblits0.60
7yr3.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
0.6596.291.00 1-1273EM3.52hetero-3-2-mer45 x NAG, 2 x ZN, 9 x NAG-NAGHHblits0.60
7yr3.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
0.6696.291.00 1-1273EM3.52hetero-3-2-mer45 x NAG, 2 x ZN, 9 x NAG-NAGHHblits0.60
7yr3.1.D
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
0.6696.291.00 1-1273EM3.52hetero-3-2-mer45 x NAG, 2 x ZN, 9 x NAG-NAGHHblits0.60
7yqu.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down)
0.6896.291.00 1-1273EM3.19homo-trimer36 x NAG, 6 x NAG-NAGHHblits0.60
7yqu.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down)
0.6896.291.00 1-1273EM3.19homo-trimer36 x NAG, 6 x NAG-NAGHHblits0.60
7yqu.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down)
0.6896.291.00 1-1273EM3.19homo-trimer36 x NAG, 6 x NAG-NAGHHblits0.60
7wti.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv264
0.6596.211.00 1-1273EM0.00hetero-3-3-3-mer36 x NAGHHblits0.60
7wti.1.B
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv264
0.6396.211.00 1-1273EM0.00hetero-3-3-3-mer36 x NAGHHblits0.60
7wti.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv264
0.6296.211.00 1-1273EM0.00hetero-3-3-3-mer36 x NAGHHblits0.60
7we7.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv282
0.6997.690.99 12-1273EM0.00hetero-3-3-3-mer27 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7we7.1.D
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv282
0.6997.690.99 12-1273EM0.00hetero-3-3-3-mer27 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7we7.1.E
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv282
0.6797.690.99 12-1273EM0.00hetero-3-3-3-mer27 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7we8.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265
0.6697.690.99 12-1273EM0.00hetero-3-1-1-mer26 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7we8.1.B
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265
0.6497.690.99 12-1273EM0.00hetero-3-1-1-mer26 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7we8.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265
0.6597.690.99 12-1273EM0.00hetero-3-1-1-mer26 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7we9.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv289
0.6197.690.99 12-1273EM0.00hetero-3-3-3-mer27 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7we9.1.B
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv289
0.6397.690.99 12-1273EM0.00hetero-3-3-3-mer27 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7we9.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv289
0.6197.690.99 12-1273EM0.00hetero-3-3-3-mer27 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7wea.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with two XGv347 binding to one close state RBD and one open state RBD
0.6797.690.99 12-1273EM0.00hetero-3-2-2-mer29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7wea.1.B
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with two XGv347 binding to one close state RBD and one open state RBD
0.6597.690.99 12-1273EM0.00hetero-3-2-2-mer29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7wea.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with two XGv347 binding to one close state RBD and one open state RBD
0.6897.690.99 12-1273EM0.00hetero-3-2-2-mer29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7web.1.E
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with two XGv347 binding to two open state RBDs
0.6597.690.99 12-1273EM0.00hetero-2-2-3-mer29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7web.1.F
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with two XGv347 binding to two open state RBDs
0.6797.690.99 12-1273EM0.00hetero-2-2-3-mer29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7web.1.G
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with two XGv347 binding to two open state RBDs
0.6897.690.99 12-1273EM0.00hetero-2-2-3-mer29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7wec.1.G
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with three XGv347 Fabs binding to three closed state RBDs
0.6997.690.99 12-1273EM0.00hetero-3-3-3-mer31 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7wec.1.H
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with three XGv347 Fabs binding to three closed state RBDs
0.6797.690.99 12-1273EM0.00hetero-3-3-3-mer31 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7wec.1.I
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with three XGv347 Fabs binding to three closed state RBDs
0.6797.690.99 12-1273EM0.00hetero-3-3-3-mer31 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7wee.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv265
0.0497.690.99 12-1273EM0.00hetero-1-1-1-merBLAST0.61
7x6a.1.A
Spike glycoprotein
SARS-CoV-2 BA.2 variant spike protein in complex with Fab BD55-5840
0.6597.140.99 12-1273EM0.00hetero-3-3-3-merBLAST0.61
7x6a.1.C
Spike glycoprotein
SARS-CoV-2 BA.2 variant spike protein in complex with Fab BD55-5840
0.6397.140.99 12-1273EM0.00hetero-3-3-3-merBLAST0.61
7xiw.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 variant spike (state 1)
0.6597.140.99 12-1273EM3.62homo-trimer29 x NAG, 13 x NAG-NAGBLAST0.61
7xix.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 variant spike (state 2)
0.6697.140.99 12-1273EM0.00homo-trimer30 x NAG, 18 x NAG-NAGBLAST0.61
7tnw.1.A
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
0.7197.530.99 12-1273EM0.00homo-trimer21 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUCBLAST0.61
7to4.1.A
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
0.7197.530.99 12-1273EM0.00homo-trimer25 x NAG, 11 x NAG-NAG, 3 x NAG-NAG-FUC, 15 x NAG-NAG-MANBLAST0.61
7to4.1.B
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
0.7197.530.99 12-1273EM0.00homo-trimer25 x NAG, 11 x NAG-NAG, 3 x NAG-NAG-FUC, 15 x NAG-NAG-MANBLAST0.61
7to4.1.C
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
0.7197.530.99 12-1273EM0.00homo-trimer25 x NAG, 11 x NAG-NAG, 3 x NAG-NAG-FUC, 15 x NAG-NAG-MANBLAST0.61
7xnr.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2.13 variant spike
0.6497.060.99 12-1273EM0.00homo-trimer27 x NAG, 15 x NAG-NAGBLAST0.61
7xo7.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
0.6797.060.99 12-1273EM0.00hetero-3-2-mer39 x NAG, 2 x ZNBLAST0.61
7xo7.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
0.6797.060.99 12-1273EM0.00hetero-3-2-mer39 x NAG, 2 x ZNBLAST0.61
7xo7.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
0.6797.060.99 12-1273EM0.00hetero-3-2-mer39 x NAG, 2 x ZNBLAST0.61
7xo8.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three human ACE2 Bound
0.6897.060.99 12-1273EM0.00hetero-3-3-mer39 x NAG, 3 x ZNBLAST0.61
7xoa.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with one mouse ACE2 Bound
0.6897.060.99 12-1273EM0.00hetero-3-1-mer34 x NAG, 1 x ZNBLAST0.61
7xod.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three JMB2002 Fab Bound
0.6797.060.99 12-1273EM0.00hetero-3-3-3-3-mer35 x NAG, 2 x NAG-NAGBLAST0.61
7xod.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three JMB2002 Fab Bound
0.6797.060.99 12-1273EM0.00hetero-3-3-3-3-mer35 x NAG, 2 x NAG-NAGBLAST0.61
7xod.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three JMB2002 Fab Bound
0.7097.060.99 12-1273EM0.00hetero-3-3-3-3-mer35 x NAG, 2 x NAG-NAGBLAST0.61
7wgb.1.A
Spike glycoprotein
Neutral Omicron Spike Trimer in complex with ACE2
0.6797.450.99 12-1273EM0.00hetero-3-2-mer33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7wgb.1.B
Spike glycoprotein
Neutral Omicron Spike Trimer in complex with ACE2
0.6897.450.99 12-1273EM0.00hetero-3-2-mer33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7wgb.1.C
Spike glycoprotein
Neutral Omicron Spike Trimer in complex with ACE2
0.6697.450.99 12-1273EM0.00hetero-3-2-mer33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7xns.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.4 variant spike
0.6496.980.99 12-1273EM0.00homo-trimer30 x NAG, 18 x NAG-NAGBLAST0.61
7wg7.1.A
Spike glycoprotein
Acidic Omicron Spike Trimer
0.6297.210.99 12-1273EM0.00homo-trimer28 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7wg7.1.B
Spike glycoprotein
Acidic Omicron Spike Trimer
0.6497.210.99 12-1273EM0.00homo-trimer28 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7wg7.1.C
Spike glycoprotein
Acidic Omicron Spike Trimer
0.6197.210.99 12-1273EM0.00homo-trimer28 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7wgc.1.B
Spike glycoprotein
Neutral Omicron Spike Trimer in complex with ACE2.
0.0297.210.99 12-1273EM0.00hetero-1-1-mer5 x NAGBLAST0.61
7xiy.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.3 variant spike
0.6597.210.99 12-1273EM0.00homo-trimer23 x NAG, 12 x NAG-NAGBLAST0.61
7dzw.1.A
Spike glycoprotein
Apo spike protein from SARS-CoV2
0.6399.520.97 14-1254EM0.00homo-trimerHHblits0.62
7dzw.1.B
Spike glycoprotein
Apo spike protein from SARS-CoV2
0.6199.520.97 14-1254EM0.00homo-trimerHHblits0.62
7dzw.1.C
Spike glycoprotein
Apo spike protein from SARS-CoV2
0.6399.520.97 14-1254EM0.00homo-trimerHHblits0.62
7xnq.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.4 variant spike
0.6396.980.99 12-1273EM0.00homo-trimer33 x NAG, 18 x NAG-NAGBLAST0.61
7yqw.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down)
0.6696.660.99 12-1273EM3.51homo-trimer33 x NAG, 6 x NAG-NAG-BMA, 9 x NAG-NAGBLAST0.61
7yqt.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
0.6396.660.99 12-1273EM0.00homo-trimer45 x NAG, 9 x NAG-NAGBLAST0.61
7yqt.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
0.6496.660.99 12-1273EM0.00homo-trimer45 x NAG, 9 x NAG-NAGBLAST0.61
7yqv.1.A
Spike glycoprotein
pH 5.5 SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
0.6196.660.99 12-1273EM0.00homo-trimer44 x NAG, 9 x NAG-NAGBLAST0.61
7yqv.1.B
Spike glycoprotein
pH 5.5 SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
0.6396.660.99 12-1273EM0.00homo-trimer44 x NAG, 9 x NAG-NAGBLAST0.61
7yqv.1.C
Spike glycoprotein
pH 5.5 SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
0.6396.660.99 12-1273EM0.00homo-trimer44 x NAG, 9 x NAG-NAGBLAST0.61
7yqt.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
0.6396.660.99 12-1273EM0.00homo-trimer45 x NAG, 9 x NAG-NAGBLAST0.61
7yqx.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1)
0.6296.660.99 12-1273EM3.72hetero-3-2-2-mer45 x NAG, 9 x NAG-NAG, 2 x NAG-NAG-BMA-FUCBLAST0.61
7yqx.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1)
0.6296.660.99 12-1273EM3.72hetero-3-2-2-mer45 x NAG, 9 x NAG-NAG, 2 x NAG-NAG-BMA-FUCBLAST0.61
7yqx.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1)
0.6396.660.99 12-1273EM3.72hetero-3-2-2-mer45 x NAG, 9 x NAG-NAG, 2 x NAG-NAG-BMA-FUCBLAST0.61
7yqy.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2)
0.6396.660.99 12-1273EM3.74hetero-3-3-3-mer44 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMA-FUCBLAST0.61
7yqy.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2)
0.6196.660.99 12-1273EM3.74hetero-3-3-3-mer44 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMA-FUCBLAST0.61
7yqy.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2)
0.6296.660.99 12-1273EM3.74hetero-3-3-3-mer44 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMA-FUCBLAST0.61
7yqz.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3)
0.6596.660.99 12-1273EM3.84hetero-3-2-2-mer45 x NAG, 2 x NAG-NAG-BMA-FUCBLAST0.61
7yqz.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3)
0.6596.660.99 12-1273EM3.84hetero-3-2-2-mer45 x NAG, 2 x NAG-NAG-BMA-FUCBLAST0.61
7yqz.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3)
0.6596.660.99 12-1273EM3.84hetero-3-2-2-mer45 x NAG, 2 x NAG-NAG-BMA-FUCBLAST0.61
7yr1.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024
0.6696.660.99 12-1273EM0.00hetero-3-3-3-mer24 x NAG, 15 x NAG-NAG, 9 x NAG-NAG-BMABLAST0.61
7yr2.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
0.6396.660.99 12-1273EM3.30hetero-1-3-mer1 x ZN, 48 x NAG, 9 x NAG-NAGBLAST0.61
7yr2.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
0.6496.660.99 12-1273EM3.30hetero-1-3-mer1 x ZN, 48 x NAG, 9 x NAG-NAGBLAST0.61
7yr2.1.D
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
0.6696.660.99 12-1273EM3.30hetero-1-3-mer1 x ZN, 48 x NAG, 9 x NAG-NAGBLAST0.61
7yr3.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
0.6496.660.99 12-1273EM3.52hetero-3-2-mer45 x NAG, 2 x ZN, 9 x NAG-NAGBLAST0.61
7yr3.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
0.6596.660.99 12-1273EM3.52hetero-3-2-mer45 x NAG, 2 x ZN, 9 x NAG-NAGBLAST0.61
7yr3.1.D
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
0.6596.660.99 12-1273EM3.52hetero-3-2-mer45 x NAG, 2 x ZN, 9 x NAG-NAGBLAST0.61
7yqu.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down)
0.6896.660.99 12-1273EM3.19homo-trimer36 x NAG, 6 x NAG-NAGBLAST0.61
7wti.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv264
0.6596.970.99 12-1273EM0.00hetero-3-3-3-mer36 x NAGBLAST0.61
7wti.1.B
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv264
0.6396.970.99 12-1273EM0.00hetero-3-3-3-mer36 x NAGBLAST0.61
7wti.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv264
0.6396.970.99 12-1273EM0.00hetero-3-3-3-mer36 x NAGBLAST0.61
7dzw.1.A
Spike glycoprotein
Apo spike protein from SARS-CoV2
0.6299.510.96 14-1232EM0.00homo-trimerBLAST0.62
7dzw.1.B
Spike glycoprotein
Apo spike protein from SARS-CoV2
0.6099.510.96 14-1232EM0.00homo-trimerBLAST0.62
7dzw.1.C
Spike glycoprotein
Apo spike protein from SARS-CoV2
0.6299.510.96 14-1232EM0.00homo-trimerBLAST0.62
7qus.1.A
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike, C3 symmetry
0.6999.260.96 1-1221EM0.00homo-trimer36 x NAG, 3 x EIC, 9 x NAG-NAG, 3 x NAG-FUC-NAG-FUCHHblits0.61
7qur.1.A
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike with ethylbenzamide-tri-iodo Siallyllactose, C3 symmetry
0.6899.260.96 1-1221EM0.00homo-trimer36 x NAG, 3 x GE9, 3 x SIA, 3 x EIC, 9 x NAG-NAG, 3 x NAG-FUC-NAG-FUCHHblits0.61
7qus.1.B
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike, C3 symmetry
0.6999.260.96 1-1221EM0.00homo-trimer36 x NAG, 3 x EIC, 9 x NAG-NAG, 3 x NAG-FUC-NAG-FUCHHblits0.61
7qur.1.B
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike with ethylbenzamide-tri-iodo Siallyllactose, C3 symmetry
0.6899.260.96 1-1221EM0.00homo-trimer36 x NAG, 3 x GE9, 3 x SIA, 3 x EIC, 9 x NAG-NAG, 3 x NAG-FUC-NAG-FUCHHblits0.61
7qus.1.C
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike, C3 symmetry
0.6999.260.96 1-1221EM0.00homo-trimer36 x NAG, 3 x EIC, 9 x NAG-NAG, 3 x NAG-FUC-NAG-FUCHHblits0.61
7qur.1.C
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike with ethylbenzamide-tri-iodo Siallyllactose, C3 symmetry
0.6899.260.96 1-1221EM0.00homo-trimer36 x NAG, 3 x GE9, 3 x SIA, 3 x EIC, 9 x NAG-NAG, 3 x NAG-FUC-NAG-FUCHHblits0.61
6zb4.1.A
Spike glycoprotein
SARS CoV-2 Spike protein, Closed conformation, C1 symmetry
0.7299.920.95 1-1213EM0.00homo-trimer25 x NAG, 3 x EIC, 1 x NAG-NAGHHblits0.62
6zb4.1.B
Spike glycoprotein
SARS CoV-2 Spike protein, Closed conformation, C1 symmetry
0.7299.920.95 1-1213EM0.00homo-trimer25 x NAG, 3 x EIC, 1 x NAG-NAGHHblits0.62
6zb4.1.C
Spike glycoprotein
SARS CoV-2 Spike protein, Closed conformation, C1 symmetry
0.7399.920.95 1-1213EM0.00homo-trimer25 x NAG, 3 x EIC, 1 x NAG-NAGHHblits0.62
6zb5.1.A
Spike glycoprotein
SARS CoV-2 Spike protein, Closed conformation, C3 symmetry
0.7299.920.95 1-1213EM0.00homo-trimer20 x NAG, 3 x EIC, 3 x NAG-NAGHHblits0.62
6zb5.1.B
Spike glycoprotein
SARS CoV-2 Spike protein, Closed conformation, C3 symmetry
0.7299.920.95 1-1213EM0.00homo-trimer20 x NAG, 3 x EIC, 3 x NAG-NAGHHblits0.62
6zb5.1.C
Spike glycoprotein
SARS CoV-2 Spike protein, Closed conformation, C3 symmetry
0.7299.920.95 1-1213EM0.00homo-trimer20 x NAG, 3 x EIC, 3 x NAG-NAGHHblits0.62
7k8s.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)
0.6899.840.95 1-1213EM0.00hetero-3-3-3-mer27 x NAG, 15 x NAG-NAGHHblits0.62
7k8s.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)
0.6799.840.95 1-1213EM0.00hetero-3-3-3-mer27 x NAG, 15 x NAG-NAGHHblits0.62
7k8s.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)
0.6899.840.95 1-1213EM0.00hetero-3-3-3-mer27 x NAG, 15 x NAG-NAGHHblits0.62
7k8t.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)
0.6899.840.95 1-1213EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAGHHblits0.62
7k8t.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)
0.6899.840.95 1-1213EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAGHHblits0.62
7k8t.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)
0.6899.840.95 1-1213EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAGHHblits0.62
7k8x.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)
0.6799.840.95 1-1213EM3.90hetero-3-2-2-mer28 x NAGHHblits0.62
7k8x.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)
0.6899.840.95 1-1213EM3.90hetero-3-2-2-mer28 x NAGHHblits0.62
7k8x.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)
0.6799.840.95 1-1213EM3.90hetero-3-2-2-mer28 x NAGHHblits0.62
7k8y.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)
0.6799.840.95 1-1213EM4.40hetero-3-1-1-mer23 x NAGHHblits0.62
7k8y.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)
0.6799.840.95 1-1213EM4.40hetero-3-1-1-mer23 x NAGHHblits0.62
7k8y.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)
0.6799.840.95 1-1213EM4.40hetero-3-1-1-mer23 x NAGHHblits0.62
7m6i.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24
0.6599.840.95 1-1213EM0.00hetero-3-2-2-mer26 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMAHHblits0.62
7m6h.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20
0.5999.840.95 1-1213EM0.00hetero-3-2-2-mer28 x NAGHHblits0.62
7m6h.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20
0.5999.840.95 1-1213EM0.00hetero-3-2-2-mer28 x NAGHHblits0.62
7m6i.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24
0.6399.840.95 1-1213EM0.00hetero-3-2-2-mer26 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMAHHblits0.62
7m6i.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24
0.6499.840.95 1-1213EM0.00hetero-3-2-2-mer26 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMAHHblits0.62
7m6h.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20
0.5799.840.95 1-1213EM0.00hetero-3-2-2-mer28 x NAGHHblits0.62
8d48.1.A
Spike glycoprotein
sd1.040 Fab in complex with SARS-CoV-2 Spike 2P glycoprotein
0.0899.840.95 1-1213EM0.00hetero-1-1-1-mer1 x NAG-NAGHHblits0.62
6xcm.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1)
0.6999.750.95 1-1213EM0.00hetero-3-2-2-mer30 x NAG, 9 x NAG-NAG, 1 x NAG-FUC, 2 x NAG-NAG-FUC, 1 x NAG-NAG-BMAHHblits0.62
6xcn.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 2)
0.6999.750.95 1-1213EM0.00hetero-3-3-3-mer24 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMA, 3 x NAG-NAG-FUCHHblits0.62
6xcn.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 2)
0.6999.750.95 1-1213EM0.00hetero-3-3-3-mer24 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMA, 3 x NAG-NAG-FUCHHblits0.62
6xcn.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 2)
0.6999.750.95 1-1213EM0.00hetero-3-3-3-mer24 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMA, 3 x NAG-NAG-FUCHHblits0.62
6xcm.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1)
0.6899.750.95 1-1213EM0.00hetero-3-2-2-mer30 x NAG, 9 x NAG-NAG, 1 x NAG-FUC, 2 x NAG-NAG-FUC, 1 x NAG-NAG-BMAHHblits0.62
6xcm.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1)
0.6799.750.95 1-1213EM0.00hetero-3-2-2-mer30 x NAG, 9 x NAG-NAG, 1 x NAG-FUC, 2 x NAG-NAG-FUC, 1 x NAG-NAG-BMAHHblits0.62
7k8z.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135
0.6999.750.95 1-1213EM0.00hetero-3-2-2-mer33 x NAG, 13 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x NAG-NAG-BMA-FUCHHblits0.62
7k8v.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110
0.6499.750.95 1-1213EM0.00hetero-3-2-2-mer21 x NAG, 10 x NAG-NAGHHblits0.62
7k8w.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119
0.6799.750.95 1-1213EM0.00hetero-3-2-2-mer34 x NAG, 13 x NAG-NAGHHblits0.62
7k8w.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119
0.6899.750.95 1-1213EM0.00hetero-3-2-2-mer34 x NAG, 13 x NAG-NAGHHblits0.62
7k8v.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110
0.6299.750.95 1-1213EM0.00hetero-3-2-2-mer21 x NAG, 10 x NAG-NAGHHblits0.62
7k8u.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104
0.6699.750.95 1-1213EM0.00hetero-3-1-1-mer2 x NAG, 1 x NAG-NAGHHblits0.62
7k8u.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104
0.6899.750.95 1-1213EM0.00hetero-3-1-1-mer2 x NAG, 1 x NAG-NAGHHblits0.62
7k8v.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110
0.6499.750.95 1-1213EM0.00hetero-3-2-2-mer21 x NAG, 10 x NAG-NAGHHblits0.62
7k8w.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119
0.6899.750.95 1-1213EM0.00hetero-3-2-2-mer34 x NAG, 13 x NAG-NAGHHblits0.62
7k8z.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135
0.6899.750.95 1-1213EM0.00hetero-3-2-2-mer33 x NAG, 13 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x NAG-NAG-BMA-FUCHHblits0.62
7k8z.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135
0.6899.750.95 1-1213EM0.00hetero-3-2-2-mer33 x NAG, 13 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x NAG-NAG-BMA-FUCHHblits0.62
7k8u.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104
0.6899.750.95 1-1213EM0.00hetero-3-1-1-mer2 x NAG, 1 x NAG-NAGHHblits0.62
7e7d.1.A
Spike glycoprotein,Collagen alpha-1(I) chain
Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate
0.7399.750.95 1-1214EM3.20homo-trimer19 x NAG, 3 x ELA, 32 x NAG-NAGHHblits0.62
7e7d.1.B
Spike glycoprotein,Collagen alpha-1(I) chain
Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate
0.7399.750.95 1-1214EM3.20homo-trimer19 x NAG, 3 x ELA, 32 x NAG-NAGHHblits0.62
7e7d.1.C
Spike glycoprotein,Collagen alpha-1(I) chain
Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate
0.7399.750.95 1-1214EM3.20homo-trimer19 x NAG, 3 x ELA, 32 x NAG-NAGHHblits0.62
7e7b.1.A
Spike glycoprotein,Collagen alpha-1(I) chain
Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate
0.7199.670.95 1-1214EM0.00homo-trimer15 x NAG, 3 x ELA, 3 x VCG, 39 x NAG-NAGHHblits0.61
7e7b.1.B
Spike glycoprotein,Collagen alpha-1(I) chain
Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate
0.7199.670.95 1-1214EM0.00homo-trimer15 x NAG, 3 x ELA, 3 x VCG, 39 x NAG-NAGHHblits0.61
7e7b.1.C
Spike glycoprotein,Collagen alpha-1(I) chain
Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate
0.7199.670.95 1-1214EM0.00homo-trimer15 x NAG, 3 x ELA, 3 x VCG, 39 x NAG-NAGHHblits0.61
8h3e.1.A
Spike glycoprotein,Fibritin
Complex structure of a small molecule (SPC-14) bound SARS-CoV-2 spike protein, closed state
0.6399.340.95 1-1214EM0.00homo-trimer3 x Q83, 15 x NAGHHblits0.61
8h3e.1.B
Spike glycoprotein,Fibritin
Complex structure of a small molecule (SPC-14) bound SARS-CoV-2 spike protein, closed state
0.6399.340.95 1-1214EM0.00homo-trimer3 x Q83, 15 x NAGHHblits0.61
8h3e.1.C
Spike glycoprotein,Fibritin
Complex structure of a small molecule (SPC-14) bound SARS-CoV-2 spike protein, closed state
0.6399.340.95 1-1214EM0.00homo-trimer3 x Q83, 15 x NAGHHblits0.61
8h3d.1.B
Spike glycoprotein,Fibritin
Structure of apo SARS-CoV-2 spike protein with one RBD up
0.6199.340.95 1-1214EM0.00homo-trimer13 x NAGHHblits0.61
8h3d.1.C
Spike glycoprotein,Fibritin
Structure of apo SARS-CoV-2 spike protein with one RBD up
0.6099.340.95 1-1214EM0.00homo-trimer13 x NAGHHblits0.61
8h3d.1.A
Spike glycoprotein,Fibritin
Structure of apo SARS-CoV-2 spike protein with one RBD up
0.6399.340.95 1-1214EM0.00homo-trimer13 x NAGHHblits0.61
7k9j.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2H04 (three down conformation)
0.6799.500.95 1-1213EM0.00hetero-3-3-3-mer3 x NAG, 12 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-NAG-BMA-FUC, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MANHHblits0.62
7k9j.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2H04 (three down conformation)
0.6799.500.95 1-1213EM0.00hetero-3-3-3-mer3 x NAG, 12 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-NAG-BMA-FUC, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MANHHblits0.62
7k9j.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2H04 (three down conformation)
0.6799.500.95 1-1213EM0.00hetero-3-3-3-mer3 x NAG, 12 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-NAG-BMA-FUC, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MANHHblits0.62
7k9h.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation)
0.6899.500.95 1-1213EM0.00hetero-3-2-2-mer3 x NAG, 14 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MANHHblits0.62
7k9h.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation)
0.6799.500.95 1-1213EM0.00hetero-3-2-2-mer3 x NAG, 14 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MANHHblits0.62
7k9h.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation)
0.6799.500.95 1-1213EM0.00hetero-3-2-2-mer3 x NAG, 14 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MANHHblits0.62
8gb0.1.A
Spike glycoprotein
SARS-CoV-2 Spike H655Y variant, One RBD Open
0.6999.420.95 1-1213EM0.00homo-trimerHHblits0.62
8gb0.1.B
Spike glycoprotein
SARS-CoV-2 Spike H655Y variant, One RBD Open
0.6899.420.95 1-1213EM0.00homo-trimerHHblits0.62
8gb0.1.C
Spike glycoprotein
SARS-CoV-2 Spike H655Y variant, One RBD Open
0.6899.420.95 1-1213EM0.00homo-trimerHHblits0.62
6xs6.1.A
Spike glycoprotein
SARS-CoV-2 Spike D614G variant, minus RBD
0.4999.420.95 1-1213EM0.00homo-trimerHHblits0.61
6xs6.1.B
Spike glycoprotein
SARS-CoV-2 Spike D614G variant, minus RBD
0.4999.420.95 1-1213EM0.00homo-trimerHHblits0.61
6xs6.1.C
Spike glycoprotein
SARS-CoV-2 Spike D614G variant, minus RBD
0.4999.420.95 1-1213EM0.00homo-trimerHHblits0.61
7kdi.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G)
0.6999.920.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7kdi.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G)
0.6999.920.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7kdi.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G)
0.6999.920.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7kdj.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G)
0.6999.830.95 1-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
7kdj.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G)
0.6699.830.95 1-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
7kdj.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G)
0.6899.830.95 1-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
7z85.1.C
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-B5 nanobody complex
0.6999.260.95 1-1212EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
7z6v.1.C
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11 nanobody complex
0.6999.260.95 1-1212EM0.00hetero-3-3-mer28 x NAG, 19 x NAG-NAGHHblits0.61
7z7x.1.C
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H6 nanobody complex
0.6999.260.95 1-1212EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
7z86.1.C
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 1Up2Down conformation
0.6999.260.95 1-1212EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
7z9q.1.C
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-A10 nanobody complex
0.6999.260.95 1-1212EM3.60hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
7z9r.1.B
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 2Up1Down conformation
0.6999.260.95 1-1212EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
7z9q.1.B
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-A10 nanobody complex
0.6999.260.95 1-1212EM3.60hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
7z86.1.B
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 1Up2Down conformation
0.6999.260.95 1-1212EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
7z7x.1.A
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H6 nanobody complex
0.7099.260.95 1-1212EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
7z6v.1.A
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11 nanobody complex
0.6999.260.95 1-1212EM0.00hetero-3-3-mer28 x NAG, 19 x NAG-NAGHHblits0.61
7z9r.1.A
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 2Up1Down conformation
0.7099.260.95 1-1212EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
7z85.1.A
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-B5 nanobody complex
0.7099.260.95 1-1212EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
7z9q.1.A
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-A10 nanobody complex
0.7099.260.95 1-1212EM3.60hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
7z86.1.A
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 1Up2Down conformation
0.7099.260.95 1-1212EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
7z9r.1.C
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 2Up1Down conformation
0.6899.260.95 1-1212EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
7z85.1.B
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-B5 nanobody complex
0.6999.260.95 1-1212EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
7z7x.1.B
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H6 nanobody complex
0.6999.260.95 1-1212EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
7z6v.1.B
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11 nanobody complex
0.6899.260.95 1-1212EM0.00hetero-3-3-mer28 x NAG, 19 x NAG-NAGHHblits0.61
6z97.1.C
Spike glycoprotein,Fibritin
Structure of the prefusion SARS-CoV-2 spike glycoprotein
0.6899.260.95 1-1212EM0.00homo-trimer27 x NAG, 11 x NAG-NAGHHblits0.61
6zhd.1.B
Spike glycoprotein,Fibritin
H11-H4 bound to Spike
0.6999.260.95 1-1212EM3.70hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
6z97.1.B
Spike glycoprotein,Fibritin
Structure of the prefusion SARS-CoV-2 spike glycoprotein
0.7099.260.95 1-1212EM0.00homo-trimer27 x NAG, 11 x NAG-NAGHHblits0.61
6z97.1.A
Spike glycoprotein,Fibritin
Structure of the prefusion SARS-CoV-2 spike glycoprotein
0.6999.260.95 1-1212EM0.00homo-trimer27 x NAG, 11 x NAG-NAGHHblits0.61
6zhd.1.A
Spike glycoprotein,Fibritin
H11-H4 bound to Spike
0.7099.260.95 1-1212EM3.70hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
6zhd.1.C
Spike glycoprotein,Fibritin
H11-H4 bound to Spike
0.6999.260.95 1-1212EM3.70hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
7a5r.1.C
Spike glycoprotein
Complex of SARS-CoV-2 spike and CR3022 Fab (Non-Uniform Refinement)
0.0499.830.95 1-1208EM0.00hetero-2-2-2-mer2 x NAG-NAGHHblits0.62
7a5r.1.D
Spike glycoprotein
Complex of SARS-CoV-2 spike and CR3022 Fab (Non-Uniform Refinement)
0.0499.830.95 1-1208EM0.00hetero-2-2-2-mer2 x NAG-NAGHHblits0.62
6zgi.1.A
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Closed Conformation
0.7199.830.95 1-1208EM0.00homo-trimer24 x NAG, 27 x NAG-NAGHHblits0.62
6zgi.1.B
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Closed Conformation
0.7199.830.95 1-1208EM0.00homo-trimer24 x NAG, 27 x NAG-NAGHHblits0.62
6zgi.1.C
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Closed Conformation
0.7199.830.95 1-1208EM0.00homo-trimer24 x NAG, 27 x NAG-NAGHHblits0.62
6zgg.1.A
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erect
0.6499.830.95 1-1208EM0.00homo-trimerHHblits0.62
6zgg.1.B
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erect
0.6499.830.95 1-1208EM0.00homo-trimerHHblits0.62
6zgg.1.C
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erect
0.6499.830.95 1-1208EM0.00homo-trimerHHblits0.62
7a5s.1.E
Spike glycoprotein
Complex of SARS-CoV-2 spike and CR3022 Fab (Homogeneous Refinement)
0.3599.830.95 1-1208EM0.00hetero-2-2-2-mer2 x NAG-NAGHHblits0.62
7a5s.1.C
Spike glycoprotein
Complex of SARS-CoV-2 spike and CR3022 Fab (Homogeneous Refinement)
0.3599.830.95 1-1208EM0.00hetero-2-2-2-mer2 x NAG-NAGHHblits0.62
7a93.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 RBDs Erect
0.6399.830.95 1-1208EM0.00homo-trimerHHblits0.62
7a95.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
0.6399.830.95 1-1208EM0.00hetero-3-1-merHHblits0.62
7a96.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
0.6299.830.95 1-1208EM0.00hetero-3-1-merHHblits0.62
7a98.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound
0.6399.830.95 1-1208EM0.00hetero-3-3-merHHblits0.62
7a98.1.E
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound
0.6299.830.95 1-1208EM0.00hetero-3-3-merHHblits0.62
7a98.1.F
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound
0.6399.830.95 1-1208EM0.00hetero-3-3-merHHblits0.62
7a94.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
0.6899.830.95 1-1208EM0.00hetero-3-1-mer23 x NAG, 1 x ZNHHblits0.62
7a94.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
0.6899.830.95 1-1208EM0.00hetero-3-1-mer23 x NAG, 1 x ZNHHblits0.62
7a94.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
0.6899.830.95 1-1208EM0.00hetero-3-1-mer23 x NAG, 1 x ZNHHblits0.62
7a97.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
0.6399.830.95 1-1208EM0.00hetero-3-2-merHHblits0.62
7a96.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
0.6299.830.95 1-1208EM0.00hetero-3-1-merHHblits0.62
7a97.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
0.6399.830.95 1-1208EM0.00hetero-3-2-merHHblits0.62
7a93.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 RBDs Erect
0.6399.830.95 1-1208EM0.00homo-trimerHHblits0.62
7a97.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
0.6299.830.95 1-1208EM0.00hetero-3-2-merHHblits0.62
7a96.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
0.6299.830.95 1-1208EM0.00hetero-3-1-merHHblits0.62
7a95.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
0.6399.830.95 1-1208EM0.00hetero-3-1-merHHblits0.62
7a95.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
0.6399.830.95 1-1208EM0.00hetero-3-1-merHHblits0.62
7a93.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 RBDs Erect
0.6299.830.95 1-1208EM0.00homo-trimerHHblits0.62
6zgh.1.B
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformation
0.6599.830.95 1-1208EM0.00homo-trimerHHblits0.62
6zgh.1.A
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformation
0.5499.830.95 1-1208EM0.00homo-trimerHHblits0.62
6zgh.1.C
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformation
0.6599.830.95 1-1208EM0.00homo-trimerHHblits0.62
7a4n.1.A
Spike glycoprotein,Fibritin
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(S-closed trimer)
0.6899.170.95 1-1212EM0.00homo-trimer15 x NAG, 3 x NAG-NAGHHblits0.61
7a4n.1.B
Spike glycoprotein,Fibritin
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(S-closed trimer)
0.6899.170.95 1-1212EM0.00homo-trimer15 x NAG, 3 x NAG-NAGHHblits0.61
7a4n.1.C
Spike glycoprotein,Fibritin
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(S-closed trimer)
0.6899.170.95 1-1212EM0.00homo-trimer15 x NAG, 3 x NAG-NAGHHblits0.61
7ad1.1.A
Spike glycoprotein,Envelope glycoprotein,Spike glycoprotein,Envelope glycoprotein,SARS-CoV-2 S protein
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer)
0.6999.170.95 1-1212EM0.00homo-trimer10 x NAG, 10 x NAG-NAGHHblits0.61
7ad1.1.B
Spike glycoprotein,Envelope glycoprotein,Spike glycoprotein,Envelope glycoprotein,SARS-CoV-2 S protein
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer)
0.6899.170.95 1-1212EM0.00homo-trimer10 x NAG, 10 x NAG-NAGHHblits0.61
7ad1.1.C
Spike glycoprotein,Envelope glycoprotein,Spike glycoprotein,Envelope glycoprotein,SARS-CoV-2 S protein
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer)
0.6899.170.95 1-1212EM0.00homo-trimer10 x NAG, 10 x NAG-NAGHHblits0.61
7q0a.1.A
Spike glycoprotein,Spike ectodomain,Spike protein S2'
SARS-CoV-2 Spike ectodomain with Fab FI3A
0.6999.340.95 1-1211EM0.00hetero-3-1-1-mer27 x NAG, 11 x NAG-NAGHHblits0.61
7q0a.1.B
Spike glycoprotein,Spike ectodomain,Spike protein S2'
SARS-CoV-2 Spike ectodomain with Fab FI3A
0.7099.340.95 1-1211EM0.00hetero-3-1-1-mer27 x NAG, 11 x NAG-NAGHHblits0.61
7q0a.1.C
Spike glycoprotein,Spike ectodomain,Spike protein S2'
SARS-CoV-2 Spike ectodomain with Fab FI3A
0.6899.340.95 1-1211EM0.00hetero-3-1-1-mer27 x NAG, 11 x NAG-NAGHHblits0.61
7kdg.1.A
Spike glycoprotein
SARS-CoV-2 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
0.7099.750.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7kdg.1.B
Spike glycoprotein
SARS-CoV-2 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
0.7099.750.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7kdg.1.C
Spike glycoprotein
SARS-CoV-2 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
0.6999.750.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7kdh.1.A
Spike glycoprotein
SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
0.6999.750.95 1-1208EM0.00homo-trimer49 x NAGHHblits0.62
7kdh.1.B
Spike glycoprotein
SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
0.6599.750.95 1-1208EM0.00homo-trimer49 x NAGHHblits0.62
7kdh.1.C
Spike glycoprotein
SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
0.6899.750.95 1-1208EM0.00homo-trimer49 x NAGHHblits0.62
7kml.1.A
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, three RBDs bound
0.6399.260.95 1-1211EM0.00hetero-3-3-3-mer18 x NAG, 21 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7kml.1.B
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, three RBDs bound
0.6399.260.95 1-1211EM0.00hetero-3-3-3-mer18 x NAG, 21 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7kml.1.C
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, three RBDs bound
0.6399.260.95 1-1211EM0.00hetero-3-3-3-mer18 x NAG, 21 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7kmk.1.B
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound
0.6299.260.95 1-1211EM0.00hetero-3-2-2-mer25 x NAG, 7 x NAG-NAG, 2 x NAG-NAG-BMAHHblits0.61
7kmk.1.C
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound
0.6299.260.95 1-1211EM0.00hetero-3-2-2-mer25 x NAG, 7 x NAG-NAG, 2 x NAG-NAG-BMAHHblits0.61
7kmk.1.A
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound
0.6399.260.95 1-1211EM0.00hetero-3-2-2-mer25 x NAG, 7 x NAG-NAG, 2 x NAG-NAG-BMAHHblits0.61
7kxj.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric
0.6299.260.95 1-1211EM0.00hetero-3-3-3-mer7 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAGHHblits0.61
7kxj.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric
0.6299.260.95 1-1211EM0.00hetero-3-3-3-mer7 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAGHHblits0.61
7kxj.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric
0.6199.260.95 1-1211EM0.00hetero-3-3-3-mer7 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAGHHblits0.61
7kxk.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation
0.6299.260.95 1-1211EM0.00hetero-3-3-3-mer16 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.61
7kxk.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation
0.6299.260.95 1-1211EM0.00hetero-3-3-3-mer16 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.61
7kxk.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation
0.6299.260.95 1-1211EM0.00hetero-3-3-3-mer16 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.61
8a94.1.A
SARS-CoV2 Spike in 2-up conformation in complex with Fab47
SARS CoV2 Spike in the 2-up state in complex with Fab47
0.6999.090.95 1-1212EM0.00hetero-3-3-3-mer43 x NAG, 7 x NAG-NAGHHblits0.61
8a94.1.B
SARS-CoV2 Spike in 2-up conformation in complex with Fab47
SARS CoV2 Spike in the 2-up state in complex with Fab47
0.6899.090.95 1-1212EM0.00hetero-3-3-3-mer43 x NAG, 7 x NAG-NAGHHblits0.61
8a94.1.C
SARS-CoV2 Spike in 2-up conformation in complex with Fab47
SARS CoV2 Spike in the 2-up state in complex with Fab47
0.7099.090.95 1-1212EM0.00hetero-3-3-3-mer43 x NAG, 7 x NAG-NAGHHblits0.61
7mxp.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody LP5 Fab in complex with SARS-CoV-2 S2P spike
0.6299.670.95 1-1208EM0.00hetero-3-3-3-mer28 x NAG, 3 x NAG-NAG-BMA-MAN-NAG-NAG-BMA-FUC, 3 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.62
7mxp.1.B
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody LP5 Fab in complex with SARS-CoV-2 S2P spike
0.6199.670.95 1-1208EM0.00hetero-3-3-3-mer28 x NAG, 3 x NAG-NAG-BMA-MAN-NAG-NAG-BMA-FUC, 3 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.62
7mxp.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody LP5 Fab in complex with SARS-CoV-2 S2P spike
0.6499.670.95 1-1208EM0.00hetero-3-3-3-mer28 x NAG, 3 x NAG-NAG-BMA-MAN-NAG-NAG-BMA-FUC, 3 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.62
7r8n.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C051
0.6299.170.95 1-1213EM0.00hetero-3-3-3-mer27 x NAG, 4 x NAG-NAGHHblits0.61
7r8n.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C051
0.6299.170.95 1-1213EM0.00hetero-3-3-3-mer27 x NAG, 4 x NAG-NAGHHblits0.61
7r8n.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C051
0.6299.170.95 1-1213EM0.00hetero-3-3-3-mer27 x NAG, 4 x NAG-NAGHHblits0.61
7r8m.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032
0.6499.170.95 1-1213EM0.00hetero-3-2-2-mer22 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7r8m.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032
0.6199.170.95 1-1213EM0.00hetero-3-2-2-mer22 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7r8m.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032
0.6299.170.95 1-1213EM0.00hetero-3-2-2-mer22 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7r8o.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C548
0.7099.170.95 1-1213EM0.00hetero-3-3-3-mer26 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-FUC, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-FUCHHblits0.61
7r8o.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C548
0.7099.170.95 1-1213EM0.00hetero-3-3-3-mer26 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-FUC, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-FUCHHblits0.61
7r8o.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C548
0.7099.170.95 1-1213EM0.00hetero-3-3-3-mer26 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-FUC, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-FUCHHblits0.61
7rkv.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C118 (State 1)
0.6799.170.95 1-1213EM0.00hetero-3-3-3-mer39 x NAGHHblits0.61
7rkv.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C118 (State 1)
0.6799.170.95 1-1213EM0.00hetero-3-3-3-mer39 x NAGHHblits0.61
7rkv.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C118 (State 1)
0.6799.170.95 1-1213EM0.00hetero-3-3-3-mer39 x NAGHHblits0.61
7s0d.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014
0.7199.170.95 1-1213EM0.00hetero-3-3-3-merHHblits0.61
7s0c.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017
0.7099.170.95 1-1213EM0.00hetero-3-2-2-mer19 x NAG, 6 x NAG-NAGHHblits0.61
7s0d.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014
0.7199.170.95 1-1213EM0.00hetero-3-3-3-merHHblits0.61
7s0d.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014
0.6999.170.95 1-1213EM0.00hetero-3-3-3-merHHblits0.61
7s0e.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S1 subunit in complex with antibody N-612-004
0.3899.170.95 1-1213EM0.00hetero-1-1-1-merHHblits0.61
7s0c.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017
0.6899.170.95 1-1213EM0.00hetero-3-2-2-mer19 x NAG, 6 x NAG-NAGHHblits0.61
7s0c.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017
0.6899.170.95 1-1213EM0.00hetero-3-2-2-mer19 x NAG, 6 x NAG-NAGHHblits0.61
7sc1.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, R40-1G8
0.6799.170.95 1-1213EM0.00hetero-3-3-3-mer45 x NAGHHblits0.61
7sc1.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, R40-1G8
0.6799.170.95 1-1213EM0.00hetero-3-3-3-mer45 x NAGHHblits0.61
7sc1.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, R40-1G8
0.6799.170.95 1-1213EM0.00hetero-3-3-3-mer45 x NAGHHblits0.61
7uar.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1717
0.6799.170.95 1-1213EM3.50hetero-3-3-3-mer27 x NAG, 6 x NAG-NAG, 1 x NAG-NAG-BMA-FUCHHblits0.61
7uap.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1520
0.6699.170.95 1-1213EM0.00hetero-3-3-3-mer35 x NAG, 12 x NAG-NAGHHblits0.61
7uaq.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 NTD in complex with C1520, local refinement
0.0799.170.95 1-1213EM0.00hetero-1-1-1-mer4 x NAG, 3 x NAG-NAGHHblits0.61
7uap.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1520
0.6499.170.95 1-1213EM0.00hetero-3-3-3-mer35 x NAG, 12 x NAG-NAGHHblits0.61
7uar.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1717
0.6499.170.95 1-1213EM3.50hetero-3-3-3-mer27 x NAG, 6 x NAG-NAG, 1 x NAG-NAG-BMA-FUCHHblits0.61
7uap.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1520
0.6699.170.95 1-1213EM0.00hetero-3-3-3-mer35 x NAG, 12 x NAG-NAGHHblits0.61
7uar.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1717
0.6699.170.95 1-1213EM3.50hetero-3-3-3-mer27 x NAG, 6 x NAG-NAG, 1 x NAG-NAG-BMA-FUCHHblits0.61
8dad.1.C
Spike glycoprotein
SARS-CoV-2 receptor binding domain in complex with AZ090 Fab
0.0499.170.95 1-1213EM0.00hetero-1-1-1-mer2 x NAG-NAGHHblits0.61
7uz9.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-34
0.6799.170.95 1-1213EM0.00hetero-3-3-3-mer42 x NAGHHblits0.61
7uz4.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-3
0.6899.170.95 1-1213EM0.00hetero-3-3-3-mer45 x NAG, 3 x NAG-NAGHHblits0.61
7uz5.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-6
0.6999.170.95 1-1213EM0.00hetero-3-1-1-mer48 x NAGHHblits0.61
7uz7.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-31
0.6899.170.95 1-1213EM0.00hetero-3-3-3-mer39 x NAG, 3 x NAG-NAGHHblits0.61
7uz7.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-31
0.6899.170.95 1-1213EM0.00hetero-3-3-3-mer39 x NAG, 3 x NAG-NAGHHblits0.61
7uz7.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-31
0.6899.170.95 1-1213EM0.00hetero-3-3-3-mer39 x NAG, 3 x NAG-NAGHHblits0.61
7uz6.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-28
0.6699.170.95 1-1213EM0.00hetero-3-3-3-mer39 x NAGHHblits0.61
7uz9.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-34
0.6799.170.95 1-1213EM0.00hetero-3-3-3-mer42 x NAGHHblits0.61
7uza.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, HSW-1
0.6799.170.95 1-1213EM0.00hetero-3-1-1-mer34 x NAG, 2 x NAG-NAGHHblits0.61
7uz5.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-6
0.6999.170.95 1-1213EM0.00hetero-3-1-1-mer48 x NAGHHblits0.61
7uz9.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-34
0.6799.170.95 1-1213EM0.00hetero-3-3-3-mer42 x NAGHHblits0.61
7uza.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, HSW-1
0.6599.170.95 1-1213EM0.00hetero-3-1-1-mer34 x NAG, 2 x NAG-NAGHHblits0.61
7uz6.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-28
0.6899.170.95 1-1213EM0.00hetero-3-3-3-mer39 x NAGHHblits0.61
7uz4.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-3
0.6899.170.95 1-1213EM0.00hetero-3-3-3-mer45 x NAG, 3 x NAG-NAGHHblits0.61
7uza.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, HSW-1
0.6699.170.95 1-1213EM0.00hetero-3-1-1-mer34 x NAG, 2 x NAG-NAGHHblits0.61
7uz5.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-6
0.6899.170.95 1-1213EM0.00hetero-3-1-1-mer48 x NAGHHblits0.61
7uz6.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-28
0.6799.170.95 1-1213EM0.00hetero-3-3-3-mer39 x NAGHHblits0.61
7uz4.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-3
0.6899.170.95 1-1213EM0.00hetero-3-3-3-mer45 x NAG, 3 x NAG-NAGHHblits0.61
7uzb.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S S1 doamin in complex with the mouse antibody Fab fragment, HSW-2
0.3699.170.95 1-1213EM0.00hetero-1-1-1-mer4 x NAGHHblits0.61
6zge.1.A
Spike glycoprotein
Uncleavable Spike Protein of SARS-CoV-2 in Closed Conformation
0.7199.670.95 1-1208EM0.00homo-trimer21 x NAG, 30 x NAG-NAGHHblits0.62
6zge.1.B
Spike glycoprotein
Uncleavable Spike Protein of SARS-CoV-2 in Closed Conformation
0.7199.670.95 1-1208EM0.00homo-trimer21 x NAG, 30 x NAG-NAGHHblits0.62
6zge.1.C
Spike glycoprotein
Uncleavable Spike Protein of SARS-CoV-2 in Closed Conformation
0.7199.670.95 1-1208EM0.00homo-trimer21 x NAG, 30 x NAG-NAGHHblits0.62
7nt9.1.B
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (closed conformation)
0.6799.670.95 1-1208EM0.00homo-trimer3 x BLA, 24 x NAG, 30 x NAG-NAGHHblits0.62
7nt9.1.A
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (closed conformation)
0.6799.670.95 1-1208EM0.00homo-trimer3 x BLA, 24 x NAG, 30 x NAG-NAGHHblits0.62
7nt9.1.C
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (closed conformation)
0.6799.670.95 1-1208EM0.00homo-trimer3 x BLA, 24 x NAG, 30 x NAG-NAGHHblits0.62
7nta.1.B
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect)
0.6799.670.95 1-1208EM0.00homo-trimer3 x BLA, 27 x NAG, 25 x NAG-NAGHHblits0.62
7nta.1.A
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect)
0.6799.670.95 1-1208EM0.00homo-trimer3 x BLA, 27 x NAG, 25 x NAG-NAGHHblits0.62
7ntc.1.B
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab
0.6599.670.95 1-1208EM0.00hetero-3-1-1-mer2 x BLA, 29 x NAG, 25 x NAG-NAGHHblits0.62
7ntc.1.C
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab
0.6499.670.95 1-1208EM0.00hetero-3-1-1-mer2 x BLA, 29 x NAG, 25 x NAG-NAGHHblits0.62
7ntc.1.A
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab
0.6499.670.95 1-1208EM0.00hetero-3-1-1-mer2 x BLA, 29 x NAG, 25 x NAG-NAGHHblits0.62
7nta.1.C
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect)
0.6699.670.95 1-1208EM0.00homo-trimer3 x BLA, 27 x NAG, 25 x NAG-NAGHHblits0.62
7zbu.1.A
Spike glycoprotein
CryoEM structure of SARS-CoV-2 spike monomer in complex with neutralising antibody P008_60
0.3999.670.95 1-1208EM0.00hetero-1-1-1-mer8 x NAG, 1 x 3Q9HHblits0.62
7ns6.1.G
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies
0.7099.010.95 1-1212EM0.00hetero-6-6-mer46 x NAG, 2 x NAG-NAG-BMAHHblits0.61
7ns6.1.H
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies
0.7099.010.95 1-1212EM0.00hetero-6-6-mer46 x NAG, 2 x NAG-NAG-BMAHHblits0.61
7ns6.1.I
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies
0.7299.010.95 1-1212EM0.00hetero-6-6-mer46 x NAG, 2 x NAG-NAG-BMAHHblits0.61
7ns6.1.J
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies
0.7099.010.95 1-1212EM0.00hetero-6-6-mer46 x NAG, 2 x NAG-NAG-BMAHHblits0.61
7ns6.1.K
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies
0.7099.010.95 1-1212EM0.00hetero-6-6-mer46 x NAG, 2 x NAG-NAG-BMAHHblits0.61
7ns6.1.L
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies
0.7199.010.95 1-1212EM0.00hetero-6-6-mer46 x NAG, 2 x NAG-NAG-BMAHHblits0.61
7kdk.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
0.6999.670.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7kdk.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
0.6999.670.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7kdk.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
0.6999.670.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7kdl.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
0.6999.670.95 1-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
7ke9.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6999.670.95 1-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
7kdl.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
0.6799.670.95 1-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
7ke9.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6799.670.95 1-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
7kdl.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
0.6899.670.95 1-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
7ke9.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6999.670.95 1-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
7ke4.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-class)
0.6899.670.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7ke4.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-class)
0.6999.670.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7ke4.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-class)
0.6899.670.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7ke6.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6999.670.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7ke6.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6999.670.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7ke6.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6999.670.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7ke7.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3-RBD-down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
0.6899.670.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7ke7.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3-RBD-down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
0.6999.670.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7ke7.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3-RBD-down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
0.6899.670.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7kea.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub classification)
0.6899.670.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.62
7kea.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub classification)
0.6699.670.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.62
7kea.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub classification)
0.6799.670.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.62
7keb.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6799.670.95 1-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
7keb.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6499.670.95 1-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
7keb.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6599.670.95 1-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
7kec.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
0.6399.670.95 1-1208EM0.00homo-trimer33 x NAG, 12 x NAG-NAGHHblits0.62
7kec.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
0.6299.670.95 1-1208EM0.00homo-trimer33 x NAG, 12 x NAG-NAGHHblits0.62
7kec.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
0.6599.670.95 1-1208EM0.00homo-trimer33 x NAG, 12 x NAG-NAGHHblits0.62
7ke8.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6999.670.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7ke8.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6999.670.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7ke8.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.7099.670.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
8c8p.1.B
Spike glycoprotein,SARS-CoV-2 spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 10D12 heavy-chain-only antibody (local refinement)
0.0199.010.95 1-1212EM0.00hetero-1-1-merHHblits0.61
7ej5.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45
0.6499.590.95 1-1207EM0.00hetero-3-3-3-mer24 x NAG, 24 x NAG-NAGHHblits0.61
7f63.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody chAb-45 (Focused refinement of S-RBD and chAb-45 region)
0.0399.590.95 1-1207EM0.00hetero-1-1-1-merHHblits0.61
7ej4.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25
0.6399.590.95 1-1207EM0.00hetero-3-3-3-mer21 x NAG, 27 x NAG-NAGHHblits0.61
7ej4.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25
0.6499.590.95 1-1207EM0.00hetero-3-3-3-mer21 x NAG, 27 x NAG-NAGHHblits0.61
7f62.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody chAb-25 (Focused refinement of S-RBD and chAb-25 region)
0.0399.590.95 1-1207EM0.00hetero-1-1-1-merHHblits0.61
7ej4.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25
0.6499.590.95 1-1207EM0.00hetero-3-3-3-mer21 x NAG, 27 x NAG-NAGHHblits0.61
7ej5.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45
0.6499.590.95 1-1207EM0.00hetero-3-3-3-mer24 x NAG, 24 x NAG-NAGHHblits0.61
7ej5.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45
0.6499.590.95 1-1207EM0.00hetero-3-3-3-mer24 x NAG, 24 x NAG-NAGHHblits0.61
7e5r.1.G
Spike glycoprotein
SARS-CoV-2 S trimer with three-antibody cocktail complex
0.6599.590.95 1-1208EM3.60hetero-3-3-3-3-3-3-…15 x NAG-NAGHHblits0.61
7e5r.1.N
Spike glycoprotein
SARS-CoV-2 S trimer with three-antibody cocktail complex
0.6599.590.95 1-1208EM3.60hetero-3-3-3-3-3-3-…15 x NAG-NAGHHblits0.61
7e5r.1.U
Spike glycoprotein
SARS-CoV-2 S trimer with three-antibody cocktail complex
0.6599.590.95 1-1208EM3.60hetero-3-3-3-3-3-3-…15 x NAG-NAGHHblits0.61
7e5s.1.B
Spike glycoprotein
SARS-CoV-2 S trimer with four-antibody cocktail complex
0.6299.590.95 1-1208EM3.60hetero-3-2-2-2-2-3-…12 x NAG-NAGHHblits0.61
7e5s.1.A
Spike glycoprotein
SARS-CoV-2 S trimer with four-antibody cocktail complex
0.6299.590.95 1-1208EM3.60hetero-3-2-2-2-2-3-…12 x NAG-NAGHHblits0.61
7e5s.1.C
Spike glycoprotein
SARS-CoV-2 S trimer with four-antibody cocktail complex
0.6399.590.95 1-1208EM3.60hetero-3-2-2-2-2-3-…12 x NAG-NAGHHblits0.61
7fb0.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in closed state
0.6699.590.95 1-1208EM0.00homo-trimerHHblits0.61
7fb0.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in closed state
0.6799.590.95 1-1208EM0.00homo-trimerHHblits0.61
7fb0.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in closed state
0.6799.590.95 1-1208EM0.00homo-trimerHHblits0.61
7fb1.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in one-RBD open state
0.6399.590.95 1-1208EM0.00homo-trimerHHblits0.61
7fb1.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in one-RBD open state
0.6399.590.95 1-1208EM0.00homo-trimerHHblits0.61
7fb1.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in one-RBD open state
0.6699.590.95 1-1208EM0.00homo-trimerHHblits0.61
7fb3.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in one-RBD weak state after CTSL-treatment
0.6699.590.95 1-1208EM0.00homo-trimerHHblits0.61
7fb4.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in two-RBD weak state after CTSL-treatment
0.5399.590.95 1-1208EM0.00homo-trimerHHblits0.61
7fb3.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in one-RBD weak state after CTSL-treatment
0.5599.590.95 1-1208EM0.00homo-trimerHHblits0.61
7fb4.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in two-RBD weak state after CTSL-treatment
0.5499.590.95 1-1208EM0.00homo-trimerHHblits0.61
7fb3.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in one-RBD weak state after CTSL-treatment
0.6699.590.95 1-1208EM0.00homo-trimerHHblits0.61
7fb4.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in two-RBD weak state after CTSL-treatment
0.6699.590.95 1-1208EM0.00homo-trimerHHblits0.61
7e3k.1.A
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
0.6799.590.95 1-1192EM0.00hetero-3-3-3-mer22 x NAGHHblits0.61
7e3l.1.A
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
0.6999.590.95 1-1192EM0.00hetero-3-3-3-mer20 x NAGHHblits0.61
7e3l.1.C
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
0.6999.590.95 1-1192EM0.00hetero-3-3-3-mer20 x NAGHHblits0.61
7e3k.1.C
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
0.6799.590.95 1-1192EM0.00hetero-3-3-3-mer22 x NAGHHblits0.61
7e3l.1.B
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
0.6999.590.95 1-1192EM0.00hetero-3-3-3-mer20 x NAGHHblits0.61
7e3k.1.B
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
0.6799.590.95 1-1192EM0.00hetero-3-3-3-mer22 x NAGHHblits0.61
7ws0.1.C
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7099.590.95 1-1192EM0.00hetero-3-3-3-mer30 x NAG, 18 x NAG-NAGHHblits0.61
7ws1.1.B
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7099.590.95 1-1192EM0.00hetero-3-4-4-mer30 x NAG, 18 x NAG-NAGHHblits0.61
7ws1.1.C
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7099.590.95 1-1192EM0.00hetero-3-4-4-mer30 x NAG, 18 x NAG-NAGHHblits0.61
7ws0.1.B
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7099.590.95 1-1192EM0.00hetero-3-3-3-mer30 x NAG, 18 x NAG-NAGHHblits0.61
7ws0.1.A
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7199.590.95 1-1192EM0.00hetero-3-3-3-mer30 x NAG, 18 x NAG-NAGHHblits0.61
7ws1.1.A
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7099.590.95 1-1192EM0.00hetero-3-4-4-mer30 x NAG, 18 x NAG-NAGHHblits0.61
7v26.1.B
Spike glycoprotein
XG005-bound SARS-CoV-2 S
0.6599.590.95 1-1192EM0.00hetero-3-3-3-mer45 x NAGHHblits0.61
7v26.1.A
Spike glycoprotein
XG005-bound SARS-CoV-2 S
0.6699.590.95 1-1192EM0.00hetero-3-3-3-mer45 x NAGHHblits0.61
7v26.1.C
Spike glycoprotein
XG005-bound SARS-CoV-2 S
0.6599.590.95 1-1192EM0.00hetero-3-3-3-mer45 x NAGHHblits0.61
7y7j.1.A
Spike glycoprotein
SARS-CoV-2 S trimer in complex with 1F Fab
0.6899.590.95 1-1192EM4.80hetero-3-1-1-mer26 x NAG, 15 x NAG-NAGHHblits0.61
7y7j.1.B
Spike glycoprotein
SARS-CoV-2 S trimer in complex with 1F Fab
0.6899.590.95 1-1192EM4.80hetero-3-1-1-mer26 x NAG, 15 x NAG-NAGHHblits0.61
7y7j.1.C
Spike glycoprotein
SARS-CoV-2 S trimer in complex with 1F Fab
0.6899.590.95 1-1192EM4.80hetero-3-1-1-mer26 x NAG, 15 x NAG-NAGHHblits0.61
7akd.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment
0.6599.590.95 1-1208EM0.00hetero-3-2-2-mer25 x NAG, 3 x FUC, 2 x MAN, 10 x NAG-NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x MAN-MANHHblits0.61
7akd.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment
0.6499.590.95 1-1208EM0.00hetero-3-2-2-mer25 x NAG, 3 x FUC, 2 x MAN, 10 x NAG-NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x MAN-MANHHblits0.61
7akd.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment
0.6499.590.95 1-1208EM0.00hetero-3-2-2-mer25 x NAG, 3 x FUC, 2 x MAN, 10 x NAG-NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x MAN-MANHHblits0.61
7oan.1.A
Spike glycoprotein
Nanobody C5 bound to Spike
0.7299.590.95 1-1208EM3.00hetero-3-3-mer36 x NAG, 15 x NAG-NAGHHblits0.61
7oan.1.B
Spike glycoprotein
Nanobody C5 bound to Spike
0.7299.590.95 1-1208EM3.00hetero-3-3-mer36 x NAG, 15 x NAG-NAGHHblits0.61
7oan.1.C
Spike glycoprotein
Nanobody C5 bound to Spike
0.7299.590.95 1-1208EM3.00hetero-3-3-mer36 x NAG, 15 x NAG-NAGHHblits0.61
7ddd.1.B
Spike glycoprotein
SARS-Cov2 S protein at close state
0.6799.590.95 1-1208EM0.00homo-trimerHHblits0.61
7ddd.1.C
Spike glycoprotein
SARS-Cov2 S protein at close state
0.6799.590.95 1-1208EM0.00homo-trimerHHblits0.61
7ddd.1.A
Spike glycoprotein
SARS-Cov2 S protein at close state
0.6799.590.95 1-1208EM0.00homo-trimerHHblits0.61
7df3.1.A
Spike glycoprotein
SARS-CoV-2 S trimer, S-closed
0.6899.590.95 1-1208EM0.00homo-trimer30 x NAG, 24 x NAG-NAGHHblits0.61
7df3.1.C
Spike glycoprotein
SARS-CoV-2 S trimer, S-closed
0.6899.590.95 1-1208EM0.00homo-trimer30 x NAG, 24 x NAG-NAGHHblits0.61
7df3.1.B
Spike glycoprotein
SARS-CoV-2 S trimer, S-closed
0.6899.590.95 1-1208EM0.00homo-trimer30 x NAG, 24 x NAG-NAGHHblits0.61
7ddn.1.C
Spike glycoprotein
SARS-Cov2 S protein at open state
0.6699.590.95 1-1208EM0.00homo-trimerHHblits0.61
7ddn.1.A
Spike glycoprotein
SARS-Cov2 S protein at open state
0.6699.590.95 1-1208EM0.00homo-trimerHHblits0.61
7dd8.1.C
Spike glycoprotein
S-3C1-F1 structure, one RBD is up and two RBDs are down, the up RBD binds with a 3C1 fab
0.6199.590.95 1-1208EM0.00hetero-1-1-3-merHHblits0.61
7dd8.1.D
Spike glycoprotein
S-3C1-F1 structure, one RBD is up and two RBDs are down, the up RBD binds with a 3C1 fab
0.6199.590.95 1-1208EM0.00hetero-1-1-3-merHHblits0.61
7dd8.1.E
Spike glycoprotein
S-3C1-F1 structure, one RBD is up and two RBDs are down, the up RBD binds with a 3C1 fab
0.6299.590.95 1-1208EM0.00hetero-1-1-3-merHHblits0.61
7ddn.1.B
Spike glycoprotein
SARS-Cov2 S protein at open state
0.6699.590.95 1-1208EM0.00homo-trimerHHblits0.61
7dk3.1.C
Spike glycoprotein
SARS-CoV-2 S trimer, S-open
0.6699.590.95 1-1208EM0.00homo-trimerHHblits0.61
7dk3.1.B
Spike glycoprotein
SARS-CoV-2 S trimer, S-open
0.6799.590.95 1-1208EM0.00homo-trimerHHblits0.61
7dk3.1.A
Spike glycoprotein
SARS-CoV-2 S trimer, S-open
0.6799.590.95 1-1208EM0.00homo-trimerHHblits0.61
7df4.1.D
Spike glycoprotein
SARS-CoV-2 S-ACE2 complex
0.6799.590.95 1-1208EM0.00hetero-1-3-mer36 x NAG, 18 x NAG-NAGHHblits0.61
7df4.1.C
Spike glycoprotein
SARS-CoV-2 S-ACE2 complex
0.6799.590.95 1-1208EM0.00hetero-1-3-mer36 x NAG, 18 x NAG-NAGHHblits0.61
7df4.1.B
Spike glycoprotein
SARS-CoV-2 S-ACE2 complex
0.6699.590.95 1-1208EM0.00hetero-1-3-mer36 x NAG, 18 x NAG-NAGHHblits0.61
7dd2.1.B
Spike glycoprotein
S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab.
0.6399.590.95 1-1208EM0.00hetero-3-2-2-merHHblits0.61
7dk5.1.E
Spike glycoprotein
S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab
0.6399.590.95 1-1208EM0.00hetero-3-1-1-merHHblits0.61
7dk5.1.B
Spike glycoprotein
S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab
0.6399.590.95 1-1208EM0.00hetero-3-1-1-merHHblits0.61
7dd2.1.A
Spike glycoprotein
S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab.
0.6399.590.95 1-1208EM0.00hetero-3-2-2-merHHblits0.61
7dk6.1.C
Spike glycoprotein
S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab.
0.6899.590.95 1-1208EM0.00hetero-3-2-2-merHHblits0.61
7dk7.1.I
Spike glycoprotein
S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab.
0.6199.590.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7dk7.1.D
Spike glycoprotein
S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab.
0.6599.590.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7dk4.1.D
Spike glycoprotein
S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab.
0.6899.590.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7dcc.1.D
Spike glycoprotein
S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with a 3C1 Fab
0.6599.590.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7dk6.1.A
Spike glycoprotein
S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab.
0.6899.590.95 1-1208EM0.00hetero-3-2-2-merHHblits0.61
7dcx.1.H
Spike glycoprotein
S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab.
0.6599.590.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7dk5.1.A
Spike glycoprotein
S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab
0.6299.590.95 1-1208EM0.00hetero-3-1-1-merHHblits0.61
7dk4.1.C
Spike glycoprotein
S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab.
0.6899.590.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7dcc.1.H
Spike glycoprotein
S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with a 3C1 Fab
0.6599.590.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7dcx.1.C
Spike glycoprotein
S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab.
0.6399.590.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7dd2.1.E
Spike glycoprotein
S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab.
0.6399.590.95 1-1208EM0.00hetero-3-2-2-merHHblits0.61
7dk6.1.B
Spike glycoprotein
S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab.
0.6799.590.95 1-1208EM0.00hetero-3-2-2-merHHblits0.61
7dk7.1.C
Spike glycoprotein
S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab.
0.6599.590.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7dcc.1.G
Spike glycoprotein
S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with a 3C1 Fab
0.6599.590.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7dcx.1.I
Spike glycoprotein
S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab.
0.6399.590.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7dk4.1.E
Spike glycoprotein
S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab.
0.6999.590.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7v2a.1.A
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with XG014 Fab
0.7099.590.95 1-1208EM3.40hetero-3-3-3-mer24 x NAGHHblits0.61
7v2a.1.E
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with XG014 Fab
0.7099.590.95 1-1208EM3.40hetero-3-3-3-mer24 x NAGHHblits0.61
7v2a.1.D
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with XG014 Fab
0.7099.590.95 1-1208EM3.40hetero-3-3-3-mer24 x NAGHHblits0.61
7jwb.1.B
Spike glycoprotein
SARS CoV2 Spike ectodomain with engineered trimerized VH binder
0.6799.590.95 1-1208EM0.00hetero-1-3-merHHblits0.61
7jwb.1.C
Spike glycoprotein
SARS CoV2 Spike ectodomain with engineered trimerized VH binder
0.6899.590.95 1-1208EM0.00hetero-1-3-merHHblits0.61
7kqe.1.C
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 3D11 complex
0.7099.590.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7m7b.1.A
Spike glycoprotein
SARS-CoV-2 Spike:Fab 3D11 complex focused refinement
0.0499.590.95 1-1208EM0.00hetero-1-1-1-mer2 x NAGHHblits0.61
7m71.1.A
Spike glycoprotein
SARS-CoV-2 Spike:5A6 Fab complex I focused refinement
0.0599.590.95 1-1208EM0.00hetero-2-1-1-mer4 x NAGHHblits0.61
7kqb.1.C
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 5A6 complex I
0.7099.590.95 1-1208EM0.00hetero-3-2-2-mer23 x NAGHHblits0.61
7kqb.1.B
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 5A6 complex I
0.7099.590.95 1-1208EM0.00hetero-3-2-2-mer23 x NAGHHblits0.61
7kqe.1.E
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 3D11 complex
0.7099.590.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7kqe.1.D
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 3D11 complex
0.7199.590.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7m71.1.B
Spike glycoprotein
SARS-CoV-2 Spike:5A6 Fab complex I focused refinement
0.0499.590.95 1-1208EM0.00hetero-2-1-1-mer4 x NAGHHblits0.61
7kqb.1.A
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 5A6 complex I
0.7199.590.95 1-1208EM0.00hetero-3-2-2-mer23 x NAGHHblits0.61
7jwb.1.D
Spike glycoprotein
SARS CoV2 Spike ectodomain with engineered trimerized VH binder
0.6799.590.95 1-1208EM0.00hetero-1-3-merHHblits0.61
8dv1.1.A
Spike glycoprotein
SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to linker variant of affinity matured ACE2 mimetic CVD432
0.0399.590.95 1-1208EM0.00hetero-1-1-mer7 x NAGHHblits0.61
8dv2.1.A
Spike glycoprotein
SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to computationally engineered ACE2 mimetic CVD293
0.0499.590.95 1-1208EM0.00hetero-1-1-mer7 x NAGHHblits0.61
8heb.1.B
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 1 conformation
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer27 x NAG, 18 x NAG-NAGHHblits0.61
8heb.1.C
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 1 conformation
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer27 x NAG, 18 x NAG-NAGHHblits0.61
8heb.1.A
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 1 conformation
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer27 x NAG, 18 x NAG-NAGHHblits0.61
8hec.1.B
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 2 conformation
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer27 x NAG, 17 x NAG-NAGHHblits0.61
8hec.1.C
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 2 conformation
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer27 x NAG, 17 x NAG-NAGHHblits0.61
8hec.1.A
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 2 conformation
0.6999.590.95 1-1208EM0.00hetero-3-3-3-mer27 x NAG, 17 x NAG-NAGHHblits0.61
7wcd.1.A
Spike glycoprotein
Cryo EM structure of SARS-CoV-2 spike in complex with TAU-2212 mAbs in conformation 4
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer33 x NAGHHblits0.61
7wcd.1.D
Spike glycoprotein
Cryo EM structure of SARS-CoV-2 spike in complex with TAU-2212 mAbs in conformation 4
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer33 x NAGHHblits0.61
7wcd.1.G
Spike glycoprotein
Cryo EM structure of SARS-CoV-2 spike in complex with TAU-2212 mAbs in conformation 4
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer33 x NAGHHblits0.61
7kni.1.B
Spike glycoprotein
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6399.590.95 1-1208EM0.00hetero-3-3-mer56 x NAG, 6 x NAG-NAGHHblits0.61
7kni.1.C
Spike glycoprotein
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6399.590.95 1-1208EM0.00hetero-3-3-mer56 x NAG, 6 x NAG-NAGHHblits0.61
7kmz.1.B
Spike glycoprotein
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4
0.6599.590.95 1-1208EM0.00hetero-3-2-mer53 x NAG, 4 x NAG-NAGHHblits0.61
6zxn.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1)
0.7399.590.95 1-1208EM0.00hetero-3-3-mer39 x NAG, 12 x NAG-NAGHHblits0.61
7a29.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation
0.7199.590.95 1-1208EM0.00hetero-3-3-mer45 x NAG, 8 x NAG-NAGHHblits0.61
7a29.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation
0.7299.590.95 1-1208EM0.00hetero-3-3-mer45 x NAG, 8 x NAG-NAGHHblits0.61
7a29.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation
0.7199.590.95 1-1208EM0.00hetero-3-3-mer45 x NAG, 8 x NAG-NAGHHblits0.61
6vsb.1.B
Spike glycoprotein
Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up
0.7099.590.95 1-1208EM0.00homo-trimer27 x NAG, 17 x NAG-NAGHHblits0.61
6zxn.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1)
0.7299.590.95 1-1208EM0.00hetero-3-3-mer39 x NAG, 12 x NAG-NAGHHblits0.61
6xey.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4
0.6799.590.95 1-1208EM0.00hetero-3-3-3-mer36 x NAG, 7 x NAG-NAG, 3 x NAG-NAG-BMA, 2 x NAG-BMAHHblits0.61
6xey.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4
0.6899.590.95 1-1208EM0.00hetero-3-3-3-mer36 x NAG, 7 x NAG-NAG, 3 x NAG-NAG-BMA, 2 x NAG-BMAHHblits0.61
6xey.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4
0.6899.590.95 1-1208EM0.00hetero-3-3-3-mer36 x NAG, 7 x NAG-NAG, 3 x NAG-NAG-BMA, 2 x NAG-BMAHHblits0.61
6vsb.1.A
Spike glycoprotein
Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up
0.6999.590.95 1-1208EM0.00homo-trimer27 x NAG, 17 x NAG-NAGHHblits0.61
6vsb.1.C
Spike glycoprotein
Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up
0.6999.590.95 1-1208EM0.00homo-trimer27 x NAG, 17 x NAG-NAGHHblits0.61
7ljr.1.B
Spike glycoprotein
SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab
0.6499.590.95 1-1208EM0.00hetero-3-1-1-merHHblits0.61
7ljr.1.A
Spike glycoprotein
SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab
0.6699.590.95 1-1208EM0.00hetero-3-1-1-merHHblits0.61
7ljr.1.C
Spike glycoprotein
SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab
0.6599.590.95 1-1208EM0.00hetero-3-1-1-merHHblits0.61
7l57.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15
0.6199.590.95 1-1208EM0.00hetero-3-1-1-mer31 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-NAG, 1 x NAG-NAG-BMA-NAGHHblits0.61
7kkk.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6
0.6999.590.95 1-1208EM0.00hetero-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.61
7kkk.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6
0.6999.590.95 1-1208EM0.00hetero-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.61
7kkk.1.E
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6
0.6999.590.95 1-1208EM0.00hetero-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.61
7l57.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15
0.6099.590.95 1-1208EM0.00hetero-3-1-1-mer31 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-NAG, 1 x NAG-NAG-BMA-NAGHHblits0.61
7l58.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4
0.6199.590.95 1-1208EM0.00hetero-3-1-1-mer33 x NAG, 4 x NAG-NAGHHblits0.61
7kkl.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6
0.7099.590.95 1-1208EM0.00hetero-3-3-mer27 x NAG, 18 x NAG-NAGHHblits0.61
7kkl.1.E
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6
0.7099.590.95 1-1208EM0.00hetero-3-3-mer27 x NAG, 18 x NAG-NAGHHblits0.61
7kkl.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6
0.7099.590.95 1-1208EM0.00hetero-3-3-mer27 x NAG, 18 x NAG-NAGHHblits0.61
7l57.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15
0.6199.590.95 1-1208EM0.00hetero-3-1-1-mer31 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-NAG, 1 x NAG-NAG-BMA-NAGHHblits0.61
7l58.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4
0.6499.590.95 1-1208EM0.00hetero-3-1-1-mer33 x NAG, 4 x NAG-NAGHHblits0.61
7l58.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4
0.6599.590.95 1-1208EM0.00hetero-3-1-1-mer33 x NAG, 4 x NAG-NAGHHblits0.61
7b18.1.A
Spike glycoprotein
SARS-CoV-spike bound to two neutralising nanobodies
0.6999.590.95 1-1208EM0.00hetero-3-3-3-mer42 x NAG, 1 x NAG-NAGHHblits0.61
7b18.1.B
Spike glycoprotein
SARS-CoV-spike bound to two neutralising nanobodies
0.7199.590.95 1-1208EM0.00hetero-3-3-3-mer42 x NAG, 1 x NAG-NAGHHblits0.61
7b18.1.C
Spike glycoprotein
SARS-CoV-spike bound to two neutralising nanobodies
0.7199.590.95 1-1208EM0.00hetero-3-3-3-mer42 x NAG, 1 x NAG-NAGHHblits0.61
7l2d.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6599.590.95 1-1208EM0.00hetero-3-1-1-mer34 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.61
7l2d.1.D
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6799.590.95 1-1208EM0.00hetero-3-1-1-mer34 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.61
7l2e.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6699.590.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 24 x NAG-NAGHHblits0.61
7l2e.1.B
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6699.590.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 24 x NAG-NAGHHblits0.61
7l2e.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6699.590.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 24 x NAG-NAGHHblits0.61
7l2f.1.B
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6699.590.95 1-1208EM0.00hetero-3-3-3-mer36 x NAG, 16 x NAG-NAG, 2 x NAG-NAG-BMAHHblits0.61
7l2f.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6699.590.95 1-1208EM0.00hetero-3-3-3-mer36 x NAG, 16 x NAG-NAG, 2 x NAG-NAG-BMAHHblits0.61
7l2d.1.E
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6799.590.95 1-1208EM0.00hetero-3-1-1-mer34 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.61
7l2f.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6699.590.95 1-1208EM0.00hetero-3-3-3-mer36 x NAG, 16 x NAG-NAG, 2 x NAG-NAG-BMAHHblits0.61
7ksg.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with nanobodies E
0.7099.590.95 1-1208EM0.00hetero-3-3-mer51 x NAGHHblits0.61
7ksg.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with nanobodies E
0.6999.590.95 1-1208EM0.00hetero-3-3-mer51 x NAGHHblits0.61
7ksg.1.B
Spike glycoprotein
SARS-CoV-2 spike in complex with nanobodies E
0.7099.590.95 1-1208EM0.00hetero-3-3-mer51 x NAGHHblits0.61
7ls9.1.D
Spike glycoprotein
Cryo-EM structure of neutralizing antibody 1-57 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6799.590.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 3 x NAG-NAG-BMA, 18 x NAG-NAGHHblits0.61
7ls9.1.G
Spike glycoprotein
Cryo-EM structure of neutralizing antibody 1-57 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6799.590.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 3 x NAG-NAG-BMA, 18 x NAG-NAGHHblits0.61
7ls9.1.A
Spike glycoprotein
Cryo-EM structure of neutralizing antibody 1-57 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6799.590.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 3 x NAG-NAG-BMA, 18 x NAG-NAGHHblits0.61
7lss.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7
0.5299.590.95 1-1208EM0.00hetero-3-1-1-mer30 x NAG, 6 x NAG-NAGHHblits0.61
7lss.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7
0.6899.590.95 1-1208EM0.00hetero-3-1-1-mer30 x NAG, 6 x NAG-NAGHHblits0.61
7lss.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7
0.5299.590.95 1-1208EM0.00hetero-3-1-1-mer30 x NAG, 6 x NAG-NAGHHblits0.61
7kne.1.C
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
0.6299.590.95 1-1208EM0.00hetero-3-1-mer44 x NAG, 6 x NAG-NAGHHblits0.61
7kms.1.B
Spike glycoprotein
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6699.590.95 1-1208EM0.00hetero-3-3-mer55 x NAG, 8 x NAG-NAGHHblits0.61
7knh.1.B
Spike glycoprotein
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6399.590.95 1-1208EM0.00hetero-3-2-mer48 x NAG, 4 x NAG-NAGHHblits0.61
7kne.1.B
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
0.6399.590.95 1-1208EM0.00hetero-3-1-mer44 x NAG, 6 x NAG-NAGHHblits0.61
7knb.1.B
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6499.590.95 1-1208EM0.00hetero-3-1-mer46 x NAG, 5 x NAG-NAGHHblits0.61
7kms.1.D
Spike glycoprotein
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6799.590.95 1-1208EM0.00hetero-3-3-mer55 x NAG, 8 x NAG-NAGHHblits0.61
7knh.1.D
Spike glycoprotein
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6399.590.95 1-1208EM0.00hetero-3-2-mer48 x NAG, 4 x NAG-NAGHHblits0.61
7kmz.1.D
Spike glycoprotein
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4
0.6599.590.95 1-1208EM0.00hetero-3-2-mer53 x NAG, 4 x NAG-NAGHHblits0.61
6zxn.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1)
0.7399.590.95 1-1208EM0.00hetero-3-3-mer39 x NAG, 12 x NAG-NAGHHblits0.61
7knh.1.A
Spike glycoprotein
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6599.590.95 1-1208EM0.00hetero-3-2-mer48 x NAG, 4 x NAG-NAGHHblits0.61
7kmz.1.A
Spike glycoprotein
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4
0.6799.590.95 1-1208EM0.00hetero-3-2-mer53 x NAG, 4 x NAG-NAGHHblits0.61
7knb.1.A
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6599.590.95 1-1208EM0.00hetero-3-1-mer46 x NAG, 5 x NAG-NAGHHblits0.61
7kne.1.A
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
0.6499.590.95 1-1208EM0.00hetero-3-1-mer44 x NAG, 6 x NAG-NAGHHblits0.61
7knb.1.C
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6299.590.95 1-1208EM0.00hetero-3-1-mer46 x NAG, 5 x NAG-NAGHHblits0.61
7kni.1.A
Spike glycoprotein
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6299.590.95 1-1208EM0.00hetero-3-3-mer56 x NAG, 6 x NAG-NAGHHblits0.61
7kms.1.C
Spike glycoprotein
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6699.590.95 1-1208EM0.00hetero-3-3-mer55 x NAG, 8 x NAG-NAGHHblits0.61
7mw2.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with all RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 21 x NAG-NAGHHblits0.61
7mw2.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with all RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 21 x NAG-NAGHHblits0.61
7mw2.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with all RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 21 x NAG-NAGHHblits0.61
7mw5.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 2
0.6899.590.95 1-1208EM0.00hetero-3-3-3-mer25 x NAG, 29 x NAG-NAGHHblits0.61
7q1z.1.B
Spike glycoprotein
Structure of formaldehyde cross-linked SARS-CoV-2 S glycoprotein
0.6999.590.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.61
7q1z.1.A
Spike glycoprotein
Structure of formaldehyde cross-linked SARS-CoV-2 S glycoprotein
0.6999.590.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.61
7q1z.1.C
Spike glycoprotein
Structure of formaldehyde cross-linked SARS-CoV-2 S glycoprotein
0.6999.590.95 1-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.61
7mw6.1.F
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with three RBDs up in complex with the Fab fragment of human neutralizing antibody clone 2
0.7199.590.95 1-1208EM0.00hetero-3-3-3-mer21 x NAG, 33 x NAG-NAGHHblits0.61
7mw4.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 6
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer28 x NAG, 23 x NAG-NAGHHblits0.61
7mw3.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 21 x NAG-NAGHHblits0.61
7mw4.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 6
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer28 x NAG, 23 x NAG-NAGHHblits0.61
7mw3.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 21 x NAG-NAGHHblits0.61
7mw6.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with three RBDs up in complex with the Fab fragment of human neutralizing antibody clone 2
0.7199.590.95 1-1208EM0.00hetero-3-3-3-mer21 x NAG, 33 x NAG-NAGHHblits0.61
7mw5.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 2
0.6799.590.95 1-1208EM0.00hetero-3-3-3-mer25 x NAG, 29 x NAG-NAGHHblits0.61
7mw4.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 6
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer28 x NAG, 23 x NAG-NAGHHblits0.61
7mw5.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 2
0.6899.590.95 1-1208EM0.00hetero-3-3-3-mer25 x NAG, 29 x NAG-NAGHHblits0.61
7mw6.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with three RBDs up in complex with the Fab fragment of human neutralizing antibody clone 2
0.7199.590.95 1-1208EM0.00hetero-3-3-3-mer21 x NAG, 33 x NAG-NAGHHblits0.61
7mw3.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 21 x NAG-NAGHHblits0.61
7p79.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation.
0.6799.590.95 1-1208EM0.00hetero-3-3-mer19 x NAG, 4 x NAG-NAG-BMA, 8 x NAG-NAG, 3 x NAG-BMA, 1 x NAG-NAG-NAGHHblits0.61
7p78.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation
0.6899.590.95 1-1208EM0.00hetero-3-3-2-mer19 x NAG, 11 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-NAG-NAGHHblits0.61
7p79.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation.
0.6599.590.95 1-1208EM0.00hetero-3-3-mer19 x NAG, 4 x NAG-NAG-BMA, 8 x NAG-NAG, 3 x NAG-BMA, 1 x NAG-NAG-NAGHHblits0.61
7p79.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation.
0.6399.590.95 1-1208EM0.00hetero-3-3-mer19 x NAG, 4 x NAG-NAG-BMA, 8 x NAG-NAG, 3 x NAG-BMA, 1 x NAG-NAG-NAGHHblits0.61
7p78.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation
0.6299.590.95 1-1208EM0.00hetero-3-3-2-mer19 x NAG, 11 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-NAG-NAGHHblits0.61
7p77.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation
0.6499.590.95 1-1208EM0.00hetero-3-3-3-mer29 x NAG, 10 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMA, 1 x NAG-NAG-NAGHHblits0.61
7p77.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation
0.6599.590.95 1-1208EM0.00hetero-3-3-3-mer29 x NAG, 10 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMA, 1 x NAG-NAG-NAGHHblits0.61
7p78.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation
0.6699.590.95 1-1208EM0.00hetero-3-3-2-mer19 x NAG, 11 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-NAG-NAGHHblits0.61
7p77.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation
0.6699.590.95 1-1208EM0.00hetero-3-3-3-mer29 x NAG, 10 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMA, 1 x NAG-NAG-NAGHHblits0.61
7ks9.1.D
Spike glycoprotein
Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab
0.6999.590.95 1-1208EM0.00hetero-1-1-3-mer35 x NAG, 12 x NAG-NAGHHblits0.61
7ks9.1.E
Spike glycoprotein
Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab
0.6899.590.95 1-1208EM0.00hetero-1-1-3-mer35 x NAG, 12 x NAG-NAGHHblits0.61
7ks9.1.C
Spike glycoprotein
Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab
0.6899.590.95 1-1208EM0.00hetero-1-1-3-mer35 x NAG, 12 x NAG-NAGHHblits0.61
7x7n.1.B
Spike glycoprotein
3D model of the 3-RBD up single trimeric spike protein of SARS-CoV2 in the presence of synthetic peptide SIH-5.
0.5999.590.95 1-1208EM0.00hetero-3-6-mer39 x NAGHHblits0.61
7n5h.1.A
Spike glycoprotein
Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6999.590.95 1-1208EM0.00hetero-3-3-3-mer9 x NAG, 16 x NAG-NAGHHblits0.61
7n5h.1.C
Spike glycoprotein
Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer9 x NAG, 16 x NAG-NAGHHblits0.61
7n5h.1.B
Spike glycoprotein
Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6999.590.95 1-1208EM0.00hetero-3-3-3-mer9 x NAG, 16 x NAG-NAGHHblits0.61
7x7n.1.A
Spike glycoprotein
3D model of the 3-RBD up single trimeric spike protein of SARS-CoV2 in the presence of synthetic peptide SIH-5.
0.5999.590.95 1-1208EM0.00hetero-3-6-mer39 x NAGHHblits0.61
7x7n.1.C
Spike glycoprotein
3D model of the 3-RBD up single trimeric spike protein of SARS-CoV2 in the presence of synthetic peptide SIH-5.
0.6099.590.95 1-1208EM0.00hetero-3-6-mer39 x NAGHHblits0.61
7rw2.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-7 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6599.590.95 1-1208EM0.00hetero-3-3-3-mer48 x NAG, 6 x NAG-NAGHHblits0.61
7rw2.1.B
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-7 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6599.590.95 1-1208EM0.00hetero-3-3-3-mer48 x NAG, 6 x NAG-NAGHHblits0.61
7rw2.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-7 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6599.590.95 1-1208EM0.00hetero-3-3-3-mer48 x NAG, 6 x NAG-NAGHHblits0.61
6zow.1.B
Spike glycoprotein
SARS-CoV-2 spike in prefusion state
0.6799.590.95 1-1208EM0.00homo-tetramer18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMAHHblits0.61
6zp7.1.B
Spike glycoprotein
SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up open conformation)
0.6799.590.95 1-1208EM0.00homo-trimer18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMAHHblits0.61
6zp5.1.B
Spike glycoprotein
SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up closed conformation)
0.6799.590.95 1-1208EM0.00homo-trimer18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMAHHblits0.61
6zow.1.A
Spike glycoprotein
SARS-CoV-2 spike in prefusion state
0.5299.590.95 1-1208EM0.00homo-tetramer18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMAHHblits0.61
6zp5.1.A
Spike glycoprotein
SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up closed conformation)
0.6899.590.95 1-1208EM0.00homo-trimer18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMAHHblits0.61
6zp7.1.A
Spike glycoprotein
SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up open conformation)
0.6899.590.95 1-1208EM0.00homo-trimer18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMAHHblits0.61
6zp7.1.C
Spike glycoprotein
SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up open conformation)
0.6399.590.95 1-1208EM0.00homo-trimer18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMAHHblits0.61
6zp5.1.C
Spike glycoprotein
SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up closed conformation)
0.6399.590.95 1-1208EM0.00homo-trimer18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMAHHblits0.61
6zow.1.C
Spike glycoprotein
SARS-CoV-2 spike in prefusion state
0.6399.590.95 1-1208EM0.00homo-tetramer18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMAHHblits0.61
6zow.1.D
Spike glycoprotein
SARS-CoV-2 spike in prefusion state
0.0399.590.95 1-1208EM0.00homo-tetramer18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMAHHblits0.61
8dxs.1.B
Spike glycoprotein
Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6699.590.95 1-1208EM0.00hetero-3-3-3-mer44 x NAGHHblits0.61
8dxs.1.A
Spike glycoprotein
Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6799.590.95 1-1208EM0.00hetero-3-3-3-mer44 x NAGHHblits0.61
8dxs.1.C
Spike glycoprotein
Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6699.590.95 1-1208EM0.00hetero-3-3-3-mer44 x NAGHHblits0.61
7l56.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43
0.6899.590.95 1-1208EM0.00hetero-3-3-3-mer31 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-NAG-GAL-MAN-MANHHblits0.61
7l56.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43
0.6899.590.95 1-1208EM0.00hetero-3-3-3-mer31 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-NAG-GAL-MAN-MANHHblits0.61
7l56.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43
0.6899.590.95 1-1208EM0.00hetero-3-3-3-mer31 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-NAG-GAL-MAN-MANHHblits0.61
7nd3.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab
0.6899.590.95 1-1208EM0.00hetero-3-1-1-mer27 x NAG, 11 x NAG-NAGHHblits0.61
7ndb.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-253H165L Fab
0.6899.590.95 1-1208EM0.00hetero-3-1-1-mer27 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7nd5.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab
0.6899.590.95 1-1208EM0.00hetero-3-1-1-mer27 x NAG, 11 x NAG-NAGHHblits0.61
7nd6.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab
0.6899.590.95 1-1208EM0.00hetero-3-1-1-mer27 x NAG, 11 x NAG-NAGHHblits0.61
6z43.1.B
Spike glycoprotein
Cryo-EM Structure of SARS-CoV-2 Spike : H11-D4 Nanobody Complex
0.6999.590.95 1-1208EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
7nd5.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab
0.7099.590.95 1-1208EM0.00hetero-3-1-1-mer27 x NAG, 11 x NAG-NAGHHblits0.61
7nd6.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab
0.7099.590.95 1-1208EM0.00hetero-3-1-1-mer27 x NAG, 11 x NAG-NAGHHblits0.61
7nd3.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab
0.7099.590.95 1-1208EM0.00hetero-3-1-1-mer27 x NAG, 11 x NAG-NAGHHblits0.61
7nd5.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab
0.6999.590.95 1-1208EM0.00hetero-3-1-1-mer27 x NAG, 11 x NAG-NAGHHblits0.61
7nd6.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab
0.6999.590.95 1-1208EM0.00hetero-3-1-1-mer27 x NAG, 11 x NAG-NAGHHblits0.61
7nd3.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab
0.6999.590.95 1-1208EM0.00hetero-3-1-1-mer27 x NAG, 11 x NAG-NAGHHblits0.61
6z43.1.A
Spike glycoprotein
Cryo-EM Structure of SARS-CoV-2 Spike : H11-D4 Nanobody Complex
0.7099.590.95 1-1208EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
6z43.1.C
Spike glycoprotein
Cryo-EM Structure of SARS-CoV-2 Spike : H11-D4 Nanobody Complex
0.6899.590.95 1-1208EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGHHblits0.61
7nd8.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab
0.7099.590.95 1-1208EM0.00hetero-3-1-1-mer30 x NAG, 15 x NAG-NAGHHblits0.61
7nd8.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab
0.7099.590.95 1-1208EM0.00hetero-3-1-1-mer30 x NAG, 15 x NAG-NAGHHblits0.61
7nda.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-253H55L Fab
0.6999.590.95 1-1208EM0.00hetero-3-1-1-mer32 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7ndc.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-159
0.7199.590.95 1-1208EM0.00hetero-3-3-3-mer24 x NAG, 15 x NAG-NAGHHblits0.61
7ndd.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-159
0.7199.590.95 1-1208EM0.00hetero-3-3-3-mer24 x NAG, 15 x NAG-NAGHHblits0.61
7ndc.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-159
0.7199.590.95 1-1208EM0.00hetero-3-3-3-mer24 x NAG, 15 x NAG-NAGHHblits0.61
7ndd.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-159
0.7199.590.95 1-1208EM0.00hetero-3-3-3-mer24 x NAG, 15 x NAG-NAGHHblits0.61
7ndc.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-159
0.7199.590.95 1-1208EM0.00hetero-3-3-3-mer24 x NAG, 15 x NAG-NAGHHblits0.61
7ndb.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-253H165L Fab
0.6999.590.95 1-1208EM0.00hetero-3-1-1-mer27 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7nd9.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-253H55L Fab
0.6999.590.95 1-1208EM0.00hetero-3-1-1-mer27 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7nd7.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab
0.6999.590.95 1-1208EM0.00hetero-3-3-3-mer25 x NAG, 15 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.61
7nd7.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab
0.6999.590.95 1-1208EM0.00hetero-3-3-3-mer25 x NAG, 15 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.61
7nd7.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab
0.6999.590.95 1-1208EM0.00hetero-3-3-3-mer25 x NAG, 15 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.61
7nd4.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-88 Fab
0.6999.590.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMAHHblits0.61
7nd4.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-88 Fab
0.6999.590.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMAHHblits0.61
7nd4.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-88 Fab
0.6999.590.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMAHHblits0.61
7nd9.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-253H55L Fab
0.7299.590.95 1-1208EM0.00hetero-3-1-1-mer27 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7nd8.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab
0.6999.590.95 1-1208EM0.00hetero-3-1-1-mer30 x NAG, 15 x NAG-NAGHHblits0.61
7ndd.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-159
0.7099.590.95 1-1208EM0.00hetero-3-3-3-mer24 x NAG, 15 x NAG-NAGHHblits0.61
7nd9.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-253H55L Fab
0.6999.590.95 1-1208EM0.00hetero-3-1-1-mer27 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7nda.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-253H55L Fab
0.6999.590.95 1-1208EM0.00hetero-3-1-1-mer32 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7nda.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-253H55L Fab
0.6999.590.95 1-1208EM0.00hetero-3-1-1-mer32 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7ndb.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-253H165L Fab
0.7099.590.95 1-1208EM0.00hetero-3-1-1-mer27 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
6zdh.1.B
Spike glycoprotein
SARS-CoV-2 Spike glycoprotein in complex with a neutralizing antibody EY6A Fab
0.6999.590.95 1-1208EM0.00hetero-3-3-3-mer23 x NAG, 13 x NAG-NAGHHblits0.61
6zdh.1.A
Spike glycoprotein
SARS-CoV-2 Spike glycoprotein in complex with a neutralizing antibody EY6A Fab
0.6999.590.95 1-1208EM0.00hetero-3-3-3-mer23 x NAG, 13 x NAG-NAGHHblits0.61
6zdh.1.C
Spike glycoprotein
SARS-CoV-2 Spike glycoprotein in complex with a neutralizing antibody EY6A Fab
0.6999.590.95 1-1208EM0.00hetero-3-3-3-mer23 x NAG, 13 x NAG-NAGHHblits0.61
7byr.1.A
Spike glycoprotein
BD23-Fab in complex with the S ectodomain trimer
0.6899.590.95 1-1208EM0.00hetero-3-1-1-mer32 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7byr.1.B
Spike glycoprotein
BD23-Fab in complex with the S ectodomain trimer
0.6899.590.95 1-1208EM0.00hetero-3-1-1-mer32 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7byr.1.C
Spike glycoprotein
BD23-Fab in complex with the S ectodomain trimer
0.6999.590.95 1-1208EM0.00hetero-3-1-1-mer32 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7bnn.1.A
Spike glycoprotein
Open conformation of D614G SARS-CoV-2 spike with 1 Erect RBD
0.6699.590.95 1-1208EM0.00homo-trimer33 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7bnn.1.B
Spike glycoprotein
Open conformation of D614G SARS-CoV-2 spike with 1 Erect RBD
0.6799.590.95 1-1208EM0.00homo-trimer33 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7bnn.1.C
Spike glycoprotein
Open conformation of D614G SARS-CoV-2 spike with 1 Erect RBD
0.6899.590.95 1-1208EM0.00homo-trimer33 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7zce.1.B
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike protein in complex with the single chain fragment scFv76
0.6698.930.95 1-1212EM0.00hetero-3-3-mer27 x NAG, 12 x NAG-NAGHHblits0.61
7zcf.1.A
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike RBD in complex with the single chain fragment scFv76 (Focused Refinement)
0.0198.930.95 1-1212EM0.00hetero-1-1-mer1 x NAGHHblits0.61
7zce.1.C
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike protein in complex with the single chain fragment scFv76
0.6498.930.95 1-1212EM0.00hetero-3-3-mer27 x NAG, 12 x NAG-NAGHHblits0.61
7zce.1.A
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike protein in complex with the single chain fragment scFv76
0.6598.930.95 1-1212EM0.00hetero-3-3-mer27 x NAG, 12 x NAG-NAGHHblits0.61
7fce.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 A372T spike glycoprotein (closed)
0.7299.500.95 1-1208EM0.00homo-trimer24 x NAG, 27 x NAG-NAGHHblits0.61
7fce.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 A372T spike glycoprotein (closed)
0.7299.500.95 1-1208EM0.00homo-trimer24 x NAG, 27 x NAG-NAGHHblits0.61
7fce.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 A372T spike glycoprotein (closed)
0.7299.500.95 1-1208EM0.00homo-trimer24 x NAG, 27 x NAG-NAGHHblits0.61
7fcd.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 A372T spike glycoprotein (open)
0.7199.500.95 1-1208EM0.00homo-trimer35 x NAGHHblits0.61
7fcd.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 A372T spike glycoprotein (open)
0.7199.500.95 1-1208EM0.00homo-trimer35 x NAGHHblits0.61
7fcd.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 A372T spike glycoprotein (open)
0.7099.500.95 1-1208EM0.00homo-trimer35 x NAGHHblits0.61
7r4q.1.A
Spike glycoprotein
The SARS-CoV-2 spike in complex with the 1.29 neutralizing nanobody
0.7199.500.95 1-1208EM0.00hetero-3-2-mer33 x NAG, 5 x NAG-NAGHHblits0.61
7r4q.1.C
Spike glycoprotein
The SARS-CoV-2 spike in complex with the 1.29 neutralizing nanobody
0.7199.500.95 1-1208EM0.00hetero-3-2-mer33 x NAG, 5 x NAG-NAGHHblits0.61
7r4i.1.B
Spike glycoprotein
The SARS-CoV-2 spike in complex with the 2.15 neutralizing nanobody
0.6799.500.95 1-1208EM0.00hetero-3-2-mer33 x NAG, 5 x NAG-NAGHHblits0.61
7r4i.1.C
Spike glycoprotein
The SARS-CoV-2 spike in complex with the 2.15 neutralizing nanobody
0.6799.500.95 1-1208EM0.00hetero-3-2-mer33 x NAG, 5 x NAG-NAGHHblits0.61
7r4i.1.A
Spike glycoprotein
The SARS-CoV-2 spike in complex with the 2.15 neutralizing nanobody
0.6799.500.95 1-1208EM0.00hetero-3-2-mer33 x NAG, 5 x NAG-NAGHHblits0.61
7r4q.1.B
Spike glycoprotein
The SARS-CoV-2 spike in complex with the 1.29 neutralizing nanobody
0.7299.500.95 1-1208EM0.00hetero-3-2-mer33 x NAG, 5 x NAG-NAGHHblits0.61
7r4r.1.A
Spike glycoprotein
The SARS-CoV-2 spike in complex with the 1.10 neutralizing nanobody
0.6099.500.95 1-1208EM0.00hetero-3-1-mer33 x NAG, 5 x NAG-NAGHHblits0.61
7r4r.1.B
Spike glycoprotein
The SARS-CoV-2 spike in complex with the 1.10 neutralizing nanobody
0.6099.500.95 1-1208EM0.00hetero-3-1-mer33 x NAG, 5 x NAG-NAGHHblits0.61
7r4r.1.C
Spike glycoprotein
The SARS-CoV-2 spike in complex with the 1.10 neutralizing nanobody
0.6099.500.95 1-1208EM0.00hetero-3-1-mer33 x NAG, 5 x NAG-NAGHHblits0.61
7eh5.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-D614G variant in complex with neutralizing antibodies, RBD-chAb15 and RBD-chAb45
0.6399.500.95 1-1207EM0.00hetero-3-3-3-3-3-mer21 x NAG, 27 x NAG-NAGHHblits0.61
7eh5.1.J
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-D614G variant in complex with neutralizing antibodies, RBD-chAb15 and RBD-chAb45
0.6399.500.95 1-1207EM0.00hetero-3-3-3-3-3-mer21 x NAG, 27 x NAG-NAGHHblits0.61
7eh5.1.K
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-D614G variant in complex with neutralizing antibodies, RBD-chAb15 and RBD-chAb45
0.6399.500.95 1-1207EM0.00hetero-3-3-3-3-3-mer21 x NAG, 27 x NAG-NAGHHblits0.61
7eaz.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 1
0.6399.500.95 1-1207EM0.00homo-trimer16 x NAG, 2 x NAG-NAG-BMA, 30 x NAG-NAGHHblits0.61
7eaz.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 1
0.6299.500.95 1-1207EM0.00homo-trimer16 x NAG, 2 x NAG-NAG-BMA, 30 x NAG-NAGHHblits0.61
7eb0.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 2
0.6299.500.95 1-1207EM0.00homo-trimer19 x NAG, 3 x NAG-NAG-BMA, 26 x NAG-NAGHHblits0.61
7eb0.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 2
0.6299.500.95 1-1207EM0.00homo-trimer19 x NAG, 3 x NAG-NAG-BMA, 26 x NAG-NAGHHblits0.61
7eb3.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 3
0.6399.500.95 1-1207EM0.00homo-trimer18 x NAG, 1 x NAG-NAG-BMA, 29 x NAG-NAGHHblits0.61
7eb4.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 1
0.6299.500.95 1-1207EM0.00homo-trimer16 x NAG, 1 x NAG-NAG-BMA, 28 x NAG-NAGHHblits0.61
7eb3.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 3
0.6299.500.95 1-1207EM0.00homo-trimer18 x NAG, 1 x NAG-NAG-BMA, 29 x NAG-NAGHHblits0.61
7eb3.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 3
0.6199.500.95 1-1207EM0.00homo-trimer18 x NAG, 1 x NAG-NAG-BMA, 29 x NAG-NAGHHblits0.61
7eb4.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 1
0.6199.500.95 1-1207EM0.00homo-trimer16 x NAG, 1 x NAG-NAG-BMA, 28 x NAG-NAGHHblits0.61
7eb4.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 1
0.6199.500.95 1-1207EM0.00homo-trimer16 x NAG, 1 x NAG-NAG-BMA, 28 x NAG-NAGHHblits0.61
7eb5.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 2
0.6199.500.95 1-1207EM0.00homo-trimer20 x NAG, 27 x NAG-NAGHHblits0.61
7eb5.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 2
0.6299.500.95 1-1207EM0.00homo-trimer20 x NAG, 27 x NAG-NAGHHblits0.61
7eb5.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 2
0.6199.500.95 1-1207EM0.00homo-trimer20 x NAG, 27 x NAG-NAGHHblits0.61
7eaz.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 1
0.6399.500.95 1-1207EM0.00homo-trimer16 x NAG, 2 x NAG-NAG-BMA, 30 x NAG-NAGHHblits0.61
7eb0.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 2
0.6199.500.95 1-1207EM0.00homo-trimer19 x NAG, 3 x NAG-NAG-BMA, 26 x NAG-NAGHHblits0.61
7wo4.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 dimer trimer )
0.6699.500.95 1-1192EM0.00hetero-6-6-6-mer90 x NAGHHblits0.61
7wo4.1.J
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 dimer trimer )
0.6699.500.95 1-1192EM0.00hetero-6-6-6-mer90 x NAGHHblits0.61
7wo5.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 trimer)
0.6799.500.95 1-1192EM0.00hetero-3-3-3-mer45 x NAGHHblits0.61
7wo4.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 dimer trimer )
0.6799.500.95 1-1192EM0.00hetero-6-6-6-mer90 x NAGHHblits0.61
7wo4.1.K
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 dimer trimer )
0.6699.500.95 1-1192EM0.00hetero-6-6-6-mer90 x NAGHHblits0.61
7wo5.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 trimer)
0.6799.500.95 1-1192EM0.00hetero-3-3-3-mer45 x NAGHHblits0.61
7wo4.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 dimer trimer )
0.6599.500.95 1-1192EM0.00hetero-6-6-6-mer90 x NAGHHblits0.61
7wo5.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 trimer)
0.6699.500.95 1-1192EM0.00hetero-3-3-3-mer45 x NAGHHblits0.61
7wo4.1.L
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 dimer trimer )
0.6599.500.95 1-1192EM0.00hetero-6-6-6-mer90 x NAGHHblits0.61
7woa.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-60 (1-up trimer)
0.6899.500.95 1-1192EM0.00hetero-3-2-2-mer39 x NAGHHblits0.61
7woa.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-60 (1-up trimer)
0.6899.500.95 1-1192EM0.00hetero-3-2-2-mer39 x NAGHHblits0.61
7wob.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-60 (2-up trimer)
0.6899.500.95 1-1192EM0.00hetero-3-3-3-mer38 x NAGHHblits0.61
7woa.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-60 (1-up trimer)
0.6799.500.95 1-1192EM0.00hetero-3-2-2-mer39 x NAGHHblits0.61
7wob.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-60 (2-up trimer)
0.6899.500.95 1-1192EM0.00hetero-3-3-3-mer38 x NAGHHblits0.61
7wob.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-60 (2-up trimer)
0.6899.500.95 1-1192EM0.00hetero-3-3-3-mer38 x NAGHHblits0.61
7wz2.1.A
Spike glycoprotein
SARS-CoV-2 (D614G) Spike trimer
0.6899.500.95 1-1192EM0.00homo-trimer34 x NAGHHblits0.61
7wz2.1.B
Spike glycoprotein
SARS-CoV-2 (D614G) Spike trimer
0.6899.500.95 1-1192EM0.00homo-trimer34 x NAGHHblits0.61
7wz2.1.C
Spike glycoprotein
SARS-CoV-2 (D614G) Spike trimer
0.6999.500.95 1-1192EM0.00homo-trimer34 x NAGHHblits0.61
7vq0.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein (2-up RBD) bound to neutralizing nanobodies P86
0.7099.500.95 1-1208EM0.00hetero-3-3-mer28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7vq0.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein (2-up RBD) bound to neutralizing nanobodies P86
0.7199.500.95 1-1208EM0.00hetero-3-3-mer28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7vq0.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein (2-up RBD) bound to neutralizing nanobodies P86
0.6999.500.95 1-1208EM0.00hetero-3-3-mer28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANHHblits0.61
7lww.1.A
Spike glycoprotein
Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 1-RBD-up conformation (S-GSAS-D614G-K417N-E484K-N501Y)
0.6999.420.95 1-1208EM0.00homo-trimer26 x NAG, 12 x NAG-NAGHHblits0.61
7lww.1.B
Spike glycoprotein
Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 1-RBD-up conformation (S-GSAS-D614G-K417N-E484K-N501Y)
0.6999.420.95 1-1208EM0.00homo-trimer26 x NAG, 12 x NAG-NAGHHblits0.61
7lww.1.C
Spike glycoprotein
Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 1-RBD-up conformation (S-GSAS-D614G-K417N-E484K-N501Y)
0.6999.420.95 1-1208EM0.00homo-trimer26 x NAG, 12 x NAG-NAGHHblits0.61
8csa.1.B
Spike glycoprotein
Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 3-RBD-up conformation (S-GSAS-D614G-K417N-E484K-N501Y)
0.6799.420.95 1-1208EM0.00homo-trimerHHblits0.61
8csa.1.C
Spike glycoprotein
Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 3-RBD-up conformation (S-GSAS-D614G-K417N-E484K-N501Y)
0.6799.420.95 1-1208EM0.00homo-trimerHHblits0.61
8csa.1.A
Spike glycoprotein
Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 3-RBD-up conformation (S-GSAS-D614G-K417N-E484K-N501Y)
0.6699.420.95 1-1208EM0.00homo-trimerHHblits0.61
7tla.1.A
Spike glycoprotein
Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 1
0.7099.420.95 1-1208EM0.00homo-trimerHHblits0.61
7tlb.1.A
Spike glycoprotein
Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 2
0.6999.420.95 1-1208EM0.00homo-trimerHHblits0.61
7tla.1.B
Spike glycoprotein
Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 1
0.6899.420.95 1-1208EM0.00homo-trimerHHblits0.61
7tla.1.C
Spike glycoprotein
Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 1
0.6999.420.95 1-1208EM0.00homo-trimerHHblits0.61
7tlb.1.B
Spike glycoprotein
Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 2
0.6999.420.95 1-1208EM0.00homo-trimerHHblits0.61
7tlb.1.C
Spike glycoprotein
Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 2
0.6999.420.95 1-1208EM0.00homo-trimerHHblits0.61
7e8c.1.A
Spike glycoprotein
SARS-CoV-2 S-6P in complex with 9 Fabs
0.6999.340.95 1-1208EM0.00hetero-3-3-3-3-3-3-…HHblits0.61
7e8c.1.B
Spike glycoprotein
SARS-CoV-2 S-6P in complex with 9 Fabs
0.7099.340.95 1-1208EM0.00hetero-3-3-3-3-3-3-…HHblits0.61
7e8c.1.C
Spike glycoprotein
SARS-CoV-2 S-6P in complex with 9 Fabs
0.6999.340.95 1-1208EM0.00hetero-3-3-3-3-3-3-…HHblits0.61
7cak.1.A
Spike glycoprotein
SARS-CoV-2 S trimer with three RBD in the open state and complexed with three H014 Fab
0.6699.340.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAGHHblits0.61
7cak.1.B
Spike glycoprotein
SARS-CoV-2 S trimer with three RBD in the open state and complexed with three H014 Fab
0.6699.340.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAGHHblits0.61
7cak.1.C
Spike glycoprotein
SARS-CoV-2 S trimer with three RBD in the open state and complexed with three H014 Fab
0.6699.340.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAGHHblits0.61
7cai.1.B
Spike glycoprotein
SARS-CoV-2 S trimer with two RBDs in the open state and complexed with two H014 Fab
0.6699.340.95 1-1208EM0.00hetero-3-2-2-mer30 x NAG, 15 x NAG-NAGHHblits0.61
7cai.1.C
Spike glycoprotein
SARS-CoV-2 S trimer with two RBDs in the open state and complexed with two H014 Fab
0.6799.340.95 1-1208EM0.00hetero-3-2-2-mer30 x NAG, 15 x NAG-NAGHHblits0.61
7cai.1.A
Spike glycoprotein
SARS-CoV-2 S trimer with two RBDs in the open state and complexed with two H014 Fab
0.6799.340.95 1-1208EM0.00hetero-3-2-2-mer30 x NAG, 15 x NAG-NAGHHblits0.61
7cyp.1.B
SARS-CoV-2 Spike glycoprotein
Complex of SARS-CoV-2 spike trimer with its neutralizing antibody HB27
0.6699.340.95 1-1208EM0.00hetero-3-3-3-mer29 x NAG, 15 x NAG-NAGHHblits0.61
7cyp.1.A
SARS-CoV-2 Spike glycoprotein
Complex of SARS-CoV-2 spike trimer with its neutralizing antibody HB27
0.6699.340.95 1-1208EM0.00hetero-3-3-3-mer29 x NAG, 15 x NAG-NAGHHblits0.61
7cyp.1.C
SARS-CoV-2 Spike glycoprotein
Complex of SARS-CoV-2 spike trimer with its neutralizing antibody HB27
0.6699.340.95 1-1208EM0.00hetero-3-3-3-mer29 x NAG, 15 x NAG-NAGHHblits0.61
7z3z.1.A
Spike glycoprotein
Locked Wuhan SARS-CoV2 Prefusion Spike ectodomain with lipid bound
0.7199.340.95 1-1208EM0.00homo-trimer36 x NAG, 3 x STE, 15 x NAG-NAGHHblits0.61
7z3z.1.B
Spike glycoprotein
Locked Wuhan SARS-CoV2 Prefusion Spike ectodomain with lipid bound
0.7199.340.95 1-1208EM0.00homo-trimer36 x NAG, 3 x STE, 15 x NAG-NAGHHblits0.61
7z3z.1.C
Spike glycoprotein
Locked Wuhan SARS-CoV2 Prefusion Spike ectodomain with lipid bound
0.7199.340.95 1-1208EM0.00homo-trimer36 x NAG, 3 x STE, 15 x NAG-NAGHHblits0.61
7x8w.1.A
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab354
0.0399.250.95 1-1208EM0.00hetero-1-1-1-mer1 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUCHHblits0.61
7x8y.1.A
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab159
0.0199.250.95 1-1208EM0.00hetero-1-1-1-mer1 x NAGHHblits0.61
7x8z.1.A
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab188
0.0299.250.95 1-1208EM0.00hetero-1-1-1-mer1 x NAGHHblits0.61
7x90.1.C
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab326
0.0199.250.95 1-1208EM0.00hetero-1-1-1-mer1 x NAG-NAGHHblits0.61
7x91.1.A
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with an Fv-clasp form of a human neutralizing antibody Ab496
0.0399.250.95 1-1208EM0.00hetero-1-1-1-mer1 x NAG-NAGHHblits0.61
7x92.1.A
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab445
0.0299.250.95 1-1208EM0.00hetero-1-1-1-mer1 x NAG-NAGHHblits0.61
7x93.1.B
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765
0.0499.250.95 1-1208EM0.00hetero-3-1-1-mer1 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MANHHblits0.61
7x95.1.A
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab709
0.0399.250.95 1-1208EM0.00hetero-1-1-1-mer1 x NAG-NAGHHblits0.61
7x94.1.A
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab712
0.0299.250.95 1-1208EM0.00hetero-1-1-1-merHHblits0.61
7x93.1.E
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765
0.0399.250.95 1-1208EM0.00hetero-3-1-1-mer1 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MANHHblits0.61
7x96.1.A
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab847
0.0299.250.95 1-1208EM0.00hetero-1-1-1-merHHblits0.61
7x93.1.A
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765
0.0399.250.95 1-1208EM0.00hetero-3-1-1-mer1 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MANHHblits0.61
7sn2.1.A
Spike glycoprotein
Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab
0.0199.250.95 1-1208EM0.00hetero-1-1-1-merHHblits0.61
7sn3.1.A
Spike glycoprotein
Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (variable region)
0.6499.250.95 1-1208EM0.00hetero-3-3-3-mer45 x NAG, 3 x NAG-NAG-BMAHHblits0.61
7sn3.1.B
Spike glycoprotein
Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (variable region)
0.6499.250.95 1-1208EM0.00hetero-3-3-3-mer45 x NAG, 3 x NAG-NAG-BMAHHblits0.61
7sn3.1.C
Spike glycoprotein
Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (variable region)
0.6399.250.95 1-1208EM0.00hetero-3-3-3-mer45 x NAG, 3 x NAG-NAG-BMAHHblits0.61
7kl9.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4)
0.6799.250.95 1-1208EM0.00hetero-3-3-mer27 x NAG, 2 x NAG-NAGHHblits0.61
7kl9.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4)
0.6599.250.95 1-1208EM0.00hetero-3-3-mer27 x NAG, 2 x NAG-NAGHHblits0.61
7kl9.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4)
0.6699.250.95 1-1208EM0.00hetero-3-3-mer27 x NAG, 2 x NAG-NAGHHblits0.61
7fae.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P36-5D2(state2)
0.6999.250.95 1-1208EM0.00hetero-3-3-3-mer27 x NAG, 17 x NAG-NAGHHblits0.61
7fae.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P36-5D2(state2)
0.6999.250.95 1-1208EM0.00hetero-3-3-3-mer27 x NAG, 17 x NAG-NAGHHblits0.61
7fae.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P36-5D2(state2)
0.6999.250.95 1-1208EM0.00hetero-3-3-3-mer27 x NAG, 17 x NAG-NAGHHblits0.61
7faf.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P36-5D2 (state1)
0.6999.250.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7faf.1.H
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P36-5D2 (state1)
0.6899.250.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7faf.1.I
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P36-5D2 (state1)
0.6799.250.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7xmz.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three D2 Fab
0.6999.250.95 1-1208EM0.00hetero-3-3-3-mer32 x NAGHHblits0.61
7xmx.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three F61 Fab
0.6599.250.95 1-1208EM0.00hetero-3-3-3-mer24 x NAGHHblits0.61
7xmx.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three F61 Fab
0.6699.250.95 1-1208EM0.00hetero-3-3-3-mer24 x NAGHHblits0.61
7xmz.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three D2 Fab
0.6999.250.95 1-1208EM0.00hetero-3-3-3-mer32 x NAGHHblits0.61
7xmz.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three D2 Fab
0.6999.250.95 1-1208EM0.00hetero-3-3-3-mer32 x NAGHHblits0.61
7xmx.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three F61 Fab
0.6599.250.95 1-1208EM0.00hetero-3-3-3-mer24 x NAGHHblits0.61
8bev.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike (HexaPro variant) in complex with nanobody W25 (map 3, focus refinement on RBD, W25 and adjacent NTD)
0.0199.250.95 1-1208EM0.00hetero-2-1-mer1 x NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAGHHblits0.61
8bev.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike (HexaPro variant) in complex with nanobody W25 (map 3, focus refinement on RBD, W25 and adjacent NTD)
0.0599.250.95 1-1208EM0.00hetero-2-1-mer1 x NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAGHHblits0.61
7yeg.1.A
Spike glycoprotein
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2
0.6299.250.95 1-1208EM0.00hetero-3-3-3-3-mer36 x NAG, 3 x ZN, 6 x NAG-NAGHHblits0.61
7ye9.1.C
Spike glycoprotein
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs
0.6299.250.95 1-1208EM0.00hetero-3-3-3-mer24 x NAG, 6 x NAG-NAGHHblits0.61
7yeg.1.B
Spike glycoprotein
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2
0.6299.250.95 1-1208EM0.00hetero-3-3-3-3-mer36 x NAG, 3 x ZN, 6 x NAG-NAGHHblits0.61
7yeg.1.C
Spike glycoprotein
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2
0.6299.250.95 1-1208EM0.00hetero-3-3-3-3-mer36 x NAG, 3 x ZN, 6 x NAG-NAGHHblits0.61
7ye9.1.A
Spike glycoprotein
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs
0.6299.250.95 1-1208EM0.00hetero-3-3-3-mer24 x NAG, 6 x NAG-NAGHHblits0.61
7ye9.1.B
Spike glycoprotein
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs
0.6299.250.95 1-1208EM0.00hetero-3-3-3-mer24 x NAG, 6 x NAG-NAGHHblits0.61
7chh.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with BD-368-2 Fabs
0.7099.250.95 1-1208EM0.00hetero-3-3-3-mer31 x NAG, 5 x NAG-NAGHHblits0.61
7chh.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with BD-368-2 Fabs
0.7099.250.95 1-1208EM0.00hetero-3-3-3-mer31 x NAG, 5 x NAG-NAGHHblits0.61
7u0p.1.A
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-S21F2
0.6199.250.95 1-1208EM0.00hetero-3-2-2-mer22 x NAG, 5 x NAG-NAGHHblits0.61
7u0p.1.C
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-S21F2
0.6299.250.95 1-1208EM0.00hetero-3-2-2-mer22 x NAG, 5 x NAG-NAGHHblits0.61
7u0p.1.B
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-S21F2
0.6299.250.95 1-1208EM0.00hetero-3-2-2-mer22 x NAG, 5 x NAG-NAGHHblits0.61
7u0q.1.C
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-02
0.6899.250.95 1-1208EM0.00hetero-3-2-2-mer23 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7u0x.1.B
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-13
0.6699.250.95 1-1208EM0.00hetero-3-2-2-mer29 x NAG, 15 x NAG-NAGHHblits0.61
7u0x.1.A
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-13
0.6699.250.95 1-1208EM0.00hetero-3-2-2-mer29 x NAG, 15 x NAG-NAGHHblits0.61
7u0x.1.C
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-13
0.6699.250.95 1-1208EM0.00hetero-3-2-2-mer29 x NAG, 15 x NAG-NAGHHblits0.61
7u0q.1.B
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-02
0.6899.250.95 1-1208EM0.00hetero-3-2-2-mer23 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7u0q.1.A
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-02
0.6899.250.95 1-1208EM0.00hetero-3-2-2-mer23 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7uow.1.B
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 034_32
0.6699.250.95 1-1208EM0.00hetero-3-2-2-mer23 x NAG, 12 x NAG-NAGHHblits0.61
7uow.1.C
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 034_32
0.6399.250.95 1-1208EM0.00hetero-3-2-2-mer23 x NAG, 12 x NAG-NAGHHblits0.61
7uow.1.A
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 034_32
0.6699.250.95 1-1208EM0.00hetero-3-2-2-mer23 x NAG, 12 x NAG-NAGHHblits0.61
7chh.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with BD-368-2 Fabs
0.7099.250.95 1-1208EM0.00hetero-3-3-3-mer31 x NAG, 5 x NAG-NAGHHblits0.61
8hc4.1.B
Spike glycoprotein
SARS-CoV-2 wildtype spike trimer (6P) in complex with 3 YB9-258 Fabs and 3 R1-32 Fabs (3 RBD up)
0.6699.250.95 1-1208EM0.00hetero-3-3-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.61
7ydy.1.C
Spike glycoprotein
SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab
0.6199.250.95 1-1208EM0.00hetero-3-1-1-mer24 x NAG, 6 x NAG-NAGHHblits0.61
7ye5.1.C
Spike glycoprotein
SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs
0.6199.250.95 1-1208EM0.00hetero-3-1-1-mer24 x NAG, 6 x NAG-NAGHHblits0.61
7ydy.1.B
Spike glycoprotein
SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab
0.6199.250.95 1-1208EM0.00hetero-3-1-1-mer24 x NAG, 6 x NAG-NAGHHblits0.61
7ye5.1.B
Spike glycoprotein
SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs
0.6199.250.95 1-1208EM0.00hetero-3-1-1-mer24 x NAG, 6 x NAG-NAGHHblits0.61
7ydy.1.A
Spike glycoprotein
SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab
0.6299.250.95 1-1208EM0.00hetero-3-1-1-mer24 x NAG, 6 x NAG-NAGHHblits0.61
7ye5.1.A
Spike glycoprotein
SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs
0.6299.250.95 1-1208EM0.00hetero-3-1-1-mer24 x NAG, 6 x NAG-NAGHHblits0.61
8hc4.1.C
Spike glycoprotein
SARS-CoV-2 wildtype spike trimer (6P) in complex with 3 YB9-258 Fabs and 3 R1-32 Fabs (3 RBD up)
0.6699.250.95 1-1208EM0.00hetero-3-3-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.61
8hc4.1.A
Spike glycoprotein
SARS-CoV-2 wildtype spike trimer (6P) in complex with 3 YB9-258 Fabs and 3 R1-32 Fabs (3 RBD up)
0.6699.250.95 1-1208EM0.00hetero-3-3-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.61
7rq6.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with non-neutralizing NTD-directed CV3-13 Fab isolated from convalescent individual
0.6299.250.95 1-1208EM0.00hetero-3-3-3-mer36 x NAG, 3 x NAG-NAGHHblits0.61
7rq6.1.D
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with non-neutralizing NTD-directed CV3-13 Fab isolated from convalescent individual
0.6299.250.95 1-1208EM0.00hetero-3-3-3-mer36 x NAG, 3 x NAG-NAGHHblits0.61
7rq6.1.G
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with non-neutralizing NTD-directed CV3-13 Fab isolated from convalescent individual
0.6299.250.95 1-1208EM0.00hetero-3-3-3-mer36 x NAG, 3 x NAG-NAGHHblits0.61
7jzl.1.E
Spike glycoprotein
SARS-CoV-2 spike in complex with LCB1 (2RBDs open)
0.6999.250.95 1-1208EM0.00hetero-3-3-mer33 x NAG, 13 x NAG-NAGHHblits0.61
7jzl.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with LCB1 (2RBDs open)
0.6999.250.95 1-1208EM0.00hetero-3-3-mer33 x NAG, 13 x NAG-NAGHHblits0.61
7jzm.1.B
Spike glycoprotein
SARS-CoV-2 spike in complex with LCB3 (local refinement of the RBD and LCB3)
0.0499.250.95 1-1208EM0.00hetero-1-1-merHHblits0.61
7jzn.1.E
Spike glycoprotein
SARS-CoV-2 spike in complex with LCB3 (2RBDs open)
0.7099.250.95 1-1208EM0.00hetero-3-3-mer33 x NAG, 13 x NAG-NAGHHblits0.61
7jzn.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with LCB3 (2RBDs open)
0.7099.250.95 1-1208EM0.00hetero-3-3-mer33 x NAG, 13 x NAG-NAGHHblits0.61
7jzu.1.B
Spike glycoprotein
SARS-CoV-2 spike in complex with LCB1 (local refinement of the RBD and LCB1)
0.0399.250.95 1-1208EM0.00hetero-1-1-merHHblits0.61
7k45.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment (local refinement of the RBD and Fab variable domains)
0.0399.250.95 1-1208EM0.00hetero-1-1-1-mer1 x NAG-NAGHHblits0.61
7ral.1.C
Spike glycoprotein
SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains)
0.0499.250.95 1-1208EM0.00hetero-1-1-1-mer1 x NAGHHblits0.61
7r7n.1.B
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment (local refinement of the RBD and S2D106)
0.0399.250.95 1-1208EM0.00hetero-1-1-1-merHHblits0.61
7tas.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (local refinement of the RBD and S2K146)
0.0499.250.95 1-1208EM0.00hetero-1-1-1-merHHblits0.61
6xkl.1.B
Spike glycoprotein
SARS-CoV-2 HexaPro S One RBD up
0.7099.250.95 1-1208EM0.00homo-trimer28 x NAG, 11 x NAG-NAGHHblits0.61
6xkl.1.A
Spike glycoprotein
SARS-CoV-2 HexaPro S One RBD up
0.6899.250.95 1-1208EM0.00homo-trimer28 x NAG, 11 x NAG-NAGHHblits0.61
6xkl.1.C
Spike glycoprotein
SARS-CoV-2 HexaPro S One RBD up
0.7099.250.95 1-1208EM0.00homo-trimer28 x NAG, 11 x NAG-NAGHHblits0.61
7jzn.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with LCB3 (2RBDs open)
0.7099.250.95 1-1208EM0.00hetero-3-3-mer33 x NAG, 13 x NAG-NAGHHblits0.61
7jzl.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with LCB1 (2RBDs open)
0.7099.250.95 1-1208EM0.00hetero-3-3-mer33 x NAG, 13 x NAG-NAGHHblits0.61
7k4n.1.G
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment
0.6999.250.95 1-1208EM0.00hetero-3-3-3-mer33 x NAG, 15 x NAG-NAGHHblits0.61
7k4n.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment
0.6999.250.95 1-1208EM0.00hetero-3-3-3-mer33 x NAG, 15 x NAG-NAGHHblits0.61
7k4n.1.D
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment
0.6999.250.95 1-1208EM0.00hetero-3-3-3-mer33 x NAG, 15 x NAG-NAGHHblits0.61
7k90.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C144
0.6999.250.95 1-1208EM0.00hetero-3-3-3-mer33 x NAGHHblits0.61
7k90.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C144
0.6999.250.95 1-1208EM0.00hetero-3-3-3-mer33 x NAGHHblits0.61
7k90.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C144
0.6999.250.95 1-1208EM0.00hetero-3-3-3-mer33 x NAGHHblits0.61
7lxy.1.A
Spike glycoprotein
SARS-CoV-2 S/S2M11/S2X333 Global Refinement
0.7199.250.95 1-1208EM0.00hetero-3-3-3-3-3-mer45 x NAG, 3 x NAG-NAG-BMA-FUC, 6 x NAG-NAGHHblits0.61
7lxw.1.C
Spike glycoprotein
SARS-CoV-2 S/S2M11/S2X333 Local Refinement
0.0099.250.95 1-1208EM2.80hetero-1-1-1-mer1 x NAG-NAG-FUC, 1 x NAG-FUCHHblits0.61
7ly2.1.A
Spike glycoprotein
SARS-CoV-2 S/S2M11/S2M28 Global Refinement
0.7399.250.95 1-1208EM0.00hetero-3-3-3-3-3-mer45 x NAG, 3 x NAG-NAG-BMA-FUC, 6 x NAG-NAGHHblits0.61
7ly2.1.K
Spike glycoprotein
SARS-CoV-2 S/S2M11/S2M28 Global Refinement
0.7399.250.95 1-1208EM0.00hetero-3-3-3-3-3-mer45 x NAG, 3 x NAG-NAG-BMA-FUC, 6 x NAG-NAGHHblits0.61
7ly2.1.F
Spike glycoprotein
SARS-CoV-2 S/S2M11/S2M28 Global Refinement
0.7399.250.95 1-1208EM0.00hetero-3-3-3-3-3-mer45 x NAG, 3 x NAG-NAG-BMA-FUC, 6 x NAG-NAGHHblits0.61
7lxy.1.F
Spike glycoprotein
SARS-CoV-2 S/S2M11/S2X333 Global Refinement
0.7199.250.95 1-1208EM0.00hetero-3-3-3-3-3-mer45 x NAG, 3 x NAG-NAG-BMA-FUC, 6 x NAG-NAGHHblits0.61
7lxy.1.K
Spike glycoprotein
SARS-CoV-2 S/S2M11/S2X333 Global Refinement
0.7199.250.95 1-1208EM0.00hetero-3-3-3-3-3-mer45 x NAG, 3 x NAG-NAG-BMA-FUC, 6 x NAG-NAGHHblits0.61
7lxz.1.F
Spike glycoprotein
SARS-CoV-2 S/S2M11/S2L28 Global Refinement
0.7199.250.95 1-1208EM0.00hetero-3-3-3-3-3-mer39 x NAG, 3 x NAG-NAG-BMA-FUC, 9 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.61
7lxx.1.C
Spike glycoprotein
SARS-CoV-2 S/S2M11/S2L28 Local Refinement
0.0099.250.95 1-1208EM0.00hetero-1-1-1-mer1 x NAG, 1 x NAG-NAG-FUCHHblits0.61
7lxz.1.K
Spike glycoprotein
SARS-CoV-2 S/S2M11/S2L28 Global Refinement
0.7199.250.95 1-1208EM0.00hetero-3-3-3-3-3-mer39 x NAG, 3 x NAG-NAG-BMA-FUC, 9 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.61
7lxz.1.A
Spike glycoprotein
SARS-CoV-2 S/S2M11/S2L28 Global Refinement
0.7199.250.95 1-1208EM0.00hetero-3-3-3-3-3-mer39 x NAG, 3 x NAG-NAG-BMA-FUC, 9 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.61
7ly0.1.A
Spike glycoprotein
SARS-CoV-2 S/S2M11/S2M28 Local Refinement
0.0099.250.95 1-1208EM0.00hetero-1-1-1-mer2 x NAG, 1 x NAG-NAG-MAN-FUCHHblits0.61
7tat.1.B
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (two receptor-binding domains open)
0.7099.250.95 1-1208EM0.00hetero-3-3-3-mer37 x NAG, 8 x NAG-NAGHHblits0.61
7tat.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (two receptor-binding domains open)
0.6999.250.95 1-1208EM0.00hetero-3-3-3-mer37 x NAG, 8 x NAG-NAGHHblits0.61
7tat.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (two receptor-binding domains open)
0.7199.250.95 1-1208EM0.00hetero-3-3-3-mer37 x NAG, 8 x NAG-NAGHHblits0.61
7uhc.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with AHB2-2GS-SB175
0.6999.250.95 1-1208EM0.00hetero-3-3-mer36 x NAG, 12 x NAG-NAGHHblits0.61
7uhc.1.E
Spike glycoprotein
SARS-CoV-2 spike in complex with AHB2-2GS-SB175
0.6999.250.95 1-1208EM0.00hetero-3-3-mer36 x NAG, 12 x NAG-NAGHHblits0.61
7uhc.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with AHB2-2GS-SB175
0.6999.250.95 1-1208EM0.00hetero-3-3-mer36 x NAG, 12 x NAG-NAGHHblits0.61
7m6f.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG1-22
0.6999.250.95 1-1208EM0.00hetero-3-2-2-mer33 x NAG, 15 x NAG-NAGHHblits0.61
7m6g.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15
0.6799.250.95 1-1208EM0.00hetero-3-2-2-mer26 x NAG, 11 x NAG-NAGHHblits0.61
7m6g.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15
0.6699.250.95 1-1208EM0.00hetero-3-2-2-mer26 x NAG, 11 x NAG-NAGHHblits0.61
7m6e.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG10-19
0.7099.250.95 1-1208EM0.00hetero-3-3-3-mer32 x NAG, 1 x NAG-NAG-FUCHHblits0.61
7m6e.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG10-19
0.7099.250.95 1-1208EM0.00hetero-3-3-3-mer32 x NAG, 1 x NAG-NAG-FUCHHblits0.61
7m6e.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG10-19
0.7099.250.95 1-1208EM0.00hetero-3-3-3-mer32 x NAG, 1 x NAG-NAG-FUCHHblits0.61
7m6f.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG1-22
0.6899.250.95 1-1208EM0.00hetero-3-2-2-mer33 x NAG, 15 x NAG-NAGHHblits0.61
7m6f.1.E
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG1-22
0.6899.250.95 1-1208EM0.00hetero-3-2-2-mer33 x NAG, 15 x NAG-NAGHHblits0.61
7m6g.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15
0.6699.250.95 1-1208EM0.00hetero-3-2-2-mer26 x NAG, 11 x NAG-NAGHHblits0.61
7my2.1.C
Spike glycoprotein
CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike
0.6799.250.95 1-1208EM0.00hetero-3-3-mer29 x NAG, 11 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMAHHblits0.61
7my2.1.A
Spike glycoprotein
CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike
0.6799.250.95 1-1208EM0.00hetero-3-3-mer29 x NAG, 11 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMAHHblits0.61
7my3.1.B
Spike glycoprotein
CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike
0.6699.250.95 1-1208EM0.00hetero-3-3-mer22 x NAG, 5 x NAG-NAG-BMA, 13 x NAG-NAGHHblits0.61
7my3.1.A
Spike glycoprotein
CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike
0.6999.250.95 1-1208EM0.00hetero-3-3-mer22 x NAG, 5 x NAG-NAG-BMA, 13 x NAG-NAGHHblits0.61
7my3.1.C
Spike glycoprotein
CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike
0.6799.250.95 1-1208EM0.00hetero-3-3-mer22 x NAG, 5 x NAG-NAG-BMA, 13 x NAG-NAGHHblits0.61
7my2.1.B
Spike glycoprotein
CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike
0.6799.250.95 1-1208EM0.00hetero-3-3-mer29 x NAG, 11 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMAHHblits0.61
7ra8.1.A
Spike glycoprotein
SARS-CoV-2 S glycoprotein in complex with S2X259 Fab
0.6799.250.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.61
7ra8.1.G
Spike glycoprotein
SARS-CoV-2 S glycoprotein in complex with S2X259 Fab
0.6799.250.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.61
7ra8.1.D
Spike glycoprotein
SARS-CoV-2 S glycoprotein in complex with S2X259 Fab
0.6799.250.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.61
7n0g.1.B
Spike glycoprotein
CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45)
0.6999.250.95 1-1208EM0.00hetero-3-3-mer35 x NAG, 19 x NAG-NAGHHblits0.61
7n0h.1.C
Spike glycoprotein
CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45)
0.6899.250.95 1-1208EM0.00hetero-3-2-mer30 x NAG, 17 x NAG-NAGHHblits0.61
7n0h.1.B
Spike glycoprotein
CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45)
0.6899.250.95 1-1208EM0.00hetero-3-2-mer30 x NAG, 17 x NAG-NAGHHblits0.61
7n0g.1.A
Spike glycoprotein
CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45)
0.6899.250.95 1-1208EM0.00hetero-3-3-mer35 x NAG, 19 x NAG-NAGHHblits0.61
7n0h.1.A
Spike glycoprotein
CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45)
0.6899.250.95 1-1208EM0.00hetero-3-2-mer30 x NAG, 17 x NAG-NAGHHblits0.61
7n0g.1.C
Spike glycoprotein
CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45)
0.6899.250.95 1-1208EM0.00hetero-3-3-mer35 x NAG, 19 x NAG-NAGHHblits0.61
7p7a.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#68 in a 2up/1flexible conformation
0.6499.250.95 1-1208EM0.00hetero-3-2-mer28 x NAG, 10 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMA, 1 x NAG-NAG-NAGHHblits0.61
7p7a.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#68 in a 2up/1flexible conformation
0.5399.250.95 1-1208EM0.00hetero-3-2-mer28 x NAG, 10 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMA, 1 x NAG-NAG-NAGHHblits0.61
7p7b.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody no68 in a 1up/2down conformation
0.6699.250.95 1-1208EM0.00homo-trimerHHblits0.61
7p7b.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody no68 in a 1up/2down conformation
0.6699.250.95 1-1208EM0.00homo-trimerHHblits0.61
7p7a.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#68 in a 2up/1flexible conformation
0.6499.250.95 1-1208EM0.00hetero-3-2-mer28 x NAG, 10 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMA, 1 x NAG-NAG-NAGHHblits0.61
7p7b.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody no68 in a 1up/2down conformation
0.6799.250.95 1-1208EM0.00homo-trimerHHblits0.61
7f46.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab (state1, local refinement of the RBD, NTD and 35B5 Fab)
0.0299.250.95 1-1208EM0.00hetero-2-1-1-mer2 x NAGHHblits0.61
7e9p.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(state2, local refinement of the RBD and 35B5 Fab)
0.0299.250.95 1-1208EM0.00hetero-1-1-1-mer1 x NAGHHblits0.61
7f46.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab (state1, local refinement of the RBD, NTD and 35B5 Fab)
0.0199.250.95 1-1208EM0.00hetero-2-1-1-mer2 x NAGHHblits0.61
7e9o.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(3 up RBDs, state2)
0.6699.250.95 1-1208EM0.00hetero-3-3-3-mer27 x NAGHHblits0.61
7e9o.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(3 up RBDs, state2)
0.6799.250.95 1-1208EM0.00hetero-3-3-3-mer27 x NAGHHblits0.61
7e9q.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 out RBD, state3)
0.6599.250.95 1-1208EM0.00hetero-3-3-3-mer27 x NAGHHblits0.61
7eng.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30 (local refinement of the RBD and Fab30)
0.0399.250.95 1-1208EM0.00hetero-1-1-1-mer1 x NAG-NAGHHblits0.61
7e9q.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 out RBD, state3)
0.6399.250.95 1-1208EM0.00hetero-3-3-3-mer27 x NAGHHblits0.61
7enf.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30
0.6999.250.95 1-1208EM0.00hetero-3-1-1-mer27 x NAG, 13 x NAG-NAGHHblits0.61
7e9o.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(3 up RBDs, state2)
0.6799.250.95 1-1208EM0.00hetero-3-3-3-mer27 x NAGHHblits0.61
7enf.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30
0.7099.250.95 1-1208EM0.00hetero-3-1-1-mer27 x NAG, 13 x NAG-NAGHHblits0.61
7e9q.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 out RBD, state3)
0.6499.250.95 1-1208EM0.00hetero-3-3-3-mer27 x NAGHHblits0.61
7enf.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30
0.6899.250.95 1-1208EM0.00hetero-3-1-1-mer27 x NAG, 13 x NAG-NAGHHblits0.61
7six.1.B
Spike glycoprotein
Antibody N3-1 bound to RBDs in the up and down conformations
0.0099.250.95 1-1208EM0.00hetero-2-1-1-mer2 x NAG-NAGHHblits0.61
7six.1.A
Spike glycoprotein
Antibody N3-1 bound to RBDs in the up and down conformations
0.0099.250.95 1-1208EM0.00hetero-2-1-1-mer2 x NAG-NAGHHblits0.61
7sj0.1.A
Spike glycoprotein
Antibody A7V3 bound to N-terminal domain of the spike
0.0499.250.95 1-1208EM0.00hetero-1-1-1-mer5 x NAGHHblits0.61
7lx5.1.A
Spike glycoprotein
The SARS-CoV-2 spike protein receptor binding domain bound to neutralizing nanobodies WNb 2 and WNb 10
0.0399.250.95 1-1208EM0.00hetero-1-1-1-merHHblits0.61
7n9e.1.C
Spike glycoprotein
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB34
0.5299.250.95 1-1208EM0.00hetero-1-3-merHHblits0.61
7n9e.1.D
Spike glycoprotein
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB34
0.6299.250.95 1-1208EM0.00hetero-1-3-merHHblits0.61
7n9c.1.C
Spike glycoprotein
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB95
0.6499.250.95 1-1208EM0.00hetero-3-2-merHHblits0.61
7n9b.1.B
Spike glycoprotein
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB21
0.6899.250.95 1-1208EM0.00hetero-3-2-merHHblits0.61
7n9c.1.B
Spike glycoprotein
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB95
0.5399.250.95 1-1208EM0.00hetero-3-2-merHHblits0.61
7n9b.1.A
Spike glycoprotein
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB21
0.6899.250.95 1-1208EM0.00hetero-3-2-merHHblits0.61
7n9b.1.C
Spike glycoprotein
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB21
0.6999.250.95 1-1208EM0.00hetero-3-2-merHHblits0.61
7n9e.1.B
Spike glycoprotein
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB34
0.6999.250.95 1-1208EM0.00hetero-1-3-merHHblits0.61
7n9c.1.A
Spike glycoprotein
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB95
0.6699.250.95 1-1208EM0.00hetero-3-2-merHHblits0.61
6zb4.1.A
Spike glycoprotein
SARS CoV-2 Spike protein, Closed conformation, C1 symmetry
0.7299.920.94 12-1213EM0.00homo-trimer25 x NAG, 3 x EIC, 1 x NAG-NAGBLAST0.62
7qus.1.A
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike, C3 symmetry
0.6999.920.94 12-1213EM0.00homo-trimer36 x NAG, 3 x EIC, 9 x NAG-NAG, 3 x NAG-FUC-NAG-FUCBLAST0.62
7sxx.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.5699.170.95 1-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.61
7sxx.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.7299.170.95 1-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.61
7sxx.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.5799.170.95 1-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.61
8dlz.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6
0.5799.170.95 1-1208EM0.00hetero-3-1-mer21 x NAG, 18 x NAG-NAGHHblits0.61
7sxr.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain
0.7399.170.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7sxr.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain
0.7299.170.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7sxr.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain
0.7399.170.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
8dlz.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6
0.5799.170.95 1-1208EM0.00hetero-3-1-mer21 x NAG, 18 x NAG-NAGHHblits0.61
7sxy.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.0499.170.95 1-1208EM0.00hetero-1-1-mer7 x NAGHHblits0.61
8dm0.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6)
0.0399.170.95 1-1208EM0.00hetero-1-1-mer1 x NAGHHblits0.61
8dlz.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6
0.7299.170.95 1-1208EM0.00hetero-3-1-mer21 x NAG, 18 x NAG-NAGHHblits0.61
7mjg.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain
0.7399.170.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7mji.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8 (focused refinement of RBD and VH ab8)
0.0499.170.95 1-1208EM0.00hetero-1-1-mer1 x NAGHHblits0.61
7mjj.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 1)
0.7299.170.95 1-1208EM0.00hetero-3-2-2-mer24 x NAG, 18 x NAG-NAGHHblits0.61
7mjg.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain
0.7399.170.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7mjj.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 1)
0.7399.170.95 1-1208EM0.00hetero-3-2-2-mer24 x NAG, 18 x NAG-NAGHHblits0.61
7mjg.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain
0.7299.170.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7mjh.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8
0.7399.170.95 1-1208EM0.00hetero-3-3-mer24 x NAG, 18 x NAG-NAGHHblits0.61
7mjh.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8
0.7399.170.95 1-1208EM0.00hetero-3-3-mer24 x NAG, 18 x NAG-NAGHHblits0.61
7mjh.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8
0.7399.170.95 1-1208EM0.00hetero-3-3-mer24 x NAG, 18 x NAG-NAGHHblits0.61
7mjj.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 1)
0.7399.170.95 1-1208EM0.00hetero-3-2-2-mer24 x NAG, 18 x NAG-NAGHHblits0.61
7mjl.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (focused refinement of RBD and Fab ab1)
0.0499.170.95 1-1208EM0.00hetero-1-1-1-mer1 x NAGHHblits0.61
7mjk.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 2)
0.7399.170.95 1-1208EM0.00hetero-3-3-3-mer24 x NAG, 18 x NAG-NAGHHblits0.61
7mjk.1.H
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 2)
0.7399.170.95 1-1208EM0.00hetero-3-3-3-mer24 x NAG, 18 x NAG-NAGHHblits0.61
7mjk.1.I
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 2)
0.7399.170.95 1-1208EM0.00hetero-3-3-3-mer24 x NAG, 18 x NAG-NAGHHblits0.61
7mjm.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain
0.7299.170.95 1-1208EM0.00hetero-3-2-mer32 x NAG, 18 x NAG-NAGHHblits0.61
7mjm.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain
0.7299.170.95 1-1208EM0.00hetero-3-2-mer32 x NAG, 18 x NAG-NAGHHblits0.61
7mjn.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.0499.170.95 1-1208EM0.00hetero-1-1-mer5 x NAGHHblits0.61
7mjm.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain
0.7399.170.95 1-1208EM0.00hetero-3-2-mer32 x NAG, 18 x NAG-NAGHHblits0.61
7cac.1.A
Spike glycoprotein
SARS-CoV-2 S trimer with one RBD in the open state and complexed with one H014 Fab.
0.6799.090.95 1-1208EM0.00hetero-3-1-1-mer30 x NAG, 15 x NAG-NAGHHblits0.61
7cac.1.C
Spike glycoprotein
SARS-CoV-2 S trimer with one RBD in the open state and complexed with one H014 Fab.
0.6799.090.95 1-1208EM0.00hetero-3-1-1-mer30 x NAG, 15 x NAG-NAGHHblits0.61
7cac.1.B
Spike glycoprotein
SARS-CoV-2 S trimer with one RBD in the open state and complexed with one H014 Fab.
0.6899.090.95 1-1208EM0.00hetero-3-1-1-mer30 x NAG, 15 x NAG-NAGHHblits0.61
7ru1.1.B
Spike glycoprotein
SARS-CoV-2-6P-Mut7 S protein (C3 symmetry)
0.7199.090.95 1-1208EM2.80homo-trimer30 x NAG, 12 x NAG-NAGHHblits0.61
7ru1.1.C
Spike glycoprotein
SARS-CoV-2-6P-Mut7 S protein (C3 symmetry)
0.7199.090.95 1-1208EM2.80homo-trimer30 x NAG, 12 x NAG-NAGHHblits0.61
7ru2.1.C
Spike glycoprotein
SARS-CoV-2-6P-Mut7 S protein (asymmetric)
0.7099.090.95 1-1208EM0.00homo-trimer34 x NAG, 14 x NAG-NAGHHblits0.61
7ru2.1.B
Spike glycoprotein
SARS-CoV-2-6P-Mut7 S protein (asymmetric)
0.7099.090.95 1-1208EM0.00homo-trimer34 x NAG, 14 x NAG-NAGHHblits0.61
7ru2.1.A
Spike glycoprotein
SARS-CoV-2-6P-Mut7 S protein (asymmetric)
0.6999.090.95 1-1208EM0.00homo-trimer34 x NAG, 14 x NAG-NAGHHblits0.61
7ru1.1.A
Spike glycoprotein
SARS-CoV-2-6P-Mut7 S protein (C3 symmetry)
0.7199.090.95 1-1208EM2.80homo-trimer30 x NAG, 12 x NAG-NAGHHblits0.61
7s6l.1.E
Spike glycoprotein
J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (conformation 3)
0.6799.090.95 1-1208EM0.00hetero-3-1-1-mer16 x NAG, 7 x NAG-NAGHHblits0.61
7s6l.1.A
Spike glycoprotein
J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (conformation 3)
0.6899.090.95 1-1208EM0.00hetero-3-1-1-mer16 x NAG, 7 x NAG-NAGHHblits0.61
7s6l.1.D
Spike glycoprotein
J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (conformation 3)
0.6899.090.95 1-1208EM0.00hetero-3-1-1-mer16 x NAG, 7 x NAG-NAGHHblits0.61
7ru5.1.A
Spike glycoprotein
CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement)
0.6899.090.95 1-1208EM0.00hetero-3-2-2-mer20 x NAG, 10 x NAG-NAGHHblits0.61
7ru8.1.C
Spike glycoprotein
CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement)
0.0299.090.95 1-1208EM0.00hetero-1-1-1-mer1 x NAG, 1 x NAG-NAGHHblits0.61
7ru3.1.C
Spike glycoprotein
CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement)
0.7199.090.95 1-1208EM0.00hetero-2-2-3-mer29 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7ru5.1.B
Spike glycoprotein
CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement)
0.7099.090.95 1-1208EM0.00hetero-3-2-2-mer20 x NAG, 10 x NAG-NAGHHblits0.61
7ru5.1.C
Spike glycoprotein
CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement)
0.7099.090.95 1-1208EM0.00hetero-3-2-2-mer20 x NAG, 10 x NAG-NAGHHblits0.61
7ru4.1.C
Spike glycoprotein
CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement)
0.0399.090.95 1-1208EM0.00hetero-1-1-1-mer1 x NAG, 1 x NAG-NAG-FUCHHblits0.61
7ru3.1.E
Spike glycoprotein
CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement)
0.7199.090.95 1-1208EM0.00hetero-2-2-3-mer29 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7ru3.1.D
Spike glycoprotein
CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement)
0.7199.090.95 1-1208EM0.00hetero-2-2-3-mer29 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
8d0z.1.B
Spike glycoprotein
S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (focused refinement)
0.6999.090.95 1-1208EM0.00hetero-3-1-1-mer11 x NAGHHblits0.61
8d0z.1.C
Spike glycoprotein
S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (focused refinement)
0.5599.090.95 1-1208EM0.00hetero-3-1-1-mer11 x NAGHHblits0.61
8d0z.1.A
Spike glycoprotein
S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (focused refinement)
0.5499.090.95 1-1208EM0.00hetero-3-1-1-mer11 x NAGHHblits0.61
7k8s.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)
0.6899.830.94 12-1213EM0.00hetero-3-3-3-mer27 x NAG, 15 x NAG-NAGBLAST0.62
7k8s.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)
0.6899.830.94 12-1213EM0.00hetero-3-3-3-mer27 x NAG, 15 x NAG-NAGBLAST0.62
7k8s.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)
0.6899.830.94 12-1213EM0.00hetero-3-3-3-mer27 x NAG, 15 x NAG-NAGBLAST0.62
7k8t.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)
0.6999.830.94 12-1213EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAGBLAST0.62
7k8t.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)
0.6999.830.94 12-1213EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAGBLAST0.62
7k8t.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)
0.6999.830.94 12-1213EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAGBLAST0.62
7k8x.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)
0.6899.830.94 12-1213EM3.90hetero-3-2-2-mer28 x NAGBLAST0.62
7k8x.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)
0.6899.830.94 12-1213EM3.90hetero-3-2-2-mer28 x NAGBLAST0.62
7k8x.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)
0.6899.830.94 12-1213EM3.90hetero-3-2-2-mer28 x NAGBLAST0.62
7k8y.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)
0.6799.830.94 12-1213EM4.40hetero-3-1-1-mer23 x NAGBLAST0.62
7k8y.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)
0.6799.830.94 12-1213EM4.40hetero-3-1-1-mer23 x NAGBLAST0.62
7k8y.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)
0.6799.830.94 12-1213EM4.40hetero-3-1-1-mer23 x NAGBLAST0.62
7m6i.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24
0.6699.830.94 12-1213EM0.00hetero-3-2-2-mer26 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMABLAST0.62
7m6h.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20
0.5999.830.94 12-1213EM0.00hetero-3-2-2-mer28 x NAGBLAST0.62
7m6h.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20
0.5999.830.94 12-1213EM0.00hetero-3-2-2-mer28 x NAGBLAST0.62
7m6i.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24
0.6499.830.94 12-1213EM0.00hetero-3-2-2-mer26 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMABLAST0.62
7m6i.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24
0.6499.830.94 12-1213EM0.00hetero-3-2-2-mer26 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMABLAST0.62
7m6h.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20
0.5799.830.94 12-1213EM0.00hetero-3-2-2-mer28 x NAGBLAST0.62
8d48.1.A
Spike glycoprotein
sd1.040 Fab in complex with SARS-CoV-2 Spike 2P glycoprotein
0.0899.830.94 12-1213EM0.00hetero-1-1-1-mer1 x NAG-NAGBLAST0.62
7sxz.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.5799.090.95 1-1208EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGHHblits0.61
7sxz.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.7399.090.95 1-1208EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGHHblits0.61
7sxs.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain
0.7399.090.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7sxz.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.7399.090.95 1-1208EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGHHblits0.61
7sxs.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain
0.7299.090.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7sxs.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain
0.7399.090.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7sy0.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.0499.090.95 1-1208EM0.00hetero-1-1-mer7 x NAGHHblits0.61
7tlc.1.A
Spike glycoprotein
Down-state locked, S2 stabilized rS2d-HexaPro SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 1
0.6999.090.95 1-1208EM0.00homo-trimerHHblits0.61
7tlc.1.B
Spike glycoprotein
Down-state locked, S2 stabilized rS2d-HexaPro SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 1
0.6899.090.95 1-1208EM0.00homo-trimerHHblits0.61
7tlc.1.C
Spike glycoprotein
Down-state locked, S2 stabilized rS2d-HexaPro SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 1
0.6999.090.95 1-1208EM0.00homo-trimerHHblits0.61
7tld.1.A
Spike glycoprotein
Down-state locked, S2 stabilized rS2d-HexaPro SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 2
0.6999.090.95 1-1208EM0.00homo-trimerHHblits0.61
7tld.1.B
Spike glycoprotein
Down-state locked, S2 stabilized rS2d-HexaPro SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 2
0.6999.090.95 1-1208EM0.00homo-trimerHHblits0.61
7tld.1.C
Spike glycoprotein
Down-state locked, S2 stabilized rS2d-HexaPro SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 2
0.6999.090.95 1-1208EM0.00homo-trimerHHblits0.61
7s6i.1.A
Spike glycoprotein
SARS-CoV-2-6P-Mut2 S protein
0.7099.090.95 1-1208EM0.00homo-trimer30 x NAG, 18 x NAG-NAGHHblits0.61
7s6i.1.B
Spike glycoprotein
SARS-CoV-2-6P-Mut2 S protein
0.7099.090.95 1-1208EM0.00homo-trimer30 x NAG, 18 x NAG-NAGHHblits0.61
7s6i.1.C
Spike glycoprotein
SARS-CoV-2-6P-Mut2 S protein
0.7099.090.95 1-1208EM0.00homo-trimer30 x NAG, 18 x NAG-NAGHHblits0.61
7s6j.1.A
Spike glycoprotein
J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut2 S protein (conformation 1)
0.6999.090.95 1-1208EM0.00hetero-3-3-3-mer15 x NAG, 9 x NAG-NAGHHblits0.61
7s6j.1.D
Spike glycoprotein
J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut2 S protein (conformation 1)
0.6999.090.95 1-1208EM0.00hetero-3-3-3-mer15 x NAG, 9 x NAG-NAGHHblits0.61
7s6j.1.G
Spike glycoprotein
J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut2 S protein (conformation 1)
0.6999.090.95 1-1208EM0.00hetero-3-3-3-mer15 x NAG, 9 x NAG-NAGHHblits0.61
7s6k.1.A
Spike glycoprotein
J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut2 S protein (conformation 2)
0.6999.090.95 1-1208EM0.00hetero-3-3-3-mer21 x NAG, 12 x NAG-NAGHHblits0.61
7s6k.1.D
Spike glycoprotein
J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut2 S protein (conformation 2)
0.6999.090.95 1-1208EM0.00hetero-3-3-3-mer21 x NAG, 12 x NAG-NAGHHblits0.61
7s6k.1.G
Spike glycoprotein
J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut2 S protein (conformation 2)
0.6999.090.95 1-1208EM0.00hetero-3-3-3-mer21 x NAG, 12 x NAG-NAGHHblits0.61
7sy1.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.5799.090.95 1-1208EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGHHblits0.61
7sy1.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.7299.090.95 1-1208EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGHHblits0.61
7sxt.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain
0.7399.090.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7sy1.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.7399.090.95 1-1208EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGHHblits0.61
7sxt.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain
0.7299.090.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7sxt.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain
0.7299.090.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7sy2.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.0499.090.95 1-1208EM0.00hetero-1-1-mer7 x NAGHHblits0.61
7v7i.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 2
0.6999.010.95 1-1207EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7v7i.1.D
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 2
0.6899.010.95 1-1207EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7v7j.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 3
0.6899.010.95 1-1207EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7v7j.1.E
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 3
0.6899.010.95 1-1207EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7v7d.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), all RBD-down conformation
0.6999.010.95 1-1207EM0.00homo-trimer14 x NAG, 34 x NAG-NAGHHblits0.61
7v7d.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), all RBD-down conformation
0.6999.010.95 1-1207EM0.00homo-trimer14 x NAG, 34 x NAG-NAGHHblits0.61
7v7e.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), one RBD-up conformation 1
0.6999.010.95 1-1207EM0.00homo-trimer14 x NAG, 34 x NAG-NAGHHblits0.61
7v7e.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), one RBD-up conformation 1
0.6999.010.95 1-1207EM0.00homo-trimer14 x NAG, 34 x NAG-NAGHHblits0.61
7v7f.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), one RBD-up conformation 2
0.7099.010.95 1-1207EM0.00homo-trimer12 x NAG, 36 x NAG-NAGHHblits0.61
7v7g.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), two RBD-up conformation
0.7099.010.95 1-1207EM0.00homo-trimer15 x NAG, 33 x NAG-NAGHHblits0.61
7v7f.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), one RBD-up conformation 2
0.7099.010.95 1-1207EM0.00homo-trimer12 x NAG, 36 x NAG-NAGHHblits0.61
7v7f.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), one RBD-up conformation 2
0.7099.010.95 1-1207EM0.00homo-trimer12 x NAG, 36 x NAG-NAGHHblits0.61
7v7g.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), two RBD-up conformation
0.6999.010.95 1-1207EM0.00homo-trimer15 x NAG, 33 x NAG-NAGHHblits0.61
7v7g.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), two RBD-up conformation
0.6999.010.95 1-1207EM0.00homo-trimer15 x NAG, 33 x NAG-NAGHHblits0.61
7v85.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6899.010.95 1-1207EM0.00hetero-3-2-mer13 x NAG, 31 x NAG-NAGHHblits0.61
7v7h.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 1
0.6899.010.95 1-1207EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7v7h.1.D
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 1
0.6899.010.95 1-1207EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7v7h.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 1
0.6999.010.95 1-1207EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7v7h.1.E
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 1
0.6999.010.95 1-1207EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7v7h.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 1
0.6899.010.95 1-1207EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7v7h.1.F
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 1
0.6899.010.95 1-1207EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7v7i.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 2
0.6899.010.95 1-1207EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7v7i.1.F
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 2
0.6899.010.95 1-1207EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7v7d.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), all RBD-down conformation
0.6999.010.95 1-1207EM0.00homo-trimer14 x NAG, 34 x NAG-NAGHHblits0.61
7v7e.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), one RBD-up conformation 1
0.6999.010.95 1-1207EM0.00homo-trimer14 x NAG, 34 x NAG-NAGHHblits0.61
7v7i.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 2
0.6999.010.95 1-1207EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7v7i.1.E
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 2
0.6999.010.95 1-1207EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7v7j.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 3
0.6999.010.95 1-1207EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7v7j.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 3
0.6899.010.95 1-1207EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7v7j.1.D
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 3
0.6899.010.95 1-1207EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7v7j.1.F
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 3
0.6999.010.95 1-1207EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7v85.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6899.010.95 1-1207EM0.00hetero-3-2-mer13 x NAG, 31 x NAG-NAGHHblits0.61
7v85.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6899.010.95 1-1207EM0.00hetero-3-2-mer13 x NAG, 31 x NAG-NAGHHblits0.61
7v86.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
0.6999.010.95 1-1207EM0.00hetero-3-3-mer13 x NAG, 37 x NAG-NAGHHblits0.61
7v87.1.A
Spike glycoprotein
Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.0399.010.95 1-1207EM0.00hetero-1-1-mer4 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAGHHblits0.61
7v86.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
0.6999.010.95 1-1207EM0.00hetero-3-3-mer13 x NAG, 37 x NAG-NAGHHblits0.61
7v86.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
0.7099.010.95 1-1207EM0.00hetero-3-3-mer13 x NAG, 37 x NAG-NAGHHblits0.61
6xcm.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1)
0.6999.750.94 12-1213EM0.00hetero-3-2-2-mer30 x NAG, 9 x NAG-NAG, 1 x NAG-FUC, 2 x NAG-NAG-FUC, 1 x NAG-NAG-BMABLAST0.62
6xcm.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1)
0.6999.750.94 12-1213EM0.00hetero-3-2-2-mer30 x NAG, 9 x NAG-NAG, 1 x NAG-FUC, 2 x NAG-NAG-FUC, 1 x NAG-NAG-BMABLAST0.62
6xcm.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1)
0.6799.750.94 12-1213EM0.00hetero-3-2-2-mer30 x NAG, 9 x NAG-NAG, 1 x NAG-FUC, 2 x NAG-NAG-FUC, 1 x NAG-NAG-BMABLAST0.62
7k8z.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135
0.6999.750.94 12-1213EM0.00hetero-3-2-2-mer33 x NAG, 13 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x NAG-NAG-BMA-FUCBLAST0.62
7k8v.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110
0.6499.750.94 12-1213EM0.00hetero-3-2-2-mer21 x NAG, 10 x NAG-NAGBLAST0.62
7k8w.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119
0.6899.750.94 12-1213EM0.00hetero-3-2-2-mer34 x NAG, 13 x NAG-NAGBLAST0.62
7k8w.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119
0.6999.750.94 12-1213EM0.00hetero-3-2-2-mer34 x NAG, 13 x NAG-NAGBLAST0.62
7k8v.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110
0.6299.750.94 12-1213EM0.00hetero-3-2-2-mer21 x NAG, 10 x NAG-NAGBLAST0.62
7k8u.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104
0.6699.750.94 12-1213EM0.00hetero-3-1-1-mer2 x NAG, 1 x NAG-NAGBLAST0.62
7k8u.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104
0.6899.750.94 12-1213EM0.00hetero-3-1-1-mer2 x NAG, 1 x NAG-NAGBLAST0.62
7k8v.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110
0.6499.750.94 12-1213EM0.00hetero-3-2-2-mer21 x NAG, 10 x NAG-NAGBLAST0.62
7k8w.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119
0.6899.750.94 12-1213EM0.00hetero-3-2-2-mer34 x NAG, 13 x NAG-NAGBLAST0.62
7k8z.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135
0.6999.750.94 12-1213EM0.00hetero-3-2-2-mer33 x NAG, 13 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x NAG-NAG-BMA-FUCBLAST0.62
7k8z.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135
0.6999.750.94 12-1213EM0.00hetero-3-2-2-mer33 x NAG, 13 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x NAG-NAG-BMA-FUCBLAST0.62
7k8u.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104
0.6999.750.94 12-1213EM0.00hetero-3-1-1-mer2 x NAG, 1 x NAG-NAGBLAST0.62
7vxc.1.A
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in C3 state
0.6899.090.95 1-1208EM3.90hetero-3-1-merHHblits0.61
7vxb.1.A
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in C2b state
0.6899.090.95 1-1208EM3.90hetero-3-1-merHHblits0.61
7vxa.1.A
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a
0.6899.090.95 1-1208EM0.00hetero-3-1-merHHblits0.61
7vxi.1.B
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in transition state
0.6899.090.95 1-1208EM0.00homo-trimerHHblits0.61
7vxi.1.C
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in transition state
0.6999.090.95 1-1208EM0.00homo-trimerHHblits0.61
7vxe.1.A
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in open state
0.7099.090.95 1-1208EM0.00homo-trimerHHblits0.61
7vxc.1.D
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in C3 state
0.6999.090.95 1-1208EM3.90hetero-3-1-merHHblits0.61
7vxe.1.B
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in open state
0.6999.090.95 1-1208EM0.00homo-trimerHHblits0.61
7vxb.1.C
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in C2b state
0.6999.090.95 1-1208EM3.90hetero-3-1-merHHblits0.61
7vxb.1.D
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in C2b state
0.6999.090.95 1-1208EM3.90hetero-3-1-merHHblits0.61
7vxc.1.C
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in C3 state
0.6899.090.95 1-1208EM3.90hetero-3-1-merHHblits0.61
7vxi.1.A
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in transition state
0.6899.090.95 1-1208EM0.00homo-trimerHHblits0.61
7vxe.1.C
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in open state
0.6999.090.95 1-1208EM0.00homo-trimerHHblits0.61
7vx5.1.B
Spike glycoprotein
ACE2-RBD in SARS-CoV-2 Kappa variant S-ACE2 complex
0.0399.090.95 1-1208EM0.00hetero-1-1-mer1 x ZN, 5 x NAGHHblits0.61
7vxa.1.C
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a
0.6899.090.95 1-1208EM0.00hetero-3-1-merHHblits0.61
7vxa.1.D
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a
0.6899.090.95 1-1208EM0.00hetero-3-1-merHHblits0.61
7lym.1.A
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the RBD-down conformation
0.6999.010.95 1-1208EM0.00homo-trimer33 x NAGHHblits0.61
7lyl.1.A
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the RBD-down conformation
0.6999.010.95 1-1208EM0.00homo-trimer28 x NAGHHblits0.61
7lym.1.B
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the RBD-down conformation
0.6999.010.95 1-1208EM0.00homo-trimer33 x NAGHHblits0.61
7lyl.1.B
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the RBD-down conformation
0.7099.010.95 1-1208EM0.00homo-trimer28 x NAGHHblits0.61
7lym.1.C
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the RBD-down conformation
0.6899.010.95 1-1208EM0.00homo-trimer33 x NAGHHblits0.61
7lyl.1.C
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the RBD-down conformation
0.6999.010.95 1-1208EM0.00homo-trimer28 x NAGHHblits0.61
7lyk.1.B
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 2-RBD-up conformation
0.6899.010.95 1-1208EM0.00homo-trimer25 x NAGHHblits0.61
7lyp.1.B
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6799.010.95 1-1208EM0.00homo-trimer28 x NAGHHblits0.61
7lyo.1.C
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6999.010.95 1-1208EM0.00homo-trimer40 x NAGHHblits0.61
7lyn.1.C
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6899.010.95 1-1208EM0.00homo-trimer38 x NAGHHblits0.61
7lyk.1.C
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 2-RBD-up conformation
0.6799.010.95 1-1208EM0.00homo-trimer25 x NAGHHblits0.61
7lyn.1.B
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6899.010.95 1-1208EM0.00homo-trimer38 x NAGHHblits0.61
7lyk.1.A
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 2-RBD-up conformation
0.6899.010.95 1-1208EM0.00homo-trimer25 x NAGHHblits0.61
7lyn.1.A
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6899.010.95 1-1208EM0.00homo-trimer38 x NAGHHblits0.61
7lyq.1.A
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6899.010.95 1-1208EM0.00homo-trimer38 x NAGHHblits0.61
7lyq.1.C
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6799.010.95 1-1208EM0.00homo-trimer38 x NAGHHblits0.61
7lyo.1.B
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6899.010.95 1-1208EM0.00homo-trimer40 x NAGHHblits0.61
7lyp.1.A
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6699.010.95 1-1208EM0.00homo-trimer28 x NAGHHblits0.61
7lyp.1.C
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6699.010.95 1-1208EM0.00homo-trimer28 x NAGHHblits0.61
7lyq.1.B
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6799.010.95 1-1208EM0.00homo-trimer38 x NAGHHblits0.61
7lyo.1.A
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.7099.010.95 1-1208EM0.00homo-trimer40 x NAGHHblits0.61
7lwn.1.C
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation
0.6999.250.95 1-1208EM0.00homo-trimer27 x NAG, 5 x NAG-NAGHHblits0.61
7lwo.1.C
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation
0.6999.250.95 1-1208EM0.00homo-trimer30 x NAG, 3 x NAG-NAGHHblits0.61
7lwq.1.B
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein(S-GSAS-D614G-delFV) missing the S1 subunit and SD2 subdomain of one protomer
0.2099.250.95 1-1208EM0.00homo-trimer27 x NAG, 1 x NAG-NAGHHblits0.61
7lwi.1.B
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6999.250.95 1-1208EM0.00homo-trimer30 x NAGHHblits0.61
7lwi.1.C
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6899.250.95 1-1208EM0.00homo-trimer30 x NAGHHblits0.61
7lwj.1.A
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6499.250.95 1-1208EM0.00homo-trimer30 x NAGHHblits0.61
7lwj.1.B
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6599.250.95 1-1208EM0.00homo-trimer30 x NAGHHblits0.61
7lwj.1.C
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6699.250.95 1-1208EM0.00homo-trimer30 x NAGHHblits0.61
7lwk.1.A
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6999.250.95 1-1208EM0.00homo-trimer30 x NAGHHblits0.61
7lwk.1.B
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6999.250.95 1-1208EM0.00homo-trimer30 x NAGHHblits0.61
7lwk.1.C
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6999.250.95 1-1208EM0.00homo-trimer30 x NAGHHblits0.61
7lwl.1.A
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6799.250.95 1-1208EM0.00homo-trimer30 x NAGHHblits0.61
7lwl.1.B
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6999.250.95 1-1208EM0.00homo-trimer30 x NAGHHblits0.61
7lwl.1.C
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6999.250.95 1-1208EM0.00homo-trimer30 x NAGHHblits0.61
7lwm.1.A
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation
0.7099.250.95 1-1208EM0.00homo-trimer31 x NAG, 3 x NAG-NAGHHblits0.61
7lwm.1.B
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation
0.6999.250.95 1-1208EM0.00homo-trimer31 x NAG, 3 x NAG-NAGHHblits0.61
7lwm.1.C
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation
0.6999.250.95 1-1208EM0.00homo-trimer31 x NAG, 3 x NAG-NAGHHblits0.61
7lwn.1.A
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation
0.7099.250.95 1-1208EM0.00homo-trimer27 x NAG, 5 x NAG-NAGHHblits0.61
7lwn.1.B
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation
0.6999.250.95 1-1208EM0.00homo-trimer27 x NAG, 5 x NAG-NAGHHblits0.61
7lwi.1.A
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6899.250.95 1-1208EM0.00homo-trimer30 x NAGHHblits0.61
7lwo.1.A
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation
0.7099.250.95 1-1208EM0.00homo-trimer30 x NAG, 3 x NAG-NAGHHblits0.61
7lwo.1.B
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation
0.6999.250.95 1-1208EM0.00homo-trimer30 x NAG, 3 x NAG-NAGHHblits0.61
7lwp.1.A
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 2-RBD up conformation
0.6899.250.95 1-1208EM0.00homo-trimer31 x NAGHHblits0.61
7lwp.1.B
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 2-RBD up conformation
0.6899.250.95 1-1208EM0.00homo-trimer31 x NAGHHblits0.61
7lwp.1.C
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 2-RBD up conformation
0.6699.250.95 1-1208EM0.00homo-trimer31 x NAGHHblits0.61
7lwq.1.A
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein(S-GSAS-D614G-delFV) missing the S1 subunit and SD2 subdomain of one protomer
0.6699.250.95 1-1208EM0.00homo-trimer27 x NAG, 1 x NAG-NAGHHblits0.61
7lwq.1.C
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein(S-GSAS-D614G-delFV) missing the S1 subunit and SD2 subdomain of one protomer
0.6799.250.95 1-1208EM0.00homo-trimer27 x NAG, 1 x NAG-NAGHHblits0.61
7sy3.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.5799.010.95 1-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.61
7sy3.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.7399.010.95 1-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.61
7sxu.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain
0.7399.010.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7sy3.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.5799.010.95 1-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.61
7sxu.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain
0.7299.010.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7sxu.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain
0.7399.010.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7sy4.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.0499.010.95 1-1208EM0.00hetero-1-1-mer7 x NAGHHblits0.61
7r12.1.B
Spike glycoprotein
Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
0.0899.170.95 1-1208EM0.00hetero-1-1-mer1 x ZN, 6 x NAGHHblits0.61
7r19.1.A
Spike glycoprotein
Mink Variant SARS-CoV-2 Spike with 2 Erect RBDs
0.6899.170.95 1-1208EM0.00homo-trimer30 x NAG, 4 x NAG-NAGHHblits0.61
7r19.1.B
Spike glycoprotein
Mink Variant SARS-CoV-2 Spike with 2 Erect RBDs
0.6799.170.95 1-1208EM0.00homo-trimer30 x NAG, 4 x NAG-NAGHHblits0.61
7r19.1.C
Spike glycoprotein
Mink Variant SARS-CoV-2 Spike with 2 Erect RBDs
0.6899.170.95 1-1208EM0.00homo-trimer30 x NAG, 4 x NAG-NAGHHblits0.61
7r1b.1.A
Spike glycoprotein
Mink Variant SARS-CoV-2 Spike with 1 Erect RBD
0.6899.170.95 1-1208EM0.00homo-trimer26 x NAG, 8 x NAG-NAGHHblits0.61
7r1b.1.B
Spike glycoprotein
Mink Variant SARS-CoV-2 Spike with 1 Erect RBD
0.6999.170.95 1-1208EM0.00homo-trimer26 x NAG, 8 x NAG-NAGHHblits0.61
7r1b.1.C
Spike glycoprotein
Mink Variant SARS-CoV-2 Spike with 1 Erect RBD
0.6999.170.95 1-1208EM0.00homo-trimer26 x NAG, 8 x NAG-NAGHHblits0.61
7sy6.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.0498.920.95 1-1208EM0.00hetero-1-1-mer7 x NAGHHblits0.61
7sy5.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.7398.920.95 1-1208EM0.00hetero-3-3-mer42 x NAG, 18 x NAG-NAGHHblits0.61
7sy5.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.7298.920.95 1-1208EM0.00hetero-3-3-mer42 x NAG, 18 x NAG-NAGHHblits0.61
7sy5.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.7398.920.95 1-1208EM0.00hetero-3-3-mer42 x NAG, 18 x NAG-NAGHHblits0.61
7sxv.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain
0.7398.920.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7sxv.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain
0.7298.920.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7sxv.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain
0.7398.920.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7sy7.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.5698.920.95 1-1208EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGHHblits0.61
7sy7.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.7298.920.95 1-1208EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGHHblits0.61
7sy7.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.7298.920.95 1-1208EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGHHblits0.61
7sxw.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain
0.7398.920.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7sy8.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.0498.920.95 1-1208EM0.00hetero-1-1-mer7 x NAGHHblits0.61
7sxw.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain
0.7298.920.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
7sxw.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain
0.7298.920.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
6zgf.1.A
Spike glycoprotein
Spike Protein of RaTG13 Bat Coronavirus in Closed Conformation
0.7396.320.96 1-1227EM0.00homo-trimer27 x NAG, 21 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-BMA, 3 x NAG-FUCHHblits0.60
7cab.1.A
Spike glycoprotein
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
0.7198.840.95 1-1208EM0.00homo-trimer30 x NAG, 15 x NAG-NAGHHblits0.61
7cab.1.B
Spike glycoprotein
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
0.7198.840.95 1-1208EM0.00homo-trimer30 x NAG, 15 x NAG-NAGHHblits0.61
7cab.1.C
Spike glycoprotein
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
0.7198.840.95 1-1208EM0.00homo-trimer30 x NAG, 15 x NAG-NAGHHblits0.61
8fez.1.A
Spike glycoprotein
Prefusion-stabilized SARS-CoV-2 spike protein
0.5698.840.95 1-1208EM0.00homo-trimerHHblits0.61
8fez.1.B
Spike glycoprotein
Prefusion-stabilized SARS-CoV-2 spike protein
0.6398.840.95 1-1208EM0.00homo-trimerHHblits0.61
8fez.1.C
Spike glycoprotein
Prefusion-stabilized SARS-CoV-2 spike protein
0.6298.840.95 1-1208EM0.00homo-trimerHHblits0.61
7e7d.1.A
Spike glycoprotein,Collagen alpha-1(I) chain
Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate
0.73100.000.94 12-1211EM3.20homo-trimer19 x NAG, 3 x ELA, 32 x NAG-NAGBLAST0.62
7p40.1.A
Spike glycoprotein
P5C3 is a potent fab neutralizer
0.7098.510.95 14-1223EM0.00hetero-3-3-3-merHHblits0.61
7p40.1.E
Spike glycoprotein
P5C3 is a potent fab neutralizer
0.7098.510.95 14-1223EM0.00hetero-3-3-3-merHHblits0.61
7p40.1.G
Spike glycoprotein
P5C3 is a potent fab neutralizer
0.7098.510.95 14-1223EM0.00hetero-3-3-3-merHHblits0.61
7e7b.1.A
Spike glycoprotein,Collagen alpha-1(I) chain
Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate
0.7199.920.94 12-1211EM0.00homo-trimer15 x NAG, 3 x ELA, 3 x VCG, 39 x NAG-NAGBLAST0.62
7tf5.1.D
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein
0.7398.760.95 1-1208EM0.00homo-hexamer48 x NAG, 36 x NAG-NAGHHblits0.61
7tf5.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein
0.7398.760.95 1-1208EM0.00homo-hexamer48 x NAG, 36 x NAG-NAGHHblits0.61
7tf4.1.D
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein (focused refinement of RBD)
0.0998.760.95 1-1208EM0.00homo-hexamer12 x NAGHHblits0.61
7tf5.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein
0.7398.760.95 1-1208EM0.00homo-hexamer48 x NAG, 36 x NAG-NAGHHblits0.61
7tf0.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2
0.5898.760.95 1-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.61
7tf5.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein
0.7398.760.95 1-1208EM0.00homo-hexamer48 x NAG, 36 x NAG-NAGHHblits0.61
7tf4.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein (focused refinement of RBD)
0.0998.760.95 1-1208EM0.00homo-hexamer12 x NAGHHblits0.61
7tez.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.0498.760.95 1-1208EM0.00hetero-1-1-mer7 x NAGHHblits0.61
7tf0.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2
0.7398.760.95 1-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.61
7tf4.1.F
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein (focused refinement of RBD)
0.0898.760.95 1-1208EM0.00homo-hexamer12 x NAGHHblits0.61
7tf5.1.F
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein
0.7398.760.95 1-1208EM0.00homo-hexamer48 x NAG, 36 x NAG-NAGHHblits0.61
7tf4.1.E
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein (focused refinement of RBD)
0.0998.760.95 1-1208EM0.00homo-hexamer12 x NAGHHblits0.61
7tf4.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein (focused refinement of RBD)
0.0998.760.95 1-1208EM0.00homo-hexamer12 x NAGHHblits0.61
7tf5.1.E
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein
0.7398.760.95 1-1208EM0.00homo-hexamer48 x NAG, 36 x NAG-NAGHHblits0.61
7tf4.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein (focused refinement of RBD)
0.0998.760.95 1-1208EM0.00homo-hexamer12 x NAGHHblits0.61
7tf0.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2
0.5898.760.95 1-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.61
7sob.1.A
Spike glycoprotein
SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement
0.7398.680.95 1-1208EM0.00hetero-3-3-3-3-3-mer51 x NAGHHblits0.61
7sob.1.F
Spike glycoprotein
SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement
0.7398.680.95 1-1208EM0.00hetero-3-3-3-3-3-mer51 x NAGHHblits0.61
7sob.1.K
Spike glycoprotein
SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement
0.7398.680.95 1-1208EM0.00hetero-3-3-3-3-3-mer51 x NAGHHblits0.61
7soc.1.A
Spike glycoprotein
SARS-CoV-2 S RBD B.1.617.1 kappa variant S309 Local Refinement
0.0498.680.95 1-1208EM0.00hetero-1-1-1-mer1 x NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUCHHblits0.61
7sod.1.C
Spike glycoprotein
SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement
0.0898.680.95 1-1208EM0.00hetero-1-1-1-mer5 x NAG, 1 x NAG-NAGHHblits0.61
7sof.1.C
Spike glycoprotein
SARS-CoV-2 S NTD B.1.617.1 kappa variant S2X303 Local Refinement
0.1098.680.95 1-1208EM0.00hetero-1-1-1-mer6 x NAG, 1 x NAG-NAG-BMAHHblits0.61
7soe.1.A
Spike glycoprotein
SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement
0.7398.680.95 1-1208EM0.00hetero-3-3-3-mer51 x NAG, 3 x NAG-NAGHHblits0.61
7soe.1.D
Spike glycoprotein
SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement
0.7398.680.95 1-1208EM0.00hetero-3-3-3-mer51 x NAG, 3 x NAG-NAGHHblits0.61
7soe.1.G
Spike glycoprotein
SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement
0.7398.680.95 1-1208EM0.00hetero-3-3-3-mer51 x NAG, 3 x NAG-NAGHHblits0.61
7tf3.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484A spike protein
0.5898.760.95 1-1208EM0.00homo-trimer20 x NAG, 18 x NAG-NAGHHblits0.61
7tf3.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484A spike protein
0.7398.760.95 1-1208EM0.00homo-trimer20 x NAG, 18 x NAG-NAGHHblits0.61
7tf3.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484A spike protein
0.5898.760.95 1-1208EM0.00homo-trimer20 x NAG, 18 x NAG-NAGHHblits0.61
7v78.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), one RBD-up conformation 1
0.6998.680.95 1-1207EM0.00homo-trimer19 x NAG, 34 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7v79.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), one RBD-up conformation 2
0.6998.680.95 1-1207EM0.00homo-trimer20 x NAG, 33 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7v7a.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), two RBD-up conformation
0.6898.680.95 1-1207EM0.00homo-trimer21 x NAG, 1 x NAG-NAG-BMA, 31 x NAG-NAGHHblits0.61
7v78.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), one RBD-up conformation 1
0.6998.680.95 1-1207EM0.00homo-trimer19 x NAG, 34 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7v78.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), one RBD-up conformation 1
0.6998.680.95 1-1207EM0.00homo-trimer19 x NAG, 34 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7v7a.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), two RBD-up conformation
0.6998.680.95 1-1207EM0.00homo-trimer21 x NAG, 1 x NAG-NAG-BMA, 31 x NAG-NAGHHblits0.61
7v84.1.A
Spike glycoprotein
Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.0498.680.95 1-1207EM0.00hetero-1-1-mer3 x NAG, 5 x NAG-NAGHHblits0.61
7v79.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), one RBD-up conformation 2
0.6998.680.95 1-1207EM0.00homo-trimer20 x NAG, 33 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7v79.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), one RBD-up conformation 2
0.6998.680.95 1-1207EM0.00homo-trimer20 x NAG, 33 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7v7a.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), two RBD-up conformation
0.6898.680.95 1-1207EM0.00homo-trimer21 x NAG, 1 x NAG-NAG-BMA, 31 x NAG-NAGHHblits0.61
7v81.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6998.680.95 1-1207EM0.00hetero-3-2-mer19 x NAG, 30 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7v81.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6898.680.95 1-1207EM0.00hetero-3-2-mer19 x NAG, 30 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7v81.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6898.680.95 1-1207EM0.00hetero-3-2-mer19 x NAG, 30 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7v82.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
0.6998.680.95 1-1207EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGHHblits0.61
7v82.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
0.6998.680.95 1-1207EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGHHblits0.61
7v83.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
0.6998.680.95 1-1207EM0.00hetero-3-3-mer29 x NAG, 30 x NAG-NAGHHblits0.61
7v82.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
0.6998.680.95 1-1207EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGHHblits0.61
7v83.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
0.6998.680.95 1-1207EM0.00hetero-3-3-mer29 x NAG, 30 x NAG-NAGHHblits0.61
7v83.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
0.6998.680.95 1-1207EM0.00hetero-3-3-mer29 x NAG, 30 x NAG-NAGHHblits0.61
7m8k.1.A
Spike glycoprotein
Cryo-EM structure of Brazil (P.1) SARS-CoV-2 spike glycoprotein variant in the prefusion state (1 RBD up)
0.6998.680.95 1-1208EM0.00homo-trimer29 x NAG, 11 x NAG-NAGHHblits0.61
7m8k.1.B
Spike glycoprotein
Cryo-EM structure of Brazil (P.1) SARS-CoV-2 spike glycoprotein variant in the prefusion state (1 RBD up)
0.6598.680.95 1-1208EM0.00homo-trimer29 x NAG, 11 x NAG-NAGHHblits0.61
7m8k.1.C
Spike glycoprotein
Cryo-EM structure of Brazil (P.1) SARS-CoV-2 spike glycoprotein variant in the prefusion state (1 RBD up)
0.7098.680.95 1-1208EM0.00homo-trimer29 x NAG, 11 x NAG-NAGHHblits0.61
7tf1.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein (focused refinement of RBD)
0.0998.760.95 1-1208EM0.00homo-hexamer12 x NAGHHblits0.61
7tf1.1.D
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein (focused refinement of RBD)
0.0998.760.95 1-1208EM0.00homo-hexamer12 x NAGHHblits0.61
7tf1.1.E
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein (focused refinement of RBD)
0.0998.760.95 1-1208EM0.00homo-hexamer12 x NAGHHblits0.61
7tf2.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein
0.7398.760.95 1-1208EM0.00homo-hexamer48 x NAG, 36 x NAG-NAGHHblits0.61
7tf2.1.D
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein
0.7398.760.95 1-1208EM0.00homo-hexamer48 x NAG, 36 x NAG-NAGHHblits0.61
7tf2.1.E
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein
0.7398.760.95 1-1208EM0.00homo-hexamer48 x NAG, 36 x NAG-NAGHHblits0.61
7tf1.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein (focused refinement of RBD)
0.0998.760.95 1-1208EM0.00homo-hexamer12 x NAGHHblits0.61
7tf2.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein
0.7398.760.95 1-1208EM0.00homo-hexamer48 x NAG, 36 x NAG-NAGHHblits0.61
7tf1.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein (focused refinement of RBD)
0.0998.760.95 1-1208EM0.00homo-hexamer12 x NAGHHblits0.61
7tf2.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein
0.7398.760.95 1-1208EM0.00homo-hexamer48 x NAG, 36 x NAG-NAGHHblits0.61
7tf1.1.F
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein (focused refinement of RBD)
0.0998.760.95 1-1208EM0.00homo-hexamer12 x NAGHHblits0.61
7tf2.1.F
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein
0.7398.760.95 1-1208EM0.00homo-hexamer48 x NAG, 36 x NAG-NAGHHblits0.61
7ws3.1.A
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7098.760.95 1-1192EM0.00hetero-3-3-3-mer24 x NAG, 15 x NAG-NAGHHblits0.61
7ws3.1.B
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7098.760.95 1-1192EM0.00hetero-3-3-3-mer24 x NAG, 15 x NAG-NAGHHblits0.61
7ws3.1.C
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.6998.760.95 1-1192EM0.00hetero-3-3-3-mer24 x NAG, 15 x NAG-NAGHHblits0.61
7w98.1.D
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C1
0.6999.000.95 1-1206EM0.00hetero-3-1-merHHblits0.61
7w99.1.D
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C2a
0.6999.000.95 1-1206EM0.00hetero-3-1-merHHblits0.61
7w9b.1.D
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C2b
0.7099.000.95 1-1206EM0.00hetero-3-1-merHHblits0.61
7w9c.1.D
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C3
0.7099.000.95 1-1206EM0.00hetero-3-1-merHHblits0.61
7w92.1.B
Spike glycoprotein
Open state of SARS-CoV-2 Delta variant spike protein
0.6699.000.95 1-1206EM0.00homo-trimerHHblits0.61
7w92.1.C
Spike glycoprotein
Open state of SARS-CoV-2 Delta variant spike protein
0.6799.000.95 1-1206EM0.00homo-trimerHHblits0.61
7w94.1.A
Spike glycoprotein
Transition state of SARS-CoV-2 Delta variant spike protein
0.6599.000.95 1-1206EM0.00homo-trimerHHblits0.61
7w94.1.B
Spike glycoprotein
Transition state of SARS-CoV-2 Delta variant spike protein
0.6599.000.95 1-1206EM0.00homo-trimerHHblits0.61
7w94.1.C
Spike glycoprotein
Transition state of SARS-CoV-2 Delta variant spike protein
0.6799.000.95 1-1206EM0.00homo-trimerHHblits0.61
7w98.1.A
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C1
0.6999.000.95 1-1206EM0.00hetero-3-1-merHHblits0.61
7w98.1.B
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C1
0.6999.000.95 1-1206EM0.00hetero-3-1-merHHblits0.61
7w92.1.A
Spike glycoprotein
Open state of SARS-CoV-2 Delta variant spike protein
0.6699.000.95 1-1206EM0.00homo-trimerHHblits0.61
7w99.1.A
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C2a
0.6999.000.95 1-1206EM0.00hetero-3-1-merHHblits0.61
7w99.1.B
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C2a
0.6999.000.95 1-1206EM0.00hetero-3-1-merHHblits0.61
7w9b.1.A
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C2b
0.6999.000.95 1-1206EM0.00hetero-3-1-merHHblits0.61
7w9b.1.B
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C2b
0.6999.000.95 1-1206EM0.00hetero-3-1-merHHblits0.61
7w9c.1.A
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C3
0.6999.000.95 1-1206EM0.00hetero-3-1-merHHblits0.61
7w9c.1.B
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C3
0.7099.000.95 1-1206EM0.00hetero-3-1-merHHblits0.61
7w9e.1.A
Spike glycoprotein
SARS-CoV-2 Delta S-8D3
0.7099.000.95 1-1206EM0.00hetero-3-1-1-merHHblits0.61
7w9e.1.B
Spike glycoprotein
SARS-CoV-2 Delta S-8D3
0.6999.000.95 1-1206EM0.00hetero-3-1-1-merHHblits0.61
7w9e.1.C
Spike glycoprotein
SARS-CoV-2 Delta S-8D3
0.6999.000.95 1-1206EM0.00hetero-3-1-1-merHHblits0.61
7tov.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; consensus state D2
0.6999.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tp8.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D12 state
0.6999.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tp9.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D13 state
0.6899.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tpf.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D17 state
0.6899.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tpl.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the M1 conformation, D4
0.1999.000.95 1-1208EM0.00homo-trimer22 x NAG, 12 x NAG-NAGHHblits0.61
7tou.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; consensus state D1
0.6999.000.95 1-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGHHblits0.61
7tou.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; consensus state D1
0.6899.000.95 1-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGHHblits0.61
7tov.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; consensus state D2
0.7099.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tpf.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D17 state
0.7099.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tov.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; consensus state D2
0.6399.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tou.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; consensus state D1
0.6999.000.95 1-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGHHblits0.61
7toy.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D6 state
0.6999.000.95 1-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGHHblits0.61
7tox.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D5 state
0.6999.000.95 1-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGHHblits0.61
7tox.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D5 state
0.6999.000.95 1-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGHHblits0.61
7tox.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D5 state
0.6999.000.95 1-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGHHblits0.61
7toy.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D6 state
0.6999.000.95 1-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGHHblits0.61
7toy.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D6 state
0.6899.000.95 1-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGHHblits0.61
7toz.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D7 state
0.6299.000.95 1-1208EM0.00homo-trimer32 x NAG, 14 x NAG-NAGHHblits0.61
7toz.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D7 state
0.6499.000.95 1-1208EM0.00homo-trimer32 x NAG, 14 x NAG-NAGHHblits0.61
7toz.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D7 state
0.6399.000.95 1-1208EM0.00homo-trimer32 x NAG, 14 x NAG-NAGHHblits0.61
7tp0.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D8 state
0.6899.000.95 1-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGHHblits0.61
7tp0.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D8 state
0.6899.000.95 1-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGHHblits0.61
7tp0.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D8 state
0.6999.000.95 1-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGHHblits0.61
7tp1.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D9 state
0.6899.000.95 1-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGHHblits0.61
7tp1.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D9 state
0.6799.000.95 1-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGHHblits0.61
7tp1.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D9 state
0.6899.000.95 1-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGHHblits0.61
7tp2.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D10 state
0.6899.000.95 1-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGHHblits0.61
7tp2.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D10 state
0.6899.000.95 1-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGHHblits0.61
7tp2.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D10 state
0.6999.000.95 1-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGHHblits0.61
7tp7.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D11 state
0.6999.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tp9.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D13 state
0.7099.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tp7.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D11 state
0.6499.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tp7.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D11 state
0.6999.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tp8.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D12 state
0.7099.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tp8.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D12 state
0.6599.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tp9.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D13 state
0.6499.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tpa.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D14 state
0.6999.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tpa.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D14 state
0.6399.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tpa.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D14 state
0.6899.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tpc.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D15 state
0.6599.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tpc.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D15 state
0.5999.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tpc.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D15 state
0.6499.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tpe.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D16 state
0.6899.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tpe.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D16 state
0.6299.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tpe.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D16 state
0.6599.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tpf.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D17 state
0.6399.000.95 1-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGHHblits0.61
7tph.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 2-RBD-up conformation - D3
0.6699.000.95 1-1208EM0.00homo-trimer36 x NAG, 8 x NAG-NAGHHblits0.61
7tph.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 2-RBD-up conformation - D3
0.6699.000.95 1-1208EM0.00homo-trimer36 x NAG, 8 x NAG-NAGHHblits0.61
7tph.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 2-RBD-up conformation - D3
0.7099.000.95 1-1208EM0.00homo-trimer36 x NAG, 8 x NAG-NAGHHblits0.61
7tpl.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the M1 conformation, D4
0.6499.000.95 1-1208EM0.00homo-trimer22 x NAG, 12 x NAG-NAGHHblits0.61
7tpl.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the M1 conformation, D4
0.6499.000.95 1-1208EM0.00homo-trimer22 x NAG, 12 x NAG-NAGHHblits0.61
7k9j.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2H04 (three down conformation)
0.6799.750.94 12-1213EM0.00hetero-3-3-3-mer3 x NAG, 12 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-NAG-BMA-FUC, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MANBLAST0.62
7k9h.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation)
0.6899.750.94 12-1213EM0.00hetero-3-2-2-mer3 x NAG, 14 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MANBLAST0.62
7k9h.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation)
0.6899.750.94 12-1213EM0.00hetero-3-2-2-mer3 x NAG, 14 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MANBLAST0.62
7k9h.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation)
0.6899.750.94 12-1213EM0.00hetero-3-2-2-mer3 x NAG, 14 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MANBLAST0.62
8dlm.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2
0.5698.510.95 1-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.61
8dlm.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2
0.7298.510.95 1-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.61
8dlm.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2
0.5698.510.95 1-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.61
8dll.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein
0.7198.510.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
8di5.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with VH domain F6 (focused refinement of RBD and VH F6)
0.0398.510.95 1-1208EM0.00hetero-1-1-mer1 x NAGHHblits0.61
8dll.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein
0.7198.510.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
8dll.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein
0.7198.510.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
8dln.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.0498.510.95 1-1208EM0.00hetero-1-1-mer7 x NAGHHblits0.61
7od3.1.A
Spike glycoprotein
SARS CoV-2 Spike protein, Bristol UK Deletion variant, Closed conformation, C3 symmetry
0.7199.670.94 1-1208EM0.00homo-trimer3 x EIC, 33 x NAGHHblits0.62
7od3.1.B
Spike glycoprotein
SARS CoV-2 Spike protein, Bristol UK Deletion variant, Closed conformation, C3 symmetry
0.7199.670.94 1-1208EM0.00homo-trimer3 x EIC, 33 x NAGHHblits0.62
7od3.1.C
Spike glycoprotein
SARS CoV-2 Spike protein, Bristol UK Deletion variant, Closed conformation, C3 symmetry
0.7199.670.94 1-1208EM0.00homo-trimer3 x EIC, 33 x NAGHHblits0.62
7odl.1.A
Spike glycoprotein
SARS CoV-2 Spike protein, Bristol UK Deletion variant, Closed conformation, C1 symmetry
0.7099.670.94 1-1208EM0.00homo-trimer3 x EIC, 30 x NAGHHblits0.62
7odl.1.B
Spike glycoprotein
SARS CoV-2 Spike protein, Bristol UK Deletion variant, Closed conformation, C1 symmetry
0.7099.670.94 1-1208EM0.00homo-trimer3 x EIC, 30 x NAGHHblits0.62
7odl.1.C
Spike glycoprotein
SARS CoV-2 Spike protein, Bristol UK Deletion variant, Closed conformation, C1 symmetry
0.7099.670.94 1-1208EM0.00homo-trimer3 x EIC, 30 x NAGHHblits0.62
8dli.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein
0.7298.590.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
8dlj.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2
0.5798.590.95 1-1208EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGHHblits0.61
8dli.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein
0.7298.590.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
8dlj.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2
0.7298.590.95 1-1208EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGHHblits0.61
8dli.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein
0.7298.590.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
8dlj.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2
0.7298.590.95 1-1208EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGHHblits0.61
8dlk.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.0498.590.95 1-1208EM0.00hetero-1-1-mer7 x NAGHHblits0.61
6xs6.1.A
Spike glycoprotein
SARS-CoV-2 Spike D614G variant, minus RBD
0.4999.670.94 12-1213EM0.00homo-trimerBLAST0.62
8gb0.1.A
Spike glycoprotein
SARS-CoV-2 Spike H655Y variant, One RBD Open
0.6999.580.94 12-1213EM0.00homo-trimerBLAST0.62
8gb0.1.B
Spike glycoprotein
SARS-CoV-2 Spike H655Y variant, One RBD Open
0.6999.580.94 12-1213EM0.00homo-trimerBLAST0.62
8gb0.1.C
Spike glycoprotein
SARS-CoV-2 Spike H655Y variant, One RBD Open
0.6999.580.94 12-1213EM0.00homo-trimerBLAST0.62
8h3e.1.A
Spike glycoprotein,Fibritin
Complex structure of a small molecule (SPC-14) bound SARS-CoV-2 spike protein, closed state
0.6399.580.94 12-1211EM0.00homo-trimer3 x Q83, 15 x NAGBLAST0.62
8h3d.1.B
Spike glycoprotein,Fibritin
Structure of apo SARS-CoV-2 spike protein with one RBD up
0.6199.580.94 12-1211EM0.00homo-trimer13 x NAGBLAST0.62
8h3d.1.C
Spike glycoprotein,Fibritin
Structure of apo SARS-CoV-2 spike protein with one RBD up
0.6099.580.94 12-1211EM0.00homo-trimer13 x NAGBLAST0.62
8h3d.1.A
Spike glycoprotein,Fibritin
Structure of apo SARS-CoV-2 spike protein with one RBD up
0.6399.580.94 12-1211EM0.00homo-trimer13 x NAGBLAST0.62
7v7n.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), all RBD-down conformation
0.6898.840.95 1-1207EM0.00homo-trimer12 x NAG, 1 x NAG-NAG-BMA, 35 x NAG-NAGHHblits0.61
7v7n.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), all RBD-down conformation
0.6898.840.95 1-1207EM0.00homo-trimer12 x NAG, 1 x NAG-NAG-BMA, 35 x NAG-NAGHHblits0.61
7v7o.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 1
0.6898.840.95 1-1207EM0.00homo-trimer13 x NAG, 35 x NAG-NAGHHblits0.61
7v7p.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 2
0.6898.840.95 1-1207EM0.00homo-trimer12 x NAG, 36 x NAG-NAGHHblits0.61
7v7q.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 3
0.6898.840.95 1-1207EM0.00homo-trimer12 x NAG, 36 x NAG-NAGHHblits0.61
7v7n.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), all RBD-down conformation
0.6898.840.95 1-1207EM0.00homo-trimer12 x NAG, 1 x NAG-NAG-BMA, 35 x NAG-NAGHHblits0.61
7v7o.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 1
0.6898.840.95 1-1207EM0.00homo-trimer13 x NAG, 35 x NAG-NAGHHblits0.61
7v7t.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 1
0.6898.840.95 1-1207EM0.00homo-trimer13 x NAG, 35 x NAG-NAGHHblits0.61
7v7o.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 1
0.6898.840.95 1-1207EM0.00homo-trimer13 x NAG, 35 x NAG-NAGHHblits0.61
7v7v.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 3
0.6898.840.95 1-1207EM0.00homo-trimer12 x NAG, 36 x NAG-NAGHHblits0.61
7v7p.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 2
0.6898.840.95 1-1207EM0.00homo-trimer12 x NAG, 36 x NAG-NAGHHblits0.61
7v7q.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 3
0.6898.840.95 1-1207EM0.00homo-trimer12 x NAG, 36 x NAG-NAGHHblits0.61
7v7v.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 3
0.6898.840.95 1-1207EM0.00homo-trimer12 x NAG, 36 x NAG-NAGHHblits0.61
7v7p.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 2
0.6898.840.95 1-1207EM0.00homo-trimer12 x NAG, 36 x NAG-NAGHHblits0.61
7v7q.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 3
0.6898.840.95 1-1207EM0.00homo-trimer12 x NAG, 36 x NAG-NAGHHblits0.61
7v7s.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 5
0.6898.840.95 1-1207EM0.00homo-trimer15 x NAG, 33 x NAG-NAGHHblits0.61
7v7u.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 2
0.6898.840.95 1-1207EM0.00homo-trimer13 x NAG, 35 x NAG-NAGHHblits0.61
7v7r.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 4
0.6898.840.95 1-1207EM0.00homo-trimer12 x NAG, 36 x NAG-NAGHHblits0.61
7v7r.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 4
0.6898.840.95 1-1207EM0.00homo-trimer12 x NAG, 36 x NAG-NAGHHblits0.61
7v7r.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 4
0.6898.840.95 1-1207EM0.00homo-trimer12 x NAG, 36 x NAG-NAGHHblits0.61
7v7s.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 5
0.6898.840.95 1-1207EM0.00homo-trimer15 x NAG, 33 x NAG-NAGHHblits0.61
7v7u.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 2
0.6898.840.95 1-1207EM0.00homo-trimer13 x NAG, 35 x NAG-NAGHHblits0.61
7v7s.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 5
0.6898.840.95 1-1207EM0.00homo-trimer15 x NAG, 33 x NAG-NAGHHblits0.61
7v7t.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 1
0.6898.840.95 1-1207EM0.00homo-trimer13 x NAG, 35 x NAG-NAGHHblits0.61
7v8a.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
0.6898.840.95 1-1207EM0.00hetero-3-3-mer16 x NAG, 38 x NAG-NAGHHblits0.61
7v7t.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 1
0.6898.840.95 1-1207EM0.00homo-trimer13 x NAG, 35 x NAG-NAGHHblits0.61
7v88.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6898.840.95 1-1207EM0.00hetero-3-2-mer15 x NAG, 37 x NAG-NAGHHblits0.61
7v7u.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 2
0.6898.840.95 1-1207EM0.00homo-trimer13 x NAG, 35 x NAG-NAGHHblits0.61
7v7v.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 3
0.6898.840.95 1-1207EM0.00homo-trimer12 x NAG, 36 x NAG-NAGHHblits0.61
7v88.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6898.840.95 1-1207EM0.00hetero-3-2-mer15 x NAG, 37 x NAG-NAGHHblits0.61
7v89.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
0.6898.840.95 1-1207EM0.00hetero-3-3-mer14 x NAG, 43 x NAG-NAGHHblits0.61
7v88.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6798.840.95 1-1207EM0.00hetero-3-2-mer15 x NAG, 37 x NAG-NAGHHblits0.61
7v89.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
0.6898.840.95 1-1207EM0.00hetero-3-3-mer14 x NAG, 43 x NAG-NAGHHblits0.61
7v89.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
0.6898.840.95 1-1207EM0.00hetero-3-3-mer14 x NAG, 43 x NAG-NAGHHblits0.61
7v8a.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
0.6898.840.95 1-1207EM0.00hetero-3-3-mer16 x NAG, 38 x NAG-NAGHHblits0.61
7v8a.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
0.6898.840.95 1-1207EM0.00hetero-3-3-mer16 x NAG, 38 x NAG-NAGHHblits0.61
7v8b.1.A
Spike glycoprotein
Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.0498.840.95 1-1207EM0.00hetero-1-1-mer3 x NAG, 1 x NAG-NAG-BMA, 4 x NAG-NAGHHblits0.61
6wps.1.A
spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment
0.7199.330.94 11-1211EM3.10hetero-3-3-3-mer33 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MAN-FUCHHblits0.61
6wps.1.G
spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment
0.7199.330.94 11-1211EM3.10hetero-3-3-3-mer33 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MAN-FUCHHblits0.61
6wps.1.D
spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment
0.7199.330.94 11-1211EM3.10hetero-3-3-3-mer33 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MAN-FUCHHblits0.61
6wpt.1.B
spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state)
0.7099.330.94 11-1211EM3.70hetero-3-2-2-mer35 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUCHHblits0.61
6wpt.1.A
spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state)
0.6999.330.94 11-1211EM3.70hetero-3-2-2-mer35 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUCHHblits0.61
6wpt.1.C
spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state)
0.7199.330.94 11-1211EM3.70hetero-3-2-2-mer35 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUCHHblits0.61
7r10.1.B
Spike glycoprotein
Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2
0.3698.840.95 1-1208EM0.00hetero-1-1-mer1 x ZN, 7 x NAGHHblits0.61
7tgy.1.A
Spike glycoprotein
Prototypic SARS-CoV-2 G614 spike (closed form)
0.6899.750.94 14-1211EM0.00homo-trimer24 x NAG, 9 x NAG-NAGHHblits0.62
7tgy.1.B
Spike glycoprotein
Prototypic SARS-CoV-2 G614 spike (closed form)
0.6999.750.94 14-1211EM0.00homo-trimer24 x NAG, 9 x NAG-NAGHHblits0.62
7tgy.1.C
Spike glycoprotein
Prototypic SARS-CoV-2 G614 spike (closed form)
0.6999.750.94 14-1211EM0.00homo-trimer24 x NAG, 9 x NAG-NAGHHblits0.62
7tgx.1.B
Spike glycoprotein
Prototypic SARS-CoV-2 G614 spike (open form)
0.6999.750.94 14-1211EM0.00homo-trimer23 x NAG, 1 x MAN, 4 x NAG-MANHHblits0.62
7tgx.1.C
Spike glycoprotein
Prototypic SARS-CoV-2 G614 spike (open form)
0.6899.750.94 14-1211EM0.00homo-trimer23 x NAG, 1 x MAN, 4 x NAG-MANHHblits0.62
7tgx.1.A
Spike glycoprotein
Prototypic SARS-CoV-2 G614 spike (open form)
0.6899.750.94 14-1211EM0.00homo-trimer23 x NAG, 1 x MAN, 4 x NAG-MANHHblits0.62
7r0z.1.B
Spike glycoprotein
Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
0.0898.760.95 1-1208EM0.00hetero-1-1-mer1 x ZN, 8 x NAGHHblits0.61
7so9.1.A
Spike glycoprotein
SARS-CoV-2 S B.1.617.2 delta variant + S2M11 + S2L20 Global Refinement
0.7398.670.95 1-1208EM0.00hetero-3-3-3-3-3-mer45 x NAG, 3 x NAG-FUCHHblits0.61
7so9.1.F
Spike glycoprotein
SARS-CoV-2 S B.1.617.2 delta variant + S2M11 + S2L20 Global Refinement
0.7398.670.95 1-1208EM0.00hetero-3-3-3-3-3-mer45 x NAG, 3 x NAG-FUCHHblits0.61
7so9.1.K
Spike glycoprotein
SARS-CoV-2 S B.1.617.2 delta variant + S2M11 + S2L20 Global Refinement
0.7398.670.95 1-1208EM0.00hetero-3-3-3-3-3-mer45 x NAG, 3 x NAG-FUCHHblits0.61
7soa.1.C
Spike glycoprotein
SARS-CoV-2 S NTD B.1.617.2 delta variant + S2L20 Local Refinement
0.1098.670.95 1-1208EM0.00hetero-1-1-1-mer4 x NAG, 1 x NAG-NAGHHblits0.61
7n8h.1.A
Spike glycoprotein
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement
0.7098.670.95 1-1208EM0.00hetero-3-3-3-3-3-mer39 x NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAGHHblits0.61
7n8h.1.F
Spike glycoprotein
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement
0.7098.670.95 1-1208EM0.00hetero-3-3-3-3-3-mer39 x NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAGHHblits0.61
7n8h.1.K
Spike glycoprotein
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement
0.7098.670.95 1-1208EM0.00hetero-3-3-3-3-3-mer39 x NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAGHHblits0.61
7n8i.1.C
Spike glycoprotein
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20)
0.0698.670.95 1-1208EM0.00hetero-1-1-1-mer5 x NAGHHblits0.61
8dlp.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2
0.7398.260.95 1-1208EM0.00hetero-3-3-mer42 x NAG, 18 x NAG-NAGHHblits0.61
8dlq.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.0498.260.95 1-1208EM0.00hetero-1-1-mer7 x NAGHHblits0.61
8dlo.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein
0.7198.260.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
8dlo.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein
0.7198.260.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
8dlo.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein
0.7198.260.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
8dlp.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2
0.7398.260.95 1-1208EM0.00hetero-3-3-mer42 x NAG, 18 x NAG-NAGHHblits0.61
8dlp.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2
0.7298.260.95 1-1208EM0.00hetero-3-3-mer42 x NAG, 18 x NAG-NAGHHblits0.61
8dlr.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4-8 (focused refinement of NTD and 4-8)
0.1098.260.95 1-1208EM0.00hetero-1-1-1-mer6 x NAGHHblits0.61
8dls.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4A8 (focused refinement of NTD and 4A8)
0.0998.260.95 1-1208EM0.00hetero-1-1-1-mer5 x NAG, 1 x NAG-NAGHHblits0.61
7kdi.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G)
0.6999.920.94 12-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7kdi.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G)
0.7099.920.94 12-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7kdi.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G)
0.7099.920.94 12-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7r1a.1.A
Spike glycoprotein
Furin Cleaved Alpha Variant SARS-CoV-2 Spike in complex with 3 ACE2
0.6798.760.95 1-1208EM0.00hetero-3-3-mer48 x NAG, 3 x ZN, 3 x NAG-NAGHHblits0.61
7r1a.1.E
Spike glycoprotein
Furin Cleaved Alpha Variant SARS-CoV-2 Spike in complex with 3 ACE2
0.6798.760.95 1-1208EM0.00hetero-3-3-mer48 x NAG, 3 x ZN, 3 x NAG-NAGHHblits0.61
7r1a.1.F
Spike glycoprotein
Furin Cleaved Alpha Variant SARS-CoV-2 Spike in complex with 3 ACE2
0.6798.760.95 1-1208EM0.00hetero-3-3-mer48 x NAG, 3 x ZN, 3 x NAG-NAGHHblits0.61
7v8c.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), Cleavable form, one RBD-up conformation
0.6898.840.95 1-1207EM0.00homo-trimer17 x NAG, 29 x NAG-NAGHHblits0.61
7v8c.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), Cleavable form, one RBD-up conformation
0.6898.840.95 1-1207EM0.00homo-trimer17 x NAG, 29 x NAG-NAGHHblits0.61
7v8c.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), Cleavable form, one RBD-up conformation
0.6898.840.95 1-1207EM0.00homo-trimer17 x NAG, 29 x NAG-NAGHHblits0.61
7kdj.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G)
0.6999.830.94 12-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGBLAST0.62
7kdj.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G)
0.6799.830.94 12-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGBLAST0.62
7kdj.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G)
0.6899.830.94 12-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGBLAST0.62
7sc1.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, R40-1G8
0.6799.420.94 12-1213EM0.00hetero-3-3-3-mer45 x NAGBLAST0.61
7uar.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1717
0.6699.420.94 12-1213EM3.50hetero-3-3-3-mer27 x NAG, 6 x NAG-NAG, 1 x NAG-NAG-BMA-FUCBLAST0.61
7uap.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1520
0.6699.420.94 12-1213EM0.00hetero-3-3-3-mer35 x NAG, 12 x NAG-NAGBLAST0.61
7uaq.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 NTD in complex with C1520, local refinement
0.0799.420.94 12-1213EM0.00hetero-1-1-1-mer4 x NAG, 3 x NAG-NAGBLAST0.61
7uap.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1520
0.6499.420.94 12-1213EM0.00hetero-3-3-3-mer35 x NAG, 12 x NAG-NAGBLAST0.61
7uar.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1717
0.6399.420.94 12-1213EM3.50hetero-3-3-3-mer27 x NAG, 6 x NAG-NAG, 1 x NAG-NAG-BMA-FUCBLAST0.61
7uap.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1520
0.6699.420.94 12-1213EM0.00hetero-3-3-3-mer35 x NAG, 12 x NAG-NAGBLAST0.61
7uar.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1717
0.6599.420.94 12-1213EM3.50hetero-3-3-3-mer27 x NAG, 6 x NAG-NAG, 1 x NAG-NAG-BMA-FUCBLAST0.61
8dad.1.C
Spike glycoprotein
SARS-CoV-2 receptor binding domain in complex with AZ090 Fab
0.0399.420.94 12-1213EM0.00hetero-1-1-1-mer2 x NAG-NAGBLAST0.61
7uz9.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-34
0.6799.420.94 12-1213EM0.00hetero-3-3-3-mer42 x NAGBLAST0.61
7uz4.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-3
0.6899.420.94 12-1213EM0.00hetero-3-3-3-mer45 x NAG, 3 x NAG-NAGBLAST0.61
7uz5.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-6
0.6999.420.94 12-1213EM0.00hetero-3-1-1-mer48 x NAGBLAST0.61
7uz7.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-31
0.6899.420.94 12-1213EM0.00hetero-3-3-3-mer39 x NAG, 3 x NAG-NAGBLAST0.61
7uz6.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-28
0.6699.420.94 12-1213EM0.00hetero-3-3-3-mer39 x NAGBLAST0.61
7uz9.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-34
0.6799.420.94 12-1213EM0.00hetero-3-3-3-mer42 x NAGBLAST0.61
7uza.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, HSW-1
0.6799.420.94 12-1213EM0.00hetero-3-1-1-mer34 x NAG, 2 x NAG-NAGBLAST0.61
7uz5.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-6
0.6999.420.94 12-1213EM0.00hetero-3-1-1-mer48 x NAGBLAST0.61
7uz9.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-34
0.6799.420.94 12-1213EM0.00hetero-3-3-3-mer42 x NAGBLAST0.61
7uza.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, HSW-1
0.6699.420.94 12-1213EM0.00hetero-3-1-1-mer34 x NAG, 2 x NAG-NAGBLAST0.61
7uz6.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-28
0.6899.420.94 12-1213EM0.00hetero-3-3-3-mer39 x NAGBLAST0.61
7uz4.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-3
0.6899.420.94 12-1213EM0.00hetero-3-3-3-mer45 x NAG, 3 x NAG-NAGBLAST0.61
7uza.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, HSW-1
0.6799.420.94 12-1213EM0.00hetero-3-1-1-mer34 x NAG, 2 x NAG-NAGBLAST0.61
7uz5.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-6
0.6899.420.94 12-1213EM0.00hetero-3-1-1-mer48 x NAGBLAST0.61
7uz6.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-28
0.6799.420.94 12-1213EM0.00hetero-3-3-3-mer39 x NAGBLAST0.61
7uz4.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-3
0.6899.420.94 12-1213EM0.00hetero-3-3-3-mer45 x NAG, 3 x NAG-NAGBLAST0.61
7uzb.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S S1 doamin in complex with the mouse antibody Fab fragment, HSW-2
0.3799.420.94 12-1213EM0.00hetero-1-1-1-mer4 x NAGBLAST0.61
7r8n.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C051
0.6299.420.94 12-1213EM0.00hetero-3-3-3-mer27 x NAG, 4 x NAG-NAGBLAST0.61
7r8m.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032
0.6399.420.94 12-1213EM0.00hetero-3-2-2-mer22 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-FUCBLAST0.61
7r8m.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032
0.6199.420.94 12-1213EM0.00hetero-3-2-2-mer22 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-FUCBLAST0.61
7r8m.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032
0.6199.420.94 12-1213EM0.00hetero-3-2-2-mer22 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-FUCBLAST0.61
7r8o.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C548
0.7099.420.94 12-1213EM0.00hetero-3-3-3-mer26 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-FUC, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-FUCBLAST0.61
7rkv.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C118 (State 1)
0.6899.420.94 12-1213EM0.00hetero-3-3-3-mer39 x NAGBLAST0.61
7s0d.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014
0.7199.420.94 12-1213EM0.00hetero-3-3-3-merBLAST0.61
7s0c.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017
0.7099.420.94 12-1213EM0.00hetero-3-2-2-mer19 x NAG, 6 x NAG-NAGBLAST0.61
7s0d.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014
0.7199.420.94 12-1213EM0.00hetero-3-3-3-merBLAST0.61
7s0d.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014
0.6899.420.94 12-1213EM0.00hetero-3-3-3-merBLAST0.61
7s0e.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S1 subunit in complex with antibody N-612-004
0.3899.420.94 12-1213EM0.00hetero-1-1-1-merBLAST0.61
7s0c.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017
0.6899.420.94 12-1213EM0.00hetero-3-2-2-mer19 x NAG, 6 x NAG-NAGBLAST0.61
7s0c.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017
0.6899.420.94 12-1213EM0.00hetero-3-2-2-mer19 x NAG, 6 x NAG-NAGBLAST0.61
6wpt.1.A
spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state)
0.7099.500.94 13-1211EM3.70hetero-3-2-2-mer35 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUCBLAST0.61
6wpt.1.C
spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state)
0.7199.500.94 13-1211EM3.70hetero-3-2-2-mer35 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUCBLAST0.61
7r13.1.A
Spike glycoprotein
Alpha Variant SARS-CoV-2 Spike in Closed conformation
0.6898.670.95 1-1208EM0.00homo-trimer39 x NAG, 9 x NAG-NAGHHblits0.61
7r13.1.B
Spike glycoprotein
Alpha Variant SARS-CoV-2 Spike in Closed conformation
0.6898.670.95 1-1208EM0.00homo-trimer39 x NAG, 9 x NAG-NAGHHblits0.61
7r13.1.C
Spike glycoprotein
Alpha Variant SARS-CoV-2 Spike in Closed conformation
0.6898.670.95 1-1208EM0.00homo-trimer39 x NAG, 9 x NAG-NAGHHblits0.61
7r14.1.A
Spike glycoprotein
Alpha Variant SARS-CoV-2 Spike with 1 Erect RBD
0.6698.670.95 1-1208EM0.00homo-trimer33 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7r14.1.B
Spike glycoprotein
Alpha Variant SARS-CoV-2 Spike with 1 Erect RBD
0.7098.670.95 1-1208EM0.00homo-trimer33 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7r14.1.C
Spike glycoprotein
Alpha Variant SARS-CoV-2 Spike with 1 Erect RBD
0.6898.670.95 1-1208EM0.00homo-trimer33 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.61
7r15.1.A
Spike glycoprotein
Alpha Variant SARS-CoV-2 Spike with 2 Erect RBDs
0.6498.670.95 1-1208EM0.00homo-trimer37 x NAG, 3 x NAG-NAGHHblits0.61
7r15.1.B
Spike glycoprotein
Alpha Variant SARS-CoV-2 Spike with 2 Erect RBDs
0.6698.670.95 1-1208EM0.00homo-trimer37 x NAG, 3 x NAG-NAGHHblits0.61
7r15.1.C
Spike glycoprotein
Alpha Variant SARS-CoV-2 Spike with 2 Erect RBDs
0.6698.670.95 1-1208EM0.00homo-trimer37 x NAG, 3 x NAG-NAGHHblits0.61
7a5r.1.C
Spike glycoprotein
Complex of SARS-CoV-2 spike and CR3022 Fab (Non-Uniform Refinement)
0.0499.830.94 12-1208EM0.00hetero-2-2-2-mer2 x NAG-NAGBLAST0.62
6zgi.1.A
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Closed Conformation
0.7199.830.94 12-1208EM0.00homo-trimer24 x NAG, 27 x NAG-NAGBLAST0.62
6zgg.1.A
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erect
0.6599.830.94 12-1208EM0.00homo-trimerBLAST0.62
6zgg.1.B
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erect
0.6599.830.94 12-1208EM0.00homo-trimerBLAST0.62
6zgg.1.C
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erect
0.6499.830.94 12-1208EM0.00homo-trimerBLAST0.62
7a5s.1.E
Spike glycoprotein
Complex of SARS-CoV-2 spike and CR3022 Fab (Homogeneous Refinement)
0.3599.830.94 12-1208EM0.00hetero-2-2-2-mer2 x NAG-NAGBLAST0.62
7a93.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 RBDs Erect
0.6399.830.94 12-1208EM0.00homo-trimerBLAST0.62
7a95.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
0.6399.830.94 12-1208EM0.00hetero-3-1-merBLAST0.62
7a96.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
0.6299.830.94 12-1208EM0.00hetero-3-1-merBLAST0.62
7a98.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound
0.6399.830.94 12-1208EM0.00hetero-3-3-merBLAST0.62
7a94.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
0.6899.830.94 12-1208EM0.00hetero-3-1-mer23 x NAG, 1 x ZNBLAST0.62
7a94.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
0.6899.830.94 12-1208EM0.00hetero-3-1-mer23 x NAG, 1 x ZNBLAST0.62
7a94.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
0.6899.830.94 12-1208EM0.00hetero-3-1-mer23 x NAG, 1 x ZNBLAST0.62
7a97.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
0.6399.830.94 12-1208EM0.00hetero-3-2-merBLAST0.62
7a96.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
0.6299.830.94 12-1208EM0.00hetero-3-1-merBLAST0.62
7a97.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
0.6499.830.94 12-1208EM0.00hetero-3-2-merBLAST0.62
7a93.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 RBDs Erect
0.6399.830.94 12-1208EM0.00homo-trimerBLAST0.62
7a97.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
0.6299.830.94 12-1208EM0.00hetero-3-2-merBLAST0.62
7a96.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
0.6399.830.94 12-1208EM0.00hetero-3-1-merBLAST0.62
7a95.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
0.6399.830.94 12-1208EM0.00hetero-3-1-merBLAST0.62
7a95.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
0.6399.830.94 12-1208EM0.00hetero-3-1-merBLAST0.62
7a93.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 RBDs Erect
0.6299.830.94 12-1208EM0.00homo-trimerBLAST0.62
6zgh.1.B
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformation
0.6599.830.94 12-1208EM0.00homo-trimerBLAST0.62
6zgh.1.A
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformation
0.5599.830.94 12-1208EM0.00homo-trimerBLAST0.62
6zgh.1.C
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformation
0.6599.830.94 12-1208EM0.00homo-trimerBLAST0.62
8dlw.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with Fab S2M11
0.7298.590.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 18 x NAG-NAG, 3 x NAG-NAG-BMA-FUCHHblits0.61
8dlw.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with Fab S2M11
0.7298.590.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 18 x NAG-NAG, 3 x NAG-NAG-BMA-FUCHHblits0.61
8dlw.1.E
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with Fab S2M11
0.7298.590.95 1-1208EM0.00hetero-3-3-3-mer30 x NAG, 18 x NAG-NAG, 3 x NAG-NAG-BMA-FUCHHblits0.61
8dlt.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein
0.7298.590.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
8dlt.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein
0.7398.590.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
8dlu.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2
0.7298.590.95 1-1208EM0.00hetero-3-2-mer36 x NAG, 18 x NAG-NAGHHblits0.61
8dlv.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.0498.590.95 1-1208EM0.00hetero-1-1-mer7 x NAGHHblits0.61
8dlu.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2
0.7398.590.95 1-1208EM0.00hetero-3-2-mer36 x NAG, 18 x NAG-NAGHHblits0.61
8dlt.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein
0.7298.590.95 1-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGHHblits0.61
8dlu.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2
0.7398.590.95 1-1208EM0.00hetero-3-2-mer36 x NAG, 18 x NAG-NAGHHblits0.61
8dlx.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6
0.5898.590.95 1-1208EM0.00hetero-3-1-mer23 x NAG, 18 x NAG-NAGHHblits0.61
8dlx.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6
0.7198.590.95 1-1208EM0.00hetero-3-1-mer23 x NAG, 18 x NAG-NAGHHblits0.61
8dlx.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6
0.7298.590.95 1-1208EM0.00hetero-3-1-mer23 x NAG, 18 x NAG-NAGHHblits0.61
8dly.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6)
0.0398.590.95 1-1208EM0.00hetero-1-1-mer1 x NAGHHblits0.61
8aqt.1.B
Spike glycoprotein,Fibritin
Beta SARS-CoV-2 Spike bound to mouse ACE2 (local)
0.0198.180.95 1-1212EM0.00hetero-1-1-mer1 x NAG, 1 x NAG-NAGHHblits0.61
7ey5.1.A
Spike glycoprotein
Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-771 Fab and BD-821 Fab
0.0298.510.95 1-1208EM0.00hetero-1-1-1-1-1-merHHblits0.61
7eya.1.A
Spike glycoprotein
Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-804 Fab
0.0198.510.95 1-1208EM0.00hetero-1-1-1-1-merHHblits0.61
7ezv.1.A
Spike glycoprotein
local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-812 Fab and BD-836 Fab
0.0298.510.95 1-1208EM0.00hetero-1-1-1-1-1-merHHblits0.61
7cn4.1.A
Spike glycoprotein
Cryo-EM structure of bat RaTG13 spike glycoprotein
0.6797.440.95 1-1213EM0.00homo-trimer36 x NAG, 9 x NAG-NAGHHblits0.61
6vxx.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein (closed state)
0.7199.580.94 14-1211EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
6vxx.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein (closed state)
0.7199.580.94 14-1211EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
6vxx.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein (closed state)
0.7199.580.94 14-1211EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7jv6.1.D
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation)
0.7199.580.94 14-1211EM0.00hetero-3-3-3-mer36 x NAG, 12 x NAG-NAGHHblits0.62
7jv6.1.G
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation)
0.7199.580.94 14-1211EM0.00hetero-3-3-3-mer36 x NAG, 12 x NAG-NAGHHblits0.62
7jv6.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation)
0.7199.580.94 14-1211EM0.00hetero-3-3-3-mer36 x NAG, 12 x NAG-NAGHHblits0.62
7jv2.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
0.0099.580.94 14-1211EM0.00hetero-1-1-1-merHHblits0.62
7jva.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains)
0.0399.580.94 14-1211EM0.00hetero-1-1-1-merHHblits0.62
7jvc.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment
0.7199.580.94 14-1211EM0.00hetero-3-3-3-mer33 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.62
7jvc.1.D
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment
0.7199.580.94 14-1211EM0.00hetero-3-3-3-mer33 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.62
7jvc.1.G
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment
0.7199.580.94 14-1211EM0.00hetero-3-3-3-mer33 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.62
7jv4.1.B
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
0.7199.580.94 14-1211EM0.00hetero-3-3-3-mer36 x NAG, 11 x NAG-NAGHHblits0.62
7jv4.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
0.7199.580.94 14-1211EM0.00hetero-3-3-3-mer36 x NAG, 11 x NAG-NAGHHblits0.62
7k43.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment
0.7299.580.94 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 18 x NAG-NAG, 3 x NAG-NAG-BMA-FUCHHblits0.62
7k43.1.G
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment
0.7299.580.94 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 18 x NAG-NAG, 3 x NAG-NAG-BMA-FUCHHblits0.62
7k43.1.D
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment
0.7299.580.94 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 18 x NAG-NAG, 3 x NAG-NAG-BMA-FUCHHblits0.62
7jw0.1.G
Spike glycoprotein
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment
0.7299.580.94 14-1211EM0.00hetero-3-3-3-mer36 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.62
7jw0.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment
0.7299.580.94 14-1211EM0.00hetero-3-3-3-mer36 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.62
7jw0.1.D
Spike glycoprotein
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment
0.7299.580.94 14-1211EM0.00hetero-3-3-3-mer36 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.62
7mtd.1.B
Spike glycoprotein
Structure of aged SARS-CoV-2 S2P spike at pH 7.4
0.4899.580.94 14-1211EM0.00homo-trimer13 x NAG, 14 x NAG-NAGHHblits0.62
7mtc.1.B
Spike glycoprotein
Structure of freshly purified SARS-CoV-2 S2P spike at pH 7.4
0.5899.580.94 14-1211EM0.00homo-trimer14 x NAG, 14 x NAG-NAGHHblits0.62
7mtd.1.A
Spike glycoprotein
Structure of aged SARS-CoV-2 S2P spike at pH 7.4
0.5799.580.94 14-1211EM0.00homo-trimer13 x NAG, 14 x NAG-NAGHHblits0.62
7mtc.1.A
Spike glycoprotein
Structure of freshly purified SARS-CoV-2 S2P spike at pH 7.4
0.6899.580.94 14-1211EM0.00homo-trimer14 x NAG, 14 x NAG-NAGHHblits0.62
7mtd.1.C
Spike glycoprotein
Structure of aged SARS-CoV-2 S2P spike at pH 7.4
0.5499.580.94 14-1211EM0.00homo-trimer13 x NAG, 14 x NAG-NAGHHblits0.62
7mtc.1.C
Spike glycoprotein
Structure of freshly purified SARS-CoV-2 S2P spike at pH 7.4
0.6899.580.94 14-1211EM0.00homo-trimer14 x NAG, 14 x NAG-NAGHHblits0.62
7jv4.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
0.7299.580.94 14-1211EM0.00hetero-3-3-3-mer36 x NAG, 11 x NAG-NAGHHblits0.62
6vxx.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein (closed state)
0.7199.580.94 14-1211EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7jv2.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
0.0099.580.94 14-1211EM0.00hetero-1-1-1-merBLAST0.62
7k43.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment
0.7399.580.94 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 18 x NAG-NAG, 3 x NAG-NAG-BMA-FUCBLAST0.62
7jw0.1.G
Spike glycoprotein
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment
0.7299.580.94 14-1211EM0.00hetero-3-3-3-mer36 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMABLAST0.62
7mtd.1.B
Spike glycoprotein
Structure of aged SARS-CoV-2 S2P spike at pH 7.4
0.4899.580.94 14-1211EM0.00homo-trimer13 x NAG, 14 x NAG-NAGBLAST0.62
7mtd.1.A
Spike glycoprotein
Structure of aged SARS-CoV-2 S2P spike at pH 7.4
0.5899.580.94 14-1211EM0.00homo-trimer13 x NAG, 14 x NAG-NAGBLAST0.62
7mtd.1.C
Spike glycoprotein
Structure of aged SARS-CoV-2 S2P spike at pH 7.4
0.5499.580.94 14-1211EM0.00homo-trimer13 x NAG, 14 x NAG-NAGBLAST0.62
7jv4.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
0.7399.580.94 14-1211EM0.00hetero-3-3-3-mer36 x NAG, 11 x NAG-NAGBLAST0.62
7kdg.1.A
Spike glycoprotein
SARS-CoV-2 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
0.7099.750.94 12-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7kdh.1.A
Spike glycoprotein
SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
0.6999.750.94 12-1208EM0.00homo-trimer49 x NAGBLAST0.62
7kdh.1.B
Spike glycoprotein
SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
0.6699.750.94 12-1208EM0.00homo-trimer49 x NAGBLAST0.62
7kdh.1.C
Spike glycoprotein
SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
0.6999.750.94 12-1208EM0.00homo-trimer49 x NAGBLAST0.62
7zr7.1.A
Spike glycoprotein,Fibritin
OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
0.7298.100.95 1-1212EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.61
7zr7.1.C
Spike glycoprotein,Fibritin
OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
0.7298.100.95 1-1212EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.61
7zrc.1.B
Spike glycoprotein,Fibritin
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE
0.7298.100.95 1-1212EM0.00hetero-3-3-3-mer28 x NAG, 12 x NAG-NAGHHblits0.61
7zr9.1.A
Spike glycoprotein,Fibritin
OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
0.7298.100.95 1-1212EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.61
7zr9.1.C
Spike glycoprotein,Fibritin
OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
0.7298.100.95 1-1212EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.61
7zr8.1.A
Spike glycoprotein,Fibritin
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement)
0.0598.100.95 1-1212EM0.00hetero-1-1-1-mer1 x NAGHHblits0.61
7zrc.1.C
Spike glycoprotein,Fibritin
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE
0.7298.100.95 1-1212EM0.00hetero-3-3-3-mer28 x NAG, 12 x NAG-NAGHHblits0.61
7zr9.1.B
Spike glycoprotein,Fibritin
OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
0.7298.100.95 1-1212EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.61
7zrc.1.A
Spike glycoprotein,Fibritin
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE
0.7398.100.95 1-1212EM0.00hetero-3-3-3-mer28 x NAG, 12 x NAG-NAGHHblits0.61
7zr7.1.B
Spike glycoprotein,Fibritin
OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
0.7298.100.95 1-1212EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.61
7kml.1.A
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, three RBDs bound
0.6499.250.94 12-1211EM0.00hetero-3-3-3-mer18 x NAG, 21 x NAG-NAG, 6 x NAG-NAG-BMABLAST0.61
7kmk.1.B
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound
0.6399.250.94 12-1211EM0.00hetero-3-2-2-mer25 x NAG, 7 x NAG-NAG, 2 x NAG-NAG-BMABLAST0.61
7kmk.1.C
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound
0.6299.250.94 12-1211EM0.00hetero-3-2-2-mer25 x NAG, 7 x NAG-NAG, 2 x NAG-NAG-BMABLAST0.61
7kmk.1.A
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound
0.6399.250.94 12-1211EM0.00hetero-3-2-2-mer25 x NAG, 7 x NAG-NAG, 2 x NAG-NAG-BMABLAST0.61
7kxj.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric
0.6199.250.94 12-1211EM0.00hetero-3-3-3-mer7 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAGBLAST0.61
7kxj.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric
0.6199.250.94 12-1211EM0.00hetero-3-3-3-mer7 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAGBLAST0.61
7kxj.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric
0.6199.250.94 12-1211EM0.00hetero-3-3-3-mer7 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAGBLAST0.61
7kxk.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation
0.6199.250.94 12-1211EM0.00hetero-3-3-3-mer16 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMABLAST0.61
7kxk.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation
0.6199.250.94 12-1211EM0.00hetero-3-3-3-mer16 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMABLAST0.61
7kxk.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation
0.6399.250.94 12-1211EM0.00hetero-3-3-3-mer16 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMABLAST0.61
6vyb.1.A
Spike glycoprotein
SARS-CoV-2 spike ectodomain structure (open state)
0.7199.500.94 14-1211EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
6vyb.1.B
Spike glycoprotein
SARS-CoV-2 spike ectodomain structure (open state)
0.7199.500.94 14-1211EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
6vyb.1.C
Spike glycoprotein
SARS-CoV-2 spike ectodomain structure (open state)
0.7199.500.94 14-1211EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
6vyb.1.A
Spike glycoprotein
SARS-CoV-2 spike ectodomain structure (open state)
0.7199.500.94 14-1211EM0.00homo-trimer35 x NAG, 12 x NAG-NAGBLAST0.62
6vyb.1.B
Spike glycoprotein
SARS-CoV-2 spike ectodomain structure (open state)
0.7199.500.94 14-1211EM0.00homo-trimer35 x NAG, 12 x NAG-NAGBLAST0.62
6vyb.1.C
Spike glycoprotein
SARS-CoV-2 spike ectodomain structure (open state)
0.7199.500.94 14-1211EM0.00homo-trimer35 x NAG, 12 x NAG-NAGBLAST0.62
7qdh.1.A
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:D614G mutant 1-up
0.6499.080.94 15-1217EM4.20homo-trimer24 x NAG, 10 x NAG-NAGHHblits0.61
7qdh.1.B
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:D614G mutant 1-up
0.6599.080.94 15-1217EM4.20homo-trimer24 x NAG, 10 x NAG-NAGHHblits0.61
7qdh.1.C
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:D614G mutant 1-up
0.6599.080.94 15-1217EM4.20homo-trimer24 x NAG, 10 x NAG-NAGHHblits0.61
7wch.1.B
Surface glycoprotein
CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWA9 Fab
0.7098.510.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7wcp.1.A
Surface glycoprotein
CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWC11 Fab
0.7098.510.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7wch.1.A
Surface glycoprotein
CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWA9 Fab
0.6998.510.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7wch.1.E
Surface glycoprotein
CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWA9 Fab
0.7198.510.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7wcp.1.B
Surface glycoprotein
CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWC11 Fab
0.7198.510.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7wcp.1.C
Surface glycoprotein
CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWC11 Fab
0.6998.510.95 1-1208EM0.00hetero-3-3-3-merHHblits0.61
7mte.1.A
Spike glycoprotein
Structure of SARS-CoV-2 S2P spike at pH 7.4 refolded by low-pH treatment
0.6699.500.94 14-1211EM0.00homo-trimer14 x NAG, 14 x NAG-NAGHHblits0.61
7mte.1.B
Spike glycoprotein
Structure of SARS-CoV-2 S2P spike at pH 7.4 refolded by low-pH treatment
0.5699.500.94 14-1211EM0.00homo-trimer14 x NAG, 14 x NAG-NAGHHblits0.61
7mte.1.C
Spike glycoprotein
Structure of SARS-CoV-2 S2P spike at pH 7.4 refolded by low-pH treatment
0.6599.500.94 14-1211EM0.00homo-trimer14 x NAG, 14 x NAG-NAGHHblits0.61
7mte.1.A
Spike glycoprotein
Structure of SARS-CoV-2 S2P spike at pH 7.4 refolded by low-pH treatment
0.6699.500.94 14-1211EM0.00homo-trimer14 x NAG, 14 x NAG-NAGBLAST0.61
7mte.1.B
Spike glycoprotein
Structure of SARS-CoV-2 S2P spike at pH 7.4 refolded by low-pH treatment
0.5699.500.94 14-1211EM0.00homo-trimer14 x NAG, 14 x NAG-NAGBLAST0.61
7mte.1.C
Spike glycoprotein
Structure of SARS-CoV-2 S2P spike at pH 7.4 refolded by low-pH treatment
0.6599.500.94 14-1211EM0.00homo-trimer14 x NAG, 14 x NAG-NAGBLAST0.61
7mxp.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody LP5 Fab in complex with SARS-CoV-2 S2P spike
0.6299.670.94 12-1208EM0.00hetero-3-3-3-mer28 x NAG, 3 x NAG-NAG-BMA-MAN-NAG-NAG-BMA-FUC, 3 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.62
7mxp.1.B
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody LP5 Fab in complex with SARS-CoV-2 S2P spike
0.6199.670.94 12-1208EM0.00hetero-3-3-3-mer28 x NAG, 3 x NAG-NAG-BMA-MAN-NAG-NAG-BMA-FUC, 3 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.62
7mxp.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody LP5 Fab in complex with SARS-CoV-2 S2P spike
0.6499.670.94 12-1208EM0.00hetero-3-3-3-mer28 x NAG, 3 x NAG-NAG-BMA-MAN-NAG-NAG-BMA-FUC, 3 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.62
6zge.1.A
Spike glycoprotein
Uncleavable Spike Protein of SARS-CoV-2 in Closed Conformation
0.7199.670.94 12-1208EM0.00homo-trimer21 x NAG, 30 x NAG-NAGBLAST0.62
7nt9.1.B
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (closed conformation)
0.6799.670.94 12-1208EM0.00homo-trimer3 x BLA, 24 x NAG, 30 x NAG-NAGBLAST0.62
7nta.1.B
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect)
0.6799.670.94 12-1208EM0.00homo-trimer3 x BLA, 27 x NAG, 25 x NAG-NAGBLAST0.62
7nta.1.A
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect)
0.6799.670.94 12-1208EM0.00homo-trimer3 x BLA, 27 x NAG, 25 x NAG-NAGBLAST0.62
7ntc.1.B
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab
0.6599.670.94 12-1208EM0.00hetero-3-1-1-mer2 x BLA, 29 x NAG, 25 x NAG-NAGBLAST0.62
7ntc.1.C
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab
0.6499.670.94 12-1208EM0.00hetero-3-1-1-mer2 x BLA, 29 x NAG, 25 x NAG-NAGBLAST0.62
7ntc.1.A
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab
0.6499.670.94 12-1208EM0.00hetero-3-1-1-mer2 x BLA, 29 x NAG, 25 x NAG-NAGBLAST0.62
7nta.1.C
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect)
0.6699.670.94 12-1208EM0.00homo-trimer3 x BLA, 27 x NAG, 25 x NAG-NAGBLAST0.62
7zbu.1.A
Spike glycoprotein
CryoEM structure of SARS-CoV-2 spike monomer in complex with neutralising antibody P008_60
0.4099.670.94 12-1208EM0.00hetero-1-1-1-mer8 x NAG, 1 x 3Q9BLAST0.62
7qdh.1.A
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:D614G mutant 1-up
0.6499.670.94 15-1213EM4.20homo-trimer24 x NAG, 10 x NAG-NAGBLAST0.62
7qdh.1.B
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:D614G mutant 1-up
0.6599.670.94 15-1213EM4.20homo-trimer24 x NAG, 10 x NAG-NAGBLAST0.62
7qdh.1.C
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:D614G mutant 1-up
0.6599.670.94 15-1213EM4.20homo-trimer24 x NAG, 10 x NAG-NAGBLAST0.62
7qdg.1.A
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:A222V + S:D614G mutant 1-up
0.6599.000.94 15-1217EM3.40homo-trimer25 x NAG, 10 x NAG-NAG, 1 x NDG-NAGHHblits0.61
7qdg.1.B
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:A222V + S:D614G mutant 1-up
0.6699.000.94 15-1217EM3.40homo-trimer25 x NAG, 10 x NAG-NAG, 1 x NDG-NAGHHblits0.61
7qdg.1.C
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:A222V + S:D614G mutant 1-up
0.6699.000.94 15-1217EM3.40homo-trimer25 x NAG, 10 x NAG-NAG, 1 x NDG-NAGHHblits0.61
7kdk.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
0.6999.670.94 12-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7kdl.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
0.6999.670.94 12-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGBLAST0.62
7kdl.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
0.6799.670.94 12-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGBLAST0.62
7kdl.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
0.6999.670.94 12-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGBLAST0.62
7ke4.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-class)
0.6999.670.94 12-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7ke4.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-class)
0.6999.670.94 12-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7ke4.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-class)
0.6999.670.94 12-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7ke6.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6999.670.94 12-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7ke6.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6999.670.94 12-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7ke6.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6999.670.94 12-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7ke7.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3-RBD-down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
0.6899.670.94 12-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7ke7.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3-RBD-down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
0.6999.670.94 12-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7ke7.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3-RBD-down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
0.6899.670.94 12-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7kea.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub classification)
0.6899.670.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.62
7kea.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub classification)
0.6699.670.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.62
7kea.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub classification)
0.6799.670.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.62
7keb.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6799.670.94 12-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGBLAST0.62
7keb.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6499.670.94 12-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGBLAST0.62
7keb.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6599.670.94 12-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGBLAST0.62
7kec.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
0.6399.670.94 12-1208EM0.00homo-trimer33 x NAG, 12 x NAG-NAGBLAST0.62
7kec.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
0.6299.670.94 12-1208EM0.00homo-trimer33 x NAG, 12 x NAG-NAGBLAST0.62
7kec.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
0.6599.670.94 12-1208EM0.00homo-trimer33 x NAG, 12 x NAG-NAGBLAST0.62
7ke8.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6999.670.94 12-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7ke8.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.6999.670.94 12-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7ke8.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
0.7199.670.94 12-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7ey0.1.D
Spike glycoprotein
Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-813 Fab and BD-744 Fab
0.0298.500.95 1-1207EM0.00hetero-1-1-1-2-1-merHHblits0.61
7ey0.1.F
Spike glycoprotein
Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-813 Fab and BD-744 Fab
0.0598.500.95 1-1207EM0.00hetero-1-1-1-2-1-merHHblits0.61
7ey4.1.C
Spike glycoprotein
Local CryoEM of the SARS-CoV-2 S6PV2 in complex with BD-667
0.0298.500.95 1-1207EM3.69hetero-1-1-1-1-merHHblits0.61
7lws.1.A
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 S-GSAS-D614G variant spike protein in the 3-RBD-down conformation
0.6998.590.95 1-1208EM0.00homo-trimer27 x NAG, 18 x NAG-NAGHHblits0.61
7lws.1.B
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 S-GSAS-D614G variant spike protein in the 3-RBD-down conformation
0.6998.590.95 1-1208EM0.00homo-trimer27 x NAG, 18 x NAG-NAGHHblits0.61
7lws.1.C
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 S-GSAS-D614G variant spike protein in the 3-RBD-down conformation
0.6998.590.95 1-1208EM0.00homo-trimer27 x NAG, 18 x NAG-NAGHHblits0.61
7lwt.1.B
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation
0.6998.590.95 1-1208EM0.00homo-trimer30 x NAG, 9 x NAG-NAGHHblits0.61
7lwv.1.C
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation
0.6998.590.95 1-1208EM0.00homo-trimer34 x NAGHHblits0.61
7lwv.1.A
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation
0.6998.590.95 1-1208EM0.00homo-trimer34 x NAGHHblits0.61
7lwu.1.A
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation
0.6998.590.95 1-1208EM0.00homo-trimer35 x NAGHHblits0.61
7lwt.1.A
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation
0.6998.590.95 1-1208EM0.00homo-trimer30 x NAG, 9 x NAG-NAGHHblits0.61
7lwt.1.C
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation
0.6998.590.95 1-1208EM0.00homo-trimer30 x NAG, 9 x NAG-NAGHHblits0.61
7lwu.1.C
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation
0.6898.590.95 1-1208EM0.00homo-trimer35 x NAGHHblits0.61
7lwv.1.B
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation
0.6998.590.95 1-1208EM0.00homo-trimer34 x NAGHHblits0.61
7lwu.1.B
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation
0.6898.590.95 1-1208EM0.00homo-trimer35 x NAGHHblits0.61
7qdg.1.A
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:A222V + S:D614G mutant 1-up
0.6599.580.94 15-1213EM3.40homo-trimer25 x NAG, 10 x NAG-NAG, 1 x NDG-NAGBLAST0.62
7qdg.1.B
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:A222V + S:D614G mutant 1-up
0.6699.580.94 15-1213EM3.40homo-trimer25 x NAG, 10 x NAG-NAG, 1 x NDG-NAGBLAST0.62
7qdg.1.C
Spike glycoprotein,Fibritin
SARS-CoV-2 S protein S:A222V + S:D614G mutant 1-up
0.6699.580.94 15-1213EM3.40homo-trimer25 x NAG, 10 x NAG-NAG, 1 x NDG-NAGBLAST0.62
7bnn.1.A
Spike glycoprotein
Open conformation of D614G SARS-CoV-2 spike with 1 Erect RBD
0.6699.580.94 12-1208EM0.00homo-trimer33 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-FUCBLAST0.62
7bnn.1.B
Spike glycoprotein
Open conformation of D614G SARS-CoV-2 spike with 1 Erect RBD
0.6899.580.94 12-1208EM0.00homo-trimer33 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-FUCBLAST0.62
7bnn.1.C
Spike glycoprotein
Open conformation of D614G SARS-CoV-2 spike with 1 Erect RBD
0.6899.580.94 12-1208EM0.00homo-trimer33 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-FUCBLAST0.62
7wcd.1.A
Spike glycoprotein
Cryo EM structure of SARS-CoV-2 spike in complex with TAU-2212 mAbs in conformation 4
0.7099.580.94 12-1208EM0.00hetero-3-3-3-mer33 x NAGBLAST0.62
7fb0.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in closed state
0.6799.580.94 12-1208EM0.00homo-trimerBLAST0.62
7fb1.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in one-RBD open state
0.6399.580.94 12-1208EM0.00homo-trimerBLAST0.62
7fb1.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in one-RBD open state
0.6399.580.94 12-1208EM0.00homo-trimerBLAST0.62
7fb1.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in one-RBD open state
0.6699.580.94 12-1208EM0.00homo-trimerBLAST0.62
7fb3.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in one-RBD weak state after CTSL-treatment
0.6599.580.94 12-1208EM0.00homo-trimerBLAST0.62
7fb3.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in one-RBD weak state after CTSL-treatment
0.5599.580.94 12-1208EM0.00homo-trimerBLAST0.62
7fb3.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in one-RBD weak state after CTSL-treatment
0.6699.580.94 12-1208EM0.00homo-trimerBLAST0.62
7ej5.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45
0.6599.580.94 12-1208EM0.00hetero-3-3-3-mer24 x NAG, 24 x NAG-NAGBLAST0.62
7ej4.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25
0.6399.580.94 12-1208EM0.00hetero-3-3-3-mer21 x NAG, 27 x NAG-NAGBLAST0.62
7ej4.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25
0.6499.580.94 12-1208EM0.00hetero-3-3-3-mer21 x NAG, 27 x NAG-NAGBLAST0.62
7ej4.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25
0.6499.580.94 12-1208EM0.00hetero-3-3-3-mer21 x NAG, 27 x NAG-NAGBLAST0.62
7ej5.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45
0.6599.580.94 12-1208EM0.00hetero-3-3-3-mer24 x NAG, 24 x NAG-NAGBLAST0.62
7ej5.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45
0.6499.580.94 12-1208EM0.00hetero-3-3-3-mer24 x NAG, 24 x NAG-NAGBLAST0.62
7v2a.1.A
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with XG014 Fab
0.7099.580.94 12-1208EM3.40hetero-3-3-3-mer24 x NAGBLAST0.62
7jwb.1.B
Spike glycoprotein
SARS CoV2 Spike ectodomain with engineered trimerized VH binder
0.6799.580.94 12-1208EM0.00hetero-1-3-merBLAST0.62
7jwb.1.C
Spike glycoprotein
SARS CoV2 Spike ectodomain with engineered trimerized VH binder
0.6999.580.94 12-1208EM0.00hetero-1-3-merBLAST0.62
7kqe.1.C
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 3D11 complex
0.7099.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.62
7m71.1.A
Spike glycoprotein
SARS-CoV-2 Spike:5A6 Fab complex I focused refinement
0.0599.580.94 12-1208EM0.00hetero-2-1-1-mer4 x NAGBLAST0.62
7kqb.1.B
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 5A6 complex I
0.7099.580.94 12-1208EM0.00hetero-3-2-2-mer23 x NAGBLAST0.62
7kqe.1.E
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 3D11 complex
0.7099.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.62
7kqe.1.D
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 3D11 complex
0.7199.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.62
7m71.1.B
Spike glycoprotein
SARS-CoV-2 Spike:5A6 Fab complex I focused refinement
0.0499.580.94 12-1208EM0.00hetero-2-1-1-mer4 x NAGBLAST0.62
7jwb.1.D
Spike glycoprotein
SARS CoV2 Spike ectodomain with engineered trimerized VH binder
0.6799.580.94 12-1208EM0.00hetero-1-3-merBLAST0.62
8dv1.1.A
Spike glycoprotein
SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to linker variant of affinity matured ACE2 mimetic CVD432
0.0399.580.94 12-1208EM0.00hetero-1-1-mer7 x NAGBLAST0.62
8dv2.1.A
Spike glycoprotein
SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to computationally engineered ACE2 mimetic CVD293
0.0499.580.94 12-1208EM0.00hetero-1-1-mer7 x NAGBLAST0.62
8heb.1.B
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 1 conformation
0.7099.580.94 12-1208EM0.00hetero-3-3-3-mer27 x NAG, 18 x NAG-NAGBLAST0.62
8hec.1.B
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 2 conformation
0.7099.580.94 12-1208EM0.00hetero-3-3-3-mer27 x NAG, 17 x NAG-NAGBLAST0.62
8hec.1.C
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 2 conformation
0.7099.580.94 12-1208EM0.00hetero-3-3-3-mer27 x NAG, 17 x NAG-NAGBLAST0.62
8hec.1.A
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 2 conformation
0.6999.580.94 12-1208EM0.00hetero-3-3-3-mer27 x NAG, 17 x NAG-NAGBLAST0.62
7z85.1.C
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-B5 nanobody complex
0.6999.580.94 12-1208EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGBLAST0.62
7z9r.1.B
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 2Up1Down conformation
0.6999.580.94 12-1208EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGBLAST0.62
7oan.1.A
Spike glycoprotein
Nanobody C5 bound to Spike
0.7299.580.94 12-1208EM3.00hetero-3-3-mer36 x NAG, 15 x NAG-NAGBLAST0.62
7z7x.1.A
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H6 nanobody complex
0.7099.580.94 12-1208EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGBLAST0.62
7z9r.1.A
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 2Up1Down conformation
0.7099.580.94 12-1208EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGBLAST0.62
7z9r.1.C
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 2Up1Down conformation
0.6999.580.94 12-1208EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGBLAST0.62
7z85.1.B
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-B5 nanobody complex
0.6999.580.94 12-1208EM0.00hetero-3-3-mer26 x NAG, 20 x NAG-NAGBLAST0.62
7ddd.1.B
Spike glycoprotein
SARS-Cov2 S protein at close state
0.6799.580.94 12-1208EM0.00homo-trimerBLAST0.62
7ddn.1.C
Spike glycoprotein
SARS-Cov2 S protein at open state
0.6699.580.94 12-1208EM0.00homo-trimerBLAST0.62
7ddn.1.A
Spike glycoprotein
SARS-Cov2 S protein at open state
0.6699.580.94 12-1208EM0.00homo-trimerBLAST0.62
7dd8.1.C
Spike glycoprotein
S-3C1-F1 structure, one RBD is up and two RBDs are down, the up RBD binds with a 3C1 fab
0.6199.580.94 12-1208EM0.00hetero-1-1-3-merBLAST0.62
7dd8.1.D
Spike glycoprotein
S-3C1-F1 structure, one RBD is up and two RBDs are down, the up RBD binds with a 3C1 fab
0.6199.580.94 12-1208EM0.00hetero-1-1-3-merBLAST0.62
7ddn.1.B
Spike glycoprotein
SARS-Cov2 S protein at open state
0.6699.580.94 12-1208EM0.00homo-trimerBLAST0.62
7dk3.1.C
Spike glycoprotein
SARS-CoV-2 S trimer, S-open
0.6699.580.94 12-1208EM0.00homo-trimerBLAST0.62
7dk3.1.B
Spike glycoprotein
SARS-CoV-2 S trimer, S-open
0.6799.580.94 12-1208EM0.00homo-trimerBLAST0.62
7dk3.1.A
Spike glycoprotein
SARS-CoV-2 S trimer, S-open
0.6799.580.94 12-1208EM0.00homo-trimerBLAST0.62
7df4.1.D
Spike glycoprotein
SARS-CoV-2 S-ACE2 complex
0.6799.580.94 12-1208EM0.00hetero-1-3-mer36 x NAG, 18 x NAG-NAGBLAST0.62
7df4.1.C
Spike glycoprotein
SARS-CoV-2 S-ACE2 complex
0.6799.580.94 12-1208EM0.00hetero-1-3-mer36 x NAG, 18 x NAG-NAGBLAST0.62
7df4.1.B
Spike glycoprotein
SARS-CoV-2 S-ACE2 complex
0.6699.580.94 12-1208EM0.00hetero-1-3-mer36 x NAG, 18 x NAG-NAGBLAST0.62
7dd2.1.B
Spike glycoprotein
S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab.
0.6399.580.94 12-1208EM0.00hetero-3-2-2-merBLAST0.62
7dk5.1.E
Spike glycoprotein
S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab
0.6399.580.94 12-1208EM0.00hetero-3-1-1-merBLAST0.62
7dk5.1.B
Spike glycoprotein
S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab
0.6399.580.94 12-1208EM0.00hetero-3-1-1-merBLAST0.62
7dd2.1.A
Spike glycoprotein
S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab.
0.6399.580.94 12-1208EM0.00hetero-3-2-2-merBLAST0.62
7dk6.1.C
Spike glycoprotein
S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab.
0.6899.580.94 12-1208EM0.00hetero-3-2-2-merBLAST0.62
7dk7.1.I
Spike glycoprotein
S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab.
0.6199.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.62
7dk7.1.D
Spike glycoprotein
S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab.
0.6599.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.62
7dk4.1.D
Spike glycoprotein
S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab.
0.6899.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.62
7dcc.1.D
Spike glycoprotein
S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with a 3C1 Fab
0.6599.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.62
7dk6.1.A
Spike glycoprotein
S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab.
0.6899.580.94 12-1208EM0.00hetero-3-2-2-merBLAST0.62
7dcx.1.H
Spike glycoprotein
S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab.
0.6599.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.62
7dk5.1.A
Spike glycoprotein
S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab
0.6299.580.94 12-1208EM0.00hetero-3-1-1-merBLAST0.62
7dk4.1.C
Spike glycoprotein
S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab.
0.6899.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.62
7dcc.1.H
Spike glycoprotein
S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with a 3C1 Fab
0.6599.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.62
7dcx.1.C
Spike glycoprotein
S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab.
0.6299.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.62
7dd2.1.E
Spike glycoprotein
S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab.
0.6399.580.94 12-1208EM0.00hetero-3-2-2-merBLAST0.62
7dk6.1.B
Spike glycoprotein
S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab.
0.6799.580.94 12-1208EM0.00hetero-3-2-2-merBLAST0.62
7dk7.1.C
Spike glycoprotein
S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab.
0.6599.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.62
7dcc.1.G
Spike glycoprotein
S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with a 3C1 Fab
0.6599.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.62
7dcx.1.I
Spike glycoprotein
S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab.
0.6399.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.62
7dk4.1.E
Spike glycoprotein
S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab.
0.6999.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.62
7q0a.1.A
Spike glycoprotein,Spike ectodomain,Spike protein S2'
SARS-CoV-2 Spike ectodomain with Fab FI3A
0.6999.580.94 12-1208EM0.00hetero-3-1-1-mer27 x NAG, 11 x NAG-NAGBLAST0.62
7q0a.1.B
Spike glycoprotein,Spike ectodomain,Spike protein S2'
SARS-CoV-2 Spike ectodomain with Fab FI3A
0.7099.580.94 12-1208EM0.00hetero-3-1-1-mer27 x NAG, 11 x NAG-NAGBLAST0.62
7q0a.1.C
Spike glycoprotein,Spike ectodomain,Spike protein S2'
SARS-CoV-2 Spike ectodomain with Fab FI3A
0.6999.580.94 12-1208EM0.00hetero-3-1-1-mer27 x NAG, 11 x NAG-NAGBLAST0.62
7e3k.1.A
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
0.6899.580.94 12-1208EM0.00hetero-3-3-3-mer22 x NAGBLAST0.62
7e3l.1.C
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
0.6999.580.94 12-1208EM0.00hetero-3-3-3-mer20 x NAGBLAST0.62
7e3l.1.B
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
0.6999.580.94 12-1208EM0.00hetero-3-3-3-mer20 x NAGBLAST0.62
7ws0.1.C
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7199.580.94 12-1208EM0.00hetero-3-3-3-mer30 x NAG, 18 x NAG-NAGBLAST0.62
7ws1.1.B
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7199.580.94 12-1208EM0.00hetero-3-4-4-mer30 x NAG, 18 x NAG-NAGBLAST0.62
7ws1.1.C
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7199.580.94 12-1208EM0.00hetero-3-4-4-mer30 x NAG, 18 x NAG-NAGBLAST0.62
7ws0.1.B
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7199.580.94 12-1208EM0.00hetero-3-3-3-mer30 x NAG, 18 x NAG-NAGBLAST0.62
7ws0.1.A
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7199.580.94 12-1208EM0.00hetero-3-3-3-mer30 x NAG, 18 x NAG-NAGBLAST0.62
7v26.1.B
Spike glycoprotein
XG005-bound SARS-CoV-2 S
0.6499.580.94 12-1208EM0.00hetero-3-3-3-mer45 x NAGBLAST0.62
7v26.1.A
Spike glycoprotein
XG005-bound SARS-CoV-2 S
0.6699.580.94 12-1208EM0.00hetero-3-3-3-mer45 x NAGBLAST0.62
7v26.1.C
Spike glycoprotein
XG005-bound SARS-CoV-2 S
0.6599.580.94 12-1208EM0.00hetero-3-3-3-mer45 x NAGBLAST0.62
7y7j.1.A
Spike glycoprotein
SARS-CoV-2 S trimer in complex with 1F Fab
0.6999.580.94 12-1208EM4.80hetero-3-1-1-mer26 x NAG, 15 x NAG-NAGBLAST0.62
7y7j.1.B
Spike glycoprotein
SARS-CoV-2 S trimer in complex with 1F Fab
0.6999.580.94 12-1208EM4.80hetero-3-1-1-mer26 x NAG, 15 x NAG-NAGBLAST0.62
7y7j.1.C
Spike glycoprotein
SARS-CoV-2 S trimer in complex with 1F Fab
0.6999.580.94 12-1208EM4.80hetero-3-1-1-mer26 x NAG, 15 x NAG-NAGBLAST0.62
7e5r.1.G
Spike glycoprotein
SARS-CoV-2 S trimer with three-antibody cocktail complex
0.6599.580.94 12-1208EM3.60hetero-3-3-3-3-3-3-…15 x NAG-NAGBLAST0.62
7e5s.1.B
Spike glycoprotein
SARS-CoV-2 S trimer with four-antibody cocktail complex
0.6299.580.94 12-1208EM3.60hetero-3-2-2-2-2-3-…12 x NAG-NAGBLAST0.62
7e5s.1.A
Spike glycoprotein
SARS-CoV-2 S trimer with four-antibody cocktail complex
0.6299.580.94 12-1208EM3.60hetero-3-2-2-2-2-3-…12 x NAG-NAGBLAST0.62
7e5s.1.C
Spike glycoprotein
SARS-CoV-2 S trimer with four-antibody cocktail complex
0.6399.580.94 12-1208EM3.60hetero-3-2-2-2-2-3-…12 x NAG-NAGBLAST0.62
7byr.1.A
Spike glycoprotein
BD23-Fab in complex with the S ectodomain trimer
0.6899.580.94 12-1208EM0.00hetero-3-1-1-mer32 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.62
7byr.1.B
Spike glycoprotein
BD23-Fab in complex with the S ectodomain trimer
0.6899.580.94 12-1208EM0.00hetero-3-1-1-mer32 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.62
7byr.1.C
Spike glycoprotein
BD23-Fab in complex with the S ectodomain trimer
0.6999.580.94 12-1208EM0.00hetero-3-1-1-mer32 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.62
7akd.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment
0.6599.580.94 12-1208EM0.00hetero-3-2-2-mer25 x NAG, 3 x FUC, 2 x MAN, 10 x NAG-NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x MAN-MANBLAST0.62
7akd.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment
0.6499.580.94 12-1208EM0.00hetero-3-2-2-mer25 x NAG, 3 x FUC, 2 x MAN, 10 x NAG-NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x MAN-MANBLAST0.62
7akd.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment
0.6499.580.94 12-1208EM0.00hetero-3-2-2-mer25 x NAG, 3 x FUC, 2 x MAN, 10 x NAG-NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x MAN-MANBLAST0.62
6z97.1.C
Spike glycoprotein,Fibritin
Structure of the prefusion SARS-CoV-2 spike glycoprotein
0.6999.580.94 12-1208EM0.00homo-trimer27 x NAG, 11 x NAG-NAGBLAST0.62
6zhd.1.B
Spike glycoprotein,Fibritin
H11-H4 bound to Spike
0.6999.580.94 12-1208EM3.70hetero-3-3-mer26 x NAG, 20 x NAG-NAGBLAST0.62
6z97.1.B
Spike glycoprotein,Fibritin
Structure of the prefusion SARS-CoV-2 spike glycoprotein
0.7099.580.94 12-1208EM0.00homo-trimer27 x NAG, 11 x NAG-NAGBLAST0.62
6z97.1.A
Spike glycoprotein,Fibritin
Structure of the prefusion SARS-CoV-2 spike glycoprotein
0.6999.580.94 12-1208EM0.00homo-trimer27 x NAG, 11 x NAG-NAGBLAST0.62
6zhd.1.A
Spike glycoprotein,Fibritin
H11-H4 bound to Spike
0.7099.580.94 12-1208EM3.70hetero-3-3-mer26 x NAG, 20 x NAG-NAGBLAST0.62
6zhd.1.C
Spike glycoprotein,Fibritin
H11-H4 bound to Spike
0.6999.580.94 12-1208EM3.70hetero-3-3-mer26 x NAG, 20 x NAG-NAGBLAST0.62
7nd8.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab
0.7099.580.94 12-1208EM0.00hetero-3-1-1-mer30 x NAG, 15 x NAG-NAGBLAST0.62
7ndc.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-159
0.7199.580.94 12-1208EM0.00hetero-3-3-3-mer24 x NAG, 15 x NAG-NAGBLAST0.62
7ndb.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-253H165L Fab
0.6999.580.94 12-1208EM0.00hetero-3-1-1-mer27 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-FUCBLAST0.62
7nd7.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab
0.7099.580.94 12-1208EM0.00hetero-3-3-3-mer25 x NAG, 15 x NAG-NAG, 3 x NAG-NAG-FUCBLAST0.62
7nd4.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-88 Fab
0.7099.580.94 12-1208EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMABLAST0.62
7nd9.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-253H55L Fab
0.7299.580.94 12-1208EM0.00hetero-3-1-1-mer27 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-FUCBLAST0.62
7nd8.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab
0.7099.580.94 12-1208EM0.00hetero-3-1-1-mer30 x NAG, 15 x NAG-NAGBLAST0.62
7ndd.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-159
0.7099.580.94 12-1208EM0.00hetero-3-3-3-mer24 x NAG, 15 x NAG-NAGBLAST0.62
7nd9.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-253H55L Fab
0.7099.580.94 12-1208EM0.00hetero-3-1-1-mer27 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-FUCBLAST0.62
7nda.1.A
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-253H55L Fab
0.6999.580.94 12-1208EM0.00hetero-3-1-1-mer32 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-FUCBLAST0.62
7nda.1.C
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-253H55L Fab
0.7099.580.94 12-1208EM0.00hetero-3-1-1-mer32 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-FUCBLAST0.62
7ndb.1.B
Spike glycoprotein
EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-253H165L Fab
0.7099.580.94 12-1208EM0.00hetero-3-1-1-mer27 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-FUCBLAST0.62
6zdh.1.B
Spike glycoprotein
SARS-CoV-2 Spike glycoprotein in complex with a neutralizing antibody EY6A Fab
0.7099.580.94 12-1208EM0.00hetero-3-3-3-mer23 x NAG, 13 x NAG-NAGBLAST0.62
7kni.1.B
Spike glycoprotein
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6399.580.94 12-1208EM0.00hetero-3-3-mer56 x NAG, 6 x NAG-NAGBLAST0.62
6zxn.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1)
0.7399.580.94 12-1208EM0.00hetero-3-3-mer39 x NAG, 12 x NAG-NAGBLAST0.62
7a29.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation
0.7199.580.94 12-1208EM0.00hetero-3-3-mer45 x NAG, 8 x NAG-NAGBLAST0.62
7a29.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation
0.7299.580.94 12-1208EM0.00hetero-3-3-mer45 x NAG, 8 x NAG-NAGBLAST0.62
7a29.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation
0.7199.580.94 12-1208EM0.00hetero-3-3-mer45 x NAG, 8 x NAG-NAGBLAST0.62
6vsb.1.B
Spike glycoprotein
Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up
0.7099.580.94 12-1208EM0.00homo-trimer27 x NAG, 17 x NAG-NAGBLAST0.62
6zxn.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1)
0.7199.580.94 12-1208EM0.00hetero-3-3-mer39 x NAG, 12 x NAG-NAGBLAST0.62
6xey.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4
0.6799.580.94 12-1208EM0.00hetero-3-3-3-mer36 x NAG, 7 x NAG-NAG, 3 x NAG-NAG-BMA, 2 x NAG-BMABLAST0.62
6vsb.1.A
Spike glycoprotein
Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up
0.6999.580.94 12-1208EM0.00homo-trimer27 x NAG, 17 x NAG-NAGBLAST0.62
6vsb.1.C
Spike glycoprotein
Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up
0.6999.580.94 12-1208EM0.00homo-trimer27 x NAG, 17 x NAG-NAGBLAST0.62
7ljr.1.B
Spike glycoprotein
SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab
0.6499.580.94 12-1208EM0.00hetero-3-1-1-merBLAST0.62
7ljr.1.A
Spike glycoprotein
SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab
0.6699.580.94 12-1208EM0.00hetero-3-1-1-merBLAST0.62
7ljr.1.C
Spike glycoprotein
SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab
0.6599.580.94 12-1208EM0.00hetero-3-1-1-merBLAST0.62
7l57.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15
0.6199.580.94 12-1208EM0.00hetero-3-1-1-mer31 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-NAG, 1 x NAG-NAG-BMA-NAGBLAST0.62
7kkk.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6
0.6999.580.94 12-1208EM0.00hetero-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.62
7l57.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15
0.5999.580.94 12-1208EM0.00hetero-3-1-1-mer31 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-NAG, 1 x NAG-NAG-BMA-NAGBLAST0.62
7l58.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4
0.6199.580.94 12-1208EM0.00hetero-3-1-1-mer33 x NAG, 4 x NAG-NAGBLAST0.62
7kkl.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6
0.7099.580.94 12-1208EM0.00hetero-3-3-mer27 x NAG, 18 x NAG-NAGBLAST0.62
7l57.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15
0.6099.580.94 12-1208EM0.00hetero-3-1-1-mer31 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-NAG, 1 x NAG-NAG-BMA-NAGBLAST0.62
7l58.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4
0.6499.580.94 12-1208EM0.00hetero-3-1-1-mer33 x NAG, 4 x NAG-NAGBLAST0.62
7l58.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4
0.6599.580.94 12-1208EM0.00hetero-3-1-1-mer33 x NAG, 4 x NAG-NAGBLAST0.62
7b18.1.A
Spike glycoprotein
SARS-CoV-spike bound to two neutralising nanobodies
0.6999.580.94 12-1208EM0.00hetero-3-3-3-mer42 x NAG, 1 x NAG-NAGBLAST0.62
7b18.1.B
Spike glycoprotein
SARS-CoV-spike bound to two neutralising nanobodies
0.7199.580.94 12-1208EM0.00hetero-3-3-3-mer42 x NAG, 1 x NAG-NAGBLAST0.62
7b18.1.C
Spike glycoprotein
SARS-CoV-spike bound to two neutralising nanobodies
0.7199.580.94 12-1208EM0.00hetero-3-3-3-mer42 x NAG, 1 x NAG-NAGBLAST0.62
7l2d.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6499.580.94 12-1208EM0.00hetero-3-1-1-mer34 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-BMABLAST0.62
7l2d.1.D
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6799.580.94 12-1208EM0.00hetero-3-1-1-mer34 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-BMABLAST0.62
7l2e.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6699.580.94 12-1208EM0.00hetero-3-3-3-mer30 x NAG, 24 x NAG-NAGBLAST0.62
7l2f.1.B
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6699.580.94 12-1208EM0.00hetero-3-3-3-mer36 x NAG, 16 x NAG-NAG, 2 x NAG-NAG-BMABLAST0.62
7l2f.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6699.580.94 12-1208EM0.00hetero-3-3-3-mer36 x NAG, 16 x NAG-NAG, 2 x NAG-NAG-BMABLAST0.62
7l2d.1.E
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6799.580.94 12-1208EM0.00hetero-3-1-1-mer34 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-BMABLAST0.62
7l2f.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6699.580.94 12-1208EM0.00hetero-3-3-3-mer36 x NAG, 16 x NAG-NAG, 2 x NAG-NAG-BMABLAST0.62
7ksg.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with nanobodies E
0.7099.580.94 12-1208EM0.00hetero-3-3-mer51 x NAGBLAST0.62
7ksg.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with nanobodies E
0.6999.580.94 12-1208EM0.00hetero-3-3-mer51 x NAGBLAST0.62
7ksg.1.B
Spike glycoprotein
SARS-CoV-2 spike in complex with nanobodies E
0.7099.580.94 12-1208EM0.00hetero-3-3-mer51 x NAGBLAST0.62
7ls9.1.D
Spike glycoprotein
Cryo-EM structure of neutralizing antibody 1-57 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6799.580.94 12-1208EM0.00hetero-3-3-3-mer30 x NAG, 3 x NAG-NAG-BMA, 18 x NAG-NAGBLAST0.62
7lss.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7
0.5299.580.94 12-1208EM0.00hetero-3-1-1-mer30 x NAG, 6 x NAG-NAGBLAST0.62
7lss.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7
0.6999.580.94 12-1208EM0.00hetero-3-1-1-mer30 x NAG, 6 x NAG-NAGBLAST0.62
7lss.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7
0.5299.580.94 12-1208EM0.00hetero-3-1-1-mer30 x NAG, 6 x NAG-NAGBLAST0.62
7kne.1.C
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
0.6299.580.94 12-1208EM0.00hetero-3-1-mer44 x NAG, 6 x NAG-NAGBLAST0.62
7kms.1.B
Spike glycoprotein
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6699.580.94 12-1208EM0.00hetero-3-3-mer55 x NAG, 8 x NAG-NAGBLAST0.62
7knh.1.B
Spike glycoprotein
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6299.580.94 12-1208EM0.00hetero-3-2-mer48 x NAG, 4 x NAG-NAGBLAST0.62
7kne.1.B
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
0.6399.580.94 12-1208EM0.00hetero-3-1-mer44 x NAG, 6 x NAG-NAGBLAST0.62
7kms.1.D
Spike glycoprotein
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6799.580.94 12-1208EM0.00hetero-3-3-mer55 x NAG, 8 x NAG-NAGBLAST0.62
7knh.1.D
Spike glycoprotein
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6399.580.94 12-1208EM0.00hetero-3-2-mer48 x NAG, 4 x NAG-NAGBLAST0.62
6zxn.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1)
0.7399.580.94 12-1208EM0.00hetero-3-3-mer39 x NAG, 12 x NAG-NAGBLAST0.62
7knh.1.A
Spike glycoprotein
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6599.580.94 12-1208EM0.00hetero-3-2-mer48 x NAG, 4 x NAG-NAGBLAST0.62
7knb.1.A
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6599.580.94 12-1208EM0.00hetero-3-1-mer46 x NAG, 5 x NAG-NAGBLAST0.62
7knb.1.C
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6299.580.94 12-1208EM0.00hetero-3-1-mer46 x NAG, 5 x NAG-NAGBLAST0.62
7kni.1.A
Spike glycoprotein
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5
0.6299.580.94 12-1208EM0.00hetero-3-3-mer56 x NAG, 6 x NAG-NAGBLAST0.62
7kms.1.C
Spike glycoprotein
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
0.6699.580.94 12-1208EM0.00hetero-3-3-mer55 x NAG, 8 x NAG-NAGBLAST0.62
7mw2.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with all RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6
0.7099.580.94 12-1208EM0.00hetero-3-3-3-mer30 x NAG, 21 x NAG-NAGBLAST0.62
7mw5.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 2
0.6899.580.94 12-1208EM0.00hetero-3-3-3-mer25 x NAG, 29 x NAG-NAGBLAST0.62
7q1z.1.B
Spike glycoprotein
Structure of formaldehyde cross-linked SARS-CoV-2 S glycoprotein
0.7099.580.94 12-1208EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7mw6.1.F
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with three RBDs up in complex with the Fab fragment of human neutralizing antibody clone 2
0.7199.580.94 12-1208EM0.00hetero-3-3-3-mer21 x NAG, 33 x NAG-NAGBLAST0.62
7mw4.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 6
0.7099.580.94 12-1208EM0.00hetero-3-3-3-mer28 x NAG, 23 x NAG-NAGBLAST0.62
7mw4.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 6
0.7099.580.94 12-1208EM0.00hetero-3-3-3-mer28 x NAG, 23 x NAG-NAGBLAST0.62
7mw3.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6
0.7099.580.94 12-1208EM0.00hetero-3-3-3-mer30 x NAG, 21 x NAG-NAGBLAST0.62
7mw6.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with three RBDs up in complex with the Fab fragment of human neutralizing antibody clone 2
0.7199.580.94 12-1208EM0.00hetero-3-3-3-mer21 x NAG, 33 x NAG-NAGBLAST0.62
7mw5.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 2
0.6799.580.94 12-1208EM0.00hetero-3-3-3-mer25 x NAG, 29 x NAG-NAGBLAST0.62
7mw4.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 6
0.7099.580.94 12-1208EM0.00hetero-3-3-3-mer28 x NAG, 23 x NAG-NAGBLAST0.62
7mw5.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody clone 2
0.6899.580.94 12-1208EM0.00hetero-3-3-3-mer25 x NAG, 29 x NAG-NAGBLAST0.62
7mw6.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with three RBDs up in complex with the Fab fragment of human neutralizing antibody clone 2
0.7199.580.94 12-1208EM0.00hetero-3-3-3-mer21 x NAG, 33 x NAG-NAGBLAST0.62
7mw3.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody clone 6
0.7099.580.94 12-1208EM0.00hetero-3-3-3-mer30 x NAG, 21 x NAG-NAGBLAST0.62
7p79.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation.
0.6799.580.94 12-1208EM0.00hetero-3-3-mer19 x NAG, 4 x NAG-NAG-BMA, 8 x NAG-NAG, 3 x NAG-BMA, 1 x NAG-NAG-NAGBLAST0.62
7p79.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation.
0.6599.580.94 12-1208EM0.00hetero-3-3-mer19 x NAG, 4 x NAG-NAG-BMA, 8 x NAG-NAG, 3 x NAG-BMA, 1 x NAG-NAG-NAGBLAST0.62
7p79.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation.
0.6299.580.94 12-1208EM0.00hetero-3-3-mer19 x NAG, 4 x NAG-NAG-BMA, 8 x NAG-NAG, 3 x NAG-BMA, 1 x NAG-NAG-NAGBLAST0.62
7p78.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation
0.6299.580.94 12-1208EM0.00hetero-3-3-2-mer19 x NAG, 11 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-NAG-NAGBLAST0.62
7p77.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation
0.6499.580.94 12-1208EM0.00hetero-3-3-3-mer29 x NAG, 10 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMA, 1 x NAG-NAG-NAGBLAST0.62
7p78.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation
0.6699.580.94 12-1208EM0.00hetero-3-3-2-mer19 x NAG, 11 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-NAG-NAGBLAST0.62
7p77.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation
0.6699.580.94 12-1208EM0.00hetero-3-3-3-mer29 x NAG, 10 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMA, 1 x NAG-NAG-NAGBLAST0.62
7ks9.1.D
Spike glycoprotein
Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab
0.6999.580.94 12-1208EM0.00hetero-1-1-3-mer35 x NAG, 12 x NAG-NAGBLAST0.62
7ks9.1.E
Spike glycoprotein
Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab
0.6899.580.94 12-1208EM0.00hetero-1-1-3-mer35 x NAG, 12 x NAG-NAGBLAST0.62
7ks9.1.C
Spike glycoprotein
Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab
0.6899.580.94 12-1208EM0.00hetero-1-1-3-mer35 x NAG, 12 x NAG-NAGBLAST0.62
7x7n.1.B
Spike glycoprotein
3D model of the 3-RBD up single trimeric spike protein of SARS-CoV2 in the presence of synthetic peptide SIH-5.
0.5999.580.94 12-1208EM0.00hetero-3-6-mer39 x NAGBLAST0.62
7n5h.1.A
Spike glycoprotein
Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6999.580.94 12-1208EM0.00hetero-3-3-3-mer9 x NAG, 16 x NAG-NAGBLAST0.62
7n5h.1.C
Spike glycoprotein
Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.7099.580.94 12-1208EM0.00hetero-3-3-3-mer9 x NAG, 16 x NAG-NAGBLAST0.62
7n5h.1.B
Spike glycoprotein
Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6999.580.94 12-1208EM0.00hetero-3-3-3-mer9 x NAG, 16 x NAG-NAGBLAST0.62
7x7n.1.A
Spike glycoprotein
3D model of the 3-RBD up single trimeric spike protein of SARS-CoV2 in the presence of synthetic peptide SIH-5.
0.5999.580.94 12-1208EM0.00hetero-3-6-mer39 x NAGBLAST0.62
7x7n.1.C
Spike glycoprotein
3D model of the 3-RBD up single trimeric spike protein of SARS-CoV2 in the presence of synthetic peptide SIH-5.
0.6099.580.94 12-1208EM0.00hetero-3-6-mer39 x NAGBLAST0.62
7rw2.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-7 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6599.580.94 12-1208EM0.00hetero-3-3-3-mer48 x NAG, 6 x NAG-NAGBLAST0.62
6zow.1.B
Spike glycoprotein
SARS-CoV-2 spike in prefusion state
0.6799.580.94 12-1208EM0.00homo-tetramer18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMABLAST0.62
6zow.1.A
Spike glycoprotein
SARS-CoV-2 spike in prefusion state
0.5299.580.94 12-1208EM0.00homo-tetramer18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMABLAST0.62
6zp7.1.C
Spike glycoprotein
SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up open conformation)
0.6499.580.94 12-1208EM0.00homo-trimer18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMABLAST0.62
6zp5.1.C
Spike glycoprotein
SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up closed conformation)
0.6399.580.94 12-1208EM0.00homo-trimer18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMABLAST0.62
6zow.1.D
Spike glycoprotein
SARS-CoV-2 spike in prefusion state
0.0399.580.94 12-1208EM0.00homo-tetramer18 x NAG, 16 x NAG-NAG, 4 x NAG-NAG-BMA-MAN, 7 x NAG-NAG-BMABLAST0.62
8dxs.1.B
Spike glycoprotein
Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6699.580.94 12-1208EM0.00hetero-3-3-3-mer44 x NAGBLAST0.62
8dxs.1.A
Spike glycoprotein
Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6799.580.94 12-1208EM0.00hetero-3-3-3-mer44 x NAGBLAST0.62
8dxs.1.C
Spike glycoprotein
Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 spike glycoprotein
0.6699.580.94 12-1208EM0.00hetero-3-3-3-mer44 x NAGBLAST0.62
7l56.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43
0.6999.580.94 12-1208EM0.00hetero-3-3-3-mer31 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-NAG-GAL-MAN-MANBLAST0.62
6x79.1.A
Spike glycoprotein
Prefusion SARS-CoV-2 S ectodomain trimer covalently stabilized in the closed conformation
0.7299.420.94 14-1211EM0.00homo-trimer33 x NAG, 9 x NAG-NAGHHblits0.61
6x79.1.B
Spike glycoprotein
Prefusion SARS-CoV-2 S ectodomain trimer covalently stabilized in the closed conformation
0.7299.420.94 14-1211EM0.00homo-trimer33 x NAG, 9 x NAG-NAGHHblits0.61
6x79.1.C
Spike glycoprotein
Prefusion SARS-CoV-2 S ectodomain trimer covalently stabilized in the closed conformation
0.7299.420.94 14-1211EM0.00homo-trimer33 x NAG, 9 x NAG-NAGHHblits0.61
6x79.1.A
Spike glycoprotein
Prefusion SARS-CoV-2 S ectodomain trimer covalently stabilized in the closed conformation
0.7299.420.94 14-1211EM0.00homo-trimer33 x NAG, 9 x NAG-NAGBLAST0.61
6zp0.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein Trimer (single Arg S1/S2 cleavage site) in Closed State
0.71100.000.94 14-1211EM0.00homo-trimer36 x NAG, 12 x NAG-NAGBLAST0.62
7wgv.1.A
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in closed state
0.69100.000.94 14-1211EM0.00homo-trimer33 x NAG, 3 x EIC, 3 x BLR, 15 x NAG-NAGBLAST0.62
7wgx.1.A
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in closed state after treatment with Cathepsin L
0.71100.000.94 14-1211EM0.00homo-trimer27 x NAG, 3 x BLR, 15 x NAG-NAGBLAST0.62
7wgy.1.A
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in Intermediate state
0.68100.000.94 14-1211EM0.00homo-trimer15 x NAG, 8 x NAG-NAGBLAST0.62
7wgy.1.B
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in Intermediate state
0.53100.000.94 14-1211EM0.00homo-trimer15 x NAG, 8 x NAG-NAGBLAST0.62
7wgy.1.C
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in Intermediate state
0.66100.000.94 14-1211EM0.00homo-trimer15 x NAG, 8 x NAG-NAGBLAST0.62
7wgz.1.A
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in open state
0.63100.000.94 14-1211EM0.00homo-trimer15 x NAG, 5 x NAG-NAGBLAST0.62
7wgz.1.B
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in open state
0.63100.000.94 14-1211EM0.00homo-trimer15 x NAG, 5 x NAG-NAGBLAST0.62
7wgz.1.C
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in open state
0.63100.000.94 14-1211EM0.00homo-trimer15 x NAG, 5 x NAG-NAGBLAST0.62
7r11.1.B
Spike glycoprotein
Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
0.0698.500.95 1-1208EM0.00hetero-1-1-mer7 x NAG, 1 x ZNHHblits0.61
7r16.1.A
Spike glycoprotein
Beta Variant SARS-CoV-2 Spike with 1 Erect RBD
0.6998.500.95 1-1208EM0.00homo-trimer28 x NAG, 6 x NAG-NAGHHblits0.61
7r16.1.B
Spike glycoprotein
Beta Variant SARS-CoV-2 Spike with 1 Erect RBD
0.6998.500.95 1-1208EM0.00homo-trimer28 x NAG, 6 x NAG-NAGHHblits0.61
7r16.1.C
Spike glycoprotein
Beta Variant SARS-CoV-2 Spike with 1 Erect RBD
0.6998.500.95 1-1208EM0.00homo-trimer28 x NAG, 6 x NAG-NAGHHblits0.61
7r17.1.A
Spike glycoprotein
Beta Variant SARS-CoV-2 Spike with 2 Erect RBDs
0.6898.500.95 1-1208EM0.00homo-trimer20 x NAG, 1 x NAG-NAGHHblits0.61
7r17.1.B
Spike glycoprotein
Beta Variant SARS-CoV-2 Spike with 2 Erect RBDs
0.6898.500.95 1-1208EM0.00homo-trimer20 x NAG, 1 x NAG-NAGHHblits0.61
7r17.1.C
Spike glycoprotein
Beta Variant SARS-CoV-2 Spike with 2 Erect RBDs
0.6998.500.95 1-1208EM0.00homo-trimer20 x NAG, 1 x NAG-NAGHHblits0.61
7a4n.1.A
Spike glycoprotein,Fibritin
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(S-closed trimer)
0.6899.500.94 12-1208EM0.00homo-trimer15 x NAG, 3 x NAG-NAGBLAST0.61
7ad1.1.A
Spike glycoprotein,Envelope glycoprotein,Spike glycoprotein,Envelope glycoprotein,SARS-CoV-2 S protein
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer)
0.6999.500.94 12-1208EM0.00homo-trimer10 x NAG, 10 x NAG-NAGBLAST0.61
7ad1.1.B
Spike glycoprotein,Envelope glycoprotein,Spike glycoprotein,Envelope glycoprotein,SARS-CoV-2 S protein
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer)
0.6899.500.94 12-1208EM0.00homo-trimer10 x NAG, 10 x NAG-NAGBLAST0.61
7ad1.1.C
Spike glycoprotein,Envelope glycoprotein,Spike glycoprotein,Envelope glycoprotein,SARS-CoV-2 S protein
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer)
0.6999.500.94 12-1208EM0.00homo-trimer10 x NAG, 10 x NAG-NAGBLAST0.61
7fce.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 A372T spike glycoprotein (closed)
0.7299.500.94 12-1208EM0.00homo-trimer24 x NAG, 27 x NAG-NAGBLAST0.61
7fcd.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 A372T spike glycoprotein (open)
0.7199.500.94 12-1208EM0.00homo-trimer35 x NAGBLAST0.61
7fcd.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 A372T spike glycoprotein (open)
0.7199.500.94 12-1208EM0.00homo-trimer35 x NAGBLAST0.61
7fcd.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 A372T spike glycoprotein (open)
0.7099.500.94 12-1208EM0.00homo-trimer35 x NAGBLAST0.61
6zp0.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein Trimer (single Arg S1/S2 cleavage site) in Closed State
0.7199.920.94 14-1211EM0.00homo-trimer36 x NAG, 12 x NAG-NAGHHblits0.62
6zp0.1.B
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein Trimer (single Arg S1/S2 cleavage site) in Closed State
0.7199.920.94 14-1211EM0.00homo-trimer36 x NAG, 12 x NAG-NAGHHblits0.62
6zp0.1.C
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein Trimer (single Arg S1/S2 cleavage site) in Closed State
0.7199.920.94 14-1211EM0.00homo-trimer36 x NAG, 12 x NAG-NAGHHblits0.62
7wgv.1.A
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in closed state
0.6999.920.94 14-1211EM0.00homo-trimer33 x NAG, 3 x EIC, 3 x BLR, 15 x NAG-NAGHHblits0.62
7wgv.1.B
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in closed state
0.6999.920.94 14-1211EM0.00homo-trimer33 x NAG, 3 x EIC, 3 x BLR, 15 x NAG-NAGHHblits0.62
7wgv.1.C
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in closed state
0.6999.920.94 14-1211EM0.00homo-trimer33 x NAG, 3 x EIC, 3 x BLR, 15 x NAG-NAGHHblits0.62
7wgx.1.A
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in closed state after treatment with Cathepsin L
0.7199.920.94 14-1211EM0.00homo-trimer27 x NAG, 3 x BLR, 15 x NAG-NAGHHblits0.62
7wgx.1.B
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in closed state after treatment with Cathepsin L
0.7199.920.94 14-1211EM0.00homo-trimer27 x NAG, 3 x BLR, 15 x NAG-NAGHHblits0.62
7wgx.1.C
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in closed state after treatment with Cathepsin L
0.7199.920.94 14-1211EM0.00homo-trimer27 x NAG, 3 x BLR, 15 x NAG-NAGHHblits0.62
7wgy.1.A
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in Intermediate state
0.6899.920.94 14-1211EM0.00homo-trimer15 x NAG, 8 x NAG-NAGHHblits0.62
7wgy.1.B
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in Intermediate state
0.5299.920.94 14-1211EM0.00homo-trimer15 x NAG, 8 x NAG-NAGHHblits0.62
7wgy.1.C
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in Intermediate state
0.6699.920.94 14-1211EM0.00homo-trimer15 x NAG, 8 x NAG-NAGHHblits0.62
7wgz.1.A
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in open state
0.6399.920.94 14-1211EM0.00homo-trimer15 x NAG, 5 x NAG-NAGHHblits0.62
7wgz.1.B
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in open state
0.6299.920.94 14-1211EM0.00homo-trimer15 x NAG, 5 x NAG-NAGHHblits0.62
7wgz.1.C
Spike glycoprotein
SARS-CoV-2 spike glycoprotein trimer in open state
0.6399.920.94 14-1211EM0.00homo-trimer15 x NAG, 5 x NAG-NAGHHblits0.62
7r4q.1.A
Spike glycoprotein
The SARS-CoV-2 spike in complex with the 1.29 neutralizing nanobody
0.7199.500.94 12-1208EM0.00hetero-3-2-mer33 x NAG, 5 x NAG-NAGBLAST0.61
7r4i.1.B
Spike glycoprotein
The SARS-CoV-2 spike in complex with the 2.15 neutralizing nanobody
0.6799.500.94 12-1208EM0.00hetero-3-2-mer33 x NAG, 5 x NAG-NAGBLAST0.61
7r4i.1.C
Spike glycoprotein
The SARS-CoV-2 spike in complex with the 2.15 neutralizing nanobody
0.6799.500.94 12-1208EM0.00hetero-3-2-mer33 x NAG, 5 x NAG-NAGBLAST0.61
7r4i.1.A
Spike glycoprotein
The SARS-CoV-2 spike in complex with the 2.15 neutralizing nanobody
0.6799.500.94 12-1208EM0.00hetero-3-2-mer33 x NAG, 5 x NAG-NAGBLAST0.61
7r4q.1.B
Spike glycoprotein
The SARS-CoV-2 spike in complex with the 1.29 neutralizing nanobody
0.7299.500.94 12-1208EM0.00hetero-3-2-mer33 x NAG, 5 x NAG-NAGBLAST0.61
7r4r.1.A
Spike glycoprotein
The SARS-CoV-2 spike in complex with the 1.10 neutralizing nanobody
0.6099.500.94 12-1208EM0.00hetero-3-1-mer33 x NAG, 5 x NAG-NAGBLAST0.61
7r4r.1.B
Spike glycoprotein
The SARS-CoV-2 spike in complex with the 1.10 neutralizing nanobody
0.6099.500.94 12-1208EM0.00hetero-3-1-mer33 x NAG, 5 x NAG-NAGBLAST0.61
7r4r.1.C
Spike glycoprotein
The SARS-CoV-2 spike in complex with the 1.10 neutralizing nanobody
0.6099.500.94 12-1208EM0.00hetero-3-1-mer33 x NAG, 5 x NAG-NAGBLAST0.61
7vrw.1.A
Spike glycoprotein
VAS5 Spike (3 RBD down)
0.6499.830.94 13-1213EM3.60homo-trimer29 x NAG, 14 x NAG-NAGBLAST0.62
7vrv.1.B
Spike glycoprotein
VAS5 Spike (1 RBD up)
0.6499.830.94 13-1213EM4.20homo-trimer31 x NAG, 13 x NAG-NAGBLAST0.62
7vrv.1.C
Spike glycoprotein
VAS5 Spike (1 RBD up)
0.6399.830.94 13-1213EM4.20homo-trimer31 x NAG, 13 x NAG-NAGBLAST0.62
7vrv.1.A
Spike glycoprotein
VAS5 Spike (1 RBD up)
0.6399.830.94 13-1213EM4.20homo-trimer31 x NAG, 13 x NAG-NAGBLAST0.62
7tey.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein
0.5798.590.95 1-1206EM0.00homo-trimer20 x NAG, 18 x NAG-NAGHHblits0.61
7tex.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2
0.5698.590.95 1-1206EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.61
7tex.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2
0.5798.590.95 1-1206EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.61
7tey.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein
0.5798.590.95 1-1206EM0.00homo-trimer20 x NAG, 18 x NAG-NAGHHblits0.61
7tew.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.0498.590.95 1-1206EM0.00hetero-1-1-mer7 x NAGHHblits0.61
7tex.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2
0.7298.590.95 1-1206EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.61
7tey.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein
0.7298.590.95 1-1206EM0.00homo-trimer20 x NAG, 18 x NAG-NAGHHblits0.61
7eh5.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-D614G variant in complex with neutralizing antibodies, RBD-chAb15 and RBD-chAb45
0.6399.500.94 12-1208EM0.00hetero-3-3-3-3-3-mer21 x NAG, 27 x NAG-NAGBLAST0.61
7eaz.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 1
0.6399.500.94 12-1208EM0.00homo-trimer16 x NAG, 2 x NAG-NAG-BMA, 30 x NAG-NAGBLAST0.61
7eaz.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 1
0.6299.500.94 12-1208EM0.00homo-trimer16 x NAG, 2 x NAG-NAG-BMA, 30 x NAG-NAGBLAST0.61
7eb0.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 2
0.6399.500.94 12-1208EM0.00homo-trimer19 x NAG, 3 x NAG-NAG-BMA, 26 x NAG-NAGBLAST0.61
7eb0.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 2
0.6299.500.94 12-1208EM0.00homo-trimer19 x NAG, 3 x NAG-NAG-BMA, 26 x NAG-NAGBLAST0.61
7eb3.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 3
0.6499.500.94 12-1208EM0.00homo-trimer18 x NAG, 1 x NAG-NAG-BMA, 29 x NAG-NAGBLAST0.61
7eb3.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 3
0.6399.500.94 12-1208EM0.00homo-trimer18 x NAG, 1 x NAG-NAG-BMA, 29 x NAG-NAGBLAST0.61
7eb3.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 3
0.6299.500.94 12-1208EM0.00homo-trimer18 x NAG, 1 x NAG-NAG-BMA, 29 x NAG-NAGBLAST0.61
7eb4.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 1
0.6299.500.94 12-1208EM0.00homo-trimer16 x NAG, 1 x NAG-NAG-BMA, 28 x NAG-NAGBLAST0.61
7eb4.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 1
0.6299.500.94 12-1208EM0.00homo-trimer16 x NAG, 1 x NAG-NAG-BMA, 28 x NAG-NAGBLAST0.61
7eb5.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 2
0.6299.500.94 12-1208EM0.00homo-trimer20 x NAG, 27 x NAG-NAGBLAST0.61
7eb5.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 2
0.6299.500.94 12-1208EM0.00homo-trimer20 x NAG, 27 x NAG-NAGBLAST0.61
7eb5.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 2
0.6099.500.94 12-1208EM0.00homo-trimer20 x NAG, 27 x NAG-NAGBLAST0.61
7eaz.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 1
0.6499.500.94 12-1208EM0.00homo-trimer16 x NAG, 2 x NAG-NAG-BMA, 30 x NAG-NAGBLAST0.61
7wo4.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 dimer trimer )
0.6699.500.94 12-1208EM0.00hetero-6-6-6-mer90 x NAGBLAST0.61
7wo4.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 dimer trimer )
0.6699.500.94 12-1208EM0.00hetero-6-6-6-mer90 x NAGBLAST0.61
7wo4.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 dimer trimer )
0.6599.500.94 12-1208EM0.00hetero-6-6-6-mer90 x NAGBLAST0.61
7wo4.1.L
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 dimer trimer )
0.6599.500.94 12-1208EM0.00hetero-6-6-6-mer90 x NAGBLAST0.61
7woa.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-60 (1-up trimer)
0.6799.500.94 12-1208EM0.00hetero-3-2-2-mer39 x NAGBLAST0.61
7woa.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-60 (1-up trimer)
0.6899.500.94 12-1208EM0.00hetero-3-2-2-mer39 x NAGBLAST0.61
7woa.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-60 (1-up trimer)
0.6699.500.94 12-1208EM0.00hetero-3-2-2-mer39 x NAGBLAST0.61
7wob.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-60 (2-up trimer)
0.6899.500.94 12-1208EM0.00hetero-3-3-3-mer38 x NAGBLAST0.61
7wob.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with IgG 553-60 (2-up trimer)
0.6899.500.94 12-1208EM0.00hetero-3-3-3-mer38 x NAGBLAST0.61
7wz2.1.A
Spike glycoprotein
SARS-CoV-2 (D614G) Spike trimer
0.6899.500.94 12-1208EM0.00homo-trimer34 x NAGBLAST0.61
7wz2.1.B
Spike glycoprotein
SARS-CoV-2 (D614G) Spike trimer
0.6799.500.94 12-1208EM0.00homo-trimer34 x NAGBLAST0.61
7wz2.1.C
Spike glycoprotein
SARS-CoV-2 (D614G) Spike trimer
0.6899.500.94 12-1208EM0.00homo-trimer34 x NAGBLAST0.61
7vq0.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein (2-up RBD) bound to neutralizing nanobodies P86
0.7099.500.94 12-1208EM0.00hetero-3-3-mer28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.61
7vq0.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein (2-up RBD) bound to neutralizing nanobodies P86
0.7199.500.94 12-1208EM0.00hetero-3-3-mer28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.61
7vq0.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein (2-up RBD) bound to neutralizing nanobodies P86
0.6999.500.94 12-1208EM0.00hetero-3-3-mer28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MANBLAST0.61
7v76.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), uncleavable form, one RBD-up conformation
0.6998.420.95 1-1207EM0.00homo-trimer15 x NAG, 31 x NAG-NAGHHblits0.61
7v76.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), uncleavable form, one RBD-up conformation
0.6898.420.95 1-1207EM0.00homo-trimer15 x NAG, 31 x NAG-NAGHHblits0.61
7v76.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), uncleavable form, one RBD-up conformation
0.6998.420.95 1-1207EM0.00homo-trimer15 x NAG, 31 x NAG-NAGHHblits0.61
7v77.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), uncleavable form, two RBD-up conformation
0.6998.420.95 1-1207EM0.00homo-trimer17 x NAG, 30 x NAG-NAGHHblits0.61
7v77.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), uncleavable form, two RBD-up conformation
0.6898.420.95 1-1207EM0.00homo-trimer17 x NAG, 30 x NAG-NAGHHblits0.61
7v77.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), uncleavable form, two RBD-up conformation
0.6998.420.95 1-1207EM0.00homo-trimer17 x NAG, 30 x NAG-NAGHHblits0.61
7v7z.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
0.6898.420.95 1-1207EM0.00hetero-3-3-mer17 x NAG, 31 x NAG-NAGHHblits0.61
7v7z.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
0.6798.420.95 1-1207EM0.00hetero-3-3-mer17 x NAG, 31 x NAG-NAGHHblits0.61
7v7z.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
0.6798.420.95 1-1207EM0.00hetero-3-3-mer17 x NAG, 31 x NAG-NAGHHblits0.61
7v80.1.A
Spike glycoprotein
Local refinement of SARS-CoV-2 S-Beta variant (B.1.351) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.0298.420.95 1-1207EM0.00hetero-1-1-mer5 x NAG, 3 x NAG-NAGHHblits0.61
7q9k.1.A
Spike glycoprotein
Beta-32 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.6698.420.95 1-1208EM0.00hetero-3-2-2-mer30 x NAG, 15 x NAG-NAGHHblits0.61
7q9k.1.B
Spike glycoprotein
Beta-32 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7098.420.95 1-1208EM0.00hetero-3-2-2-mer30 x NAG, 15 x NAG-NAGHHblits0.61
7q9k.1.C
Spike glycoprotein
Beta-32 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.6998.420.95 1-1208EM0.00hetero-3-2-2-mer30 x NAG, 15 x NAG-NAGHHblits0.61
7q9f.1.A
Spike glycoprotein
Beta-50 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7098.420.95 1-1208EM0.00hetero-3-3-3-mer25 x NAG, 1 x NAG-NAG-FUC, 14 x NAG-NAG, 2 x NAG-NAG-BMA-FUCHHblits0.61
7q9f.1.B
Spike glycoprotein
Beta-50 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7098.420.95 1-1208EM0.00hetero-3-3-3-mer25 x NAG, 1 x NAG-NAG-FUC, 14 x NAG-NAG, 2 x NAG-NAG-BMA-FUCHHblits0.61
7q9f.1.C
Spike glycoprotein
Beta-50 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7198.420.95 1-1208EM0.00hetero-3-3-3-mer25 x NAG, 1 x NAG-NAG-FUC, 14 x NAG-NAG, 2 x NAG-NAG-BMA-FUCHHblits0.61
7q9g.1.A
Spike glycoprotein
COVOX-222 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7298.420.95 1-1208EM0.00hetero-3-2-2-mer28 x NAG, 12 x NAG-NAGHHblits0.61
7q9g.1.B
Spike glycoprotein
COVOX-222 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7298.420.95 1-1208EM0.00hetero-3-2-2-mer28 x NAG, 12 x NAG-NAGHHblits0.61
7q9i.1.C
Spike glycoprotein
Beta-43 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7298.420.95 1-1208EM0.00hetero-3-3-3-mer29 x NAG, 12 x NAG-NAGHHblits0.61
7q9g.1.C
Spike glycoprotein
COVOX-222 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7298.420.95 1-1208EM0.00hetero-3-2-2-mer28 x NAG, 12 x NAG-NAGHHblits0.61
7q9i.1.A
Spike glycoprotein
Beta-43 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7298.420.95 1-1208EM0.00hetero-3-3-3-mer29 x NAG, 12 x NAG-NAGHHblits0.61
7q9i.1.B
Spike glycoprotein
Beta-43 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7298.420.95 1-1208EM0.00hetero-3-3-3-mer29 x NAG, 12 x NAG-NAGHHblits0.61
7q9m.1.A
Spike glycoprotein
Beta-53 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7098.420.95 1-1208EM0.00hetero-3-3-3-mer15 x NAG, 2 x NAG-NAG-BMA, 11 x NAG-NAGHHblits0.61
7q9m.1.B
Spike glycoprotein
Beta-53 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7098.420.95 1-1208EM0.00hetero-3-3-3-mer15 x NAG, 2 x NAG-NAG-BMA, 11 x NAG-NAGHHblits0.61
7q9m.1.C
Spike glycoprotein
Beta-53 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7198.420.95 1-1208EM0.00hetero-3-3-3-mer15 x NAG, 2 x NAG-NAG-BMA, 11 x NAG-NAGHHblits0.61
8a94.1.A
SARS-CoV2 Spike in 2-up conformation in complex with Fab47
SARS CoV2 Spike in the 2-up state in complex with Fab47
0.6999.420.94 12-1208EM0.00hetero-3-3-3-mer43 x NAG, 7 x NAG-NAGBLAST0.61
8a94.1.B
SARS-CoV2 Spike in 2-up conformation in complex with Fab47
SARS CoV2 Spike in the 2-up state in complex with Fab47
0.6899.420.94 12-1208EM0.00hetero-3-3-3-mer43 x NAG, 7 x NAG-NAGBLAST0.61
8a94.1.C
SARS-CoV2 Spike in 2-up conformation in complex with Fab47
SARS CoV2 Spike in the 2-up state in complex with Fab47
0.7099.420.94 12-1208EM0.00hetero-3-3-3-mer43 x NAG, 7 x NAG-NAGBLAST0.61
7p40.1.A
Spike glycoprotein
P5C3 is a potent fab neutralizer
0.7199.250.94 14-1211EM0.00hetero-3-3-3-merBLAST0.61
7lww.1.A
Spike glycoprotein
Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 1-RBD-up conformation (S-GSAS-D614G-K417N-E484K-N501Y)
0.6999.420.94 12-1208EM0.00homo-trimer26 x NAG, 12 x NAG-NAGBLAST0.61
7lww.1.B
Spike glycoprotein
Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 1-RBD-up conformation (S-GSAS-D614G-K417N-E484K-N501Y)
0.6999.420.94 12-1208EM0.00homo-trimer26 x NAG, 12 x NAG-NAGBLAST0.61
7lww.1.C
Spike glycoprotein
Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 1-RBD-up conformation (S-GSAS-D614G-K417N-E484K-N501Y)
0.6999.420.94 12-1208EM0.00homo-trimer26 x NAG, 12 x NAG-NAGBLAST0.61
8csa.1.B
Spike glycoprotein
Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 3-RBD-up conformation (S-GSAS-D614G-K417N-E484K-N501Y)
0.6799.420.94 12-1208EM0.00homo-trimerBLAST0.61
8csa.1.C
Spike glycoprotein
Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 3-RBD-up conformation (S-GSAS-D614G-K417N-E484K-N501Y)
0.6799.420.94 12-1208EM0.00homo-trimerBLAST0.61
8csa.1.A
Spike glycoprotein
Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 3-RBD-up conformation (S-GSAS-D614G-K417N-E484K-N501Y)
0.6699.420.94 12-1208EM0.00homo-trimerBLAST0.61
6zp1.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Closed State
0.7099.830.94 14-1211EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7tla.1.A
Spike glycoprotein
Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 1
0.7099.420.94 12-1208EM0.00homo-trimerBLAST0.61
7tla.1.B
Spike glycoprotein
Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 1
0.6899.420.94 12-1208EM0.00homo-trimerBLAST0.61
7tla.1.C
Spike glycoprotein
Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 1
0.7099.420.94 12-1208EM0.00homo-trimerBLAST0.61
7tlb.1.B
Spike glycoprotein
Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 2
0.7099.420.94 12-1208EM0.00homo-trimerBLAST0.61
7tlb.1.C
Spike glycoprotein
Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 2
0.7099.420.94 12-1208EM0.00homo-trimerBLAST0.61
7ns6.1.G
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies
0.7099.330.94 12-1208EM0.00hetero-6-6-mer46 x NAG, 2 x NAG-NAG-BMABLAST0.61
7e8c.1.A
Spike glycoprotein
SARS-CoV-2 S-6P in complex with 9 Fabs
0.6999.330.94 12-1208EM0.00hetero-3-3-3-3-3-3-…BLAST0.61
7e8c.1.B
Spike glycoprotein
SARS-CoV-2 S-6P in complex with 9 Fabs
0.7099.330.94 12-1208EM0.00hetero-3-3-3-3-3-3-…BLAST0.61
7e8c.1.C
Spike glycoprotein
SARS-CoV-2 S-6P in complex with 9 Fabs
0.6999.330.94 12-1208EM0.00hetero-3-3-3-3-3-3-…BLAST0.61
7cak.1.A
Spike glycoprotein
SARS-CoV-2 S trimer with three RBD in the open state and complexed with three H014 Fab
0.6699.330.94 12-1208EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAGBLAST0.61
7cai.1.B
Spike glycoprotein
SARS-CoV-2 S trimer with two RBDs in the open state and complexed with two H014 Fab
0.6699.330.94 12-1208EM0.00hetero-3-2-2-mer30 x NAG, 15 x NAG-NAGBLAST0.61
7cai.1.C
Spike glycoprotein
SARS-CoV-2 S trimer with two RBDs in the open state and complexed with two H014 Fab
0.6799.330.94 12-1208EM0.00hetero-3-2-2-mer30 x NAG, 15 x NAG-NAGBLAST0.61
7cai.1.A
Spike glycoprotein
SARS-CoV-2 S trimer with two RBDs in the open state and complexed with two H014 Fab
0.6799.330.94 12-1208EM0.00hetero-3-2-2-mer30 x NAG, 15 x NAG-NAGBLAST0.61
7cyp.1.B
SARS-CoV-2 Spike glycoprotein
Complex of SARS-CoV-2 spike trimer with its neutralizing antibody HB27
0.6699.330.94 12-1208EM0.00hetero-3-3-3-mer29 x NAG, 15 x NAG-NAGBLAST0.61
7cyp.1.C
SARS-CoV-2 Spike glycoprotein
Complex of SARS-CoV-2 spike trimer with its neutralizing antibody HB27
0.6699.330.94 12-1208EM0.00hetero-3-3-3-mer29 x NAG, 15 x NAG-NAGBLAST0.61
7z3z.1.A
Spike glycoprotein
Locked Wuhan SARS-CoV2 Prefusion Spike ectodomain with lipid bound
0.7199.330.94 12-1208EM0.00homo-trimer36 x NAG, 3 x STE, 15 x NAG-NAGBLAST0.61
6zox.1.A
Spike glycoprotein
Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x2 disulphide-bond mutant, G413C, V987C, single Arg S1/S2 cleavage site)
0.7199.830.94 14-1211EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7xu1.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-122 Conformation
0.6999.830.94 14-1211EM0.00homo-trimer37 x NAG, 3 x BLA, 3 x EIC, 13 x NAG-NAGBLAST0.62
7xu1.1.C
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-122 Conformation
0.7199.830.94 14-1211EM0.00homo-trimer37 x NAG, 3 x BLA, 3 x EIC, 13 x NAG-NAGBLAST0.62
6zp1.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Closed State
0.7099.750.94 14-1211EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
6zp1.1.B
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Closed State
0.7099.750.94 14-1211EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
6zp1.1.C
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Closed State
0.7099.750.94 14-1211EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
8c8p.1.B
Spike glycoprotein,SARS-CoV-2 spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 10D12 heavy-chain-only antibody (local refinement)
0.0199.330.94 12-1208EM0.00hetero-1-1-merBLAST0.61
6zox.1.A
Spike glycoprotein
Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x2 disulphide-bond mutant, G413C, V987C, single Arg S1/S2 cleavage site)
0.7099.750.94 14-1211EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
6zox.1.B
Spike glycoprotein
Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x2 disulphide-bond mutant, G413C, V987C, single Arg S1/S2 cleavage site)
0.7099.750.94 14-1211EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
6zox.1.C
Spike glycoprotein
Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x2 disulphide-bond mutant, G413C, V987C, single Arg S1/S2 cleavage site)
0.7099.750.94 14-1211EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7xu1.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-122 Conformation
0.6999.750.94 14-1211EM0.00homo-trimer37 x NAG, 3 x BLA, 3 x EIC, 13 x NAG-NAGHHblits0.62
7xu1.1.B
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-122 Conformation
0.7099.750.94 14-1211EM0.00homo-trimer37 x NAG, 3 x BLA, 3 x EIC, 13 x NAG-NAGHHblits0.62
7xu1.1.C
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-122 Conformation
0.7199.750.94 14-1211EM0.00homo-trimer37 x NAG, 3 x BLA, 3 x EIC, 13 x NAG-NAGHHblits0.62
7tb8.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1
0.6599.580.94 14-1208EM0.00hetero-3-3-3-1-1-mer25 x NAG, 9 x NAG-NAGHHblits0.62
7tb8.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1
0.6599.580.94 14-1208EM0.00hetero-3-3-3-1-1-mer25 x NAG, 9 x NAG-NAGHHblits0.62
7tb8.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1
0.6299.580.94 14-1208EM0.00hetero-3-3-3-1-1-mer25 x NAG, 9 x NAG-NAGHHblits0.62
7vnc.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UDD-state, state 1)
0.6299.580.94 14-1208EM0.00hetero-3-1-mer18 x NAG, 3 x NAG-NAG-NAG, 12 x NAG-NAGHHblits0.62
7vnc.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UDD-state, state 1)
0.6499.580.94 14-1208EM0.00hetero-3-1-mer18 x NAG, 3 x NAG-NAG-NAG, 12 x NAG-NAGHHblits0.62
7vnc.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UDD-state, state 1)
0.6399.580.94 14-1208EM0.00hetero-3-1-mer18 x NAG, 3 x NAG-NAG-NAG, 12 x NAG-NAGHHblits0.62
7vnd.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UUD-state, state 2)
0.6599.580.94 14-1208EM0.00hetero-3-2-mer20 x NAG, 16 x NAG-NAGHHblits0.62
7vnd.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UUD-state, state 2)
0.6199.580.94 14-1208EM0.00hetero-3-2-mer20 x NAG, 16 x NAG-NAGHHblits0.62
7vnd.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UUD-state, state 2)
0.6399.580.94 14-1208EM0.00hetero-3-2-mer20 x NAG, 16 x NAG-NAGHHblits0.62
7vne.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113.1 (UUU-state)
0.6399.580.94 14-1208EM0.00hetero-3-3-mer21 x NAG, 20 x NAG-NAG, 2 x NAG-NAG-NAGHHblits0.62
7vne.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113.1 (UUU-state)
0.6499.580.94 14-1208EM0.00hetero-3-3-mer21 x NAG, 20 x NAG-NAG, 2 x NAG-NAG-NAGHHblits0.62
7vne.1.E
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113.1 (UUU-state)
0.6299.580.94 14-1208EM0.00hetero-3-3-mer21 x NAG, 20 x NAG-NAG, 2 x NAG-NAG-NAGHHblits0.62
6xlu.1.A
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 4.0
0.7199.580.94 14-1208EM0.00homo-trimer32 x NAG, 15 x NAG-NAGHHblits0.62
6xlu.1.B
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 4.0
0.7099.580.94 14-1208EM0.00homo-trimer32 x NAG, 15 x NAG-NAGHHblits0.62
6xlu.1.C
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 4.0
0.7099.580.94 14-1208EM0.00homo-trimer32 x NAG, 15 x NAG-NAGHHblits0.62
7jwy.1.A
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 4.5
0.7199.580.94 14-1208EM0.00homo-trimer30 x NAG, 17 x NAG-NAGHHblits0.62
7jwy.1.B
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 4.5
0.7099.580.94 14-1208EM0.00homo-trimer30 x NAG, 17 x NAG-NAGHHblits0.62
6xm0.1.A
Spike glycoprotein
Consensus structure of SARS-CoV-2 spike at pH 5.5
0.7099.580.94 14-1208EM0.00homo-trimer28 x NAG, 14 x NAG-NAGHHblits0.62
6xm3.1.A
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 1
0.6999.580.94 14-1208EM0.00homo-trimer26 x NAG, 17 x NAG-NAGHHblits0.62
6xm0.1.B
Spike glycoprotein
Consensus structure of SARS-CoV-2 spike at pH 5.5
0.6299.580.94 14-1208EM0.00homo-trimer28 x NAG, 14 x NAG-NAGHHblits0.62
6xm0.1.C
Spike glycoprotein
Consensus structure of SARS-CoV-2 spike at pH 5.5
0.6999.580.94 14-1208EM0.00homo-trimer28 x NAG, 14 x NAG-NAGHHblits0.62
6xm3.1.B
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 1
0.6699.580.94 14-1208EM0.00homo-trimer26 x NAG, 17 x NAG-NAGHHblits0.62
6xm3.1.C
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 1
0.6999.580.94 14-1208EM0.00homo-trimer26 x NAG, 17 x NAG-NAGHHblits0.62
6xm4.1.A
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 2
0.6999.580.94 14-1208EM0.00homo-trimer25 x NAG, 18 x NAG-NAGHHblits0.62
6xm4.1.B
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 2
0.6599.580.94 14-1208EM0.00homo-trimer25 x NAG, 18 x NAG-NAGHHblits0.62
6xm4.1.C
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 2
0.6999.580.94 14-1208EM0.00homo-trimer25 x NAG, 18 x NAG-NAGHHblits0.62
6xm5.1.A
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 5.5, all RBDs down
0.6899.580.94 14-1208EM0.00homo-trimer26 x NAG, 16 x NAG-NAGHHblits0.62
6xm5.1.B
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 5.5, all RBDs down
0.6699.580.94 14-1208EM0.00homo-trimer26 x NAG, 16 x NAG-NAGHHblits0.62
6xm5.1.C
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 5.5, all RBDs down
0.6799.580.94 14-1208EM0.00homo-trimer26 x NAG, 16 x NAG-NAGHHblits0.62
7jwy.1.C
Spike glycoprotein
Structure of SARS-CoV-2 spike at pH 4.5
0.7199.580.94 14-1208EM0.00homo-trimer30 x NAG, 17 x NAG-NAGHHblits0.62
6xf5.1.A
Spike glycoprotein
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (RBDs down)
0.7099.580.94 14-1208EM0.00homo-trimer36 x NAG, 12 x NAG-NAGHHblits0.62
6xf5.1.B
Spike glycoprotein
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (RBDs down)
0.7099.580.94 14-1208EM0.00homo-trimer36 x NAG, 12 x NAG-NAGHHblits0.62
6xf5.1.C
Spike glycoprotein
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (RBDs down)
0.7099.580.94 14-1208EM0.00homo-trimer36 x NAG, 12 x NAG-NAGHHblits0.62
6xf6.1.A
Spike glycoprotein
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (1 RBD up)
0.6899.580.94 14-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
6xf6.1.B
Spike glycoprotein
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (1 RBD up)
0.6799.580.94 14-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
6xf6.1.C
Spike glycoprotein
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (1 RBD up)
0.6899.580.94 14-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
7lqv.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike
0.6599.580.94 14-1208EM0.00hetero-3-3-3-mer27 x NAGHHblits0.62
7lqv.1.B
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike
0.6199.580.94 14-1208EM0.00hetero-3-3-3-mer27 x NAGHHblits0.62
7lqv.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike
0.6699.580.94 14-1208EM0.00hetero-3-3-3-mer27 x NAGHHblits0.62
7lqw.1.E
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike
0.6499.580.94 14-1208EM0.00hetero-1-1-3-mer25 x NAGHHblits0.62
7lqw.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike
0.6299.580.94 14-1208EM0.00hetero-1-1-3-mer25 x NAGHHblits0.62
7lqw.1.D
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike
0.6099.580.94 14-1208EM0.00hetero-1-1-3-mer25 x NAGHHblits0.62
6xf5.1.A
Spike glycoprotein
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (RBDs down)
0.7099.580.94 14-1208EM0.00homo-trimer36 x NAG, 12 x NAG-NAGBLAST0.62
6xf6.1.A
Spike glycoprotein
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (1 RBD up)
0.6899.580.94 14-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGBLAST0.62
6xf6.1.B
Spike glycoprotein
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (1 RBD up)
0.6799.580.94 14-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGBLAST0.62
6xf6.1.C
Spike glycoprotein
Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (1 RBD up)
0.6899.580.94 14-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGBLAST0.62
7lqv.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike
0.6599.580.94 14-1208EM0.00hetero-3-3-3-mer27 x NAGBLAST0.62
7lqv.1.B
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike
0.6199.580.94 14-1208EM0.00hetero-3-3-3-mer27 x NAGBLAST0.62
7lqv.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike
0.6699.580.94 14-1208EM0.00hetero-3-3-3-mer27 x NAGBLAST0.62
7lqw.1.E
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike
0.6499.580.94 14-1208EM0.00hetero-1-1-3-mer25 x NAGBLAST0.62
7lqw.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike
0.6299.580.94 14-1208EM0.00hetero-1-1-3-mer25 x NAGBLAST0.62
7lqw.1.D
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike
0.6099.580.94 14-1208EM0.00hetero-1-1-3-mer25 x NAGBLAST0.62
7sn2.1.A
Spike glycoprotein
Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab
0.0199.250.94 12-1208EM0.00hetero-1-1-1-merBLAST0.61
7sn3.1.A
Spike glycoprotein
Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (variable region)
0.6599.250.94 12-1208EM0.00hetero-3-3-3-mer45 x NAG, 3 x NAG-NAG-BMABLAST0.61
7sn3.1.B
Spike glycoprotein
Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (variable region)
0.6499.250.94 12-1208EM0.00hetero-3-3-3-mer45 x NAG, 3 x NAG-NAG-BMABLAST0.61
7sn3.1.C
Spike glycoprotein
Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (variable region)
0.6399.250.94 12-1208EM0.00hetero-3-3-3-mer45 x NAG, 3 x NAG-NAG-BMABLAST0.61
7yeg.1.A
Spike glycoprotein
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2
0.6299.250.94 12-1208EM0.00hetero-3-3-3-3-mer36 x NAG, 3 x ZN, 6 x NAG-NAGBLAST0.61
7chh.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with BD-368-2 Fabs
0.7099.250.94 12-1208EM0.00hetero-3-3-3-mer31 x NAG, 5 x NAG-NAGBLAST0.61
7chh.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with BD-368-2 Fabs
0.7099.250.94 12-1208EM0.00hetero-3-3-3-mer31 x NAG, 5 x NAG-NAGBLAST0.61
7u0p.1.A
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-S21F2
0.6199.250.94 12-1208EM0.00hetero-3-2-2-mer22 x NAG, 5 x NAG-NAGBLAST0.61
7u0p.1.C
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-S21F2
0.6299.250.94 12-1208EM0.00hetero-3-2-2-mer22 x NAG, 5 x NAG-NAGBLAST0.61
7u0p.1.B
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-S21F2
0.6299.250.94 12-1208EM0.00hetero-3-2-2-mer22 x NAG, 5 x NAG-NAGBLAST0.61
7u0q.1.C
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-02
0.6899.250.94 12-1208EM0.00hetero-3-2-2-mer23 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7u0x.1.B
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-13
0.6699.250.94 12-1208EM0.00hetero-3-2-2-mer29 x NAG, 15 x NAG-NAGBLAST0.61
7u0x.1.A
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-13
0.6699.250.94 12-1208EM0.00hetero-3-2-2-mer29 x NAG, 15 x NAG-NAGBLAST0.61
7u0x.1.C
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-13
0.6699.250.94 12-1208EM0.00hetero-3-2-2-mer29 x NAG, 15 x NAG-NAGBLAST0.61
7u0q.1.B
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-02
0.6899.250.94 12-1208EM0.00hetero-3-2-2-mer23 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7u0q.1.A
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-02
0.6799.250.94 12-1208EM0.00hetero-3-2-2-mer23 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7uow.1.B
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 034_32
0.6699.250.94 12-1208EM0.00hetero-3-2-2-mer23 x NAG, 12 x NAG-NAGBLAST0.61
7uow.1.C
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 034_32
0.6399.250.94 12-1208EM0.00hetero-3-2-2-mer23 x NAG, 12 x NAG-NAGBLAST0.61
7uow.1.A
Spike glycoprotein
SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 034_32
0.6699.250.94 12-1208EM0.00hetero-3-2-2-mer23 x NAG, 12 x NAG-NAGBLAST0.61
7chh.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with BD-368-2 Fabs
0.7099.250.94 12-1208EM0.00hetero-3-3-3-mer31 x NAG, 5 x NAG-NAGBLAST0.61
8hc4.1.B
Spike glycoprotein
SARS-CoV-2 wildtype spike trimer (6P) in complex with 3 YB9-258 Fabs and 3 R1-32 Fabs (3 RBD up)
0.6599.250.94 12-1208EM0.00hetero-3-3-3-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.61
7ydy.1.C
Spike glycoprotein
SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab
0.6099.250.94 12-1208EM0.00hetero-3-1-1-mer24 x NAG, 6 x NAG-NAGBLAST0.61
7ydy.1.B
Spike glycoprotein
SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab
0.6199.250.94 12-1208EM0.00hetero-3-1-1-mer24 x NAG, 6 x NAG-NAGBLAST0.61
7ydy.1.A
Spike glycoprotein
SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab
0.6199.250.94 12-1208EM0.00hetero-3-1-1-mer24 x NAG, 6 x NAG-NAGBLAST0.61
8hc4.1.C
Spike glycoprotein
SARS-CoV-2 wildtype spike trimer (6P) in complex with 3 YB9-258 Fabs and 3 R1-32 Fabs (3 RBD up)
0.6699.250.94 12-1208EM0.00hetero-3-3-3-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.61
8hc4.1.A
Spike glycoprotein
SARS-CoV-2 wildtype spike trimer (6P) in complex with 3 YB9-258 Fabs and 3 R1-32 Fabs (3 RBD up)
0.6699.250.94 12-1208EM0.00hetero-3-3-3-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.61
7x8w.1.A
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab354
0.0399.250.94 12-1208EM0.00hetero-1-1-1-mer1 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUCBLAST0.61
7x8y.1.A
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab159
0.0199.250.94 12-1208EM0.00hetero-1-1-1-mer1 x NAGBLAST0.61
7x8z.1.A
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab188
0.0299.250.94 12-1208EM0.00hetero-1-1-1-mer1 x NAGBLAST0.61
7x90.1.C
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab326
0.0199.250.94 12-1208EM0.00hetero-1-1-1-mer1 x NAG-NAGBLAST0.61
7x91.1.A
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with an Fv-clasp form of a human neutralizing antibody Ab496
0.0399.250.94 12-1208EM0.00hetero-1-1-1-mer1 x NAG-NAGBLAST0.61
7x92.1.A
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab445
0.0299.250.94 12-1208EM0.00hetero-1-1-1-mer1 x NAG-NAGBLAST0.61
7x93.1.B
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765
0.0499.250.94 12-1208EM0.00hetero-3-1-1-mer1 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MANBLAST0.61
7x95.1.A
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab709
0.0399.250.94 12-1208EM0.00hetero-1-1-1-mer1 x NAG-NAGBLAST0.61
7x94.1.A
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab712
0.0299.250.94 12-1208EM0.00hetero-1-1-1-merBLAST0.61
7x93.1.E
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765
0.0399.250.94 12-1208EM0.00hetero-3-1-1-mer1 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MANBLAST0.61
7x96.1.A
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab847
0.0299.250.94 12-1208EM0.00hetero-1-1-1-merBLAST0.61
7x93.1.A
Spike glycoprotein
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765
0.0399.250.94 12-1208EM0.00hetero-3-1-1-mer1 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MANBLAST0.61
7rq6.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with non-neutralizing NTD-directed CV3-13 Fab isolated from convalescent individual
0.6299.250.94 12-1208EM0.00hetero-3-3-3-mer36 x NAG, 3 x NAG-NAGBLAST0.61
7fae.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P36-5D2(state2)
0.6999.250.94 12-1208EM0.00hetero-3-3-3-mer27 x NAG, 17 x NAG-NAGBLAST0.61
7fae.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P36-5D2(state2)
0.6999.250.94 12-1208EM0.00hetero-3-3-3-mer27 x NAG, 17 x NAG-NAGBLAST0.61
7fae.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P36-5D2(state2)
0.7099.250.94 12-1208EM0.00hetero-3-3-3-mer27 x NAG, 17 x NAG-NAGBLAST0.61
7faf.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P36-5D2 (state1)
0.6999.250.94 12-1208EM0.00hetero-3-3-3-merBLAST0.61
7faf.1.H
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P36-5D2 (state1)
0.6899.250.94 12-1208EM0.00hetero-3-3-3-merBLAST0.61
7faf.1.I
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P36-5D2 (state1)
0.6799.250.94 12-1208EM0.00hetero-3-3-3-merBLAST0.61
7xmz.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three D2 Fab
0.6999.250.94 12-1208EM0.00hetero-3-3-3-mer32 x NAGBLAST0.61
7xmx.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three F61 Fab
0.6599.250.94 12-1208EM0.00hetero-3-3-3-mer24 x NAGBLAST0.61
7xmx.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three F61 Fab
0.6599.250.94 12-1208EM0.00hetero-3-3-3-mer24 x NAGBLAST0.61
7xmz.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three D2 Fab
0.6999.250.94 12-1208EM0.00hetero-3-3-3-mer32 x NAGBLAST0.61
7xmz.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three D2 Fab
0.7099.250.94 12-1208EM0.00hetero-3-3-3-mer32 x NAGBLAST0.61
7xmx.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three F61 Fab
0.6599.250.94 12-1208EM0.00hetero-3-3-3-mer24 x NAGBLAST0.61
7kl9.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4)
0.6799.250.94 12-1208EM0.00hetero-3-3-mer27 x NAG, 2 x NAG-NAGBLAST0.61
7kl9.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4)
0.6599.250.94 12-1208EM0.00hetero-3-3-mer27 x NAG, 2 x NAG-NAGBLAST0.61
7kl9.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4)
0.6699.250.94 12-1208EM0.00hetero-3-3-mer27 x NAG, 2 x NAG-NAGBLAST0.61
8bev.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike (HexaPro variant) in complex with nanobody W25 (map 3, focus refinement on RBD, W25 and adjacent NTD)
0.0199.250.94 12-1208EM0.00hetero-2-1-mer1 x NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAGBLAST0.61
8bev.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike (HexaPro variant) in complex with nanobody W25 (map 3, focus refinement on RBD, W25 and adjacent NTD)
0.0599.250.94 12-1208EM0.00hetero-2-1-mer1 x NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAGBLAST0.61
7jzl.1.E
Spike glycoprotein
SARS-CoV-2 spike in complex with LCB1 (2RBDs open)
0.6999.250.94 12-1208EM0.00hetero-3-3-mer33 x NAG, 13 x NAG-NAGBLAST0.61
6xkl.1.B
Spike glycoprotein
SARS-CoV-2 HexaPro S One RBD up
0.7099.250.94 12-1208EM0.00homo-trimer28 x NAG, 11 x NAG-NAGBLAST0.61
6xkl.1.A
Spike glycoprotein
SARS-CoV-2 HexaPro S One RBD up
0.6999.250.94 12-1208EM0.00homo-trimer28 x NAG, 11 x NAG-NAGBLAST0.61
6xkl.1.C
Spike glycoprotein
SARS-CoV-2 HexaPro S One RBD up
0.7099.250.94 12-1208EM0.00homo-trimer28 x NAG, 11 x NAG-NAGBLAST0.61
7jzn.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with LCB3 (2RBDs open)
0.7199.250.94 12-1208EM0.00hetero-3-3-mer33 x NAG, 13 x NAG-NAGBLAST0.61
7jzl.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with LCB1 (2RBDs open)
0.7099.250.94 12-1208EM0.00hetero-3-3-mer33 x NAG, 13 x NAG-NAGBLAST0.61
7k4n.1.G
Spike glycoprotein
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment
0.7099.250.94 12-1208EM0.00hetero-3-3-3-mer33 x NAG, 15 x NAG-NAGBLAST0.61
7k90.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C144
0.6999.250.94 12-1208EM0.00hetero-3-3-3-mer33 x NAGBLAST0.61
7lxy.1.A
Spike glycoprotein
SARS-CoV-2 S/S2M11/S2X333 Global Refinement
0.7199.250.94 12-1208EM0.00hetero-3-3-3-3-3-mer45 x NAG, 3 x NAG-NAG-BMA-FUC, 6 x NAG-NAGBLAST0.61
7lxz.1.F
Spike glycoprotein
SARS-CoV-2 S/S2M11/S2L28 Global Refinement
0.7199.250.94 12-1208EM0.00hetero-3-3-3-3-3-mer39 x NAG, 3 x NAG-NAG-BMA-FUC, 9 x NAG-NAG, 3 x NAG-NAG-FUCBLAST0.61
7ly0.1.A
Spike glycoprotein
SARS-CoV-2 S/S2M11/S2M28 Local Refinement
0.0099.250.94 12-1208EM0.00hetero-1-1-1-mer2 x NAG, 1 x NAG-NAG-MAN-FUCBLAST0.61
7m6f.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG1-22
0.6999.250.94 12-1208EM0.00hetero-3-2-2-mer33 x NAG, 15 x NAG-NAGBLAST0.61
7m6g.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15
0.6799.250.94 12-1208EM0.00hetero-3-2-2-mer26 x NAG, 11 x NAG-NAGBLAST0.61
7m6g.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15
0.6699.250.94 12-1208EM0.00hetero-3-2-2-mer26 x NAG, 11 x NAG-NAGBLAST0.61
7m6e.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG10-19
0.6999.250.94 12-1208EM0.00hetero-3-3-3-mer32 x NAG, 1 x NAG-NAG-FUCBLAST0.61
7m6f.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG1-22
0.6899.250.94 12-1208EM0.00hetero-3-2-2-mer33 x NAG, 15 x NAG-NAGBLAST0.61
7m6f.1.E
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG1-22
0.6999.250.94 12-1208EM0.00hetero-3-2-2-mer33 x NAG, 15 x NAG-NAGBLAST0.61
7m6g.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15
0.6699.250.94 12-1208EM0.00hetero-3-2-2-mer26 x NAG, 11 x NAG-NAGBLAST0.61
7my2.1.C
Spike glycoprotein
CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike
0.6699.250.94 12-1208EM0.00hetero-3-3-mer29 x NAG, 11 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMABLAST0.61
7my2.1.A
Spike glycoprotein
CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike
0.6799.250.94 12-1208EM0.00hetero-3-3-mer29 x NAG, 11 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMABLAST0.61
7my3.1.B
Spike glycoprotein
CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike
0.6699.250.94 12-1208EM0.00hetero-3-3-mer22 x NAG, 5 x NAG-NAG-BMA, 13 x NAG-NAGBLAST0.61
7my3.1.A
Spike glycoprotein
CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike
0.7099.250.94 12-1208EM0.00hetero-3-3-mer22 x NAG, 5 x NAG-NAG-BMA, 13 x NAG-NAGBLAST0.61
7my3.1.C
Spike glycoprotein
CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike
0.6799.250.94 12-1208EM0.00hetero-3-3-mer22 x NAG, 5 x NAG-NAG-BMA, 13 x NAG-NAGBLAST0.61
7my2.1.B
Spike glycoprotein
CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike
0.6799.250.94 12-1208EM0.00hetero-3-3-mer29 x NAG, 11 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMABLAST0.61
7ra8.1.A
Spike glycoprotein
SARS-CoV-2 S glycoprotein in complex with S2X259 Fab
0.6799.250.94 12-1208EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.61
7n0g.1.B
Spike glycoprotein
CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45)
0.6999.250.94 12-1208EM0.00hetero-3-3-mer35 x NAG, 19 x NAG-NAGBLAST0.61
7n0h.1.C
Spike glycoprotein
CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45)
0.6899.250.94 12-1208EM0.00hetero-3-2-mer30 x NAG, 17 x NAG-NAGBLAST0.61
7n0h.1.B
Spike glycoprotein
CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45)
0.6899.250.94 12-1208EM0.00hetero-3-2-mer30 x NAG, 17 x NAG-NAGBLAST0.61
7n0g.1.A
Spike glycoprotein
CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45)
0.6899.250.94 12-1208EM0.00hetero-3-3-mer35 x NAG, 19 x NAG-NAGBLAST0.61
7n0g.1.C
Spike glycoprotein
CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45)
0.6899.250.94 12-1208EM0.00hetero-3-3-mer35 x NAG, 19 x NAG-NAGBLAST0.61
7p7a.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#68 in a 2up/1flexible conformation
0.6499.250.94 12-1208EM0.00hetero-3-2-mer28 x NAG, 10 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMA, 1 x NAG-NAG-NAGBLAST0.61
7p7a.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#68 in a 2up/1flexible conformation
0.5399.250.94 12-1208EM0.00hetero-3-2-mer28 x NAG, 10 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMA, 1 x NAG-NAG-NAGBLAST0.61
7p7b.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody no68 in a 1up/2down conformation
0.6699.250.94 12-1208EM0.00homo-trimerBLAST0.61
7p7b.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody no68 in a 1up/2down conformation
0.6699.250.94 12-1208EM0.00homo-trimerBLAST0.61
7p7a.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody#68 in a 2up/1flexible conformation
0.6499.250.94 12-1208EM0.00hetero-3-2-mer28 x NAG, 10 x NAG-NAG, 4 x NAG-NAG-BMA, 1 x NAG-BMA, 1 x NAG-NAG-NAGBLAST0.61
7p7b.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with sybody no68 in a 1up/2down conformation
0.6799.250.94 12-1208EM0.00homo-trimerBLAST0.61
7f46.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab (state1, local refinement of the RBD, NTD and 35B5 Fab)
0.0299.250.94 12-1208EM0.00hetero-2-1-1-mer2 x NAGBLAST0.61
7f46.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab (state1, local refinement of the RBD, NTD and 35B5 Fab)
0.0199.250.94 12-1208EM0.00hetero-2-1-1-mer2 x NAGBLAST0.61
7e9o.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(3 up RBDs, state2)
0.6799.250.94 12-1208EM0.00hetero-3-3-3-mer27 x NAGBLAST0.61
7e9o.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(3 up RBDs, state2)
0.6799.250.94 12-1208EM0.00hetero-3-3-3-mer27 x NAGBLAST0.61
7e9q.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 out RBD, state3)
0.6599.250.94 12-1208EM0.00hetero-3-3-3-mer27 x NAGBLAST0.61
7eng.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30 (local refinement of the RBD and Fab30)
0.0399.250.94 12-1208EM0.00hetero-1-1-1-mer1 x NAG-NAGBLAST0.61
7e9q.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 out RBD, state3)
0.6399.250.94 12-1208EM0.00hetero-3-3-3-mer27 x NAGBLAST0.61
7enf.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30
0.7099.250.94 12-1208EM0.00hetero-3-1-1-mer27 x NAG, 13 x NAG-NAGBLAST0.61
7e9o.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(3 up RBDs, state2)
0.6799.250.94 12-1208EM0.00hetero-3-3-3-mer27 x NAGBLAST0.61
7enf.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30
0.7099.250.94 12-1208EM0.00hetero-3-1-1-mer27 x NAG, 13 x NAG-NAGBLAST0.61
7e9q.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 out RBD, state3)
0.6599.250.94 12-1208EM0.00hetero-3-3-3-mer27 x NAGBLAST0.61
7enf.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30
0.6899.250.94 12-1208EM0.00hetero-3-1-1-mer27 x NAG, 13 x NAG-NAGBLAST0.61
7six.1.B
Spike glycoprotein
Antibody N3-1 bound to RBDs in the up and down conformations
0.0099.250.94 12-1208EM0.00hetero-2-1-1-mer2 x NAG-NAGBLAST0.61
7six.1.A
Spike glycoprotein
Antibody N3-1 bound to RBDs in the up and down conformations
0.0099.250.94 12-1208EM0.00hetero-2-1-1-mer2 x NAG-NAGBLAST0.61
7sj0.1.A
Spike glycoprotein
Antibody A7V3 bound to N-terminal domain of the spike
0.0499.250.94 12-1208EM0.00hetero-1-1-1-mer5 x NAGBLAST0.61
7zce.1.B
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike protein in complex with the single chain fragment scFv76
0.6599.250.94 12-1208EM0.00hetero-3-3-mer27 x NAG, 12 x NAG-NAGBLAST0.61
7zce.1.C
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike protein in complex with the single chain fragment scFv76
0.6499.250.94 12-1208EM0.00hetero-3-3-mer27 x NAG, 12 x NAG-NAGBLAST0.61
7zce.1.A
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike protein in complex with the single chain fragment scFv76
0.6599.250.94 12-1208EM0.00hetero-3-3-mer27 x NAG, 12 x NAG-NAGBLAST0.61
7lx5.1.A
Spike glycoprotein
The SARS-CoV-2 spike protein receptor binding domain bound to neutralizing nanobodies WNb 2 and WNb 10
0.0399.250.94 12-1208EM0.00hetero-1-1-1-merBLAST0.61
7n9e.1.C
Spike glycoprotein
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB34
0.5299.250.94 12-1208EM0.00hetero-1-3-merBLAST0.61
7n9e.1.D
Spike glycoprotein
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB34
0.6299.250.94 12-1208EM0.00hetero-1-3-merBLAST0.61
7n9c.1.C
Spike glycoprotein
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB95
0.6499.250.94 12-1208EM0.00hetero-3-2-merBLAST0.61
7n9b.1.B
Spike glycoprotein
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB21
0.6899.250.94 12-1208EM0.00hetero-3-2-merBLAST0.61
7n9c.1.B
Spike glycoprotein
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB95
0.5399.250.94 12-1208EM0.00hetero-3-2-merBLAST0.61
7n9b.1.A
Spike glycoprotein
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB21
0.6899.250.94 12-1208EM0.00hetero-3-2-merBLAST0.61
7n9b.1.C
Spike glycoprotein
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB21
0.6999.250.94 12-1208EM0.00hetero-3-2-merBLAST0.61
7n9e.1.B
Spike glycoprotein
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB34
0.7099.250.94 12-1208EM0.00hetero-1-3-merBLAST0.61
7n9c.1.A
Spike glycoprotein
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB95
0.6699.250.94 12-1208EM0.00hetero-3-2-merBLAST0.61
7lwn.1.C
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation
0.6999.500.94 12-1208EM0.00homo-trimer27 x NAG, 5 x NAG-NAGBLAST0.62
7lwi.1.B
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6999.500.94 12-1208EM0.00homo-trimer30 x NAGBLAST0.62
7lwi.1.C
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6999.500.94 12-1208EM0.00homo-trimer30 x NAGBLAST0.62
7lwj.1.A
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6499.500.94 12-1208EM0.00homo-trimer30 x NAGBLAST0.62
7lwj.1.B
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6599.500.94 12-1208EM0.00homo-trimer30 x NAGBLAST0.62
7lwj.1.C
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6699.500.94 12-1208EM0.00homo-trimer30 x NAGBLAST0.62
7lwk.1.A
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6999.500.94 12-1208EM0.00homo-trimer30 x NAGBLAST0.62
7lwk.1.B
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6999.500.94 12-1208EM0.00homo-trimer30 x NAGBLAST0.62
7lwk.1.C
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6999.500.94 12-1208EM0.00homo-trimer30 x NAGBLAST0.62
7lwl.1.A
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6899.500.94 12-1208EM0.00homo-trimer30 x NAGBLAST0.62
7lwl.1.B
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.7099.500.94 12-1208EM0.00homo-trimer30 x NAGBLAST0.62
7lwl.1.C
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.7099.500.94 12-1208EM0.00homo-trimer30 x NAGBLAST0.62
7lwm.1.A
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation
0.7099.500.94 12-1208EM0.00homo-trimer31 x NAG, 3 x NAG-NAGBLAST0.62
7lwm.1.B
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation
0.6999.500.94 12-1208EM0.00homo-trimer31 x NAG, 3 x NAG-NAGBLAST0.62
7lwm.1.C
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation
0.7099.500.94 12-1208EM0.00homo-trimer31 x NAG, 3 x NAG-NAGBLAST0.62
7lwn.1.A
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation
0.7099.500.94 12-1208EM0.00homo-trimer27 x NAG, 5 x NAG-NAGBLAST0.62
7lwn.1.B
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation
0.6999.500.94 12-1208EM0.00homo-trimer27 x NAG, 5 x NAG-NAGBLAST0.62
7lwi.1.A
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
0.6999.500.94 12-1208EM0.00homo-trimer30 x NAGBLAST0.62
7lwo.1.A
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation
0.7099.500.94 12-1208EM0.00homo-trimer30 x NAG, 3 x NAG-NAGBLAST0.62
7lwo.1.B
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation
0.6999.500.94 12-1208EM0.00homo-trimer30 x NAG, 3 x NAG-NAGBLAST0.62
7lwp.1.A
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 2-RBD up conformation
0.6899.500.94 12-1208EM0.00homo-trimer31 x NAGBLAST0.62
7lwp.1.B
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 2-RBD up conformation
0.6899.500.94 12-1208EM0.00homo-trimer31 x NAGBLAST0.62
7lwp.1.C
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 2-RBD up conformation
0.6699.500.94 12-1208EM0.00homo-trimer31 x NAGBLAST0.62
7lwq.1.A
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein(S-GSAS-D614G-delFV) missing the S1 subunit and SD2 subdomain of one protomer
0.6699.500.94 12-1208EM0.00homo-trimer27 x NAG, 1 x NAG-NAGBLAST0.62
7lwq.1.C
Spike glycoprotein
Mink Cluster 5-associated SARS-CoV-2 spike protein(S-GSAS-D614G-delFV) missing the S1 subunit and SD2 subdomain of one protomer
0.6799.500.94 12-1208EM0.00homo-trimer27 x NAG, 1 x NAG-NAGBLAST0.62
7vrw.1.A
Spike glycoprotein
VAS5 Spike (3 RBD down)
0.6499.500.94 13-1213EM3.60homo-trimer29 x NAG, 14 x NAG-NAGHHblits0.62
7vrw.1.B
Spike glycoprotein
VAS5 Spike (3 RBD down)
0.6499.500.94 13-1213EM3.60homo-trimer29 x NAG, 14 x NAG-NAGHHblits0.62
7vrw.1.C
Spike glycoprotein
VAS5 Spike (3 RBD down)
0.6499.500.94 13-1213EM3.60homo-trimer29 x NAG, 14 x NAG-NAGHHblits0.62
7vrv.1.B
Spike glycoprotein
VAS5 Spike (1 RBD up)
0.6499.500.94 13-1213EM4.20homo-trimer31 x NAG, 13 x NAG-NAGHHblits0.62
7vrv.1.C
Spike glycoprotein
VAS5 Spike (1 RBD up)
0.6399.500.94 13-1213EM4.20homo-trimer31 x NAG, 13 x NAG-NAGHHblits0.62
7vrv.1.A
Spike glycoprotein
VAS5 Spike (1 RBD up)
0.6399.500.94 13-1213EM4.20homo-trimer31 x NAG, 13 x NAG-NAGHHblits0.62
7kj2.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound
0.6999.500.94 14-1208EM0.00hetero-3-1-mer36 x NAG, 17 x NAG-NAGHHblits0.61
7kj3.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound
0.6999.500.94 14-1208EM0.00hetero-3-2-mer40 x NAG, 20 x NAG-NAGHHblits0.61
7kj5.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein, prefusion with one RBD up conformation
0.6899.500.94 14-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.61
7kj2.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound
0.6899.500.94 14-1208EM0.00hetero-3-1-mer36 x NAG, 17 x NAG-NAGHHblits0.61
7kj5.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein, prefusion with one RBD up conformation
0.6899.500.94 14-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.61
7kj2.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound
0.6899.500.94 14-1208EM0.00hetero-3-1-mer36 x NAG, 17 x NAG-NAGHHblits0.61
7kj3.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound
0.6899.500.94 14-1208EM0.00hetero-3-2-mer40 x NAG, 20 x NAG-NAGHHblits0.61
7kj5.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein, prefusion with one RBD up conformation
0.6899.500.94 14-1208EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.61
7kj3.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound
0.6999.500.94 14-1208EM0.00hetero-3-2-mer40 x NAG, 20 x NAG-NAGHHblits0.61
7kj4.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound
0.6999.500.94 14-1208EM0.00hetero-3-3-mer42 x NAG, 24 x NAG-NAGHHblits0.61
7kj4.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound
0.6999.500.94 14-1208EM0.00hetero-3-3-mer42 x NAG, 24 x NAG-NAGHHblits0.61
7kj4.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound
0.6999.500.94 14-1208EM0.00hetero-3-3-mer42 x NAG, 24 x NAG-NAGHHblits0.61
6zoy.1.A
Spike glycoprotein
Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x1 disulphide-bond mutant, S383C, D985C, K986P, V987P, single Arg S1/S2 cleavage site) in Closed State
0.6999.660.94 14-1211EM0.00homo-trimer36 x NAG, 12 x NAG-NAGBLAST0.62
6zoz.1.A
Spike glycoprotein
Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x1 disulphide-bond mutant, S383C, D985C, K986P, V987P, single Arg S1/S2 cleavage site) in Locked State
0.6999.660.94 14-1211EM0.00homo-trimer39 x NAG, 3 x BLA, 12 x NAG-NAGBLAST0.62
7wuh.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with Fab of m31A7
0.5899.500.94 14-1208EM0.00hetero-3-3-3-mer19 x NAG, 2 x NAG-NAG-FUC, 8 x NAG-NAG, 2 x NAG-NAG-BMA-MAN, 4 x NAG-NAG-BMA, 3 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA-FUC, 1 x NAG-FUC, 1 x NAG-NAG-BMA-MAN-NAG-MAN, 1 x NAG-NAG-BMA-MAN-MAN-MANHHblits0.61
7wuh.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with Fab of m31A7
0.5799.500.94 14-1208EM0.00hetero-3-3-3-mer19 x NAG, 2 x NAG-NAG-FUC, 8 x NAG-NAG, 2 x NAG-NAG-BMA-MAN, 4 x NAG-NAG-BMA, 3 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA-FUC, 1 x NAG-FUC, 1 x NAG-NAG-BMA-MAN-NAG-MAN, 1 x NAG-NAG-BMA-MAN-MAN-MANHHblits0.61
7wuh.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with Fab of m31A7
0.5699.500.94 14-1208EM0.00hetero-3-3-3-mer19 x NAG, 2 x NAG-NAG-FUC, 8 x NAG-NAG, 2 x NAG-NAG-BMA-MAN, 4 x NAG-NAG-BMA, 3 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA-FUC, 1 x NAG-FUC, 1 x NAG-NAG-BMA-MAN-NAG-MAN, 1 x NAG-NAG-BMA-MAN-MAN-MANHHblits0.61
7r12.1.B
Spike glycoprotein
Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
0.0899.410.94 12-1208EM0.00hetero-1-1-mer1 x ZN, 6 x NAGBLAST0.61
7r19.1.A
Spike glycoprotein
Mink Variant SARS-CoV-2 Spike with 2 Erect RBDs
0.6899.410.94 12-1208EM0.00homo-trimer30 x NAG, 4 x NAG-NAGBLAST0.61
7r19.1.B
Spike glycoprotein
Mink Variant SARS-CoV-2 Spike with 2 Erect RBDs
0.6799.410.94 12-1208EM0.00homo-trimer30 x NAG, 4 x NAG-NAGBLAST0.61
7r19.1.C
Spike glycoprotein
Mink Variant SARS-CoV-2 Spike with 2 Erect RBDs
0.6999.410.94 12-1208EM0.00homo-trimer30 x NAG, 4 x NAG-NAGBLAST0.61
7r1b.1.A
Spike glycoprotein
Mink Variant SARS-CoV-2 Spike with 1 Erect RBD
0.6999.410.94 12-1208EM0.00homo-trimer26 x NAG, 8 x NAG-NAGBLAST0.61
7r1b.1.B
Spike glycoprotein
Mink Variant SARS-CoV-2 Spike with 1 Erect RBD
0.6999.410.94 12-1208EM0.00homo-trimer26 x NAG, 8 x NAG-NAGBLAST0.61
7r1b.1.C
Spike glycoprotein
Mink Variant SARS-CoV-2 Spike with 1 Erect RBD
0.7099.410.94 12-1208EM0.00homo-trimer26 x NAG, 8 x NAG-NAGBLAST0.61
6zoy.1.A
Spike glycoprotein
Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x1 disulphide-bond mutant, S383C, D985C, K986P, V987P, single Arg S1/S2 cleavage site) in Closed State
0.6899.580.94 14-1211EM0.00homo-trimer36 x NAG, 12 x NAG-NAGHHblits0.62
6zoy.1.B
Spike glycoprotein
Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x1 disulphide-bond mutant, S383C, D985C, K986P, V987P, single Arg S1/S2 cleavage site) in Closed State
0.6899.580.94 14-1211EM0.00homo-trimer36 x NAG, 12 x NAG-NAGHHblits0.62
6zoy.1.C
Spike glycoprotein
Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x1 disulphide-bond mutant, S383C, D985C, K986P, V987P, single Arg S1/S2 cleavage site) in Closed State
0.6899.580.94 14-1211EM0.00homo-trimer36 x NAG, 12 x NAG-NAGHHblits0.62
6zoz.1.A
Spike glycoprotein
Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x1 disulphide-bond mutant, S383C, D985C, K986P, V987P, single Arg S1/S2 cleavage site) in Locked State
0.6999.580.94 14-1211EM0.00homo-trimer39 x NAG, 3 x BLA, 12 x NAG-NAGHHblits0.62
6zoz.1.C
Spike glycoprotein
Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x1 disulphide-bond mutant, S383C, D985C, K986P, V987P, single Arg S1/S2 cleavage site) in Locked State
0.6999.580.94 14-1211EM0.00homo-trimer39 x NAG, 3 x BLA, 12 x NAG-NAGHHblits0.62
6zoz.1.B
Spike glycoprotein
Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x1 disulphide-bond mutant, S383C, D985C, K986P, V987P, single Arg S1/S2 cleavage site) in Locked State
0.6999.580.94 14-1211EM0.00homo-trimer39 x NAG, 3 x BLA, 12 x NAG-NAGHHblits0.62
7sxx.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.5799.160.94 12-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGBLAST0.61
7sxr.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain
0.7399.160.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7sxr.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain
0.7299.160.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7sxr.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain
0.7399.160.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7sxy.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.0499.160.94 12-1208EM0.00hetero-1-1-mer7 x NAGBLAST0.61
8dm0.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6)
0.0299.160.94 12-1208EM0.00hetero-1-1-mer1 x NAGBLAST0.61
7vxm.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state
0.6698.420.94 1-1206EM0.00hetero-3-1-merHHblits0.61
7vxk.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state
0.6798.420.94 1-1206EM0.00hetero-3-1-merHHblits0.61
7vxd.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state
0.6698.420.94 1-1206EM0.00hetero-3-1-merHHblits0.61
7vxf.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2B state
0.6698.420.94 1-1206EM0.00hetero-3-1-merHHblits0.61
7vxf.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2B state
0.6698.420.94 1-1206EM0.00hetero-3-1-merHHblits0.61
7vxm.1.D
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state
0.6698.420.94 1-1206EM0.00hetero-3-1-merHHblits0.61
7vxm.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state
0.6798.420.94 1-1206EM0.00hetero-3-1-merHHblits0.61
7wev.1.C
Spike glycoprotein
SARS-COV-2 BETA VARIANT SPIKE PROTEIN IN TRANSITION STATE
0.7098.420.94 1-1206EM3.60homo-trimerHHblits0.61
7wev.1.A
Spike glycoprotein
SARS-COV-2 BETA VARIANT SPIKE PROTEIN IN TRANSITION STATE
0.6498.420.94 1-1206EM3.60homo-trimerHHblits0.61
7wev.1.B
Spike glycoprotein
SARS-COV-2 BETA VARIANT SPIKE PROTEIN IN TRANSITION STATE
0.6898.420.94 1-1206EM3.60homo-trimerHHblits0.61
7wd9.1.C
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with three S3H3 Fabs
0.6598.420.94 1-1206EM0.00hetero-3-3-3-merHHblits0.61
7wd0.1.B
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with two S5D2 Fabs
0.6798.420.94 1-1206EM0.00hetero-3-2-2-merHHblits0.61
7wcr.1.A
Spike glycoprotein
RBD-1 of SARS-CoV-2 Beta spike in complex with S5D2 Fab
0.0198.420.94 1-1206EM0.00hetero-1-1-1-merHHblits0.61
7wdf.1.A
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with two S3H3 Fabs
0.6498.420.94 1-1206EM0.00hetero-3-2-2-merHHblits0.61
7wd7.1.A
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with three S5D2 Fabs
0.6898.420.94 1-1206EM0.00hetero-3-3-3-merHHblits0.61
7wd0.1.A
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with two S5D2 Fabs
0.7098.420.94 1-1206EM0.00hetero-3-2-2-merHHblits0.61
7wcz.1.A
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with one S5D2 Fab
0.7098.420.94 1-1206EM0.00hetero-3-1-1-merHHblits0.61
7wd7.1.D
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with three S5D2 Fabs
0.6698.420.94 1-1206EM0.00hetero-3-3-3-merHHblits0.61
7wdf.1.C
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with two S3H3 Fabs
0.6598.420.94 1-1206EM0.00hetero-3-2-2-merHHblits0.61
7wd9.1.B
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with three S3H3 Fabs
0.6498.420.94 1-1206EM0.00hetero-3-3-3-merHHblits0.61
7wd7.1.G
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with three S5D2 Fabs
0.6798.420.94 1-1206EM0.00hetero-3-3-3-merHHblits0.61
7wd8.1.D
Spike glycoprotein
SARS-CoV-2 Beta spike SD1 in complex with S3H3 Fab
0.0098.420.94 1-1206EM0.00hetero-2-1-1-merHHblits0.61
7wdf.1.B
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with two S3H3 Fabs
0.6498.420.94 1-1206EM0.00hetero-3-2-2-merHHblits0.61
7wcz.1.E
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with one S5D2 Fab
0.6598.420.94 1-1206EM0.00hetero-3-1-1-merHHblits0.61
7wcz.1.D
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with one S5D2 Fab
0.6598.420.94 1-1206EM0.00hetero-3-1-1-merHHblits0.61
7wd0.1.C
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with two S5D2 Fabs
0.6598.420.94 1-1206EM0.00hetero-3-2-2-merHHblits0.61
7wd8.1.A
Spike glycoprotein
SARS-CoV-2 Beta spike SD1 in complex with S3H3 Fab
0.0098.420.94 1-1206EM0.00hetero-2-1-1-merHHblits0.61
7wd9.1.A
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with three S3H3 Fabs
0.6598.420.94 1-1206EM0.00hetero-3-3-3-merHHblits0.61
7vxd.1.D
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state
0.6498.420.94 1-1206EM0.00hetero-3-1-merHHblits0.61
7vxk.1.D
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state
0.6898.420.94 1-1206EM0.00hetero-3-1-merHHblits0.61
7vxf.1.D
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2B state
0.6498.420.94 1-1206EM0.00hetero-3-1-merHHblits0.61
7vxd.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state
0.6498.420.94 1-1206EM0.00hetero-3-1-merHHblits0.61
7vxk.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state
0.6698.420.94 1-1206EM0.00hetero-3-1-merHHblits0.61
7vx1.1.C
Spike glycoprotein
SARS-CoV-2 Beta variant spike protein in open state
0.6598.420.94 1-1206EM0.00homo-trimerHHblits0.61
7vx4.1.B
Spike glycoprotein
ACE2-RBD in SARS-CoV-2 Beta variant S-ACE2 complex
0.0298.420.94 1-1206EM3.90hetero-1-1-mer1 x ZN, 5 x NAGHHblits0.61
7vx1.1.B
Spike glycoprotein
SARS-CoV-2 Beta variant spike protein in open state
0.6598.420.94 1-1206EM0.00homo-trimerHHblits0.61
7vx1.1.A
Spike glycoprotein
SARS-CoV-2 Beta variant spike protein in open state
0.6798.420.94 1-1206EM0.00homo-trimerHHblits0.61
6x6p.1.A
Spike glycoprotein
Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis
0.7099.580.94 15-1208EM0.00homo-trimer33 x NAG, 12 x NAG-NAGHHblits0.62
6x6p.1.B
Spike glycoprotein
Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis
0.7099.580.94 15-1208EM0.00homo-trimer33 x NAG, 12 x NAG-NAGHHblits0.62
6x6p.1.C
Spike glycoprotein
Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis
0.7099.580.94 15-1208EM0.00homo-trimer33 x NAG, 12 x NAG-NAGHHblits0.62
7mjg.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain
0.7399.160.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7mjg.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain
0.7399.160.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7mjg.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain
0.7299.160.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7mjh.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8
0.7399.160.94 12-1208EM0.00hetero-3-3-mer24 x NAG, 18 x NAG-NAGBLAST0.61
7mjh.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8
0.7399.160.94 12-1208EM0.00hetero-3-3-mer24 x NAG, 18 x NAG-NAGBLAST0.61
7mjh.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8
0.7399.160.94 12-1208EM0.00hetero-3-3-mer24 x NAG, 18 x NAG-NAGBLAST0.61
7mjj.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 1)
0.7399.160.94 12-1208EM0.00hetero-3-2-2-mer24 x NAG, 18 x NAG-NAGBLAST0.61
7mjk.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 2)
0.7399.160.94 12-1208EM0.00hetero-3-3-3-mer24 x NAG, 18 x NAG-NAGBLAST0.61
7mjm.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain
0.7299.160.94 12-1208EM0.00hetero-3-2-mer32 x NAG, 18 x NAG-NAGBLAST0.61
7mjm.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain
0.7399.160.94 12-1208EM0.00hetero-3-2-mer32 x NAG, 18 x NAG-NAGBLAST0.61
7cac.1.A
Spike glycoprotein
SARS-CoV-2 S trimer with one RBD in the open state and complexed with one H014 Fab.
0.6799.080.94 12-1208EM0.00hetero-3-1-1-mer30 x NAG, 15 x NAG-NAGBLAST0.61
7cac.1.B
Spike glycoprotein
SARS-CoV-2 S trimer with one RBD in the open state and complexed with one H014 Fab.
0.6899.080.94 12-1208EM0.00hetero-3-1-1-mer30 x NAG, 15 x NAG-NAGBLAST0.61
7l3n.1.A
Spike glycoprotein
SARS-CoV 2 Spike Protein bound to LY-CoV555
0.5599.250.94 13-1208EM0.00hetero-3-1-1-mer16 x NAG, 3 x NAG-NAGHHblits0.61
7l3n.1.B
Spike glycoprotein
SARS-CoV 2 Spike Protein bound to LY-CoV555
0.6999.250.94 13-1208EM0.00hetero-3-1-1-mer16 x NAG, 3 x NAG-NAGHHblits0.61
7l3n.1.C
Spike glycoprotein
SARS-CoV 2 Spike Protein bound to LY-CoV555
0.6999.250.94 13-1208EM0.00hetero-3-1-1-mer16 x NAG, 3 x NAG-NAGHHblits0.61
7ru1.1.B
Spike glycoprotein
SARS-CoV-2-6P-Mut7 S protein (C3 symmetry)
0.7199.080.94 12-1208EM2.80homo-trimer30 x NAG, 12 x NAG-NAGBLAST0.61
7s6l.1.E
Spike glycoprotein
J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (conformation 3)
0.6799.080.94 12-1208EM0.00hetero-3-1-1-mer16 x NAG, 7 x NAG-NAGBLAST0.61
7s6l.1.A
Spike glycoprotein
J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (conformation 3)
0.6899.080.94 12-1208EM0.00hetero-3-1-1-mer16 x NAG, 7 x NAG-NAGBLAST0.61
7s6l.1.D
Spike glycoprotein
J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (conformation 3)
0.6899.080.94 12-1208EM0.00hetero-3-1-1-mer16 x NAG, 7 x NAG-NAGBLAST0.61
7ru5.1.A
Spike glycoprotein
CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement)
0.6899.080.94 12-1208EM0.00hetero-3-2-2-mer20 x NAG, 10 x NAG-NAGBLAST0.61
7ru8.1.C
Spike glycoprotein
CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement)
0.0299.080.94 12-1208EM0.00hetero-1-1-1-mer1 x NAG, 1 x NAG-NAGBLAST0.61
7ru3.1.C
Spike glycoprotein
CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement)
0.7199.080.94 12-1208EM0.00hetero-2-2-3-mer29 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-FUCBLAST0.61
7ru5.1.B
Spike glycoprotein
CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement)
0.7099.080.94 12-1208EM0.00hetero-3-2-2-mer20 x NAG, 10 x NAG-NAGBLAST0.61
7ru5.1.C
Spike glycoprotein
CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement)
0.7099.080.94 12-1208EM0.00hetero-3-2-2-mer20 x NAG, 10 x NAG-NAGBLAST0.61
7ru4.1.C
Spike glycoprotein
CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement)
0.0399.080.94 12-1208EM0.00hetero-1-1-1-mer1 x NAG, 1 x NAG-NAG-FUCBLAST0.61
7ru3.1.E
Spike glycoprotein
CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement)
0.7199.080.94 12-1208EM0.00hetero-2-2-3-mer29 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-FUCBLAST0.61
7ru3.1.D
Spike glycoprotein
CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement)
0.7199.080.94 12-1208EM0.00hetero-2-2-3-mer29 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-FUCBLAST0.61
8d0z.1.B
Spike glycoprotein
S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (focused refinement)
0.6999.080.94 12-1208EM0.00hetero-3-1-1-mer11 x NAGBLAST0.61
8d0z.1.C
Spike glycoprotein
S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (focused refinement)
0.5599.080.94 12-1208EM0.00hetero-3-1-1-mer11 x NAGBLAST0.61
8d0z.1.A
Spike glycoprotein
S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (focused refinement)
0.5599.080.94 12-1208EM0.00hetero-3-1-1-mer11 x NAGBLAST0.61
7vxc.1.A
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in C3 state
0.6899.080.94 12-1208EM3.90hetero-3-1-merBLAST0.61
7vxi.1.B
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in transition state
0.6899.080.94 12-1208EM0.00homo-trimerBLAST0.61
7vxi.1.C
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in transition state
0.6999.080.94 12-1208EM0.00homo-trimerBLAST0.61
7vxc.1.D
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in C3 state
0.6999.080.94 12-1208EM3.90hetero-3-1-merBLAST0.61
7vxe.1.B
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in open state
0.6999.080.94 12-1208EM0.00homo-trimerBLAST0.61
7vxb.1.C
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in C2b state
0.6899.080.94 12-1208EM3.90hetero-3-1-merBLAST0.61
7vxb.1.D
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in C2b state
0.6899.080.94 12-1208EM3.90hetero-3-1-merBLAST0.61
7vxc.1.C
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in C3 state
0.6899.080.94 12-1208EM3.90hetero-3-1-merBLAST0.61
7vxi.1.A
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in transition state
0.6899.080.94 12-1208EM0.00homo-trimerBLAST0.61
7vxe.1.C
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in open state
0.6999.080.94 12-1208EM0.00homo-trimerBLAST0.61
7vx5.1.B
Spike glycoprotein
ACE2-RBD in SARS-CoV-2 Kappa variant S-ACE2 complex
0.0299.080.94 12-1208EM0.00hetero-1-1-mer1 x ZN, 5 x NAGBLAST0.61
7vxa.1.C
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a
0.6899.080.94 12-1208EM0.00hetero-3-1-merBLAST0.61
7vxa.1.D
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a
0.6899.080.94 12-1208EM0.00hetero-3-1-merBLAST0.61
7sxz.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.5799.080.94 12-1208EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGBLAST0.61
7sxs.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain
0.7399.080.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7sxs.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain
0.7299.080.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7sxs.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain
0.7399.080.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7sy0.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.0499.080.94 12-1208EM0.00hetero-1-1-mer7 x NAGBLAST0.61
8aqs.1.A
Spike glycoprotein,Fibritin
BA.4/5 SARS-CoV-2 Spike bound to human ACE2 (local)
0.0196.780.95 1-1212EM0.00hetero-1-1-mer6 x NAG, 1 x ZNHHblits0.60
7tlc.1.A
Spike glycoprotein
Down-state locked, S2 stabilized rS2d-HexaPro SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 1
0.7099.080.94 12-1208EM0.00homo-trimerBLAST0.61
7tlc.1.B
Spike glycoprotein
Down-state locked, S2 stabilized rS2d-HexaPro SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 1
0.6999.080.94 12-1208EM0.00homo-trimerBLAST0.61
7tlc.1.C
Spike glycoprotein
Down-state locked, S2 stabilized rS2d-HexaPro SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 1
0.7099.080.94 12-1208EM0.00homo-trimerBLAST0.61
7tld.1.A
Spike glycoprotein
Down-state locked, S2 stabilized rS2d-HexaPro SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 2
0.6999.080.94 12-1208EM0.00homo-trimerBLAST0.61
7tld.1.B
Spike glycoprotein
Down-state locked, S2 stabilized rS2d-HexaPro SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 2
0.6999.080.94 12-1208EM0.00homo-trimerBLAST0.61
7tld.1.C
Spike glycoprotein
Down-state locked, S2 stabilized rS2d-HexaPro SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 2
0.6999.080.94 12-1208EM0.00homo-trimerBLAST0.61
7s6i.1.A
Spike glycoprotein
SARS-CoV-2-6P-Mut2 S protein
0.7099.080.94 12-1208EM0.00homo-trimer30 x NAG, 18 x NAG-NAGBLAST0.61
7s6j.1.A
Spike glycoprotein
J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut2 S protein (conformation 1)
0.6999.080.94 12-1208EM0.00hetero-3-3-3-mer15 x NAG, 9 x NAG-NAGBLAST0.61
7s6k.1.A
Spike glycoprotein
J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut2 S protein (conformation 2)
0.6999.080.94 12-1208EM0.00hetero-3-3-3-mer21 x NAG, 12 x NAG-NAGBLAST0.61
7r40.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 87G7 antibody Fab fragment
0.6999.330.94 14-1208EM0.00hetero-3-3-3-mer27 x NAG, 12 x NAG-NAGHHblits0.61
7r40.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 87G7 antibody Fab fragment
0.6999.330.94 14-1208EM0.00hetero-3-3-3-mer27 x NAG, 12 x NAG-NAGHHblits0.61
7r40.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 87G7 antibody Fab fragment
0.6999.330.94 14-1208EM0.00hetero-3-3-3-mer27 x NAG, 12 x NAG-NAGHHblits0.61
7sy1.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.5799.080.94 12-1208EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGBLAST0.61
7sxt.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain
0.7399.080.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7sxt.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain
0.7299.080.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7sxt.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain
0.7399.080.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7sy2.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.0499.080.94 12-1208EM0.00hetero-1-1-mer7 x NAGBLAST0.61
7v7i.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 2
0.6999.000.94 12-1208EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMABLAST0.61
7v7d.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), all RBD-down conformation
0.6999.000.94 12-1208EM0.00homo-trimer14 x NAG, 34 x NAG-NAGBLAST0.61
7v7d.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), all RBD-down conformation
0.6999.000.94 12-1208EM0.00homo-trimer14 x NAG, 34 x NAG-NAGBLAST0.61
7v7e.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), one RBD-up conformation 1
0.6999.000.94 12-1208EM0.00homo-trimer14 x NAG, 34 x NAG-NAGBLAST0.61
7v7e.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), one RBD-up conformation 1
0.6999.000.94 12-1208EM0.00homo-trimer14 x NAG, 34 x NAG-NAGBLAST0.61
7v7f.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), one RBD-up conformation 2
0.7099.000.94 12-1208EM0.00homo-trimer12 x NAG, 36 x NAG-NAGBLAST0.61
7v7f.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), one RBD-up conformation 2
0.7099.000.94 12-1208EM0.00homo-trimer12 x NAG, 36 x NAG-NAGBLAST0.61
7v7f.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), one RBD-up conformation 2
0.7099.000.94 12-1208EM0.00homo-trimer12 x NAG, 36 x NAG-NAGBLAST0.61
7v7g.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), two RBD-up conformation
0.6999.000.94 12-1208EM0.00homo-trimer15 x NAG, 33 x NAG-NAGBLAST0.61
7v7g.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), two RBD-up conformation
0.6999.000.94 12-1208EM0.00homo-trimer15 x NAG, 33 x NAG-NAGBLAST0.61
7v7h.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 1
0.6999.000.94 12-1208EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMABLAST0.61
7v7h.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 1
0.6999.000.94 12-1208EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMABLAST0.61
7v7h.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 1
0.6999.000.94 12-1208EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMABLAST0.61
7v7i.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 2
0.6999.000.94 12-1208EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMABLAST0.61
7v7d.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), all RBD-down conformation
0.6999.000.94 12-1208EM0.00homo-trimer14 x NAG, 34 x NAG-NAGBLAST0.61
7v7i.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 2
0.6999.000.94 12-1208EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMABLAST0.61
7v7j.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 3
0.6999.000.94 12-1208EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMABLAST0.61
7v7j.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 3
0.6899.000.94 12-1208EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMABLAST0.61
7v7j.1.D
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 3
0.6899.000.94 12-1208EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMABLAST0.61
7v7j.1.F
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 3
0.6999.000.94 12-1208EM0.00homo-hexamer24 x NAG, 66 x NAG-NAG, 6 x NAG-NAG-BMABLAST0.61
7v85.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6899.000.94 12-1208EM0.00hetero-3-2-mer13 x NAG, 31 x NAG-NAGBLAST0.61
7v85.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6899.000.94 12-1208EM0.00hetero-3-2-mer13 x NAG, 31 x NAG-NAGBLAST0.61
7v86.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
0.6999.000.94 12-1208EM0.00hetero-3-3-mer13 x NAG, 37 x NAG-NAGBLAST0.61
7v86.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
0.6999.000.94 12-1208EM0.00hetero-3-3-mer13 x NAG, 37 x NAG-NAGBLAST0.61
7v86.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
0.7099.000.94 12-1208EM0.00hetero-3-3-mer13 x NAG, 37 x NAG-NAGBLAST0.61
7lym.1.A
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the RBD-down conformation
0.6999.000.94 12-1208EM0.00homo-trimer33 x NAGBLAST0.61
7lym.1.B
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the RBD-down conformation
0.6999.000.94 12-1208EM0.00homo-trimer33 x NAGBLAST0.61
7lym.1.C
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the RBD-down conformation
0.6999.000.94 12-1208EM0.00homo-trimer33 x NAGBLAST0.61
7lyk.1.B
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 2-RBD-up conformation
0.6899.000.94 12-1208EM0.00homo-trimer25 x NAGBLAST0.61
7lyp.1.B
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6899.000.94 12-1208EM0.00homo-trimer28 x NAGBLAST0.61
7lyo.1.C
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.7099.000.94 12-1208EM0.00homo-trimer40 x NAGBLAST0.61
7lyk.1.C
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 2-RBD-up conformation
0.6899.000.94 12-1208EM0.00homo-trimer25 x NAGBLAST0.61
7lyn.1.B
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6899.000.94 12-1208EM0.00homo-trimer38 x NAGBLAST0.61
7lyk.1.A
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 2-RBD-up conformation
0.6899.000.94 12-1208EM0.00homo-trimer25 x NAGBLAST0.61
7lyn.1.A
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6999.000.94 12-1208EM0.00homo-trimer38 x NAGBLAST0.61
7lyq.1.A
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6999.000.94 12-1208EM0.00homo-trimer38 x NAGBLAST0.61
7lyq.1.C
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6899.000.94 12-1208EM0.00homo-trimer38 x NAGBLAST0.61
7lyo.1.B
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6899.000.94 12-1208EM0.00homo-trimer40 x NAGBLAST0.61
7lyp.1.A
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6699.000.94 12-1208EM0.00homo-trimer28 x NAGBLAST0.61
7lyp.1.C
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6799.000.94 12-1208EM0.00homo-trimer28 x NAGBLAST0.61
7lyq.1.B
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.6799.000.94 12-1208EM0.00homo-trimer38 x NAGBLAST0.61
7lyo.1.A
Spike glycoprotein
South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation
0.7099.000.94 12-1208EM0.00homo-trimer40 x NAGBLAST0.61
7sy3.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.5799.000.94 12-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGBLAST0.61
7sxu.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain
0.7399.000.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7sxu.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain
0.7299.000.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7sxu.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain
0.7399.000.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7sy4.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.0499.000.94 12-1208EM0.00hetero-1-1-mer7 x NAGBLAST0.61
7q6e.1.A
Spike glycoprotein
Beta049 fab in complex with SARS-CoV2 beta-Spike glycoprotein, The Beta mAb response underscores the antigenic distance to other SARS-CoV-2 variants
0.7098.420.94 1-1205EM0.00hetero-3-3-3-mer26 x NAG, 2 x NAG-NAG-BMA-MAN-MAN-MAN-FUC, 14 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUCHHblits0.61
7q9j.1.A
Spike glycoprotein
Beta-26 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7198.420.94 1-1205EM0.00hetero-3-3-3-mer31 x NAG, 13 x NAG-NAGHHblits0.61
7q9j.1.B
Spike glycoprotein
Beta-26 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7198.420.94 1-1205EM0.00hetero-3-3-3-mer31 x NAG, 13 x NAG-NAGHHblits0.61
7q9j.1.C
Spike glycoprotein
Beta-26 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7198.420.94 1-1205EM0.00hetero-3-3-3-mer31 x NAG, 13 x NAG-NAGHHblits0.61
7q6e.1.B
Spike glycoprotein
Beta049 fab in complex with SARS-CoV2 beta-Spike glycoprotein, The Beta mAb response underscores the antigenic distance to other SARS-CoV-2 variants
0.7098.420.94 1-1205EM0.00hetero-3-3-3-mer26 x NAG, 2 x NAG-NAG-BMA-MAN-MAN-MAN-FUC, 14 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUCHHblits0.61
7q6e.1.C
Spike glycoprotein
Beta049 fab in complex with SARS-CoV2 beta-Spike glycoprotein, The Beta mAb response underscores the antigenic distance to other SARS-CoV-2 variants
0.7098.420.94 1-1205EM0.00hetero-3-3-3-mer26 x NAG, 2 x NAG-NAG-BMA-MAN-MAN-MAN-FUC, 14 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUCHHblits0.61
7q9p.1.A
Spike glycoprotein
Beta-06 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7098.420.94 1-1205EM0.00hetero-3-3-3-mer28 x NAG, 12 x NAG-NAGHHblits0.61
7q9p.1.B
Spike glycoprotein
Beta-06 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7198.420.94 1-1205EM0.00hetero-3-3-3-mer28 x NAG, 12 x NAG-NAGHHblits0.61
7q9p.1.C
Spike glycoprotein
Beta-06 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7098.420.94 1-1205EM0.00hetero-3-3-3-mer28 x NAG, 12 x NAG-NAGHHblits0.61
7lrt.1.G
SARS-CoV-2 spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain
0.6799.250.94 14-1208EM0.00hetero-3-3-3-mer27 x NAG, 4 x NAG-NAG-BMA, 15 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MANHHblits0.61
7lrt.1.H
SARS-CoV-2 spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain
0.6799.250.94 14-1208EM0.00hetero-3-3-3-mer27 x NAG, 4 x NAG-NAG-BMA, 15 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MANHHblits0.61
7lrt.1.I
SARS-CoV-2 spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain
0.6799.250.94 14-1208EM0.00hetero-3-3-3-mer27 x NAG, 4 x NAG-NAG-BMA, 15 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MANHHblits0.61
7mm0.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain
0.6499.250.94 14-1208EM0.00hetero-1-1-3-mer27 x NAG, 13 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7mm0.1.D
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain
0.6499.250.94 14-1208EM0.00hetero-1-1-3-mer27 x NAG, 13 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7mm0.1.E
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain
0.6099.250.94 14-1208EM0.00hetero-1-1-3-mer27 x NAG, 13 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
8f0h.1.B
Spike glycoprotein
Structure of SARS-CoV-2 spike with antibody Fabs 2A10 and 1H2 (Local refinement of the RBD and Fabs 1H2 and 2A10)
0.0399.250.94 14-1208EM0.00hetero-1-1-1-1-1-merHHblits0.61
7rbv.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with PVI.V6-14 Fab
0.6099.250.94 14-1208EM0.00hetero-2-2-3-mer18 x NAG, 15 x NAG-NAG, 6 x NAG-NAG-BMA-MAN-MAN, 6 x NAG-NAG-BMA-MAN, 3 x NAG-NAG-BMAHHblits0.61
7rbv.1.F
Spike glycoprotein
SARS-CoV-2 Spike in complex with PVI.V6-14 Fab
0.6099.250.94 14-1208EM0.00hetero-2-2-3-mer18 x NAG, 15 x NAG-NAG, 6 x NAG-NAG-BMA-MAN-MAN, 6 x NAG-NAG-BMA-MAN, 3 x NAG-NAG-BMAHHblits0.61
7rbv.1.G
Spike glycoprotein
SARS-CoV-2 Spike in complex with PVI.V6-14 Fab
0.5999.250.94 14-1208EM0.00hetero-2-2-3-mer18 x NAG, 15 x NAG-NAG, 6 x NAG-NAG-BMA-MAN-MAN, 6 x NAG-NAG-BMA-MAN, 3 x NAG-NAG-BMAHHblits0.61
7u9o.1.A
Spike glycoprotein
SARS-CoV-2 spike trimer RBD in complex with Fab NE12
0.0899.250.94 14-1208EM0.00hetero-2-1-1-mer3 x NAGHHblits0.61
7u9o.1.B
Spike glycoprotein
SARS-CoV-2 spike trimer RBD in complex with Fab NE12
0.0299.250.94 14-1208EM0.00hetero-2-1-1-mer3 x NAGHHblits0.61
7u9p.1.A
Spike glycoprotein
SARS-CoV-2 spike trimer RBD in complex with Fab NA8
0.0899.250.94 14-1208EM0.00hetero-2-1-1-mer4 x NAGHHblits0.61
7u9p.1.B
Spike glycoprotein
SARS-CoV-2 spike trimer RBD in complex with Fab NA8
0.0499.250.94 14-1208EM0.00hetero-2-1-1-mer4 x NAGHHblits0.61
7tyz.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with FSR22, an anti-SARS-CoV-2 DARPin
0.6499.250.94 14-1208EM0.00hetero-3-3-mer18 x NAG, 3 x NAG-NAG-BMA-MAN, 9 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7tyz.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with FSR22, an anti-SARS-CoV-2 DARPin
0.6499.250.94 14-1208EM0.00hetero-3-3-mer18 x NAG, 3 x NAG-NAG-BMA-MAN, 9 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7tyz.1.E
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with FSR22, an anti-SARS-CoV-2 DARPin
0.6499.250.94 14-1208EM0.00hetero-3-3-mer18 x NAG, 3 x NAG-NAG-BMA-MAN, 9 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.61
7tz0.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with FSR22, an anti-SARS-CoV-2 DARPin (Local refinement of FSR22 and RBD)
0.0099.250.94 14-1208EM0.00hetero-1-1-merHHblits0.61
8f0h.1.B
Spike glycoprotein
Structure of SARS-CoV-2 spike with antibody Fabs 2A10 and 1H2 (Local refinement of the RBD and Fabs 1H2 and 2A10)
0.0399.250.94 14-1208EM0.00hetero-1-1-1-1-1-merBLAST0.61
7kmb.1.B
Spike glycoprotein
ACE2-RBD Focused Refinement Using Symmetry Expansion of Applied C3 for Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 7.4
0.0199.580.94 16-1208EM0.00hetero-1-1-mer5 x NAG, 2 x NAG-NAGHHblits0.62
7sy6.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.0498.910.94 12-1208EM0.00hetero-1-1-mer7 x NAGBLAST0.61
7sxv.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain
0.7398.910.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7sxv.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain
0.7298.910.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7sxv.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain
0.7398.910.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7sy7.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.5798.910.94 12-1208EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGBLAST0.61
7sy7.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement)
0.7298.910.94 12-1208EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGBLAST0.61
7sy8.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2)
0.0498.910.94 12-1208EM0.00hetero-1-1-mer7 x NAGBLAST0.61
7sxw.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain
0.7398.910.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7sxw.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain
0.7298.910.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
7n8h.1.A
Spike glycoprotein
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement
0.7199.000.94 12-1208EM0.00hetero-3-3-3-3-3-mer39 x NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAGBLAST0.61
7cab.1.A
Spike glycoprotein
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
0.7198.830.94 12-1208EM0.00homo-trimer30 x NAG, 15 x NAG-NAGBLAST0.61
8fez.1.A
Spike glycoprotein
Prefusion-stabilized SARS-CoV-2 spike protein
0.5698.830.94 12-1208EM0.00homo-trimerBLAST0.61
8fez.1.B
Spike glycoprotein
Prefusion-stabilized SARS-CoV-2 spike protein
0.6398.830.94 12-1208EM0.00homo-trimerBLAST0.61
8fez.1.C
Spike glycoprotein
Prefusion-stabilized SARS-CoV-2 spike protein
0.6298.830.94 12-1208EM0.00homo-trimerBLAST0.61
7v8c.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), Cleavable form, one RBD-up conformation
0.6999.250.94 12-1208EM0.00homo-trimer17 x NAG, 29 x NAG-NAGBLAST0.61
7v8c.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), Cleavable form, one RBD-up conformation
0.6999.250.94 12-1208EM0.00homo-trimer17 x NAG, 29 x NAG-NAGBLAST0.61
7v8c.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), Cleavable form, one RBD-up conformation
0.6899.250.94 12-1208EM0.00homo-trimer17 x NAG, 29 x NAG-NAGBLAST0.61
8dlw.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with Fab S2M11
0.7398.910.94 12-1208EM0.00hetero-3-3-3-mer30 x NAG, 18 x NAG-NAG, 3 x NAG-NAG-BMA-FUCBLAST0.61
8dlt.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein
0.7398.910.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
8dlt.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein
0.7398.910.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
8dlu.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2
0.7398.910.94 12-1208EM0.00hetero-3-2-mer36 x NAG, 18 x NAG-NAGBLAST0.61
8dlu.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2
0.7498.910.94 12-1208EM0.00hetero-3-2-mer36 x NAG, 18 x NAG-NAGBLAST0.61
8dlt.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein
0.7398.910.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
8dlx.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6
0.7298.910.94 12-1208EM0.00hetero-3-1-mer23 x NAG, 18 x NAG-NAGBLAST0.61
8dlx.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6
0.7298.910.94 12-1208EM0.00hetero-3-1-mer23 x NAG, 18 x NAG-NAGBLAST0.61
6zgf.1.A
Spike glycoprotein
Spike Protein of RaTG13 Bat Coronavirus in Closed Conformation
0.7396.530.95 12-1225EM0.00homo-trimer27 x NAG, 21 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-BMA, 3 x NAG-FUCBLAST0.60
7r10.1.B
Spike glycoprotein
Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2
0.3799.330.94 12-1208EM0.00hetero-1-1-mer1 x ZN, 7 x NAGBLAST0.61
7tf5.1.D
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein
0.7398.750.94 12-1208EM0.00homo-hexamer48 x NAG, 36 x NAG-NAGBLAST0.61
7tf5.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein
0.7398.750.94 12-1208EM0.00homo-hexamer48 x NAG, 36 x NAG-NAGBLAST0.61
7tez.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.0398.750.94 12-1208EM0.00hetero-1-1-mer7 x NAGBLAST0.61
7tf4.1.F
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein (focused refinement of RBD)
0.0898.750.94 12-1208EM0.00homo-hexamer12 x NAGBLAST0.61
7tf4.1.E
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein (focused refinement of RBD)
0.0998.750.94 12-1208EM0.00homo-hexamer12 x NAGBLAST0.61
7tf4.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein (focused refinement of RBD)
0.0898.750.94 12-1208EM0.00homo-hexamer12 x NAGBLAST0.61
7tf0.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2
0.5998.750.94 12-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGBLAST0.61
7r0z.1.B
Spike glycoprotein
Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
0.0799.250.94 12-1208EM0.00hetero-1-1-mer1 x ZN, 8 x NAGBLAST0.61
7tf3.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484A spike protein
0.5898.750.94 12-1208EM0.00homo-trimer20 x NAG, 18 x NAG-NAGBLAST0.61
7tf3.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484A spike protein
0.5898.750.94 12-1208EM0.00homo-trimer20 x NAG, 18 x NAG-NAGBLAST0.61
7od3.1.A
Spike glycoprotein
SARS CoV-2 Spike protein, Bristol UK Deletion variant, Closed conformation, C3 symmetry
0.7199.920.93 12-1208EM0.00homo-trimer3 x EIC, 33 x NAGBLAST0.62
6x29.1.A
Spike glycoprotein
SARS-CoV-2 rS2d Down State Spike Protein Trimer
0.7099.410.94 16-1208EM0.00homo-trimerHHblits0.61
6x29.1.B
Spike glycoprotein
SARS-CoV-2 rS2d Down State Spike Protein Trimer
0.6999.410.94 16-1208EM0.00homo-trimerHHblits0.61
6x29.1.C
Spike glycoprotein
SARS-CoV-2 rS2d Down State Spike Protein Trimer
0.7099.410.94 16-1208EM0.00homo-trimerHHblits0.61
7tf1.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein (focused refinement of RBD)
0.0898.750.94 12-1208EM0.00homo-hexamer12 x NAGBLAST0.61
7tf1.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein (focused refinement of RBD)
0.0998.750.94 12-1208EM0.00homo-hexamer12 x NAGBLAST0.61
7tf1.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein (focused refinement of RBD)
0.0898.750.94 12-1208EM0.00homo-hexamer12 x NAGBLAST0.61
7tf1.1.F
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein (focused refinement of RBD)
0.0898.750.94 12-1208EM0.00homo-hexamer12 x NAGBLAST0.61
7tov.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; consensus state D2
0.7099.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tou.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; consensus state D1
0.6999.080.94 12-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGBLAST0.61
7tou.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; consensus state D1
0.6899.080.94 12-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGBLAST0.61
7tov.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; consensus state D2
0.7099.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tov.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; consensus state D2
0.6399.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tou.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; consensus state D1
0.7099.080.94 12-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGBLAST0.61
7tox.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D5 state
0.6999.080.94 12-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGBLAST0.61
7tox.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D5 state
0.6999.080.94 12-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGBLAST0.61
7tox.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D5 state
0.6999.080.94 12-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGBLAST0.61
7toy.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D6 state
0.6999.080.94 12-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGBLAST0.61
7toy.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D6 state
0.6899.080.94 12-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGBLAST0.61
7toz.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D7 state
0.6299.080.94 12-1208EM0.00homo-trimer32 x NAG, 14 x NAG-NAGBLAST0.61
7toz.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D7 state
0.6499.080.94 12-1208EM0.00homo-trimer32 x NAG, 14 x NAG-NAGBLAST0.61
7toz.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D7 state
0.6399.080.94 12-1208EM0.00homo-trimer32 x NAG, 14 x NAG-NAGBLAST0.61
7tp0.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D8 state
0.6899.080.94 12-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGBLAST0.61
7tp0.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D8 state
0.6999.080.94 12-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGBLAST0.61
7tp0.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D8 state
0.6999.080.94 12-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGBLAST0.61
7tp1.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D9 state
0.6899.080.94 12-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGBLAST0.61
7tp1.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D9 state
0.6799.080.94 12-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGBLAST0.61
7tp1.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D9 state
0.6899.080.94 12-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGBLAST0.61
7tp2.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D10 state
0.6899.080.94 12-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGBLAST0.61
7tp2.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D10 state
0.6899.080.94 12-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGBLAST0.61
7tp2.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D10 state
0.6999.080.94 12-1208EM0.00homo-trimer33 x NAG, 14 x NAG-NAGBLAST0.61
7tp7.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D11 state
0.6999.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tp7.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D11 state
0.6499.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tp7.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D11 state
0.6999.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tp8.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D12 state
0.7099.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tp8.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D12 state
0.6599.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tp9.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D13 state
0.6499.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tpa.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D14 state
0.7099.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tpa.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D14 state
0.6399.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tpa.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D14 state
0.6999.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tpc.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D15 state
0.6599.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tpc.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D15 state
0.5999.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tpc.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D15 state
0.6499.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tpe.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D16 state
0.6899.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tpe.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D16 state
0.6299.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tpe.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D16 state
0.6599.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tpf.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Subclassification D17 state
0.6399.080.94 12-1208EM0.00homo-trimer34 x NAG, 12 x NAG-NAGBLAST0.61
7tph.1.A
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 2-RBD-up conformation - D3
0.6699.080.94 12-1208EM0.00homo-trimer36 x NAG, 8 x NAG-NAGBLAST0.61
7tph.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 2-RBD-up conformation - D3
0.6799.080.94 12-1208EM0.00homo-trimer36 x NAG, 8 x NAG-NAGBLAST0.61
7tph.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 2-RBD-up conformation - D3
0.7099.080.94 12-1208EM0.00homo-trimer36 x NAG, 8 x NAG-NAGBLAST0.61
7tpl.1.B
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the M1 conformation, D4
0.6499.080.94 12-1208EM0.00homo-trimer22 x NAG, 12 x NAG-NAGBLAST0.61
7tpl.1.C
Spike glycoprotein
Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the M1 conformation, D4
0.6399.080.94 12-1208EM0.00homo-trimer22 x NAG, 12 x NAG-NAGBLAST0.61
7r1a.1.A
Spike glycoprotein
Furin Cleaved Alpha Variant SARS-CoV-2 Spike in complex with 3 ACE2
0.6899.250.94 12-1208EM0.00hetero-3-3-mer48 x NAG, 3 x ZN, 3 x NAG-NAGBLAST0.61
7ws3.1.A
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7098.750.94 12-1208EM0.00hetero-3-3-3-mer24 x NAG, 15 x NAG-NAGBLAST0.61
7ws3.1.B
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7098.750.94 12-1208EM0.00hetero-3-3-3-mer24 x NAG, 15 x NAG-NAGBLAST0.61
7ws3.1.C
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7098.750.94 12-1208EM0.00hetero-3-3-3-mer24 x NAG, 15 x NAG-NAGBLAST0.61
7sob.1.A
Spike glycoprotein
SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement
0.7398.660.94 12-1208EM0.00hetero-3-3-3-3-3-mer51 x NAGBLAST0.61
7soe.1.A
Spike glycoprotein
SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement
0.7398.660.94 12-1208EM0.00hetero-3-3-3-mer51 x NAG, 3 x NAG-NAGBLAST0.61
7r13.1.A
Spike glycoprotein
Alpha Variant SARS-CoV-2 Spike in Closed conformation
0.6999.160.94 12-1208EM0.00homo-trimer39 x NAG, 9 x NAG-NAGBLAST0.61
7r14.1.A
Spike glycoprotein
Alpha Variant SARS-CoV-2 Spike with 1 Erect RBD
0.6799.160.94 12-1208EM0.00homo-trimer33 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-FUCBLAST0.61
7r14.1.B
Spike glycoprotein
Alpha Variant SARS-CoV-2 Spike with 1 Erect RBD
0.7099.160.94 12-1208EM0.00homo-trimer33 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-FUCBLAST0.61
7r14.1.C
Spike glycoprotein
Alpha Variant SARS-CoV-2 Spike with 1 Erect RBD
0.6999.160.94 12-1208EM0.00homo-trimer33 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-FUCBLAST0.61
7r15.1.A
Spike glycoprotein
Alpha Variant SARS-CoV-2 Spike with 2 Erect RBDs
0.6499.160.94 12-1208EM0.00homo-trimer37 x NAG, 3 x NAG-NAGBLAST0.61
7r15.1.B
Spike glycoprotein
Alpha Variant SARS-CoV-2 Spike with 2 Erect RBDs
0.6699.160.94 12-1208EM0.00homo-trimer37 x NAG, 3 x NAG-NAGBLAST0.61
7r15.1.C
Spike glycoprotein
Alpha Variant SARS-CoV-2 Spike with 2 Erect RBDs
0.6799.160.94 12-1208EM0.00homo-trimer37 x NAG, 3 x NAG-NAGBLAST0.61
7v78.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), one RBD-up conformation 1
0.6998.660.94 12-1208EM0.00homo-trimer19 x NAG, 34 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7v78.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), one RBD-up conformation 1
0.6998.660.94 12-1208EM0.00homo-trimer19 x NAG, 34 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7v78.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), one RBD-up conformation 1
0.6998.660.94 12-1208EM0.00homo-trimer19 x NAG, 34 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7v79.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), one RBD-up conformation 2
0.7098.660.94 12-1208EM0.00homo-trimer20 x NAG, 33 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7v79.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), one RBD-up conformation 2
0.6998.660.94 12-1208EM0.00homo-trimer20 x NAG, 33 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7v7a.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), two RBD-up conformation
0.6898.660.94 12-1208EM0.00homo-trimer21 x NAG, 1 x NAG-NAG-BMA, 31 x NAG-NAGBLAST0.61
7v81.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6998.660.94 12-1208EM0.00hetero-3-2-mer19 x NAG, 30 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7v81.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6898.660.94 12-1208EM0.00hetero-3-2-mer19 x NAG, 30 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7v81.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6898.660.94 12-1208EM0.00hetero-3-2-mer19 x NAG, 30 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7v82.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
0.6998.660.94 12-1208EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGBLAST0.61
7v82.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
0.6998.660.94 12-1208EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGBLAST0.61
7v82.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
0.6998.660.94 12-1208EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGBLAST0.61
7v83.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
0.7098.660.94 12-1208EM0.00hetero-3-3-mer29 x NAG, 30 x NAG-NAGBLAST0.61
7v83.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
0.7098.660.94 12-1208EM0.00hetero-3-3-mer29 x NAG, 30 x NAG-NAGBLAST0.61
7m8k.1.A
Spike glycoprotein
Cryo-EM structure of Brazil (P.1) SARS-CoV-2 spike glycoprotein variant in the prefusion state (1 RBD up)
0.6998.660.94 12-1208EM0.00homo-trimer29 x NAG, 11 x NAG-NAGBLAST0.61
7m8k.1.B
Spike glycoprotein
Cryo-EM structure of Brazil (P.1) SARS-CoV-2 spike glycoprotein variant in the prefusion state (1 RBD up)
0.6598.660.94 12-1208EM0.00homo-trimer29 x NAG, 11 x NAG-NAGBLAST0.61
7m8k.1.C
Spike glycoprotein
Cryo-EM structure of Brazil (P.1) SARS-CoV-2 spike glycoprotein variant in the prefusion state (1 RBD up)
0.7098.660.94 12-1208EM0.00homo-trimer29 x NAG, 11 x NAG-NAGBLAST0.61
7w98.1.D
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C1
0.6999.000.94 12-1206EM0.00hetero-3-1-merBLAST0.61
7w92.1.B
Spike glycoprotein
Open state of SARS-CoV-2 Delta variant spike protein
0.6699.000.94 12-1206EM0.00homo-trimerBLAST0.61
7w92.1.C
Spike glycoprotein
Open state of SARS-CoV-2 Delta variant spike protein
0.6799.000.94 12-1206EM0.00homo-trimerBLAST0.61
7w94.1.A
Spike glycoprotein
Transition state of SARS-CoV-2 Delta variant spike protein
0.6599.000.94 12-1206EM0.00homo-trimerBLAST0.61
7w94.1.B
Spike glycoprotein
Transition state of SARS-CoV-2 Delta variant spike protein
0.6599.000.94 12-1206EM0.00homo-trimerBLAST0.61
7w94.1.C
Spike glycoprotein
Transition state of SARS-CoV-2 Delta variant spike protein
0.6699.000.94 12-1206EM0.00homo-trimerBLAST0.61
7w98.1.A
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C1
0.6899.000.94 12-1206EM0.00hetero-3-1-merBLAST0.61
7w98.1.B
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C1
0.6899.000.94 12-1206EM0.00hetero-3-1-merBLAST0.61
7w92.1.A
Spike glycoprotein
Open state of SARS-CoV-2 Delta variant spike protein
0.6699.000.94 12-1206EM0.00homo-trimerBLAST0.61
7w99.1.A
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C2a
0.6999.000.94 12-1206EM0.00hetero-3-1-merBLAST0.61
7w99.1.B
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C2a
0.6999.000.94 12-1206EM0.00hetero-3-1-merBLAST0.61
7w9b.1.A
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C2b
0.6899.000.94 12-1206EM0.00hetero-3-1-merBLAST0.61
7w9b.1.B
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C2b
0.6999.000.94 12-1206EM0.00hetero-3-1-merBLAST0.61
7w9c.1.A
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C3
0.6999.000.94 12-1206EM0.00hetero-3-1-merBLAST0.61
7w9c.1.B
Spike glycoprotein
SARS-CoV-2 Delta S-ACE2-C3
0.6999.000.94 12-1206EM0.00hetero-3-1-merBLAST0.61
7w9e.1.A
Spike glycoprotein
SARS-CoV-2 Delta S-8D3
0.7099.000.94 12-1206EM0.00hetero-3-1-1-merBLAST0.61
7w9e.1.B
Spike glycoprotein
SARS-CoV-2 Delta S-8D3
0.6999.000.94 12-1206EM0.00hetero-3-1-1-merBLAST0.61
7w9e.1.C
Spike glycoprotein
SARS-CoV-2 Delta S-8D3
0.6999.000.94 12-1206EM0.00hetero-3-1-1-merBLAST0.61
8dli.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein
0.7298.660.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
8dli.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein
0.7298.660.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
8dli.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein
0.7298.660.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
8dlj.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2
0.7298.660.94 12-1208EM0.00hetero-3-1-mer28 x NAG, 18 x NAG-NAGBLAST0.61
7m0j.1.A
Spike glycoprotein
SARS-CoV-2 u1S2q All Down RBD State Spike Protein Trimer - asymmetric refinement
0.6899.250.94 16-1208EM0.00homo-trimerHHblits0.61
6x2c.1.B
Spike glycoprotein
SARS-CoV-2 u1S2q All Down RBD State Spike Protein Trimer
0.6999.250.94 16-1208EM0.00homo-trimerHHblits0.61
6x2c.1.A
Spike glycoprotein
SARS-CoV-2 u1S2q All Down RBD State Spike Protein Trimer
0.6999.250.94 16-1208EM0.00homo-trimerHHblits0.61
6x2c.1.C
Spike glycoprotein
SARS-CoV-2 u1S2q All Down RBD State Spike Protein Trimer
0.6999.250.94 16-1208EM0.00homo-trimerHHblits0.61
7m0j.1.C
Spike glycoprotein
SARS-CoV-2 u1S2q All Down RBD State Spike Protein Trimer - asymmetric refinement
0.6999.250.94 16-1208EM0.00homo-trimerHHblits0.61
7m0j.1.B
Spike glycoprotein
SARS-CoV-2 u1S2q All Down RBD State Spike Protein Trimer - asymmetric refinement
0.6999.250.94 16-1208EM0.00homo-trimerHHblits0.61
6x2a.1.A
Spike glycoprotein
SARS-CoV-2 u1S2q 1-RBD Up Spike Protein Trimer
0.6999.250.94 16-1208EM0.00homo-trimerHHblits0.61
6x2b.1.A
Spike glycoprotein
SARS-CoV-2 u1S2q 2-RBD Up Spike Protein Trimer
0.6899.250.94 16-1208EM0.00homo-trimerHHblits0.61
6x2b.1.B
Spike glycoprotein
SARS-CoV-2 u1S2q 2-RBD Up Spike Protein Trimer
0.6899.250.94 16-1208EM0.00homo-trimerHHblits0.61
6x2a.1.B
Spike glycoprotein
SARS-CoV-2 u1S2q 1-RBD Up Spike Protein Trimer
0.6999.250.94 16-1208EM0.00homo-trimerHHblits0.61
6x2b.1.C
Spike glycoprotein
SARS-CoV-2 u1S2q 2-RBD Up Spike Protein Trimer
0.6899.250.94 16-1208EM0.00homo-trimerHHblits0.61
6x2a.1.C
Spike glycoprotein
SARS-CoV-2 u1S2q 1-RBD Up Spike Protein Trimer
0.6999.250.94 16-1208EM0.00homo-trimerHHblits0.61
7lws.1.A
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 S-GSAS-D614G variant spike protein in the 3-RBD-down conformation
0.7099.160.94 12-1208EM0.00homo-trimer27 x NAG, 18 x NAG-NAGBLAST0.61
7lws.1.B
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 S-GSAS-D614G variant spike protein in the 3-RBD-down conformation
0.6999.160.94 12-1208EM0.00homo-trimer27 x NAG, 18 x NAG-NAGBLAST0.61
7lws.1.C
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 S-GSAS-D614G variant spike protein in the 3-RBD-down conformation
0.6999.160.94 12-1208EM0.00homo-trimer27 x NAG, 18 x NAG-NAGBLAST0.61
7lwt.1.B
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation
0.6999.160.94 12-1208EM0.00homo-trimer30 x NAG, 9 x NAG-NAGBLAST0.61
7lwv.1.C
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation
0.6999.160.94 12-1208EM0.00homo-trimer34 x NAGBLAST0.61
7lwv.1.A
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation
0.7099.160.94 12-1208EM0.00homo-trimer34 x NAGBLAST0.61
7lwu.1.A
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation
0.7099.160.94 12-1208EM0.00homo-trimer35 x NAGBLAST0.61
7lwt.1.A
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation
0.7099.160.94 12-1208EM0.00homo-trimer30 x NAG, 9 x NAG-NAGBLAST0.61
7lwt.1.C
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation
0.7099.160.94 12-1208EM0.00homo-trimer30 x NAG, 9 x NAG-NAGBLAST0.61
7lwu.1.C
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation
0.6999.160.94 12-1208EM0.00homo-trimer35 x NAGBLAST0.61
7lwv.1.B
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation
0.6999.160.94 12-1208EM0.00homo-trimer34 x NAGBLAST0.61
7lwu.1.B
Spike glycoprotein
UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation
0.6999.160.94 12-1208EM0.00homo-trimer35 x NAGBLAST0.61
7v7n.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), all RBD-down conformation
0.7098.910.94 12-1208EM0.00homo-trimer12 x NAG, 1 x NAG-NAG-BMA, 35 x NAG-NAGBLAST0.61
7v7n.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), all RBD-down conformation
0.6998.910.94 12-1208EM0.00homo-trimer12 x NAG, 1 x NAG-NAG-BMA, 35 x NAG-NAGBLAST0.61
7v7o.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 1
0.7098.910.94 12-1208EM0.00homo-trimer13 x NAG, 35 x NAG-NAGBLAST0.61
7v7o.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 1
0.7098.910.94 12-1208EM0.00homo-trimer13 x NAG, 35 x NAG-NAGBLAST0.61
7v7p.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 2
0.7098.910.94 12-1208EM0.00homo-trimer12 x NAG, 36 x NAG-NAGBLAST0.61
7v7p.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 2
0.7098.910.94 12-1208EM0.00homo-trimer12 x NAG, 36 x NAG-NAGBLAST0.61
7v7r.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 4
0.6998.910.94 12-1208EM0.00homo-trimer12 x NAG, 36 x NAG-NAGBLAST0.61
7v7r.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 4
0.7098.910.94 12-1208EM0.00homo-trimer12 x NAG, 36 x NAG-NAGBLAST0.61
7v7r.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 4
0.6998.910.94 12-1208EM0.00homo-trimer12 x NAG, 36 x NAG-NAGBLAST0.61
7v7s.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 5
0.6998.910.94 12-1208EM0.00homo-trimer15 x NAG, 33 x NAG-NAGBLAST0.61
7v7s.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 5
0.6998.910.94 12-1208EM0.00homo-trimer15 x NAG, 33 x NAG-NAGBLAST0.61
7v7t.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 1
0.7098.910.94 12-1208EM0.00homo-trimer13 x NAG, 35 x NAG-NAGBLAST0.61
7v7t.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 1
0.6998.910.94 12-1208EM0.00homo-trimer13 x NAG, 35 x NAG-NAGBLAST0.61
7v7u.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 2
0.7098.910.94 12-1208EM0.00homo-trimer13 x NAG, 35 x NAG-NAGBLAST0.61
7v7v.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 3
0.7098.910.94 12-1208EM0.00homo-trimer12 x NAG, 36 x NAG-NAGBLAST0.61
7v88.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6998.910.94 12-1208EM0.00hetero-3-2-mer15 x NAG, 37 x NAG-NAGBLAST0.61
7v88.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form
0.6998.910.94 12-1208EM0.00hetero-3-2-mer15 x NAG, 37 x NAG-NAGBLAST0.61
7v89.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
0.7098.910.94 12-1208EM0.00hetero-3-3-mer14 x NAG, 43 x NAG-NAGBLAST0.61
7v89.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1
0.7098.910.94 12-1208EM0.00hetero-3-3-mer14 x NAG, 43 x NAG-NAGBLAST0.61
7v8a.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
0.7098.910.94 12-1208EM0.00hetero-3-3-mer16 x NAG, 38 x NAG-NAGBLAST0.61
7v8a.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2
0.7098.910.94 12-1208EM0.00hetero-3-3-mer16 x NAG, 38 x NAG-NAGBLAST0.61
7v8b.1.A
Spike glycoprotein
Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.0298.910.94 12-1208EM0.00hetero-1-1-mer3 x NAG, 1 x NAG-NAG-BMA, 4 x NAG-NAGBLAST0.61
8aqv.1.B
Spike glycoprotein,Fibritin
BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
0.0096.690.95 1-1212EM0.00hetero-1-1-mer1 x NAG, 1 x NAG-NAGHHblits0.60
7r11.1.B
Spike glycoprotein
Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
0.0698.910.94 12-1208EM0.00hetero-1-1-mer7 x NAG, 1 x ZNBLAST0.61
7r16.1.A
Spike glycoprotein
Beta Variant SARS-CoV-2 Spike with 1 Erect RBD
0.6998.910.94 12-1208EM0.00homo-trimer28 x NAG, 6 x NAG-NAGBLAST0.61
7r16.1.B
Spike glycoprotein
Beta Variant SARS-CoV-2 Spike with 1 Erect RBD
0.6998.910.94 12-1208EM0.00homo-trimer28 x NAG, 6 x NAG-NAGBLAST0.61
7r16.1.C
Spike glycoprotein
Beta Variant SARS-CoV-2 Spike with 1 Erect RBD
0.7098.910.94 12-1208EM0.00homo-trimer28 x NAG, 6 x NAG-NAGBLAST0.61
7r17.1.A
Spike glycoprotein
Beta Variant SARS-CoV-2 Spike with 2 Erect RBDs
0.6898.910.94 12-1208EM0.00homo-trimer20 x NAG, 1 x NAG-NAGBLAST0.61
7r17.1.B
Spike glycoprotein
Beta Variant SARS-CoV-2 Spike with 2 Erect RBDs
0.6898.910.94 12-1208EM0.00homo-trimer20 x NAG, 1 x NAG-NAGBLAST0.61
7r17.1.C
Spike glycoprotein
Beta Variant SARS-CoV-2 Spike with 2 Erect RBDs
0.7098.910.94 12-1208EM0.00homo-trimer20 x NAG, 1 x NAG-NAGBLAST0.61
8dlm.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2
0.5798.500.94 12-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGBLAST0.61
8dll.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein
0.7198.500.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
8di5.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with VH domain F6 (focused refinement of RBD and VH F6)
0.0398.500.94 12-1208EM0.00hetero-1-1-mer1 x NAGBLAST0.61
8dll.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein
0.7198.500.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
8dll.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein
0.7198.500.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
8dln.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.0498.500.94 12-1208EM0.00hetero-1-1-mer7 x NAGBLAST0.61
8aqt.1.B
Spike glycoprotein,Fibritin
Beta SARS-CoV-2 Spike bound to mouse ACE2 (local)
0.0198.910.94 12-1208EM0.00hetero-1-1-mer1 x NAG, 1 x NAG-NAGBLAST0.61
7ub0.1.B
Spike glycoprotein
SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2)
0.7197.260.95 1-1208EM0.00homo-trimer30 x NAG, 10 x NAG-NAGHHblits0.61
7ub5.1.C
Spike glycoprotein
SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2)
0.7097.260.95 1-1208EM0.00homo-trimer27 x NAG, 10 x NAG-NAGHHblits0.61
7ub0.1.A
Spike glycoprotein
SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2)
0.7197.260.95 1-1208EM0.00homo-trimer30 x NAG, 10 x NAG-NAGHHblits0.61
7ub0.1.C
Spike glycoprotein
SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2)
0.7097.260.95 1-1208EM0.00homo-trimer30 x NAG, 10 x NAG-NAGHHblits0.61
7ub5.1.A
Spike glycoprotein
SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2)
0.7197.260.95 1-1208EM0.00homo-trimer27 x NAG, 10 x NAG-NAGHHblits0.61
7ub5.1.B
Spike glycoprotein
SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2)
0.7097.260.95 1-1208EM0.00homo-trimer27 x NAG, 10 x NAG-NAGHHblits0.61
7ub6.1.A
Spike glycoprotein
SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2)
0.7197.260.95 1-1208EM0.00homo-trimer28 x NAG, 4 x NAG-NAGHHblits0.61
7ub6.1.B
Spike glycoprotein
SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2)
0.7197.260.95 1-1208EM0.00homo-trimer28 x NAG, 4 x NAG-NAGHHblits0.61
7ub6.1.C
Spike glycoprotein
SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2)
0.7097.260.95 1-1208EM0.00homo-trimer28 x NAG, 4 x NAG-NAGHHblits0.61
7v76.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), uncleavable form, one RBD-up conformation
0.7098.830.94 12-1208EM0.00homo-trimer15 x NAG, 31 x NAG-NAGBLAST0.61
7v76.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), uncleavable form, one RBD-up conformation
0.6998.830.94 12-1208EM0.00homo-trimer15 x NAG, 31 x NAG-NAGBLAST0.61
7v76.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), uncleavable form, one RBD-up conformation
0.7098.830.94 12-1208EM0.00homo-trimer15 x NAG, 31 x NAG-NAGBLAST0.61
7v77.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), uncleavable form, two RBD-up conformation
0.7098.830.94 12-1208EM0.00homo-trimer17 x NAG, 30 x NAG-NAGBLAST0.61
7v77.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), uncleavable form, two RBD-up conformation
0.6998.830.94 12-1208EM0.00homo-trimer17 x NAG, 30 x NAG-NAGBLAST0.61
7v77.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), uncleavable form, two RBD-up conformation
0.7098.830.94 12-1208EM0.00homo-trimer17 x NAG, 30 x NAG-NAGBLAST0.61
7v7z.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
0.6998.830.94 12-1208EM0.00hetero-3-3-mer17 x NAG, 31 x NAG-NAGBLAST0.61
7v7z.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
0.6898.830.94 12-1208EM0.00hetero-3-3-mer17 x NAG, 31 x NAG-NAGBLAST0.61
7v7z.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form
0.6898.830.94 12-1208EM0.00hetero-3-3-mer17 x NAG, 31 x NAG-NAGBLAST0.61
7v80.1.A
Spike glycoprotein
Local refinement of SARS-CoV-2 S-Beta variant (B.1.351) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.0198.830.94 12-1208EM0.00hetero-1-1-mer5 x NAG, 3 x NAG-NAGBLAST0.61
7q9k.1.A
Spike glycoprotein
Beta-32 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.6798.830.94 12-1208EM0.00hetero-3-2-2-mer30 x NAG, 15 x NAG-NAGBLAST0.61
7q9f.1.A
Spike glycoprotein
Beta-50 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7198.830.94 12-1208EM0.00hetero-3-3-3-mer25 x NAG, 1 x NAG-NAG-FUC, 14 x NAG-NAG, 2 x NAG-NAG-BMA-FUCBLAST0.61
7q9f.1.B
Spike glycoprotein
Beta-50 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7198.830.94 12-1208EM0.00hetero-3-3-3-mer25 x NAG, 1 x NAG-NAG-FUC, 14 x NAG-NAG, 2 x NAG-NAG-BMA-FUCBLAST0.61
7q9f.1.C
Spike glycoprotein
Beta-50 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7298.830.94 12-1208EM0.00hetero-3-3-3-mer25 x NAG, 1 x NAG-NAG-FUC, 14 x NAG-NAG, 2 x NAG-NAG-BMA-FUCBLAST0.61
7q9g.1.A
Spike glycoprotein
COVOX-222 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7298.830.94 12-1208EM0.00hetero-3-2-2-mer28 x NAG, 12 x NAG-NAGBLAST0.61
7q9g.1.B
Spike glycoprotein
COVOX-222 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7298.830.94 12-1208EM0.00hetero-3-2-2-mer28 x NAG, 12 x NAG-NAGBLAST0.61
7q9g.1.C
Spike glycoprotein
COVOX-222 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7298.830.94 12-1208EM0.00hetero-3-2-2-mer28 x NAG, 12 x NAG-NAGBLAST0.61
7q9i.1.A
Spike glycoprotein
Beta-43 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7298.830.94 12-1208EM0.00hetero-3-3-3-mer29 x NAG, 12 x NAG-NAGBLAST0.61
7q9i.1.B
Spike glycoprotein
Beta-43 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7298.830.94 12-1208EM0.00hetero-3-3-3-mer29 x NAG, 12 x NAG-NAGBLAST0.61
7q9m.1.A
Spike glycoprotein
Beta-53 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7198.830.94 12-1208EM0.00hetero-3-3-3-mer15 x NAG, 2 x NAG-NAG-BMA, 11 x NAG-NAGBLAST0.61
7q9m.1.B
Spike glycoprotein
Beta-53 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7198.830.94 12-1208EM0.00hetero-3-3-3-mer15 x NAG, 2 x NAG-NAG-BMA, 11 x NAG-NAGBLAST0.61
7q9m.1.C
Spike glycoprotein
Beta-53 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7298.830.94 12-1208EM0.00hetero-3-3-3-mer15 x NAG, 2 x NAG-NAG-BMA, 11 x NAG-NAGBLAST0.61
7zr7.1.C
Spike glycoprotein,Fibritin
OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
0.7298.830.94 12-1208EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.61
7zrc.1.B
Spike glycoprotein,Fibritin
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE
0.7298.830.94 12-1208EM0.00hetero-3-3-3-mer28 x NAG, 12 x NAG-NAGBLAST0.61
7zr9.1.A
Spike glycoprotein,Fibritin
OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
0.7198.830.94 12-1208EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.61
7zr9.1.C
Spike glycoprotein,Fibritin
OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
0.7298.830.94 12-1208EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.61
7zr8.1.A
Spike glycoprotein,Fibritin
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement)
0.0598.830.94 12-1208EM0.00hetero-1-1-1-mer1 x NAGBLAST0.61
7zr9.1.B
Spike glycoprotein,Fibritin
OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
0.7198.830.94 12-1208EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.61
7zrc.1.A
Spike glycoprotein,Fibritin
OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE
0.7398.830.94 12-1208EM0.00hetero-3-3-3-mer28 x NAG, 12 x NAG-NAGBLAST0.61
7zr7.1.B
Spike glycoprotein,Fibritin
OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
0.7298.830.94 12-1208EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.61
7t5o.1.A
Spike glycoprotein
VFLIP Spike Trimer with GAR03
0.1798.250.94 14-1220EM0.00hetero-3-1-1-merHHblits0.61
7t5o.1.B
Spike glycoprotein
VFLIP Spike Trimer with GAR03
0.5398.250.94 14-1220EM0.00hetero-3-1-1-merHHblits0.61
7t5o.1.C
Spike glycoprotein
VFLIP Spike Trimer with GAR03
0.5598.250.94 14-1220EM0.00hetero-3-1-1-merHHblits0.61
7so9.1.A
Spike glycoprotein
SARS-CoV-2 S B.1.617.2 delta variant + S2M11 + S2L20 Global Refinement
0.7398.740.94 12-1208EM0.00hetero-3-3-3-3-3-mer45 x NAG, 3 x NAG-FUCBLAST0.61
8dlp.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2
0.7398.250.94 12-1208EM0.00hetero-3-3-mer42 x NAG, 18 x NAG-NAGBLAST0.61
8dlo.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein
0.7098.250.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
8dlo.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein
0.7198.250.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
8dlo.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein
0.7198.250.94 12-1208EM0.00homo-trimer24 x NAG, 18 x NAG-NAGBLAST0.61
8dlp.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2
0.7398.250.94 12-1208EM0.00hetero-3-3-mer42 x NAG, 18 x NAG-NAGBLAST0.61
8dlp.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2
0.7398.250.94 12-1208EM0.00hetero-3-3-mer42 x NAG, 18 x NAG-NAGBLAST0.61
8dlr.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4-8 (focused refinement of NTD and 4-8)
0.1098.250.94 12-1208EM0.00hetero-1-1-1-mer6 x NAGBLAST0.61
8dls.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4A8 (focused refinement of NTD and 4A8)
0.0898.250.94 12-1208EM0.00hetero-1-1-1-mer5 x NAG, 1 x NAG-NAGBLAST0.61
8hhx.1.A
Spike glycoprotein
SARS-CoV-2 Delta Spike in complex with FP-12A
0.5198.910.94 14-1208EM0.00hetero-3-2-2-mer21 x NAG, 7 x NAG-NAGBLAST0.61
8hhx.1.B
Spike glycoprotein
SARS-CoV-2 Delta Spike in complex with FP-12A
0.6198.910.94 14-1208EM0.00hetero-3-2-2-mer21 x NAG, 7 x NAG-NAGBLAST0.61
8hhx.1.C
Spike glycoprotein
SARS-CoV-2 Delta Spike in complex with FP-12A
0.5798.910.94 14-1208EM0.00hetero-3-2-2-mer21 x NAG, 7 x NAG-NAGBLAST0.61
8hhy.1.G
Spike glycoprotein
SARS-CoV-2 Delta Spike in complex with IS-9A
0.6098.910.94 14-1208EM0.00hetero-3-3-3-mer24 x NAG, 4 x NAG-NAGBLAST0.61
8hhy.1.H
Spike glycoprotein
SARS-CoV-2 Delta Spike in complex with IS-9A
0.5898.910.94 14-1208EM0.00hetero-3-3-3-mer24 x NAG, 4 x NAG-NAGBLAST0.61
8hhy.1.I
Spike glycoprotein
SARS-CoV-2 Delta Spike in complex with IS-9A
0.5698.910.94 14-1208EM0.00hetero-3-3-3-mer24 x NAG, 4 x NAG-NAGBLAST0.61
7wch.1.B
Surface glycoprotein
CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWA9 Fab
0.7198.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.61
7wch.1.A
Surface glycoprotein
CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWA9 Fab
0.7098.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.61
7wch.1.E
Surface glycoprotein
CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWA9 Fab
0.7298.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.61
7wcp.1.B
Surface glycoprotein
CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWC11 Fab
0.7298.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.61
7wcp.1.C
Surface glycoprotein
CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWC11 Fab
0.7098.580.94 12-1208EM0.00hetero-3-3-3-merBLAST0.61
7t5o.1.A
Spike glycoprotein
VFLIP Spike Trimer with GAR03
0.1798.580.94 14-1216EM0.00hetero-3-1-1-merBLAST0.61
7t5o.1.B
Spike glycoprotein
VFLIP Spike Trimer with GAR03
0.5398.580.94 14-1216EM0.00hetero-3-1-1-merBLAST0.61
7t5o.1.C
Spike glycoprotein
VFLIP Spike Trimer with GAR03
0.5598.580.94 14-1216EM0.00hetero-3-1-1-merBLAST0.61
7ey5.1.A
Spike glycoprotein
Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-771 Fab and BD-821 Fab
0.0298.580.94 12-1208EM0.00hetero-1-1-1-1-1-merBLAST0.61
7eya.1.A
Spike glycoprotein
Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-804 Fab
0.0198.580.94 12-1208EM0.00hetero-1-1-1-1-merBLAST0.61
7ezv.1.A
Spike glycoprotein
local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-812 Fab and BD-836 Fab
0.0298.580.94 12-1208EM0.00hetero-1-1-1-1-1-merBLAST0.61
7v22.1.A
Spike glycoprotein
Local CryoEM structure del68-76/del679-688 prefusion-stabilized spike
0.0799.410.93 1-1208EM0.00monomerHHblits0.61
7v23.1.B
Spike glycoprotein
CryoEM structure of del68-76/del679-688 prefusion-stabilized spike in complex with the Fab of N12-9
0.7199.410.93 1-1208EM0.00hetero-3-3-3-mer28 x NAG, 10 x NAG-NAGHHblits0.61
7v20.1.B
Spike glycoprotein
CryoEM structure of del68-76/del679-688 prefusion-stabilized spike
0.7099.410.93 1-1208EM0.00homo-trimer28 x NAG, 9 x NAG-NAGHHblits0.61
7v20.1.C
Spike glycoprotein
CryoEM structure of del68-76/del679-688 prefusion-stabilized spike
0.7099.410.93 1-1208EM0.00homo-trimer28 x NAG, 9 x NAG-NAGHHblits0.61
7v20.1.A
Spike glycoprotein
CryoEM structure of del68-76/del679-688 prefusion-stabilized spike
0.6999.410.93 1-1208EM0.00homo-trimer28 x NAG, 9 x NAG-NAGHHblits0.61
7v23.1.A
Spike glycoprotein
CryoEM structure of del68-76/del679-688 prefusion-stabilized spike in complex with the Fab of N12-9
0.6999.410.93 1-1208EM0.00hetero-3-3-3-mer28 x NAG, 10 x NAG-NAGHHblits0.61
7v24.1.C
Spike glycoprotein
Local CryoEM structure of del68-76/del679-688 prefusion-stabilized spike in complex with the Fab of N12-9
0.0899.410.93 1-1208EM0.00hetero-1-1-1-merHHblits0.61
7v23.1.C
Spike glycoprotein
CryoEM structure of del68-76/del679-688 prefusion-stabilized spike in complex with the Fab of N12-9
0.7199.410.93 1-1208EM0.00hetero-3-3-3-mer28 x NAG, 10 x NAG-NAGHHblits0.61
7cn4.1.A
Spike glycoprotein
Cryo-EM structure of bat RaTG13 spike glycoprotein
0.6797.500.94 12-1213EM0.00homo-trimer36 x NAG, 9 x NAG-NAGBLAST0.61
7vxm.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state
0.6698.830.94 12-1206EM0.00hetero-3-1-merBLAST0.61
7vxm.1.D
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state
0.6798.830.94 12-1206EM0.00hetero-3-1-merBLAST0.61
7vxm.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state
0.6898.830.94 12-1206EM0.00hetero-3-1-merBLAST0.61
7wev.1.C
Spike glycoprotein
SARS-COV-2 BETA VARIANT SPIKE PROTEIN IN TRANSITION STATE
0.7098.830.94 12-1206EM3.60homo-trimerBLAST0.61
7wev.1.A
Spike glycoprotein
SARS-COV-2 BETA VARIANT SPIKE PROTEIN IN TRANSITION STATE
0.6498.830.94 12-1206EM3.60homo-trimerBLAST0.61
7wev.1.B
Spike glycoprotein
SARS-COV-2 BETA VARIANT SPIKE PROTEIN IN TRANSITION STATE
0.6998.830.94 12-1206EM3.60homo-trimerBLAST0.61
7wd9.1.C
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with three S3H3 Fabs
0.6698.830.94 12-1206EM0.00hetero-3-3-3-merBLAST0.61
7wd0.1.B
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with two S5D2 Fabs
0.6798.830.94 12-1206EM0.00hetero-3-2-2-merBLAST0.61
7wcr.1.A
Spike glycoprotein
RBD-1 of SARS-CoV-2 Beta spike in complex with S5D2 Fab
0.0198.830.94 12-1206EM0.00hetero-1-1-1-merBLAST0.61
7wdf.1.A
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with two S3H3 Fabs
0.6598.830.94 12-1206EM0.00hetero-3-2-2-merBLAST0.61
7wd7.1.A
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with three S5D2 Fabs
0.6998.830.94 12-1206EM0.00hetero-3-3-3-merBLAST0.61
7wd7.1.D
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with three S5D2 Fabs
0.6798.830.94 12-1206EM0.00hetero-3-3-3-merBLAST0.61
7wdf.1.C
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with two S3H3 Fabs
0.6598.830.94 12-1206EM0.00hetero-3-2-2-merBLAST0.61
7wd9.1.B
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with three S3H3 Fabs
0.6598.830.94 12-1206EM0.00hetero-3-3-3-merBLAST0.61
7wd7.1.G
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with three S5D2 Fabs
0.6798.830.94 12-1206EM0.00hetero-3-3-3-merBLAST0.61
7wd8.1.D
Spike glycoprotein
SARS-CoV-2 Beta spike SD1 in complex with S3H3 Fab
0.0098.830.94 12-1206EM0.00hetero-2-1-1-merBLAST0.61
7wdf.1.B
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with two S3H3 Fabs
0.6598.830.94 12-1206EM0.00hetero-3-2-2-merBLAST0.61
7wcz.1.E
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with one S5D2 Fab
0.6698.830.94 12-1206EM0.00hetero-3-1-1-merBLAST0.61
7wd8.1.A
Spike glycoprotein
SARS-CoV-2 Beta spike SD1 in complex with S3H3 Fab
0.0098.830.94 12-1206EM0.00hetero-2-1-1-merBLAST0.61
7wd9.1.A
Spike glycoprotein
SARS-CoV-2 Beta spike in complex with three S3H3 Fabs
0.6698.830.94 12-1206EM0.00hetero-3-3-3-merBLAST0.61
7vxd.1.D
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state
0.6498.830.94 12-1206EM0.00hetero-3-1-merBLAST0.61
7vxk.1.D
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state
0.6998.830.94 12-1206EM0.00hetero-3-1-merBLAST0.61
7vxf.1.D
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2B state
0.6498.830.94 12-1206EM0.00hetero-3-1-merBLAST0.61
7vxk.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state
0.6798.830.94 12-1206EM0.00hetero-3-1-merBLAST0.61
7vx1.1.C
Spike glycoprotein
SARS-CoV-2 Beta variant spike protein in open state
0.6598.830.94 12-1206EM0.00homo-trimerBLAST0.61
7vx4.1.B
Spike glycoprotein
ACE2-RBD in SARS-CoV-2 Beta variant S-ACE2 complex
0.0298.830.94 12-1206EM3.90hetero-1-1-mer1 x ZN, 5 x NAGBLAST0.61
7vx1.1.B
Spike glycoprotein
SARS-CoV-2 Beta variant spike protein in open state
0.6598.830.94 12-1206EM0.00homo-trimerBLAST0.61
7vx1.1.A
Spike glycoprotein
SARS-CoV-2 Beta variant spike protein in open state
0.6898.830.94 12-1206EM0.00homo-trimerBLAST0.61
8hhx.1.A
Spike glycoprotein
SARS-CoV-2 Delta Spike in complex with FP-12A
0.5198.830.94 14-1208EM0.00hetero-3-2-2-mer21 x NAG, 7 x NAG-NAGHHblits0.61
8hhx.1.B
Spike glycoprotein
SARS-CoV-2 Delta Spike in complex with FP-12A
0.6098.830.94 14-1208EM0.00hetero-3-2-2-mer21 x NAG, 7 x NAG-NAGHHblits0.61
8hhx.1.C
Spike glycoprotein
SARS-CoV-2 Delta Spike in complex with FP-12A
0.5898.830.94 14-1208EM0.00hetero-3-2-2-mer21 x NAG, 7 x NAG-NAGHHblits0.61
8hhy.1.G
Spike glycoprotein
SARS-CoV-2 Delta Spike in complex with IS-9A
0.6098.830.94 14-1208EM0.00hetero-3-3-3-mer24 x NAG, 4 x NAG-NAGHHblits0.61
8hhy.1.H
Spike glycoprotein
SARS-CoV-2 Delta Spike in complex with IS-9A
0.5898.830.94 14-1208EM0.00hetero-3-3-3-mer24 x NAG, 4 x NAG-NAGHHblits0.61
8hhy.1.I
Spike glycoprotein
SARS-CoV-2 Delta Spike in complex with IS-9A
0.5798.830.94 14-1208EM0.00hetero-3-3-3-mer24 x NAG, 4 x NAG-NAGHHblits0.61
7ey0.1.D
Spike glycoprotein
Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-813 Fab and BD-744 Fab
0.0298.580.94 12-1207EM0.00hetero-1-1-1-2-1-merBLAST0.61
7ey0.1.F
Spike glycoprotein
Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-813 Fab and BD-744 Fab
0.0598.580.94 12-1207EM0.00hetero-1-1-1-2-1-merBLAST0.61
7ey4.1.C
Spike glycoprotein
Local CryoEM of the SARS-CoV-2 S6PV2 in complex with BD-667
0.0298.580.94 12-1207EM3.69hetero-1-1-1-1-merBLAST0.61
7fem.1.A
Spike glycoprotein
SARS-CoV-2 B.1.1.7 S-ACE2 complex
0.6298.990.94 15-1208EM0.00hetero-3-1-mer27 x NAG, 16 x NAG-NAGBLAST0.61
7fem.1.B
Spike glycoprotein
SARS-CoV-2 B.1.1.7 S-ACE2 complex
0.6398.990.94 15-1208EM0.00hetero-3-1-mer27 x NAG, 16 x NAG-NAGBLAST0.61
7fem.1.C
Spike glycoprotein
SARS-CoV-2 B.1.1.7 S-ACE2 complex
0.6398.990.94 15-1208EM0.00hetero-3-1-mer27 x NAG, 16 x NAG-NAGBLAST0.61
7fet.1.A
Spike glycoprotein
SARS-CoV-2 B.1.1.7 Spike Glycoprotein trimer
0.6298.990.94 15-1208EM0.00homo-trimer23 x NAG, 9 x NAG-NAGBLAST0.61
7fet.1.B
Spike glycoprotein
SARS-CoV-2 B.1.1.7 Spike Glycoprotein trimer
0.6398.990.94 15-1208EM0.00homo-trimer23 x NAG, 9 x NAG-NAGBLAST0.61
7fet.1.C
Spike glycoprotein
SARS-CoV-2 B.1.1.7 Spike Glycoprotein trimer
0.6398.990.94 15-1208EM0.00homo-trimer23 x NAG, 9 x NAG-NAGBLAST0.61
7tey.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein
0.5898.660.94 12-1206EM0.00homo-trimer20 x NAG, 18 x NAG-NAGBLAST0.61
7tey.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein
0.5898.660.94 12-1206EM0.00homo-trimer20 x NAG, 18 x NAG-NAGBLAST0.61
7tew.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.0398.660.94 12-1206EM0.00hetero-1-1-mer7 x NAGBLAST0.61
7tey.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein
0.7398.660.94 12-1206EM0.00homo-trimer20 x NAG, 18 x NAG-NAGBLAST0.61
8dm1.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein
0.5996.760.95 1-1208EM0.00homo-trimer19 x NAG, 18 x NAG-NAGHHblits0.60
8dm1.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein
0.7296.760.95 1-1208EM0.00homo-trimer19 x NAG, 18 x NAG-NAGHHblits0.60
8dm2.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein (focused refinement of NTD)
0.0896.760.95 1-1208EM0.00monomer4 x NAG, 1 x NAG-NAGHHblits0.60
8dm4.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with Fab 4A8 (focused refinement of NTD and 4A8)
0.0996.760.95 1-1208EM0.00hetero-1-1-1-mer4 x NAG, 1 x NAG-NAGHHblits0.60
8dm7.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2
0.7296.760.95 1-1208EM0.00hetero-3-2-mer25 x NAG, 18 x NAG-NAGHHblits0.60
8dm5.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2
0.7396.760.95 1-1208EM0.00hetero-3-2-mer33 x NAG, 18 x NAG-NAGHHblits0.60
8dm1.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein
0.5996.760.95 1-1208EM0.00homo-trimer19 x NAG, 18 x NAG-NAGHHblits0.60
8dm3.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with Fab 4A8
0.7296.760.95 1-1208EM0.00hetero-3-3-3-mer21 x NAG, 18 x NAG-NAGHHblits0.60
8dm5.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2
0.7396.760.95 1-1208EM0.00hetero-3-2-mer33 x NAG, 18 x NAG-NAGHHblits0.60
8dm7.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2
0.7296.760.95 1-1208EM0.00hetero-3-2-mer25 x NAG, 18 x NAG-NAGHHblits0.60
8dm3.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with Fab 4A8
0.7296.760.95 1-1208EM0.00hetero-3-3-3-mer21 x NAG, 18 x NAG-NAGHHblits0.60
8dm3.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with Fab 4A8
0.7296.760.95 1-1208EM0.00hetero-3-3-3-mer21 x NAG, 18 x NAG-NAGHHblits0.60
8dm7.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2
0.7396.760.95 1-1208EM0.00hetero-3-2-mer25 x NAG, 18 x NAG-NAGHHblits0.60
8dm6.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.0396.760.95 1-1208EM0.00hetero-1-1-mer7 x NAGHHblits0.60
8dm8.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2 (focused refinement of RBD and ACE2)
0.0396.760.95 1-1208EM0.00hetero-1-1-mer3 x NAGHHblits0.60
8dm5.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2
0.7396.760.95 1-1208EM0.00hetero-3-2-mer33 x NAG, 18 x NAG-NAGHHblits0.60
7fjn.1.B
Spike glycoprotein,Envelope glycoprotein
Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with two T6 Fab
0.6998.490.94 16-1211EM0.00hetero-3-2-2-mer25 x NAGHHblits0.61
7fjn.1.A
Spike glycoprotein,Envelope glycoprotein
Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with two T6 Fab
0.6998.490.94 16-1211EM0.00hetero-3-2-2-mer25 x NAGHHblits0.61
7fjn.1.C
Spike glycoprotein,Envelope glycoprotein
Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with two T6 Fab
0.6898.490.94 16-1211EM0.00hetero-3-2-2-mer25 x NAGHHblits0.61
7q6e.1.A
Spike glycoprotein
Beta049 fab in complex with SARS-CoV2 beta-Spike glycoprotein, The Beta mAb response underscores the antigenic distance to other SARS-CoV-2 variants
0.7198.820.94 12-1205EM0.00hetero-3-3-3-mer26 x NAG, 2 x NAG-NAG-BMA-MAN-MAN-MAN-FUC, 14 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUCBLAST0.61
7q9j.1.A
Spike glycoprotein
Beta-26 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7298.820.94 12-1205EM0.00hetero-3-3-3-mer31 x NAG, 13 x NAG-NAGBLAST0.61
7q9j.1.C
Spike glycoprotein
Beta-26 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7298.820.94 12-1205EM0.00hetero-3-3-3-mer31 x NAG, 13 x NAG-NAGBLAST0.61
7q6e.1.B
Spike glycoprotein
Beta049 fab in complex with SARS-CoV2 beta-Spike glycoprotein, The Beta mAb response underscores the antigenic distance to other SARS-CoV-2 variants
0.7198.820.94 12-1205EM0.00hetero-3-3-3-mer26 x NAG, 2 x NAG-NAG-BMA-MAN-MAN-MAN-FUC, 14 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUCBLAST0.61
7q9p.1.A
Spike glycoprotein
Beta-06 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7198.820.94 12-1205EM0.00hetero-3-3-3-mer28 x NAG, 12 x NAG-NAGBLAST0.61
7q9p.1.B
Spike glycoprotein
Beta-06 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7198.820.94 12-1205EM0.00hetero-3-3-3-mer28 x NAG, 12 x NAG-NAGBLAST0.61
7q9p.1.C
Spike glycoprotein
Beta-06 fab in complex with SARS-CoV-2 beta-Spike glycoprotein
0.7198.820.94 12-1205EM0.00hetero-3-3-3-mer28 x NAG, 12 x NAG-NAGBLAST0.61
8aqw.1.A
Spike glycoprotein,Fibritin
BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local)
0.0096.430.95 1-1212EM0.00hetero-1-1-mer1 x NAG, 1 x NAG-NAGHHblits0.60
7edf.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 1
0.6799.080.93 16-1208EM0.00homo-trimer15 x NAG, 32 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7edf.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 1
0.6599.080.93 16-1208EM0.00homo-trimer15 x NAG, 32 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7edf.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 1
0.6599.080.93 16-1208EM0.00homo-trimer15 x NAG, 32 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7edg.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 2
0.6599.080.93 16-1208EM0.00homo-trimer18 x NAG, 29 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7edg.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 2
0.6299.080.93 16-1208EM0.00homo-trimer18 x NAG, 29 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7edg.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 2
0.6599.080.93 16-1208EM0.00homo-trimer18 x NAG, 29 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7edh.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 3
0.5299.080.93 16-1208EM0.00homo-trimer16 x NAG, 29 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7edh.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 3
0.6399.080.93 16-1208EM0.00homo-trimer16 x NAG, 29 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7edh.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 3
0.6399.080.93 16-1208EM0.00homo-trimer16 x NAG, 29 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.61
7edi.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), two RBD-up conformation
0.6699.080.93 16-1208EM0.00homo-trimer16 x NAG, 31 x NAG-NAGBLAST0.61
7edi.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), two RBD-up conformation
0.6399.080.93 16-1208EM0.00homo-trimer16 x NAG, 31 x NAG-NAGBLAST0.61
7edi.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), two RBD-up conformation
0.6799.080.93 16-1208EM0.00homo-trimer16 x NAG, 31 x NAG-NAGBLAST0.61
7edj.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.6599.080.93 16-1208EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGBLAST0.61
7edj.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.6599.080.93 16-1208EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGBLAST0.61
7edj.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.6699.080.93 16-1208EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGBLAST0.61
7fjo.1.H
Spike glycoprotein
Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with three T6 Fab
0.6998.820.93 16-1208EM0.00hetero-3-3-3-mer25 x NAGBLAST0.61
7fjo.1.G
Spike glycoprotein
Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with three T6 Fab
0.6998.820.93 16-1208EM0.00hetero-3-3-3-mer25 x NAGBLAST0.61
7fjo.1.I
Spike glycoprotein
Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with three T6 Fab
0.6898.820.93 16-1208EM0.00hetero-3-3-3-mer25 x NAGBLAST0.61
7fjn.1.A
Spike glycoprotein,Envelope glycoprotein
Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with two T6 Fab
0.6898.820.93 16-1208EM0.00hetero-3-2-2-mer25 x NAGBLAST0.61
7fjn.1.C
Spike glycoprotein,Envelope glycoprotein
Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with two T6 Fab
0.6898.820.93 16-1208EM0.00hetero-3-2-2-mer25 x NAGBLAST0.61
7fjo.1.H
Spike glycoprotein
Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with three T6 Fab
0.6998.740.93 16-1208EM0.00hetero-3-3-3-mer25 x NAGHHblits0.61
7fjo.1.G
Spike glycoprotein
Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with three T6 Fab
0.6998.740.93 16-1208EM0.00hetero-3-3-3-mer25 x NAGHHblits0.61
7fjo.1.I
Spike glycoprotein
Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with three T6 Fab
0.6898.740.93 16-1208EM0.00hetero-3-3-3-mer25 x NAGHHblits0.61
7xst.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike glycoprotein in complex with three F61 Fab and three D2 Fab
0.7095.860.95 1-1213EM0.00hetero-3-3-3-3-3-mer31 x NAGHHblits0.60
7xst.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike glycoprotein in complex with three F61 Fab and three D2 Fab
0.6995.860.95 1-1213EM0.00hetero-3-3-3-3-3-mer31 x NAGHHblits0.60
7xst.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike glycoprotein in complex with three F61 Fab and three D2 Fab
0.6995.860.95 1-1213EM0.00hetero-3-3-3-3-3-mer31 x NAGHHblits0.60
7dzy.1.A
Spike glycoprotein
Spike protein from SARS-CoV2 with Fab fragment of enhancing antibody 2490
0.6399.490.93 27-1211EM0.00hetero-3-3-3-merHHblits0.61
7dzy.1.B
Spike glycoprotein
Spike protein from SARS-CoV2 with Fab fragment of enhancing antibody 2490
0.6399.490.93 27-1211EM0.00hetero-3-3-3-merHHblits0.61
7dzy.1.C
Spike glycoprotein
Spike protein from SARS-CoV2 with Fab fragment of enhancing antibody 2490
0.6499.490.93 27-1211EM0.00hetero-3-3-3-merHHblits0.61
8fu9.1.A
Spike glycoprotein
Structure of Covid Spike variant deltaN25 with one erect RBD
0.6098.990.93 1-1208EM0.00homo-trimer38 x NAGHHblits0.61
8fu9.1.B
Spike glycoprotein
Structure of Covid Spike variant deltaN25 with one erect RBD
0.6098.990.93 1-1208EM0.00homo-trimer38 x NAGHHblits0.61
8fu9.1.C
Spike glycoprotein
Structure of Covid Spike variant deltaN25 with one erect RBD
0.6098.990.93 1-1208EM0.00homo-trimer38 x NAGHHblits0.61
7edf.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 1
0.6798.570.93 16-1207EM0.00homo-trimer15 x NAG, 32 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7edf.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 1
0.6598.570.93 16-1207EM0.00homo-trimer15 x NAG, 32 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7edf.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 1
0.6498.570.93 16-1207EM0.00homo-trimer15 x NAG, 32 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7edg.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 2
0.6598.570.93 16-1207EM0.00homo-trimer18 x NAG, 29 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7edg.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 2
0.6298.570.93 16-1207EM0.00homo-trimer18 x NAG, 29 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7edg.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 2
0.6498.570.93 16-1207EM0.00homo-trimer18 x NAG, 29 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7edh.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 3
0.5198.570.93 16-1207EM0.00homo-trimer16 x NAG, 29 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7edh.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 3
0.6398.570.93 16-1207EM0.00homo-trimer16 x NAG, 29 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7edh.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 3
0.6398.570.93 16-1207EM0.00homo-trimer16 x NAG, 29 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.61
7edi.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), two RBD-up conformation
0.6598.570.93 16-1207EM0.00homo-trimer16 x NAG, 31 x NAG-NAGHHblits0.61
7edi.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), two RBD-up conformation
0.6398.570.93 16-1207EM0.00homo-trimer16 x NAG, 31 x NAG-NAGHHblits0.61
7edi.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), two RBD-up conformation
0.6798.570.93 16-1207EM0.00homo-trimer16 x NAG, 31 x NAG-NAGHHblits0.61
7edj.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.6598.570.93 16-1207EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGHHblits0.61
7edj.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.6598.570.93 16-1207EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGHHblits0.61
7edj.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
0.6698.570.93 16-1207EM0.00hetero-3-3-mer26 x NAG, 29 x NAG-NAGHHblits0.61
7fem.1.A
Spike glycoprotein
SARS-CoV-2 B.1.1.7 S-ACE2 complex
0.6298.400.93 15-1208EM0.00hetero-3-1-mer27 x NAG, 16 x NAG-NAGHHblits0.61
7fem.1.B
Spike glycoprotein
SARS-CoV-2 B.1.1.7 S-ACE2 complex
0.6398.400.93 15-1208EM0.00hetero-3-1-mer27 x NAG, 16 x NAG-NAGHHblits0.61
7fem.1.C
Spike glycoprotein
SARS-CoV-2 B.1.1.7 S-ACE2 complex
0.6398.400.93 15-1208EM0.00hetero-3-1-mer27 x NAG, 16 x NAG-NAGHHblits0.61
7fet.1.A
Spike glycoprotein
SARS-CoV-2 B.1.1.7 Spike Glycoprotein trimer
0.6298.400.93 15-1208EM0.00homo-trimer23 x NAG, 9 x NAG-NAGHHblits0.61
7fet.1.B
Spike glycoprotein
SARS-CoV-2 B.1.1.7 Spike Glycoprotein trimer
0.6398.400.93 15-1208EM0.00homo-trimer23 x NAG, 9 x NAG-NAGHHblits0.61
7fet.1.C
Spike glycoprotein
SARS-CoV-2 B.1.1.7 Spike Glycoprotein trimer
0.6398.400.93 15-1208EM0.00homo-trimer23 x NAG, 9 x NAG-NAGHHblits0.61
7qo7.1.A
Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529
0.6495.850.95 1-1212EM0.00homo-trimer14 x NAG, 1 x NAG-NAG-BMA-MAN, 3 x NAG-NAG, 18 x NAG-NAG-BMA, 1 x NAG-NAG-FUCHHblits0.60
7qo7.1.B
Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529
0.6495.850.95 1-1212EM0.00homo-trimer14 x NAG, 1 x NAG-NAG-BMA-MAN, 3 x NAG-NAG, 18 x NAG-NAG-BMA, 1 x NAG-NAG-FUCHHblits0.60
7qo7.1.C
Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529
0.6495.850.95 1-1212EM0.00homo-trimer14 x NAG, 1 x NAG-NAG-BMA-MAN, 3 x NAG-NAG, 18 x NAG-NAG-BMA, 1 x NAG-NAG-FUCHHblits0.60
7qo9.1.B
Spike glycoprotein,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529 - RBD and NTD (Local)
0.3095.850.95 1-1212EM0.00homo-dimer2 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAGHHblits0.60
7qo9.1.A
Spike glycoprotein,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529 - RBD and NTD (Local)
0.3695.850.95 1-1212EM0.00homo-dimer2 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAGHHblits0.60
7qti.1.K
Spike glycoprotein,Envelope glycoprotein
SARS-CoV-2 S Omicron Spike B.1.1.529 - 3-P2G3 and 1-P5C3 Fabs (Global)
0.6795.850.95 1-1212EM0.00hetero-3-3-1-1-3-mer26 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 2 x NAG-NAG-BMAHHblits0.60
7qti.1.I
Spike glycoprotein,Envelope glycoprotein
SARS-CoV-2 S Omicron Spike B.1.1.529 - 3-P2G3 and 1-P5C3 Fabs (Global)
0.6895.850.95 1-1212EM0.00hetero-3-3-1-1-3-mer26 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 2 x NAG-NAG-BMAHHblits0.60
7qti.1.J
Spike glycoprotein,Envelope glycoprotein
SARS-CoV-2 S Omicron Spike B.1.1.529 - 3-P2G3 and 1-P5C3 Fabs (Global)
0.6795.850.95 1-1212EM0.00hetero-3-3-1-1-3-mer26 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 2 x NAG-NAG-BMAHHblits0.60
8aqu.1.B
Spike glycoprotein,Fibritin
BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
0.0095.850.95 1-1212EM0.00hetero-1-1-mer1 x NAG, 1 x NAG-NAGHHblits0.60
7zrv.1.C
Spike glycoprotein,Envelope glycoprotein
cryo-EM structure of omicron spike in complex with de novo designed binder, full map
0.6895.850.95 1-1212EM0.00hetero-3-2-mer16 x NAG, 18 x NAG-NAG, 12 x NAG-NAG-BMAHHblits0.60
7zrv.1.B
Spike glycoprotein,Envelope glycoprotein
cryo-EM structure of omicron spike in complex with de novo designed binder, full map
0.6995.850.95 1-1212EM0.00hetero-3-2-mer16 x NAG, 18 x NAG-NAG, 12 x NAG-NAG-BMAHHblits0.60
7zrv.1.A
Spike glycoprotein,Envelope glycoprotein
cryo-EM structure of omicron spike in complex with de novo designed binder, full map
0.6895.850.95 1-1212EM0.00hetero-3-2-mer16 x NAG, 18 x NAG-NAG, 12 x NAG-NAG-BMAHHblits0.60
7uz8.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 Omicron BA.1 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-31
0.6996.100.95 1-1212EM0.00hetero-3-3-3-mer27 x NAG, 3 x NAG-NAGHHblits0.60
7uz8.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 Omicron BA.1 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-31
0.6996.100.95 1-1212EM0.00hetero-3-3-3-mer27 x NAG, 3 x NAG-NAGHHblits0.60
7uz8.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 Omicron BA.1 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-31
0.6996.100.95 1-1212EM0.00hetero-3-3-3-mer27 x NAG, 3 x NAG-NAGHHblits0.60
8aqs.1.A
Spike glycoprotein,Fibritin
BA.4/5 SARS-CoV-2 Spike bound to human ACE2 (local)
0.0097.160.94 12-1208EM0.00hetero-1-1-mer6 x NAG, 1 x ZNBLAST0.61
8fu8.1.A
Spike glycoprotein
Structure of Covid Spike variant deltaN135 with one erect RBD
0.6598.150.94 1-1208EM0.00homo-trimer48 x NAGHHblits0.61
8fu8.1.B
Spike glycoprotein
Structure of Covid Spike variant deltaN135 with one erect RBD
0.6598.150.94 1-1208EM0.00homo-trimer48 x NAGHHblits0.61
8fu8.1.C
Spike glycoprotein
Structure of Covid Spike variant deltaN135 with one erect RBD
0.6698.150.94 1-1208EM0.00homo-trimer48 x NAGHHblits0.61
7y9z.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
0.7196.180.95 1-1208EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGHHblits0.60
7y9z.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
0.7096.180.95 1-1208EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGHHblits0.60
7y9z.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
0.7096.180.95 1-1208EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGHHblits0.60
7ub0.1.B
Spike glycoprotein
SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2)
0.7197.400.94 12-1208EM0.00homo-trimer30 x NAG, 10 x NAG-NAGBLAST0.61
7ub0.1.A
Spike glycoprotein
SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2)
0.7197.400.94 12-1208EM0.00homo-trimer30 x NAG, 10 x NAG-NAGBLAST0.61
7ub0.1.C
Spike glycoprotein
SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2)
0.7097.400.94 12-1208EM0.00homo-trimer30 x NAG, 10 x NAG-NAGBLAST0.61
7ub5.1.A
Spike glycoprotein
SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2)
0.7197.400.94 12-1208EM0.00homo-trimer27 x NAG, 10 x NAG-NAGBLAST0.61
7ub5.1.B
Spike glycoprotein
SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2)
0.7097.400.94 12-1208EM0.00homo-trimer27 x NAG, 10 x NAG-NAGBLAST0.61
7ub6.1.A
Spike glycoprotein
SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2)
0.7097.400.94 12-1208EM0.00homo-trimer28 x NAG, 4 x NAG-NAGBLAST0.61
7ub6.1.B
Spike glycoprotein
SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2)
0.7197.400.94 12-1208EM0.00homo-trimer28 x NAG, 4 x NAG-NAGBLAST0.61
7ub6.1.C
Spike glycoprotein
SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron-BA.2)
0.7097.400.94 12-1208EM0.00homo-trimer28 x NAG, 4 x NAG-NAGBLAST0.61
7qtk.1.A
Surface glycoprotein
SARS-CoV-2 S Omicron Spike B.1.1.529 - RBD down - 1-P2G3 Fab (Local)
0.0296.170.94 1-1208EM0.00hetero-1-1-1-mer1 x NAG-NAGHHblits0.60
7qtj.1.D
Surface glycoprotein
SARS-CoV-2 S Omicron Spike B.1.1.529 - RBD up - 1-P2G3 and 1-P5C3 Fabs (Local)
0.0296.170.94 1-1208EM0.00hetero-1-1-2-1-1-mer1 x NAG-NAG-BMA, 1 x NAG-NAGHHblits0.60
7qtj.1.C
Surface glycoprotein
SARS-CoV-2 S Omicron Spike B.1.1.529 - RBD up - 1-P2G3 and 1-P5C3 Fabs (Local)
0.0296.170.94 1-1208EM0.00hetero-1-1-2-1-1-mer1 x NAG-NAG-BMA, 1 x NAG-NAGHHblits0.60
7wvp.1.D
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C2 state
0.6696.170.94 1-1208EM0.00hetero-1-3-merHHblits0.60
7wvp.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C2 state
0.6796.170.94 1-1208EM0.00hetero-1-3-merHHblits0.60
7wvp.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C2 state
0.6696.170.94 1-1208EM0.00hetero-1-3-merHHblits0.60
7wk6.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with human ACE2 (focus refinement on RBD-1/ACE2)
0.0396.170.94 1-1208EM0.00hetero-1-1-merHHblits0.60
7wk9.1.E
Spike glycoprotein
SARS-CoV-2 Omicron open state spike protein in complex with S3H3 Fab
0.6496.170.94 1-1208EM0.00hetero-3-2-2-merHHblits0.60
7wka.1.E
Spike glycoprotein
SARS-CoV-2 Omicron closed state spike protein in complex with S3H3 Fab
0.6496.170.94 1-1208EM0.00hetero-3-2-2-merHHblits0.60
7wvq.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C3 state
0.6096.170.94 1-1208EM0.00hetero-3-1-merHHblits0.60
7wk8.1.D
Spike glycoprotein
SARS-CoV-2 Omicron spike protein SD1 in complex with S3H3 Fab
0.0096.170.94 1-1208EM0.00hetero-1-1-2-merHHblits0.60
7wvq.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C3 state
0.5996.170.94 1-1208EM0.00hetero-3-1-merHHblits0.60
7wvq.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C3 state
0.5996.170.94 1-1208EM0.00hetero-3-1-merHHblits0.60
7wk9.1.A
Spike glycoprotein
SARS-CoV-2 Omicron open state spike protein in complex with S3H3 Fab
0.6596.170.94 1-1208EM0.00hetero-3-2-2-merHHblits0.60
7wk8.1.C
Spike glycoprotein
SARS-CoV-2 Omicron spike protein SD1 in complex with S3H3 Fab
0.0096.170.94 1-1208EM0.00hetero-1-1-2-merHHblits0.60
7wk9.1.B
Spike glycoprotein
SARS-CoV-2 Omicron open state spike protein in complex with S3H3 Fab
0.6496.170.94 1-1208EM0.00hetero-3-2-2-merHHblits0.60
7wka.1.B
Spike glycoprotein
SARS-CoV-2 Omicron closed state spike protein in complex with S3H3 Fab
0.6396.170.94 1-1208EM0.00hetero-3-2-2-merHHblits0.60
7wka.1.A
Spike glycoprotein
SARS-CoV-2 Omicron closed state spike protein in complex with S3H3 Fab
0.6396.170.94 1-1208EM0.00hetero-3-2-2-merHHblits0.60
7wk3.1.B
Spike glycoprotein
SARS-CoV-2 Omicron S-open
0.6896.170.94 1-1208EM0.00homo-trimerHHblits0.60
7wk2.1.C
Spike glycoprotein
SARS-CoV-2 Omicron S-close
0.6596.170.94 1-1208EM0.00homo-trimerHHblits0.60
7wk3.1.A
Spike glycoprotein
SARS-CoV-2 Omicron S-open
0.6796.170.94 1-1208EM0.00homo-trimerHHblits0.60
7wk3.1.C
Spike glycoprotein
SARS-CoV-2 Omicron S-open
0.6796.170.94 1-1208EM0.00homo-trimerHHblits0.60
7wpf.1.C
Spike glycoprotein
SARS-CoV-2 Omicron Variant S Trimer complexed with three JMB2002 Fab
0.6896.170.94 1-1208EM0.00hetero-3-3-3-3-mer35 x NAG, 2 x NAG-NAGHHblits0.60
7wpc.1.B
Spike glycoprotein
The second RBD of SARS-CoV-2 Omicron Variant in complexed with RBD-ACE2
0.0296.170.94 1-1208EM0.00hetero-2-1-mer1 x ZN, 3 x NAG, 2 x NAG-NAGHHblits0.60
7wpa.1.A
Spike glycoprotein
SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2
0.6796.170.94 1-1208EM0.00hetero-3-1-mer21 x NAG, 1 x ZN, 12 x NAG-NAGHHblits0.60
7wpa.1.B
Spike glycoprotein
SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2
0.6896.170.94 1-1208EM0.00hetero-3-1-mer21 x NAG, 1 x ZN, 12 x NAG-NAGHHblits0.60
7wp9.1.B
Spike glycoprotein
SARS-CoV-2 Omicron Variant SPIKE trimer, all RBDs down
0.6996.170.94 1-1208EM0.00homo-trimer14 x NAG, 7 x NAG-NAGHHblits0.60
7wp9.1.C
Spike glycoprotein
SARS-CoV-2 Omicron Variant SPIKE trimer, all RBDs down
0.6596.170.94 1-1208EM0.00homo-trimer14 x NAG, 7 x NAG-NAGHHblits0.60
7wpf.1.A
Spike glycoprotein
SARS-CoV-2 Omicron Variant S Trimer complexed with three JMB2002 Fab
0.6796.170.94 1-1208EM0.00hetero-3-3-3-3-mer35 x NAG, 2 x NAG-NAGHHblits0.60
7wpc.1.A
Spike glycoprotein
The second RBD of SARS-CoV-2 Omicron Variant in complexed with RBD-ACE2
0.0296.170.94 1-1208EM0.00hetero-2-1-mer1 x ZN, 3 x NAG, 2 x NAG-NAGHHblits0.60
7wp9.1.A
Spike glycoprotein
SARS-CoV-2 Omicron Variant SPIKE trimer, all RBDs down
0.6796.170.94 1-1208EM0.00homo-trimer14 x NAG, 7 x NAG-NAGHHblits0.60
7wpd.1.A
Spike glycoprotein
SARS-CoV-2 Omicron Variant S Trimer complexed with one JMB2002 Fab
0.6896.170.94 1-1208EM0.00hetero-3-1-1-1-mer33 x NAG, 2 x NAG-NAGHHblits0.60
7wpd.1.B
Spike glycoprotein
SARS-CoV-2 Omicron Variant S Trimer complexed with one JMB2002 Fab
0.6896.170.94 1-1208EM0.00hetero-3-1-1-1-mer33 x NAG, 2 x NAG-NAGHHblits0.60
7wpe.1.C
Spike glycoprotein
SARS-CoV-2 Omicron Variant S Trimer complexed with two JMB2002 Fab
0.6996.170.94 1-1208EM0.00hetero-3-2-2-2-mer36 x NAG, 2 x NAG-NAGHHblits0.60
7wpf.1.B
Spike glycoprotein
SARS-CoV-2 Omicron Variant S Trimer complexed with three JMB2002 Fab
0.6796.170.94 1-1208EM0.00hetero-3-3-3-3-mer35 x NAG, 2 x NAG-NAGHHblits0.60
7wpd.1.C
Spike glycoprotein
SARS-CoV-2 Omicron Variant S Trimer complexed with one JMB2002 Fab
0.6896.170.94 1-1208EM0.00hetero-3-1-1-1-mer33 x NAG, 2 x NAG-NAGHHblits0.60
7wpe.1.A
Spike glycoprotein
SARS-CoV-2 Omicron Variant S Trimer complexed with two JMB2002 Fab
0.6996.170.94 1-1208EM0.00hetero-3-2-2-2-mer36 x NAG, 2 x NAG-NAGHHblits0.60
7wpb.1.A
Spike glycoprotein
SARS-CoV-2 Omicron Variant RBD complexed with ACE2
0.0396.170.94 1-1208EM0.00hetero-1-1-mer3 x NAG, 1 x ZNHHblits0.60
7wpa.1.C
Spike glycoprotein
SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2
0.6896.170.94 1-1208EM0.00hetero-3-1-mer21 x NAG, 1 x ZN, 12 x NAG-NAGHHblits0.60
7wrv.1.A
Spike glycoprotein
The interface of JMB2002 Fab binds to SARS-CoV-2 Omicron Variant S
0.0496.170.94 1-1208EM0.00hetero-1-1-1-merHHblits0.60
7wpe.1.B
Spike glycoprotein
SARS-CoV-2 Omicron Variant S Trimer complexed with two JMB2002 Fab
0.6896.170.94 1-1208EM0.00hetero-3-2-2-2-mer36 x NAG, 2 x NAG-NAGHHblits0.60
7wk2.1.A
Spike glycoprotein
SARS-CoV-2 Omicron S-close
0.6596.170.94 1-1208EM0.00homo-trimerHHblits0.60
7wk2.1.B
Spike glycoprotein
SARS-CoV-2 Omicron S-close
0.6496.170.94 1-1208EM0.00homo-trimerHHblits0.60
7xo4.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with two mouse ACE2 Bound
0.6596.170.94 1-1208EM0.00hetero-3-2-mer39 x NAG, 2 x ZNHHblits0.60
7xh8.1.A
Spike glycoprotein
The structure of ZCB11 Fab against SARS-CoV-2 Omicron Spike
0.0196.170.94 1-1208EM0.00hetero-1-1-1-merHHblits0.60
7xo5.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with one mouse ACE2 Bound
0.6496.170.94 1-1208EM0.00hetero-3-1-mer37 x NAG, 1 x ZNHHblits0.60
7xo6.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Variant RBD with mouse ACE2 Bound
0.0296.170.94 1-1208EM0.00hetero-1-1-mer1 x ZN, 2 x NAG, 1 x NAG-NAGHHblits0.60
7xo5.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with one mouse ACE2 Bound
0.6596.170.94 1-1208EM0.00hetero-3-1-mer37 x NAG, 1 x ZNHHblits0.60
7xo4.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with two mouse ACE2 Bound
0.6596.170.94 1-1208EM0.00hetero-3-2-mer39 x NAG, 2 x ZNHHblits0.60
7xo4.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with two mouse ACE2 Bound
0.6696.170.94 1-1208EM0.00hetero-3-2-mer39 x NAG, 2 x ZNHHblits0.60
7xo5.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with one mouse ACE2 Bound
0.6496.170.94 1-1208EM0.00hetero-3-1-mer37 x NAG, 1 x ZNHHblits0.60
7ykj.1.B
Spike glycoprotein
Omicron RBDs bound with P3E6 Fab (one up and one down)
0.0396.170.94 1-1208EM0.00hetero-2-1-1-merHHblits0.60
7ykj.1.A
Spike glycoprotein
Omicron RBDs bound with P3E6 Fab (one up and one down)
0.0596.170.94 1-1208EM0.00hetero-2-1-1-merHHblits0.60
8h00.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab in the class 1 conformation
0.7096.010.94 1-1192EM0.00hetero-3-3-3-mer15 x NAG, 15 x NAG-NAGHHblits0.60
8h00.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab in the class 1 conformation
0.7196.010.94 1-1192EM0.00hetero-3-3-3-mer15 x NAG, 15 x NAG-NAGHHblits0.60
8h00.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab in the class 1 conformation
0.7096.010.94 1-1192EM0.00hetero-3-3-3-mer15 x NAG, 15 x NAG-NAGHHblits0.60
8h01.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab in class 2 conformation
0.7096.010.94 1-1192EM0.00hetero-3-3-3-mer14 x NAG, 15 x NAG-NAGHHblits0.60
8itu.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 IgG.
0.7096.010.94 1-1192EM0.00hetero-3-3-3-mer14 x NAG, 15 x NAG-NAGHHblits0.60
8h01.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab in class 2 conformation
0.7096.010.94 1-1192EM0.00hetero-3-3-3-mer14 x NAG, 15 x NAG-NAGHHblits0.60
8itu.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 IgG.
0.7096.010.94 1-1192EM0.00hetero-3-3-3-mer14 x NAG, 15 x NAG-NAGHHblits0.60
8h01.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab in class 2 conformation
0.7096.010.94 1-1192EM0.00hetero-3-3-3-mer14 x NAG, 15 x NAG-NAGHHblits0.60
8itu.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 IgG.
0.7096.010.94 1-1192EM0.00hetero-3-3-3-mer14 x NAG, 15 x NAG-NAGHHblits0.60
7xst.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike glycoprotein in complex with three F61 Fab and three D2 Fab
0.7096.740.94 12-1213EM0.00hetero-3-3-3-3-3-mer31 x NAGBLAST0.60
7xst.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike glycoprotein in complex with three F61 Fab and three D2 Fab
0.7096.740.94 12-1213EM0.00hetero-3-3-3-3-3-mer31 x NAGBLAST0.60
7xst.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike glycoprotein in complex with three F61 Fab and three D2 Fab
0.7096.740.94 12-1213EM0.00hetero-3-3-3-3-3-mer31 x NAGBLAST0.60
8erq.1.C
Spike glycoprotein
SARS-CoV-2 BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment (local refinement of the RBD and S2X324)
0.0496.090.94 1-1207EM0.00hetero-1-1-1-mer1 x NAGHHblits0.60
8err.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment
0.7196.090.94 1-1207EM0.00hetero-3-3-3-mer48 x NAG, 1 x NAG-NAGHHblits0.60
8err.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment
0.7096.090.94 1-1207EM0.00hetero-3-3-3-mer48 x NAG, 1 x NAG-NAGHHblits0.60
8err.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment
0.7196.090.94 1-1207EM0.00hetero-3-3-3-mer48 x NAG, 1 x NAG-NAGHHblits0.60
8aqv.1.B
Spike glycoprotein,Fibritin
BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
0.0097.150.94 12-1208EM0.00hetero-1-1-mer1 x NAG, 1 x NAG-NAGBLAST0.61
7wjz.1.G
Spike glycoprotein
Omicron Spike bitrimer with 6m6 antibody
0.6695.840.94 1-1192EM0.00hetero-6-6-6-mer49 x NAGHHblits0.60
7wjz.1.D
Spike glycoprotein
Omicron Spike bitrimer with 6m6 antibody
0.6595.840.94 1-1192EM0.00hetero-6-6-6-mer49 x NAGHHblits0.60
7wjz.1.P
Spike glycoprotein
Omicron Spike bitrimer with 6m6 antibody
0.6595.840.94 1-1192EM0.00hetero-6-6-6-mer49 x NAGHHblits0.60
7wjz.1.J
Spike glycoprotein
Omicron Spike bitrimer with 6m6 antibody
0.6595.840.94 1-1192EM0.00hetero-6-6-6-mer49 x NAGHHblits0.60
7wjz.1.M
Spike glycoprotein
Omicron Spike bitrimer with 6m6 antibody
0.6595.840.94 1-1192EM0.00hetero-6-6-6-mer49 x NAGHHblits0.60
7wjz.1.A
Spike glycoprotein
Omicron Spike bitrimer with 6m6 antibody
0.6595.840.94 1-1192EM0.00hetero-6-6-6-mer49 x NAGHHblits0.60
7whi.1.C
Spike glycoprotein
The state 2 complex structure of Omicron spike with Bn03 (2-up RBD, 4 nanobodies)
0.6895.840.94 1-1192EM0.00hetero-3-3-1-mer36 x NAGHHblits0.60
7whj.1.A
Spike glycoprotein
The state 1 complex structure of Omicron spike with Bn03 (1-up RBD, 3 nanobodies)
0.6895.840.94 1-1192EM0.00hetero-3-2-1-mer40 x NAGHHblits0.60
7whj.1.B
Spike glycoprotein
The state 1 complex structure of Omicron spike with Bn03 (1-up RBD, 3 nanobodies)
0.6895.840.94 1-1192EM0.00hetero-3-2-1-mer40 x NAGHHblits0.60
7whj.1.C
Spike glycoprotein
The state 1 complex structure of Omicron spike with Bn03 (1-up RBD, 3 nanobodies)
0.6795.840.94 1-1192EM0.00hetero-3-2-1-mer40 x NAGHHblits0.60
7whk.1.A
Spike glycoprotein
The state 3 complex structure of Omicron spike with Bn03 (2-up RBD, 5 nanobodies)
0.6995.840.94 1-1192EM0.00hetero-3-2-3-mer28 x NAGHHblits0.60
7whk.1.B
Spike glycoprotein
The state 3 complex structure of Omicron spike with Bn03 (2-up RBD, 5 nanobodies)
0.6995.840.94 1-1192EM0.00hetero-3-2-3-mer28 x NAGHHblits0.60
7whk.1.C
Spike glycoprotein
The state 3 complex structure of Omicron spike with Bn03 (2-up RBD, 5 nanobodies)
0.6895.840.94 1-1192EM0.00hetero-3-2-3-mer28 x NAGHHblits0.60
7whi.1.A
Spike glycoprotein
The state 2 complex structure of Omicron spike with Bn03 (2-up RBD, 4 nanobodies)
0.6895.840.94 1-1192EM0.00hetero-3-3-1-mer36 x NAGHHblits0.60
7whi.1.B
Spike glycoprotein
The state 2 complex structure of Omicron spike with Bn03 (2-up RBD, 4 nanobodies)
0.6995.840.94 1-1192EM0.00hetero-3-3-1-mer36 x NAGHHblits0.60
7wjy.1.G
Spike glycoprotein
Omicron spike trimer with 6m6 antibody
0.6695.840.94 1-1192EM0.00hetero-3-2-2-mer24 x NAGHHblits0.60
7wjy.1.D
Spike glycoprotein
Omicron spike trimer with 6m6 antibody
0.6595.840.94 1-1192EM0.00hetero-3-2-2-mer24 x NAGHHblits0.60
7wz1.1.B
Spike glycoprotein
SARS-CoV-2 Omicron Spike trimer
0.6695.840.94 1-1192EM0.00homo-trimer28 x NAGHHblits0.60
7woq.1.B
Spike glycoprotein
The state 1 of Omicron Spike with bispecific antibody FD01
0.6695.840.94 1-1192EM0.00hetero-3-1-mer28 x NAGHHblits0.60
7wz1.1.A
Spike glycoprotein
SARS-CoV-2 Omicron Spike trimer
0.6595.840.94 1-1192EM0.00homo-trimer28 x NAGHHblits0.60
7woq.1.A
Spike glycoprotein
The state 1 of Omicron Spike with bispecific antibody FD01
0.6695.840.94 1-1192EM0.00hetero-3-1-mer28 x NAGHHblits0.60
7wjy.1.A
Spike glycoprotein
Omicron spike trimer with 6m6 antibody
0.6695.840.94 1-1192EM0.00hetero-3-2-2-mer24 x NAGHHblits0.60
7wz1.1.C
Spike glycoprotein
SARS-CoV-2 Omicron Spike trimer
0.6695.840.94 1-1192EM0.00homo-trimer28 x NAGHHblits0.60
7woq.1.C
Spike glycoprotein
The state 1 of Omicron Spike with bispecific antibody FD01
0.6695.840.94 1-1192EM0.00hetero-3-1-mer28 x NAGHHblits0.60
7wow.1.C
Spike glycoprotein
The state 6 of Omicron Spike with bispecific antibody FD01
0.6495.840.94 1-1192EM0.00hetero-3-3-3-merHHblits0.60
7wos.1.C
Spike glycoprotein
The state 3 of Omicron Spike with bispecific antibody FD01
0.6595.840.94 1-1192EM0.00hetero-3-2-2-mer21 x NAGHHblits0.60
7wov.1.C
Spike glycoprotein
The state 5 of Omicron Spike with bispecific antibody FD01
0.6595.840.94 1-1192EM0.00hetero-3-3-3-mer18 x NAGHHblits0.60
7wow.2.C
Spike glycoprotein
The state 6 of Omicron Spike with bispecific antibody FD01
0.6495.840.94 1-1192EM0.00hetero-3-3-3-merHHblits0.60
7wov.1.A
Spike glycoprotein
The state 5 of Omicron Spike with bispecific antibody FD01
0.6695.840.94 1-1192EM0.00hetero-3-3-3-mer18 x NAGHHblits0.60
7wow.2.A
Spike glycoprotein
The state 6 of Omicron Spike with bispecific antibody FD01
0.6595.840.94 1-1192EM0.00hetero-3-3-3-merHHblits0.60
7wow.1.A
Spike glycoprotein
The state 6 of Omicron Spike with bispecific antibody FD01
0.6595.840.94 1-1192EM0.00hetero-3-3-3-merHHblits0.60
7wov.1.B
Spike glycoprotein
The state 5 of Omicron Spike with bispecific antibody FD01
0.6795.840.94 1-1192EM0.00hetero-3-3-3-mer18 x NAGHHblits0.60
7wow.2.B
Spike glycoprotein
The state 6 of Omicron Spike with bispecific antibody FD01
0.6695.840.94 1-1192EM0.00hetero-3-3-3-merHHblits0.60
7wow.1.B
Spike glycoprotein
The state 6 of Omicron Spike with bispecific antibody FD01
0.6695.840.94 1-1192EM0.00hetero-3-3-3-merHHblits0.60
7wou.1.B
Spike glycoprotein
The state 4 of Omicron Spike with bispecific antibody FD01
0.6795.840.94 1-1192EM0.00hetero-3-2-2-mer23 x NAGHHblits0.60
7wos.1.B
Spike glycoprotein
The state 3 of Omicron Spike with bispecific antibody FD01
0.6695.840.94 1-1192EM0.00hetero-3-2-2-mer21 x NAGHHblits0.60
7wor.1.A
Spike glycoprotein
The state 2 of Omicron Spike with bispecific antibody FD01
0.6595.840.94 1-1192EM0.00hetero-3-2-1-mer23 x NAGHHblits0.60
7wos.1.A
Spike glycoprotein
The state 3 of Omicron Spike with bispecific antibody FD01
0.6595.840.94 1-1192EM0.00hetero-3-2-2-mer21 x NAGHHblits0.60
7wor.1.B
Spike glycoprotein
The state 2 of Omicron Spike with bispecific antibody FD01
0.6695.840.94 1-1192EM0.00hetero-3-2-1-mer23 x NAGHHblits0.60
7wor.1.C
Spike glycoprotein
The state 2 of Omicron Spike with bispecific antibody FD01
0.6595.840.94 1-1192EM0.00hetero-3-2-1-mer23 x NAGHHblits0.60
7wou.1.A
Spike glycoprotein
The state 4 of Omicron Spike with bispecific antibody FD01
0.6795.840.94 1-1192EM0.00hetero-3-2-2-mer23 x NAGHHblits0.60
7wou.1.C
Spike glycoprotein
The state 4 of Omicron Spike with bispecific antibody FD01
0.6695.840.94 1-1192EM0.00hetero-3-2-2-mer23 x NAGHHblits0.60
7xj8.1.C
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab in the class 2 conformation
0.7095.840.94 1-1192EM0.00hetero-3-2-2-1-1-mer15 x NAG, 15 x NAG-NAGHHblits0.60
7xj6.1.C
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab in the class 1 conformation
0.7095.840.94 1-1192EM0.00hetero-3-3-3-1-1-mer15 x NAG, 14 x NAG-NAGHHblits0.60
7xj8.1.B
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab in the class 2 conformation
0.7095.840.94 1-1192EM0.00hetero-3-2-2-1-1-mer15 x NAG, 15 x NAG-NAGHHblits0.60
7xj6.1.B
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab in the class 1 conformation
0.7095.840.94 1-1192EM0.00hetero-3-3-3-1-1-mer15 x NAG, 14 x NAG-NAGHHblits0.60
7xj6.1.A
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab in the class 1 conformation
0.7095.840.94 1-1192EM0.00hetero-3-3-3-1-1-mer15 x NAG, 14 x NAG-NAGHHblits0.60
7xj8.1.A
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab in the class 2 conformation
0.5795.840.94 1-1192EM0.00hetero-3-2-2-1-1-mer15 x NAG, 15 x NAG-NAGHHblits0.60
7t9k.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2
0.7295.840.94 1-1208EM0.00hetero-3-2-mer34 x NAG, 18 x NAG-NAGHHblits0.60
7t9k.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2
0.7295.840.94 1-1208EM0.00hetero-3-2-mer34 x NAG, 18 x NAG-NAGHHblits0.60
7t9l.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
0.0495.840.94 1-1208EM0.00hetero-1-1-mer7 x NAGHHblits0.60
8dma.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2 (focused refinement of RBD and ACE2)
0.0495.840.94 1-1208EM0.00hetero-1-1-mer3 x NAGHHblits0.60
7t9j.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 Omicron spike protein
0.5895.840.94 1-1208EM0.00homo-trimer22 x NAG, 18 x NAG-NAGHHblits0.60
7t9j.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 Omicron spike protein
0.7295.840.94 1-1208EM0.00homo-trimer22 x NAG, 18 x NAG-NAGHHblits0.60
8dm9.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2
0.7295.840.94 1-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.60
7t9j.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 Omicron spike protein
0.5895.840.94 1-1208EM0.00homo-trimer22 x NAG, 18 x NAG-NAGHHblits0.60
8dm9.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2
0.7295.840.94 1-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.60
7t9k.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2
0.5795.840.94 1-1208EM0.00hetero-3-2-mer34 x NAG, 18 x NAG-NAGHHblits0.60
8dm9.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2
0.7295.840.94 1-1208EM0.00hetero-3-1-mer26 x NAG, 18 x NAG-NAGHHblits0.60
7wly.1.A
Spike glycoprotein
Cryo-EM structure of the Omicron S in complex with 35B5 Fab(1 down- and 2 up RBDs)
0.6995.840.94 1-1208EM0.00hetero-3-2-2-mer27 x NAG, 2 x NAG-NAGHHblits0.60
7wlz.1.A
Spike glycoprotein
Cryo-EM structure of the Omicron S in complex with 35B5 Fab(1 down-, 1 up- and 1 invisible RBDs)
0.6895.840.94 1-1208EM0.00hetero-3-1-1-mer27 x NAGHHblits0.60
7wly.1.C
Spike glycoprotein
Cryo-EM structure of the Omicron S in complex with 35B5 Fab(1 down- and 2 up RBDs)
0.6995.840.94 1-1208EM0.00hetero-3-2-2-mer27 x NAG, 2 x NAG-NAGHHblits0.60
7wm0.1.A
Spike glycoprotein
Cryo-EM structure of the Omicron RBD in complex with 35B5 Fab( local refinement of the RBD and 35B5 Fab)
0.0395.840.94 1-1208EM3.35hetero-1-1-1-mer1 x NAGHHblits0.60
7wly.1.B
Spike glycoprotein
Cryo-EM structure of the Omicron S in complex with 35B5 Fab(1 down- and 2 up RBDs)
0.6895.840.94 1-1208EM0.00hetero-3-2-2-mer27 x NAG, 2 x NAG-NAGHHblits0.60
7wlz.1.B
Spike glycoprotein
Cryo-EM structure of the Omicron S in complex with 35B5 Fab(1 down-, 1 up- and 1 invisible RBDs)
0.6995.840.94 1-1208EM0.00hetero-3-1-1-mer27 x NAGHHblits0.60
7wlz.1.C
Spike glycoprotein
Cryo-EM structure of the Omicron S in complex with 35B5 Fab(1 down-, 1 up- and 1 invisible RBDs)
0.5695.840.94 1-1208EM0.00hetero-3-1-1-mer27 x NAGHHblits0.60
8dzh.1.C
Spike glycoprotein
Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody MB.02
0.6995.840.94 1-1208EM0.00hetero-3-3-3-mer19 x NAG, 27 x NAG-NAGHHblits0.60
8dzi.1.G
Spike glycoprotein
Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody MB.02
0.6895.840.94 1-1208EM0.00hetero-3-3-3-mer22 x NAG, 20 x NAG-NAGHHblits0.60
8dzi.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody MB.02
0.6895.840.94 1-1208EM0.00hetero-3-3-3-mer22 x NAG, 20 x NAG-NAGHHblits0.60
8dzh.1.B
Spike glycoprotein
Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody MB.02
0.6895.840.94 1-1208EM0.00hetero-3-3-3-mer19 x NAG, 27 x NAG-NAGHHblits0.60
8dzi.1.D
Spike glycoprotein
Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody MB.02
0.6995.840.94 1-1208EM0.00hetero-3-3-3-mer22 x NAG, 20 x NAG-NAGHHblits0.60
8dzh.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody MB.02
0.6795.840.94 1-1208EM0.00hetero-3-3-3-mer19 x NAG, 27 x NAG-NAGHHblits0.60
7ws4.1.A
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
0.7195.840.94 1-1208EM0.00hetero-3-1-1-mer10 x NAG, 14 x NAG-NAGHHblits0.60
7ws5.1.A
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7195.840.94 1-1208EM0.00hetero-3-3-3-mer10 x NAG, 14 x NAG-NAGHHblits0.60
7wwj.1.A
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab in the class 2 conformation
0.5795.840.94 1-1208EM0.00hetero-3-2-2-mer15 x NAG, 14 x NAG-NAGHHblits0.60
7ws4.1.B
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
0.7195.840.94 1-1208EM0.00hetero-3-1-1-mer10 x NAG, 14 x NAG-NAGHHblits0.60
7ws4.1.C
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
0.7195.840.94 1-1208EM0.00hetero-3-1-1-mer10 x NAG, 14 x NAG-NAGHHblits0.60
7ws5.1.C
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7195.840.94 1-1208EM0.00hetero-3-3-3-mer10 x NAG, 14 x NAG-NAGHHblits0.60
7ws5.1.B
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7295.840.94 1-1208EM0.00hetero-3-3-3-mer10 x NAG, 14 x NAG-NAGHHblits0.60
7ws8.1.A
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7295.840.94 1-1208EM0.00hetero-3-2-mer20 x NAG, 14 x NAG-NAGHHblits0.60
7ws8.1.B
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7295.840.94 1-1208EM0.00hetero-3-2-mer20 x NAG, 14 x NAG-NAGHHblits0.60
7ws8.1.C
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7295.840.94 1-1208EM0.00hetero-3-2-mer20 x NAG, 14 x NAG-NAGHHblits0.60
7ws9.1.A
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7195.840.94 1-1208EM0.00hetero-3-1-mer12 x NAG, 14 x NAG-NAGHHblits0.60
7ws9.1.B
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7195.840.94 1-1208EM0.00hetero-3-1-mer12 x NAG, 14 x NAG-NAGHHblits0.60
7ws9.1.C
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7295.840.94 1-1208EM0.00hetero-3-1-mer12 x NAG, 14 x NAG-NAGHHblits0.60
7wwj.1.C
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab in the class 2 conformation
0.7095.840.94 1-1208EM0.00hetero-3-2-2-mer15 x NAG, 14 x NAG-NAGHHblits0.60
7wwi.1.C
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab in the class 1 conformation
0.7195.840.94 1-1208EM0.00hetero-3-3-3-mer15 x NAG, 14 x NAG-NAGHHblits0.60
7wwi.1.B
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab in the class 1 conformation
0.7195.840.94 1-1208EM0.00hetero-3-3-3-mer15 x NAG, 14 x NAG-NAGHHblits0.60
7wwj.1.B
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab in the class 2 conformation
0.7195.840.94 1-1208EM0.00hetero-3-2-2-mer15 x NAG, 14 x NAG-NAGHHblits0.60
7wwi.1.A
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab in the class 1 conformation
0.7195.840.94 1-1208EM0.00hetero-3-3-3-mer15 x NAG, 14 x NAG-NAGHHblits0.60
7xic.1.A
Spike glycoprotein
S-ECD (Omicron) in complex with STS165
0.6995.840.94 1-1208EM0.00hetero-3-3-3-mer29 x NAG, 19 x NAG-NAGHHblits0.60
7xic.1.B
Spike glycoprotein
S-ECD (Omicron) in complex with STS165
0.6895.840.94 1-1208EM0.00hetero-3-3-3-mer29 x NAG, 19 x NAG-NAGHHblits0.60
7xic.1.C
Spike glycoprotein
S-ECD (Omicron) in complex with STS165
0.6995.840.94 1-1208EM0.00hetero-3-3-3-mer29 x NAG, 19 x NAG-NAGHHblits0.60
7xid.1.A
Spike glycoprotein
S-ECD (Omicron) in complex with PD of ACE2
0.6795.840.94 1-1208EM0.00hetero-3-2-mer37 x NAG, 23 x NAG-NAGHHblits0.60
7xid.1.B
Spike glycoprotein
S-ECD (Omicron) in complex with PD of ACE2
0.6895.840.94 1-1208EM0.00hetero-3-2-mer37 x NAG, 23 x NAG-NAGHHblits0.60
7xid.1.C
Spike glycoprotein
S-ECD (Omicron) in complex with PD of ACE2
0.6895.840.94 1-1208EM0.00hetero-3-2-mer37 x NAG, 23 x NAG-NAGHHblits0.60
8fu8.1.B
Spike glycoprotein
Structure of Covid Spike variant deltaN135 with one erect RBD
0.6399.240.93 12-1208EM0.00homo-trimer48 x NAGBLAST0.61
8fu8.1.C
Spike glycoprotein
Structure of Covid Spike variant deltaN135 with one erect RBD
0.6599.240.93 12-1208EM0.00homo-trimer48 x NAGBLAST0.61
8fu7.1.A
Spike glycoprotein
Structure of Covid Spike variant deltaN135 in fully closed form
0.6598.150.93 1-1204EM0.00homo-trimer48 x NAGHHblits0.61
8fu7.1.B
Spike glycoprotein
Structure of Covid Spike variant deltaN135 in fully closed form
0.6598.150.93 1-1204EM0.00homo-trimer48 x NAGHHblits0.61
8fu7.1.C
Spike glycoprotein
Structure of Covid Spike variant deltaN135 in fully closed form
0.6598.150.93 1-1204EM0.00homo-trimer48 x NAGHHblits0.61
8dm1.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein
0.5996.900.94 12-1208EM0.00homo-trimer19 x NAG, 18 x NAG-NAGBLAST0.60
8dm1.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein
0.5996.900.94 12-1208EM0.00homo-trimer19 x NAG, 18 x NAG-NAGBLAST0.60
8dm3.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with Fab 4A8
0.7196.900.94 12-1208EM0.00hetero-3-3-3-mer21 x NAG, 18 x NAG-NAGBLAST0.60
8dm3.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with Fab 4A8
0.7196.900.94 12-1208EM0.00hetero-3-3-3-mer21 x NAG, 18 x NAG-NAGBLAST0.60
8dm7.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2
0.7296.900.94 12-1208EM0.00hetero-3-2-mer25 x NAG, 18 x NAG-NAGBLAST0.60
7v22.1.A
Spike glycoprotein
Local CryoEM structure del68-76/del679-688 prefusion-stabilized spike
0.0799.490.93 12-1208EM0.00monomerBLAST0.61
7v20.1.B
Spike glycoprotein
CryoEM structure of del68-76/del679-688 prefusion-stabilized spike
0.7099.490.93 12-1208EM0.00homo-trimer28 x NAG, 9 x NAG-NAGBLAST0.61
7v20.1.C
Spike glycoprotein
CryoEM structure of del68-76/del679-688 prefusion-stabilized spike
0.7099.490.93 12-1208EM0.00homo-trimer28 x NAG, 9 x NAG-NAGBLAST0.61
7v20.1.A
Spike glycoprotein
CryoEM structure of del68-76/del679-688 prefusion-stabilized spike
0.6999.490.93 12-1208EM0.00homo-trimer28 x NAG, 9 x NAG-NAGBLAST0.61
7v23.1.A
Spike glycoprotein
CryoEM structure of del68-76/del679-688 prefusion-stabilized spike in complex with the Fab of N12-9
0.6999.490.93 12-1208EM0.00hetero-3-3-3-mer28 x NAG, 10 x NAG-NAGBLAST0.61
7v23.1.C
Spike glycoprotein
CryoEM structure of del68-76/del679-688 prefusion-stabilized spike in complex with the Fab of N12-9
0.7199.490.93 12-1208EM0.00hetero-3-3-3-mer28 x NAG, 10 x NAG-NAGBLAST0.61
8bgg.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike (Omicron BA.1 variant) in complex with nanobody W25 (map 5, focus refinement on RBD, W25 and adjacent NTD)
0.0695.840.94 1-1207EM0.00hetero-2-1-mer5 x NAG, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMAHHblits0.60
8bgg.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike (Omicron BA.1 variant) in complex with nanobody W25 (map 5, focus refinement on RBD, W25 and adjacent NTD)
0.0295.840.94 1-1207EM0.00hetero-2-1-mer5 x NAG, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMAHHblits0.60
7thk.1.A
Spike glycoprotein
Cryo-EM structure of prefusion SARS-CoV-2 spike omicron B.1.1.529 variant
0.5896.160.94 1-1205EM0.00homo-trimer38 x NAGHHblits0.60
7thk.1.B
Spike glycoprotein
Cryo-EM structure of prefusion SARS-CoV-2 spike omicron B.1.1.529 variant
0.7296.160.94 1-1205EM0.00homo-trimer38 x NAGHHblits0.60
7thk.1.C
Spike glycoprotein
Cryo-EM structure of prefusion SARS-CoV-2 spike omicron B.1.1.529 variant
0.7196.160.94 1-1205EM0.00homo-trimer38 x NAGHHblits0.60
7wk5.1.D
Spike glycoprotein
Cryo-EM structure of Omicron S-ACE2, C2 state
0.6696.160.94 1-1205EM0.00hetero-1-3-merHHblits0.60
7wk5.1.C
Spike glycoprotein
Cryo-EM structure of Omicron S-ACE2, C2 state
0.6796.160.94 1-1205EM0.00hetero-1-3-merHHblits0.60
7wk5.1.B
Spike glycoprotein
Cryo-EM structure of Omicron S-ACE2, C2 state
0.6696.160.94 1-1205EM0.00hetero-1-3-merHHblits0.60
7wvo.1.A
Spike glycoprotein
SARS-CoV-2 Omicron S-open-2
0.6596.160.94 1-1205EM0.00homo-trimerHHblits0.60
7wvn.1.C
Spike glycoprotein
SARS-CoV-2 Omicron S-open
0.6496.160.94 1-1205EM0.00homo-trimerHHblits0.60
7wk4.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state
0.6796.160.94 1-1205EM0.00hetero-1-3-merHHblits0.60
7wvn.1.B
Spike glycoprotein
SARS-CoV-2 Omicron S-open
0.6496.160.94 1-1205EM0.00homo-trimerHHblits0.60
7wk4.1.D
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state
0.6696.160.94 1-1205EM0.00hetero-1-3-merHHblits0.60
7wk4.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state
0.6696.160.94 1-1205EM0.00hetero-1-3-merHHblits0.60
7tgw.1.A
Spike glycoprotein
Omicron spike at 3.0 A (open form)
0.6697.060.94 14-1211EM0.00homo-trimer21 x NAG, 12 x NAG-NAGBLAST0.61
7tgw.1.B
Spike glycoprotein
Omicron spike at 3.0 A (open form)
0.6797.060.94 14-1211EM0.00homo-trimer21 x NAG, 12 x NAG-NAGBLAST0.61
7tgw.1.C
Spike glycoprotein
Omicron spike at 3.0 A (open form)
0.6797.060.94 14-1211EM0.00homo-trimer21 x NAG, 12 x NAG-NAGBLAST0.61
8aqw.1.A
Spike glycoprotein,Fibritin
BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local)
0.0097.150.94 12-1208EM0.00hetero-1-1-mer1 x NAG, 1 x NAG-NAGBLAST0.61
7uz8.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 Omicron BA.1 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-31
0.7096.900.94 12-1212EM0.00hetero-3-3-3-mer27 x NAG, 3 x NAG-NAGBLAST0.60
8hhz.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike in complex with IY-2A
0.5697.060.94 14-1210EM0.00hetero-3-3-3-merBLAST0.61
8hhz.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike in complex with IY-2A
0.5797.060.94 14-1210EM0.00hetero-3-3-3-merBLAST0.61
8hhz.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike in complex with IY-2A
0.6097.060.94 14-1210EM0.00hetero-3-3-3-merBLAST0.61
7wk3.1.B
Spike glycoprotein
SARS-CoV-2 Omicron S-open
0.6897.060.94 12-1208EM0.00homo-trimerBLAST0.61
7wk3.1.A
Spike glycoprotein
SARS-CoV-2 Omicron S-open
0.6797.060.94 12-1208EM0.00homo-trimerBLAST0.61
7wk3.1.C
Spike glycoprotein
SARS-CoV-2 Omicron S-open
0.6797.060.94 12-1208EM0.00homo-trimerBLAST0.61
7wpf.1.C
Spike glycoprotein
SARS-CoV-2 Omicron Variant S Trimer complexed with three JMB2002 Fab
0.6897.060.94 12-1208EM0.00hetero-3-3-3-3-mer35 x NAG, 2 x NAG-NAGBLAST0.61
7wpc.1.B
Spike glycoprotein
The second RBD of SARS-CoV-2 Omicron Variant in complexed with RBD-ACE2
0.0297.060.94 12-1208EM0.00hetero-2-1-mer1 x ZN, 3 x NAG, 2 x NAG-NAGBLAST0.61
7wpa.1.A
Spike glycoprotein
SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2
0.6897.060.94 12-1208EM0.00hetero-3-1-mer21 x NAG, 1 x ZN, 12 x NAG-NAGBLAST0.61
7wpa.1.B
Spike glycoprotein
SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2
0.6897.060.94 12-1208EM0.00hetero-3-1-mer21 x NAG, 1 x ZN, 12 x NAG-NAGBLAST0.61
7wp9.1.B
Spike glycoprotein
SARS-CoV-2 Omicron Variant SPIKE trimer, all RBDs down
0.7097.060.94 12-1208EM0.00homo-trimer14 x NAG, 7 x NAG-NAGBLAST0.61
7wp9.1.C
Spike glycoprotein
SARS-CoV-2 Omicron Variant SPIKE trimer, all RBDs down
0.6697.060.94 12-1208EM0.00homo-trimer14 x NAG, 7 x NAG-NAGBLAST0.61
7wpf.1.A
Spike glycoprotein
SARS-CoV-2 Omicron Variant S Trimer complexed with three JMB2002 Fab
0.6797.060.94 12-1208EM0.00hetero-3-3-3-3-mer35 x NAG, 2 x NAG-NAGBLAST0.61
7wpc.1.A
Spike glycoprotein
The second RBD of SARS-CoV-2 Omicron Variant in complexed with RBD-ACE2
0.0297.060.94 12-1208EM0.00hetero-2-1-mer1 x ZN, 3 x NAG, 2 x NAG-NAGBLAST0.61
7wp9.1.A
Spike glycoprotein
SARS-CoV-2 Omicron Variant SPIKE trimer, all RBDs down
0.6897.060.94 12-1208EM0.00homo-trimer14 x NAG, 7 x NAG-NAGBLAST0.61
7wpd.1.A
Spike glycoprotein
SARS-CoV-2 Omicron Variant S Trimer complexed with one JMB2002 Fab
0.6797.060.94 12-1208EM0.00hetero-3-1-1-1-mer33 x NAG, 2 x NAG-NAGBLAST0.61
7wpd.1.B
Spike glycoprotein
SARS-CoV-2 Omicron Variant S Trimer complexed with one JMB2002 Fab
0.6797.060.94 12-1208EM0.00hetero-3-1-1-1-mer33 x NAG, 2 x NAG-NAGBLAST0.61
7wpf.1.B
Spike glycoprotein
SARS-CoV-2 Omicron Variant S Trimer complexed with three JMB2002 Fab
0.6797.060.94 12-1208EM0.00hetero-3-3-3-3-mer35 x NAG, 2 x NAG-NAGBLAST0.61
7wpd.1.C
Spike glycoprotein
SARS-CoV-2 Omicron Variant S Trimer complexed with one JMB2002 Fab
0.6897.060.94 12-1208EM0.00hetero-3-1-1-1-mer33 x NAG, 2 x NAG-NAGBLAST0.61
7wpb.1.A
Spike glycoprotein
SARS-CoV-2 Omicron Variant RBD complexed with ACE2
0.0397.060.94 12-1208EM0.00hetero-1-1-mer3 x NAG, 1 x ZNBLAST0.61
7wpa.1.C
Spike glycoprotein
SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2
0.6897.060.94 12-1208EM0.00hetero-3-1-mer21 x NAG, 1 x ZN, 12 x NAG-NAGBLAST0.61
7wrv.1.A
Spike glycoprotein
The interface of JMB2002 Fab binds to SARS-CoV-2 Omicron Variant S
0.0397.060.94 12-1208EM0.00hetero-1-1-1-merBLAST0.61
7wpe.1.B
Spike glycoprotein
SARS-CoV-2 Omicron Variant S Trimer complexed with two JMB2002 Fab
0.6897.060.94 12-1208EM0.00hetero-3-2-2-2-mer36 x NAG, 2 x NAG-NAGBLAST0.61
7wk2.1.A
Spike glycoprotein
SARS-CoV-2 Omicron S-close
0.6597.060.94 12-1208EM0.00homo-trimerBLAST0.61
7wk2.1.B
Spike glycoprotein
SARS-CoV-2 Omicron S-close
0.6497.060.94 12-1208EM0.00homo-trimerBLAST0.61
7xo4.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with two mouse ACE2 Bound
0.6597.060.94 12-1208EM0.00hetero-3-2-mer39 x NAG, 2 x ZNBLAST0.61
7xh8.1.A
Spike glycoprotein
The structure of ZCB11 Fab against SARS-CoV-2 Omicron Spike
0.0097.060.94 12-1208EM0.00hetero-1-1-1-merBLAST0.61
7xo5.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with one mouse ACE2 Bound
0.6497.060.94 12-1208EM0.00hetero-3-1-mer37 x NAG, 1 x ZNBLAST0.61
7xo6.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Variant RBD with mouse ACE2 Bound
0.0297.060.94 12-1208EM0.00hetero-1-1-mer1 x ZN, 2 x NAG, 1 x NAG-NAGBLAST0.61
7xo5.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with one mouse ACE2 Bound
0.6497.060.94 12-1208EM0.00hetero-3-1-mer37 x NAG, 1 x ZNBLAST0.61
7xo4.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with two mouse ACE2 Bound
0.6597.060.94 12-1208EM0.00hetero-3-2-mer39 x NAG, 2 x ZNBLAST0.61
7xo4.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with two mouse ACE2 Bound
0.6597.060.94 12-1208EM0.00hetero-3-2-mer39 x NAG, 2 x ZNBLAST0.61
7xo5.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with one mouse ACE2 Bound
0.6497.060.94 12-1208EM0.00hetero-3-1-mer37 x NAG, 1 x ZNBLAST0.61
7ykj.1.B
Spike glycoprotein
Omicron RBDs bound with P3E6 Fab (one up and one down)
0.0397.060.94 12-1208EM0.00hetero-2-1-1-merBLAST0.61
7ykj.1.A
Spike glycoprotein
Omicron RBDs bound with P3E6 Fab (one up and one down)
0.0497.060.94 12-1208EM0.00hetero-2-1-1-merBLAST0.61
7wk6.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with human ACE2 (focus refinement on RBD-1/ACE2)
0.0297.060.94 12-1208EM0.00hetero-1-1-merBLAST0.61
7wk9.1.E
Spike glycoprotein
SARS-CoV-2 Omicron open state spike protein in complex with S3H3 Fab
0.6497.060.94 12-1208EM0.00hetero-3-2-2-merBLAST0.61
7wvq.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C3 state
0.5997.060.94 12-1208EM0.00hetero-3-1-merBLAST0.61
7wk8.1.D
Spike glycoprotein
SARS-CoV-2 Omicron spike protein SD1 in complex with S3H3 Fab
0.0097.060.94 12-1208EM0.00hetero-1-1-2-merBLAST0.61
7wvq.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C3 state
0.5997.060.94 12-1208EM0.00hetero-3-1-merBLAST0.61
7wvq.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C3 state
0.5897.060.94 12-1208EM0.00hetero-3-1-merBLAST0.61
7wk9.1.A
Spike glycoprotein
SARS-CoV-2 Omicron open state spike protein in complex with S3H3 Fab
0.6597.060.94 12-1208EM0.00hetero-3-2-2-merBLAST0.61
7wk8.1.C
Spike glycoprotein
SARS-CoV-2 Omicron spike protein SD1 in complex with S3H3 Fab
0.0097.060.94 12-1208EM0.00hetero-1-1-2-merBLAST0.61
7wk9.1.B
Spike glycoprotein
SARS-CoV-2 Omicron open state spike protein in complex with S3H3 Fab
0.6497.060.94 12-1208EM0.00hetero-3-2-2-merBLAST0.61
7wka.1.A
Spike glycoprotein
SARS-CoV-2 Omicron closed state spike protein in complex with S3H3 Fab
0.6397.060.94 12-1208EM0.00hetero-3-2-2-merBLAST0.61
7qo7.1.A
Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529
0.6497.060.94 12-1208EM0.00homo-trimer14 x NAG, 1 x NAG-NAG-BMA-MAN, 3 x NAG-NAG, 18 x NAG-NAG-BMA, 1 x NAG-NAG-FUCBLAST0.61
7qo7.1.B
Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529
0.6497.060.94 12-1208EM0.00homo-trimer14 x NAG, 1 x NAG-NAG-BMA-MAN, 3 x NAG-NAG, 18 x NAG-NAG-BMA, 1 x NAG-NAG-FUCBLAST0.61
7qo7.1.C
Surface glycoprotein,Fibritin,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529
0.6497.060.94 12-1208EM0.00homo-trimer14 x NAG, 1 x NAG-NAG-BMA-MAN, 3 x NAG-NAG, 18 x NAG-NAG-BMA, 1 x NAG-NAG-FUCBLAST0.61
7qo9.1.B
Spike glycoprotein,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529 - RBD and NTD (Local)
0.3097.060.94 12-1208EM0.00homo-dimer2 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAGBLAST0.61
7qo9.1.A
Spike glycoprotein,SARS-CoV-2 S Omicron Spike B.1.1.529
SARS-CoV-2 S Omicron Spike B.1.1.529 - RBD and NTD (Local)
0.3697.060.94 12-1208EM0.00homo-dimer2 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAGBLAST0.61
7qtk.1.A
Surface glycoprotein
SARS-CoV-2 S Omicron Spike B.1.1.529 - RBD down - 1-P2G3 Fab (Local)
0.0197.060.94 12-1208EM0.00hetero-1-1-1-mer1 x NAG-NAGBLAST0.61
7qti.1.K
Spike glycoprotein,Envelope glycoprotein
SARS-CoV-2 S Omicron Spike B.1.1.529 - 3-P2G3 and 1-P5C3 Fabs (Global)
0.6797.060.94 12-1208EM0.00hetero-3-3-1-1-3-mer26 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 2 x NAG-NAG-BMABLAST0.61
7qti.1.I
Spike glycoprotein,Envelope glycoprotein
SARS-CoV-2 S Omicron Spike B.1.1.529 - 3-P2G3 and 1-P5C3 Fabs (Global)
0.6897.060.94 12-1208EM0.00hetero-3-3-1-1-3-mer26 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 2 x NAG-NAG-BMABLAST0.61
7qtj.1.D
Surface glycoprotein
SARS-CoV-2 S Omicron Spike B.1.1.529 - RBD up - 1-P2G3 and 1-P5C3 Fabs (Local)
0.0197.060.94 12-1208EM0.00hetero-1-1-2-1-1-mer1 x NAG-NAG-BMA, 1 x NAG-NAGBLAST0.61
7qti.1.J
Spike glycoprotein,Envelope glycoprotein
SARS-CoV-2 S Omicron Spike B.1.1.529 - 3-P2G3 and 1-P5C3 Fabs (Global)
0.6797.060.94 12-1208EM0.00hetero-3-3-1-1-3-mer26 x NAG, 14 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 2 x NAG-NAG-BMABLAST0.61
7qtj.1.C
Surface glycoprotein
SARS-CoV-2 S Omicron Spike B.1.1.529 - RBD up - 1-P2G3 and 1-P5C3 Fabs (Local)
0.0197.060.94 12-1208EM0.00hetero-1-1-2-1-1-mer1 x NAG-NAG-BMA, 1 x NAG-NAGBLAST0.61
8aqu.1.B
Spike glycoprotein,Fibritin
BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local)
0.0097.060.94 12-1208EM0.00hetero-1-1-mer1 x NAG, 1 x NAG-NAGBLAST0.61
7zrv.1.C
Spike glycoprotein,Envelope glycoprotein
cryo-EM structure of omicron spike in complex with de novo designed binder, full map
0.6897.060.94 12-1208EM0.00hetero-3-2-mer16 x NAG, 18 x NAG-NAG, 12 x NAG-NAG-BMABLAST0.61
7zrv.1.B
Spike glycoprotein,Envelope glycoprotein
cryo-EM structure of omicron spike in complex with de novo designed binder, full map
0.6897.060.94 12-1208EM0.00hetero-3-2-mer16 x NAG, 18 x NAG-NAG, 12 x NAG-NAG-BMABLAST0.61
7zrv.1.A
Spike glycoprotein,Envelope glycoprotein
cryo-EM structure of omicron spike in complex with de novo designed binder, full map
0.6897.060.94 12-1208EM0.00hetero-3-2-mer16 x NAG, 18 x NAG-NAG, 12 x NAG-NAG-BMABLAST0.61
7tly.1.C
Spike glycoprotein
SARS-CoV-2 S B.1.1.529 Omicron variant (RBD + S309 Local Refinement)
0.0395.830.94 1-1205EM0.00hetero-1-1-1-merHHblits0.60
7tm0.1.A
Spike glycoprotein
SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement
0.7295.830.94 1-1205EM0.00hetero-3-3-3-3-3-mer50 x NAG, 1 x NAG-NAGHHblits0.60
7tm0.1.B
Spike glycoprotein
SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement
0.7195.830.94 1-1205EM0.00hetero-3-3-3-3-3-mer50 x NAG, 1 x NAG-NAGHHblits0.60
7tm0.1.C
Spike glycoprotein
SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement
0.7295.830.94 1-1205EM0.00hetero-3-3-3-3-3-mer50 x NAG, 1 x NAG-NAGHHblits0.60
7tlz.1.C
Spike glycoprotein
SARS-CoV-2 S NTD B.1.1.529 Omicron variant + S309 Local Refinement
0.0995.830.94 1-1205EM0.00hetero-1-1-1-mer6 x NAGHHblits0.60
7y9z.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
0.7196.980.94 12-1208EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGBLAST0.60
7y9z.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
0.7096.980.94 12-1208EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGBLAST0.60
7y9z.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (one-RBD-up state)
0.7096.980.94 12-1208EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGBLAST0.60
7upl.1.A
Spike glycoprotein
SARS-Cov2 Omicron varient S protein structure in complex with neutralizing monoclonal antibody 002-S21F2
0.5995.500.94 1-1207EM0.00hetero-3-2-2-mer28 x NAG, 13 x NAG-NAGHHblits0.60
7upl.1.B
Spike glycoprotein
SARS-Cov2 Omicron varient S protein structure in complex with neutralizing monoclonal antibody 002-S21F2
0.5995.500.94 1-1207EM0.00hetero-3-2-2-mer28 x NAG, 13 x NAG-NAGHHblits0.60
7upl.1.C
Spike glycoprotein
SARS-Cov2 Omicron varient S protein structure in complex with neutralizing monoclonal antibody 002-S21F2
0.5995.500.94 1-1207EM0.00hetero-3-2-2-mer28 x NAG, 13 x NAG-NAGHHblits0.60
7ya0.1.A
Spike glycoprotein
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
0.6997.220.93 14-1208EM0.00hetero-3-3-mer33 x NAG, 3 x ZN, 15 x NAG-NAGBLAST0.61
7ya0.1.B
Spike glycoprotein
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
0.7097.220.93 14-1208EM0.00hetero-3-3-mer33 x NAG, 3 x ZN, 15 x NAG-NAGBLAST0.61
7ya0.1.C
Spike glycoprotein
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
0.6997.220.93 14-1208EM0.00hetero-3-3-mer33 x NAG, 3 x ZN, 15 x NAG-NAGBLAST0.61
8h00.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab in the class 1 conformation
0.7196.730.94 12-1208EM0.00hetero-3-3-3-mer15 x NAG, 15 x NAG-NAGBLAST0.60
8h01.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab in class 2 conformation
0.7196.730.94 12-1208EM0.00hetero-3-3-3-mer14 x NAG, 15 x NAG-NAGBLAST0.60
8h01.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab in class 2 conformation
0.7196.730.94 12-1208EM0.00hetero-3-3-3-mer14 x NAG, 15 x NAG-NAGBLAST0.60
8h01.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab in class 2 conformation
0.7196.730.94 12-1208EM0.00hetero-3-3-3-mer14 x NAG, 15 x NAG-NAGBLAST0.60
8itu.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 IgG.
0.7196.730.94 12-1208EM0.00hetero-3-3-3-mer14 x NAG, 15 x NAG-NAGBLAST0.60
7cn8.1.A
Glycoprotein
Cryo-EM structure of PCoV_GX spike glycoprotein
0.690.8691.680.95 1-1220EM0.00homo-trimer27 x NAG, 3 x EIC, 33 x NAG-NAGHHblits0.59
8gs6.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 BA.2.75 spike glycoprotein (closed state 1)
0.6896.150.94 12-1210EM0.00homo-trimer31 x NAG, 5 x NAG-NAGBLAST0.60
8gs6.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 BA.2.75 spike glycoprotein (closed state 1)
0.6896.150.94 12-1210EM0.00homo-trimer31 x NAG, 5 x NAG-NAGBLAST0.60
8gs6.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 BA.2.75 spike glycoprotein (closed state 1)
0.6796.150.94 12-1210EM0.00homo-trimer31 x NAG, 5 x NAG-NAGBLAST0.60
8fu7.1.A
Spike glycoprotein
Structure of Covid Spike variant deltaN135 in fully closed form
0.6599.240.92 12-1204EM0.00homo-trimer48 x NAGBLAST0.61
7tb4.1.A
Surface glycoprotein
Cryo-EM structure of the spike of SARS-CoV-2 Omicron variant of concern
0.6597.060.93 14-1208EM0.00homo-trimer29 x NAG, 15 x NAG-NAGBLAST0.61
7tb4.1.B
Surface glycoprotein
Cryo-EM structure of the spike of SARS-CoV-2 Omicron variant of concern
0.6597.060.93 14-1208EM0.00homo-trimer29 x NAG, 15 x NAG-NAGBLAST0.61
7tb4.1.C
Surface glycoprotein
Cryo-EM structure of the spike of SARS-CoV-2 Omicron variant of concern
0.6497.060.93 14-1208EM0.00homo-trimer29 x NAG, 15 x NAG-NAGBLAST0.61
7ws4.1.A
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
0.7296.730.94 12-1208EM0.00hetero-3-1-1-mer10 x NAG, 14 x NAG-NAGBLAST0.60
7ws4.1.B
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
0.7296.730.94 12-1208EM0.00hetero-3-1-1-mer10 x NAG, 14 x NAG-NAGBLAST0.60
7ws4.1.C
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
0.7296.730.94 12-1208EM0.00hetero-3-1-1-mer10 x NAG, 14 x NAG-NAGBLAST0.60
7ws5.1.B
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7296.730.94 12-1208EM0.00hetero-3-3-3-mer10 x NAG, 14 x NAG-NAGBLAST0.60
7ws8.1.A
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7296.730.94 12-1208EM0.00hetero-3-2-mer20 x NAG, 14 x NAG-NAGBLAST0.60
7ws8.1.B
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7296.730.94 12-1208EM0.00hetero-3-2-mer20 x NAG, 14 x NAG-NAGBLAST0.60
7ws8.1.C
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7396.730.94 12-1208EM0.00hetero-3-2-mer20 x NAG, 14 x NAG-NAGBLAST0.60
7ws9.1.A
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7296.730.94 12-1208EM0.00hetero-3-1-mer12 x NAG, 14 x NAG-NAGBLAST0.60
7ws9.1.B
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7296.730.94 12-1208EM0.00hetero-3-1-mer12 x NAG, 14 x NAG-NAGBLAST0.60
7ws9.1.C
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.7296.730.94 12-1208EM0.00hetero-3-1-mer12 x NAG, 14 x NAG-NAGBLAST0.60
7wwj.1.C
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab in the class 2 conformation
0.7196.730.94 12-1208EM0.00hetero-3-2-2-mer15 x NAG, 14 x NAG-NAGBLAST0.60
7wwi.1.B
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab in the class 1 conformation
0.7196.730.94 12-1208EM0.00hetero-3-3-3-mer15 x NAG, 14 x NAG-NAGBLAST0.60
7wwi.1.A
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab in the class 1 conformation
0.7196.730.94 12-1208EM0.00hetero-3-3-3-mer15 x NAG, 14 x NAG-NAGBLAST0.60
7xic.1.A
Spike glycoprotein
S-ECD (Omicron) in complex with STS165
0.6996.730.94 12-1208EM0.00hetero-3-3-3-mer29 x NAG, 19 x NAG-NAGBLAST0.60
7xic.1.B
Spike glycoprotein
S-ECD (Omicron) in complex with STS165
0.6996.730.94 12-1208EM0.00hetero-3-3-3-mer29 x NAG, 19 x NAG-NAGBLAST0.60
7xic.1.C
Spike glycoprotein
S-ECD (Omicron) in complex with STS165
0.6996.730.94 12-1208EM0.00hetero-3-3-3-mer29 x NAG, 19 x NAG-NAGBLAST0.60
7xid.1.A
Spike glycoprotein
S-ECD (Omicron) in complex with PD of ACE2
0.6796.730.94 12-1208EM0.00hetero-3-2-mer37 x NAG, 23 x NAG-NAGBLAST0.60
7xid.1.B
Spike glycoprotein
S-ECD (Omicron) in complex with PD of ACE2
0.6996.730.94 12-1208EM0.00hetero-3-2-mer37 x NAG, 23 x NAG-NAGBLAST0.60
7xid.1.C
Spike glycoprotein
S-ECD (Omicron) in complex with PD of ACE2
0.6996.730.94 12-1208EM0.00hetero-3-2-mer37 x NAG, 23 x NAG-NAGBLAST0.60
7t9k.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2
0.7296.730.94 12-1208EM0.00hetero-3-2-mer34 x NAG, 18 x NAG-NAGBLAST0.60
7t9j.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 Omicron spike protein
0.5896.730.94 12-1208EM0.00homo-trimer22 x NAG, 18 x NAG-NAGBLAST0.60
7t9j.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 Omicron spike protein
0.5896.730.94 12-1208EM0.00homo-trimer22 x NAG, 18 x NAG-NAGBLAST0.60
7t9k.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2
0.5796.730.94 12-1208EM0.00hetero-3-2-mer34 x NAG, 18 x NAG-NAGBLAST0.60
7wly.1.A
Spike glycoprotein
Cryo-EM structure of the Omicron S in complex with 35B5 Fab(1 down- and 2 up RBDs)
0.6996.730.94 12-1208EM0.00hetero-3-2-2-mer27 x NAG, 2 x NAG-NAGBLAST0.60
7wly.1.C
Spike glycoprotein
Cryo-EM structure of the Omicron S in complex with 35B5 Fab(1 down- and 2 up RBDs)
0.7096.730.94 12-1208EM0.00hetero-3-2-2-mer27 x NAG, 2 x NAG-NAGBLAST0.60
7wly.1.B
Spike glycoprotein
Cryo-EM structure of the Omicron S in complex with 35B5 Fab(1 down- and 2 up RBDs)
0.6996.730.94 12-1208EM0.00hetero-3-2-2-mer27 x NAG, 2 x NAG-NAGBLAST0.60
7wlz.1.C
Spike glycoprotein
Cryo-EM structure of the Omicron S in complex with 35B5 Fab(1 down-, 1 up- and 1 invisible RBDs)
0.5796.730.94 12-1208EM0.00hetero-3-1-1-mer27 x NAGBLAST0.60
8dzh.1.C
Spike glycoprotein
Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody MB.02
0.7096.730.94 12-1208EM0.00hetero-3-3-3-mer19 x NAG, 27 x NAG-NAGBLAST0.60
8dzi.1.G
Spike glycoprotein
Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody MB.02
0.7196.730.94 12-1208EM0.00hetero-3-3-3-mer22 x NAG, 20 x NAG-NAGBLAST0.60
8dzi.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody MB.02
0.7096.730.94 12-1208EM0.00hetero-3-3-3-mer22 x NAG, 20 x NAG-NAGBLAST0.60
8dzh.1.B
Spike glycoprotein
Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody MB.02
0.6996.730.94 12-1208EM0.00hetero-3-3-3-mer19 x NAG, 27 x NAG-NAGBLAST0.60
8dzi.1.D
Spike glycoprotein
Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with one RBD down in complex with the Fab fragment of human neutralizing antibody MB.02
0.7196.730.94 12-1208EM0.00hetero-3-3-3-mer22 x NAG, 20 x NAG-NAGBLAST0.60
8dzh.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with two RBDs down in complex with the Fab fragment of human neutralizing antibody MB.02
0.6896.730.94 12-1208EM0.00hetero-3-3-3-mer19 x NAG, 27 x NAG-NAGBLAST0.60
7wjz.1.G
Spike glycoprotein
Omicron Spike bitrimer with 6m6 antibody
0.6696.730.94 12-1208EM0.00hetero-6-6-6-mer49 x NAGBLAST0.60
7whi.1.C
Spike glycoprotein
The state 2 complex structure of Omicron spike with Bn03 (2-up RBD, 4 nanobodies)
0.6896.730.94 12-1208EM0.00hetero-3-3-1-mer36 x NAGBLAST0.60
7whj.1.A
Spike glycoprotein
The state 1 complex structure of Omicron spike with Bn03 (1-up RBD, 3 nanobodies)
0.6996.730.94 12-1208EM0.00hetero-3-2-1-mer40 x NAGBLAST0.60
7whj.1.B
Spike glycoprotein
The state 1 complex structure of Omicron spike with Bn03 (1-up RBD, 3 nanobodies)
0.7096.730.94 12-1208EM0.00hetero-3-2-1-mer40 x NAGBLAST0.60
7whj.1.C
Spike glycoprotein
The state 1 complex structure of Omicron spike with Bn03 (1-up RBD, 3 nanobodies)
0.6896.730.94 12-1208EM0.00hetero-3-2-1-mer40 x NAGBLAST0.60
7whk.1.A
Spike glycoprotein
The state 3 complex structure of Omicron spike with Bn03 (2-up RBD, 5 nanobodies)
0.7096.730.94 12-1208EM0.00hetero-3-2-3-mer28 x NAGBLAST0.60
7whk.1.B
Spike glycoprotein
The state 3 complex structure of Omicron spike with Bn03 (2-up RBD, 5 nanobodies)
0.7096.730.94 12-1208EM0.00hetero-3-2-3-mer28 x NAGBLAST0.60
7whk.1.C
Spike glycoprotein
The state 3 complex structure of Omicron spike with Bn03 (2-up RBD, 5 nanobodies)
0.6996.730.94 12-1208EM0.00hetero-3-2-3-mer28 x NAGBLAST0.60
7whi.1.A
Spike glycoprotein
The state 2 complex structure of Omicron spike with Bn03 (2-up RBD, 4 nanobodies)
0.6996.730.94 12-1208EM0.00hetero-3-3-1-mer36 x NAGBLAST0.60
7whi.1.B
Spike glycoprotein
The state 2 complex structure of Omicron spike with Bn03 (2-up RBD, 4 nanobodies)
0.7096.730.94 12-1208EM0.00hetero-3-3-1-mer36 x NAGBLAST0.60
7wjy.1.G
Spike glycoprotein
Omicron spike trimer with 6m6 antibody
0.6796.730.94 12-1208EM0.00hetero-3-2-2-mer24 x NAGBLAST0.60
7wjy.1.D
Spike glycoprotein
Omicron spike trimer with 6m6 antibody
0.6696.730.94 12-1208EM0.00hetero-3-2-2-mer24 x NAGBLAST0.60
7wz1.1.B
Spike glycoprotein
SARS-CoV-2 Omicron Spike trimer
0.6696.730.94 12-1208EM0.00homo-trimer28 x NAGBLAST0.60
7wz1.1.A
Spike glycoprotein
SARS-CoV-2 Omicron Spike trimer
0.6696.730.94 12-1208EM0.00homo-trimer28 x NAGBLAST0.60
7wjy.1.A
Spike glycoprotein
Omicron spike trimer with 6m6 antibody
0.6796.730.94 12-1208EM0.00hetero-3-2-2-mer24 x NAGBLAST0.60
7wz1.1.C
Spike glycoprotein
SARS-CoV-2 Omicron Spike trimer
0.6696.730.94 12-1208EM0.00homo-trimer28 x NAGBLAST0.60
7wow.1.C
Spike glycoprotein
The state 6 of Omicron Spike with bispecific antibody FD01
0.6496.730.94 12-1208EM0.00hetero-3-3-3-merBLAST0.60
7wov.1.A
Spike glycoprotein
The state 5 of Omicron Spike with bispecific antibody FD01
0.6796.730.94 12-1208EM0.00hetero-3-3-3-mer18 x NAGBLAST0.60
7wov.1.B
Spike glycoprotein
The state 5 of Omicron Spike with bispecific antibody FD01
0.6896.730.94 12-1208EM0.00hetero-3-3-3-mer18 x NAGBLAST0.60
7wor.1.A
Spike glycoprotein
The state 2 of Omicron Spike with bispecific antibody FD01
0.6596.730.94 12-1208EM0.00hetero-3-2-1-mer23 x NAGBLAST0.60
7wos.1.A
Spike glycoprotein
The state 3 of Omicron Spike with bispecific antibody FD01
0.6596.730.94 12-1208EM0.00hetero-3-2-2-mer21 x NAGBLAST0.60
7wor.1.B
Spike glycoprotein
The state 2 of Omicron Spike with bispecific antibody FD01
0.6796.730.94 12-1208EM0.00hetero-3-2-1-mer23 x NAGBLAST0.60
7wor.1.C
Spike glycoprotein
The state 2 of Omicron Spike with bispecific antibody FD01
0.6696.730.94 12-1208EM0.00hetero-3-2-1-mer23 x NAGBLAST0.60
7wou.1.A
Spike glycoprotein
The state 4 of Omicron Spike with bispecific antibody FD01
0.6896.730.94 12-1208EM0.00hetero-3-2-2-mer23 x NAGBLAST0.60
7wou.1.C
Spike glycoprotein
The state 4 of Omicron Spike with bispecific antibody FD01
0.6796.730.94 12-1208EM0.00hetero-3-2-2-mer23 x NAGBLAST0.60
7xj8.1.C
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab in the class 2 conformation
0.7196.730.94 12-1208EM0.00hetero-3-2-2-1-1-mer15 x NAG, 15 x NAG-NAGBLAST0.60
7xj8.1.B
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab in the class 2 conformation
0.7296.730.94 12-1208EM0.00hetero-3-2-2-1-1-mer15 x NAG, 15 x NAG-NAGBLAST0.60
7xj6.1.B
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab in the class 1 conformation
0.7196.730.94 12-1208EM0.00hetero-3-3-3-1-1-mer15 x NAG, 14 x NAG-NAGBLAST0.60
7xj6.1.A
Spike glycoprotein
SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab in the class 1 conformation
0.7196.730.94 12-1208EM0.00hetero-3-3-3-1-1-mer15 x NAG, 14 x NAG-NAGBLAST0.60
8erq.1.C
Spike glycoprotein
SARS-CoV-2 BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment (local refinement of the RBD and S2X324)
0.0396.890.93 12-1207EM0.00hetero-1-1-1-mer1 x NAGBLAST0.60
7xch.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
0.6896.970.93 14-1208EM0.00hetero-3-2-mer24 x NAG, 2 x ZN, 23 x NAG-NAGBLAST0.60
7xch.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
0.6996.970.93 14-1208EM0.00hetero-3-2-mer24 x NAG, 2 x ZN, 23 x NAG-NAGBLAST0.60
7xch.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
0.6996.970.93 14-1208EM0.00hetero-3-2-mer24 x NAG, 2 x ZN, 23 x NAG-NAGBLAST0.60
7xco.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with S309 fab
0.7196.970.93 14-1208EM0.00hetero-3-3-3-mer25 x NAG, 19 x NAG-NAGBLAST0.60
7xco.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with S309 fab
0.7196.970.93 14-1208EM0.00hetero-3-3-3-mer25 x NAG, 19 x NAG-NAGBLAST0.60
7xco.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with S309 fab
0.7196.970.93 14-1208EM0.00hetero-3-3-3-mer25 x NAG, 19 x NAG-NAGBLAST0.60
8fu9.1.A
Spike glycoprotein
Structure of Covid Spike variant deltaN25 with one erect RBD
0.6099.070.92 12-1208EM0.00homo-trimer38 x NAGBLAST0.61
8fu9.1.B
Spike glycoprotein
Structure of Covid Spike variant deltaN25 with one erect RBD
0.5999.070.92 12-1208EM0.00homo-trimer38 x NAGBLAST0.61
8fu9.1.C
Spike glycoprotein
Structure of Covid Spike variant deltaN25 with one erect RBD
0.6099.070.92 12-1208EM0.00homo-trimer38 x NAGBLAST0.61
8hc2.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 1 YB9-258 Fab (1 RBD up)
0.6796.970.93 14-1211EM0.00hetero-3-1-1-mer30 x NAG, 12 x NAG-NAGBLAST0.61
8hc2.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 1 YB9-258 Fab (1 RBD up)
0.6496.970.93 14-1211EM0.00hetero-3-1-1-mer30 x NAG, 12 x NAG-NAGBLAST0.61
8hc2.1.E
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 1 YB9-258 Fab (1 RBD up)
0.6796.970.93 14-1211EM0.00hetero-3-1-1-mer30 x NAG, 12 x NAG-NAGBLAST0.61
8hc3.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 2 YB9-258 Fabs (2 RBD up)
0.6496.970.93 14-1211EM0.00hetero-3-2-2-mer30 x NAG, 12 x NAG-NAGBLAST0.61
8hc3.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 2 YB9-258 Fabs (2 RBD up)
0.6596.970.93 14-1211EM0.00hetero-3-2-2-mer30 x NAG, 12 x NAG-NAGBLAST0.61
8hc9.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (3 RBD down)
0.6296.970.93 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.61
8hc9.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (3 RBD down)
0.6296.970.93 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.61
8hc9.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (3 RBD down)
0.6396.970.93 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.61
8hca.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (1 RBD up)
0.6396.970.93 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.61
8hca.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (1 RBD up)
0.6596.970.93 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.61
8hca.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (1 RBD up)
0.6696.970.93 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.61
8hcb.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (2 RBD up)
0.6696.970.93 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.61
8hcb.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (2 RBD up)
0.6796.970.93 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.61
8hcb.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (2 RBD up)
0.6896.970.93 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGBLAST0.61
7y9s.1.A
Spike glycoprotein
Cryo-EM structure of apo SARS-CoV-2 Omicron spike protein (S-2P-GSAS)
0.6897.050.93 15-1208EM0.00homo-trimer21 x NAG, 16 x NAG-NAGBLAST0.61
7y9s.1.B
Spike glycoprotein
Cryo-EM structure of apo SARS-CoV-2 Omicron spike protein (S-2P-GSAS)
0.6997.050.93 15-1208EM0.00homo-trimer21 x NAG, 16 x NAG-NAGBLAST0.61
7y9s.1.C
Spike glycoprotein
Cryo-EM structure of apo SARS-CoV-2 Omicron spike protein (S-2P-GSAS)
0.6897.050.93 15-1208EM0.00homo-trimer21 x NAG, 16 x NAG-NAGBLAST0.61
8bgg.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike (Omicron BA.1 variant) in complex with nanobody W25 (map 5, focus refinement on RBD, W25 and adjacent NTD)
0.0796.720.93 12-1207EM0.00hetero-2-1-mer5 x NAG, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMABLAST0.60
8bgg.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike (Omicron BA.1 variant) in complex with nanobody W25 (map 5, focus refinement on RBD, W25 and adjacent NTD)
0.0196.720.93 12-1207EM0.00hetero-2-1-mer5 x NAG, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMABLAST0.60
7wk5.1.D
Spike glycoprotein
Cryo-EM structure of Omicron S-ACE2, C2 state
0.6697.050.93 12-1205EM0.00hetero-1-3-merBLAST0.61
7wk5.1.C
Spike glycoprotein
Cryo-EM structure of Omicron S-ACE2, C2 state
0.6697.050.93 12-1205EM0.00hetero-1-3-merBLAST0.61
7wk5.1.B
Spike glycoprotein
Cryo-EM structure of Omicron S-ACE2, C2 state
0.6697.050.93 12-1205EM0.00hetero-1-3-merBLAST0.61
7wvo.1.A
Spike glycoprotein
SARS-CoV-2 Omicron S-open-2
0.6597.050.93 12-1205EM0.00homo-trimerBLAST0.61
7wvn.1.C
Spike glycoprotein
SARS-CoV-2 Omicron S-open
0.6497.050.93 12-1205EM0.00homo-trimerBLAST0.61
7wk4.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state
0.6797.050.93 12-1205EM0.00hetero-1-3-merBLAST0.61
7wvn.1.B
Spike glycoprotein
SARS-CoV-2 Omicron S-open
0.6497.050.93 12-1205EM0.00homo-trimerBLAST0.61
7wk4.1.D
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state
0.6697.050.93 12-1205EM0.00hetero-1-3-merBLAST0.61
7wk4.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state
0.6697.050.93 12-1205EM0.00hetero-1-3-merBLAST0.61
7thk.1.A
Spike glycoprotein
Cryo-EM structure of prefusion SARS-CoV-2 spike omicron B.1.1.529 variant
0.5997.050.93 12-1205EM0.00homo-trimer38 x NAGBLAST0.61
7thk.1.B
Spike glycoprotein
Cryo-EM structure of prefusion SARS-CoV-2 spike omicron B.1.1.529 variant
0.7397.050.93 12-1205EM0.00homo-trimer38 x NAGBLAST0.61
7thk.1.C
Spike glycoprotein
Cryo-EM structure of prefusion SARS-CoV-2 spike omicron B.1.1.529 variant
0.7397.050.93 12-1205EM0.00homo-trimer38 x NAGBLAST0.61
7upl.1.A
Spike glycoprotein
SARS-Cov2 Omicron varient S protein structure in complex with neutralizing monoclonal antibody 002-S21F2
0.5996.560.94 12-1207EM0.00hetero-3-2-2-mer28 x NAG, 13 x NAG-NAGBLAST0.60
7upl.1.B
Spike glycoprotein
SARS-Cov2 Omicron varient S protein structure in complex with neutralizing monoclonal antibody 002-S21F2
0.5896.560.94 12-1207EM0.00hetero-3-2-2-mer28 x NAG, 13 x NAG-NAGBLAST0.60
7upl.1.C
Spike glycoprotein
SARS-Cov2 Omicron varient S protein structure in complex with neutralizing monoclonal antibody 002-S21F2
0.5896.560.94 12-1207EM0.00hetero-3-2-2-mer28 x NAG, 13 x NAG-NAGBLAST0.60
7tgw.1.A
Spike glycoprotein
Omicron spike at 3.0 A (open form)
0.6696.230.94 14-1211EM0.00homo-trimer21 x NAG, 12 x NAG-NAGHHblits0.60
7tgw.1.B
Spike glycoprotein
Omicron spike at 3.0 A (open form)
0.6796.230.94 14-1211EM0.00homo-trimer21 x NAG, 12 x NAG-NAGHHblits0.60
7tgw.1.C
Spike glycoprotein
Omicron spike at 3.0 A (open form)
0.6796.230.94 14-1211EM0.00homo-trimer21 x NAG, 12 x NAG-NAGHHblits0.60
8f0g.1.C
Spike glycoprotein
Structure of SARS-CoV-2 Omicron BA.1 spike in complex with antibody Fab 1C3
0.6096.720.93 14-1208EM0.00hetero-1-1-3-mer18 x NAG, 3 x NAG-NAGBLAST0.60
8f0g.1.D
Spike glycoprotein
Structure of SARS-CoV-2 Omicron BA.1 spike in complex with antibody Fab 1C3
0.3596.720.93 14-1208EM0.00hetero-1-1-3-mer18 x NAG, 3 x NAG-NAGBLAST0.60
8f0g.1.E
Spike glycoprotein
Structure of SARS-CoV-2 Omicron BA.1 spike in complex with antibody Fab 1C3
0.5096.720.93 14-1208EM0.00hetero-1-1-3-mer18 x NAG, 3 x NAG-NAGBLAST0.60
7wrh.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2
0.7196.720.93 15-1208EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGBLAST0.60
7wrh.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2
0.7196.720.93 15-1208EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGBLAST0.60
7wrh.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2
0.7196.720.93 15-1208EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGBLAST0.60
7tca.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibody A19-46.1
0.6397.050.93 14-1205EM0.00hetero-3-2-2-mer27 x NAG, 14 x NAG-NAGBLAST0.61
7tca.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibody A19-46.1
0.6397.050.93 14-1205EM0.00hetero-3-2-2-mer27 x NAG, 14 x NAG-NAGBLAST0.61
7tca.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibody A19-46.1
0.6297.050.93 14-1205EM0.00hetero-3-2-2-mer27 x NAG, 14 x NAG-NAGBLAST0.61
7tcc.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibodies A19-46.1 and B1-182.1
0.6297.050.93 14-1205EM0.00hetero-3-3-3-3-3-mer15 x NAG, 13 x NAG-NAGBLAST0.61
7tcc.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibodies A19-46.1 and B1-182.1
0.6397.050.93 14-1205EM0.00hetero-3-3-3-3-3-mer15 x NAG, 13 x NAG-NAGBLAST0.61
7tcc.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibodies A19-46.1 and B1-182.1
0.6297.050.93 14-1205EM0.00hetero-3-3-3-3-3-mer15 x NAG, 13 x NAG-NAGBLAST0.61
7wri.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with mouse ACE2
0.0196.960.93 14-1205EM0.00hetero-1-1-mer1 x ZN, 1 x NAGBLAST0.60
8hhz.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike in complex with IY-2A
0.5696.140.94 14-1210EM0.00hetero-3-3-3-merHHblits0.60
8hhz.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike in complex with IY-2A
0.5796.140.94 14-1210EM0.00hetero-3-3-3-merHHblits0.60
8hhz.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 Spike in complex with IY-2A
0.5996.140.94 14-1210EM0.00hetero-3-3-3-merHHblits0.60
7ya0.1.A
Spike glycoprotein
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
0.6996.390.93 14-1208EM0.00hetero-3-3-mer33 x NAG, 3 x ZN, 15 x NAG-NAGHHblits0.60
7ya0.1.B
Spike glycoprotein
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
0.7096.390.93 14-1208EM0.00hetero-3-3-mer33 x NAG, 3 x ZN, 15 x NAG-NAGHHblits0.60
7ya0.1.C
Spike glycoprotein
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (S-6P-RRAR)
0.6996.390.93 14-1208EM0.00hetero-3-3-mer33 x NAG, 3 x ZN, 15 x NAG-NAGHHblits0.60
7tly.1.C
Spike glycoprotein
SARS-CoV-2 S B.1.1.529 Omicron variant (RBD + S309 Local Refinement)
0.0396.630.93 12-1205EM0.00hetero-1-1-1-merBLAST0.60
7tlz.1.C
Spike glycoprotein
SARS-CoV-2 S NTD B.1.1.529 Omicron variant + S309 Local Refinement
0.1196.630.93 12-1205EM0.00hetero-1-1-1-mer6 x NAGBLAST0.60
8gs6.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 BA.2.75 spike glycoprotein (closed state 1)
0.6895.560.94 12-1210EM0.00homo-trimer31 x NAG, 5 x NAG-NAGHHblits0.60
8gs6.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 BA.2.75 spike glycoprotein (closed state 1)
0.6795.560.94 12-1210EM0.00homo-trimer31 x NAG, 5 x NAG-NAGHHblits0.60
8gs6.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 BA.2.75 spike glycoprotein (closed state 1)
0.6795.560.94 12-1210EM0.00homo-trimer31 x NAG, 5 x NAG-NAGHHblits0.60
7xch.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
0.6896.130.93 14-1208EM0.00hetero-3-2-mer24 x NAG, 2 x ZN, 23 x NAG-NAGHHblits0.60
7xch.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
0.6996.130.93 14-1208EM0.00hetero-3-2-mer24 x NAG, 2 x ZN, 23 x NAG-NAGHHblits0.60
7xch.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodomain (two-RBD-up state)
0.6996.130.93 14-1208EM0.00hetero-3-2-mer24 x NAG, 2 x ZN, 23 x NAG-NAGHHblits0.60
7xco.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with S309 fab
0.7196.130.93 14-1208EM0.00hetero-3-3-3-mer25 x NAG, 19 x NAG-NAGHHblits0.60
7xco.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with S309 fab
0.7196.130.93 14-1208EM0.00hetero-3-3-3-mer25 x NAG, 19 x NAG-NAGHHblits0.60
7xco.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with S309 fab
0.7196.130.93 14-1208EM0.00hetero-3-3-3-mer25 x NAG, 19 x NAG-NAGHHblits0.60
8hc2.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 1 YB9-258 Fab (1 RBD up)
0.6796.130.93 14-1211EM0.00hetero-3-1-1-mer30 x NAG, 12 x NAG-NAGHHblits0.60
8hc3.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 2 YB9-258 Fabs (2 RBD up)
0.6796.130.93 14-1211EM0.00hetero-3-2-2-mer30 x NAG, 12 x NAG-NAGHHblits0.60
8hc2.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 1 YB9-258 Fab (1 RBD up)
0.6496.130.93 14-1211EM0.00hetero-3-1-1-mer30 x NAG, 12 x NAG-NAGHHblits0.60
8hc2.1.E
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 1 YB9-258 Fab (1 RBD up)
0.6796.130.93 14-1211EM0.00hetero-3-1-1-mer30 x NAG, 12 x NAG-NAGHHblits0.60
8hc3.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 2 YB9-258 Fabs (2 RBD up)
0.6396.130.93 14-1211EM0.00hetero-3-2-2-mer30 x NAG, 12 x NAG-NAGHHblits0.60
8hc3.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 2 YB9-258 Fabs (2 RBD up)
0.6496.130.93 14-1211EM0.00hetero-3-2-2-mer30 x NAG, 12 x NAG-NAGHHblits0.60
8hc9.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (3 RBD down)
0.6196.130.93 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.60
8hc9.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (3 RBD down)
0.6296.130.93 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.60
8hc9.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (3 RBD down)
0.6396.130.93 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.60
8hca.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (1 RBD up)
0.6396.130.93 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.60
8hca.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (1 RBD up)
0.6596.130.93 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.60
8hca.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (1 RBD up)
0.6696.130.93 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.60
8hcb.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (2 RBD up)
0.6696.130.93 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.60
8hcb.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (2 RBD up)
0.6796.130.93 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.60
8hcb.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (2 RBD up)
0.6896.130.93 14-1211EM0.00hetero-3-3-3-mer30 x NAG, 12 x NAG-NAGHHblits0.60
7tb4.1.A
Surface glycoprotein
Cryo-EM structure of the spike of SARS-CoV-2 Omicron variant of concern
0.6596.130.93 14-1208EM0.00homo-trimer29 x NAG, 15 x NAG-NAGHHblits0.60
7tb4.1.B
Surface glycoprotein
Cryo-EM structure of the spike of SARS-CoV-2 Omicron variant of concern
0.6596.130.93 14-1208EM0.00homo-trimer29 x NAG, 15 x NAG-NAGHHblits0.60
7tb4.1.C
Surface glycoprotein
Cryo-EM structure of the spike of SARS-CoV-2 Omicron variant of concern
0.6496.130.93 14-1208EM0.00homo-trimer29 x NAG, 15 x NAG-NAGHHblits0.60
7y9s.1.A
Spike glycoprotein
Cryo-EM structure of apo SARS-CoV-2 Omicron spike protein (S-2P-GSAS)
0.6896.130.93 15-1208EM0.00homo-trimer21 x NAG, 16 x NAG-NAGHHblits0.60
7y9s.1.B
Spike glycoprotein
Cryo-EM structure of apo SARS-CoV-2 Omicron spike protein (S-2P-GSAS)
0.6996.130.93 15-1208EM0.00homo-trimer21 x NAG, 16 x NAG-NAGHHblits0.60
7y9s.1.C
Spike glycoprotein
Cryo-EM structure of apo SARS-CoV-2 Omicron spike protein (S-2P-GSAS)
0.6896.130.93 15-1208EM0.00homo-trimer21 x NAG, 16 x NAG-NAGHHblits0.60
8f0g.1.C
Spike glycoprotein
Structure of SARS-CoV-2 Omicron BA.1 spike in complex with antibody Fab 1C3
0.5995.790.93 14-1208EM0.00hetero-1-1-3-mer18 x NAG, 3 x NAG-NAGHHblits0.60
8f0g.1.D
Spike glycoprotein
Structure of SARS-CoV-2 Omicron BA.1 spike in complex with antibody Fab 1C3
0.3595.790.93 14-1208EM0.00hetero-1-1-3-mer18 x NAG, 3 x NAG-NAGHHblits0.60
8f0g.1.E
Spike glycoprotein
Structure of SARS-CoV-2 Omicron BA.1 spike in complex with antibody Fab 1C3
0.5095.790.93 14-1208EM0.00hetero-1-1-3-mer18 x NAG, 3 x NAG-NAGHHblits0.60
7wrh.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2
0.7195.790.93 15-1208EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGHHblits0.60
7wrh.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2
0.7195.790.93 15-1208EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGHHblits0.60
7wrh.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2
0.7195.790.93 15-1208EM0.00hetero-3-1-mer23 x NAG, 1 x ZN, 22 x NAG-NAGHHblits0.60
7tca.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibody A19-46.1
0.6396.120.93 14-1205EM0.00hetero-3-2-2-mer27 x NAG, 14 x NAG-NAGHHblits0.60
7tca.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibody A19-46.1
0.6396.120.93 14-1205EM0.00hetero-3-2-2-mer27 x NAG, 14 x NAG-NAGHHblits0.60
7tca.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibody A19-46.1
0.6296.120.93 14-1205EM0.00hetero-3-2-2-mer27 x NAG, 14 x NAG-NAGHHblits0.60
7tcc.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibodies A19-46.1 and B1-182.1
0.6296.120.93 14-1205EM0.00hetero-3-3-3-3-3-mer15 x NAG, 13 x NAG-NAGHHblits0.60
7tcc.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibodies A19-46.1 and B1-182.1
0.6396.120.93 14-1205EM0.00hetero-3-3-3-3-3-mer15 x NAG, 13 x NAG-NAGHHblits0.60
7tcc.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibodies A19-46.1 and B1-182.1
0.6296.120.93 14-1205EM0.00hetero-3-3-3-3-3-mer15 x NAG, 13 x NAG-NAGHHblits0.60
7wri.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with mouse ACE2
0.0196.040.93 14-1205EM0.00hetero-1-1-mer1 x ZN, 1 x NAGHHblits0.60
7cn8.1.A
Glycoprotein
Cryo-EM structure of PCoV_GX spike glycoprotein
0.690.8592.160.94 12-1216EM0.00homo-trimer27 x NAG, 3 x EIC, 33 x NAG-NAGBLAST0.59
8d8q.1.C
Spike glycoprotein
SARS-CoV-2 Spike RBD in complex with DMAbs 2130 and 2196
0.03100.000.91 16-1175EM0.00hetero-1-1-1-1-1-mer1 x NAGBLAST0.62
8d8r.1.C
Spike glycoprotein
SARS-CoV-2 Spike RBD in complex with DMAb 2196
0.02100.000.91 16-1175EM0.00hetero-1-1-1-mer1 x NAGBLAST0.62
8d8q.1.C
Spike glycoprotein
SARS-CoV-2 Spike RBD in complex with DMAbs 2130 and 2196
0.0399.570.91 16-1180EM0.00hetero-1-1-1-1-1-mer1 x NAGHHblits0.62
8d8r.1.C
Spike glycoprotein
SARS-CoV-2 Spike RBD in complex with DMAb 2196
0.0299.570.91 16-1180EM0.00hetero-1-1-1-mer1 x NAGHHblits0.62
7bbh.1.A
Surface glycoprotein
Structure of Coronavirus Spike from Smuggled Guangdong Pangolin
0.720.8189.740.94 1-1208EM0.00homo-trimer45 x NAG, 12 x NAG-NAGHHblits0.58
7t3m.1.A
Spike glycoprotein
SARS-CoV-2 S (Spike Glycoprotein) D614G with Three (3) RBDs Up, Bound to Antibody 2-7 scFv, composite map
0.6899.480.90 1-1149EM0.00hetero-3-3-3-mer45 x NAG, 3 x NAG-NAGHHblits0.61
7t3m.1.B
Spike glycoprotein
SARS-CoV-2 S (Spike Glycoprotein) D614G with Three (3) RBDs Up, Bound to Antibody 2-7 scFv, composite map
0.6899.480.90 1-1149EM0.00hetero-3-3-3-mer45 x NAG, 3 x NAG-NAGHHblits0.61
7t3m.1.D
Spike glycoprotein
SARS-CoV-2 S (Spike Glycoprotein) D614G with Three (3) RBDs Up, Bound to Antibody 2-7 scFv, composite map
0.6899.480.90 1-1149EM0.00hetero-3-3-3-mer45 x NAG, 3 x NAG-NAGHHblits0.61
7t67.1.A
Spike glycoprotein
SARS-CoV-2 S (Spike Glycoprotein) D614G with One(1) RBD Up
0.6599.480.90 1-1149EM0.00homo-trimer45 x NAG, 3 x NAG-NAGHHblits0.61
7t67.1.B
Spike glycoprotein
SARS-CoV-2 S (Spike Glycoprotein) D614G with One(1) RBD Up
0.6699.480.90 1-1149EM0.00homo-trimer45 x NAG, 3 x NAG-NAGHHblits0.61
7t67.1.C
Spike glycoprotein
SARS-CoV-2 S (Spike Glycoprotein) D614G with One(1) RBD Up
0.6699.480.90 1-1149EM0.00homo-trimer45 x NAG, 3 x NAG-NAGHHblits0.61
7bnm.1.A
Spike glycoprotein
Closed conformation of D614G SARS-CoV-2 spike protein
0.6999.560.90 1-1145EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7bnm.1.B
Spike glycoprotein
Closed conformation of D614G SARS-CoV-2 spike protein
0.6999.560.90 1-1145EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7bnm.1.C
Spike glycoprotein
Closed conformation of D614G SARS-CoV-2 spike protein
0.6999.560.90 1-1145EM0.00homo-trimer33 x NAG, 15 x NAG-NAGHHblits0.62
7bno.1.A
Spike glycoprotein
Open conformation of D614G SARS-CoV-2 spike with 2 Erect RBDs
0.6499.560.90 1-1145EM0.00homo-trimer31 x NAG, 1 x NAG-NAGHHblits0.62
7bno.1.B
Spike glycoprotein
Open conformation of D614G SARS-CoV-2 spike with 2 Erect RBDs
0.6499.560.90 1-1145EM0.00homo-trimer31 x NAG, 1 x NAG-NAGHHblits0.62
7bno.1.C
Spike glycoprotein
Open conformation of D614G SARS-CoV-2 spike with 2 Erect RBDs
0.6499.560.90 1-1145EM0.00homo-trimer31 x NAG, 1 x NAG-NAGHHblits0.62
7a25.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23)
0.7199.560.90 1-1145EM0.00hetero-3-3-mer45 x NAG, 9 x NAG-NAGHHblits0.62
7a25.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23)
0.7299.560.90 1-1145EM0.00hetero-3-3-mer45 x NAG, 9 x NAG-NAGHHblits0.62
7a25.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23)
0.7299.560.90 1-1145EM0.00hetero-3-3-mer45 x NAG, 9 x NAG-NAGHHblits0.62
7bbh.1.A
Surface glycoprotein
Structure of Coronavirus Spike from Smuggled Guangdong Pangolin
0.720.8190.490.93 12-1208EM0.00homo-trimer45 x NAG, 12 x NAG-NAGBLAST0.59
7zss.1.A
Spike glycoprotein
cryo-EM structure of D614 spike in complex with de novo designed binder
0.6699.480.90 1-1145EM0.00hetero-3-3-mer32 x NAG, 7 x NAG-NAGHHblits0.61
7zss.1.B
Spike glycoprotein
cryo-EM structure of D614 spike in complex with de novo designed binder
0.6699.480.90 1-1145EM0.00hetero-3-3-mer32 x NAG, 7 x NAG-NAGHHblits0.61
7zss.1.C
Spike glycoprotein
cryo-EM structure of D614 spike in complex with de novo designed binder
0.6699.480.90 1-1145EM0.00hetero-3-3-mer32 x NAG, 7 x NAG-NAGHHblits0.61
7tpr.1.A
Spike glycoprotein
Camel nanobodies 7A3 and 8A2 broadly neutralize SARS-CoV-2 variants
0.6699.210.90 15-1159EM0.00hetero-3-2-3-merHHblits0.61
7tpr.1.B
Spike glycoprotein
Camel nanobodies 7A3 and 8A2 broadly neutralize SARS-CoV-2 variants
0.6699.210.90 15-1159EM0.00hetero-3-2-3-merHHblits0.61
7tpr.1.C
Spike glycoprotein
Camel nanobodies 7A3 and 8A2 broadly neutralize SARS-CoV-2 variants
0.6599.210.90 15-1159EM0.00hetero-3-2-3-merHHblits0.61
7r18.1.A
Spike glycoprotein
Mink Variant SARS-CoV-2 Spike in Closed conformation
0.7099.130.90 1-1145EM0.00homo-trimer39 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.61
7r18.1.B
Spike glycoprotein
Mink Variant SARS-CoV-2 Spike in Closed conformation
0.6999.130.90 1-1145EM0.00homo-trimer39 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.61
7r18.1.C
Spike glycoprotein
Mink Variant SARS-CoV-2 Spike in Closed conformation
0.7099.130.90 1-1145EM0.00homo-trimer39 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.61
7t3m.1.A
Spike glycoprotein
SARS-CoV-2 S (Spike Glycoprotein) D614G with Three (3) RBDs Up, Bound to Antibody 2-7 scFv, composite map
0.6899.470.89 12-1149EM0.00hetero-3-3-3-mer45 x NAG, 3 x NAG-NAGBLAST0.62
7t67.1.A
Spike glycoprotein
SARS-CoV-2 S (Spike Glycoprotein) D614G with One(1) RBD Up
0.6599.470.89 12-1149EM0.00homo-trimer45 x NAG, 3 x NAG-NAGBLAST0.62
7t67.1.B
Spike glycoprotein
SARS-CoV-2 S (Spike Glycoprotein) D614G with One(1) RBD Up
0.6599.470.89 12-1149EM0.00homo-trimer45 x NAG, 3 x NAG-NAGBLAST0.62
7t67.1.C
Spike glycoprotein
SARS-CoV-2 S (Spike Glycoprotein) D614G with One(1) RBD Up
0.6699.470.89 12-1149EM0.00homo-trimer45 x NAG, 3 x NAG-NAGBLAST0.62
7cws.1.M
Spike glycoprotein
SARS-CoV-2 Spike Proteins Trimer in Complex with FC05 and H014 Fabs Cocktail
0.64100.000.89 14-1147EM0.00hetero-3-3-3-3-3-mer16 x NAG, 15 x NAG-NAGBLAST0.62
7cwt.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with hb27 and fc05 Fab cocktail
0.66100.000.89 14-1147EM0.00hetero-3-3-3-3-3-mer14 x NAGBLAST0.62
7cwt.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with hb27 and fc05 Fab cocktail
0.65100.000.89 14-1147EM0.00hetero-3-3-3-3-3-mer14 x NAGBLAST0.62
7cws.1.M
Spike glycoprotein
SARS-CoV-2 Spike Proteins Trimer in Complex with FC05 and H014 Fabs Cocktail
0.64100.000.89 14-1146EM0.00hetero-3-3-3-3-3-mer16 x NAG, 15 x NAG-NAGHHblits0.62
7cws.1.N
Spike glycoprotein
SARS-CoV-2 Spike Proteins Trimer in Complex with FC05 and H014 Fabs Cocktail
0.64100.000.89 14-1146EM0.00hetero-3-3-3-3-3-mer16 x NAG, 15 x NAG-NAGHHblits0.62
7cws.1.O
Spike glycoprotein
SARS-CoV-2 Spike Proteins Trimer in Complex with FC05 and H014 Fabs Cocktail
0.64100.000.89 14-1146EM0.00hetero-3-3-3-3-3-mer16 x NAG, 15 x NAG-NAGHHblits0.62
7cwt.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with hb27 and fc05 Fab cocktail
0.66100.000.89 14-1146EM0.00hetero-3-3-3-3-3-mer14 x NAGHHblits0.62
7cwt.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with hb27 and fc05 Fab cocktail
0.65100.000.89 14-1146EM0.00hetero-3-3-3-3-3-mer14 x NAGHHblits0.62
7cwt.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with hb27 and fc05 Fab cocktail
0.66100.000.89 14-1146EM0.00hetero-3-3-3-3-3-mer14 x NAGHHblits0.62
7wg6.1.A
Spike glycoprotein
Neutral Omicron Spike Trimer
0.6797.730.90 14-1162EM3.40homo-trimer24 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7wg6.1.B
Spike glycoprotein
Neutral Omicron Spike Trimer
0.6797.730.90 14-1162EM3.40homo-trimer24 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7wg6.1.C
Spike glycoprotein
Neutral Omicron Spike Trimer
0.6797.730.90 14-1162EM3.40homo-trimer24 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7bnm.1.A
Spike glycoprotein
Closed conformation of D614G SARS-CoV-2 spike protein
0.6999.560.89 12-1146EM0.00homo-trimer33 x NAG, 15 x NAG-NAGBLAST0.62
7bno.1.A
Spike glycoprotein
Open conformation of D614G SARS-CoV-2 spike with 2 Erect RBDs
0.6399.560.89 12-1146EM0.00homo-trimer31 x NAG, 1 x NAG-NAGBLAST0.62
7bno.1.B
Spike glycoprotein
Open conformation of D614G SARS-CoV-2 spike with 2 Erect RBDs
0.6499.560.89 12-1146EM0.00homo-trimer31 x NAG, 1 x NAG-NAGBLAST0.62
7bno.1.C
Spike glycoprotein
Open conformation of D614G SARS-CoV-2 spike with 2 Erect RBDs
0.6499.560.89 12-1146EM0.00homo-trimer31 x NAG, 1 x NAG-NAGBLAST0.62
7a25.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23)
0.7199.560.89 12-1146EM0.00hetero-3-3-mer45 x NAG, 9 x NAG-NAGBLAST0.62
7a25.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23)
0.7299.560.89 12-1146EM0.00hetero-3-3-mer45 x NAG, 9 x NAG-NAGBLAST0.62
7a25.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23)
0.7299.560.89 12-1146EM0.00hetero-3-3-mer45 x NAG, 9 x NAG-NAGBLAST0.62
8cyd.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-45
0.6599.820.89 15-1147EM0.00hetero-3-3-merBLAST0.62
8cyd.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-45
0.6699.820.89 15-1147EM0.00hetero-3-3-merBLAST0.62
8cyd.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-45
0.6699.820.89 15-1147EM0.00hetero-3-3-merBLAST0.62
7zss.1.A
Spike glycoprotein
cryo-EM structure of D614 spike in complex with de novo designed binder
0.6699.470.89 12-1146EM0.00hetero-3-3-mer32 x NAG, 7 x NAG-NAGBLAST0.62
7zss.1.B
Spike glycoprotein
cryo-EM structure of D614 spike in complex with de novo designed binder
0.6699.470.89 12-1146EM0.00hetero-3-3-mer32 x NAG, 7 x NAG-NAGBLAST0.62
7zss.1.C
Spike glycoprotein
cryo-EM structure of D614 spike in complex with de novo designed binder
0.6699.470.89 12-1146EM0.00hetero-3-3-mer32 x NAG, 7 x NAG-NAGBLAST0.62
7vhh.1.C
Spike glycoprotein
Delta variant of SARS-CoV-2 Spike protein
0.6699.380.89 14-1148EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
7vhh.1.A
Spike glycoprotein
Delta variant of SARS-CoV-2 Spike protein
0.6799.380.89 14-1148EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
7vhh.1.B
Spike glycoprotein
Delta variant of SARS-CoV-2 Spike protein
0.6799.380.89 14-1148EM0.00homo-trimer35 x NAG, 12 x NAG-NAGHHblits0.62
7vhn.1.B
Spike glycoprotein
Spike of SARS-CoV-2 spike protein(1 up)
0.6699.380.89 14-1148EM0.00homo-trimer31 x NAGHHblits0.62
7vhn.1.C
Spike glycoprotein
Spike of SARS-CoV-2 spike protein(1 up)
0.6799.380.89 14-1148EM0.00homo-trimer31 x NAGHHblits0.62
7vhn.1.A
Spike glycoprotein
Spike of SARS-CoV-2 spike protein(1 up)
0.6799.380.89 14-1148EM0.00homo-trimer31 x NAGHHblits0.62
8cyd.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-45
0.6599.820.89 15-1146EM0.00hetero-3-3-merHHblits0.62
8cyd.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-45
0.6699.820.89 15-1146EM0.00hetero-3-3-merHHblits0.62
8cyd.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-45
0.6699.820.89 15-1146EM0.00hetero-3-3-merHHblits0.62
7vx9.1.A
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in complex wth ACE2, state C1
0.6799.470.89 14-1146EM0.00hetero-3-1-merHHblits0.62
7vx9.1.B
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in complex wth ACE2, state C1
0.6799.470.89 14-1146EM0.00hetero-3-1-merHHblits0.62
7vx9.1.C
Spike glycoprotein
SARS-CoV-2 Kappa variant spike protein in complex wth ACE2, state C1
0.6699.470.89 14-1146EM0.00hetero-3-1-merHHblits0.62
7swx.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-57 (three down conformation)
0.7099.470.89 14-1146EM0.00hetero-3-1-1-mer25 x NAG, 28 x NAG-NAGBLAST0.62
7swx.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-57 (three down conformation)
0.6999.470.89 14-1146EM0.00hetero-3-1-1-mer25 x NAG, 28 x NAG-NAGBLAST0.62
7r18.1.A
Spike glycoprotein
Mink Variant SARS-CoV-2 Spike in Closed conformation
0.7099.380.89 12-1146EM0.00homo-trimer39 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-FUCBLAST0.62
7wg6.1.A
Spike glycoprotein
Neutral Omicron Spike Trimer
0.6797.030.90 14-1162EM3.40homo-trimer24 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7wg6.1.B
Spike glycoprotein
Neutral Omicron Spike Trimer
0.6797.030.90 14-1162EM3.40homo-trimer24 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7wg6.1.C
Spike glycoprotein
Neutral Omicron Spike Trimer
0.6797.030.90 14-1162EM3.40homo-trimer24 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.61
7swx.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-57 (three down conformation)
0.7099.470.89 14-1145EM0.00hetero-3-1-1-mer25 x NAG, 28 x NAG-NAGHHblits0.62
7swx.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-57 (three down conformation)
0.7099.470.89 14-1145EM0.00hetero-3-1-1-mer25 x NAG, 28 x NAG-NAGHHblits0.62
7swx.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-57 (three down conformation)
0.6999.470.89 14-1145EM0.00hetero-3-1-1-mer25 x NAG, 28 x NAG-NAGHHblits0.62
7wg8.1.A
Spike glycoprotein
Delta Spike Trimer(3 RBD Down)
0.6499.210.89 14-1148EM0.00homo-trimer39 x NAG, 6 x NAG-NAGBLAST0.61
7wg8.1.A
Spike glycoprotein
Delta Spike Trimer(3 RBD Down)
0.6499.120.89 14-1148EM0.00homo-trimer39 x NAG, 6 x NAG-NAGHHblits0.61
7wg8.1.B
Spike glycoprotein
Delta Spike Trimer(3 RBD Down)
0.6499.120.89 14-1148EM0.00homo-trimer39 x NAG, 6 x NAG-NAGHHblits0.61
7wg8.1.C
Spike glycoprotein
Delta Spike Trimer(3 RBD Down)
0.6499.120.89 14-1148EM0.00homo-trimer39 x NAG, 6 x NAG-NAGHHblits0.61
6zp2.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Locked State
0.6999.820.89 14-1141EM0.00homo-trimer3 x BLA, 39 x NAG, 3 x EIC, 15 x NAG-NAGBLAST0.62
7zjl.1.A
Spike glycoprotein
Delta SARS-CoV-2 spike protein in complex with REGN10987 Fab homologue.
0.6999.380.89 15-1146EM0.00hetero-3-3-3-merBLAST0.62
7zjl.1.B
Spike glycoprotein
Delta SARS-CoV-2 spike protein in complex with REGN10987 Fab homologue.
0.6999.380.89 15-1146EM0.00hetero-3-3-3-merBLAST0.62
7zjl.1.C
Spike glycoprotein
Delta SARS-CoV-2 spike protein in complex with REGN10987 Fab homologue.
0.6999.380.89 15-1146EM0.00hetero-3-3-3-merBLAST0.62
6zp2.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Locked State
0.6999.820.89 14-1140EM0.00homo-trimer3 x BLA, 39 x NAG, 3 x EIC, 15 x NAG-NAGHHblits0.62
6zp2.1.B
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Locked State
0.6999.820.89 14-1140EM0.00homo-trimer3 x BLA, 39 x NAG, 3 x EIC, 15 x NAG-NAGHHblits0.62
6zp2.1.C
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Locked State
0.6999.820.89 14-1140EM0.00homo-trimer3 x BLA, 39 x NAG, 3 x EIC, 15 x NAG-NAGHHblits0.62
7vhj.1.A
Spike glycoprotein
Furin Site deletion of SARS-CoV-2 spike
0.6399.820.89 14-1147EM0.00homo-trimerBLAST0.62
7vhj.1.B
Spike glycoprotein
Furin Site deletion of SARS-CoV-2 spike
0.6299.820.89 14-1147EM0.00homo-trimerBLAST0.62
7vhj.1.C
Spike glycoprotein
Furin Site deletion of SARS-CoV-2 spike
0.6299.820.89 14-1147EM0.00homo-trimerBLAST0.62
7wtf.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv051
0.6496.850.90 14-1162EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7wtf.1.D
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv051
0.6696.850.90 14-1162EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7wtf.1.E
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv051
0.6696.850.90 14-1162EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMABLAST0.61
7wtk.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv286
0.6196.850.90 14-1162EM0.00hetero-3-3-3-mer27 x NAG, 12 x NAG-NAG, 6 x NAG-NAG-BMABLAST0.61
7wtk.1.D
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv286
0.6396.850.90 14-1162EM0.00hetero-3-3-3-mer27 x NAG, 12 x NAG-NAG, 6 x NAG-NAG-BMABLAST0.61
7wtk.1.E
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv286
0.6296.850.90 14-1162EM0.00hetero-3-3-3-mer27 x NAG, 12 x NAG-NAG, 6 x NAG-NAG-BMABLAST0.61
7zjl.1.A
Spike glycoprotein
Delta SARS-CoV-2 spike protein in complex with REGN10987 Fab homologue.
0.6999.290.89 15-1145EM0.00hetero-3-3-3-merHHblits0.61
7zjl.1.B
Spike glycoprotein
Delta SARS-CoV-2 spike protein in complex with REGN10987 Fab homologue.
0.6999.290.89 15-1145EM0.00hetero-3-3-3-merHHblits0.61
7zjl.1.C
Spike glycoprotein
Delta SARS-CoV-2 spike protein in complex with REGN10987 Fab homologue.
0.6999.290.89 15-1145EM0.00hetero-3-3-3-merHHblits0.61
7cn9.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike ectodomain
0.5599.560.89 14-1140EM0.00homo-trimer23 x NAG, 8 x NAG-NAG, 1 x NAG-NAG-FUC, 2 x NAG-NAG-BMA, 2 x NAG-NAG-BMA-MANHHblits0.62
7cn9.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike ectodomain
0.5599.560.89 14-1140EM0.00homo-trimer23 x NAG, 8 x NAG-NAG, 1 x NAG-NAG-FUC, 2 x NAG-NAG-BMA, 2 x NAG-NAG-BMA-MANHHblits0.62
7cn9.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike ectodomain
0.5699.560.89 14-1140EM0.00homo-trimer23 x NAG, 8 x NAG-NAG, 1 x NAG-NAG-FUC, 2 x NAG-NAG-BMA, 2 x NAG-NAG-BMA-MANHHblits0.62
7vhj.1.A
Spike glycoprotein
Furin Site deletion of SARS-CoV-2 spike
0.6399.470.88 14-1146EM0.00homo-trimerHHblits0.62
7vhj.1.B
Spike glycoprotein
Furin Site deletion of SARS-CoV-2 spike
0.6299.470.88 14-1146EM0.00homo-trimerHHblits0.62
7vhj.1.C
Spike glycoprotein
Furin Site deletion of SARS-CoV-2 spike
0.6299.470.88 14-1146EM0.00homo-trimerHHblits0.62
8c1v.1.A
Spike glycoprotein
SARS-CoV-2 S-trimer (3 RBDs up) bound to TriSb92, fitted into cryo-EM map
0.6699.820.88 26-1149EM0.00hetero-3-3-mer39 x NAG, 6 x NAG-NAGHHblits0.62
8c1v.1.B
Spike glycoprotein
SARS-CoV-2 S-trimer (3 RBDs up) bound to TriSb92, fitted into cryo-EM map
0.6699.820.88 26-1149EM0.00hetero-3-3-mer39 x NAG, 6 x NAG-NAGHHblits0.62
8c1v.1.C
Spike glycoprotein
SARS-CoV-2 S-trimer (3 RBDs up) bound to TriSb92, fitted into cryo-EM map
0.6699.820.88 26-1149EM0.00hetero-3-3-mer39 x NAG, 6 x NAG-NAGHHblits0.62
7xtz.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-1 Conformation
0.6999.820.88 14-1141EM0.00homo-trimer39 x NAG, 3 x BLA, 3 x EIC, 15 x NAG-NAGBLAST0.62
7xu0.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-211 Conformation
0.6899.820.88 14-1141EM0.00homo-trimer38 x NAG, 3 x EIC, 3 x BLA, 14 x NAG-NAGBLAST0.62
7xu2.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-2 Conformation
0.6999.820.88 14-1140EM0.00homo-trimer36 x NAG, 3 x BLA, 3 x EIC, 12 x NAG-NAGBLAST0.62
7xu3.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Closed Conformation
0.7099.820.88 14-1140EM0.00homo-trimer3 x BLA, 27 x NAG, 9 x NAG-NAGBLAST0.62
7xu6.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), incubated in Low pH after 40-Day Storage in PBS, Locked-2 Conformation
0.7199.820.88 14-1140EM0.00homo-trimer39 x NAG, 3 x BLA, 12 x NAG-NAGBLAST0.62
7xu2.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-2 Conformation
0.6999.730.88 14-1140EM0.00homo-trimer36 x NAG, 3 x BLA, 3 x EIC, 12 x NAG-NAGHHblits0.62
7xu2.1.B
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-2 Conformation
0.6999.730.88 14-1140EM0.00homo-trimer36 x NAG, 3 x BLA, 3 x EIC, 12 x NAG-NAGHHblits0.62
7xu2.1.C
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-2 Conformation
0.6999.730.88 14-1140EM0.00homo-trimer36 x NAG, 3 x BLA, 3 x EIC, 12 x NAG-NAGHHblits0.62
7xu3.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Closed Conformation
0.7099.730.88 14-1140EM0.00homo-trimer3 x BLA, 27 x NAG, 9 x NAG-NAGHHblits0.62
7xu3.1.B
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Closed Conformation
0.7099.730.88 14-1140EM0.00homo-trimer3 x BLA, 27 x NAG, 9 x NAG-NAGHHblits0.62
7xu3.1.C
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Closed Conformation
0.7099.730.88 14-1140EM0.00homo-trimer3 x BLA, 27 x NAG, 9 x NAG-NAGHHblits0.62
7xu6.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), incubated in Low pH after 40-Day Storage in PBS, Locked-2 Conformation
0.7199.730.88 14-1140EM0.00homo-trimer39 x NAG, 3 x BLA, 12 x NAG-NAGHHblits0.62
7xu6.1.B
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), incubated in Low pH after 40-Day Storage in PBS, Locked-2 Conformation
0.7199.730.88 14-1140EM0.00homo-trimer39 x NAG, 3 x BLA, 12 x NAG-NAGHHblits0.62
7xu6.1.C
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), incubated in Low pH after 40-Day Storage in PBS, Locked-2 Conformation
0.7199.730.88 14-1140EM0.00homo-trimer39 x NAG, 3 x BLA, 12 x NAG-NAGHHblits0.62
7xtz.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-1 Conformation
0.6999.730.88 14-1140EM0.00homo-trimer39 x NAG, 3 x BLA, 3 x EIC, 15 x NAG-NAGHHblits0.62
7xtz.1.B
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-1 Conformation
0.6999.730.88 14-1140EM0.00homo-trimer39 x NAG, 3 x BLA, 3 x EIC, 15 x NAG-NAGHHblits0.62
7xtz.1.C
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-1 Conformation
0.6999.730.88 14-1140EM0.00homo-trimer39 x NAG, 3 x BLA, 3 x EIC, 15 x NAG-NAGHHblits0.62
7xu0.1.B
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-211 Conformation
0.6999.730.88 14-1140EM0.00homo-trimer38 x NAG, 3 x EIC, 3 x BLA, 14 x NAG-NAGHHblits0.62
7xu0.1.C
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-211 Conformation
0.7099.730.88 14-1140EM0.00homo-trimer38 x NAG, 3 x EIC, 3 x BLA, 14 x NAG-NAGHHblits0.62
7xu0.1.A
Spike glycoprotein
Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-211 Conformation
0.6899.730.88 14-1140EM0.00homo-trimer38 x NAG, 3 x EIC, 3 x BLA, 14 x NAG-NAGHHblits0.62
7xu4.1.A
Spike glycoprotein
Structure of SARS-CoV-2 D614G Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-2 Conformation
0.6899.730.88 14-1140EM0.00homo-trimer39 x NAG, 3 x BLA, 3 x EIC, 12 x NAG-NAGBLAST0.62
7xu5.1.A
Spike glycoprotein
Structure of SARS-CoV-2 D614G Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Closed Conformation
0.6999.730.88 14-1140EM0.00homo-trimer3 x BLA, 30 x NAG, 6 x NAG-NAGBLAST0.62
7xu4.1.A
Spike glycoprotein
Structure of SARS-CoV-2 D614G Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-2 Conformation
0.6899.640.88 14-1140EM0.00homo-trimer39 x NAG, 3 x BLA, 3 x EIC, 12 x NAG-NAGHHblits0.62
7xu4.1.B
Spike glycoprotein
Structure of SARS-CoV-2 D614G Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-2 Conformation
0.6899.640.88 14-1140EM0.00homo-trimer39 x NAG, 3 x BLA, 3 x EIC, 12 x NAG-NAGHHblits0.62
7xu4.1.C
Spike glycoprotein
Structure of SARS-CoV-2 D614G Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Locked-2 Conformation
0.6899.640.88 14-1140EM0.00homo-trimer39 x NAG, 3 x BLA, 3 x EIC, 12 x NAG-NAGHHblits0.62
7xu5.1.A
Spike glycoprotein
Structure of SARS-CoV-2 D614G Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Closed Conformation
0.6999.640.88 14-1140EM0.00homo-trimer3 x BLA, 30 x NAG, 6 x NAG-NAGHHblits0.62
7xu5.1.B
Spike glycoprotein
Structure of SARS-CoV-2 D614G Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Closed Conformation
0.6999.640.88 14-1140EM0.00homo-trimer3 x BLA, 30 x NAG, 6 x NAG-NAGHHblits0.62
7xu5.1.C
Spike glycoprotein
Structure of SARS-CoV-2 D614G Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg S1/S2 cleavage site), Closed Conformation
0.6999.640.88 14-1140EM0.00homo-trimer3 x BLA, 30 x NAG, 6 x NAG-NAGHHblits0.62
7wtf.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv051
0.6495.980.90 14-1162EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.60
7wtf.1.D
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv051
0.6695.980.90 14-1162EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.60
7wtf.1.E
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv051
0.6695.980.90 14-1162EM0.00hetero-3-3-3-mer30 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMAHHblits0.60
7wtk.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv286
0.6095.980.90 14-1162EM0.00hetero-3-3-3-mer27 x NAG, 12 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.60
7wtk.1.D
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv286
0.6395.980.90 14-1162EM0.00hetero-3-3-3-mer27 x NAG, 12 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.60
7wtk.1.E
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv286
0.6295.980.90 14-1162EM0.00hetero-3-3-3-mer27 x NAG, 12 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.60
7l06.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to two copies of domain-swapped antibody 2G12
0.7099.820.88 27-1147EM0.00hetero-3-4-4-mer25 x NAG, 8 x NAG-NAG, 2 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA-MAN-MAN-MAN-BMA-BMA, 2 x NAG-NAG-BMA-MAN-BMABLAST0.62
7lab.1.F
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1052
0.6999.820.88 27-1147EM2.97hetero-3-3-3-mer31 x NAG, 14 x NAG-NAGBLAST0.62
7lcn.1.D
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1050.1
0.6899.820.88 27-1147EM3.35hetero-3-3-3-mer33 x NAG, 15 x NAG-NAGBLAST0.62
7lcn.1.G
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1050.1
0.6799.820.88 27-1147EM3.35hetero-3-3-3-mer33 x NAG, 15 x NAG-NAGBLAST0.62
7lcn.1.A
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1050.1
0.6899.820.88 27-1147EM3.35hetero-3-3-3-mer33 x NAG, 15 x NAG-NAGBLAST0.62
7lab.1.G
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1052
0.7099.820.88 27-1147EM2.97hetero-3-3-3-mer31 x NAG, 14 x NAG-NAGBLAST0.62
7lab.1.E
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1052
0.6999.820.88 27-1147EM2.97hetero-3-3-3-mer31 x NAG, 14 x NAG-NAGBLAST0.62
7laa.1.A
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1041
0.6799.730.88 27-1147EM0.00hetero-3-1-1-mer17 x NAG, 11 x NAG-NAG, 6 x NAG-NAG-BMABLAST0.62
7laa.1.B
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1041
0.5499.730.88 27-1147EM0.00hetero-3-1-1-mer17 x NAG, 11 x NAG-NAG, 6 x NAG-NAG-BMABLAST0.62
7laa.1.E
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1041
0.5499.730.88 27-1147EM0.00hetero-3-1-1-mer17 x NAG, 11 x NAG-NAG, 6 x NAG-NAG-BMABLAST0.62
7tht.1.B
Spike glycoprotein
CryoEM structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1042
0.6999.730.88 27-1147EM3.42hetero-3-3-3-mer33 x NAG, 1 x NAG-NAG-BMA, 12 x NAG-NAGBLAST0.62
7tht.1.A
Spike glycoprotein
CryoEM structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1042
0.6899.730.88 27-1147EM3.42hetero-3-3-3-mer33 x NAG, 1 x NAG-NAG-BMA, 12 x NAG-NAGBLAST0.62
7tht.1.C
Spike glycoprotein
CryoEM structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1042
0.6999.730.88 27-1147EM3.42hetero-3-3-3-mer33 x NAG, 1 x NAG-NAG-BMA, 12 x NAG-NAGBLAST0.62
7l06.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to two copies of domain-swapped antibody 2G12
0.6999.820.88 27-1146EM0.00hetero-3-4-4-mer25 x NAG, 8 x NAG-NAG, 2 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA-MAN-MAN-MAN-BMA-BMA, 2 x NAG-NAG-BMA-MAN-BMAHHblits0.62
7l06.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to two copies of domain-swapped antibody 2G12
0.6999.820.88 27-1146EM0.00hetero-3-4-4-mer25 x NAG, 8 x NAG-NAG, 2 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA-MAN-MAN-MAN-BMA-BMA, 2 x NAG-NAG-BMA-MAN-BMAHHblits0.62
7l09.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound domain-swapped antibody 2G12 from masked 3D refinement
0.7099.820.88 27-1146EM0.00hetero-3-2-2-mer32 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-MAN-MAN-MAN-BMA-BMA, 1 x NAG-NAG-BMA-MAN-BMAHHblits0.62
7l02.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to one copy of domain-swapped antibody 2G12
0.7099.820.88 27-1146EM0.00hetero-3-2-2-mer31 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-MAN-MAN-MAN-BMA-BMA, 1 x NAG-NAG-BMA-MAN-BMAHHblits0.62
7l09.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound domain-swapped antibody 2G12 from masked 3D refinement
0.7099.820.88 27-1146EM0.00hetero-3-2-2-mer32 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-MAN-MAN-MAN-BMA-BMA, 1 x NAG-NAG-BMA-MAN-BMAHHblits0.62
7l06.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to two copies of domain-swapped antibody 2G12
0.7099.820.88 27-1146EM0.00hetero-3-4-4-mer25 x NAG, 8 x NAG-NAG, 2 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA-MAN-MAN-MAN-BMA-BMA, 2 x NAG-NAG-BMA-MAN-BMAHHblits0.62
7l09.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound domain-swapped antibody 2G12 from masked 3D refinement
0.6999.820.88 27-1146EM0.00hetero-3-2-2-mer32 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-MAN-MAN-MAN-BMA-BMA, 1 x NAG-NAG-BMA-MAN-BMAHHblits0.62
7l02.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to one copy of domain-swapped antibody 2G12
0.6999.820.88 27-1146EM0.00hetero-3-2-2-mer31 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-MAN-MAN-MAN-BMA-BMA, 1 x NAG-NAG-BMA-MAN-BMAHHblits0.62
7l02.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to one copy of domain-swapped antibody 2G12
0.7099.820.88 27-1146EM0.00hetero-3-2-2-mer31 x NAG, 10 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-MAN-MAN-MAN-BMA-BMA, 1 x NAG-NAG-BMA-MAN-BMAHHblits0.62
7lab.1.F
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1052
0.6999.820.88 27-1146EM2.97hetero-3-3-3-mer31 x NAG, 14 x NAG-NAGHHblits0.62
7lcn.1.D
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1050.1
0.6899.820.88 27-1146EM3.35hetero-3-3-3-mer33 x NAG, 15 x NAG-NAGHHblits0.62
7lcn.1.G
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1050.1
0.6799.820.88 27-1146EM3.35hetero-3-3-3-mer33 x NAG, 15 x NAG-NAGHHblits0.62
7lcn.1.A
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1050.1
0.6899.820.88 27-1146EM3.35hetero-3-3-3-mer33 x NAG, 15 x NAG-NAGHHblits0.62
7lab.1.G
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1052
0.7099.820.88 27-1146EM2.97hetero-3-3-3-mer31 x NAG, 14 x NAG-NAGHHblits0.62
7lab.1.E
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1052
0.6999.820.88 27-1146EM2.97hetero-3-3-3-mer31 x NAG, 14 x NAG-NAGHHblits0.62
7whb.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (3U)
0.7099.820.88 27-1146EM0.00hetero-3-3-3-mer18 x NAG, 18 x NAG-NAGBLAST0.62
7whb.1.B
Spike glycoprotein
SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (3U)
0.6999.820.88 27-1146EM0.00hetero-3-3-3-mer18 x NAG, 18 x NAG-NAGBLAST0.62
7whd.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (2u1d)
0.6999.820.88 27-1146EM0.00hetero-3-3-3-mer20 x NAG, 17 x NAG-NAGBLAST0.62
7whd.1.B
Spike glycoprotein
SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (2u1d)
0.6899.820.88 27-1146EM0.00hetero-3-3-3-mer20 x NAG, 17 x NAG-NAGBLAST0.62
7whd.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (2u1d)
0.6999.820.88 27-1146EM0.00hetero-3-3-3-mer20 x NAG, 17 x NAG-NAGBLAST0.62
7y42.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein in complex with all-trans retinoic acid
0.6899.730.88 27-1147EM0.00homo-trimer27 x NAG, 3 x REABLAST0.62
7laa.1.A
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1041
0.6799.730.88 27-1146EM0.00hetero-3-1-1-mer17 x NAG, 11 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.62
7laa.1.B
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1041
0.5399.730.88 27-1146EM0.00hetero-3-1-1-mer17 x NAG, 11 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.62
7laa.1.E
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1041
0.5399.730.88 27-1146EM0.00hetero-3-1-1-mer17 x NAG, 11 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.62
7tht.1.B
Spike glycoprotein
CryoEM structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1042
0.6999.730.88 27-1146EM3.42hetero-3-3-3-mer33 x NAG, 1 x NAG-NAG-BMA, 12 x NAG-NAGHHblits0.62
7tht.1.A
Spike glycoprotein
CryoEM structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1042
0.6899.730.88 27-1146EM3.42hetero-3-3-3-mer33 x NAG, 1 x NAG-NAG-BMA, 12 x NAG-NAGHHblits0.62
7tht.1.C
Spike glycoprotein
CryoEM structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1042
0.6999.730.88 27-1146EM3.42hetero-3-3-3-mer33 x NAG, 1 x NAG-NAG-BMA, 12 x NAG-NAGHHblits0.62
7ld1.1.A
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1047
0.6699.460.88 27-1147EM3.40hetero-3-3-3-mer24 x NAG, 13 x NAG-NAG-BMA, 2 x NAG-NAGBLAST0.62
7ld1.1.B
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1047
0.6899.460.88 27-1147EM3.40hetero-3-3-3-mer24 x NAG, 13 x NAG-NAG-BMA, 2 x NAG-NAGBLAST0.62
7ld1.1.C
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1047
0.6899.460.88 27-1147EM3.40hetero-3-3-3-mer24 x NAG, 13 x NAG-NAG-BMA, 2 x NAG-NAGBLAST0.62
7tei.1.A
Spike glycoprotein
SARS-CoV-2 Omicron 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6996.140.90 1-1147EM0.00homo-trimer15 x NAG, 11 x NAG-NAG-BMA, 8 x NAG-NAG-BMA-MAN-MAN, 14 x NAG-NAGHHblits0.60
7tei.1.B
Spike glycoprotein
SARS-CoV-2 Omicron 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6696.140.90 1-1147EM0.00homo-trimer15 x NAG, 11 x NAG-NAG-BMA, 8 x NAG-NAG-BMA-MAN-MAN, 14 x NAG-NAGHHblits0.60
7tei.1.C
Spike glycoprotein
SARS-CoV-2 Omicron 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6796.140.90 1-1147EM0.00homo-trimer15 x NAG, 11 x NAG-NAG-BMA, 8 x NAG-NAG-BMA-MAN-MAN, 14 x NAG-NAGHHblits0.60
7tf8.1.A
Spike glycoprotein
SARS-CoV-2 Omicron 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6896.140.90 1-1147EM0.00homo-trimer25 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMA-MAN, 4 x NAG-NAG-BMA-MAN-MAN, 3 x NAG-NAG-BMAHHblits0.60
7tf8.1.B
Spike glycoprotein
SARS-CoV-2 Omicron 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6596.140.90 1-1147EM0.00homo-trimer25 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMA-MAN, 4 x NAG-NAG-BMA-MAN-MAN, 3 x NAG-NAG-BMAHHblits0.60
7tf8.1.C
Spike glycoprotein
SARS-CoV-2 Omicron 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6796.140.90 1-1147EM0.00homo-trimer25 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMA-MAN, 4 x NAG-NAG-BMA-MAN-MAN, 3 x NAG-NAG-BMAHHblits0.60
7tge.1.A
Spike glycoprotein
SARS-CoV-2 Omicron 1-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6596.140.90 1-1147EM0.00homo-trimer22 x NAG, 9 x NAG-NAGHHblits0.60
7tge.1.B
Spike glycoprotein
SARS-CoV-2 Omicron 1-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.5496.140.90 1-1147EM0.00homo-trimer22 x NAG, 9 x NAG-NAGHHblits0.60
7tge.1.C
Spike glycoprotein
SARS-CoV-2 Omicron 1-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.5396.140.90 1-1147EM0.00homo-trimer22 x NAG, 9 x NAG-NAGHHblits0.60
7tl1.1.A
Spike glycoprotein
SARS-CoV-2 Omicron 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6896.140.90 1-1147EM0.00homo-trimer26 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-BMA-MANHHblits0.60
7tl1.1.B
Spike glycoprotein
SARS-CoV-2 Omicron 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6696.140.90 1-1147EM0.00homo-trimer26 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-BMA-MANHHblits0.60
7tl1.1.C
Spike glycoprotein
SARS-CoV-2 Omicron 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6796.140.90 1-1147EM0.00homo-trimer26 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-BMA-MANHHblits0.60
7tl9.1.A
Spike glycoprotein
SARS-CoV-2 Omicron 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6696.140.90 1-1147EM0.00homo-trimer21 x NAG, 15 x NAG-NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG-MANHHblits0.60
7tl9.1.B
Spike glycoprotein
SARS-CoV-2 Omicron 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6696.140.90 1-1147EM0.00homo-trimer21 x NAG, 15 x NAG-NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG-MANHHblits0.60
7tl9.1.C
Spike glycoprotein
SARS-CoV-2 Omicron 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6896.140.90 1-1147EM0.00homo-trimer21 x NAG, 15 x NAG-NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG-MANHHblits0.60
7y42.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein in complex with all-trans retinoic acid
0.6899.730.88 27-1146EM0.00homo-trimer27 x NAG, 3 x REAHHblits0.62
7y42.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein in complex with all-trans retinoic acid
0.6899.730.88 27-1146EM0.00homo-trimer27 x NAG, 3 x REAHHblits0.62
7y42.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein in complex with all-trans retinoic acid
0.6899.730.88 27-1146EM0.00homo-trimer27 x NAG, 3 x REAHHblits0.62
7whb.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (3U)
0.7099.820.88 27-1145EM0.00hetero-3-3-3-mer18 x NAG, 18 x NAG-NAGHHblits0.62
7whb.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (3U)
0.7099.820.88 27-1145EM0.00hetero-3-3-3-mer18 x NAG, 18 x NAG-NAGHHblits0.62
7whb.1.B
Spike glycoprotein
SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (3U)
0.6999.820.88 27-1145EM0.00hetero-3-3-3-mer18 x NAG, 18 x NAG-NAGHHblits0.62
7whd.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (2u1d)
0.6999.820.88 27-1145EM0.00hetero-3-3-3-mer20 x NAG, 17 x NAG-NAGHHblits0.62
7whd.1.B
Spike glycoprotein
SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (2u1d)
0.6899.820.88 27-1145EM0.00hetero-3-3-3-mer20 x NAG, 17 x NAG-NAGHHblits0.62
7whd.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (2u1d)
0.6999.820.88 27-1145EM0.00hetero-3-3-3-mer20 x NAG, 17 x NAG-NAGHHblits0.62
7mkl.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-38 (three down conformation)
0.6199.460.88 27-1147EM0.00hetero-3-1-1-mer33 x NAG, 15 x NAG-NAGBLAST0.62
7mkl.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-38 (three down conformation)
0.6199.460.88 27-1147EM0.00hetero-3-1-1-mer33 x NAG, 15 x NAG-NAGBLAST0.62
7mkl.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-38 (three down conformation)
0.6399.460.88 27-1147EM0.00hetero-3-1-1-mer33 x NAG, 15 x NAG-NAGBLAST0.62
7e9n.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 down RBD, state1)
0.6599.460.88 27-1147EM0.00hetero-3-3-3-mer27 x NAGBLAST0.62
7e9n.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 down RBD, state1)
0.6799.460.88 27-1147EM0.00hetero-3-3-3-mer27 x NAGBLAST0.62
7e9n.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 down RBD, state1)
0.6699.460.88 27-1147EM0.00hetero-3-3-3-mer27 x NAGBLAST0.62
7dzx.1.A
Spike glycoprotein
Spike protein from SARS-CoV2 with Fab fragment of enhancing antibody 8D2
0.6399.460.88 27-1147EM0.00hetero-3-1-1-merHHblits0.62
7dzx.1.B
Spike glycoprotein
Spike protein from SARS-CoV2 with Fab fragment of enhancing antibody 8D2
0.6399.460.88 27-1147EM0.00hetero-3-1-1-merHHblits0.62
7dzx.1.C
Spike glycoprotein
Spike protein from SARS-CoV2 with Fab fragment of enhancing antibody 8D2
0.6399.460.88 27-1147EM0.00hetero-3-1-1-merHHblits0.62
7ld1.1.A
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1047
0.6699.460.88 27-1146EM3.40hetero-3-3-3-mer24 x NAG, 13 x NAG-NAG-BMA, 2 x NAG-NAGHHblits0.62
7ld1.1.B
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1047
0.6899.460.88 27-1146EM3.40hetero-3-3-3-mer24 x NAG, 13 x NAG-NAG-BMA, 2 x NAG-NAGHHblits0.62
7ld1.1.C
Spike glycoprotein
Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1047
0.6899.460.88 27-1146EM3.40hetero-3-3-3-mer24 x NAG, 13 x NAG-NAG-BMA, 2 x NAG-NAGHHblits0.62
7mkl.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-38 (three down conformation)
0.6199.460.88 27-1146EM0.00hetero-3-1-1-mer33 x NAG, 15 x NAG-NAGHHblits0.62
7mkl.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-38 (three down conformation)
0.6199.460.88 27-1146EM0.00hetero-3-1-1-mer33 x NAG, 15 x NAG-NAGHHblits0.62
7mkl.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-38 (three down conformation)
0.6399.460.88 27-1146EM0.00hetero-3-1-1-mer33 x NAG, 15 x NAG-NAGHHblits0.62
7e9n.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 down RBD, state1)
0.6599.460.88 27-1146EM0.00hetero-3-3-3-mer27 x NAGHHblits0.62
7e9n.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 down RBD, state1)
0.6799.460.88 27-1146EM0.00hetero-3-3-3-mer27 x NAGHHblits0.62
7e9n.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 down RBD, state1)
0.6699.460.88 27-1146EM0.00hetero-3-3-3-mer27 x NAGHHblits0.62
7vhm.1.A
Spike glycoprotein
Double deletion S-2P trimer(3 down)
0.6599.280.88 14-1147EM0.00homo-trimerBLAST0.61
7vhl.1.B
Spike glycoprotein
Double deletion S-2P trimer(1 Up)
0.5999.280.88 14-1147EM0.00homo-trimerBLAST0.61
7vhl.1.C
Spike glycoprotein
Double deletion S-2P trimer(1 Up)
0.6299.280.88 14-1147EM0.00homo-trimerBLAST0.61
7vhl.1.A
Spike glycoprotein
Double deletion S-2P trimer(1 Up)
0.6299.280.88 14-1147EM0.00homo-trimerBLAST0.61
7tei.1.A
Spike glycoprotein
SARS-CoV-2 Omicron 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.7097.080.89 12-1147EM0.00homo-trimer15 x NAG, 11 x NAG-NAG-BMA, 8 x NAG-NAG-BMA-MAN-MAN, 14 x NAG-NAGBLAST0.61
7tei.1.B
Spike glycoprotein
SARS-CoV-2 Omicron 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6697.080.89 12-1147EM0.00homo-trimer15 x NAG, 11 x NAG-NAG-BMA, 8 x NAG-NAG-BMA-MAN-MAN, 14 x NAG-NAGBLAST0.61
7tei.1.C
Spike glycoprotein
SARS-CoV-2 Omicron 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6897.080.89 12-1147EM0.00homo-trimer15 x NAG, 11 x NAG-NAG-BMA, 8 x NAG-NAG-BMA-MAN-MAN, 14 x NAG-NAGBLAST0.61
7tf8.1.A
Spike glycoprotein
SARS-CoV-2 Omicron 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6897.080.89 12-1147EM0.00homo-trimer25 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMA-MAN, 4 x NAG-NAG-BMA-MAN-MAN, 3 x NAG-NAG-BMABLAST0.61
7tf8.1.B
Spike glycoprotein
SARS-CoV-2 Omicron 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6597.080.89 12-1147EM0.00homo-trimer25 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMA-MAN, 4 x NAG-NAG-BMA-MAN-MAN, 3 x NAG-NAG-BMABLAST0.61
7tf8.1.C
Spike glycoprotein
SARS-CoV-2 Omicron 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6797.080.89 12-1147EM0.00homo-trimer25 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMA-MAN, 4 x NAG-NAG-BMA-MAN-MAN, 3 x NAG-NAG-BMABLAST0.61
7tge.1.A
Spike glycoprotein
SARS-CoV-2 Omicron 1-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6497.080.89 12-1147EM0.00homo-trimer22 x NAG, 9 x NAG-NAGBLAST0.61
7tge.1.B
Spike glycoprotein
SARS-CoV-2 Omicron 1-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.5597.080.89 12-1147EM0.00homo-trimer22 x NAG, 9 x NAG-NAGBLAST0.61
7tge.1.C
Spike glycoprotein
SARS-CoV-2 Omicron 1-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.5497.080.89 12-1147EM0.00homo-trimer22 x NAG, 9 x NAG-NAGBLAST0.61
7tl1.1.A
Spike glycoprotein
SARS-CoV-2 Omicron 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6897.080.89 12-1147EM0.00homo-trimer26 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-BMA-MANBLAST0.61
7tl1.1.B
Spike glycoprotein
SARS-CoV-2 Omicron 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6697.080.89 12-1147EM0.00homo-trimer26 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-BMA-MANBLAST0.61
7tl1.1.C
Spike glycoprotein
SARS-CoV-2 Omicron 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6897.080.89 12-1147EM0.00homo-trimer26 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-BMA-MANBLAST0.61
7tl9.1.A
Spike glycoprotein
SARS-CoV-2 Omicron 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6797.080.89 12-1147EM0.00homo-trimer21 x NAG, 15 x NAG-NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG-MANBLAST0.61
7tl9.1.B
Spike glycoprotein
SARS-CoV-2 Omicron 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6697.080.89 12-1147EM0.00homo-trimer21 x NAG, 15 x NAG-NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG-MANBLAST0.61
7tl9.1.C
Spike glycoprotein
SARS-CoV-2 Omicron 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-Omicron)
0.6997.080.89 12-1147EM0.00homo-trimer21 x NAG, 15 x NAG-NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG-MANBLAST0.61
7wbh.1.B
Spike glycoprotein
overall structure of hu33 and spike
0.6898.840.88 27-1146EM0.00hetero-1-2-3-3-mer26 x NAG, 3 x NAG-NAG-BMA, 10 x NAG-NAGBLAST0.61
7wbh.1.C
Spike glycoprotein
overall structure of hu33 and spike
0.6798.840.88 27-1146EM0.00hetero-1-2-3-3-mer26 x NAG, 3 x NAG-NAG-BMA, 10 x NAG-NAGBLAST0.61
7vhk.1.A
Spike glycoprotein
S1-S2 deletion S-2P trimer(3 down)
0.6299.820.88 27-1147EM0.00homo-trimerBLAST0.62
7wbh.1.A
Spike glycoprotein
overall structure of hu33 and spike
0.6798.750.88 27-1146EM0.00hetero-1-2-3-3-mer26 x NAG, 3 x NAG-NAG-BMA, 10 x NAG-NAGBLAST0.61
7wbh.1.B
Spike glycoprotein
overall structure of hu33 and spike
0.6898.840.88 27-1145EM0.00hetero-1-2-3-3-mer26 x NAG, 3 x NAG-NAG-BMA, 10 x NAG-NAGHHblits0.61
7wbh.1.C
Spike glycoprotein
overall structure of hu33 and spike
0.6798.840.88 27-1145EM0.00hetero-1-2-3-3-mer26 x NAG, 3 x NAG-NAG-BMA, 10 x NAG-NAGHHblits0.61
7wbh.1.A
Spike glycoprotein
overall structure of hu33 and spike
0.6798.750.88 27-1145EM0.00hetero-1-2-3-3-mer26 x NAG, 3 x NAG-NAG-BMA, 10 x NAG-NAGHHblits0.61
7xdk.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta Spike protein in complex with BA7054 and BA7125 fab
0.6998.840.88 26-1143EM0.00hetero-3-3-3-3-3-mer12 x NAG, 12 x NAG-NAGHHblits0.61
7xdk.1.F
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta Spike protein in complex with BA7054 and BA7125 fab
0.6998.840.88 26-1143EM0.00hetero-3-3-3-3-3-mer12 x NAG, 12 x NAG-NAGHHblits0.61
7xdk.1.K
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta Spike protein in complex with BA7054 and BA7125 fab
0.6898.840.88 26-1143EM0.00hetero-3-3-3-3-3-mer12 x NAG, 12 x NAG-NAGHHblits0.61
7vhm.1.A
Spike glycoprotein
Double deletion S-2P trimer(3 down)
0.6598.930.88 14-1146EM0.00homo-trimerHHblits0.61
7vhm.1.B
Spike glycoprotein
Double deletion S-2P trimer(3 down)
0.6598.930.88 14-1146EM0.00homo-trimerHHblits0.61
7vhm.1.C
Spike glycoprotein
Double deletion S-2P trimer(3 down)
0.6598.930.88 14-1146EM0.00homo-trimerHHblits0.61
7vhl.1.B
Spike glycoprotein
Double deletion S-2P trimer(1 Up)
0.5998.930.88 14-1146EM0.00homo-trimerHHblits0.61
7vhl.1.C
Spike glycoprotein
Double deletion S-2P trimer(1 Up)
0.6298.930.88 14-1146EM0.00homo-trimerHHblits0.61
7vhl.1.A
Spike glycoprotein
Double deletion S-2P trimer(1 Up)
0.6298.930.88 14-1146EM0.00homo-trimerHHblits0.61
7vhk.1.A
Spike glycoprotein
S1-S2 deletion S-2P trimer(3 down)
0.6299.460.87 27-1146EM0.00homo-trimerHHblits0.62
7vhk.1.B
Spike glycoprotein
S1-S2 deletion S-2P trimer(3 down)
0.6299.460.87 27-1146EM0.00homo-trimerHHblits0.62
7vhk.1.C
Spike glycoprotein
S1-S2 deletion S-2P trimer(3 down)
0.6299.460.87 27-1146EM0.00homo-trimerHHblits0.62
7xdl.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta Spike protein in complex with BA7208 and BA7125 fab
0.7098.840.88 26-1143EM3.08hetero-3-3-3-3-3-mer12 x NAG, 12 x NAG-NAGBLAST0.61
7xdl.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta Spike protein in complex with BA7208 and BA7125 fab
0.6998.840.88 26-1143EM3.08hetero-3-3-3-3-3-mer12 x NAG, 12 x NAG-NAGBLAST0.61
7xdl.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta Spike protein in complex with BA7208 and BA7125 fab
0.6998.840.88 26-1143EM3.08hetero-3-3-3-3-3-mer12 x NAG, 12 x NAG-NAGBLAST0.61
7xdl.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta Spike protein in complex with BA7208 and BA7125 fab
0.7098.750.88 26-1143EM3.08hetero-3-3-3-3-3-mer12 x NAG, 12 x NAG-NAGHHblits0.61
7xdl.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta Spike protein in complex with BA7208 and BA7125 fab
0.6998.750.88 26-1143EM3.08hetero-3-3-3-3-3-mer12 x NAG, 12 x NAG-NAGHHblits0.61
7xdl.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta Spike protein in complex with BA7208 and BA7125 fab
0.6998.750.88 26-1143EM3.08hetero-3-3-3-3-3-mer12 x NAG, 12 x NAG-NAGHHblits0.61
7xdb.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein in complex with BA7208 fab
0.7296.950.87 26-1144EM0.00hetero-3-3-3-mer16 x NAG, 11 x NAG-NAGBLAST0.61
7xdb.1.F
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein in complex with BA7208 fab
0.7196.950.87 26-1144EM0.00hetero-3-3-3-mer16 x NAG, 11 x NAG-NAGBLAST0.61
7xdb.1.G
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein in complex with BA7208 fab
0.7196.950.87 26-1144EM0.00hetero-3-3-3-mer16 x NAG, 11 x NAG-NAGBLAST0.61
7xdb.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein in complex with BA7208 fab
0.7196.050.88 26-1144EM0.00hetero-3-3-3-mer16 x NAG, 11 x NAG-NAGHHblits0.60
7xdb.1.F
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein in complex with BA7208 fab
0.7096.050.88 26-1144EM0.00hetero-3-3-3-mer16 x NAG, 11 x NAG-NAGHHblits0.60
7xdb.1.G
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron Spike protein in complex with BA7208 fab
0.7096.050.88 26-1144EM0.00hetero-3-3-3-mer16 x NAG, 11 x NAG-NAGHHblits0.60
6acc.1.A
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-free conformation with three RBD in down conformation
0.640.7876.790.93 1-1214EM0.00homo-trimerHHblits0.55
6acd.1.C
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-free conformation with one RBD in up conformation
0.640.8076.790.93 1-1214EM0.00homo-trimerHHblits0.55
6acg.1.A
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
0.570.7776.790.93 1-1214EM0.00homo-trimerHHblits0.55
6acg.1.B
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
0.580.7776.790.93 1-1214EM0.00homo-trimerHHblits0.55
6acg.1.C
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
0.590.7776.790.93 1-1214EM0.00homo-trimerHHblits0.55
6acj.1.A
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 2
0.610.8076.790.93 1-1214EM0.00homo-trimerHHblits0.55
6acj.1.B
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 2
0.600.8076.790.93 1-1214EM0.00homo-trimerHHblits0.55
6acj.1.C
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 2
0.610.8076.790.93 1-1214EM0.00homo-trimerHHblits0.55
6ack.1.A
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 3
0.6076.790.93 1-1214EM0.00hetero-3-1-merHHblits0.55
6ack.1.B
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 3
0.5976.790.93 1-1214EM0.00hetero-3-1-merHHblits0.55
6ack.1.C
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 3
0.6176.790.93 1-1214EM0.00hetero-3-1-merHHblits0.55
5xlr.1.A
Spike glycoprotein
Structure of SARS-CoV spike glycoprotein
0.5776.700.93 1-1214EM0.00homo-trimerHHblits0.55
5wrg.1.A
Spike glycoprotein
SARS-CoV spike glycoprotein
0.3976.700.93 1-1214EM0.00homo-trimerHHblits0.55
7sg4.1.A
Spike glycoprotein
Structure of SARS-CoV S protein in complex with Receptor Binding Domain antibody DH1047
0.6476.580.93 1-1208EM0.00hetero-3-1-1-mer47 x NAGHHblits0.54
7sg4.1.B
Spike glycoprotein
Structure of SARS-CoV S protein in complex with Receptor Binding Domain antibody DH1047
0.6376.580.93 1-1208EM0.00hetero-3-1-1-mer47 x NAGHHblits0.54
7sg4.1.C
Spike glycoprotein
Structure of SARS-CoV S protein in complex with Receptor Binding Domain antibody DH1047
0.6376.580.93 1-1208EM0.00hetero-3-1-1-mer47 x NAGHHblits0.54
7zh1.1.A
Spike glycoprotein,Fibritin
SARS CoV Spike protein, Closed C3 conformation
0.6776.960.92 14-1214EM0.00homo-trimer3 x EIC, 30 x NAG, 3 x NAG-NAGHHblits0.55
6nb6.1.A
Spike glycoprotein
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 1)
0.6976.920.92 18-1211EM0.00hetero-3-2-2-mer17 x NAG, 27 x NAG-NAG-BMA, 9 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG, 1 x NAG-NAG-BMA-MANHHblits0.55
6nb6.1.B
Spike glycoprotein
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 1)
0.6976.920.92 18-1211EM0.00hetero-3-2-2-mer17 x NAG, 27 x NAG-NAG-BMA, 9 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG, 1 x NAG-NAG-BMA-MANHHblits0.55
6nb6.1.C
Spike glycoprotein
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 1)
0.7076.920.92 18-1211EM0.00hetero-3-2-2-mer17 x NAG, 27 x NAG-NAG-BMA, 9 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG, 1 x NAG-NAG-BMA-MANHHblits0.55
6nb7.1.A
Spike glycoprotein
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 2)
0.6876.920.92 18-1211EM0.00hetero-3-3-3-mer16 x NAG, 21 x NAG-NAG-BMA, 6 x NAG-NAG-BMA-MAN-MAN, 4 x NAG-NAG-BMA-MAN, 6 x NAG-NAGHHblits0.55
6nb7.1.B
Spike glycoprotein
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 2)
0.6976.920.92 18-1211EM0.00hetero-3-3-3-mer16 x NAG, 21 x NAG-NAG-BMA, 6 x NAG-NAG-BMA-MAN-MAN, 4 x NAG-NAG-BMA-MAN, 6 x NAG-NAGHHblits0.55
6nb7.1.C
Spike glycoprotein
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 2)
0.6976.920.92 18-1211EM0.00hetero-3-3-3-mer16 x NAG, 21 x NAG-NAG-BMA, 6 x NAG-NAG-BMA-MAN-MAN, 4 x NAG-NAG-BMA-MAN, 6 x NAG-NAGHHblits0.55
6acc.1.A
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-free conformation with three RBD in down conformation
0.6277.720.92 26-1214EM0.00homo-trimerBLAST0.55
6acd.1.C
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-free conformation with one RBD in up conformation
0.6277.720.92 26-1214EM0.00homo-trimerBLAST0.55
6acg.1.A
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
0.5677.720.92 26-1214EM0.00hetero-3-1-merBLAST0.55
6acg.1.B
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
0.5777.720.92 26-1214EM0.00hetero-3-1-merBLAST0.55
6acg.1.C
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 1
0.5777.720.92 26-1214EM0.00hetero-3-1-merBLAST0.55
6acj.1.A
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 2
0.5977.720.92 26-1214EM0.00hetero-3-1-merBLAST0.55
6acj.1.B
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 2
0.5877.720.92 26-1214EM0.00hetero-3-1-merBLAST0.55
6acj.1.C
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 2
0.6077.720.92 26-1214EM0.00hetero-3-1-merBLAST0.55
6ack.1.A
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 3
0.5877.720.92 26-1214EM0.00hetero-3-1-merBLAST0.55
6ack.1.B
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 3
0.5777.720.92 26-1214EM0.00hetero-3-1-merBLAST0.55
6ack.1.C
Spike glycoprotein
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conformation 3
0.5977.720.92 26-1214EM0.00hetero-3-1-merBLAST0.55
5xlr.1.A
Spike glycoprotein
Structure of SARS-CoV spike glycoprotein
0.5777.630.92 26-1214EM0.00homo-trimerBLAST0.55
5wrg.1.A
Spike glycoprotein
SARS-CoV spike glycoprotein
0.3977.630.92 26-1214EM0.00homo-trimerBLAST0.55
5x58.1.A
Spike glycoprotein
Prefusion structure of SARS-CoV spike glycoprotein, conformation 1
0.6377.750.91 26-1211EM0.00homo-trimer42 x NAGBLAST0.55
5x5b.1.A
Spike glycoprotein
Prefusion structure of SARS-CoV spike glycoprotein, conformation 2
0.6377.750.91 26-1211EM0.00homo-trimerBLAST0.55
5x5b.1.C
Spike glycoprotein
Prefusion structure of SARS-CoV spike glycoprotein, conformation 2
0.6177.750.91 26-1211EM0.00homo-trimerBLAST0.55
7zh1.1.A
Spike glycoprotein,Fibritin
SARS CoV Spike protein, Closed C3 conformation
0.6877.750.91 26-1211EM0.00homo-trimer3 x EIC, 30 x NAG, 3 x NAG-NAGBLAST0.55
7zh2.1.A
Spike glycoprotein,Fibritin
SARS CoV Spike protein, Closed C1 conformation
0.6877.750.91 26-1211EM0.00homo-trimer3 x EIC, 27 x NAG, 3 x NAG-NAGBLAST0.55
7zh5.1.A
Spike glycoprotein,Fibritin
SARS CoV Spike protein, Open conformation
0.6077.750.91 26-1211EM0.00homo-trimer23 x NAGBLAST0.55
7zh5.1.B
Spike glycoprotein,Fibritin
SARS CoV Spike protein, Open conformation
0.6077.750.91 26-1211EM0.00homo-trimer23 x NAGBLAST0.55
7zh5.1.C
Spike glycoprotein,Fibritin
SARS CoV Spike protein, Open conformation
0.6277.750.91 26-1211EM0.00homo-trimer23 x NAGBLAST0.55
8h15.1.A
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein (S/native) at pH 5.5, Closed Conformation
0.6877.660.91 26-1211EM0.00homo-trimer18 x NAGBLAST0.55
8h16.1.A
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein (S/native) at pH 5.5, Open Conformation
0.6677.660.91 26-1211EM0.00homo-trimer32 x NAGBLAST0.55
8h16.1.B
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein (S/native) at pH 5.5, Open Conformation
0.5377.660.91 26-1211EM0.00homo-trimer32 x NAGBLAST0.55
8h16.1.C
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein (S/native) at pH 5.5, Open Conformation
0.6777.660.91 26-1211EM0.00homo-trimer32 x NAGBLAST0.55
6nb6.1.A
Spike glycoprotein
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 1)
0.6977.580.91 26-1211EM0.00hetero-3-2-2-mer17 x NAG, 27 x NAG-NAG-BMA, 9 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG, 1 x NAG-NAG-BMA-MANBLAST0.55
6nb6.1.B
Spike glycoprotein
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 1)
0.6977.580.91 26-1211EM0.00hetero-3-2-2-mer17 x NAG, 27 x NAG-NAG-BMA, 9 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG, 1 x NAG-NAG-BMA-MANBLAST0.55
6nb6.1.C
Spike glycoprotein
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 1)
0.7077.580.91 26-1211EM0.00hetero-3-2-2-mer17 x NAG, 27 x NAG-NAG-BMA, 9 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG, 1 x NAG-NAG-BMA-MANBLAST0.55
6nb7.1.A
Spike glycoprotein
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 2)
0.6877.580.91 26-1211EM0.00hetero-3-3-3-mer16 x NAG, 21 x NAG-NAG-BMA, 6 x NAG-NAG-BMA-MAN-MAN, 4 x NAG-NAG-BMA-MAN, 6 x NAG-NAGBLAST0.55
6nb7.1.B
Spike glycoprotein
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 2)
0.6977.580.91 26-1211EM0.00hetero-3-3-3-mer16 x NAG, 21 x NAG-NAG-BMA, 6 x NAG-NAG-BMA-MAN-MAN, 4 x NAG-NAG-BMA-MAN, 6 x NAG-NAGBLAST0.55
6nb7.1.C
Spike glycoprotein
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 2)
0.6977.580.91 26-1211EM0.00hetero-3-3-3-mer16 x NAG, 21 x NAG-NAG-BMA, 6 x NAG-NAG-BMA-MAN-MAN, 4 x NAG-NAG-BMA-MAN, 6 x NAG-NAGBLAST0.55
7zh2.1.A
Spike glycoprotein,Fibritin
SARS CoV Spike protein, Closed C1 conformation
0.6777.290.92 25-1214EM0.00homo-trimer3 x EIC, 27 x NAG, 3 x NAG-NAGHHblits0.55
7zh5.1.A
Spike glycoprotein,Fibritin
SARS CoV Spike protein, Open conformation
0.6077.290.92 25-1214EM0.00homo-trimer23 x NAGHHblits0.55
7zh5.1.B
Spike glycoprotein,Fibritin
SARS CoV Spike protein, Open conformation
0.5877.290.92 25-1214EM0.00homo-trimer23 x NAGHHblits0.55
7zh5.1.C
Spike glycoprotein,Fibritin
SARS CoV Spike protein, Open conformation
0.6177.290.92 25-1214EM0.00homo-trimer23 x NAGHHblits0.55
5x58.1.A
Spike glycoprotein
Prefusion structure of SARS-CoV spike glycoprotein, conformation 1
0.6277.290.92 25-1214EM0.00homo-trimer42 x NAGHHblits0.55
5x5b.1.A
Spike glycoprotein
Prefusion structure of SARS-CoV spike glycoprotein, conformation 2
0.6277.290.92 25-1214EM0.00homo-trimerHHblits0.55
5x5b.1.C
Spike glycoprotein
Prefusion structure of SARS-CoV spike glycoprotein, conformation 2
0.6077.290.92 25-1214EM0.00homo-trimerHHblits0.55
8h13.1.A
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x2 Disulfide (G400C and V969C), Closed Conformation
0.6377.490.91 26-1211EM0.00homo-trimer21 x NAGBLAST0.55
8h12.1.C
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x2 Disulfide (G400C and V969C), Locked-2 Conformation
0.6877.490.91 26-1211EM0.00homo-trimer39 x NAG, 3 x NAG-NAGBLAST0.55
8h14.1.A
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x3 Disulfide (D414C and V969C), Locked-1 Conformation
0.6977.490.91 26-1211EM0.00homo-trimer42 x NAG, 3 x EICBLAST0.55
8h0y.1.C
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-112 Conformation
0.6977.490.91 26-1211EM0.00homo-trimer3 x EIC, 46 x NAG, 3 x BLABLAST0.55
8h11.1.A
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Closed Conformation
0.6877.490.91 26-1211EM0.00homo-trimer37 x NAG, 1 x NAG-NAGBLAST0.55
8h10.1.A
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-2 Conformation
0.6977.490.91 26-1211EM0.00homo-trimer42 x NAG, 3 x BLA, 3 x EIC, 3 x NAG-NAGBLAST0.55
8h0y.1.B
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-112 Conformation
0.7077.490.91 26-1211EM0.00homo-trimer3 x EIC, 46 x NAG, 3 x BLABLAST0.55
8h0z.1.C
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-122 Conformation
0.6977.490.91 26-1211EM0.00homo-trimer39 x NAG, 3 x BLA, 3 x EIC, 3 x NAG-NAGBLAST0.55
8h0z.1.A
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-122 Conformation
0.6977.490.91 26-1211EM0.00homo-trimer39 x NAG, 3 x BLA, 3 x EIC, 3 x NAG-NAGBLAST0.55
8h0z.1.B
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-122 Conformation
0.6977.490.91 26-1211EM0.00homo-trimer39 x NAG, 3 x BLA, 3 x EIC, 3 x NAG-NAGBLAST0.55
8h15.1.A
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein (S/native) at pH 5.5, Closed Conformation
0.6777.490.91 25-1211EM0.00homo-trimer18 x NAGHHblits0.55
8h16.1.A
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein (S/native) at pH 5.5, Open Conformation
0.6577.490.91 25-1211EM0.00homo-trimer32 x NAGHHblits0.55
8h16.1.B
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein (S/native) at pH 5.5, Open Conformation
0.5277.490.91 25-1211EM0.00homo-trimer32 x NAGHHblits0.55
8h16.1.C
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein (S/native) at pH 5.5, Open Conformation
0.6677.490.91 25-1211EM0.00homo-trimer32 x NAGHHblits0.55
8h0y.1.C
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-112 Conformation
0.6877.320.91 25-1211EM0.00homo-trimer3 x EIC, 46 x NAG, 3 x BLAHHblits0.55
8h11.1.A
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Closed Conformation
0.6777.320.91 25-1211EM0.00homo-trimer37 x NAG, 1 x NAG-NAGHHblits0.55
8h10.1.A
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-2 Conformation
0.6877.320.91 25-1211EM0.00homo-trimer42 x NAG, 3 x BLA, 3 x EIC, 3 x NAG-NAGHHblits0.55
8h0y.1.B
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-112 Conformation
0.6977.320.91 25-1211EM0.00homo-trimer3 x EIC, 46 x NAG, 3 x BLAHHblits0.55
8h0z.1.C
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-122 Conformation
0.6877.320.91 25-1211EM0.00homo-trimer39 x NAG, 3 x BLA, 3 x EIC, 3 x NAG-NAGHHblits0.55
8h0z.1.A
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-122 Conformation
0.6877.320.91 25-1211EM0.00homo-trimer39 x NAG, 3 x BLA, 3 x EIC, 3 x NAG-NAGHHblits0.55
8h0z.1.B
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x1 Disulfide (S370C and D967C), Locked-122 Conformation
0.6877.320.91 25-1211EM0.00homo-trimer39 x NAG, 3 x BLA, 3 x EIC, 3 x NAG-NAGHHblits0.55
8h14.1.A
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x3 Disulfide (D414C and V969C), Locked-1 Conformation
0.6877.320.91 25-1211EM0.00homo-trimer42 x NAG, 3 x EICHHblits0.55
7sg4.1.A
Spike glycoprotein
Structure of SARS-CoV S protein in complex with Receptor Binding Domain antibody DH1047
0.6377.430.91 26-1208EM0.00hetero-3-1-1-mer47 x NAGBLAST0.55
7sg4.1.B
Spike glycoprotein
Structure of SARS-CoV S protein in complex with Receptor Binding Domain antibody DH1047
0.6377.430.91 26-1208EM0.00hetero-3-1-1-mer47 x NAGBLAST0.55
7sg4.1.C
Spike glycoprotein
Structure of SARS-CoV S protein in complex with Receptor Binding Domain antibody DH1047
0.6277.430.91 26-1208EM0.00hetero-3-1-1-mer47 x NAGBLAST0.55
6crv.1.A
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein, Stabilized variant, C3 symmetry
0.5877.350.91 26-1208EM0.00homo-trimer18 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMABLAST0.55
6crw.1.A
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein, Stabilized variant, single upwards S1 CTD conformation
0.6677.350.91 26-1208EM0.00homo-trimer13 x NAG, 5 x NAG-NAG-BMA, 7 x NAG-NAG-BMA-MAN, 9 x NAG-NAGBLAST0.55
6crw.1.B
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein, Stabilized variant, single upwards S1 CTD conformation
0.6777.350.91 26-1208EM0.00homo-trimer13 x NAG, 5 x NAG-NAG-BMA, 7 x NAG-NAG-BMA-MAN, 9 x NAG-NAGBLAST0.55
6crw.1.C
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein, Stabilized variant, single upwards S1 CTD conformation
0.6777.350.91 26-1208EM0.00homo-trimer13 x NAG, 5 x NAG-NAG-BMA, 7 x NAG-NAG-BMA-MAN, 9 x NAG-NAGBLAST0.55
6crx.1.A
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein, Stabilized variant, two S1 CTDs in the upwards conformation
0.6777.350.91 26-1208EM0.00homo-trimer7 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-BMA, 5 x NAG-NAG-BMA-MANBLAST0.55
6crx.1.B
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein, Stabilized variant, two S1 CTDs in the upwards conformation
0.6877.350.91 26-1208EM0.00homo-trimer7 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-BMA, 5 x NAG-NAG-BMA-MANBLAST0.55
6crx.1.C
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein, Stabilized variant, two S1 CTDs in the upwards conformation
0.6777.350.91 26-1208EM0.00homo-trimer7 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-BMA, 5 x NAG-NAG-BMA-MANBLAST0.55
6cs2.1.A
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
0.5677.350.91 26-1208EM0.00hetero-3-1-mer6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MANBLAST0.55
6cs2.1.B
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
0.6777.350.91 26-1208EM0.00hetero-3-1-mer6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MANBLAST0.55
6cs2.1.C
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
0.5677.350.91 26-1208EM0.00hetero-3-1-mer6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MANBLAST0.55
6crw.1.A
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein, Stabilized variant, single upwards S1 CTD conformation
0.6576.910.92 25-1212EM0.00homo-trimer13 x NAG, 5 x NAG-NAG-BMA, 7 x NAG-NAG-BMA-MAN, 9 x NAG-NAGHHblits0.55
6crw.1.B
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein, Stabilized variant, single upwards S1 CTD conformation
0.6676.910.92 25-1212EM0.00homo-trimer13 x NAG, 5 x NAG-NAG-BMA, 7 x NAG-NAG-BMA-MAN, 9 x NAG-NAGHHblits0.55
6crw.1.C
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein, Stabilized variant, single upwards S1 CTD conformation
0.6676.910.92 25-1212EM0.00homo-trimer13 x NAG, 5 x NAG-NAG-BMA, 7 x NAG-NAG-BMA-MAN, 9 x NAG-NAGHHblits0.55
6crx.1.A
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein, Stabilized variant, two S1 CTDs in the upwards conformation
0.6676.910.92 25-1212EM0.00homo-trimer7 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-BMA, 5 x NAG-NAG-BMA-MANHHblits0.55
6crx.1.B
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein, Stabilized variant, two S1 CTDs in the upwards conformation
0.6776.910.92 25-1212EM0.00homo-trimer7 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-BMA, 5 x NAG-NAG-BMA-MANHHblits0.55
6crx.1.C
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein, Stabilized variant, two S1 CTDs in the upwards conformation
0.6676.910.92 25-1212EM0.00homo-trimer7 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-BMA, 5 x NAG-NAG-BMA-MANHHblits0.55
6cs2.1.A
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
0.5476.910.92 25-1212EM0.00hetero-3-1-mer6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MANHHblits0.55
6cs2.1.B
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
0.6676.910.92 25-1212EM0.00hetero-3-1-mer6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MANHHblits0.55
6cs2.1.C
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles
0.5476.910.92 25-1212EM0.00hetero-3-1-mer6 x NAG, 9 x NAG-NAG-BMA, 7 x NAG-NAG, 11 x NAG-NAG-BMA-MANHHblits0.55
6crv.1.A
Spike glycoprotein,Fibritin
SARS Spike Glycoprotein, Stabilized variant, C3 symmetry
0.5676.910.92 25-1212EM0.00homo-trimer18 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.55
8h13.1.A
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x2 Disulfide (G400C and V969C), Closed Conformation
0.6277.300.91 26-1211EM0.00homo-trimer21 x NAGHHblits0.55
8h12.1.C
Spike glycoprotein
Structure of SARS-CoV-1 Spike Protein with Engineered x2 Disulfide (G400C and V969C), Locked-2 Conformation
0.6777.300.91 26-1211EM0.00homo-trimer39 x NAG, 3 x NAG-NAGHHblits0.55
7akj.1.A
Spike glycoprotein
Structure of the SARS-CoV spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment
0.6676.920.89 26-1178EM0.00hetero-3-3-3-mer33 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-FUCBLAST0.55
7akj.1.A
Spike glycoprotein
Structure of the SARS-CoV spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment
0.6576.810.89 26-1178EM0.00hetero-3-3-3-mer33 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-FUCHHblits0.55
5x5c.1.A
S protein
Prefusion structure of MERS-CoV spike glycoprotein, conformation 1
0.4731.070.92 10-1211EM0.00homo-trimerHHblits0.35
5x5c.1.B
S protein
Prefusion structure of MERS-CoV spike glycoprotein, conformation 1
0.4731.070.92 10-1211EM0.00homo-trimerHHblits0.35
5x5c.1.C
S protein
Prefusion structure of MERS-CoV spike glycoprotein, conformation 1
0.4731.070.92 10-1211EM0.00homo-trimerHHblits0.35
5x5f.1.C
S protein
Prefusion structure of MERS-CoV spike glycoprotein, conformation 2
0.4731.070.92 10-1211EM0.00homo-trimerHHblits0.35
7v3l.1.A
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 6516
0.4731.060.91 11-1207EM0.00hetero-3-3-3-merHHblits0.35
7v3l.1.B
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 6516
0.4731.060.91 11-1207EM0.00hetero-3-3-3-merHHblits0.35
7v3l.1.C
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 6516
0.4831.060.91 11-1207EM0.00hetero-3-3-3-merHHblits0.35
5w9m.1.A
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.2130.950.91 11-1208EM0.00hetero-6-2-2-merHHblits0.35
5w9k.1.L
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.3330.950.91 11-1208EM0.00hetero-6-3-3-merHHblits0.35
5w9k.1.K
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.3330.950.91 11-1208EM0.00hetero-6-3-3-merHHblits0.35
5w9n.1.J
MERS S
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.3430.950.91 11-1208EM0.00hetero-6-2-2-merHHblits0.35
5w9p.1.J
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.2330.950.91 11-1208EM0.00hetero-6-3-3-merHHblits0.35
5w9n.1.G
MERS S
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.2130.950.91 11-1208EM0.00hetero-6-2-2-merHHblits0.35
5w9j.1.D
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.2130.950.91 11-1208EM0.00hetero-6-3-3-merHHblits0.35
5w9j.1.L
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.3430.950.91 11-1208EM0.00hetero-6-3-3-merHHblits0.35
5w9m.1.E
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.2130.950.91 11-1208EM0.00hetero-6-2-2-merHHblits0.35
5w9m.1.D
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.2130.950.91 11-1208EM0.00hetero-6-2-2-merHHblits0.35
5w9l.1.H
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.3330.950.91 11-1208EM0.00hetero-6-2-2-merHHblits0.35
5w9l.1.B
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.2030.950.91 11-1208EM0.00hetero-6-2-2-merHHblits0.35
5w9l.1.E
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.2130.950.91 11-1208EM0.00hetero-6-2-2-merHHblits0.35
5w9p.1.I
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.2230.950.91 11-1208EM0.00hetero-6-3-3-merHHblits0.35
7x2a.1.A
MERS-CoV Spike glycoprotein
MERS-CoV spike complex with S41 neutralizing antibody Fab Class1 (1u2d RBD with 1Fab)
0.5230.970.91 11-1207EM0.00hetero-3-1-1-merHHblits0.35
7x29.1.C
Spike glycoprotein
MERS-CoV spike complex with S41 neutralizing antibody Fab Class2 (1u2d RBD with 2Fab)
0.5330.970.91 11-1207EM0.00hetero-3-2-2-merHHblits0.35
7x29.1.A
Spike glycoprotein
MERS-CoV spike complex with S41 neutralizing antibody Fab Class2 (1u2d RBD with 2Fab)
0.4630.970.91 11-1207EM0.00hetero-3-2-2-merHHblits0.35
7x28.1.C
Spike glycoprotein
MERS-CoV spike complex with S41 neutralizing antibody Fab Class3 (2u1d RBD with 2Fab)
0.5230.970.91 11-1207EM0.00hetero-2-2-3-merHHblits0.35
7x28.1.D
Spike glycoprotein
MERS-CoV spike complex with S41 neutralizing antibody Fab Class3 (2u1d RBD with 2Fab)
0.5230.970.91 11-1207EM0.00hetero-2-2-3-merHHblits0.35
7x25.1.E
Spike glycoprotein
MERS-CoV spike complex with S41 neutralizing antibody Fab Class4 (2u1d RBD with 3Fab)
0.5230.970.91 11-1207EM0.00hetero-3-3-3-merHHblits0.35
7x25.1.G
Spike glycoprotein
MERS-CoV spike complex with S41 neutralizing antibody Fab Class4 (2u1d RBD with 3Fab)
0.5330.970.91 11-1207EM0.00hetero-3-3-3-merHHblits0.35
7x25.1.H
Spike glycoprotein
MERS-CoV spike complex with S41 neutralizing antibody Fab Class4 (2u1d RBD with 3Fab)
0.5230.970.91 11-1207EM0.00hetero-3-3-3-merHHblits0.35
6q04.1.A
Spike glycoprotein
MERS-CoV S structure in complex with 5-N-acetyl neuraminic acid
0.5231.120.90 31-1211EM2.50homo-trimer21 x NAG, 3 x FOL, 3 x SIA, 6 x NAG-NAG-BMA-MAN, 12 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MAN-MAN-MAN, 3 x NAG-NAG-BMA, 6 x NAG-NAG-BMA-MAN-MANHHblits0.35
6nb3.1.G
Spike glycoprotein
MERS-CoV complex with human neutralizing LCA60 antibody Fab fragment (state 1)
0.5231.120.90 31-1211EM0.00hetero-3-2-2-mer5 x NAG, 14 x NAG-NAG, 15 x NAG-NAG-BMA, 8 x NAG-NAG-BMA-MAN-MAN-MAN, 6 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-MANHHblits0.35
6nb3.1.A
Spike glycoprotein
MERS-CoV complex with human neutralizing LCA60 antibody Fab fragment (state 1)
0.5231.120.90 31-1211EM0.00hetero-3-2-2-mer5 x NAG, 14 x NAG-NAG, 15 x NAG-NAG-BMA, 8 x NAG-NAG-BMA-MAN-MAN-MAN, 6 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-MANHHblits0.35
7u6r.1.A
PDF-2180 Spike glycoprotein
Cryo-EM structure of PDF-2180 Spike glycoprotein
0.5331.810.89 31-1211EM0.00homo-trimer39 x NAG, 6 x NAG-NAGHHblits0.36
7sb3.1.A
Spike protein
Structure of OC43 spike in complex with polyclonal Fab1 (Donor 269)
0.5430.800.90 1-1194EM0.00hetero-3-2-mer27 x NAG, 3 x 8Z9, 13 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.35
7sb3.1.C
Spike protein
Structure of OC43 spike in complex with polyclonal Fab1 (Donor 269)
0.5430.800.90 1-1194EM0.00hetero-3-2-mer27 x NAG, 3 x 8Z9, 13 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.35
7sb4.1.A
Spike protein
Structure of OC43 spike in complex with polyclonal Fab2 (Donor 1412)
0.5430.800.90 1-1194EM0.00hetero-3-2-mer31 x NAG, 3 x 8Z9, 9 x NAG-NAG, 2 x NAG-NAG-BMAHHblits0.35
7sb4.1.B
Spike protein
Structure of OC43 spike in complex with polyclonal Fab2 (Donor 1412)
0.5430.800.90 1-1194EM0.00hetero-3-2-mer31 x NAG, 3 x 8Z9, 9 x NAG-NAG, 2 x NAG-NAG-BMAHHblits0.35
7sb4.1.C
Spike protein
Structure of OC43 spike in complex with polyclonal Fab2 (Donor 1412)
0.5430.800.90 1-1194EM0.00hetero-3-2-mer31 x NAG, 3 x 8Z9, 9 x NAG-NAG, 2 x NAG-NAG-BMAHHblits0.35
7sbw.1.C
Spike protein
Structure of OC43 spike in complex with polyclonal Fab5 (Donor 1051)
0.5530.800.90 1-1194EM0.00hetero-2-3-mer12 x NAG, 3 x 8Z9, 11 x NAG-NAG-BMA, 20 x NAG-NAGHHblits0.35
5i08.1.A
Spike glycoprotein,Foldon chimera
Prefusion structure of a human coronavirus spike protein
0.4628.960.89 31-1222EM0.00homo-trimerHHblits0.34
7pnm.1.A
Spike glycoprotein
Human coronavirus OC43 spike glycoprotein ectodomain in complex with the 46C12 antibody Fab fragment
0.5431.050.87 13-1160EM0.00hetero-3-3-3-mer24 x NAG, 12 x NAG-NAGHHblits0.35
7po5.1.C
Spike glycoprotein
Human coronavirus OC43 spike glycoprotein ectodomain in complex with the 47C9 antibody Fab fragment
0.5331.050.87 13-1160EM0.00hetero-3-3-3-mer15 x NAGHHblits0.35
6nzk.1.A
Spike surface glycoprotein
Structural basis for human coronavirus attachment to sialic acid receptors
0.5531.050.87 13-1160EM0.00homo-trimer15 x NAG, 3 x MJJ, 15 x NAG-NAG-BMA, 6 x NAG-NAG-BMA-MAN, 9 x NAG-NAGHHblits0.35
7pnq.1.F
Spike glycoprotein
Human coronavirus OC43 spike glycoprotein ectodomain in complex with the 43E6 antibody Fab fragment
0.5431.080.87 13-1159EM0.00hetero-3-3-3-mer15 x NAGHHblits0.35
3jcl.1.A
Spike glycoprotein
Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer
0.4830.570.86 30-1161EM0.00homo-trimerHHblits0.35
7x27.1.A
Spike glycoprotein
MERS-CoV spike complex
0.4430.540.86 10-1144EM0.00homo-trimerHHblits0.35
6vsj.1.A
Spike glycoprotein
Cryo-electron microscopy structure of mouse coronavirus spike protein complexed with its murine receptor
0.4930.750.86 30-1172EM0.00hetero-3-3-mer12 x NAGHHblits0.35
7v5k.1.A
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 0722 (state 1)
0.4430.860.85 10-1122EM0.00hetero-3-3-3-merHHblits0.35
7v5k.1.B
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 0722 (state 1)
0.4430.860.85 10-1122EM0.00hetero-3-3-3-merHHblits0.35
7v5k.1.C
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 0722 (state 1)
0.4530.860.85 10-1122EM0.00hetero-3-3-3-merHHblits0.35
7v6n.1.B
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 111 state1
0.4230.860.85 10-1122EM0.00hetero-3-3-3-merHHblits0.35
7v6n.1.C
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 111 state1
0.4330.860.85 10-1122EM0.00hetero-3-3-3-merHHblits0.35
7v6n.1.A
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 111 state1
0.4330.860.85 10-1122EM0.00hetero-3-3-3-merHHblits0.35
7v5j.1.B
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 0722(state 2)
0.4430.860.85 10-1122EM0.00hetero-3-3-3-merHHblits0.35
7v5j.1.A
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 0722(state 2)
0.4530.860.85 10-1122EM0.00hetero-3-3-3-merHHblits0.35
7v5j.1.C
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 0722(state 2)
0.4430.860.85 10-1122EM0.00hetero-3-3-3-merHHblits0.35
7v6o.1.C
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 111 (state 2)
0.4430.860.85 10-1122EM0.00hetero-3-3-3-merHHblits0.35
7v6o.1.A
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 111 (state 2)
0.4430.860.85 10-1122EM0.00hetero-3-3-3-merHHblits0.35
7v6o.1.B
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 111 (state 2)
0.4330.860.85 10-1122EM0.00hetero-3-3-3-merHHblits0.35
7u6r.1.A
PDF-2180 Spike glycoprotein
Cryo-EM structure of PDF-2180 Spike glycoprotein
0.3937.010.77 200-1211EM0.00homo-trimer39 x NAG, 6 x NAG-NAGBLAST0.38
5x5c.1.A
S protein
Prefusion structure of MERS-CoV spike glycoprotein, conformation 1
0.3137.140.73 263-1211EM0.00homo-trimerBLAST0.38
5x5c.1.B
S protein
Prefusion structure of MERS-CoV spike glycoprotein, conformation 1
0.3037.140.73 263-1211EM0.00homo-trimerBLAST0.38
5x5c.1.C
S protein
Prefusion structure of MERS-CoV spike glycoprotein, conformation 1
0.3037.140.73 263-1211EM0.00homo-trimerBLAST0.38
5x5f.1.C
S protein
Prefusion structure of MERS-CoV spike glycoprotein, conformation 2
0.3137.140.73 263-1211EM0.00homo-trimerBLAST0.38
6q04.1.A
Spike glycoprotein
MERS-CoV S structure in complex with 5-N-acetyl neuraminic acid
0.3637.030.73 263-1211EM2.50homo-trimer21 x NAG, 3 x FOL, 3 x SIA, 6 x NAG-NAG-BMA-MAN, 12 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MAN-MAN-MAN, 3 x NAG-NAG-BMA, 6 x NAG-NAG-BMA-MAN-MANBLAST0.38
6nb3.1.G
Spike glycoprotein
MERS-CoV complex with human neutralizing LCA60 antibody Fab fragment (state 1)
0.3637.030.73 263-1211EM0.00hetero-3-2-2-mer5 x NAG, 14 x NAG-NAG, 15 x NAG-NAG-BMA, 8 x NAG-NAG-BMA-MAN-MAN-MAN, 6 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-MANBLAST0.38
6nb3.1.A
Spike glycoprotein
MERS-CoV complex with human neutralizing LCA60 antibody Fab fragment (state 1)
0.3637.030.73 263-1211EM0.00hetero-3-2-2-mer5 x NAG, 14 x NAG-NAG, 15 x NAG-NAG-BMA, 8 x NAG-NAG-BMA-MAN-MAN-MAN, 6 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-MANBLAST0.38
7v3l.1.A
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 6516
0.3037.230.73 263-1206EM0.00hetero-3-3-3-merBLAST0.38
7v3l.1.B
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 6516
0.3037.230.73 263-1206EM0.00hetero-3-3-3-merBLAST0.38
7v3l.1.C
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 6516
0.3137.230.73 263-1206EM0.00hetero-3-3-3-merBLAST0.38
7x2a.1.A
MERS-CoV Spike glycoprotein
MERS-CoV spike complex with S41 neutralizing antibody Fab Class1 (1u2d RBD with 1Fab)
0.3537.230.73 263-1206EM0.00hetero-3-1-1-merBLAST0.38
7x29.1.C
Spike glycoprotein
MERS-CoV spike complex with S41 neutralizing antibody Fab Class2 (1u2d RBD with 2Fab)
0.3737.230.73 263-1206EM0.00hetero-3-2-2-merBLAST0.38
7x29.1.A
Spike glycoprotein
MERS-CoV spike complex with S41 neutralizing antibody Fab Class2 (1u2d RBD with 2Fab)
0.3237.230.73 263-1206EM0.00hetero-3-2-2-merBLAST0.38
7x28.1.C
Spike glycoprotein
MERS-CoV spike complex with S41 neutralizing antibody Fab Class3 (2u1d RBD with 2Fab)
0.3537.230.73 263-1206EM0.00hetero-2-2-3-merBLAST0.38
7x28.1.D
Spike glycoprotein
MERS-CoV spike complex with S41 neutralizing antibody Fab Class3 (2u1d RBD with 2Fab)
0.3537.230.73 263-1206EM0.00hetero-2-2-3-merBLAST0.38
7x25.1.E
Spike glycoprotein
MERS-CoV spike complex with S41 neutralizing antibody Fab Class4 (2u1d RBD with 3Fab)
0.3737.230.73 263-1206EM0.00hetero-3-3-3-merBLAST0.38
7x25.1.G
Spike glycoprotein
MERS-CoV spike complex with S41 neutralizing antibody Fab Class4 (2u1d RBD with 3Fab)
0.3737.230.73 263-1206EM0.00hetero-3-3-3-merBLAST0.38
7x25.1.H
Spike glycoprotein
MERS-CoV spike complex with S41 neutralizing antibody Fab Class4 (2u1d RBD with 3Fab)
0.3637.230.73 263-1206EM0.00hetero-3-3-3-merBLAST0.38
5w9m.1.A
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.1537.120.73 263-1206EM0.00hetero-6-2-2-merBLAST0.38
5w9k.1.L
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.1137.120.73 263-1206EM0.00hetero-6-3-3-merBLAST0.38
5w9k.1.K
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.1237.120.73 263-1206EM0.00hetero-6-3-3-merBLAST0.38
5w9n.1.J
MERS S
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.1137.120.73 263-1206EM0.00hetero-6-2-2-merBLAST0.38
5w9p.1.J
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.0537.120.73 263-1206EM0.00hetero-6-3-3-merBLAST0.38
5w9n.1.G
MERS S
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.1537.120.73 263-1206EM0.00hetero-6-2-2-merBLAST0.38
5w9j.1.D
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.1537.120.73 263-1206EM0.00hetero-6-3-3-merBLAST0.38
5w9j.1.L
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.1237.120.73 263-1206EM0.00hetero-6-3-3-merBLAST0.38
5w9m.1.E
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.1537.120.73 263-1206EM0.00hetero-6-2-2-merBLAST0.38
5w9m.1.D
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.1537.120.73 263-1206EM0.00hetero-6-2-2-merBLAST0.38
5w9l.1.H
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.1137.120.73 263-1206EM0.00hetero-6-2-2-merBLAST0.38
5w9l.1.B
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.1537.120.73 263-1206EM0.00hetero-6-2-2-merBLAST0.38
5w9l.1.E
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.1537.120.73 263-1206EM0.00hetero-6-2-2-merBLAST0.38
5w9p.1.I
Spike glycoprotein
MERS S ectodomain trimer in complex with variable domain of neutralizing antibody G4
0.1737.120.73 263-1206EM0.00hetero-6-3-3-merBLAST0.38
7a91.1.B
Spike glycoprotein
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
0.19100.000.53 1-679EM0.00hetero-1-1-mer7 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.62
7a92.1.B
Spike glycoprotein
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement)
0.39100.000.53 1-676EM0.00hetero-1-1-mer7 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.62
8hc5.1.A
Spike glycoprotein
SARS-CoV-2 wildtype S1 in complex with YB9-258 Fab and R1-32 Fab
0.37100.000.53 1-675EM0.00hetero-1-1-1-1-1-mer1 x NAGHHblits0.62
7a91.1.B
Spike glycoprotein
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
0.20100.000.53 12-685EM0.00hetero-1-1-mer7 x NAG, 1 x ZN, 1 x NAG-NAGBLAST0.62
8hc5.1.A
Spike glycoprotein
SARS-CoV-2 wildtype S1 in complex with YB9-258 Fab and R1-32 Fab
0.37100.000.52 12-676EM0.00hetero-1-1-1-1-1-mer1 x NAGBLAST0.62
7x27.1.A
Spike glycoprotein
MERS-CoV spike complex
0.3037.490.66 263-1120EM0.00homo-trimerBLAST0.39
7v5k.1.A
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 0722 (state 1)
0.2837.370.66 263-1120EM0.00hetero-3-3-3-merBLAST0.39
7v5k.1.B
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 0722 (state 1)
0.2837.370.66 263-1120EM0.00hetero-3-3-3-merBLAST0.39
7v5k.1.C
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 0722 (state 1)
0.2937.370.66 263-1120EM0.00hetero-3-3-3-merBLAST0.39
7v6n.1.B
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 111 state1
0.2537.370.66 263-1120EM0.00hetero-3-3-3-merBLAST0.39
7v6n.1.C
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 111 state1
0.2637.370.66 263-1120EM0.00hetero-3-3-3-merBLAST0.39
7v6n.1.A
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 111 state1
0.2637.370.66 263-1120EM0.00hetero-3-3-3-merBLAST0.39
7v5j.1.B
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 0722(state 2)
0.2837.370.66 263-1120EM0.00hetero-3-3-3-merBLAST0.39
7v5j.1.A
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 0722(state 2)
0.2837.370.66 263-1120EM0.00hetero-3-3-3-merBLAST0.39
7v5j.1.C
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 0722(state 2)
0.2837.370.66 263-1120EM0.00hetero-3-3-3-merBLAST0.39
7v6o.1.C
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 111 (state 2)
0.2837.370.66 263-1120EM0.00hetero-3-3-3-merBLAST0.39
7v6o.1.A
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 111 (state 2)
0.2837.370.66 263-1120EM0.00hetero-3-3-3-merBLAST0.39
7v6o.1.B
Spike glycoprotein
MERS S ectodomain trimer in complex with neutralizing antibody 111 (state 2)
0.2837.370.66 263-1120EM0.00hetero-3-3-3-merBLAST0.39
6jx7.1.A
Feline Infectious Peritonitis Virus Spike Protein
Cryo-EM structure of spike protein of feline infectious peritonitis virus strain UU4
0.3028.420.68 263-1216EM0.00homo-trimer27 x NAG, 21 x NAG-NAG, 9 x NAG-NAG-BMA, 6 x NAG-NAG-BMA-MAN-MAN-MAN-MAN, 12 x NAG-NAG-BMA-MAN, 3 x NAG-NAG-BMA-FUC, 3 x NAG-NAG-BMA-MAN-MANHHblits0.35
7us6.1.A
Spike glycoprotein
Structure of the human coronavirus CCoV-HuPn-2018 spike glycoprotein with domain 0 in the proximal conformation
0.3128.440.67 263-1215EM0.00homo-trimer43 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MAN, 3 x BMA-MAN-MANHHblits0.35
7usa.1.A
Spike glycoprotein
Structure of the human coronavirus CCoV-HuPn-2018 spike glycoprotein with domain 0 in the swung out conformation
0.3028.440.67 263-1215EM0.00homo-trimer30 x NAG, 21 x NAG-NAG, 6 x NAG-NAG-BMAHHblits0.35
6m16.1.A
Spike glycoprotein
Cryo-EM structures of SADS-CoV spike glycoproteins
0.3128.180.67 258-1211EM0.00homo-trimer33 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.34
6m15.1.A
Spike glycoprotein
Cryo-EM structures of HKU2 spike glycoproteins
0.3228.010.66 263-1211EM0.00homo-trimer27 x NAG, 18 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.34
6cv0.1.A
Spike glycoprotein
Cryo-electron microscopy structure of infectious bronchitis coronavirus spike protein
0.2528.450.65 263-1201EM0.00homo-trimer39 x NAG, 15 x NAG-NAG, 6 x NAG-NAG-NAGHHblits0.34
6m39.1.A
Spike glycoprotein
Cryo-EM structure of SADS-CoV spike
0.3028.290.60 272-1138EM0.00homo-trimer54 x NAGHHblits0.35
6bfu.1.A
Spike protein
Glycan shield and fusion activation of a deltacoronavirus spike glycoprotein fine-tuned for enteric infections
0.2829.180.59 264-1149EM0.00homo-trimer24 x NAG, 9 x NAG-NAG-BMA-MAN-MAN-MAN, 21 x NAG-NAG-BMA, 6 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MANHHblits0.35
7kip.1.A
Spike glycoprotein
A 3.4 Angstrom cryo-EM structure of the human coronavirus spike trimer computationally derived from vitrified NL63 virus particles
0.2431.340.58 479-1266EM0.00homo-trimer24 x NAG, 3 x NAG-NAG-BMA-MAN-MAN-MAN, 33 x NAG-NAG, 9 x NAG-NAG-BMA-MAN, 3 x NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN, 3 x NAG-BMA, 6 x NAG-NAG-BMA-MAN-MAN, 6 x NAG-NAG-BMAHHblits0.36
6b7n.1.A
Spike protein
Cryo-electron microscopy structure of porcine delta coronavirus spike protein in the pre-fusion state
0.2829.160.59 266-1140EM0.00homo-trimer24 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-NAGHHblits0.35
7w6m.1.A
Spike glycoprotein
Cryo-EM map of PEDV (Pintung 52) S protein with all three protomers in the D0-down conformation determined in situ on intact viral particles.
0.2331.960.57 485-1266EM0.00homo-trimer18 x NAG, 6 x NAG-NAG-BMA-FUC, 21 x NAG-NAG-BMA-MAN-MAN, 9 x NAG-NAG-BMA, 3 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-FUC, 3 x NAG-NAG-FUCHHblits0.37
7w73.1.C
Spike glycoprotein
Cryo-EM map of PEDV S protein with one protomer in the D0-up conformation while the other two in the D0-down conformation
0.2231.960.57 485-1266EM0.00homo-trimer19 x NAG, 25 x NAG-NAG-BMA-MAN-MAN, 9 x NAG-NAG-BMA, 4 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN, 4 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x NAG-FUCHHblits0.37
7w73.1.A
Spike glycoprotein
Cryo-EM map of PEDV S protein with one protomer in the D0-up conformation while the other two in the D0-down conformation
0.2131.960.57 485-1266EM0.00homo-trimer19 x NAG, 25 x NAG-NAG-BMA-MAN-MAN, 9 x NAG-NAG-BMA, 4 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN, 4 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x NAG-FUCHHblits0.37
7w73.1.B
Spike glycoprotein
Cryo-EM map of PEDV S protein with one protomer in the D0-up conformation while the other two in the D0-down conformation
0.2131.960.57 485-1266EM0.00homo-trimer19 x NAG, 25 x NAG-NAG-BMA-MAN-MAN, 9 x NAG-NAG-BMA, 4 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN, 4 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x NAG-FUCHHblits0.37
7e9t.1.A
Spike protein S2
Nanometer resolution in situ structure of SARS-CoV-2 post-fusion spike
0.27100.000.42 703-1232EM0.00homo-trimer9 x NAG, 3 x NAG-NAG, 9 x NAG-NAG-MANBLAST0.61
7e9t.1.A
Spike protein S2
Nanometer resolution in situ structure of SARS-CoV-2 post-fusion spike
0.27100.000.42 704-1233EM0.00homo-trimer9 x NAG, 3 x NAG-NAG, 9 x NAG-NAG-MANHHblits0.61
7e9t.1.B
Spike protein S2
Nanometer resolution in situ structure of SARS-CoV-2 post-fusion spike
0.27100.000.42 704-1233EM0.00homo-trimer9 x NAG, 3 x NAG-NAG, 9 x NAG-NAG-MANHHblits0.61
7e9t.1.C
Spike protein S2
Nanometer resolution in situ structure of SARS-CoV-2 post-fusion spike
0.27100.000.42 704-1233EM0.00homo-trimer9 x NAG, 3 x NAG-NAG, 9 x NAG-NAG-MANHHblits0.61
8dya.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein S2 subunit
0.2598.470.41 686-1208EM0.00homo-trimer18 x NAGBLAST0.60
8dya.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein S2 subunit
0.2598.460.41 690-1208EM0.00homo-trimer18 x NAGHHblits0.60
8dya.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein S2 subunit
0.2598.460.41 690-1208EM0.00homo-trimer18 x NAGHHblits0.60
8dya.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein S2 subunit
0.2598.460.41 690-1208EM0.00homo-trimer18 x NAGHHblits0.60
8hc7.1.A
Spike protein S1
SARS-CoV-2 Omicron BA.1 spike trimer (6P) complex with YB9-258 Fab, focused refinement of RBD-dimer region
0.2996.250.40 14-526EM0.00hetero-1-1-1-1-mer7 x NAGBLAST0.61
8hc7.1.A
Spike protein S1
SARS-CoV-2 Omicron BA.1 spike trimer (6P) complex with YB9-258 Fab, focused refinement of RBD-dimer region
0.300.0094.290.40 14-526EM0.00monomer7 x NAGHHblits0.60
6u7h.1.A
spike glycoprotein
Cryo-EM structure of the HCoV-229E spike glycoprotein
0.2433.190.54 485-1221EM0.00homo-trimer33 x NAG, 3 x NAG-NAG-BMA-MAN-MAN-MAN-MAN, 9 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.37
7cyc.1.A
Spike glycoprotein
Cryo-EM structures of Alphacoronavirus spike glycoprotein
0.2233.530.53 485-1214EM0.00homo-trimer48 x NAG, 3 x NAG-NAG-BMA-MAN-MAN-MAN-MAN, 6 x NAG-NAG-BMA, 3 x NAG-NAGHHblits0.37
7cyd.1.A
Spike glycoprotein
Cryo-EM structures of Alphacoronavirus spike glycoprotein
0.2333.530.53 485-1214EM0.00homo-trimer42 x NAG, 3 x NAG-NAG-BMA-MAN-MAN-MAN-MAN, 3 x NAG-NAG-BMAHHblits0.37
5szs.1.A
Spike glycoprotein
Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy
0.2431.520.53 479-1208EM3.40homo-trimer21 x NAG, 3 x NAG-NAG-BMA-MAN-MAN-MAN, 33 x NAG-NAG, 9 x NAG-NAG-BMA-MAN, 3 x NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN, 9 x NAG-NAG-BMA, 6 x NAG-NAG-BMA-MAN-MANHHblits0.36
7sb3.1.A
Spike protein
Structure of OC43 spike in complex with polyclonal Fab1 (Donor 269)
0.260.3839.810.51 528-1194EM0.00homo-trimer27 x NAG, 3 x 8Z9, 13 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.39
7sb3.1.C
Spike protein
Structure of OC43 spike in complex with polyclonal Fab1 (Donor 269)
0.260.3839.810.51 528-1194EM0.00homo-trimer27 x NAG, 3 x 8Z9, 13 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.39
7sb4.1.A
Spike protein
Structure of OC43 spike in complex with polyclonal Fab2 (Donor 1412)
0.260.3939.810.51 528-1194EM0.00homo-trimer31 x NAG, 3 x 8Z9, 9 x NAG-NAG, 2 x NAG-NAG-BMABLAST0.39
7sb4.1.B
Spike protein
Structure of OC43 spike in complex with polyclonal Fab2 (Donor 1412)
0.260.3939.810.51 528-1194EM0.00homo-trimer31 x NAG, 3 x 8Z9, 9 x NAG-NAG, 2 x NAG-NAG-BMABLAST0.39
7sb4.1.C
Spike protein
Structure of OC43 spike in complex with polyclonal Fab2 (Donor 1412)
0.260.3939.810.51 528-1194EM0.00homo-trimer31 x NAG, 3 x 8Z9, 9 x NAG-NAG, 2 x NAG-NAG-BMABLAST0.39
7sbw.1.C
Spike protein
Structure of OC43 spike in complex with polyclonal Fab5 (Donor 1051)
0.260.3939.810.51 528-1194EM0.00homo-trimer12 x NAG, 3 x 8Z9, 11 x NAG-NAG-BMA, 20 x NAG-NAGBLAST0.39
7y6s.1.A
Spike glycoprotein
Cryo-EM map of IPEC-J2 cell-derived PEDV PT52 S protein with three D0-up
0.2431.800.53 485-1208EM0.00homo-trimer12 x NAG, 3 x NAG-NAG-BMA-FUC, 3 x NAG-NAG-BMA-MAN-MAN-MAN-MAN, 3 x NAG-FUC, 12 x NAG-NAG-BMA, 12 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.36
7y6s.1.C
Spike glycoprotein
Cryo-EM map of IPEC-J2 cell-derived PEDV PT52 S protein with three D0-up
0.2431.800.53 485-1208EM0.00homo-trimer12 x NAG, 3 x NAG-NAG-BMA-FUC, 3 x NAG-NAG-BMA-MAN-MAN-MAN-MAN, 3 x NAG-FUC, 12 x NAG-NAG-BMA, 12 x NAG-NAG, 3 x NAG-NAG-FUCHHblits0.36
7y6t.1.A
Spike glycoprotein
Cryo-EM map of IPEC-J2 cell-derived PEDV PT52 S protein one D0-down and two D0-up
0.2331.800.53 485-1208EM0.00homo-trimer18 x NAG, 3 x NAG-NAG-BMA-MAN-MAN, 12 x NAG-NAG-BMA, 10 x NAG-NAG, 2 x NAG-NAG-FUC, 3 x NAG-NAG-BMA-FUC, 4 x NAG-FUCHHblits0.36
7y6t.1.B
Spike glycoprotein
Cryo-EM map of IPEC-J2 cell-derived PEDV PT52 S protein one D0-down and two D0-up
0.2331.800.53 485-1208EM0.00homo-trimer18 x NAG, 3 x NAG-NAG-BMA-MAN-MAN, 12 x NAG-NAG-BMA, 10 x NAG-NAG, 2 x NAG-NAG-FUC, 3 x NAG-NAG-BMA-FUC, 4 x NAG-FUCHHblits0.36
7y6t.1.C
Spike glycoprotein
Cryo-EM map of IPEC-J2 cell-derived PEDV PT52 S protein one D0-down and two D0-up
0.2231.800.53 485-1208EM0.00homo-trimer18 x NAG, 3 x NAG-NAG-BMA-MAN-MAN, 12 x NAG-NAG-BMA, 10 x NAG-NAG, 2 x NAG-NAG-FUC, 3 x NAG-NAG-BMA-FUC, 4 x NAG-FUCHHblits0.36
7y6u.1.A
Spike glycoprotein
Symmetry-expanded and locally refined protomer structure of IPEC-J2 cell-derived PEDV PT52 S with a CTD-close conformation
0.2431.800.53 485-1208EM0.00monomer7 x NAG, 2 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-FUC, 4 x NAG-NAG-BMA, 2 x NAG-NAGHHblits0.36
7y6v.1.A
Spike glycoprotein
Symmetry-expanded and locally refined protomer structure of IPEC-J2 cell-derived PEDV PT52 S with a CTD-open conformation
0.2431.800.53 485-1208EM0.00monomer7 x NAG, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-FUC, 4 x NAG-NAG-BMA, 5 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.36
6vv5.1.A
Spike glycoprotein
Cryo-EM structure of porcine epidemic diarrhea virus (PEDV) spike protein
0.2330.700.53 485-1208EM0.00homo-trimer15 x NAG, 6 x PAM, 3 x NAG-NAG-BMA-MAN-MAN-MAN-NAG-MAN, 24 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.36
6u7k.1.A
Spike glycoprotein
Prefusion structure of PEDV spike
0.2231.150.53 485-1208EM0.00homo-trimer39 x NAG, 3 x NAG-NAG-BMA-MAN-MAN-MAN, 12 x NAG-NAGHHblits0.36
6m3w.1.A
Spike glycoprotein
Post-fusion structure of SARS-CoV spike glycoprotein
0.2690.220.39 706-1196EM0.00homo-trimer24 x NAGBLAST0.58
6m3w.1.A
Spike glycoprotein
Post-fusion structure of SARS-CoV spike glycoprotein
0.2690.200.38 707-1196EM0.00homo-trimer24 x NAGHHblits0.58
6pz8.1.B
S protein
MERS S0 trimer in complex with variable domain of antibody G2
0.1921.960.50 10-677EM0.00hetero-3-3-3-3-mer18 x NAG, 18 x NAG-NAG, 3 x NAG-NAG-BMA, 3 x NAG-NAG-BMA-MAN-MANHHblits0.31
6b3o.1.A
Spike glycoprotein
Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion
0.1641.990.39 706-1202EM0.00homo-trimerHHblits0.41
6pz8.1.A
S protein
MERS S0 trimer in complex with variable domain of antibody G2
0.2544.140.34 705-1140EM0.00hetero-3-3-3-3-mer18 x NAG, 18 x NAG-NAG, 3 x NAG-NAG-BMA, 3 x NAG-NAG-BMA-MAN-MANHHblits0.41
7l2c.1.A
Spike glycoprotein
Crystallographic structure of neutralizing antibody 2-51 in complex with SARS-CoV-2 spike N-terminal domain (NTD)
0.2199.700.26 1-335X-ray3.65hetero-1-1-1-mer6 x NAG, 17 x CA, 1 x NAG-NAGHHblits0.62
7l2c.2.A
Spike glycoprotein
Crystallographic structure of neutralizing antibody 2-51 in complex with SARS-CoV-2 spike N-terminal domain (NTD)
0.2199.700.26 1-335X-ray3.65hetero-1-1-1-mer7 x NAG, 13 x CA, 1 x CACHHblits0.62
7l2c.1.A
Spike glycoprotein
Crystallographic structure of neutralizing antibody 2-51 in complex with SARS-CoV-2 spike N-terminal domain (NTD)
0.20100.000.25 12-334X-ray3.65hetero-1-1-1-mer6 x NAG, 17 x CA, 1 x NAG-NAGBLAST0.62
7l2c.2.A
Spike glycoprotein
Crystallographic structure of neutralizing antibody 2-51 in complex with SARS-CoV-2 spike N-terminal domain (NTD)
0.21100.000.25 12-334X-ray3.65hetero-1-1-1-mer7 x NAG, 13 x CA, 1 x CACBLAST0.62
7b62.1.A
Spike glycoprotein
Crystal structure of SARS-CoV-2 spike protein N-terminal domain in complex with biliverdin
0.19100.000.24 1-311X-ray1.82monomer1 x BLA, 7 x NAGHHblits0.62
7b62.1.A
Spike glycoprotein
Crystal structure of SARS-CoV-2 spike protein N-terminal domain in complex with biliverdin
0.18100.000.24 12-311X-ray1.82monomer1 x BLA, 7 x NAGBLAST0.62
7rbu.1.A
Spike protein S1
SARS-CoV-2 Spike in complex with PVI.V6-14 Fab
0.18100.000.23 14-307EM0.00hetero-1-1-1-mer3 x NAG, 2 x NAG-NAGHHblits0.62
7ly3.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 S NTD bound to S2M28 Fab
0.1899.660.23 14-307X-ray3.00hetero-1-1-1-mer2 x NAG, 1 x XYL, 2 x NAG-NAG-BMA-FUC, 2 x NAG-FUC, 1 x NAG-NAG-BMA-MAN-FUCHHblits0.62
7ly3.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 S NTD bound to S2M28 Fab
0.1899.660.23 14-307X-ray3.00hetero-1-1-1-mer3 x NAG, 1 x XYL, 1 x NAG-NAG-BMA-MAN-FUC, 1 x NAG-NAG-BMA-FUC, 2 x NAG-FUCHHblits0.62
7ly3.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 S NTD bound to S2M28 Fab
0.1899.660.23 14-307X-ray3.00hetero-1-1-1-mer2 x NAG, 1 x XYL, 2 x NAG-NAG-BMA-FUC, 2 x NAG-FUC, 1 x NAG-NAG-BMA-MAN-FUCBLAST0.62
7sww.1.A
Spike protein S1
SARS-CoV-2 Spike NTD in complex with neutralizing Fab SARS2-57 (local refinement)
0.19100.000.23 14-304EM0.00hetero-1-1-1-mer4 x NAG, 2 x NAG-NAGHHblits0.62
7e8f.1.A
Spike protein S1
SARS-CoV-2 NTD in complex with N9 Fab
0.17100.000.23 13-303EM0.00hetero-1-1-1-1-1-1-…HHblits0.62
7e7x.1.A
Spike protein S1
SARS-CoV-2 Spike Protein N terminal domain in Complex with N11 Fab
0.17100.000.23 13-303X-ray2.78hetero-1-1-1-merHHblits0.62
7e7x.2.A
Spike protein S1
SARS-CoV-2 Spike Protein N terminal domain in Complex with N11 Fab
0.16100.000.23 13-303X-ray2.78hetero-1-1-1-merHHblits0.62
7q0i.1.E
Spike protein S1
Crystal structure of the N-terminal domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-43
0.1998.620.23 13-305X-ray2.39hetero-2-2-2-mer7 x NAG, 2 x NAG-FUC, 1 x NAG-NAG-FUC, 2 x NAG-NAGBLAST0.62
7q0i.1.F
Spike protein S1
Crystal structure of the N-terminal domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-43
0.1898.620.23 13-305X-ray2.39hetero-2-2-2-mer7 x NAG, 2 x NAG-FUC, 1 x NAG-NAG-FUC, 2 x NAG-NAGBLAST0.62
7ey4.1.D
Spike glycoprotein
Local CryoEM of the SARS-CoV-2 S6PV2 in complex with BD-667
0.1498.610.23 1-290EM3.69hetero-1-1-1-1-merHHblits0.62
7eya.1.D
Spike glycoprotein
Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-804 Fab
0.1498.610.23 1-290EM0.00hetero-1-1-1-1-merHHblits0.62
7q0i.1.E
Spike protein S1
Crystal structure of the N-terminal domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-43
0.1896.890.23 13-305X-ray2.39hetero-2-2-2-mer7 x NAG, 2 x NAG-FUC, 1 x NAG-NAG-FUC, 2 x NAG-NAGHHblits0.61
7q0i.1.F
Spike protein S1
Crystal structure of the N-terminal domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-43
0.1896.890.23 13-305X-ray2.39hetero-2-2-2-mer7 x NAG, 2 x NAG-FUC, 1 x NAG-NAG-FUC, 2 x NAG-NAGHHblits0.61
7xrp.1.A
Spike protein S1
Cryo-EM structure of SARS-CoV-2 spike protein in complex with nanobody C5G2 (localized refinement)
0.16100.000.22 27-309EM0.00hetero-1-1-1-mer4 x NAGHHblits0.62
7wh8.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (focused refinement on Fab-RBD)
0.18100.000.22 317-593EM0.00hetero-1-1-1-merHHblits0.63
7d4g.1.A
Spike glycoprotein S1
A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2
0.18100.000.22 13-290EM0.00hetero-1-1-1-merHHblits0.62
7ey4.1.D
Spike glycoprotein
Local CryoEM of the SARS-CoV-2 S6PV2 in complex with BD-667
0.1498.910.22 12-290EM3.69hetero-1-1-1-1-merBLAST0.62
7eya.1.D
Spike glycoprotein
Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-804 Fab
0.1498.910.22 12-290EM0.00hetero-1-1-1-1-merBLAST0.62
7wph.1.A
Spike protein S1
SARS-CoV2 RBD bound to Fab06
0.12100.000.21 319-591X-ray2.89hetero-1-1-1-mer1 x NAGHHblits0.63
7wph.2.A
Spike protein S1
SARS-CoV2 RBD bound to Fab06
0.12100.000.21 319-591X-ray2.89hetero-1-1-1-mer1 x NAGHHblits0.63
7m3i.2.C
Spike protein S1
Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a neutralizing antibody, CV2-75 Fab
0.13100.000.21 319-591X-ray2.80hetero-1-1-1-mer1 x NAGHHblits0.63
7m3i.1.C
Spike protein S1
Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a neutralizing antibody, CV2-75 Fab
0.13100.000.21 319-591X-ray2.80hetero-1-1-1-mer1 x NAGHHblits0.63
6xe1.1.C
Spike protein S1
Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a potent neutralizing antibody, CV30 Fab
0.12100.000.21 319-591X-ray2.75hetero-1-1-1-mer1 x NAGHHblits0.63
7wph.1.A
Spike protein S1
SARS-CoV2 RBD bound to Fab06
0.12100.000.21 319-591X-ray2.89hetero-1-1-1-mer1 x NAGBLAST0.63
7wph.2.A
Spike protein S1
SARS-CoV2 RBD bound to Fab06
0.12100.000.21 319-591X-ray2.89hetero-1-1-1-mer1 x NAGBLAST0.63
7fcp.1.A
Spike protein S1
Crystallographic structure of two neutralizing antibodies in complex with SARS-CoV-2 spike receptor-binding Domain (RBD)
0.11100.000.21 321-591X-ray2.40hetero-1-1-1-1-1-mer1 x NAGHHblits0.63
7fcp.1.A
Spike protein S1
Crystallographic structure of two neutralizing antibodies in complex with SARS-CoV-2 spike receptor-binding Domain (RBD)
0.11100.000.21 321-591X-ray2.40hetero-1-1-1-1-1-mer1 x NAGBLAST0.63
8hc6.1.D
Spike protein S1
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with YB9-258 Fab, focused refinement of Fab region
0.1698.520.21 14-289EM0.00hetero-1-1-1-1-mer7 x NAGBLAST0.62
8hc6.1.D
Spike protein S1
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with YB9-258 Fab, focused refinement of Fab region
0.170.0094.830.21 14-289EM0.00monomer7 x NAGHHblits0.60
7xck.1.C
Spike protein S1
Cryo-EM structure of SARS-CoV-2 Omicron RBD in complex with S309 fab (local refinement)
0.160.0094.050.21 322-590EM0.00monomerHHblits0.61
7xiz.1.A
Spike protein S1
SARS-CoV-2 Omicron BA.3 variant spike (local)
0.150.0094.380.21 323-589EM0.00monomer2 x NAGBLAST0.61
8hc6.1.A
Spike protein S1
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with YB9-258 Fab, focused refinement of Fab region
0.150.0094.010.21 322-588EM0.00monomer7 x NAGHHblits0.60
8hc7.1.B
Spike protein S1
SARS-CoV-2 Omicron BA.1 spike trimer (6P) complex with YB9-258 Fab, focused refinement of RBD-dimer region
0.140.0094.010.21 322-588EM0.00monomer7 x NAGHHblits0.60
7xiz.1.A
Spike protein S1
SARS-CoV-2 Omicron BA.3 variant spike (local)
0.150.0094.360.21 324-589EM0.00monomer2 x NAGHHblits0.61
7m8j.1.A
Spike protein S1
SARS-CoV-2 S-NTD + Fab CM25
0.14100.000.20 14-270EM0.00hetero-1-1-1-merHHblits0.62
7fh0.1.A
Spike protein S1,Spike protein S1
Crystallographic structure of two neutralizing nanobodies in complex with SARS-CoV-2 spike receptor-binding Domain (RBD)
0.110.0093.250.19 295-537X-ray3.20monomer1 x NAG, 1 x NAG-NAGHHblits0.60
7nll.1.A
Surface glycoprotein
SARS-CoV-2 Spike RBD (dimer) in complex with two Fu2 nanobodies
0.1198.690.18 319-550EM0.00hetero-2-2-mer2 x RTVBLAST0.62
7nll.1.A
Surface glycoprotein
SARS-CoV-2 Spike RBD (dimer) in complex with two Fu2 nanobodies
0.1196.490.18 319-547EM0.00hetero-2-2-mer2 x RTVHHblits0.61
7nll.1.B
Surface glycoprotein
SARS-CoV-2 Spike RBD (dimer) in complex with two Fu2 nanobodies
0.1096.490.18 319-547EM0.00hetero-2-2-mer2 x RTVHHblits0.61
7vyr.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with the D27 neutralizing antibody Fab fragment
0.09100.000.18 319-541X-ray2.20hetero-1-1-1-merHHblits0.63
7vyr.2.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with the D27 neutralizing antibody Fab fragment
0.09100.000.18 319-541X-ray2.20hetero-1-1-1-merHHblits0.63
7k9z.1.E
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with the Fab fragments of neutralizing antibodies 298 and 52
0.12100.000.18 319-541X-ray2.95hetero-1-1-1-1-1-mer1 x NAGHHblits0.63
7vyr.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with the D27 neutralizing antibody Fab fragment
0.09100.000.18 319-541X-ray2.20hetero-1-1-1-merBLAST0.63
7vyr.2.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with the D27 neutralizing antibody Fab fragment
0.09100.000.18 319-541X-ray2.20hetero-1-1-1-merBLAST0.63
7eam.1.A
Spike protein S1
immune complex of SARS-CoV-2 RBD and cross-neutralizing antibody 7D6
0.10100.000.18 319-541X-ray1.40hetero-1-1-1-mer1 x NAG, 1 x NAG-NAGBLAST0.63
7bnv.1.A
Surface glycoprotein
Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody ION-300
0.11100.000.18 319-541X-ray2.35hetero-1-1-1-mer1 x NAGBLAST0.63
6xdg.1.A
Spike protein S1
Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies
0.11100.000.18 319-541EM0.00hetero-1-1-1-1-1-merBLAST0.63
7m42.1.C
Spike protein S1
Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of neutralizing antibodies REGN10985 and REGN10989
0.10100.000.18 319-541EM0.00hetero-1-1-1-1-1-merBLAST0.63
7c01.1.A
Spike protein S1
Molecular basis for a potent human neutralizing antibody targeting SARS-CoV-2 RBD
0.11100.000.18 319-541X-ray2.88hetero-1-1-1-mer1 x NAGBLAST0.63
7nkt.1.A
Spike protein S1
RBD domain of SARS-CoV2 in complex with neutralizing nanobody NM1226
0.10100.000.18 319-541X-ray2.30hetero-1-1-mer1 x NAGBLAST0.63
6m0j.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2
0.11100.000.18 319-541X-ray2.45hetero-1-1-mer1 x ZN, 5 x NAGBLAST0.63
7l4z.3.A
Spike protein S1
Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide
0.09100.000.18 319-541X-ray3.96hetero-1-1-mer2 x NAGBLAST0.63
7l4z.4.A
Spike protein S1
Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide
0.11100.000.18 319-541X-ray3.96hetero-1-1-mer1 x NAGBLAST0.63
7l4z.5.A
Spike protein S1
Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide
0.10100.000.18 319-541X-ray3.96hetero-1-1-mer1 x NAGBLAST0.63
7l4z.1.A
Spike protein S1
Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide
0.10100.000.18 319-541X-ray3.96hetero-1-1-mer1 x NAGBLAST0.63
7b0b.1.C
Surface glycoprotein
Fab HbnC3t1p1_C6 bound to SARS-CoV-2 RBD
0.10100.000.18 319-541X-ray2.98hetero-1-1-1-mer1 x NAG-NAGBLAST0.63
7w6u.1.B
Spike protein S1
Structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor equine ACE2
0.11100.000.18 319-541X-ray2.56hetero-1-1-mer1 x ZN, 1 x NAGBLAST0.63
6xc4.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3
0.10100.000.18 319-541X-ray2.34hetero-1-1-1-mer1 x NAGBLAST0.63
6xc3.1.E
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.1 and CR3022
0.11100.000.18 319-541X-ray2.70hetero-1-1-1-1-1-mer1 x NAG-NAGBLAST0.63
6xc2.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1
0.10100.000.18 319-541X-ray3.11hetero-1-1-1-mer1 x NAGBLAST0.63
6xc4.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3
0.10100.000.18 319-541X-ray2.34hetero-1-1-1-mer1 x NAGBLAST0.63
6xc7.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3 and CR3022
0.11100.000.18 319-541X-ray2.88hetero-1-1-1-1-1-merBLAST0.63
6w41.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022
0.11100.000.18 319-541X-ray3.08hetero-1-1-1-mer1 x NAGBLAST0.63
6xkq.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-250
0.08100.000.18 319-541X-ray2.55hetero-1-1-1-mer2 x NAGBLAST0.63
6zlr.2.A
Spike glycoprotein
Soaking competent crystal form of the SARS-CoV-2 Receptor Binding Domain (RBD):CR3022 complex.
0.10100.000.18 319-541X-ray3.10hetero-1-1-1-mer1 x NAGBLAST0.63
7kn6.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH V and antibody Fab CC12.3
0.10100.000.18 319-541X-ray2.55hetero-1-1-1-1-mer1 x NAGBLAST0.63
7kn5.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobodies VHH E and U
0.10100.000.18 319-541X-ray1.87hetero-1-1-1-mer1 x NAGBLAST0.63
7lop.2.E
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV05-163 and CR3022
0.11100.000.18 319-541X-ray2.25hetero-1-1-1-1-1-mer1 x NAGBLAST0.63
7s4s.1.A
Spike protein S1
Crystal Structure of SARS-CoV-2 S receptor-binding domain (RBD) in complex CoV11 Fab
0.10100.000.18 319-541X-ray2.05hetero-1-1-1-mer1 x NAGBLAST0.63
7s5r.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV07-287 and COVA1-16
0.10100.000.18 319-541X-ray2.45hetero-1-1-1-1-1-mer1 x NAGBLAST0.63
7tp3.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K288.2
0.10100.000.18 319-541X-ray2.33hetero-1-1-1-mer3 x CACBLAST0.63
7kfv.1.A
Spike glycoprotein
Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B12 Fab)
0.11100.000.18 319-541X-ray2.10hetero-1-1-1-mer1 x NAGBLAST0.63
7kfv.3.A
Spike glycoprotein
Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B12 Fab)
0.10100.000.18 319-541X-ray2.10hetero-1-1-1-mer1 x NAGBLAST0.63
7kfw.1.A
Spike glycoprotein
Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B3 Fab)
0.11100.000.18 319-541X-ray2.79hetero-1-1-1-mer1 x NAGBLAST0.63
7kfw.3.A
Spike glycoprotein
Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B3 Fab)
0.10100.000.18 319-541X-ray2.79hetero-1-1-1-mer1 x NAGBLAST0.63
7dpm.3.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with MW06 Fab
0.10100.000.18 319-541X-ray3.30hetero-1-1-1-mer1 x NAGBLAST0.63
7chc.1.C
Spike protein S1
Crystal structure of the SARS-CoV-2 S RBD in complex with BD-629 Fab and BD-368-2 Fab
0.09100.000.18 319-541X-ray2.71hetero-1-1-1-1-1-merBLAST0.63
7ch4.1.C
Spike protein S1
Crystal structure of the SARS-CoV-2 S RBD in complex with BD-604 Fab
0.11100.000.18 319-541X-ray3.15hetero-1-1-1-merBLAST0.63
7che.1.C
Spike protein S1
Crystal structure of the SARS-CoV-2 RBD in complex with BD-236 Fab and BD-368-2 Fab
0.12100.000.18 319-541X-ray3.42hetero-1-1-1-1-1-merBLAST0.63
7e7y.1.C
Spike protein S1
Crystal structure of the SARS-CoV-2 S RBD in complex with BD-623 Fab
0.10100.000.18 319-541X-ray2.41hetero-1-1-1-merBLAST0.63
7e8f.1.H
Spike protein S1
SARS-CoV-2 NTD in complex with N9 Fab
0.11100.000.18 319-541EM0.00hetero-1-1-1-1-1-1-…BLAST0.63
6m17.1.C
Spike protein S1
The 2019-nCoV RBD/ACE2-B0AT1 complex
0.10100.000.18 319-541EM0.00hetero-2-2-2-mer10 x NAG, 2 x LEU, 2 x ZN, 14 x NAG-NAG, 2 x NAG-NAG-NAGBLAST0.63
7ean.1.A
Spike protein S1
immune complex of SARS-CoV-2 RBD and cross-neutralizing antibody 6D6
0.11100.000.18 319-541X-ray1.91hetero-1-1-1-mer1 x NAGBLAST0.63
7dk2.2.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with MW07 Fab
0.11100.000.18 319-541X-ray3.00hetero-1-1-1-mer1 x NAGBLAST0.63
7dk0.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with MW05 Fab
0.11100.000.18 319-541X-ray3.20hetero-1-1-1-mer1 x NAGBLAST0.63
7djz.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with MW01 Fab
0.10100.000.18 319-541X-ray2.40hetero-1-1-1-mer1 x NAGBLAST0.63
7e5y.1.A
Spike protein S1
Molecular basis for neutralizing antibody 2B11 targeting SARS-CoV-2 RBD
0.11100.000.18 319-541X-ray3.59hetero-1-1-1-merBLAST0.63
7e5y.2.A
Spike protein S1
Molecular basis for neutralizing antibody 2B11 targeting SARS-CoV-2 RBD
0.11100.000.18 319-541X-ray3.59hetero-1-1-1-merBLAST0.63
7ejy.1.A
Spike protein S1
Complex Structure of antibody BD-503 and RBD of COVID-19
0.11100.000.18 319-541X-ray3.04hetero-1-1-1-mer1 x NAGBLAST0.63
7xa7.3.B
Spike protein S1
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
0.11100.000.18 319-541X-ray3.31hetero-1-1-mer1 x ZN, 1 x NAGBLAST0.63
7xa7.2.B
Spike protein S1
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
0.11100.000.18 319-541X-ray3.31hetero-1-1-mer1 x ZN, 1 x NAGBLAST0.63
7xa7.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
0.11100.000.18 319-541X-ray3.31hetero-1-1-mer1 x ZN, 1 x NAGBLAST0.63
7jvb.1.A
Spike protein S1
Crystal structure of the SARS-CoV-2 spike receptor-binding domain (RBD) with nanobody Nb20
0.11100.000.18 319-541X-ray3.29hetero-1-1-mer2 x CACBLAST0.63
7ejz.1.A
Spike protein S1
Complex Structure of antibody BD-503 and RBD-S477N of COVID-19
0.1199.550.18 319-541X-ray3.63hetero-1-1-1-mer1 x NAGBLAST0.63
7ekh.1.B
Spike protein S1
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with human ACE2
0.1199.550.18 319-541X-ray2.40hetero-1-1-mer4 x NAG, 1 x ZNBLAST0.63
7w8s.1.B
Spike protein S1
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with American mink ACE2
0.1099.550.18 319-541EM0.00hetero-1-1-mer1 x ZN, 1 x NAG-NAGBLAST0.63
7f6y.1.A
Spike protein S1
Complex Structure of antibody BD-503 and RBD-E484K of COVID-19
0.1199.550.18 319-541X-ray3.00hetero-1-1-1-mer1 x NAGBLAST0.63
7eke.1.B
Spike protein S1
Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with human ACE2
0.1199.550.18 319-541X-ray2.70hetero-1-1-mer4 x NAG, 1 x ZNBLAST0.63
7zdq.1.B
Spike protein S1
Cryo-EM structure of Human ACE2 bound to a high-affinity SARS CoV-2 mutant
0.0999.100.18 319-541EM0.00hetero-1-1-mer3 x NAGBLAST0.63
7ekf.1.B
Spike protein S1
Structure of SARS-CoV-2 Alpha variant spike receptor-binding domain complexed with human ACE2
0.1199.550.18 319-541X-ray2.85hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAGBLAST0.63
7ek0.1.A
Spike protein S1
Complex Structure of antibody BD-503 and RBD-N501Y of COVID-19
0.1299.550.18 319-541X-ray2.70hetero-1-1-1-merBLAST0.63
7urs.1.A
Spike protein S1
Crystal Structure of SARS-CoV-2 S delta variant receptor-binding domain (RBD) in complex CoV11 Fab crystal form 2
0.1099.100.18 319-541X-ray2.40hetero-1-1-1-mer1 x NAGBLAST0.63
7wbq.1.B
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant spike glycoprotein in complex with its receptor human ACE2
0.1099.100.18 319-541X-ray3.34hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAG, 1 x NAG-FULBLAST0.63
7b27.1.A
Surface glycoprotein
RBD domain SARS-CoV2 in complex with neutralizing nanobody NM1230
0.11100.000.17 319-540X-ray2.90hetero-1-1-mer1 x NAGBLAST0.63
7b27.2.A
Surface glycoprotein
RBD domain SARS-CoV2 in complex with neutralizing nanobody NM1230
0.10100.000.17 319-540X-ray2.90hetero-1-1-mer1 x NAGBLAST0.63
7s5p.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibody CS23
0.1198.650.18 319-541X-ray2.86hetero-1-1-1-mer1 x NAGBLAST0.62
7s5q.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibodies CS44 and COVA1-16
0.1098.650.18 319-541X-ray2.88hetero-1-1-1-1-1-mer1 x NAGBLAST0.62
7ekg.1.B
Spike protein S1
Structure of SARS-CoV-2 Beta variant spike receptor-binding domain complexed with human ACE2
0.1198.650.18 319-541X-ray2.63hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGBLAST0.62
7f6z.1.A
Spike protein S1
Complex Structure of antibody BD-503 and RBD-501Y.V2 of COVID-19
0.1198.650.18 319-541X-ray3.00hetero-1-1-1-mer1 x NAG-NAGBLAST0.62
6xdg.1.A
Spike protein S1
Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies
0.1199.550.17 319-541EM0.00hetero-1-1-1-1-1-merHHblits0.63
7m42.1.C
Spike protein S1
Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of neutralizing antibodies REGN10985 and REGN10989
0.1199.550.17 319-541EM0.00hetero-1-1-1-1-1-merHHblits0.63
7bnv.1.A
Surface glycoprotein
Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody ION-300
0.1199.550.17 319-541X-ray2.35hetero-1-1-1-mer1 x NAGHHblits0.63
7kfv.1.A
Spike glycoprotein
Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B12 Fab)
0.1199.550.17 319-541X-ray2.10hetero-1-1-1-mer1 x NAGHHblits0.63
7kfv.2.A
Spike glycoprotein
Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B12 Fab)
0.1199.550.17 319-541X-ray2.10hetero-1-1-1-mer1 x NAGHHblits0.63
7kfw.2.A
Spike glycoprotein
Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B3 Fab)
0.1199.550.17 319-541X-ray2.79hetero-1-1-1-mer1 x NAGHHblits0.63
7kfx.1.A
Spike glycoprotein
Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-C2 Fab)
0.1099.550.17 319-541X-ray2.23hetero-1-1-1-mer1 x NAGHHblits0.63
7kfy.1.A
Spike glycoprotein
Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-F10 Fab)
0.1099.550.17 319-541X-ray2.16hetero-1-1-1-mer1 x NAGHHblits0.63
7kfv.3.A
Spike glycoprotein
Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B12 Fab)
0.1099.550.17 319-541X-ray2.10hetero-1-1-1-mer1 x NAGHHblits0.63
7kfw.1.A
Spike glycoprotein
Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B3 Fab)
0.1199.550.17 319-541X-ray2.79hetero-1-1-1-mer1 x NAGHHblits0.63
7kfw.3.A
Spike glycoprotein
Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B3 Fab)
0.1099.550.17 319-541X-ray2.79hetero-1-1-1-mer1 x NAGHHblits0.63
7dpm.3.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with MW06 Fab
0.1099.550.17 319-541X-ray3.30hetero-1-1-1-mer1 x NAGHHblits0.63
7dpm.4.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with MW06 Fab
0.1099.550.17 319-541X-ray3.30hetero-1-1-1-mer1 x NAGHHblits0.63
7dpm.2.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with MW06 Fab
0.1199.550.17 319-541X-ray3.30hetero-1-1-1-mer1 x NAGHHblits0.63
7dpm.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with MW06 Fab
0.1199.550.17 319-541X-ray3.30hetero-1-1-1-merHHblits0.63
7chc.1.C
Spike protein S1
Crystal structure of the SARS-CoV-2 S RBD in complex with BD-629 Fab and BD-368-2 Fab
0.0999.550.17 319-541X-ray2.71hetero-1-1-1-1-1-merHHblits0.63
7ch5.1.C
Spike protein S1
Crystal structure of the SARS-CoV-2 S RBD in complex with BD-629 Fab
0.0999.550.17 319-541X-ray2.70hetero-1-1-1-merHHblits0.63
7ch4.1.C
Spike protein S1
Crystal structure of the SARS-CoV-2 S RBD in complex with BD-604 Fab
0.1199.550.17 319-541X-ray3.15hetero-1-1-1-merHHblits0.63
7chf.1.C
Spike protein S1
Crystal structure of the SARS-CoV-2 RBD in complex with BD-604 Fab and BD-368-2 Fab
0.1099.550.17 319-541X-ray2.67hetero-1-1-1-1-1-merHHblits0.63
7chb.1.C
Spike protein S1
Crystal structure of the SARS-CoV-2 RBD in complex with BD-236 Fab
0.1099.550.17 319-541X-ray2.40hetero-1-1-1-mer1 x NAG-NAGHHblits0.63
7che.1.C
Spike protein S1
Crystal structure of the SARS-CoV-2 RBD in complex with BD-236 Fab and BD-368-2 Fab
0.1299.550.17 319-541X-ray3.42hetero-1-1-1-1-1-merHHblits0.63
7e7y.1.C
Spike protein S1
Crystal structure of the SARS-CoV-2 S RBD in complex with BD-623 Fab
0.1099.550.17 319-541X-ray2.41hetero-1-1-1-merHHblits0.63
7e7y.2.C
Spike protein S1
Crystal structure of the SARS-CoV-2 S RBD in complex with BD-623 Fab
0.1199.550.17 319-541X-ray2.41hetero-1-1-1-merHHblits0.63
7e8f.1.H
Spike protein S1
SARS-CoV-2 NTD in complex with N9 Fab
0.1199.550.17 319-541EM0.00hetero-1-1-1-1-1-1-…HHblits0.63
6m17.1.C
Spike protein S1
The 2019-nCoV RBD/ACE2-B0AT1 complex
0.1099.550.17 319-541EM0.00hetero-2-2-2-mer10 x NAG, 2 x LEU, 2 x ZN, 14 x NAG-NAG, 2 x NAG-NAG-NAGHHblits0.63
6m17.1.F
Spike protein S1
The 2019-nCoV RBD/ACE2-B0AT1 complex
0.1099.550.17 319-541EM0.00hetero-2-2-2-mer10 x NAG, 2 x LEU, 2 x ZN, 14 x NAG-NAG, 2 x NAG-NAG-NAGHHblits0.63
7ean.1.A
Spike protein S1
immune complex of SARS-CoV-2 RBD and cross-neutralizing antibody 6D6
0.1199.550.17 319-541X-ray1.91hetero-1-1-1-mer1 x NAGHHblits0.63
7dk2.2.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with MW07 Fab
0.1199.550.17 319-541X-ray3.00hetero-1-1-1-mer1 x NAGHHblits0.63
7dk2.4.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with MW07 Fab
0.1099.550.17 319-541X-ray3.00hetero-1-1-1-mer1 x NAGHHblits0.63
7dk2.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with MW07 Fab
0.1099.550.17 319-541X-ray3.00hetero-1-1-1-mer1 x NAGHHblits0.63
7dk2.3.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with MW07 Fab
0.1099.550.17 319-541X-ray3.00hetero-1-1-1-mer1 x NAGHHblits0.63
7dk0.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with MW05 Fab
0.1199.550.17 319-541X-ray3.20hetero-1-1-1-mer1 x NAGHHblits0.63
7djz.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with MW01 Fab
0.1199.550.17 319-541X-ray2.40hetero-1-1-1-mer1 x NAGHHblits0.63
7e5y.1.A
Spike protein S1
Molecular basis for neutralizing antibody 2B11 targeting SARS-CoV-2 RBD
0.1199.550.17 319-541X-ray3.59hetero-1-1-1-merHHblits0.63
7e5y.2.A
Spike protein S1
Molecular basis for neutralizing antibody 2B11 targeting SARS-CoV-2 RBD
0.1199.550.17 319-541X-ray3.59hetero-1-1-1-merHHblits0.63
7ejy.1.A
Spike protein S1
Complex Structure of antibody BD-503 and RBD of COVID-19
0.1199.550.17 319-541X-ray3.04hetero-1-1-1-mer1 x NAGHHblits0.63
7xa7.3.B
Spike protein S1
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
0.1199.550.17 319-541X-ray3.31hetero-1-1-mer1 x ZN, 1 x NAGHHblits0.63
7xa7.4.B
Spike protein S1
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
0.1199.550.17 319-541X-ray3.31hetero-1-1-mer1 x ZN, 1 x NAGHHblits0.63
7xa7.2.B
Spike protein S1
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
0.1199.550.17 319-541X-ray3.31hetero-1-1-mer1 x ZN, 1 x NAGHHblits0.63
7xa7.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat ACE2
0.1199.550.17 319-541X-ray3.31hetero-1-1-mer1 x ZN, 1 x NAGHHblits0.63
7jvb.1.A
Spike protein S1
Crystal structure of the SARS-CoV-2 spike receptor-binding domain (RBD) with nanobody Nb20
0.1199.550.17 319-541X-ray3.29hetero-1-1-mer2 x CACHHblits0.63
7jvb.2.A
Spike protein S1
Crystal structure of the SARS-CoV-2 spike receptor-binding domain (RBD) with nanobody Nb20
0.1099.550.17 319-541X-ray3.29hetero-1-1-mer2 x CACHHblits0.63
6xc4.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3
0.0999.550.17 319-541X-ray2.34hetero-1-1-1-mer1 x NAGHHblits0.63
7kn4.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody S-E6 Fab
0.1099.550.17 319-541X-ray2.70hetero-1-1-1-mer1 x NAGHHblits0.63
7kn4.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody S-E6 Fab
0.1299.550.17 319-541X-ray2.70hetero-1-1-1-mer1 x NAGHHblits0.63
7jmw.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with cross-neutralizing antibody COVA1-16 Fab
0.1099.550.17 319-541X-ray2.89hetero-1-1-1-mer1 x NAG-NAGHHblits0.63
7lm8.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with two cross-neutralizing antibodies CV38-142 and COVA1-16 Fabs isolated from COVID-19 patients
0.1099.550.17 319-541X-ray1.94hetero-1-1-1-1-1-merHHblits0.63
7jmo.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-04
0.1099.550.17 319-541X-ray2.36hetero-1-1-1-mer1 x NAGHHblits0.63
7jmp.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39
0.0999.550.17 319-541X-ray1.71hetero-1-1-1-mer1 x NAGHHblits0.63
6xc3.1.E
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.1 and CR3022
0.1199.550.17 319-541X-ray2.70hetero-1-1-1-1-1-mer1 x NAG-NAGHHblits0.63
6xc2.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1
0.1099.550.17 319-541X-ray3.11hetero-1-1-1-mer1 x NAGHHblits0.63
6xc2.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1
0.1199.550.17 319-541X-ray3.11hetero-1-1-1-mer1 x NAGHHblits0.63
6xc4.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3
0.1099.550.17 319-541X-ray2.34hetero-1-1-1-mer1 x NAGHHblits0.63
6xkp.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-270
0.1099.550.17 319-541X-ray2.72hetero-1-1-1-mer1 x NAGHHblits0.63
6xkp.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-270
0.1099.550.17 319-541X-ray2.72hetero-1-1-1-mer1 x NAGHHblits0.63
7kn7.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH W and antibody Fab CC12.3
0.1099.550.17 319-541X-ray2.73hetero-1-1-1-1-mer1 x NAGHHblits0.63
6xc7.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3 and CR3022
0.1199.550.17 319-541X-ray2.88hetero-1-1-1-1-1-merHHblits0.63
6w41.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022
0.1099.550.17 319-541X-ray3.08hetero-1-1-1-mer1 x NAGHHblits0.63
6xkq.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-250
0.0799.550.17 319-541X-ray2.55hetero-1-1-1-mer2 x NAGHHblits0.63
6zlr.2.A
Spike glycoprotein
Soaking competent crystal form of the SARS-CoV-2 Receptor Binding Domain (RBD):CR3022 complex.
0.1199.550.17 319-541X-ray3.10hetero-1-1-1-mer1 x NAGHHblits0.63
6zlr.3.A
Spike glycoprotein
Soaking competent crystal form of the SARS-CoV-2 Receptor Binding Domain (RBD):CR3022 complex.
0.1199.550.17 319-541X-ray3.10hetero-1-1-1-mer1 x NAGHHblits0.63
6zlr.1.A
Spike glycoprotein
Soaking competent crystal form of the SARS-CoV-2 Receptor Binding Domain (RBD):CR3022 complex.
0.1199.550.17 319-541X-ray3.10hetero-1-1-1-mer1 x NAGHHblits0.63
7kn6.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH V and antibody Fab CC12.3
0.1099.550.17 319-541X-ray2.55hetero-1-1-1-1-mer1 x NAGHHblits0.63
7kn5.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobodies VHH E and U
0.1099.550.17 319-541X-ray1.87hetero-1-1-1-mer1 x NAGHHblits0.63
7kn5.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobodies VHH E and U
0.1099.550.17 319-541X-ray1.87hetero-1-1-1-mer1 x NAG-NAGHHblits0.63
7kn3.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody S-B8 Fab
0.1099.550.17 319-541X-ray2.25hetero-1-1-1-mer1 x NAGHHblits0.63
7kn3.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody S-B8 Fab
0.1099.550.17 319-541X-ray2.25hetero-1-1-1-mer1 x NAGHHblits0.63
7lop.2.E
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV05-163 and CR3022
0.1199.550.17 319-541X-ray2.25hetero-1-1-1-1-1-mer1 x NAGHHblits0.63
7lop.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV05-163 and CR3022
0.1199.550.17 319-541X-ray2.25hetero-1-1-1-1-1-mer1 x NAGHHblits0.63
7s4s.1.A
Spike protein S1
Crystal Structure of SARS-CoV-2 S receptor-binding domain (RBD) in complex CoV11 Fab
0.1099.550.17 319-541X-ray2.05hetero-1-1-1-mer1 x NAGHHblits0.63
7s5r.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV07-287 and COVA1-16
0.1099.550.17 319-541X-ray2.45hetero-1-1-1-1-1-mer1 x NAGHHblits0.63
7tp3.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K288.2
0.1099.550.17 319-541X-ray2.33hetero-1-1-1-mer3 x CACHHblits0.63
7eam.1.A
Spike protein S1
immune complex of SARS-CoV-2 RBD and cross-neutralizing antibody 7D6
0.1099.550.17 319-541X-ray1.40hetero-1-1-1-mer1 x NAG, 1 x NAG-NAGHHblits0.63
7eam.2.A
Spike protein S1
immune complex of SARS-CoV-2 RBD and cross-neutralizing antibody 7D6
0.0999.550.17 319-541X-ray1.40hetero-1-1-1-mer1 x NAG, 1 x NAG-NAGHHblits0.63
7c01.1.A
Spike protein S1
Molecular basis for a potent human neutralizing antibody targeting SARS-CoV-2 RBD
0.1199.550.17 319-541X-ray2.88hetero-1-1-1-mer1 x NAGHHblits0.63
7c01.2.A
Spike protein S1
Molecular basis for a potent human neutralizing antibody targeting SARS-CoV-2 RBD
0.1099.550.17 319-541X-ray2.88hetero-1-1-1-mer1 x NAGHHblits0.63
7nkt.1.A
Spike protein S1
RBD domain of SARS-CoV2 in complex with neutralizing nanobody NM1226
0.1099.550.17 319-541X-ray2.30hetero-1-1-mer1 x NAGHHblits0.63
6m0j.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2
0.1199.550.17 319-541X-ray2.45hetero-1-1-mer1 x ZN, 5 x NAGHHblits0.63
7bz5.1.A
Spike protein S1
Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody
0.1099.550.17 319-541X-ray1.84hetero-1-1-1-mer1 x NAGHHblits0.63
7l4z.3.A
Spike protein S1
Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide
0.0999.550.17 319-541X-ray3.96hetero-1-1-mer2 x NAGHHblits0.63
7l4z.2.A
Spike protein S1
Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide
0.0999.550.17 319-541X-ray3.96hetero-1-1-mer2 x NAGHHblits0.63
7l4z.4.A
Spike protein S1
Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide
0.1199.550.17 319-541X-ray3.96hetero-1-1-mer1 x NAGHHblits0.63
7l4z.5.A
Spike protein S1
Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide
0.1099.550.17 319-541X-ray3.96hetero-1-1-mer1 x NAGHHblits0.63
7l4z.1.A
Spike protein S1
Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide
0.1099.550.17 319-541X-ray3.96hetero-1-1-mer1 x NAGHHblits0.63
7b0b.1.C
Surface glycoprotein
Fab HbnC3t1p1_C6 bound to SARS-CoV-2 RBD
0.1099.550.17 319-541X-ray2.98hetero-1-1-1-mer1 x NAG-NAGHHblits0.63
7w6u.1.B
Spike protein S1
Structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor equine ACE2
0.1099.550.17 319-541X-ray2.56hetero-1-1-mer1 x ZN, 1 x NAGHHblits0.63
7wnm.1.B
Spike protein S1
Structure of SARS-CoV-2 Gamma variant receptor-binding domain complexed with high affinity human ACE2 mutant (T27F,R273Q)
0.1098.650.18 319-541X-ray2.70hetero-1-1-mer1 x ZN, 1 x NAGBLAST0.62
7ekc.1.B
Spike protein S1
Structure of SARS-CoV-2 Gamma variant spike receptor-binding domain complexed with human ACE2
0.1198.650.18 319-541X-ray2.80hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGBLAST0.62
7ejz.1.A
Spike protein S1
Complex Structure of antibody BD-503 and RBD-S477N of COVID-19
0.1299.100.17 319-541X-ray3.63hetero-1-1-1-mer1 x NAGHHblits0.63
7f6y.1.A
Spike protein S1
Complex Structure of antibody BD-503 and RBD-E484K of COVID-19
0.1199.100.17 319-541X-ray3.00hetero-1-1-1-mer1 x NAGHHblits0.63
7ekh.1.B
Spike protein S1
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with human ACE2
0.1199.100.17 319-541X-ray2.40hetero-1-1-mer4 x NAG, 1 x ZNHHblits0.63
7w8s.1.B
Spike protein S1
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with American mink ACE2
0.1099.100.17 319-541EM0.00hetero-1-1-mer1 x ZN, 1 x NAG-NAGHHblits0.63
7eke.1.B
Spike protein S1
Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with human ACE2
0.1199.100.17 319-541X-ray2.70hetero-1-1-mer4 x NAG, 1 x ZNHHblits0.63
7wa1.1.B
Spike protein S1
Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with American mink ACE2
0.1199.100.17 319-541EM0.00hetero-1-1-mer1 x ZNHHblits0.63
7np1.3.A
Spike protein S1
Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody ION-360
0.10100.000.17 319-541X-ray2.80hetero-1-1-1-mer1 x NAG-FUCBLAST0.63
7np1.2.A
Spike protein S1
Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody ION-360
0.09100.000.17 319-541X-ray2.80hetero-1-1-1-mer1 x NAGBLAST0.63
7np1.1.A
Spike protein S1
Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody ION-360
0.09100.000.17 319-541X-ray2.80hetero-1-1-1-mer1 x NAG-FUCBLAST0.63
7zdq.1.B
Spike protein S1
Cryo-EM structure of Human ACE2 bound to a high-affinity SARS CoV-2 mutant
0.0998.650.17 319-541EM0.00hetero-1-1-mer3 x NAGHHblits0.62
7ek0.1.A
Spike protein S1
Complex Structure of antibody BD-503 and RBD-N501Y of COVID-19
0.1299.100.17 319-541X-ray2.70hetero-1-1-1-merHHblits0.62
7ekf.1.B
Spike protein S1
Structure of SARS-CoV-2 Alpha variant spike receptor-binding domain complexed with human ACE2
0.1199.100.17 319-541X-ray2.85hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.62
7b27.1.A
Surface glycoprotein
RBD domain SARS-CoV2 in complex with neutralizing nanobody NM1230
0.1099.550.17 319-540X-ray2.90hetero-1-1-mer1 x NAGHHblits0.63
7b27.2.A
Surface glycoprotein
RBD domain SARS-CoV2 in complex with neutralizing nanobody NM1230
0.0999.550.17 319-540X-ray2.90hetero-1-1-mer1 x NAGHHblits0.63
7fh0.1.A
Spike protein S1,Spike protein S1
Crystallographic structure of two neutralizing nanobodies in complex with SARS-CoV-2 spike receptor-binding Domain (RBD)
0.0999.100.17 319-540X-ray3.20hetero-1-2-mer1 x NAG, 1 x NAG-NAGHHblits0.62
7sn0.1.B
Surface glycoprotein
Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunocompromised patient (d146*) in complex with human receptor ACE2
0.1197.310.18 319-541X-ray3.08hetero-1-1-mer1 x ZN, 1 x NAG, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-NAG-GAL-NAG-MAN-NAG-GAL, 1 x NAG-NAG-BMA-MAN-NAG-GAL-NAG-GAL-MAN-NAG, 1 x NAG-NAGBLAST0.62
7sn0.2.B
Surface glycoprotein
Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunocompromised patient (d146*) in complex with human receptor ACE2
0.1097.310.18 319-541X-ray3.08hetero-1-1-mer1 x ZN, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA-MAN-NAG-MAN, 1 x NAG-NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-NAG-GAL-NAG-MAN-NAGBLAST0.62
7f6z.1.A
Spike protein S1
Complex Structure of antibody BD-503 and RBD-501Y.V2 of COVID-19
0.1198.200.17 319-541X-ray3.00hetero-1-1-1-mer1 x NAG-NAGHHblits0.62
7s5p.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibody CS23
0.1098.200.17 319-541X-ray2.86hetero-1-1-1-mer1 x NAGHHblits0.62
7s5q.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibodies CS44 and COVA1-16
0.1098.200.17 319-541X-ray2.88hetero-1-1-1-1-1-mer1 x NAGHHblits0.62
7ekg.1.B
Spike protein S1
Structure of SARS-CoV-2 Beta variant spike receptor-binding domain complexed with human ACE2
0.1198.200.17 319-541X-ray2.63hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.62
7fh0.1.A
Spike protein S1,Spike protein S1
Crystallographic structure of two neutralizing nanobodies in complex with SARS-CoV-2 spike receptor-binding Domain (RBD)
0.0999.550.17 317-537X-ray3.20hetero-1-2-mer1 x NAG, 1 x NAG-NAGBLAST0.63
7wnm.1.B
Spike protein S1
Structure of SARS-CoV-2 Gamma variant receptor-binding domain complexed with high affinity human ACE2 mutant (T27F,R273Q)
0.1098.200.17 319-541X-ray2.70hetero-1-1-mer1 x ZN, 1 x NAGHHblits0.62
7ekc.1.B
Spike protein S1
Structure of SARS-CoV-2 Gamma variant spike receptor-binding domain complexed with human ACE2
0.1098.200.17 319-541X-ray2.80hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.62
7fh0.1.A
Spike protein S1,Spike protein S1
Crystallographic structure of two neutralizing nanobodies in complex with SARS-CoV-2 spike receptor-binding Domain (RBD)
0.0999.550.17 319-539X-ray3.20hetero-1-2-mer1 x NAG, 1 x NAG-NAGBLAST0.62
7np1.3.A
Spike protein S1
Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody ION-360
0.1099.550.17 319-541X-ray2.80hetero-1-1-1-mer1 x NAG-FUCHHblits0.63
7np1.4.A
Spike protein S1
Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody ION-360
0.1099.550.17 319-541X-ray2.80hetero-1-1-1-mer1 x NAGHHblits0.63
7np1.2.A
Spike protein S1
Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody ION-360
0.0999.550.17 319-541X-ray2.80hetero-1-1-1-mer1 x NAGHHblits0.63
7np1.1.A
Spike protein S1
Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody ION-360
0.0999.550.17 319-541X-ray2.80hetero-1-1-1-mer1 x NAG-FUCHHblits0.63
7sn0.1.B
Surface glycoprotein
Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunocompromised patient (d146*) in complex with human receptor ACE2
0.1196.850.17 319-541X-ray3.08hetero-1-1-mer1 x ZN, 1 x NAG, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-NAG-GAL-NAG-MAN-NAG-GAL, 1 x NAG-NAG-BMA-MAN-NAG-GAL-NAG-GAL-MAN-NAG, 1 x NAG-NAGHHblits0.62
7sn0.2.B
Surface glycoprotein
Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunocompromised patient (d146*) in complex with human receptor ACE2
0.1096.850.17 319-541X-ray3.08hetero-1-1-mer1 x ZN, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA-MAN-NAG-MAN, 1 x NAG-NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-NAG-GAL-NAG-MAN-NAGHHblits0.62
7si2.1.C
Spike protein S1
Crystal structure of neutralizing antibody 10-28 in complex with SARS-CoV-2 spike receptor binding domain (RBD)
0.10100.000.17 319-537X-ray3.20hetero-1-1-1-mer1 x NAG-NAGBLAST0.63
7ul0.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 RBD in complex with the ridge-binding nAb EH8 isolated from a nonvaccinated pediatric patient
0.10100.000.17 319-537X-ray2.49hetero-1-1-1-mer1 x NAG, 1 x NAG-NAGBLAST0.63
7l5b.1.A
Spike protein S1
Crystallographic structure of neutralizing antibody 2-15 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD).
0.10100.000.17 319-537X-ray3.18hetero-1-1-1-merBLAST0.63
7sd5.1.A
Spike protein S1
Crystallographic structure of neutralizing antibody 10-40 in complex with SARS-CoV-2 spike receptor binding domain
0.09100.000.17 319-537X-ray1.53hetero-1-1-1-mer1 x NAG-NAGBLAST0.63
7cm4.1.A
Spike glycoprotein
Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59
0.10100.000.17 319-536X-ray2.71hetero-1-1-1-mer2 x NI, 1 x NAG-NAG-MAN-MAN-FUCBLAST0.63
7efp.1.B
Spike glycoprotein
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (S19W,N330Y)
0.10100.000.17 320-537X-ray2.70hetero-1-1-mer5 x NAGBLAST0.63
7rpv.4.B
Spike protein S1
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.10100.000.17 320-537X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNBLAST0.63
7rpv.2.B
Spike protein S1
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.09100.000.17 320-537X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNBLAST0.63
7rpv.3.B
Spike protein S1
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.11100.000.17 320-537X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNBLAST0.63
7rpv.1.B
Spike protein S1
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.10100.000.17 320-537X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNBLAST0.63
7w1s.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with neutralizing nanobody Nb-007
0.09100.000.17 320-537X-ray2.00hetero-1-1-merBLAST0.63
7urq.1.A
Spike protein S1
Crystal Structure of SARS-CoV-2 S delta variant receptor-binding domain (RBD) in complex CoV11 Fab crystal form 1
0.1099.090.17 319-537X-ray2.05hetero-1-1-1-mer1 x NAGHHblits0.62
7urq.1.A
Spike protein S1
Crystal Structure of SARS-CoV-2 S delta variant receptor-binding domain (RBD) in complex CoV11 Fab crystal form 1
0.1099.090.17 319-537X-ray2.05hetero-1-1-1-mer1 x NAGBLAST0.62
7x63.1.C
Spike protein S1
SARS-CoV-2-Beta-RBD and BD-236-GWP/P-VK antibody complex
0.1098.630.17 319-537X-ray2.24hetero-1-1-1-merBLAST0.62
7xil.1.A
Spike protein S1
SARS-CoV-2-Beta-RBD and B38-GWP/P-VK antibody complex
0.1198.630.17 319-537X-ray2.91hetero-1-1-1-mer1 x NAGBLAST0.62
7l5b.1.A
Spike protein S1
Crystallographic structure of neutralizing antibody 2-15 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD).
0.0999.540.17 319-537X-ray3.18hetero-1-1-1-merHHblits0.63
7sd5.1.A
Spike protein S1
Crystallographic structure of neutralizing antibody 10-40 in complex with SARS-CoV-2 spike receptor binding domain
0.0999.540.17 319-537X-ray1.53hetero-1-1-1-mer1 x NAG-NAGHHblits0.63
7ul0.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 RBD in complex with the ridge-binding nAb EH8 isolated from a nonvaccinated pediatric patient
0.1099.540.17 319-537X-ray2.49hetero-1-1-1-mer1 x NAG, 1 x NAG-NAGHHblits0.63
7si2.1.C
Spike protein S1
Crystal structure of neutralizing antibody 10-28 in complex with SARS-CoV-2 spike receptor binding domain (RBD)
0.1099.540.17 319-537X-ray3.20hetero-1-1-1-mer1 x NAG-NAGHHblits0.63
7si2.2.C
Spike protein S1
Crystal structure of neutralizing antibody 10-28 in complex with SARS-CoV-2 spike receptor binding domain (RBD)
0.0999.540.17 319-537X-ray3.20hetero-1-1-1-mer1 x NAG-NAGHHblits0.63
7si2.3.C
Spike protein S1
Crystal structure of neutralizing antibody 10-28 in complex with SARS-CoV-2 spike receptor binding domain (RBD)
0.1099.540.17 319-537X-ray3.20hetero-1-1-1-mer1 x NAG-NAGHHblits0.63
7efr.1.B
Spike glycoprotein
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (T27W,N330Y)
0.11100.000.17 321-537X-ray2.49hetero-1-1-mer5 x NAGBLAST0.63
7km5.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 RBD complexed with Nanosota-1
0.11100.000.17 319-535X-ray3.19hetero-1-1-mer1 x NAG-NAGBLAST0.63
7km5.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 RBD complexed with Nanosota-1
0.11100.000.17 319-535X-ray3.19hetero-1-1-mer1 x NAG-NAGBLAST0.63
7spp.1.A
Spike protein S1
Crystal structure of the SARS-CoV-2 receptor binding domain in complex with VNAR 2C02
0.10100.000.17 319-535X-ray1.96hetero-1-1-mer1 x NAGBLAST0.63
7cm4.1.A
Spike glycoprotein
Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59
0.1099.540.17 319-536X-ray2.71hetero-1-1-1-mer2 x NI, 1 x NAG-NAG-MAN-MAN-FUCHHblits0.63
7efp.1.B
Spike glycoprotein
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (S19W,N330Y)
0.0999.540.17 320-537X-ray2.70hetero-1-1-mer5 x NAGHHblits0.63
7rpv.4.B
Spike protein S1
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.1099.540.17 320-537X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNHHblits0.63
7rpv.2.B
Spike protein S1
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.0999.540.17 320-537X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNHHblits0.63
7rpv.3.B
Spike protein S1
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.1199.540.17 320-537X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNHHblits0.63
7rpv.1.B
Spike protein S1
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD
0.1099.540.17 320-537X-ray3.54hetero-1-1-mer6 x NAG, 1 x ZNHHblits0.63
7w1s.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with neutralizing nanobody Nb-007
0.0999.540.17 320-537X-ray2.00hetero-1-1-merHHblits0.63
7wbp.1.B
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron variant spike glycoprotein in complex with its receptor human ACE2
0.100.0093.270.18 319-541X-ray3.00monomer5 x NAG, 1 x ZN, 1 x NAG-NAGBLAST0.60
7wsk.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with civet ACE2
0.0993.270.18 319-541X-ray3.30hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAG-MANBLAST0.60
7xby.1.B
Spike protein S1
The crystal structure of SARS-CoV-2 Omicron BA.1 variant RBD in complex with equine ACE2
0.1093.270.18 319-541X-ray2.85hetero-1-1-mer1 x ZN, 6 x BR, 1 x NAGBLAST0.60
7wsc.1.A
Spike protein S1
Local structure of BD55-3500 and omicron RBD complex
0.1193.270.18 319-541EM0.00hetero-1-1-1-mer1 x NAG-NAGBLAST0.60
7wn2.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike receptor-binding domain (RBD) in complex with NCV2SG53 Fab
0.10100.000.17 321-536X-ray2.35hetero-1-1-1-mer1 x NAGBLAST0.63
7wnb.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab
0.10100.000.17 321-536X-ray2.18hetero-1-1-1-mer1 x NAG-NAGBLAST0.63
7x63.1.C
Spike protein S1
SARS-CoV-2-Beta-RBD and BD-236-GWP/P-VK antibody complex
0.0998.170.17 319-537X-ray2.24hetero-1-1-1-merHHblits0.62
7xil.1.A
Spike protein S1
SARS-CoV-2-Beta-RBD and B38-GWP/P-VK antibody complex
0.1198.170.17 319-537X-ray2.91hetero-1-1-1-mer1 x NAGHHblits0.62
7y75.1.C
Spike protein S1
SIT1-ACE2-BA.2 RBD
0.1092.830.18 319-541EM0.00hetero-2-2-2-mer6 x NAG, 6 x 3PH, 2 x ZN, 16 x NAG-NAGHHblits0.60
7y75.1.F
Spike protein S1
SIT1-ACE2-BA.2 RBD
0.1092.830.18 319-541EM0.00hetero-2-2-2-mer6 x NAG, 6 x 3PH, 2 x ZN, 16 x NAG-NAGHHblits0.60
7y75.1.C
Spike protein S1
SIT1-ACE2-BA.2 RBD
0.1092.830.18 319-541EM0.00hetero-2-2-2-mer6 x NAG, 6 x 3PH, 2 x ZN, 16 x NAG-NAGBLAST0.60
7efr.1.B
Spike glycoprotein
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (T27W,N330Y)
0.1199.540.17 321-537X-ray2.49hetero-1-1-mer5 x NAGHHblits0.63
7km5.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 RBD complexed with Nanosota-1
0.1199.540.17 319-535X-ray3.19hetero-1-1-mer1 x NAG-NAGHHblits0.63
7km5.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 RBD complexed with Nanosota-1
0.1199.540.17 319-535X-ray3.19hetero-1-1-mer1 x NAG-NAGHHblits0.63
7spp.1.A
Spike protein S1
Crystal structure of the SARS-CoV-2 receptor binding domain in complex with VNAR 2C02
0.1099.540.17 319-535X-ray1.96hetero-1-1-mer1 x NAGHHblits0.63
7y76.1.C
Spike protein S1
SIT1-ACE2-BA.5 RBD
0.1092.380.18 319-541EM0.00hetero-2-2-2-mer6 x NAG, 6 x 3PH, 2 x ZN, 16 x NAG-NAGHHblits0.60
7y76.1.F
Spike protein S1
SIT1-ACE2-BA.5 RBD
0.1092.380.18 319-541EM0.00hetero-2-2-2-mer6 x NAG, 6 x 3PH, 2 x ZN, 16 x NAG-NAGHHblits0.60
7y76.1.C
Spike protein S1
SIT1-ACE2-BA.5 RBD
0.1092.380.18 319-541EM0.00hetero-2-2-2-mer6 x NAG, 6 x 3PH, 2 x ZN, 16 x NAG-NAGBLAST0.60
7e5o.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193
0.10100.000.17 322-536X-ray2.80hetero-1-1-1-mer1 x NAG-NAGHHblits0.63
7x7o.2.A
Spike protein S1
SARS-CoV-2 spike RBD in complex with neutralizing antibody UT28K
0.10100.000.17 322-536X-ray3.75hetero-1-1-1-merHHblits0.63
7x7o.3.A
Spike protein S1
SARS-CoV-2 spike RBD in complex with neutralizing antibody UT28K
0.09100.000.17 322-536X-ray3.75hetero-1-1-1-merHHblits0.63
7x7o.1.A
Spike protein S1
SARS-CoV-2 spike RBD in complex with neutralizing antibody UT28K
0.09100.000.17 322-536X-ray3.75hetero-1-1-1-merHHblits0.63
7x7o.4.A
Spike protein S1
SARS-CoV-2 spike RBD in complex with neutralizing antibody UT28K
0.08100.000.17 322-536X-ray3.75hetero-1-1-1-merHHblits0.63
8i5i.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 delta variant spike receptor-binding domain (RBD) in complex with NCV2SG53 Fab
0.1199.070.17 321-536X-ray3.06hetero-1-1-1-merBLAST0.62
5x4s.1.A
Spike glycoprotein
Structure of the N-terminal domain (NTD)of SARS-CoV spike protein
0.1456.590.20 31-305X-ray2.20monomer1 x NAG, 1 x NAG-NAGHHblits0.49
7s0b.1.C
Spike protein S1
Structure of the SARS-CoV-2 RBD in complex with neutralizing antibody N-612-056
0.10100.000.17 319-533X-ray2.90hetero-1-1-1-mer1 x NAGBLAST0.63
7urs.1.A
Spike protein S1
Crystal Structure of SARS-CoV-2 S delta variant receptor-binding domain (RBD) in complex CoV11 Fab crystal form 2
0.0895.890.17 319-541X-ray2.40hetero-1-1-1-mer1 x NAGHHblits0.61
7wn2.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike receptor-binding domain (RBD) in complex with NCV2SG53 Fab
0.1099.530.17 321-536X-ray2.35hetero-1-1-1-mer1 x NAGHHblits0.63
7wn2.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike receptor-binding domain (RBD) in complex with NCV2SG53 Fab
0.1099.530.17 321-536X-ray2.35hetero-1-1-1-mer1 x NAGHHblits0.63
7wnb.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab
0.1099.530.17 321-536X-ray2.18hetero-1-1-1-mer1 x NAG-NAGHHblits0.63
7wbq.1.B
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant spike glycoprotein in complex with its receptor human ACE2
0.0895.430.17 319-541X-ray3.34hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAG, 1 x NAG-FULHHblits0.61
7wbq.2.B
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant spike glycoprotein in complex with its receptor human ACE2
0.0995.430.17 319-541X-ray3.34hetero-1-1-mer6 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.61
7d6i.1.A
Spike protein S1
A neutralizing MAb targeting receptor-binding-domain of SARS-CoV-2
0.10100.000.17 319-532X-ray3.41hetero-1-1-1-mer1 x NAG-NAGBLAST0.63
7p8i.1.B
Spike glycoprotein
Receptor-binding domain (RBD) of the spike protein of the bat coronavirus RaTG13 virus in complex with the extracellular domain of human angiotensin-converting enzyme 2 (ACE2) - Crystal form 1
0.100.0090.130.18 319-541X-ray4.50monomer2 x NAG-NAG, 3 x NAG-NAG-BMABLAST0.60
7p8i.2.B
Spike glycoprotein
Receptor-binding domain (RBD) of the spike protein of the bat coronavirus RaTG13 virus in complex with the extracellular domain of human angiotensin-converting enzyme 2 (ACE2) - Crystal form 1
0.090.0090.130.18 319-541X-ray4.50monomer3 x NAG, 2 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.60
7drv.1.B
Spike glycoprotein
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
0.110.0090.130.18 319-541X-ray3.09monomer4 x NAG, 1 x ZN, 2 x NAG-NAGBLAST0.60
7drv.2.B
Spike glycoprotein
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
0.110.0090.130.18 319-541X-ray3.09monomer1 x ZN, 1 x NAG, 1 x NAG-NAGBLAST0.60
7w6r.1.B
Spike glycoprotein
Structure of Bat coronavirus RaTG13 spike receptor-binding domain complexed with its receptor equine ACE2
0.100.0090.130.18 319-541X-ray2.60monomer1 x ZN, 1 x NAGBLAST0.60
7s0b.1.C
Spike protein S1
Structure of the SARS-CoV-2 RBD in complex with neutralizing antibody N-612-056
0.0999.530.17 319-533X-ray2.90hetero-1-1-1-mer1 x NAGHHblits0.63
7s0b.2.C
Spike protein S1
Structure of the SARS-CoV-2 RBD in complex with neutralizing antibody N-612-056
0.1099.530.17 319-533X-ray2.90hetero-1-1-1-mer1 x NAGHHblits0.63
7xbg.1.B
RshSTT182/200 coronavirus receptor binding domain insert2 mutant
The crystal structure of RshSTT182/200 RBD-insert2-T346R-Y496G mutant in complex with human ACE2
0.100.0087.110.18 316-541X-ray3.37monomer6 x NAG, 1 x ZNBLAST0.59
7vnb.1.B
Spike protein S1
Crystal structure of the SARS-CoV-2 RBD in complex with a human single domain antibody n3113
0.09100.000.17 319-531X-ray2.27hetero-1-1-mer1 x NAGHHblits0.63
7dmu.1.B
Spike protein S1
Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39
0.10100.000.17 319-531X-ray3.20hetero-1-1-mer1 x NAG, 1 x ZN, 2 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.63
7ttx.1.A
Spike glycoprotein
Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat RaTG13 receptor-binding domain
0.110.0089.690.18 319-541X-ray2.80monomer1 x NAGBLAST0.59
7wsc.1.A
Spike protein S1
Local structure of BD55-3500 and omicron RBD complex
0.1191.400.17 319-541EM0.00hetero-1-1-1-mer1 x NAG-NAGHHblits0.60
7wbp.1.B
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron variant spike glycoprotein in complex with its receptor human ACE2
0.1091.400.17 319-541X-ray3.00hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.60
7wsk.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with civet ACE2
0.0991.400.17 319-541X-ray3.30hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAG-MANHHblits0.60
7xby.1.B
Spike protein S1
The crystal structure of SARS-CoV-2 Omicron BA.1 variant RBD in complex with equine ACE2
0.0991.400.17 319-541X-ray2.85hetero-1-1-mer1 x ZN, 6 x BR, 1 x NAGHHblits0.60
7xbf.1.B
RshSTT182/200 coronavirus receptor binding domain insert2
The complex structure of RshSTT182/200 RBD-insert2 bound to human ACE2
0.100.0086.220.18 316-541X-ray3.51monomer6 x NAG, 1 x ZNBLAST0.58
7xbf.2.B
RshSTT182/200 coronavirus receptor binding domain insert2
The complex structure of RshSTT182/200 RBD-insert2 bound to human ACE2
0.090.0086.220.18 316-541X-ray3.51monomer5 x NAG, 1 x ZNBLAST0.58
7xik.1.A
Spike protein S1
SARS-CoV-2-Omicron-RBD and B38-GWP/P-VK antibody complex
0.1093.150.17 319-537X-ray2.89hetero-1-1-1-merBLAST0.60
7dmu.1.B
Spike protein S1
Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39
0.1099.530.17 319-531X-ray3.20hetero-1-1-mer1 x NAG, 1 x ZN, 2 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.63
7dmu.2.B
Spike protein S1
Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39
0.1099.530.17 319-531X-ray3.20hetero-1-1-mer2 x NAG, 1 x ZN, 2 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAGHHblits0.63
7d6i.1.A
Spike protein S1
A neutralizing MAb targeting receptor-binding-domain of SARS-CoV-2
0.1099.530.17 319-531X-ray3.41hetero-1-1-1-mer1 x NAG-NAGHHblits0.63
7bwj.1.A
Spike protein S1
crystal structure of SARS-CoV-2 antibody with RBD
0.09100.000.17 319-529X-ray2.85hetero-1-1-1-mer1 x NAGBLAST0.63
7chp.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 antibody P5A-3C8 with RBD
0.09100.000.17 319-529X-ray2.36hetero-1-1-1-mer1 x NAGBLAST0.63
7cdj.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 antibody P2C-1A3 with RBD
0.10100.000.17 319-529X-ray3.40hetero-1-1-1-mer1 x NAGBLAST0.63
7cho.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 antibody P5A-1D2 with RBD
0.10100.000.17 319-529X-ray2.56hetero-1-1-1-mer1 x NAGBLAST0.63
7chs.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 antibody P22A-1D1 with RBD
0.10100.000.17 319-529X-ray2.40hetero-1-1-1-mer1 x NAGBLAST0.63
7cho.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 antibody P5A-1D2 with RBD
0.11100.000.17 319-529X-ray2.56hetero-1-1-1-mer1 x NAGBLAST0.63
7te1.1.E
Spike protein S1
SARS-CoV-2 Receptor Binding Domain in Complex with Ab17
0.08100.000.17 319-529X-ray3.50hetero-2-2-2-merBLAST0.63
8gx9.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 RBD with P2C-1F11 and P2B-1G5
0.10100.000.17 319-529X-ray4.01hetero-2-2-2-2-2-merBLAST0.63
7xbg.1.B
RshSTT182/200 coronavirus receptor binding domain insert2 mutant
The crystal structure of RshSTT182/200 RBD-insert2-T346R-Y496G mutant in complex with human ACE2
0.090.0077.540.19 297-541X-ray3.37monomer6 x NAG, 1 x ZNHHblits0.54
7ws6.1.A
Spike protein S1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.1093.120.17 319-536EM0.00hetero-1-1-1-merBLAST0.60
7rby.1.A
Spike protein S1
Crystal structure of Nanobody nb112 and SARS-CoV-2 RBD
0.10100.000.16 329-538X-ray2.82hetero-1-1-mer1 x NAGBLAST0.63
7rby.2.A
Spike protein S1
Crystal structure of Nanobody nb112 and SARS-CoV-2 RBD
0.10100.000.16 329-538X-ray2.82hetero-1-1-mer1 x NAG, 1 x MGBLAST0.63
7ul1.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing IGHV3-53-encoded antibody EH3 isolated from a nonvaccinated pediatric patient
0.10100.000.16 329-538X-ray2.65hetero-1-1-1-mer1 x NAGBLAST0.63
7xbf.1.B
RshSTT182/200 coronavirus receptor binding domain insert2
The complex structure of RshSTT182/200 RBD-insert2 bound to human ACE2
0.090.0076.690.19 297-541X-ray3.51monomer6 x NAG, 1 x ZNHHblits0.54
7xbf.2.B
RshSTT182/200 coronavirus receptor binding domain insert2
The complex structure of RshSTT182/200 RBD-insert2 bound to human ACE2
0.090.0076.690.19 297-541X-ray3.51monomer5 x NAG, 1 x ZNHHblits0.54
7rby.1.A
Spike protein S1
Crystal structure of Nanobody nb112 and SARS-CoV-2 RBD
0.10100.000.16 330-538X-ray2.82hetero-1-1-mer1 x NAGHHblits0.63
7rby.2.A
Spike protein S1
Crystal structure of Nanobody nb112 and SARS-CoV-2 RBD
0.10100.000.16 330-538X-ray2.82hetero-1-1-mer1 x NAG, 1 x MGHHblits0.63
7ul1.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing IGHV3-53-encoded antibody EH3 isolated from a nonvaccinated pediatric patient
0.10100.000.16 330-538X-ray2.65hetero-1-1-1-mer1 x NAGHHblits0.63
7l7f.1.B
Spike glycoprotein, Envelope glycoprotein fusion
Cryo-EM structure of human ACE2 receptor bound to protein encoded by vaccine candidate BNT162b1
0.100.0094.860.17 319-532EM0.00monomerHHblits0.61
7l7f.1.D
Spike glycoprotein, Envelope glycoprotein fusion
Cryo-EM structure of human ACE2 receptor bound to protein encoded by vaccine candidate BNT162b1
0.100.0094.860.17 319-532EM0.00monomerHHblits0.61
6lzg.1.B
Spike protein S1
Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2
0.11100.000.16 319-527X-ray2.50hetero-1-1-mer4 x NAG, 1 x ZNBLAST0.63
7dhx.1.B
Spike glycoprotein
Crystal structure of SARS-CoV-2 RBD binding to pangolin ACE2
0.10100.000.16 319-527X-ray2.30hetero-1-1-mer2 x NAG, 1 x ZNBLAST0.63
7y0v.1.C
Spike protein S1
The co-crystal structure of BA.1-RBD with Fab-5549
0.0992.170.17 325-541X-ray2.48hetero-1-1-1-merBLAST0.60
7yow.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 omicron variant spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab
0.1093.060.17 321-536X-ray3.30hetero-1-1-1-merBLAST0.60
7yow.2.C
Spike protein S1
Crystal structure of SARS-CoV-2 omicron variant spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab
0.1093.060.17 321-536X-ray3.30hetero-1-1-1-merBLAST0.60
7bwj.1.A
Spike protein S1
crystal structure of SARS-CoV-2 antibody with RBD
0.0999.520.16 319-528X-ray2.85hetero-1-1-1-mer1 x NAGHHblits0.63
7cdi.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 antibody P2C-1F11 with RBD
0.1099.520.16 319-528X-ray2.96hetero-1-1-1-mer1 x NAGHHblits0.63
7chp.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 antibody P5A-3C8 with RBD
0.0999.520.16 319-528X-ray2.36hetero-1-1-1-mer1 x NAGHHblits0.63
7cdj.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 antibody P2C-1A3 with RBD
0.1099.520.16 319-528X-ray3.40hetero-1-1-1-mer1 x NAGHHblits0.63
7cho.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 antibody P5A-1D2 with RBD
0.0999.520.16 319-528X-ray2.56hetero-1-1-1-mer1 x NAGHHblits0.63
7chs.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 antibody P22A-1D1 with RBD
0.0999.520.16 319-528X-ray2.40hetero-1-1-1-mer1 x NAGHHblits0.63
7wbz.1.A
Spike protein S1
Crystal structure of the SARS-Cov-2 RBD in complex with Fab 2303
0.1099.520.16 319-528X-ray2.42hetero-1-1-1-mer1 x NAGHHblits0.63
7cho.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 antibody P5A-1D2 with RBD
0.1099.520.16 319-528X-ray2.56hetero-1-1-1-mer1 x NAGHHblits0.63
7te1.1.E
Spike protein S1
SARS-CoV-2 Receptor Binding Domain in Complex with Ab17
0.0899.520.16 319-528X-ray3.50hetero-2-2-2-merHHblits0.63
8gx9.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 RBD with P2C-1F11 and P2B-1G5
0.1099.520.16 319-528X-ray4.01hetero-2-2-2-2-2-merHHblits0.63
8gx9.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 RBD with P2C-1F11 and P2B-1G5
0.1099.520.16 319-528X-ray4.01hetero-2-2-2-2-2-merHHblits0.63
7voa.1.B
Spike glycoprotein
Crystal structure of SARS-CoV-2 RBD in complex with aRBD5
0.11100.000.16 321-528X-ray1.80hetero-1-1-mer1 x NAGBLAST0.63
7p19.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 RBD Q498Y complexed with human ACE2
0.0999.520.16 334-541X-ray3.24hetero-1-1-mer3 x NAG, 1 x ZNHHblits0.63
7p19.2.B
Spike protein S1
Crystal structure of SARS-CoV-2 RBD Q498Y complexed with human ACE2
0.0999.520.16 334-541X-ray3.24hetero-1-1-mer4 x NAG, 1 x ZNHHblits0.63
7xik.1.A
Spike protein S1
SARS-CoV-2-Omicron-RBD and B38-GWP/P-VK antibody complex
0.0991.240.17 319-537X-ray2.89hetero-1-1-1-merHHblits0.59
6lzg.1.B
Spike protein S1
Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2
0.1099.520.16 319-527X-ray2.50hetero-1-1-mer4 x NAG, 1 x ZNHHblits0.63
7dhx.1.B
Spike glycoprotein
Crystal structure of SARS-CoV-2 RBD binding to pangolin ACE2
0.1099.520.16 319-527X-ray2.30hetero-1-1-mer2 x NAG, 1 x ZNHHblits0.63
7ddo.1.B
Spike protein S1
Cryo-EM structure of human ACE2 and GD/1/2019 RBD
0.1097.130.16 319-527EM0.00hetero-1-1-mer1 x ZN, 4 x NAGBLAST0.62
8i5i.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 delta variant spike receptor-binding domain (RBD) in complex with NCV2SG53 Fab
0.0995.280.17 321-536X-ray3.06hetero-1-1-1-merHHblits0.61
7xwa.1.B
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
0.0992.090.17 322-536X-ray3.36hetero-1-1-mer1 x ZN, 1 x NAG, 2 x NAG-NAG, 2 x NAG-NAG-BMABLAST0.60
7xwa.2.B
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
0.0992.090.17 322-536X-ray3.36hetero-1-1-mer1 x ZN, 2 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAG-BMA-MAN, 1 x NAG-NAGBLAST0.60
7voa.1.B
Spike glycoprotein
Crystal structure of SARS-CoV-2 RBD in complex with aRBD5
0.1099.520.16 321-528X-ray1.80hetero-1-1-mer1 x NAGHHblits0.63
7ws6.1.A
Spike protein S1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.0991.200.17 319-536EM0.00hetero-1-1-1-merHHblits0.59
7uzc.1.A
Spike protein S1
Structure of the SARS-CoV-2 RBD in complex with the mouse antibody Fab fragment, M8a-34
0.10100.000.16 329-533X-ray2.20hetero-1-1-1-merHHblits0.63
7uzc.2.A
Spike protein S1
Structure of the SARS-CoV-2 RBD in complex with the mouse antibody Fab fragment, M8a-34
0.09100.000.16 329-533X-ray2.20hetero-1-1-1-merHHblits0.63
7uzd.1.A
Spike protein S1
Structure of the SARS-CoV-2 RBD in complex with the mouse antibody Fab fragment, HSW-2
0.10100.000.16 329-533X-ray3.00hetero-1-1-1-mer1 x NAG-NAGHHblits0.63
7rku.2.A
Spike protein S1
Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment, C022
0.10100.000.16 328-533X-ray3.20hetero-1-1-1-merHHblits0.63
7rku.4.A
Spike protein S1
Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment, C022
0.10100.000.16 328-533X-ray3.20hetero-1-1-1-mer1 x NAGHHblits0.63
7rku.1.A
Spike protein S1
Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment, C022
0.10100.000.16 328-533X-ray3.20hetero-1-1-1-merHHblits0.63
7rku.3.A
Spike protein S1
Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment, C022
0.10100.000.16 328-533X-ray3.20hetero-1-1-1-mer1 x NAGHHblits0.63
7n3i.1.A
Spike protein S1
Crystal structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment C098
0.10100.000.16 328-533X-ray2.03hetero-1-1-1-mer1 x NAGHHblits0.63
7m6d.1.C
Spike protein S1
Structure of the SARS-CoV-2 RBD in complex with neutralizing antibodies BG4-25 and CR3022
0.10100.000.16 328-533X-ray3.10hetero-1-1-1-1-1-merHHblits0.63
7uzc.1.A
Spike protein S1
Structure of the SARS-CoV-2 RBD in complex with the mouse antibody Fab fragment, M8a-34
0.10100.000.16 328-533X-ray2.20hetero-1-1-1-merBLAST0.63
7uzd.1.A
Spike protein S1
Structure of the SARS-CoV-2 RBD in complex with the mouse antibody Fab fragment, HSW-2
0.10100.000.16 328-533X-ray3.00hetero-1-1-1-mer1 x NAG-NAGBLAST0.63
7l7f.1.B
Spike glycoprotein, Envelope glycoprotein fusion
Cryo-EM structure of human ACE2 receptor bound to protein encoded by vaccine candidate BNT162b1
0.1097.600.16 323-530EM0.00hetero-2-2-merBLAST0.62
7y0v.1.C
Spike protein S1
The co-crystal structure of BA.1-RBD with Fab-5549
0.0990.700.17 326-541X-ray2.48hetero-1-1-1-merHHblits0.59
7ddo.1.B
Spike protein S1
Cryo-EM structure of human ACE2 and GD/1/2019 RBD
0.1096.630.16 319-527EM0.00hetero-1-1-mer1 x ZN, 4 x NAGHHblits0.62
7xbh.1.A
RshSTT182/200 coronavirus receptor binding domain
The complex structure of RshSTT182/200 RBD bound to human ACE2
0.090.0086.240.17 319-541X-ray3.02monomer5 x NAG, 1 x ZNBLAST0.58
7ws7.1.A
Spike protein S1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.10100.000.16 326-530EM0.00hetero-1-2-2-mer1 x NAG-NAGBLAST0.63
7yow.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 omicron variant spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab
0.1091.120.17 321-536X-ray3.30hetero-1-1-1-merHHblits0.60
7yow.2.C
Spike protein S1
Crystal structure of SARS-CoV-2 omicron variant spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab
0.0991.120.17 321-536X-ray3.30hetero-1-1-1-merHHblits0.60
8a96.1.A
Spike protein S1
SARS Cov2 Spike RBD in complex with Fab47
0.1199.510.16 327-531EM0.00hetero-1-1-1-merBLAST0.63
6vw1.1.B
SARS-CoV-2 chimeric RBD
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2
0.0985.710.17 319-535X-ray2.68hetero-1-1-mer1 x ZN, 1 x NAG, 3 x NAG-NAG-BMA, 2 x NAG-NAGBLAST0.58
6vw1.2.B
SARS-CoV-2 chimeric RBD
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2
0.0985.710.17 319-535X-ray2.68hetero-1-1-mer1 x ZN, 2 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-NAGBLAST0.58
7ttx.1.A
Spike glycoprotein
Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat RaTG13 receptor-binding domain
0.0986.700.17 319-541X-ray2.80hetero-1-1-1-mer1 x NAGHHblits0.58
7m7w.1.E
Spike protein S1
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape
0.10100.000.16 328-531X-ray2.65hetero-1-1-1-1-1-mer1 x NAGHHblits0.63
7m7w.2.E
Spike protein S1
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape
0.11100.000.16 328-531X-ray2.65hetero-1-1-1-1-1-mer1 x NAGHHblits0.63
7r6w.1.E
Spike protein S1
SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2X35 Fab and S309 Fab
0.10100.000.16 328-531X-ray1.83hetero-1-1-1-1-1-mer2 x POL, 1 x NAG-NAGHHblits0.63
7r6x.1.C
Spike protein S1
SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2E12 Fab, S309 Fab, and S304 Fab
0.09100.000.16 328-531X-ray2.95hetero-1-1-1-1-1-1-…1 x NAGHHblits0.63
7m7w.1.E
Spike protein S1
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape
0.10100.000.16 328-531X-ray2.65hetero-1-1-1-1-1-mer1 x NAGBLAST0.63
7r6w.1.E
Spike protein S1
SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2X35 Fab and S309 Fab
0.10100.000.16 328-531X-ray1.83hetero-1-1-1-1-1-mer2 x POL, 1 x NAG-NAGBLAST0.63
7r6x.1.C
Spike protein S1
SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2E12 Fab, S309 Fab, and S304 Fab
0.09100.000.16 328-531X-ray2.95hetero-1-1-1-1-1-1-…1 x NAGBLAST0.63
7jx3.1.G
Spike protein S1
Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology
0.10100.000.16 328-531X-ray2.65hetero-1-1-1-1-1-1-…1 x NAGBLAST0.63
7ws7.1.A
Spike protein S1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.10100.000.16 326-529EM0.00hetero-1-2-2-mer1 x NAG-NAGHHblits0.63
7x7t.1.A
Spike protein S1
Cryo-EM structure of SARS-CoV-2 spike protein in complex with three nAbs X01, X10 and X17
0.10100.000.16 324-527EM0.00hetero-1-1-1-1-1-1-…1 x NAGBLAST0.63
7l0n.1.F
Spike protein S1
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
0.1099.510.16 328-531X-ray2.78hetero-1-1-1-1-1-1-…1 x PG5, 1 x ZN, 4 x NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUCBLAST0.63
8a96.1.A
Spike protein S1
SARS Cov2 Spike RBD in complex with Fab47
0.1199.510.16 327-530EM0.00hetero-1-1-1-merHHblits0.63
6vw1.1.B
SARS-CoV-2 chimeric RBD
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2
0.0985.650.17 319-534X-ray2.68hetero-1-1-mer1 x ZN, 1 x NAG, 3 x NAG-NAG-BMA, 2 x NAG-NAGHHblits0.58
6vw1.2.B
SARS-CoV-2 chimeric RBD
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2
0.0985.650.17 319-534X-ray2.68hetero-1-1-mer1 x ZN, 2 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-NAGHHblits0.58
7p8i.1.B
Spike glycoprotein
Receptor-binding domain (RBD) of the spike protein of the bat coronavirus RaTG13 virus in complex with the extracellular domain of human angiotensin-converting enzyme 2 (ACE2) - Crystal form 1
0.0885.780.17 319-541X-ray4.50hetero-1-1-mer2 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.58
7p8i.2.B
Spike glycoprotein
Receptor-binding domain (RBD) of the spike protein of the bat coronavirus RaTG13 virus in complex with the extracellular domain of human angiotensin-converting enzyme 2 (ACE2) - Crystal form 1
0.0885.780.17 319-541X-ray4.50hetero-1-1-mer3 x NAG, 2 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.58
7drv.1.B
Spike glycoprotein
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
0.0885.780.17 319-541X-ray3.09hetero-1-1-mer4 x NAG, 1 x ZN, 2 x NAG-NAGHHblits0.58
7drv.2.B
Spike glycoprotein
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2
0.0985.780.17 319-541X-ray3.09hetero-1-1-mer1 x ZN, 1 x NAG, 1 x NAG-NAGHHblits0.58
7w6r.1.B
Spike glycoprotein
Structure of Bat coronavirus RaTG13 spike receptor-binding domain complexed with its receptor equine ACE2
0.0885.780.17 319-541X-ray2.60hetero-1-1-mer1 x ZN, 1 x NAGHHblits0.58
7jx3.1.G
Spike protein S1
Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology
0.10100.000.16 328-530X-ray2.65hetero-1-1-1-1-1-1-…1 x NAGHHblits0.63
6yla.1.A
Spike glycoprotein
Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab
0.10100.000.16 330-532X-ray2.42hetero-1-1-1-mer2 x NAGHHblits0.63
6ym0.1.A
Spike glycoprotein
Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab (crystal form 1)
0.10100.000.16 330-532X-ray4.36hetero-1-1-1-merHHblits0.63
6yla.2.A
Spike glycoprotein
Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab
0.10100.000.16 330-532X-ray2.42hetero-1-1-1-mer1 x NAGHHblits0.63
7spo.2.A
Spike protein S1
Crystal structure of the SARS-CoV-2 receptor binding domain in complex with VNAR 3B4
0.09100.000.16 330-532X-ray1.92hetero-1-1-merHHblits0.63
7spo.1.A
Spike protein S1
Crystal structure of the SARS-CoV-2 receptor binding domain in complex with VNAR 3B4
0.10100.000.16 330-532X-ray1.92hetero-1-1-merHHblits0.63
7oay.1.A
Spike protein S1
Nanobody F2 bound to RBD
0.10100.000.16 330-532X-ray2.34hetero-1-1-mer1 x NAGBLAST0.63
6yz7.1.A
Spike glycoprotein
H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex
0.10100.000.16 330-532X-ray3.30hetero-1-1-1-1-mer1 x NAGBLAST0.63
6zbp.1.A
Spike glycoprotein
H11-H4 complex with SARS-CoV-2
0.09100.000.16 330-532X-ray1.85hetero-1-1-mer1 x NAGBLAST0.63
7oao.1.A
Spike protein S1
Nanobody C5 bound to RBD
0.10100.000.16 330-532X-ray1.50hetero-1-1-mer1 x NAGBLAST0.63
7oay.2.A
Spike protein S1
Nanobody F2 bound to RBD
0.10100.000.16 330-532X-ray2.34hetero-1-1-mer1 x NAGBLAST0.63
7z1d.1.A
Spike protein S1
Nanobody H11-H6 bound to RBD
0.09100.000.16 330-532X-ray1.55hetero-1-1-mer1 x NAGBLAST0.63
7z1b.2.A
Spike protein S1
Nanobody H11-A10 and F2 bound to RBD
0.09100.000.16 330-532X-ray2.30hetero-1-1-1-mer1 x NAGBLAST0.63
6zer.3.A
Spike protein S1
Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with EY6A Fab
0.10100.000.16 330-532X-ray3.80hetero-1-1-1-mer1 x NAGBLAST0.63
7x7t.1.A
Spike protein S1
Cryo-EM structure of SARS-CoV-2 spike protein in complex with three nAbs X01, X10 and X17
0.10100.000.16 325-527EM0.00hetero-1-1-1-1-1-1-…1 x NAGHHblits0.63
7x7u.1.A
Spike protein S1
Cryo-EM structure of SARS-CoV-2 Delta variant spike protein in complex with three nAbs X01, X10 and X17
0.1099.020.16 324-527EM0.00hetero-1-1-1-1-1-1-…1 x NAGBLAST0.63
7x66.1.C
Spike protein S1
SARS-CoV-2-Omicron-RBD and BD-236-GWP/P-VK antibody complex
0.0992.860.16 319-528X-ray2.40hetero-1-1-1-merBLAST0.60
7l0n.1.F
Spike protein S1
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
0.0999.510.16 328-530X-ray2.78hetero-1-1-1-1-1-1-…1 x PG5, 1 x ZN, 4 x NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUCHHblits0.63
7l0n.2.F
Spike protein S1
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
0.1099.510.16 328-530X-ray2.78hetero-1-1-1-1-1-1-…1 x ZN, 5 x NAG, 1 x NAG-NAG-BMA-MAN-FUCHHblits0.63
7oau.1.A
Spike protein S1
Nanobody C5 bound to Kent variant RBD (N501Y)
0.1099.510.16 330-532X-ray1.65hetero-1-1-mer1 x NAGBLAST0.63
7oaq.1.B
Spike protein S1
Nanobody H3 AND C1 bound to RBD with Kent mutation
0.1099.510.16 330-532X-ray1.55hetero-1-1-1-mer1 x NAGBLAST0.63
7x1m.1.G
Spike protein S1
The complex structure of Omicron BA.1 RBD with BD604, S309,and S304
0.1092.820.16 333-541EM0.00hetero-1-1-1-1-1-1-…BLAST0.60
7f5g.1.A
Spike glycoprotein
The crystal structure of RBD-Nanobody complex, DL4 (SA4)
0.10100.000.16 330-531X-ray1.75hetero-1-1-merHHblits0.63
7f5g.2.A
Spike glycoprotein
The crystal structure of RBD-Nanobody complex, DL4 (SA4)
0.10100.000.16 330-531X-ray1.75hetero-1-1-merHHblits0.63
7c8v.1.B
Spike protein S1
Structure of sybody SR4 in complex with the SARS-CoV-2 S Receptor Binding domain (RBD)
0.10100.000.16 330-531X-ray2.15hetero-1-1-mer1 x NAGHHblits0.63
7d30.1.B
Spike protein S1
Structure of sybody MR17-SR31 fusion in complex with the SARS-CoV-2 S Receptor Binding domain (RBD)
0.09100.000.16 330-531X-ray2.10hetero-1-1-mer5 x BU2, 17 x CD, 1 x NAG-NAG-BMA-MAN-FUC-FUCHHblits0.63
7cyv.1.B
Spike protein S1
Crystal structure of FD20, a neutralizing single-chain variable fragment (scFv) in complex with SARS-CoV-2 Spike receptor-binding domain (RBD)
0.10100.000.16 330-531X-ray3.13hetero-1-1-merHHblits0.63
7c8w.1.B
Spike protein S1
Structure of sybody MR17 in complex with the SARS-CoV-2 S receptor-binding domain (RBD)
0.10100.000.16 330-531X-ray2.77hetero-1-1-merHHblits0.63
7can.1.B
Spike protein S1
Structure of sybody MR17-K99Y in complex with the SARS-CoV-2 S Receptor-binding domain (RBD)
0.10100.000.16 330-531X-ray2.94hetero-1-1-merHHblits0.63
7d2z.1.B
Spike protein S1
Structure of sybody SR31 in complex with the SARS-CoV-2 S Receptor Binding domain (RBD)
0.10100.000.16 330-531X-ray1.97hetero-1-1-merHHblits0.63
7f5h.2.A
SARS-CoV-2 Spike Receptor-Binding Domain (RBD)
The crystal structure of RBD-Nanobody complex, DL28 (SC4)
0.10100.000.16 330-531X-ray3.00hetero-1-1-merHHblits0.63
7f5h.1.A
SARS-CoV-2 Spike Receptor-Binding Domain (RBD)
The crystal structure of RBD-Nanobody complex, DL28 (SC4)
0.10100.000.16 330-531X-ray3.00hetero-1-1-merHHblits0.63
7wqv.1.A
Spike protein S1
Crystal structure of a neutralizing monoclonal antibody (Ab08) in complex with SARS-CoV-2 receptor-binding domain (RBD)
0.10100.000.16 330-531X-ray2.80hetero-1-1-mer1 x CA, 1 x NAG-FUCBLAST0.63
7wqv.2.A
Spike protein S1
Crystal structure of a neutralizing monoclonal antibody (Ab08) in complex with SARS-CoV-2 receptor-binding domain (RBD)
0.10100.000.16 330-531X-ray2.80hetero-1-1-mer1 x NAG, 1 x CABLAST0.63
7oay.1.A
Spike protein S1
Nanobody F2 bound to RBD
0.10100.000.16 331-532X-ray2.34hetero-1-1-mer1 x NAGHHblits0.63
7oay.3.A
Spike protein S1
Nanobody F2 bound to RBD
0.09100.000.16 331-532X-ray2.34hetero-1-1-mer1 x NAGHHblits0.63
7oay.5.A
Spike protein S1
Nanobody F2 bound to RBD
0.09100.000.16 331-532X-ray2.34hetero-1-1-mer1 x NAGHHblits0.63
7z1c.1.A
Spike protein S1
Nanobody H11-B5 and H11-F2 bound to RBD
0.09100.000.16 331-532X-ray1.90hetero-1-1-1-mer1 x NAGHHblits0.63
7z1a.2.A
Spike protein S1
Nanobody H11 and F2 bound to RBD
0.09100.000.16 331-532X-ray2.59hetero-1-1-1-mer1 x NAGHHblits0.63
7z1c.2.A
Spike protein S1
Nanobody H11-B5 and H11-F2 bound to RBD
0.09100.000.16 331-532X-ray1.90hetero-1-1-1-mer1 x NAGHHblits0.63
7z1b.1.A
Spike protein S1
Nanobody H11-A10 and F2 bound to RBD
0.10100.000.16 331-532X-ray2.30hetero-1-1-1-mer1 x NAGHHblits0.63
7z1a.1.A
Spike protein S1
Nanobody H11 and F2 bound to RBD
0.09100.000.16 331-532X-ray2.59hetero-1-1-1-mer1 x NAGHHblits0.63
6yz7.1.A
Spike glycoprotein
H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex
0.10100.000.16 331-532X-ray3.30hetero-1-1-1-1-mer1 x NAGHHblits0.63
6yz7.2.A
Spike glycoprotein
H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex
0.10100.000.16 331-532X-ray3.30hetero-1-1-1-1-mer1 x NAGHHblits0.63
6zbp.1.A
Spike glycoprotein
H11-H4 complex with SARS-CoV-2
0.09100.000.16 331-532X-ray1.85hetero-1-1-mer1 x NAGHHblits0.63
6yz5.1.A
Spike glycoprotein
H11-D4 complex with SARS-CoV-2 RBD
0.09100.000.16 331-532X-ray1.80hetero-1-1-mer1 x NAGHHblits0.63
7z1e.1.A
Spike protein S1
Nanobody H11-H4 Q98R H100E bound to RBD
0.10100.000.16 331-532X-ray1.59hetero-1-1-mer1 x NAGHHblits0.63
7oao.1.A
Spike protein S1
Nanobody C5 bound to RBD
0.10100.000.16 331-532X-ray1.50hetero-1-1-mer1 x NAGHHblits0.63
7oay.2.A
Spike protein S1
Nanobody F2 bound to RBD
0.10100.000.16 331-532X-ray2.34hetero-1-1-mer1 x NAGHHblits0.63
7oay.4.A
Spike protein S1
Nanobody F2 bound to RBD
0.09100.000.16 331-532X-ray2.34hetero-1-1-mer1 x NAGHHblits0.63
7oay.6.A
Spike protein S1
Nanobody F2 bound to RBD
0.10100.000.16 331-532X-ray2.34hetero-1-1-mer1 x NAGHHblits0.63
7z1d.1.A
Spike protein S1
Nanobody H11-H6 bound to RBD
0.09100.000.16 331-532X-ray1.55hetero-1-1-mer1 x NAGHHblits0.63
7z1b.2.A
Spike protein S1
Nanobody H11-A10 and F2 bound to RBD
0.09100.000.16 331-532X-ray2.30hetero-1-1-1-mer1 x NAGHHblits0.63
7oap.1.B
Spike protein S1
Nanobody H3 AND C1 bound to RBD
0.10100.000.16 331-532X-ray1.90hetero-1-1-1-mer1 x NAGBLAST0.63
7xxl.1.C
Spike protein S1
RBD in complex with Fab14
0.10100.000.16 331-532EM0.00hetero-1-1-1-mer1 x NAGBLAST0.63
7u0n.1.B
Spike protein S1
Crystal structure of chimeric omicron RBD (strain BA.1) complexed with human ACE2
0.0882.950.17 319-535X-ray2.61hetero-1-1-mer5 x NAG, 1 x ZN, 2 x NAG-NAG-BMABLAST0.57
7ufk.1.B
Spike protein S1
Crystal structure of chimeric omicron RBD (strain BA.2) complexed with human ACE2
0.0982.490.17 319-535X-ray2.38hetero-1-1-mer1 x ZN, 5 x NAG, 2 x NAG-NAG-BMABLAST0.57
7oau.1.A
Spike protein S1
Nanobody C5 bound to Kent variant RBD (N501Y)
0.1099.500.16 331-532X-ray1.65hetero-1-1-mer1 x NAGHHblits0.63
7oau.2.A
Spike protein S1
Nanobody C5 bound to Kent variant RBD (N501Y)
0.0999.500.16 331-532X-ray1.65hetero-1-1-mer1 x NAGHHblits0.63
7oaq.1.B
Spike protein S1
Nanobody H3 AND C1 bound to RBD with Kent mutation
0.1099.500.16 331-532X-ray1.55hetero-1-1-1-mer1 x NAGHHblits0.63
7klg.1.C
Spike glycoprotein
SARS-CoV-2 RBD in complex with Fab 15033
0.10100.000.16 328-528X-ray3.20hetero-1-1-1-mer1 x NAGHHblits0.63
7klg.2.C
Spike glycoprotein
SARS-CoV-2 RBD in complex with Fab 15033
0.09100.000.16 328-528X-ray3.20hetero-1-1-1-mer1 x NAGHHblits0.63
7klh.1.C
Spike glycoprotein
SARS-CoV-2 RBD in complex with Fab 15033-7
0.10100.000.16 328-528X-ray3.00hetero-1-1-1-mer1 x NAGHHblits0.63
7klh.2.C
Spike glycoprotein
SARS-CoV-2 RBD in complex with Fab 15033-7
0.09100.000.16 328-528X-ray3.00hetero-1-1-1-mer1 x NAGHHblits0.63
7t01.1.A
Spike protein S1
SARS-CoV-2 S-RBD + Fab 54042-4
0.11100.000.16 329-529EM0.00hetero-1-1-1-merBLAST0.63
6zer.3.A
Spike protein S1
Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with EY6A Fab
0.10100.000.16 331-531X-ray3.80hetero-1-1-1-mer1 x NAGHHblits0.63
6zer.1.A
Spike protein S1
Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with EY6A Fab
0.10100.000.16 331-531X-ray3.80hetero-1-1-1-mer1 x NAGHHblits0.63
6zer.2.A
Spike protein S1
Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with EY6A Fab
0.10100.000.16 331-531X-ray3.80hetero-1-1-1-mer1 x NAGHHblits0.63
6yor.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike S1 protein in complex with CR3022 Fab
0.10100.000.16 331-531EM0.00hetero-1-1-1-merHHblits0.63
6yor.2.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike S1 protein in complex with CR3022 Fab
0.10100.000.16 331-531EM0.00hetero-1-1-1-merHHblits0.63
7wvl.1.C
Spike protein S1
Structure of P4A2 Fab in complex with Spike-RBD from SARS-CoV-2
0.08100.000.16 332-532X-ray3.00hetero-1-1-1-merBLAST0.63
7u0n.1.B
Spike protein S1
Crystal structure of chimeric omicron RBD (strain BA.1) complexed with human ACE2
0.0882.870.17 319-534X-ray2.61hetero-1-1-mer5 x NAG, 1 x ZN, 2 x NAG-NAG-BMAHHblits0.57
7u0n.2.B
Spike protein S1
Crystal structure of chimeric omicron RBD (strain BA.1) complexed with human ACE2
0.0982.870.17 319-534X-ray2.61hetero-1-1-mer3 x NAG, 1 x ZN, 1 x MG, 3 x NAG-NAG-BMA, 1 x NAG-NAGHHblits0.57
8df5.1.K
Spike protein S1
SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab
0.1098.510.16 328-529X-ray2.70hetero-2-2-2-2-2-2-…2 x ZN, 13 x NAG, 2 x NAG-NAGBLAST0.63
7ufk.1.B
Spike protein S1
Crystal structure of chimeric omicron RBD (strain BA.2) complexed with human ACE2
0.0982.410.17 319-534X-ray2.38hetero-1-1-mer1 x ZN, 5 x NAG, 2 x NAG-NAG-BMAHHblits0.57
7ufk.2.B
Spike protein S1
Crystal structure of chimeric omicron RBD (strain BA.2) complexed with human ACE2
0.0982.410.17 319-534X-ray2.38hetero-1-1-mer1 x ZN, 3 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MANHHblits0.57
7ufl.1.B
Spike protein S1
Crystal structure of chimeric omicron RBD (strain BA.2) complexed with chimeric mouse ACE2
0.0982.410.17 319-534X-ray2.84hetero-1-1-mer1 x ZN, 3 x NAG, 1 x NAG-NAG-BMAHHblits0.57
7ufl.2.B
Spike protein S1
Crystal structure of chimeric omicron RBD (strain BA.2) complexed with chimeric mouse ACE2
0.0982.410.17 319-534X-ray2.84hetero-1-1-mer1 x ZN, 2 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.57
7l7d.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibody AZD8895
0.10100.000.16 330-529X-ray2.50hetero-1-1-1-mer1 x NAGBLAST0.63
7l7e.1.E
Spike protein S1
Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and AZD1061
0.10100.000.16 330-529X-ray3.00hetero-1-1-1-1-1-mer1 x NAGBLAST0.63
7ws2.1.B
Spike protein S1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.11100.000.16 331-530EM0.00hetero-1-1-1-merBLAST0.63
8hed.1.A
Spike protein S1
Local refinement of the SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab
0.10100.000.16 331-530EM0.00hetero-1-1-1-mer1 x NAG, 1 x NAG-NAGBLAST0.63
7xxl.1.C
Spike protein S1
RBD in complex with Fab14
0.10100.000.16 332-531EM0.00hetero-1-1-1-mer1 x NAGHHblits0.63
7tn0.1.F
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab
0.0991.350.16 324-531X-ray2.85hetero-1-1-1-1-1-1-…1 x ZN, 6 x NAGBLAST0.60
7xwa.1.B
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
0.0888.630.17 322-536X-ray3.36hetero-1-1-mer1 x ZN, 1 x NAG, 2 x NAG-NAG, 2 x NAG-NAG-BMAHHblits0.59
7xwa.2.B
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein in complex with its receptor ACE2
0.0888.630.17 322-536X-ray3.36hetero-1-1-mer1 x ZN, 2 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAG-BMA-MAN, 1 x NAG-NAGHHblits0.59
7kmg.1.C
Spike protein S1
LY-CoV555 neutralizing antibody against SARS-CoV-2
0.09100.000.16 329-527X-ray2.16hetero-1-1-1-merBLAST0.63
7mmo.1.C
Spike protein S1
LY-CoV1404 neutralizing antibody against SARS-CoV-2
0.09100.000.16 329-527X-ray2.43hetero-1-1-1-mer1 x NAGBLAST0.63
7t01.1.A
Spike protein S1
SARS-CoV-2 S-RBD + Fab 54042-4
0.10100.000.16 330-528EM0.00hetero-1-1-1-merHHblits0.63
7l7d.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibody AZD8895
0.10100.000.16 331-529X-ray2.50hetero-1-1-1-mer1 x NAGHHblits0.63
7l7e.2.E
Spike protein S1
Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and AZD1061
0.09100.000.16 331-529X-ray3.00hetero-1-1-1-1-1-mer1 x NAGHHblits0.63
7l7e.3.E
Spike protein S1
Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and AZD1061
0.10100.000.16 331-529X-ray3.00hetero-1-1-1-1-1-mer1 x NAGHHblits0.63
7l7e.1.E
Spike protein S1
Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and AZD1061
0.10100.000.16 331-529X-ray3.00hetero-1-1-1-1-1-mer1 x NAGHHblits0.63
7l7e.4.E
Spike protein S1
Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and AZD1061
0.10100.000.16 331-529X-ray3.00hetero-1-1-1-1-1-mer1 x NAGHHblits0.63
7oap.1.B
Spike protein S1
Nanobody H3 AND C1 bound to RBD
0.10100.000.16 334-532X-ray1.90hetero-1-1-1-mer1 x NAGHHblits0.63
7x66.1.C
Spike protein S1
SARS-CoV-2-Omicron-RBD and BD-236-GWP/P-VK antibody complex
0.0990.870.16 319-528X-ray2.40hetero-1-1-1-merHHblits0.59
7kmg.1.C
Spike protein S1
LY-CoV555 neutralizing antibody against SARS-CoV-2
0.09100.000.16 330-527X-ray2.16hetero-1-1-1-merHHblits0.63
7kmh.1.C
Spike protein S1
LY-CoV488 neutralizing antibody against SARS-CoV-2
0.09100.000.16 330-527X-ray1.72hetero-1-1-1-mer1 x NAG, 1 x PROHHblits0.63
7kmi.1.C
Spike protein S1
LY-CoV481 neutralizing antibody against SARS-CoV-2
0.10100.000.16 330-527X-ray1.73hetero-1-1-1-mer1 x NAGHHblits0.63
7kmg.2.C
Spike protein S1
LY-CoV555 neutralizing antibody against SARS-CoV-2
0.10100.000.16 330-527X-ray2.16hetero-1-1-1-merHHblits0.63
7mmo.2.C
Spike protein S1
LY-CoV1404 neutralizing antibody against SARS-CoV-2
0.10100.000.16 330-527X-ray2.43hetero-1-1-1-merHHblits0.63
7mmo.1.C
Spike protein S1
LY-CoV1404 neutralizing antibody against SARS-CoV-2
0.09100.000.16 330-527X-ray2.43hetero-1-1-1-mer1 x NAGHHblits0.63
7yck.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with FP-12A Fab
0.09100.000.16 333-530X-ray2.60hetero-1-1-1-merBLAST0.63
7ycl.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with IS-9A Fab
0.10100.000.16 333-530X-ray2.13hetero-1-1-1-merBLAST0.63
7lq7.1.E
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16
0.10100.000.16 333-530X-ray3.40hetero-3-3-3-3-3-mer3 x NAGBLAST0.63
7mf1.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1
0.11100.000.16 333-530X-ray2.09hetero-1-1-1-mer1 x NAG, 1 x NAG-NAG-FUCBLAST0.63
7sbu.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a highly potent antibody J08 Fab
0.10100.000.16 333-530X-ray2.53hetero-1-1-1-mer1 x NAGBLAST0.63
8cwv.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 2-31 and a human antibody CC12.1 Fab
0.10100.000.16 333-530X-ray2.51hetero-1-1-1-1-merBLAST0.63
8cwu.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 1-21
0.09100.000.16 333-530X-ray1.71hetero-1-1-merBLAST0.63
7tp4.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K398.22
0.10100.000.16 333-530X-ray1.95hetero-1-1-1-merBLAST0.63
7u2e.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADI-55688
0.10100.000.16 333-530X-ray2.85hetero-1-1-1-mer1 x NAGBLAST0.63
7wd2.1.A
Spike protein S1
Crystal structure of S43 bound to SARS-CoV-2 RBD
0.09100.000.16 333-530X-ray2.69hetero-1-1-mer1 x NAG, 1 x NAG-NAG-FUCBLAST0.63
7wd2.2.A
Spike protein S1
Crystal structure of S43 bound to SARS-CoV-2 RBD
0.10100.000.16 333-530X-ray2.69hetero-1-1-mer1 x NAG-NAG, 1 x NAG-FUCBLAST0.63
8gjn.1.C
Spike protein S2'
17B10 fab in complex with up-RBD of SARS-CoV-2 Spike G614 trimer
0.10100.000.16 333-530EM0.00hetero-1-1-1-mer1 x NAGBLAST0.63
7wvl.1.C
Spike protein S1
Structure of P4A2 Fab in complex with Spike-RBD from SARS-CoV-2
0.08100.000.16 335-532X-ray3.00hetero-1-1-1-merHHblits0.63
7wck.1.C
Surface glycoprotein
Local CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWA9 Fab
0.1098.990.16 333-531EM0.00hetero-1-1-1-merBLAST0.63
7wcu.1.C
Surface glycoprotein
Local CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWC11 Fab
0.1098.990.16 333-531EM0.00hetero-1-1-1-merBLAST0.63
7qf1.1.A
Spike protein S1
Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.6264
0.0999.490.16 331-528X-ray2.80hetero-2-2-2-mer1 x NAG, 1 x NAG-BMABLAST0.63
7qf0.1.A
Spike protein S1
Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.2325
0.0999.490.16 331-528X-ray2.30hetero-1-1-1-mer1 x NAG-NAGBLAST0.63
7qez.1.A
Spike protein S1
Crystal structure of the SARS-CoV-2 RBD in complex with the ultrapotent antibody CV2.1169 and CR3022
0.1199.490.16 331-528X-ray2.89hetero-1-1-1-1-1-mer1 x NAGBLAST0.63
7q3q.1.B
Spike glycoprotein
Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobody VHH-12
0.0999.490.16 331-528X-ray2.30hetero-1-1-mer1 x NAG-NAGBLAST0.63
7q3r.1.A
Spike glycoprotein
Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobodies VHH-F04 and VHH-G09
0.1099.490.16 331-528X-ray1.92hetero-1-1-1-mer1 x NAG-NAGBLAST0.63
7x1m.1.G
Spike protein S1
The complex structure of Omicron BA.1 RBD with BD604, S309,and S304
0.0991.260.16 335-541EM0.00hetero-1-1-1-1-1-1-…HHblits0.60
8df5.1.K
Spike protein S1
SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab
0.0997.010.16 329-529X-ray2.70hetero-2-2-2-2-2-2-…2 x ZN, 13 x NAG, 2 x NAG-NAGHHblits0.62
8df5.1.L
Spike protein S1
SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab
0.0997.010.16 329-529X-ray2.70hetero-2-2-2-2-2-2-…2 x ZN, 13 x NAG, 2 x NAG-NAGHHblits0.62
7lo4.1.B
Spike protein S1
SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2
0.0999.490.16 333-530X-ray2.47hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAG-FUCBLAST0.63
8gz5.1.A
Spike protein S1
Crystal structure of neutralizing VHH P17 in complex with SARS-CoV-2 Alpha variant spike receptor-binding domain
0.1099.490.16 333-530X-ray1.70hetero-1-1-merBLAST0.63
7ddp.1.B
Spike protein S1
Cryo-EM structure of human ACE2 and GX/P2V/2017 RBD
0.1087.080.16 319-527EM0.00hetero-1-1-mer1 x ZN, 5 x NAGBLAST0.59
7xnf.1.C
Spike protein S1
Structure of SARS-CoV-2 antibody P2C-1F11 with GX/P2V/2017 RBD
0.0887.080.16 319-527X-ray2.79hetero-1-1-1-merBLAST0.59
7xsw.1.C
Spike protein S1
Structure of SARS-CoV-2 antibody S309 with GX/P2V/2017 RBD
0.0987.080.16 319-527X-ray3.30hetero-1-1-1-merBLAST0.59
7xsw.2.C
Spike protein S1
Structure of SARS-CoV-2 antibody S309 with GX/P2V/2017 RBD
0.0987.080.16 319-527X-ray3.30hetero-1-1-1-merBLAST0.59
8dw2.1.B
Spike protein S1
Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR22, and two antibody Fabs, S309 and CR3022
0.08100.000.15 330-526EM0.00hetero-1-1-1-1-1-1-…BLAST0.63
8dw3.1.B
Spike protein S1
Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR16m, and two antibody Fabs, S309 and CR3022
0.09100.000.15 330-526EM0.00hetero-1-1-1-1-1-1-…BLAST0.63
7mzi.1.C
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab WCSL 129
0.09100.000.15 331-527X-ray1.85hetero-1-1-1-merBLAST0.63
7mzl.1.A
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab PDI 210
0.10100.000.15 331-527X-ray3.70hetero-1-1-1-merBLAST0.63
7mzm.1.C
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab PDI 215
0.09100.000.15 331-527X-ray2.30hetero-1-1-1-mer1 x NAG-FUCBLAST0.63
7mzn.1.A
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab PDI 231
0.10100.000.15 331-527X-ray3.10hetero-1-1-1-merBLAST0.63
7mzf.1.A
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab PDI 37
0.10100.000.15 331-527X-ray2.49hetero-1-1-1-merBLAST0.63
7mzj.2.C
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 93
0.10100.000.15 331-527X-ray2.40hetero-1-1-1-1-1-merBLAST0.63
7mzh.2.A
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab WCSL 119
0.10100.000.15 331-527X-ray2.10hetero-1-1-1-merBLAST0.63
7n4l.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2125.
0.10100.000.15 331-527X-ray3.60hetero-1-1-1-merBLAST0.63
7n4m.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2151.
0.10100.000.15 331-527X-ray3.79hetero-1-1-1-mer1 x NAG-NAGBLAST0.63
7n4j.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2173.
0.09100.000.15 331-527X-ray2.21hetero-1-1-1-merBLAST0.63
7u8e.1.C
Spike protein S1
Crystal structure of antibody Ab246 in complex with SARS-CoV-2 receptor binding domain
0.10100.000.15 331-527X-ray2.29hetero-1-1-1-mer1 x NAGBLAST0.63
7ldj.1.A
Spike glycoprotein
SARS-CoV-2 receptor binding domain in complex with WNb-2
0.10100.000.15 331-527X-ray2.36hetero-1-1-merBLAST0.63
7ldj.2.A
Spike glycoprotein
SARS-CoV-2 receptor binding domain in complex with WNb-2
0.10100.000.15 331-527X-ray2.36hetero-1-1-mer1 x MAN, 1 x NAG-NAG-MAN-MAN-NAG-FULBLAST0.63
7ldj.3.A
Spike glycoprotein
SARS-CoV-2 receptor binding domain in complex with WNb-2
0.10100.000.15 331-527X-ray2.36hetero-1-1-merBLAST0.63
7ldj.4.A
Spike glycoprotein
SARS-CoV-2 receptor binding domain in complex with WNb-2
0.09100.000.15 331-527X-ray2.36hetero-1-1-mer1 x NAGBLAST0.63
7mlz.1.A
Spike protein S1
Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain
0.09100.000.15 331-527EM0.00hetero-1-1-1-merBLAST0.63
7fc5.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 RBD and horse ACE2
0.09100.000.15 333-529X-ray2.89hetero-1-1-mer5 x NAGBLAST0.63
7z0x.1.C
Spike protein S1
THSC20.HVTR26 Fab bound to SARS-CoV-2 Receptor Binding Domain
0.10100.000.15 331-527X-ray1.80hetero-1-1-1-merBLAST0.63
7z0y.1.C
Spike protein S1
THSC20.HVTR04 Fab bound to SARS-CoV-2 Receptor Binding Domain
0.10100.000.15 331-527X-ray2.95hetero-1-1-1-merBLAST0.63
7fcq.1.A
Spike protein S1
Crystallographic structure of neutralizing antibody P14-44 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD)
0.09100.000.15 332-528X-ray1.89hetero-1-1-1-mer1 x NAGBLAST0.63
7mfu.2.A
Spike protein S1
Crystal structure of synthetic nanobody (Sb14+Sb68) complexes with SARS-CoV-2 receptor binding domain
0.10100.000.15 332-528X-ray1.70hetero-1-1-1-merBLAST0.63
6zh9.1.C
Spike glycoprotein
Ternary complex CR3022 H11-H4 and RBD (SARS-CoV-2)
0.09100.000.15 332-528X-ray3.31hetero-1-1-1-1-merBLAST0.63
6z2m.1.A
Spike glycoprotein
H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex
0.10100.000.15 332-528X-ray2.71hetero-1-1-1-1-mer1 x NAGBLAST0.63
6z2m.2.A
Spike glycoprotein
H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex
0.10100.000.15 332-528X-ray2.71hetero-1-1-1-1-mer1 x NAGBLAST0.63
7f15.1.A
Spike protein S1
A SARS-CoV-2 neutralizing antibody
0.09100.000.15 334-530X-ray2.65hetero-1-1-mer1 x NAGBLAST0.63
7det.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv
0.09100.000.15 334-530X-ray2.20hetero-1-1-mer1 x NAGBLAST0.63
7deo.2.B
Spike protein S1
Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv
0.09100.000.15 334-530X-ray2.50hetero-1-1-mer1 x CA, 1 x NAGBLAST0.63
7deo.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv
0.10100.000.15 334-530X-ray2.50hetero-1-1-mer1 x CA, 1 x NAGBLAST0.63
7deu.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv
0.10100.000.15 334-530X-ray2.10hetero-1-1-mer1 x NAGBLAST0.63
7wqv.1.A
Spike protein S1
Crystal structure of a neutralizing monoclonal antibody (Ab08) in complex with SARS-CoV-2 receptor-binding domain (RBD)
0.10100.000.15 335-531X-ray2.80hetero-1-1-mer1 x CA, 1 x NAG-FUCHHblits0.63
7wqv.3.A
Spike protein S1
Crystal structure of a neutralizing monoclonal antibody (Ab08) in complex with SARS-CoV-2 receptor-binding domain (RBD)
0.10100.000.15 335-531X-ray2.80hetero-1-1-mer1 x CA, 1 x NAG-FUCHHblits0.63
7wqv.4.A
Spike protein S1
Crystal structure of a neutralizing monoclonal antibody (Ab08) in complex with SARS-CoV-2 receptor-binding domain (RBD)
0.10100.000.15 335-531X-ray2.80hetero-1-1-mer1 x NAG-FUCHHblits0.63
7wqv.5.A
Spike protein S1
Crystal structure of a neutralizing monoclonal antibody (Ab08) in complex with SARS-CoV-2 receptor-binding domain (RBD)
0.09100.000.15 335-531X-ray2.80hetero-1-1-merHHblits0.63
7wqv.6.A
Spike protein S1
Crystal structure of a neutralizing monoclonal antibody (Ab08) in complex with SARS-CoV-2 receptor-binding domain (RBD)
0.09100.000.15 335-531X-ray2.80hetero-1-1-mer1 x CAHHblits0.63
7wqv.7.A
Spike protein S1
Crystal structure of a neutralizing monoclonal antibody (Ab08) in complex with SARS-CoV-2 receptor-binding domain (RBD)
0.09100.000.15 335-531X-ray2.80hetero-1-1-mer1 x CAHHblits0.63
7wqv.8.A
Spike protein S1
Crystal structure of a neutralizing monoclonal antibody (Ab08) in complex with SARS-CoV-2 receptor-binding domain (RBD)
0.10100.000.15 335-531X-ray2.80hetero-1-1-mer1 x NAG, 1 x CAHHblits0.63
7wqv.2.A
Spike protein S1
Crystal structure of a neutralizing monoclonal antibody (Ab08) in complex with SARS-CoV-2 receptor-binding domain (RBD)
0.10100.000.15 335-531X-ray2.80hetero-1-1-mer1 x NAG, 1 x CAHHblits0.63
7ws2.1.B
Spike protein S1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.10100.000.15 334-529EM0.00hetero-1-1-1-merHHblits0.63
8hed.1.A
Spike protein S1
Local refinement of the SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab
0.10100.000.15 334-529EM0.00hetero-1-1-1-mer1 x NAG, 1 x NAG-NAGHHblits0.63
7msq.1.A
Spike protein S1
Complex between the Fab arm of AB-3467 and the SARS-CoV-2 receptor binding domain (RBD)
0.09100.000.15 333-528X-ray2.29hetero-1-1-1-merBLAST0.63
7kzb.1.C
Spike glycoprotein
Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1antibodies
0.10100.000.15 333-528X-ray2.83hetero-1-1-1-1-1-merBLAST0.63
8dxt.1.C
Spike protein S1
Fab arm of antibody GAR12 bound to the receptor binding domain of SARS-CoV-2.
0.09100.000.15 333-528X-ray2.25hetero-1-1-1-merBLAST0.63
7t72.1.C
Spike protein S1
Epitope-based selection of SARS-CoV-2 neutralizing antibodies from convalescent patients
0.09100.000.15 333-528X-ray3.18hetero-1-1-1-mer1 x NAGBLAST0.63
7wd1.2.A
Spike protein S1
Crystal structure of R14 bound to SARS-CoV-2 RBD
0.10100.000.15 333-528X-ray2.50hetero-1-1-mer1 x NAG-FUCBLAST0.63
7x2l.1.A
Spike protein S1
Crystal structure of nanobody 3-2A2-4 with SARS-CoV-2 RBD
0.10100.000.15 333-528X-ray2.40hetero-1-1-merBLAST0.63
7kgj.1.A
Spike glycoprotein
Crystal structure of synthetic nanobody (Sb45) complexes with SARS-CoV-2 receptor binding domain
0.09100.000.15 333-528X-ray2.30hetero-1-1-merBLAST0.63
7b14.1.A
Spike protein S1
Nanobody E bound to Spike-RBD in a localized reconstruction
0.10100.000.15 333-528EM0.00hetero-1-1-mer1 x NAGBLAST0.63
7zfd.1.B
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with Omi-25 Fab
0.0992.610.16 330-532X-ray3.39hetero-1-1-1-merBLAST0.60
7z0x.1.C
Spike protein S1
THSC20.HVTR26 Fab bound to SARS-CoV-2 Receptor Binding Domain
0.10100.000.15 332-527X-ray1.80hetero-1-1-1-merHHblits0.63
7z0y.1.C
Spike protein S1
THSC20.HVTR04 Fab bound to SARS-CoV-2 Receptor Binding Domain
0.10100.000.15 332-527X-ray2.95hetero-1-1-1-merHHblits0.63
7fbj.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6
0.10100.000.15 332-527X-ray2.85hetero-1-1-mer1 x NAGHHblits0.63
7fbj.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6
0.10100.000.15 332-527X-ray2.85hetero-1-1-mer1 x NAGHHblits0.63
7fbj.3.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6
0.10100.000.15 332-527X-ray2.85hetero-1-1-mer1 x NAGHHblits0.63
7fbj.4.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6
0.10100.000.15 332-527X-ray2.85hetero-1-1-mer1 x NAG-NAGHHblits0.63
7fbj.5.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6
0.10100.000.15 332-527X-ray2.85hetero-1-1-mer1 x NAG-NAGHHblits0.63
7fbj.6.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6
0.10100.000.15 332-527X-ray2.85hetero-1-1-merHHblits0.63
7fbj.7.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6
0.10100.000.15 332-527X-ray2.85hetero-1-1-mer1 x NAG-NAGHHblits0.63
7fbj.8.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6
0.10100.000.15 332-527X-ray2.85hetero-1-1-mer1 x NAG-NAGHHblits0.63
7lrs.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain
0.10100.000.15 332-527EM0.00hetero-1-1-1-merBLAST0.63
7phg.1.A
Surface glycoprotein
MaP OF P5C3RBD Interface
0.11100.000.15 332-527EM0.00hetero-1-1-1-merBLAST0.63
7tbf.1.A
Spike glycoprotein
Locally refined region of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1
0.10100.000.15 332-527EM0.00hetero-1-1-1-1-1-mer1 x NAG-NAGBLAST0.63
8dw2.1.B
Spike protein S1
Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR22, and two antibody Fabs, S309 and CR3022
0.08100.000.15 331-526EM0.00hetero-1-1-1-1-1-1-…HHblits0.63
8dw3.1.B
Spike protein S1
Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR16m, and two antibody Fabs, S309 and CR3022
0.09100.000.15 331-526EM0.00hetero-1-1-1-1-1-1-…HHblits0.63
7det.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv
0.09100.000.15 335-530X-ray2.20hetero-1-1-mer1 x NAGHHblits0.63
7det.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv
0.10100.000.15 335-530X-ray2.20hetero-1-1-mer1 x NAGHHblits0.63
7deo.2.B
Spike protein S1
Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv
0.09100.000.15 335-530X-ray2.50hetero-1-1-mer1 x CA, 1 x NAGHHblits0.63
7deo.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv
0.10100.000.15 335-530X-ray2.50hetero-1-1-mer1 x CA, 1 x NAGHHblits0.63
7deu.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv
0.09100.000.15 335-530X-ray2.10hetero-1-1-mer1 x NAGHHblits0.63
7f15.1.A
Spike protein S1
A SARS-CoV-2 neutralizing antibody
0.09100.000.15 335-530X-ray2.65hetero-1-1-mer1 x NAGHHblits0.63
7lq7.1.E
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16
0.10100.000.15 335-530X-ray3.40hetero-3-3-3-3-3-mer3 x NAGHHblits0.63
7lq7.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16
0.09100.000.15 335-530X-ray3.40hetero-3-3-3-3-3-mer3 x NAGHHblits0.63
7lq7.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16
0.09100.000.15 335-530X-ray3.40hetero-3-3-3-3-3-mer3 x NAGHHblits0.63
7t7b.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing antibody ADI-62113 Fab
0.09100.000.15 335-530X-ray2.59hetero-1-1-1-merHHblits0.63
7mf1.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1
0.10100.000.15 335-530X-ray2.09hetero-1-1-1-mer1 x NAG, 1 x NAG-NAG-FUCHHblits0.63
7sbu.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a highly potent antibody J08 Fab
0.09100.000.15 335-530X-ray2.53hetero-1-1-1-mer1 x NAGHHblits0.63
8cwv.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 2-31 and a human antibody CC12.1 Fab
0.10100.000.15 335-530X-ray2.51hetero-1-1-1-1-merHHblits0.63
8cwu.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 1-21
0.09100.000.15 335-530X-ray1.71hetero-1-1-merHHblits0.63
7tp4.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K398.22
0.10100.000.15 335-530X-ray1.95hetero-1-1-1-merHHblits0.63
7u2e.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADI-55688
0.10100.000.15 335-530X-ray2.85hetero-1-1-1-mer1 x NAGHHblits0.63
7u2d.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADG20
0.10100.000.15 335-530X-ray2.76hetero-1-1-1-mer1 x NAGHHblits0.63
7zf7.1.B
Spike protein S1
SARS-CoV-2 Omicron BA.2 RBD in complex with ACE2
0.1092.120.16 330-532X-ray3.46hetero-1-1-mer6 x NAG, 1 x ZNBLAST0.60
7x2m.1.A
Spike protein S1
Crystal structure of nanobody 1-2C7 with SARS-CoV-2 RBD
0.0998.480.15 333-529X-ray1.80hetero-1-1-merBLAST0.63
7wed.1.A
Spike protein S1
SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv347
0.1094.030.16 330-530EM0.00hetero-1-1-1-merBLAST0.61
7wef.1.B
Spike protein S1
SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv289
0.1094.030.16 330-530EM0.00hetero-1-1-1-merBLAST0.61
7qnx.1.E
Surface glycoprotein
The receptor binding domain of SARS-CoV-2 spike glycoprotein in complex with Beta-55 and EY6A Fabs
0.0999.490.15 333-528X-ray2.92hetero-1-1-1-1-1-mer1 x NAG-NAGBLAST0.63
7qny.1.C
Surface glycoprotein
The receptor binding domain of SARS-CoV-2 spike glycoprotein in complex with COVOX-58 and COVOX-158 Fabs
0.0999.490.15 333-528X-ray2.84hetero-1-1-1-1-1-mer1 x NAGBLAST0.63
7bel.2.A
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-88 and COVOX-45 Fabs
0.0999.490.15 333-528X-ray2.53hetero-1-1-1-1-1-mer1 x NAG, 1 x NAG-NAG-BMA-MAN-MAN-MANBLAST0.63
7bei.1.C
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab
0.1099.490.15 333-528X-ray2.30hetero-1-1-1-merBLAST0.63
7beo.2.A
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-253H55L and COVOX-75 Fabs
0.0999.490.15 333-528X-ray3.19hetero-1-1-1-1-1-merBLAST0.63
7neh.1.C
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 Fab
0.0999.490.15 333-528X-ray1.77hetero-1-1-1-merBLAST0.63
7bem.1.C
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 scFv
0.0999.490.15 333-528X-ray2.52hetero-1-1-1-mer4 x PRO, 1 x NAG-NAG-FUCBLAST0.63
7nx6.1.C
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs
0.0999.490.15 333-528X-ray2.25hetero-1-1-1-1-1-mer1 x NAGBLAST0.63
7fbk.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain N501Y mutant in complex with neutralizing nanobody 20G6
0.1099.490.15 332-527X-ray1.90hetero-1-1-merHHblits0.63
7fbk.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain N501Y mutant in complex with neutralizing nanobody 20G6
0.0999.490.15 332-527X-ray1.90hetero-1-1-merHHblits0.63
7x7u.1.A
Spike protein S1
Cryo-EM structure of SARS-CoV-2 Delta variant spike protein in complex with three nAbs X01, X10 and X17
0.0895.500.16 325-527EM0.00hetero-1-1-1-1-1-1-…1 x NAGHHblits0.61
7lo4.1.B
Spike protein S1
SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2
0.0999.490.15 335-530X-ray2.47hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAG-FUCHHblits0.63
8be1.1.C
Spike protein S1
SARS-CoV-2 RBD in complex with a Fab fragment of a neutralising antibody mRBD2
0.09100.000.15 333-527X-ray1.98hetero-1-1-1-merHHblits0.63
8be1.2.C
Spike protein S1
SARS-CoV-2 RBD in complex with a Fab fragment of a neutralising antibody mRBD2
0.09100.000.15 333-527X-ray1.98hetero-1-1-1-merHHblits0.63
7ycn.4.A
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with IY-2A Fab
0.10100.000.15 333-527X-ray2.85hetero-1-1-1-merBLAST0.63
7olz.1.C
Spike protein S1
Crystal structure of the SARS-CoV-2 RBD with neutralizing-VHHs Re5D06 and Re9F06
0.08100.000.15 333-527X-ray1.75hetero-1-1-1-mer1 x DMXBLAST0.63
7e3j.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 RBD binding to dog ACE2
0.11100.000.15 333-527X-ray2.99hetero-1-1-mer1 x ZN, 1 x NAGBLAST0.63
7kgk.1.A
Spike protein S1
Crystal structure of synthetic nanobody (Sb16) complexes with SARS-CoV-2 receptor binding domain
0.10100.000.15 333-527X-ray2.60hetero-1-1-merBLAST0.63
7k9i.1.A
Spike protein S1
SARS-CoV-2 Spike RBD in complex with neutralizing Fab 2B04 (local refinement)
0.10100.000.15 333-527EM0.00hetero-1-1-1-mer1 x NAGBLAST0.63
7k9k.1.A
Spike protein S1
SARS-CoV-2 Spike RBD in complex with neutralizing Fab 2H04 (local refinement)
0.09100.000.15 333-527EM0.00hetero-1-1-1-merBLAST0.63
7whz.1.A
Spike protein S1
SARS-CoV-2 spike protein in complex with three human neutralizing antibodies
0.12100.000.15 333-527EM0.00hetero-1-1-1-1-1-1-…1 x NAGBLAST0.63
7wue.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 Receptor Binding Domain in complex with the monoclonal antibody m31A7
0.10100.000.15 333-527X-ray3.20hetero-1-1-1-merBLAST0.63
7wue.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 Receptor Binding Domain in complex with the monoclonal antibody m31A7
0.10100.000.15 333-527X-ray3.20hetero-1-1-1-merBLAST0.63
7the.1.A
Spike protein S1
Structure of RBD directed antibody DH1042 in complex with SARS-CoV-2 spike: Local refinement of RBD-Fab interface
0.10100.000.15 333-527EM0.00hetero-1-1-1-mer1 x NAGBLAST0.63
7wse.1.B
Spike protein S1
Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor minke whale ACE2
0.10100.000.15 333-527EM0.00hetero-1-1-mer1 x ZNBLAST0.63
7wsh.1.B
Spike protein S1
Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain in complex with sea lion ACE2
0.09100.000.15 333-527EM0.00hetero-1-1-mer1 x ZN, 1 x NAGBLAST0.63
7c8d.1.B
Spike protein S1
Cryo-EM structure of cat ACE2 and SARS-CoV-2 RBD
0.10100.000.15 333-527EM0.00hetero-1-1-mer1 x ZNBLAST0.63
7c8j.1.B
SARS-CoV-2 Receptor binding domain
Structural basis for cross-species recognition of COVID-19 virus spike receptor binding domain to bat ACE2
0.09100.000.15 333-527X-ray3.18hetero-1-1-mer1 x ZNBLAST0.63
8dw9.2.A
Spike protein S1
Crystal structure of neutralizing antibody D29 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD)
0.09100.000.15 333-527X-ray4.00hetero-1-1-1-merBLAST0.63
7ycn.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with IY-2A Fab
0.09100.000.15 333-527X-ray2.85hetero-1-1-1-mer1 x NAGBLAST0.63
7f7e.1.C
Spike protein S1
SARS-CoV-2 S protein RBD in complex with A5-10 Fab
0.09100.000.15 333-527X-ray2.49hetero-1-1-1-mer1 x NAGBLAST0.63
7n9a.1.B
Spike protein S1
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS RBD with NB21
0.11100.000.15 334-528EM0.00hetero-1-1-merBLAST0.63
7r8l.1.C
Spike protein S1
Structure of the SARS-CoV-2 RBD in complex with neutralizing antibody C099 and CR3022
0.10100.000.15 334-528X-ray2.60hetero-1-1-1-1-1-merBLAST0.63
7swp.1.A
Spike protein S1
G32Q4 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction)
0.08100.000.15 334-528EM0.00hetero-1-1-1-merBLAST0.63
7swo.1.A
Spike protein S1
C98C7 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction)
0.10100.000.15 334-528EM0.00hetero-1-1-1-merBLAST0.63
7b17.1.A
Spike protein S1
SARS-CoV-spike RBD bound to two neutralising nanobodies.
0.09100.000.15 334-528EM0.00hetero-1-1-mer1 x NAGBLAST0.63
7x2h.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with 6-2C Fab
0.09100.000.15 334-528X-ray2.10hetero-1-1-1-mer1 x NAGBLAST0.63
7x2h.2.C
Spike protein S1
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with 6-2C Fab
0.08100.000.15 334-528X-ray2.10hetero-1-1-1-mer1 x NAGBLAST0.63
7xcz.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta RBD in complex with BA7054 and BA7125 fab (local refinement)
0.1198.980.15 333-528EM0.00hetero-1-1-1-1-1-merBLAST0.63
7yck.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with FP-12A Fab
0.09100.000.15 335-529X-ray2.60hetero-1-1-1-merHHblits0.63
7yck.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with FP-12A Fab
0.09100.000.15 335-529X-ray2.60hetero-1-1-1-merHHblits0.63
7ycl.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with IS-9A Fab
0.09100.000.15 335-529X-ray2.13hetero-1-1-1-merHHblits0.63
7ycl.2.C
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with IS-9A Fab
0.10100.000.15 335-529X-ray2.13hetero-1-1-1-merHHblits0.63
7wd2.1.A
Spike protein S1
Crystal structure of S43 bound to SARS-CoV-2 RBD
0.09100.000.15 335-529X-ray2.69hetero-1-1-mer1 x NAG, 1 x NAG-NAG-FUCHHblits0.63
7wd2.2.A
Spike protein S1
Crystal structure of S43 bound to SARS-CoV-2 RBD
0.10100.000.15 335-529X-ray2.69hetero-1-1-mer1 x NAG-NAG, 1 x NAG-FUCHHblits0.63
8gjn.1.C
Spike protein S2'
17B10 fab in complex with up-RBD of SARS-CoV-2 Spike G614 trimer
0.09100.000.15 335-529EM0.00hetero-1-1-1-mer1 x NAGHHblits0.63
7nx7.1.C
Spike protein S1
Crystal structure of the K417N mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs
0.1098.980.15 333-528X-ray2.30hetero-1-1-1-1-1-mer1 x NAGBLAST0.63
7xnf.1.C
Spike protein S1
Structure of SARS-CoV-2 antibody P2C-1F11 with GX/P2V/2017 RBD
0.0886.470.16 319-527X-ray2.79hetero-1-1-1-merHHblits0.58
7xsw.1.C
Spike protein S1
Structure of SARS-CoV-2 antibody S309 with GX/P2V/2017 RBD
0.0986.470.16 319-527X-ray3.30hetero-1-1-1-merHHblits0.58
7xsw.2.C
Spike protein S1
Structure of SARS-CoV-2 antibody S309 with GX/P2V/2017 RBD
0.0986.470.16 319-527X-ray3.30hetero-1-1-1-merHHblits0.58
7ddp.1.B
Spike protein S1
Cryo-EM structure of human ACE2 and GX/P2V/2017 RBD
0.0986.470.16 319-527EM0.00hetero-1-1-mer1 x ZN, 5 x NAGHHblits0.58
7ora.1.A
Spike protein S1
Crystal structure of the T478K mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-45 and COVOX-253 Fabs
0.1098.980.15 333-528X-ray2.60hetero-1-1-1-1-1-mer1 x NAG-FUC, 1 x NAG-NAG-FUCBLAST0.63
7nx8.1.C
Spike protein S1
Crystal structure of the K417T mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs
0.0998.980.15 333-528X-ray1.95hetero-1-1-1-1-1-mer1 x NAGBLAST0.63
7orb.1.A
Spike protein S1
Crystal structure of the L452R mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-75 and COVOX-253 Fabs
0.0898.980.15 333-528X-ray2.50hetero-1-1-1-1-1-merBLAST0.63
7f5r.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
0.0999.490.15 333-527X-ray3.01hetero-1-1-mer2 x NAG, 1 x NAG-NAG, 1 x NAG-FUCBLAST0.63
7f5r.2.B
Spike protein S1
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
0.0999.490.15 333-527X-ray3.01hetero-1-1-mer3 x NAGBLAST0.63
7f5r.3.B
Spike protein S1
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
0.0999.490.15 333-527X-ray3.01hetero-1-1-mer1 x NAG, 1 x NAG-NAGBLAST0.63
7neg.1.C
Surface glycoprotein
Crystal structure of the N501Y mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 Fab
0.0898.980.15 333-528X-ray2.19hetero-1-1-1-merBLAST0.63
7nx9.1.C
Spike protein S1
Crystal structure of the N501Y mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs
0.0998.980.15 333-528X-ray2.40hetero-1-1-1-1-1-mer1 x NAGBLAST0.63
7qf1.1.A
Spike protein S1
Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.6264
0.0999.490.15 334-528X-ray2.80hetero-2-2-2-mer1 x NAG, 1 x NAG-BMAHHblits0.63
7qf1.1.B
Spike protein S1
Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.6264
0.0999.490.15 334-528X-ray2.80hetero-2-2-2-mer1 x NAG, 1 x NAG-BMAHHblits0.63
7qf0.1.A
Spike protein S1
Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.2325
0.0999.490.15 334-528X-ray2.30hetero-1-1-1-mer1 x NAG-NAGHHblits0.63
7qez.1.A
Spike protein S1
Crystal structure of the SARS-CoV-2 RBD in complex with the ultrapotent antibody CV2.1169 and CR3022
0.1099.490.15 334-528X-ray2.89hetero-1-1-1-1-1-mer1 x NAGHHblits0.63
7q3q.1.B
Spike glycoprotein
Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobody VHH-12
0.0999.490.15 334-528X-ray2.30hetero-1-1-mer1 x NAG-NAGHHblits0.63
7q3r.1.A
Spike glycoprotein
Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobodies VHH-F04 and VHH-G09
0.1099.490.15 334-528X-ray1.92hetero-1-1-1-mer1 x NAG-NAGHHblits0.63
7pki.1.B
BANAL 236 coronavirus spike receptor-binding domain
Crystal structure of human ACE2 bound to the spike receptor-binding domain from a cave bat sarbecovirus closely related to SARS-CoV-2.
0.1096.950.15 332-528X-ray2.94hetero-1-1-mer6 x NAG, 1 x ZN, 1 x NAG-NAGBLAST0.62
7zf7.1.B
Spike protein S1
SARS-CoV-2 Omicron BA.2 RBD in complex with ACE2
0.1092.080.16 331-532X-ray3.46hetero-1-1-mer6 x NAG, 1 x ZNHHblits0.60
8bbn.1.C
Spike protein S1
SARS-CoV-2 Delta-RBD complexed with BA.2-10 and EY6A Fabs
0.0998.470.15 333-528X-ray3.58hetero-1-1-1-1-1-merBLAST0.62
8bbo.1.A
Spike glycoprotein
SARS-CoV-2 Delta-RBD complexed with BA.2-36 Fab
0.0898.470.15 333-528X-ray2.75hetero-1-1-1-mer1 x NAGBLAST0.62
8c3v.1.C
Spike protein S1
SARS-CoV-2 Delta-RBD complexed with BA.2-13 Fab and C1 nanobody
0.0998.470.15 333-528X-ray2.74hetero-1-1-1-1-merBLAST0.62
8gz5.1.A
Spike protein S1
Crystal structure of neutralizing VHH P17 in complex with SARS-CoV-2 Alpha variant spike receptor-binding domain
0.0999.490.15 335-529X-ray1.70hetero-1-1-merHHblits0.63
7mzi.1.C
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab WCSL 129
0.09100.000.15 334-527X-ray1.85hetero-1-1-1-merHHblits0.63
7mzk.1.B
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 96
0.09100.000.15 334-527X-ray2.25hetero-1-1-1-1-1-merHHblits0.63
7mzk.2.C
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 96
0.10100.000.15 334-527X-ray2.25hetero-1-1-1-1-1-merHHblits0.63
7mzj.1.C
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 93
0.10100.000.15 334-527X-ray2.40hetero-1-1-1-1-1-merHHblits0.63
7mzh.1.A
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab WCSL 119
0.09100.000.15 334-527X-ray2.10hetero-1-1-1-merHHblits0.63
7mzl.1.A
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab PDI 210
0.10100.000.15 334-527X-ray3.70hetero-1-1-1-merHHblits0.63
7mzg.1.C
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab PDI 42
0.09100.000.15 334-527X-ray2.00hetero-1-1-1-merHHblits0.63
7n4i.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2057.
0.10100.000.15 334-527X-ray2.28hetero-1-1-1-merHHblits0.63
7s83.1.B
Spike protein S1
Crystal structure of SARS CoV-2 Spike Receptor Binding Domain in complex with shark neutralizing VNARs ShAb01 and ShAb02
0.09100.000.15 334-527X-ray2.52hetero-1-1-1-mer1 x NAG-NAGHHblits0.63
7mzm.1.C
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab PDI 215
0.09100.000.15 334-527X-ray2.30hetero-1-1-1-mer1 x NAG-FUCHHblits0.63
7mzn.1.A
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab PDI 231
0.09100.000.15 334-527X-ray3.10hetero-1-1-1-merHHblits0.63
7mzf.1.A
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab PDI 37
0.10100.000.15 334-527X-ray2.49hetero-1-1-1-merHHblits0.63
7mzj.2.C
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 93
0.10100.000.15 334-527X-ray2.40hetero-1-1-1-1-1-merHHblits0.63
7mzh.2.A
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab WCSL 119
0.10100.000.15 334-527X-ray2.10hetero-1-1-1-merHHblits0.63
7n4l.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2125.
0.10100.000.15 334-527X-ray3.60hetero-1-1-1-merHHblits0.63
7n4m.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2151.
0.10100.000.15 334-527X-ray3.79hetero-1-1-1-mer1 x NAG-NAGHHblits0.63
7n4j.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2173.
0.09100.000.15 334-527X-ray2.21hetero-1-1-1-merHHblits0.63
7u8e.1.C
Spike protein S1
Crystal structure of antibody Ab246 in complex with SARS-CoV-2 receptor binding domain
0.10100.000.15 334-527X-ray2.29hetero-1-1-1-mer1 x NAGHHblits0.63
7ldj.1.A
Spike glycoprotein
SARS-CoV-2 receptor binding domain in complex with WNb-2
0.09100.000.15 334-527X-ray2.36hetero-1-1-merHHblits0.63
7ldj.2.A
Spike glycoprotein
SARS-CoV-2 receptor binding domain in complex with WNb-2
0.10100.000.15 334-527X-ray2.36hetero-1-1-mer1 x MAN, 1 x NAG-NAG-MAN-MAN-NAG-FULHHblits0.63
7ldj.3.A
Spike glycoprotein
SARS-CoV-2 receptor binding domain in complex with WNb-2
0.09100.000.15 334-527X-ray2.36hetero-1-1-merHHblits0.63
7ldj.4.A
Spike glycoprotein
SARS-CoV-2 receptor binding domain in complex with WNb-2
0.09100.000.15 334-527X-ray2.36hetero-1-1-mer1 x NAGHHblits0.63
7mlz.1.A
Spike protein S1
Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain
0.09100.000.15 334-527EM0.00hetero-1-1-1-merHHblits0.63
7cah.1.C
Spike protein S1
The interface of H014 Fab binds to SARS-CoV-2 S
0.09100.000.15 334-527EM0.00hetero-1-1-1-merBLAST0.63
7cjf.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody Fab
0.09100.000.15 334-527X-ray2.11hetero-1-1-1-mer1 x NAGBLAST0.63
7cyh.1.A
Spike glycoprotein
Binding interface of SARS-CoV-2 RBD and its neutralizing antibody HB27
0.10100.000.15 334-527EM0.00hetero-1-1-1-merBLAST0.63
7klw.1.A
Spike protein S1
Crystal structure of synthetic nanobody (Sb45+Sb68) complexes with SARS-CoV-2 receptor binding domain
0.10100.000.15 334-527X-ray2.60hetero-1-1-1-merBLAST0.63
7rr0.1.A
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab PDI 222
0.10100.000.15 334-527EM0.00hetero-1-1-1-mer1 x NAGBLAST0.63
7f0x.1.A
Spike protein S1
A SARS-CoV-2 neutralizing antibody
0.09100.000.15 334-527X-ray2.80hetero-1-1-merBLAST0.63
7v27.1.A
Spike protein S1
RBD/XG005 local refinement
0.10100.000.15 334-527EM0.00hetero-1-1-1-mer1 x NAGBLAST0.63
7woc.1.A
Spike protein S1
Locally refined region of SARS-CoV-2 Spike in complex with IgG 553-60
0.11100.000.15 334-527EM0.00hetero-1-1-1-mer1 x NAGBLAST0.63
7wo7.1.C
Spike protein S1
Locally refined region of SARS-CoV-2 Spike in complex with IgG 553-15
0.10100.000.15 334-527EM0.00hetero-1-1-1-mer1 x NAGBLAST0.63
7x7e.1.A
Spike protein S1
SARS-CoV-2 RBD and Nb22
0.09100.000.15 334-527X-ray2.67hetero-3-3-merBLAST0.63
7x7e.1.B
Spike protein S1
SARS-CoV-2 RBD and Nb22
0.09100.000.15 334-527X-ray2.67hetero-3-3-merBLAST0.63
7x7e.1.E
Spike protein S1
SARS-CoV-2 RBD and Nb22
0.09100.000.15 334-527X-ray2.67hetero-3-3-merBLAST0.63
7swn.1.A
Spike protein S1
G32A4 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction)
0.09100.000.15 334-527EM0.00hetero-1-1-1-merBLAST0.63
7xs8.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P5S-1H1 Fab
0.09100.000.15 334-527X-ray2.80hetero-1-1-1-mer1 x NAGBLAST0.63
7xda.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta RBD in complex with BA7208 and BA7125 fab (local refinement)
0.0998.970.15 334-528EM0.00hetero-1-1-1-1-1-merBLAST0.63
7msq.1.A
Spike protein S1
Complex between the Fab arm of AB-3467 and the SARS-CoV-2 receptor binding domain (RBD)
0.09100.000.15 335-528X-ray2.29hetero-1-1-1-merHHblits0.63
7msq.2.A
Spike protein S1
Complex between the Fab arm of AB-3467 and the SARS-CoV-2 receptor binding domain (RBD)
0.09100.000.15 335-528X-ray2.29hetero-1-1-1-merHHblits0.63
7kzb.1.C
Spike glycoprotein
Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1antibodies
0.10100.000.15 335-528X-ray2.83hetero-1-1-1-1-1-merHHblits0.63
8dxu.1.A
Spike protein S1
Fab arms of antibodies GAR03 and 10G4 bound to the receptor binding domain of SARS-CoV-2 in a 1:1:1 complex.
0.10100.000.15 335-528X-ray2.73hetero-1-1-1-1-1-mer1 x NAGHHblits0.63
8dxt.1.C
Spike protein S1
Fab arm of antibody GAR12 bound to the receptor binding domain of SARS-CoV-2.
0.09100.000.15 335-528X-ray2.25hetero-1-1-1-merHHblits0.63
7t72.1.C
Spike protein S1
Epitope-based selection of SARS-CoV-2 neutralizing antibodies from convalescent patients
0.08100.000.15 335-528X-ray3.18hetero-1-1-1-mer1 x NAGHHblits0.63
7mfu.2.A
Spike protein S1
Crystal structure of synthetic nanobody (Sb14+Sb68) complexes with SARS-CoV-2 receptor binding domain
0.10100.000.15 335-528X-ray1.70hetero-1-1-1-merHHblits0.63
7mfu.1.A
Spike protein S1
Crystal structure of synthetic nanobody (Sb14+Sb68) complexes with SARS-CoV-2 receptor binding domain
0.09100.000.15 335-528X-ray1.70hetero-1-1-1-merHHblits0.63
6zh9.1.C
Spike glycoprotein
Ternary complex CR3022 H11-H4 and RBD (SARS-CoV-2)
0.09100.000.15 335-528X-ray3.31hetero-1-1-1-1-merHHblits0.63
6z2m.1.A
Spike glycoprotein
H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex
0.10100.000.15 335-528X-ray2.71hetero-1-1-1-1-mer1 x NAGHHblits0.63
6z2m.2.A
Spike glycoprotein
H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex
0.10100.000.15 335-528X-ray2.71hetero-1-1-1-1-mer1 x NAGHHblits0.63
7fc5.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 RBD and horse ACE2
0.09100.000.15 335-528X-ray2.89hetero-1-1-mer5 x NAGHHblits0.63
7n9a.1.B
Spike protein S1
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS RBD with NB21
0.10100.000.15 335-528EM0.00hetero-1-1-merHHblits0.63
7r8l.1.C
Spike protein S1
Structure of the SARS-CoV-2 RBD in complex with neutralizing antibody C099 and CR3022
0.10100.000.15 335-528X-ray2.60hetero-1-1-1-1-1-merHHblits0.63
7swp.1.A
Spike protein S1
G32Q4 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction)
0.08100.000.15 335-528EM0.00hetero-1-1-1-merHHblits0.63
7swo.1.A
Spike protein S1
C98C7 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction)
0.10100.000.15 335-528EM0.00hetero-1-1-1-merHHblits0.63
7b17.1.A
Spike protein S1
SARS-CoV-spike RBD bound to two neutralising nanobodies.
0.09100.000.15 335-528EM0.00hetero-1-1-mer1 x NAGHHblits0.63
7x2h.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with 6-2C Fab
0.09100.000.15 335-528X-ray2.10hetero-1-1-1-mer1 x NAGHHblits0.63
7x2h.2.C
Spike protein S1
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with 6-2C Fab
0.08100.000.15 335-528X-ray2.10hetero-1-1-1-mer1 x NAGHHblits0.63
7wd1.2.A
Spike protein S1
Crystal structure of R14 bound to SARS-CoV-2 RBD
0.09100.000.15 335-528X-ray2.50hetero-1-1-mer1 x NAG-FUCHHblits0.63
7wd1.1.A
Spike protein S1
Crystal structure of R14 bound to SARS-CoV-2 RBD
0.09100.000.15 335-528X-ray2.50hetero-1-1-merHHblits0.63
7x2l.1.A
Spike protein S1
Crystal structure of nanobody 3-2A2-4 with SARS-CoV-2 RBD
0.10100.000.15 335-528X-ray2.40hetero-1-1-merHHblits0.63
7kgj.1.A
Spike glycoprotein
Crystal structure of synthetic nanobody (Sb45) complexes with SARS-CoV-2 receptor binding domain
0.09100.000.15 335-528X-ray2.30hetero-1-1-merHHblits0.63
7b14.1.A
Spike protein S1
Nanobody E bound to Spike-RBD in a localized reconstruction
0.10100.000.15 335-528EM0.00hetero-1-1-mer1 x NAGHHblits0.63
7fcq.1.A
Spike protein S1
Crystallographic structure of neutralizing antibody P14-44 in complex with SARS-CoV-2 spike receptor-binding Domain (RBD)
0.09100.000.15 335-528X-ray1.89hetero-1-1-1-mer1 x NAGHHblits0.63
7wlc.1.A
Spike protein S1
SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv282
0.1092.540.16 330-530EM0.00hetero-1-1-1-merBLAST0.60
7wsa.1.A
Spike protein S1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.0992.540.16 330-530EM0.00hetero-1-1-mer7 x NAGBLAST0.60
7wtj.1.C
Spike protein S1
SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv286
0.1092.540.16 330-530EM0.00hetero-1-1-1-merBLAST0.60
7wtg.1.A
Spike protein S1
SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv051
0.1092.540.16 330-530EM0.00hetero-1-1-1-merBLAST0.60
7wth.1.A
Spike protein S1
SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv264
0.0992.540.16 330-530EM0.00hetero-1-1-1-merBLAST0.60
7pr0.2.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with FD-5D Fab
0.09100.000.15 333-526X-ray2.92hetero-1-1-1-mer1 x NAGBLAST0.63
6zdg.1.G
Spike protein S1
Association of three complexes of largely structurally disordered Spike ectodomain with bound EY6A Fab
0.09100.000.15 333-526EM0.00hetero-3-3-3-mer3 x NAGBLAST0.63
7e23.1.A
Spike protein S1
SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD)
0.11100.000.15 333-526EM0.00hetero-1-1-1-mer1 x NAGBLAST0.63
7e88.1.C
Spike protein S1
Crystal structure of the SARS-CoV-2 S RBD in complex with BD-515 Fab
0.10100.000.15 333-526X-ray3.14hetero-1-1-1-merBLAST0.63
7e3c.1.A
Spike protein S1
SARS-CoV-2 spike in complex with the Ab1 neutralizing antibody (focused refinement on Fab-RBD)
0.10100.000.15 333-526EM0.00hetero-1-1-1-mer1 x NAGBLAST0.63
7e39.1.A
Spike protein S1
SARS-CoV-2 spike in complex with the Ab4 neutralizing antibody (State 3)
0.10100.000.15 333-526EM0.00hetero-1-1-1-mer1 x NAGBLAST0.63
7e3b.1.A
Spike protein S1
SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD)
0.10100.000.15 333-526EM0.00hetero-1-1-1-mer1 x NAGBLAST0.63
7dx4.1.B
Spike protein S1
The structure of FC08 Fab-hA.CE2-RBD complex
0.10100.000.15 333-526EM0.00hetero-1-1-1-1-mer5 x NAGBLAST0.63
7x2k.1.A
Spike protein S1
Crystal structure of nanobody Nb70 with antibody 1F11 fab and SARS-CoV-2 RBD
0.09100.000.15 333-526X-ray2.40hetero-1-1-1-1-mer1 x NAGBLAST0.63
7e86.1.A
Spike protein S1
Crystal structure of the SARS-CoV-2 S RBD in complex with BD-508 Fab
0.10100.000.15 333-526X-ray2.90hetero-1-1-1-merBLAST0.63
7nxa.1.C
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 B.1.351 variant Spike glycoprotein in complex with COVOX-222 and EY6A Fabs
0.0997.960.15 333-528X-ray2.50hetero-1-1-1-1-1-mer1 x NAGBLAST0.62
7nxb.1.C
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with COVOX-222 and EY6A Fabs
0.1097.960.15 333-528X-ray2.67hetero-1-1-1-1-1-mer1 x NAGBLAST0.62
7nxc.1.B
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with ACE2
0.0997.960.15 333-528X-ray3.14hetero-1-1-mer5 x NAGBLAST0.62
7fjs.1.B
Spike protein S1
Crystal structure of T6 Fab bound to theSARS-CoV-2 RBD of B.1.351
0.1098.460.15 333-527X-ray2.90hetero-2-2-2-mer2 x NAGBLAST0.63
7fjs.1.E
Spike protein S1
Crystal structure of T6 Fab bound to theSARS-CoV-2 RBD of B.1.351
0.0898.460.15 333-527X-ray2.90hetero-2-2-2-mer2 x NAGBLAST0.63
7b3o.1.A
Spike protein S1
Crystal structure of the SARS-CoV-2 RBD in complex with STE90-C11 Fab
0.09100.000.15 331-524X-ray2.00hetero-1-1-1-mer1 x NAG-NAGBLAST0.63
7wed.1.A
Spike protein S1
SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv347
0.1093.970.16 331-529EM0.00hetero-1-1-1-merHHblits0.61
7wef.1.B
Spike protein S1
SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv289
0.1093.970.16 331-529EM0.00hetero-1-1-1-merHHblits0.61
7bel.2.A
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-88 and COVOX-45 Fabs
0.0999.480.15 335-528X-ray2.53hetero-1-1-1-1-1-mer1 x NAG, 1 x NAG-NAG-BMA-MAN-MAN-MANHHblits0.63
7beh.1.A
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab
0.1099.480.15 335-528X-ray2.30hetero-1-1-1-merHHblits0.63
7bep.2.A
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-384 and S309 Fabs
0.0999.480.15 335-528X-ray2.61hetero-1-1-1-1-1-mer2 x IMD, 1 x GLU, 3 x GLY, 1 x NAG-NAG-BMA-MAN-MAN-FUCHHblits0.63
7bej.1.C
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-158 Fab (crystal form 1)
0.0999.480.15 335-528X-ray2.42hetero-1-1-1-merHHblits0.63
7bel.1.A
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-88 and COVOX-45 Fabs
0.1099.480.15 335-528X-ray2.53hetero-1-1-1-1-1-mer1 x NAG, 1 x NAG-NAG-BMA-MAN-MAN-MANHHblits0.63
7bei.1.C
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab
0.0999.480.15 335-528X-ray2.30hetero-1-1-1-merHHblits0.63
7bep.1.A
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-384 and S309 Fabs
0.1099.480.15 335-528X-ray2.61hetero-1-1-1-1-1-mer3 x IMD, 1 x GLU, 3 x GLY, 1 x NAG-NAG-BMA-MAN-MAN-FUCHHblits0.63
7beo.2.A
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-253H55L and COVOX-75 Fabs
0.0999.480.15 335-528X-ray3.19hetero-1-1-1-1-1-merHHblits0.63
7ben.2.A
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-253 and COVOX-75 Fabs
0.0899.480.15 335-528X-ray2.50hetero-1-1-1-1-1-mer8 x BR, 1 x PG6, 2 x IMD, 1 x NAG-NAG-FUCHHblits0.63
7ben.1.A
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-253 and COVOX-75 Fabs
0.0999.480.15 335-528X-ray2.50hetero-1-1-1-1-1-mer2 x IMD, 6 x BR, 1 x PG6, 1 x NAG-NAG-FUCHHblits0.63
7beo.1.A
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-253H55L and COVOX-75 Fabs
0.0899.480.15 335-528X-ray3.19hetero-1-1-1-1-1-mer1 x NAG, 1 x NAG-NAG-FUCHHblits0.63
7neh.1.C
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 Fab
0.0999.480.15 335-528X-ray1.77hetero-1-1-1-merHHblits0.63
7bek.1.C
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-158 Fab (crystal form 2)
0.0999.480.15 335-528X-ray2.04hetero-1-1-1-merHHblits0.63
7or9.1.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and COVOX-278 Fabs
0.0999.480.15 335-528X-ray2.34hetero-1-1-1-1-1-merHHblits0.63
7bem.1.C
Spike glycoprotein
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 scFv
0.0999.480.15 335-528X-ray2.52hetero-1-1-1-mer4 x PRO, 1 x NAG-NAG-FUCHHblits0.63
7nx6.1.C
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs
0.0999.480.15 335-528X-ray2.25hetero-1-1-1-1-1-mer1 x NAGHHblits0.63
7qnx.1.E
Surface glycoprotein
The receptor binding domain of SARS-CoV-2 spike glycoprotein in complex with Beta-55 and EY6A Fabs
0.0899.480.15 335-528X-ray2.92hetero-1-1-1-1-1-mer1 x NAG-NAGHHblits0.63
7qny.1.C
Surface glycoprotein
The receptor binding domain of SARS-CoV-2 spike glycoprotein in complex with COVOX-58 and COVOX-158 Fabs
0.0999.480.15 335-528X-ray2.84hetero-1-1-1-1-1-mer1 x NAGHHblits0.63
7fdg.1.B
Spike protein S1
SARS-COV-2 Spike RBDMACSp6 binding to hACE2
0.1099.480.15 333-526EM0.00hetero-1-1-mer5 x NAGBLAST0.63
7dqa.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV2 RBD-ACE2 complex
0.1099.480.15 333-526EM0.00hetero-1-1-mer1 x ZN, 5 x NAGBLAST0.63
7tpk.1.A
Spike protein S1
SARS-CoV-2 E406W mutant RBD - Local Refinement
0.0999.480.15 333-526EM0.00monomer1 x NAGBLAST0.63
8i5h.3.A
Spike protein S1
Crystal structure of SARS-CoV-2 delta variant spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab
0.0998.970.15 334-527X-ray2.38hetero-1-1-1-mer1 x NAGBLAST0.63
7x7d.1.C
Spike protein S1
SARS-CoV-2 Delta RBD and Nb22
0.0998.970.15 334-527X-ray2.92hetero-3-3-merBLAST0.63
7yad.1.C
Spike protein S1
Cryo-EM structure of S309-RBD-RBD-S309 in the S309-bound Omicron spike protein (local refinement)
0.0992.500.16 330-529EM0.00hetero-2-2-2-merBLAST0.60
7yad.1.F
Spike protein S1
Cryo-EM structure of S309-RBD-RBD-S309 in the S309-bound Omicron spike protein (local refinement)
0.0992.500.16 330-529EM0.00hetero-2-2-2-merBLAST0.60
7f7e.1.C
Spike protein S1
SARS-CoV-2 S protein RBD in complex with A5-10 Fab
0.09100.000.15 335-527X-ray2.49hetero-1-1-1-mer1 x NAGHHblits0.63
7lrs.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain
0.10100.000.15 335-527EM0.00hetero-1-1-1-merHHblits0.63
7phg.1.A
Surface glycoprotein
MaP OF P5C3RBD Interface
0.11100.000.15 335-527EM0.00hetero-1-1-1-merHHblits0.63
7tbf.1.A
Spike glycoprotein
Locally refined region of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1
0.10100.000.15 335-527EM0.00hetero-1-1-1-1-1-mer1 x NAG-NAGHHblits0.63
7cah.1.C
Spike protein S1
The interface of H014 Fab binds to SARS-CoV-2 S
0.09100.000.15 335-527EM0.00hetero-1-1-1-merHHblits0.63
7cjf.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody Fab
0.09100.000.15 335-527X-ray2.11hetero-1-1-1-mer1 x NAGHHblits0.63
7cyh.1.A
Spike glycoprotein
Binding interface of SARS-CoV-2 RBD and its neutralizing antibody HB27
0.10100.000.15 335-527EM0.00hetero-1-1-1-merHHblits0.63
7klw.1.A
Spike protein S1
Crystal structure of synthetic nanobody (Sb45+Sb68) complexes with SARS-CoV-2 receptor binding domain
0.09100.000.15 335-527X-ray2.60hetero-1-1-1-merHHblits0.63
7rr0.1.A
Spike protein S1
SARS-CoV-2 receptor binding domain bound to Fab PDI 222
0.10100.000.15 335-527EM0.00hetero-1-1-1-mer1 x NAGHHblits0.63
7f0x.1.A
Spike protein S1
A SARS-CoV-2 neutralizing antibody
0.09100.000.15 335-527X-ray2.80hetero-1-1-merHHblits0.63
7v27.1.A
Spike protein S1
RBD/XG005 local refinement
0.10100.000.15 335-527EM0.00hetero-1-1-1-mer1 x NAGHHblits0.63
7woc.1.A
Spike protein S1
Locally refined region of SARS-CoV-2 Spike in complex with IgG 553-60
0.11100.000.15 335-527EM0.00hetero-1-1-1-mer1 x NAGHHblits0.63
7wo7.1.C
Spike protein S1
Locally refined region of SARS-CoV-2 Spike in complex with IgG 553-15
0.10100.000.15 335-527EM0.00hetero-1-1-1-mer1 x NAGHHblits0.63
7x7e.1.A
Spike protein S1
SARS-CoV-2 RBD and Nb22
0.09100.000.15 335-527X-ray2.67hetero-3-3-merHHblits0.63
7x7e.1.B
Spike protein S1
SARS-CoV-2 RBD and Nb22
0.09100.000.15 335-527X-ray2.67hetero-3-3-merHHblits0.63
7x7e.1.E
Spike protein S1
SARS-CoV-2 RBD and Nb22
0.09100.000.15 335-527X-ray2.67hetero-3-3-merHHblits0.63
7swn.1.A
Spike protein S1
G32A4 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction)
0.09100.000.15 335-527EM0.00hetero-1-1-1-merHHblits0.63
7xs8.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P5S-1H1 Fab
0.09100.000.15 335-527X-ray2.80hetero-1-1-1-mer1 x NAGHHblits0.63
7ycn.4.A
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with IY-2A Fab
0.09100.000.15 335-527X-ray2.85hetero-1-1-1-merHHblits0.63
7ycn.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with IY-2A Fab
0.09100.000.15 335-527X-ray2.85hetero-1-1-1-merHHblits0.63
7ycn.3.A
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with IY-2A Fab
0.09100.000.15 335-527X-ray2.85hetero-1-1-1-mer1 x NAGHHblits0.63
7olz.1.C
Spike protein S1
Crystal structure of the SARS-CoV-2 RBD with neutralizing-VHHs Re5D06 and Re9F06
0.08100.000.15 335-527X-ray1.75hetero-1-1-1-mer1 x DMXHHblits0.63
7e3j.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 RBD binding to dog ACE2
0.10100.000.15 335-527X-ray2.99hetero-1-1-mer1 x ZN, 1 x NAGHHblits0.63
7kgk.1.A
Spike protein S1
Crystal structure of synthetic nanobody (Sb16) complexes with SARS-CoV-2 receptor binding domain
0.09100.000.15 335-527X-ray2.60hetero-1-1-merHHblits0.63
7k9i.1.A
Spike protein S1
SARS-CoV-2 Spike RBD in complex with neutralizing Fab 2B04 (local refinement)
0.10100.000.15 335-527EM0.00hetero-1-1-1-mer1 x NAGHHblits0.63
7k9k.1.A
Spike protein S1
SARS-CoV-2 Spike RBD in complex with neutralizing Fab 2H04 (local refinement)
0.09100.000.15 335-527EM0.00hetero-1-1-1-merHHblits0.63
7whz.1.A
Spike protein S1
SARS-CoV-2 spike protein in complex with three human neutralizing antibodies
0.12100.000.15 335-527EM0.00hetero-1-1-1-1-1-1-…1 x NAGHHblits0.63
7wue.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 Receptor Binding Domain in complex with the monoclonal antibody m31A7
0.10100.000.15 335-527X-ray3.20hetero-1-1-1-merHHblits0.63
7wue.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 Receptor Binding Domain in complex with the monoclonal antibody m31A7
0.10100.000.15 335-527X-ray3.20hetero-1-1-1-merHHblits0.63
7the.1.A
Spike protein S1
Structure of RBD directed antibody DH1042 in complex with SARS-CoV-2 spike: Local refinement of RBD-Fab interface
0.09100.000.15 335-527EM0.00hetero-1-1-1-mer1 x NAGHHblits0.63
7wse.1.B
Spike protein S1
Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor minke whale ACE2
0.09100.000.15 335-527EM0.00hetero-1-1-mer1 x ZNHHblits0.63
7wsh.1.B
Spike protein S1
Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain in complex with sea lion ACE2
0.09100.000.15 335-527EM0.00hetero-1-1-mer1 x ZN, 1 x NAGHHblits0.63
7c8d.1.B
Spike protein S1
Cryo-EM structure of cat ACE2 and SARS-CoV-2 RBD
0.10100.000.15 335-527EM0.00hetero-1-1-mer1 x ZNHHblits0.63
7c8j.1.B
SARS-CoV-2 Receptor binding domain
Structural basis for cross-species recognition of COVID-19 virus spike receptor binding domain to bat ACE2
0.09100.000.15 335-527X-ray3.18hetero-1-1-mer1 x ZNHHblits0.63
8dw9.2.A
Spike protein S1
Crystal structure of neutralizing antibody D29 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD)
0.08100.000.15 335-527X-ray4.00hetero-1-1-1-merHHblits0.63
8dw9.1.A
Spike protein S1
Crystal structure of neutralizing antibody D29 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD)
0.08100.000.15 335-527X-ray4.00hetero-1-1-1-merHHblits0.63
7ycn.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 Spike RBD in complex with IY-2A Fab
0.09100.000.15 335-527X-ray2.85hetero-1-1-1-mer1 x NAGHHblits0.63
7rxd.1.E
Spike protein S1
CryoEM structure of RBD domain of COVID-19 in complex with Legobody
0.07100.000.15 334-526EM0.00hetero-1-1-1-1-1-mer1 x GLC-GLCBLAST0.63
7ydi.1.B
Spike protein S1
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region
0.11100.000.15 334-526EM0.00hetero-1-1-1-1-mer1 x ZN, 4 x NAGBLAST0.63
7nx7.1.C
Spike protein S1
Crystal structure of the K417N mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs
0.0998.970.15 335-528X-ray2.30hetero-1-1-1-1-1-mer1 x NAGHHblits0.63
7w9f.1.C
Spike protein S1
SARS-CoV-2 Delta S-RBD-8D3
0.1098.970.15 333-526EM0.00hetero-1-1-1-merBLAST0.63
7w9i.1.B
Spike protein S1
SARS-CoV-2 Delta S-RBD-ACE2
0.1098.970.15 333-526EM0.00hetero-1-1-merBLAST0.63
7f12.1.A
Spike protein S1
A SARS-CoV-2 neutralizing antibody
0.0896.920.15 334-528X-ray3.15hetero-1-1-mer1 x NAGBLAST0.62
7nx8.1.C
Spike protein S1
Crystal structure of the K417T mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs
0.0998.970.15 335-528X-ray1.95hetero-1-1-1-1-1-mer1 x NAGHHblits0.63
7fdh.1.B
Spike protein S1
SARS-COV-2 Spike RBDMACSp25 binding to hACE2
0.1098.970.15 333-526EM0.00hetero-1-1-mer5 x NAGBLAST0.63
7ora.1.A
Spike protein S1
Crystal structure of the T478K mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-45 and COVOX-253 Fabs
0.1098.970.15 335-528X-ray2.60hetero-1-1-1-1-1-mer1 x NAG-FUC, 1 x NAG-NAG-FUCHHblits0.63
7ora.2.A
Spike protein S1
Crystal structure of the T478K mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-45 and COVOX-253 Fabs
0.0998.970.15 335-528X-ray2.60hetero-1-1-1-1-1-merHHblits0.63
7f5r.1.B
Spike protein S1
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
0.0999.480.15 335-527X-ray3.01hetero-1-1-mer2 x NAG, 1 x NAG-NAG, 1 x NAG-FUCHHblits0.63
7f5r.2.B
Spike protein S1
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
0.0899.480.15 335-527X-ray3.01hetero-1-1-mer3 x NAGHHblits0.63
7f5r.3.B
Spike protein S1
Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2
0.0999.480.15 335-527X-ray3.01hetero-1-1-mer1 x NAG, 1 x NAG-NAGHHblits0.63
7fdi.1.B
Spike protein S1
SARS-COV-2 Spike RBDMACSp36 binding to hACE2
0.1098.450.15 333-526EM0.00hetero-1-1-mer5 x NAGBLAST0.63
7nx9.1.C
Spike protein S1
Crystal structure of the N501Y mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-222 and EY6A Fabs
0.0998.970.15 335-528X-ray2.40hetero-1-1-1-1-1-mer1 x NAGHHblits0.63
7neg.1.C
Surface glycoprotein
Crystal structure of the N501Y mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-269 Fab
0.0898.970.15 335-528X-ray2.19hetero-1-1-1-merHHblits0.63
7x2m.1.A
Spike protein S1
Crystal structure of nanobody 1-2C7 with SARS-CoV-2 RBD
0.0998.450.15 335-528X-ray1.80hetero-1-1-merHHblits0.63
7zfc.1.F
Spike protein S1
SARS-CoV-2 Beta RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs
0.0998.450.15 333-526X-ray3.24hetero-1-1-1-1-1-1-…1 x NAG-FUCBLAST0.62
7ps1.1.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-27 Fab
0.0998.450.15 333-526X-ray2.40hetero-1-1-1-mer1 x NAGBLAST0.62
7prz.1.B
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with beta-22 Fabs
0.0998.450.15 333-526X-ray3.20hetero-1-1-1-mer1 x NAG-NAG-FUC, 1 x NAG-FUCBLAST0.62
7ps0.2.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with beta-24 Fabs
0.0898.450.15 333-526X-ray2.92hetero-1-1-1-mer1 x NAGBLAST0.62
7pry.1.E
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with COVOX-45 and beta-6 Fabs
0.0998.450.15 333-526X-ray3.10hetero-1-1-1-1-1-merBLAST0.62
7ps2.1.B
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-29 and Beta-53 Fabs
0.1098.450.15 333-526X-ray2.99hetero-1-1-1-1-1-merBLAST0.62
7ps4.1.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-38
0.0998.450.15 333-526X-ray1.94hetero-1-1-1-mer1 x NAG-NAGBLAST0.62
7ps4.2.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-38
0.0998.450.15 333-526X-ray1.94hetero-1-1-1-mer1 x NAG-NAGBLAST0.62
7ps6.1.C
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-44 and Beta-54 Fabs
0.0898.450.15 333-526X-ray2.26hetero-1-1-1-1-1-mer1 x NAG-FUCBLAST0.62
7q0g.1.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-49 and FI-3A Fabs
0.0998.450.15 333-526X-ray1.82hetero-1-1-1-1-1-mer14 x K, 3 x TAR, 1 x NAG-NAG-BMA-MAN-FUCBLAST0.62
7b3o.1.A
Spike protein S1
Crystal structure of the SARS-CoV-2 RBD in complex with STE90-C11 Fab
0.09100.000.15 332-524X-ray2.00hetero-1-1-1-mer1 x NAG-NAGHHblits0.63
7fdk.1.B
Spike protein S1
SARS-COV-2 Spike RBDMACSp36 binding to mACE2
0.1098.450.15 333-526EM0.00hetero-1-1-mer3 x NAGBLAST0.62
7zfd.1.B
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with Omi-25 Fab
0.0991.040.16 331-532X-ray3.39hetero-1-1-1-merHHblits0.60
7zfd.2.B
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with Omi-25 Fab
0.0991.040.16 331-532X-ray3.39hetero-1-1-1-merHHblits0.60
7fdg.1.B
Spike protein S1
SARS-COV-2 Spike RBDMACSp6 binding to hACE2
0.1098.450.15 332-526EM0.00hetero-1-1-mer5 x NAGHHblits0.62
7bh9.1.B
Spike protein S1
SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain
0.0895.410.15 333-528EM0.00hetero-1-1-mer1 x ZN, 3 x NAGBLAST0.62
7wry.1.A
Spike protein S1
Local structure of BD55-3546 Fab and SARS-COV2 Delta RBD complex
0.1198.960.15 334-526EM0.00hetero-1-1-1-merBLAST0.63
7rxd.1.E
Spike protein S1
CryoEM structure of RBD domain of COVID-19 in complex with Legobody
0.07100.000.15 335-526EM0.00hetero-1-1-1-1-1-mer1 x GLC-GLCHHblits0.63
7pqy.1.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with FI-3A Fab
0.09100.000.15 335-526X-ray3.00hetero-1-1-1-merHHblits0.63
7pqy.2.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with FI-3A Fab
0.08100.000.15 335-526X-ray3.00hetero-1-1-1-merHHblits0.63
6zcz.1.A
Spike protein S1
Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in ternary complex with EY6A Fab and a nanobody.
0.09100.000.15 335-526X-ray2.65hetero-1-1-1-1-mer1 x NAG, 1 x MGHHblits0.63
7pqz.1.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with FI-3A and FD-11A Fabs
0.10100.000.15 335-526X-ray3.20hetero-1-1-1-1-1-mer1 x NAG-NAGHHblits0.63
7pr0.2.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with FD-5D Fab
0.09100.000.15 335-526X-ray2.92hetero-1-1-1-mer1 x NAGHHblits0.63
7pr0.1.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with FD-5D Fab
0.08100.000.15 335-526X-ray2.92hetero-1-1-1-mer1 x NAGHHblits0.63
7pr0.3.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with FD-5D Fab
0.08100.000.15 335-526X-ray2.92hetero-1-1-1-mer1 x NAGHHblits0.63
7e86.1.A
Spike protein S1
Crystal structure of the SARS-CoV-2 S RBD in complex with BD-508 Fab
0.09100.000.15 335-526X-ray2.90hetero-1-1-1-merHHblits0.63
7ydi.1.B
Spike protein S1
SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region
0.11100.000.15 335-526EM0.00hetero-1-1-1-1-mer1 x ZN, 4 x NAGHHblits0.63
6zdg.1.G
Spike protein S1
Association of three complexes of largely structurally disordered Spike ectodomain with bound EY6A Fab
0.09100.000.15 335-526EM0.00hetero-3-3-3-mer3 x NAGHHblits0.63
6zfo.1.A
Spike protein S1
Association of two complexes of largely structurally disordered Spike ectodomain with bound EY6A Fab
0.09100.000.15 335-526EM0.00hetero-1-1-1-mer1 x NAGHHblits0.63
6zdg.1.D
Spike protein S1
Association of three complexes of largely structurally disordered Spike ectodomain with bound EY6A Fab
0.09100.000.15 335-526EM0.00hetero-3-3-3-mer3 x NAGHHblits0.63
6zdg.1.A
Spike protein S1
Association of three complexes of largely structurally disordered Spike ectodomain with bound EY6A Fab
0.09100.000.15 335-526EM0.00hetero-3-3-3-mer3 x NAGHHblits0.63
6zfo.2.A
Spike protein S1
Association of two complexes of largely structurally disordered Spike ectodomain with bound EY6A Fab
0.09100.000.15 335-526EM0.00hetero-1-1-1-mer1 x NAGHHblits0.63
7e23.1.A
Spike protein S1
SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD)
0.11100.000.15 335-526EM0.00hetero-1-1-1-mer1 x NAGHHblits0.63
7e88.1.C
Spike protein S1
Crystal structure of the SARS-CoV-2 S RBD in complex with BD-515 Fab
0.09100.000.15 335-526X-ray3.14hetero-1-1-1-merHHblits0.63
7e88.2.C
Spike protein S1
Crystal structure of the SARS-CoV-2 S RBD in complex with BD-515 Fab
0.10100.000.15 335-526X-ray3.14hetero-1-1-1-merHHblits0.63
7e88.3.C
Spike protein S1
Crystal structure of the SARS-CoV-2 S RBD in complex with BD-515 Fab
0.10100.000.15 335-526X-ray3.14hetero-1-1-1-merHHblits0.63
7e88.4.D
Spike protein S1
Crystal structure of the SARS-CoV-2 S RBD in complex with BD-515 Fab
0.10100.000.15 335-526X-ray3.14hetero-2-1-1-merHHblits0.63
7e3c.1.A
Spike protein S1
SARS-CoV-2 spike in complex with the Ab1 neutralizing antibody (focused refinement on Fab-RBD)
0.10100.000.15 335-526EM0.00hetero-1-1-1-mer1 x NAGHHblits0.63
7e39.1.A
Spike protein S1
SARS-CoV-2 spike in complex with the Ab4 neutralizing antibody (State 3)
0.10100.000.15 335-526EM0.00hetero-1-1-1-mer1 x NAGHHblits0.63
7e3b.1.A
Spike protein S1
SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD)
0.10100.000.15 335-526EM0.00hetero-1-1-1-mer1 x NAGHHblits0.63
7dx4.1.B
Spike protein S1
The structure of FC08 Fab-hA.CE2-RBD complex
0.10100.000.15 335-526EM0.00hetero-1-1-1-1-mer5 x NAGHHblits0.63
7x2k.1.A
Spike protein S1
Crystal structure of nanobody Nb70 with antibody 1F11 fab and SARS-CoV-2 RBD
0.09100.000.15 335-526X-ray2.40hetero-1-1-1-1-mer1 x NAGHHblits0.63
7xrp.1.C
Spike protein S1
Cryo-EM structure of SARS-CoV-2 spike protein in complex with nanobody C5G2 (localized refinement)
0.09100.000.15 330-521EM0.00hetero-1-1-1-mer4 x NAGBLAST0.63
7nxa.1.C
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 B.1.351 variant Spike glycoprotein in complex with COVOX-222 and EY6A Fabs
0.0997.940.15 335-528X-ray2.50hetero-1-1-1-1-1-mer1 x NAGHHblits0.62
7orb.1.A
Spike protein S1
Crystal structure of the L452R mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-75 and COVOX-253 Fabs
0.0898.960.15 335-527X-ray2.50hetero-1-1-1-1-1-merHHblits0.63
7orb.2.A
Spike protein S1
Crystal structure of the L452R mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-75 and COVOX-253 Fabs
0.0898.960.15 335-527X-ray2.50hetero-1-1-1-1-1-mer1 x BTB, 1 x NAG-NAG-BMA-MAN-FUC, 1 x NAG-NAG-BMA-FUCHHblits0.63
7fdh.1.B
Spike protein S1
SARS-COV-2 Spike RBDMACSp25 binding to hACE2
0.1097.940.15 332-526EM0.00hetero-1-1-mer5 x NAGHHblits0.62
7f12.1.A
Spike protein S1
A SARS-CoV-2 neutralizing antibody
0.0896.910.15 335-528X-ray3.15hetero-1-1-mer1 x NAGHHblits0.62
7nxb.1.C
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with COVOX-222 and EY6A Fabs
0.1097.940.15 335-528X-ray2.67hetero-1-1-1-1-1-mer1 x NAGHHblits0.62
7nxc.1.B
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with ACE2
0.0997.940.15 335-528X-ray3.14hetero-1-1-mer5 x NAGHHblits0.62
7pki.1.B
BANAL 236 coronavirus spike receptor-binding domain
Crystal structure of human ACE2 bound to the spike receptor-binding domain from a cave bat sarbecovirus closely related to SARS-CoV-2.
0.1096.910.15 335-528X-ray2.94hetero-1-1-mer6 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.62
7tn0.1.F
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab
0.0989.160.16 327-531X-ray2.85hetero-1-1-1-1-1-1-…1 x ZN, 6 x NAGHHblits0.59
7tn0.2.F
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab
0.0989.160.16 327-531X-ray2.85hetero-1-1-1-1-1-1-…5 x NAG, 1 x ZNHHblits0.59
7fdi.1.B
Spike protein S1
SARS-COV-2 Spike RBDMACSp36 binding to hACE2
0.1097.420.15 332-526EM0.00hetero-1-1-mer5 x NAGHHblits0.62
7y0c.1.C
Spike protein S1
Crystal structure of BD55-1403 and SARS-CoV-2 Omicron RBD
0.1091.960.16 330-528X-ray2.94hetero-1-1-1-merBLAST0.60
7y0c.2.A
Spike protein S1
Crystal structure of BD55-1403 and SARS-CoV-2 Omicron RBD
0.0991.960.16 330-528X-ray2.94hetero-1-1-1-merBLAST0.60
7fjs.1.B
Spike protein S1
Crystal structure of T6 Fab bound to theSARS-CoV-2 RBD of B.1.351
0.0998.450.15 335-527X-ray2.90hetero-2-2-2-mer2 x NAGHHblits0.63
7e8m.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 antibody P2C-1F11 with mutated RBD
0.0998.450.15 335-527X-ray2.09hetero-1-1-1-mer1 x NAGHHblits0.63
7fjs.1.E
Spike protein S1
Crystal structure of T6 Fab bound to theSARS-CoV-2 RBD of B.1.351
0.0898.450.15 335-527X-ray2.90hetero-2-2-2-mer2 x NAGHHblits0.63
7fdk.1.B
Spike protein S1
SARS-COV-2 Spike RBDMACSp36 binding to mACE2
0.1097.420.15 332-526EM0.00hetero-1-1-mer3 x NAGHHblits0.62
8bbn.1.C
Spike protein S1
SARS-CoV-2 Delta-RBD complexed with BA.2-10 and EY6A Fabs
0.0998.450.15 335-527X-ray3.58hetero-1-1-1-1-1-merHHblits0.62
8bbn.2.C
Spike protein S1
SARS-CoV-2 Delta-RBD complexed with BA.2-10 and EY6A Fabs
0.0998.450.15 335-527X-ray3.58hetero-1-1-1-1-1-merHHblits0.62
8bbn.3.C
Spike protein S1
SARS-CoV-2 Delta-RBD complexed with BA.2-10 and EY6A Fabs
0.0998.450.15 335-527X-ray3.58hetero-1-1-1-1-1-merHHblits0.62
8bbo.1.A
Spike glycoprotein
SARS-CoV-2 Delta-RBD complexed with BA.2-36 Fab
0.0898.450.15 335-527X-ray2.75hetero-1-1-1-mer1 x NAGHHblits0.62
8bcz.1.A
Spike protein S1
SARS-CoV-2 Delta-RBD complexed with Fabs BA.2-36, BA.2-23, EY6A and COVOX-45
0.0998.450.15 335-527EM0.00hetero-1-1-1-1-1-1-…HHblits0.62
8c3v.1.C
Spike protein S1
SARS-CoV-2 Delta-RBD complexed with BA.2-13 Fab and C1 nanobody
0.0998.450.15 335-527X-ray2.74hetero-1-1-1-1-merHHblits0.62
8c3v.2.A
Spike protein S1
SARS-CoV-2 Delta-RBD complexed with BA.2-13 Fab and C1 nanobody
0.0898.450.15 335-527X-ray2.74hetero-1-1-1-1-merHHblits0.62
8c3v.3.A
Spike protein S1
SARS-CoV-2 Delta-RBD complexed with BA.2-13 Fab and C1 nanobody
0.0998.450.15 335-527X-ray2.74hetero-1-1-1-1-merHHblits0.62
7jn5.1.C
Spike glycoprotein
Crystal structure of SARS-CoV receptor binding domain in complex with human antibody CR3022
0.0971.890.17 319-541X-ray2.71hetero-1-1-1-mer1 x NAG, 1 x NAG-NAGHHblits0.53
7lm9.1.A
Spike glycoprotein
Crystal structure of SARS-CoV spike protein receptor-binding domain in complex with a cross-neutralizing antibody CV38-142 Fab isolated from COVID-19 patient
0.0871.890.17 319-541X-ray1.53hetero-1-1-1-merHHblits0.53
7xbh.1.A
RshSTT182/200 coronavirus receptor binding domain
The complex structure of RshSTT182/200 RBD bound to human ACE2
0.0976.850.17 319-541X-ray3.02hetero-1-1-mer5 x NAG, 1 x ZNHHblits0.54
7tpk.1.A
Spike protein S1
SARS-CoV-2 E406W mutant RBD - Local Refinement
0.0999.480.15 335-526EM0.00monomer1 x NAGHHblits0.63
7dqa.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV2 RBD-ACE2 complex
0.1099.480.15 335-526EM0.00hetero-1-1-mer1 x ZN, 5 x NAGHHblits0.63
7wk0.1.C
Spike protein S1
Local refine of Omicron spike bitrimer with 6m6 antibody
0.1092.420.16 331-528EM0.00hetero-2-2-2-mer2 x NAGBLAST0.60
7wk0.1.F
Spike protein S1
Local refine of Omicron spike bitrimer with 6m6 antibody
0.1092.420.16 331-528EM0.00hetero-2-2-2-mer2 x NAGBLAST0.60
7wog.1.A
Spike protein S1
SARS-CoV-2 Omicron S monomer complexed with 553-49
0.0992.420.16 331-528EM0.00hetero-1-1-1-merBLAST0.60
7wop.1.A
Spike protein S1
The local refined map of Omicron spike with bispecific antibody FD01
0.0992.420.16 331-528EM0.00hetero-1-1-1-merBLAST0.60
7e3o.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody nCoV617
0.08100.000.15 337-527X-ray2.51hetero-1-1-1-merHHblits0.63
7xrp.1.C
Spike protein S1
Cryo-EM structure of SARS-CoV-2 spike protein in complex with nanobody C5G2 (localized refinement)
0.09100.000.15 331-521EM0.00hetero-1-1-1-mer4 x NAGHHblits0.63
7fat.1.A
Spike protein S1
Structure Determination of the RBD-NB1A7
0.08100.000.15 333-523X-ray1.99hetero-1-1-mer1 x NAG-NAGHHblits0.63
7fau.1.A
Spike protein S1
Structure Determination of the NB1B11-RBD Complex
0.07100.000.15 333-523X-ray2.08hetero-1-1-mer3 x ZNHHblits0.63
7fau.2.A
Spike protein S1
Structure Determination of the NB1B11-RBD Complex
0.08100.000.15 333-523X-ray2.08hetero-1-1-mer2 x ZNHHblits0.63
7fat.1.A
Spike protein S1
Structure Determination of the RBD-NB1A7
0.08100.000.15 333-523X-ray1.99hetero-1-1-mer1 x NAG-NAGBLAST0.63
7fau.1.A
Spike protein S1
Structure Determination of the NB1B11-RBD Complex
0.07100.000.15 333-523X-ray2.08hetero-1-1-mer3 x ZNBLAST0.63
7fau.2.A
Spike protein S1
Structure Determination of the NB1B11-RBD Complex
0.09100.000.15 333-523X-ray2.08hetero-1-1-mer2 x ZNBLAST0.63
7zfc.1.F
Spike protein S1
SARS-CoV-2 Beta RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs
0.0998.440.15 335-526X-ray3.24hetero-1-1-1-1-1-1-…1 x NAG-FUCHHblits0.62
7ps1.1.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-27 Fab
0.0898.440.15 335-526X-ray2.40hetero-1-1-1-mer1 x NAGHHblits0.62
7ps7.1.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-40 Fab
0.0998.440.15 335-526X-ray3.90hetero-1-1-1-merHHblits0.62
7ps7.2.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-40 Fab
0.0998.440.15 335-526X-ray3.90hetero-1-1-1-merHHblits0.62
7q0h.1.E
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-50 and Beta-54
0.1098.440.15 335-526X-ray3.65hetero-1-1-1-1-1-merHHblits0.62
7prz.1.B
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with beta-22 Fabs
0.0998.440.15 335-526X-ray3.20hetero-1-1-1-mer1 x NAG-NAG-FUC, 1 x NAG-FUCHHblits0.62
7ps0.2.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with beta-24 Fabs
0.0898.440.15 335-526X-ray2.92hetero-1-1-1-mer1 x NAGHHblits0.62
7ps5.1.C
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-47 Fab
0.0998.440.15 335-526X-ray3.14hetero-1-1-1-merHHblits0.62
7pry.1.E
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with COVOX-45 and beta-6 Fabs
0.0998.440.15 335-526X-ray3.10hetero-1-1-1-1-1-merHHblits0.62
7pry.2.C
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with COVOX-45 and beta-6 Fabs
0.0998.440.15 335-526X-ray3.10hetero-1-1-1-1-1-merHHblits0.62
7ps0.1.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with beta-24 Fabs
0.0998.440.15 335-526X-ray2.92hetero-1-1-1-mer1 x NAGHHblits0.62
7ps2.1.B
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-29 and Beta-53 Fabs
0.0998.440.15 335-526X-ray2.99hetero-1-1-1-1-1-merHHblits0.62
7ps4.1.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-38
0.0998.440.15 335-526X-ray1.94hetero-1-1-1-mer1 x NAG-NAGHHblits0.62
7ps4.2.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-38
0.0998.440.15 335-526X-ray1.94hetero-1-1-1-mer1 x NAG-NAGHHblits0.62
7ps6.1.C
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-44 and Beta-54 Fabs
0.0898.440.15 335-526X-ray2.26hetero-1-1-1-1-1-mer1 x NAG-FUCHHblits0.62
7q0g.1.A
Spike protein S1
Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-49 and FI-3A Fabs
0.0998.440.15 335-526X-ray1.82hetero-1-1-1-1-1-mer14 x K, 3 x TAR, 1 x NAG-NAG-BMA-MAN-FUCHHblits0.62
7bh9.1.B
Spike protein S1
SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain
0.0895.360.15 335-528EM0.00hetero-1-1-mer1 x ZN, 3 x NAGHHblits0.62
7ya1.1.B
Spike protein S1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (local refinement)
0.0893.850.15 333-527EM0.00hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGBLAST0.61
7wlc.1.A
Spike protein S1
SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv282
0.1090.910.16 331-529EM0.00hetero-1-1-1-merHHblits0.60
7wsa.1.A
Spike protein S1
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
0.0990.910.16 331-529EM0.00hetero-1-1-mer7 x NAGHHblits0.60
7wtj.1.C
Spike protein S1
SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv286
0.1090.910.16 331-529EM0.00hetero-1-1-1-merHHblits0.60
7wtg.1.A
Spike protein S1
SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv051
0.0990.910.16 331-529EM0.00hetero-1-1-1-merHHblits0.60
7wth.1.A
Spike protein S1
SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv264
0.0890.910.16 331-529EM0.00hetero-1-1-1-merHHblits0.60
8dcc.1.A
Spike protein S1
SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 3 Bound to P2B-2F6 Fab
0.0996.370.15 334-526X-ray2.60hetero-1-1-1-mer1 x NAGBLAST0.62
7zsd.1.A
Spike glycoprotein
cryo-EM structure of omicron spike in complex with de novo designed binder, local
0.0992.350.15 332-527EM0.00hetero-1-1-mer1 x NAG-NAGBLAST0.60
7u0d.1.A
Surface glycoprotein
Local refinement of cryo-EM structure of the interface of the Omicron RBD in complex with antibodies B-182.1 and A19-46.1
0.0992.350.15 331-526EM0.00hetero-1-1-1-1-1-mer1 x NAGBLAST0.60
7won.1.A
Spike protein S1
Cryo-EM structure of SARS-CoV-2 S2P trimer in complex with neutralizing antibody VacW-209 (local refinement)
0.09100.000.15 333-521EM0.00hetero-1-1-1-mer1 x NAG-NAGBLAST0.63
7wp6.1.D
Spike protein S1
Cryo-EM structure of SARS-CoV-2 recombinant spike protein STFK in complex with three neutralizing antibodies
0.10100.000.15 333-521EM0.00hetero-1-1-1-1-1-1-…1 x NAG, 1 x NAG-NAGBLAST0.63
7yad.1.C
Spike protein S1
Cryo-EM structure of S309-RBD-RBD-S309 in the S309-bound Omicron spike protein (local refinement)
0.0990.860.15 331-528EM0.00hetero-2-2-2-merHHblits0.60
7yad.1.F
Spike protein S1
Cryo-EM structure of S309-RBD-RBD-S309 in the S309-bound Omicron spike protein (local refinement)
0.0890.860.15 331-528EM0.00hetero-2-2-2-merHHblits0.60
8dcc.1.A
Spike protein S1
SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 3 Bound to P2B-2F6 Fab
0.0996.350.15 335-526X-ray2.60hetero-1-1-1-mer1 x NAGHHblits0.62
7wck.1.C
Surface glycoprotein
Local CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWA9 Fab
0.0895.340.15 335-530EM0.00hetero-1-1-1-merHHblits0.61
7wcu.1.C
Surface glycoprotein
Local CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWC11 Fab
0.0895.340.15 335-530EM0.00hetero-1-1-1-merHHblits0.61
3sci.1.B
Spike glycoprotein
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus human strain complexed with human receptor ACE2
0.0671.960.17 319-541X-ray2.90hetero-1-1-mer1 x ZNHHblits0.53
7xb1.1.B
Spike protein S1
Crystal structure of Omicron BA.3 RBD complexed with hACE2
0.0992.310.15 333-527X-ray2.70hetero-1-1-mer1 x ZN, 3 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMABLAST0.60
8dce.1.B
Spike protein S1
SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 1 Bound to C144 scFv
0.0895.830.15 335-526X-ray2.00hetero-1-1-merHHblits0.61
8dce.1.B
Spike protein S1
SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 1 Bound to C144 scFv
0.0895.830.15 334-525X-ray2.00hetero-1-1-merBLAST0.61
7wbl.1.B
Spike protein S1
Cryo-EM structure of human ACE2 complexed with SARS-CoV-2 Omicron RBD
0.0992.310.15 333-527EM0.00hetero-1-1-mer4 x NAG, 1 x ZNBLAST0.60
7wi0.1.A
Spike protein S1
SARS-CoV-2 Omicron variant spike in complex with three human neutralizing antibodies
0.1092.310.15 333-527EM0.00hetero-1-1-1-1-1-1-…1 x NAGBLAST0.60
7xcp.1.B
Spike protein S1
Cryo-EM structure of Omicron RBD complexed with ACE2 and 304 Fab
0.0992.310.15 333-527EM0.00hetero-1-1-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGBLAST0.60
7xci.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron RBD in complex with human ACE2 ectodomain (local refinement)
0.0992.310.15 333-527EM0.00hetero-1-1-mer1 x ZN, 6 x NAG, 1 x NAG-NAGBLAST0.60
7tc9.1.A
Spike protein S1
Locally refined region of SARS-CoV-2 spike in complex with antibody A19-46.1
0.1092.310.15 332-526EM0.00hetero-1-1-1-mer1 x NAGBLAST0.60
7xaz.1.B
Spike protein S1
Crystal structure of Omicron BA.1.1 RBD complexed with hACE2
0.0991.790.15 333-527X-ray3.00hetero-1-1-mer6 x NAG, 1 x ZNBLAST0.60
7xaz.2.B
Spike protein S1
Crystal structure of Omicron BA.1.1 RBD complexed with hACE2
0.0991.790.15 333-527X-ray3.00hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGBLAST0.60
7wp0.1.C
Spike protein S1
Cryo-EM structure of SARS-CoV-2 Delta S6P trimer in complex with neutralizing antibody VacW-209 (local refinement)
0.0798.940.15 333-521EM0.00hetero-1-1-1-mer1 x NAGBLAST0.63
7xb0.1.B
Spike protein S1
Crystal structure of Omicron BA.2 RBD complexed with hACE2
0.0991.790.15 333-527X-ray2.90hetero-1-1-mer1 x ZN, 3 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAGBLAST0.60
7mkm.1.A
Spike protein S1
SARS-CoV-2 Spike RBD in complex with neutralizing Fab SARS2-38 (local refinement)
0.08100.000.15 333-520EM0.00hetero-1-1-1-mer1 x NAGBLAST0.63
7wp1.1.C
Spike protein S1
Cryo-EM structure of SARS-CoV-2 Mu S6P trimer in complex with neutralizing antibody VacW-209 (local refinement)
0.1098.410.15 333-521EM0.00hetero-1-1-1-mer1 x NAG-NAGBLAST0.63
7ttm.1.A
Spike protein S1
Crystal structure of potent neutralizing antibody 10-40 in complex with Sarbecovirus bat SHC014 receptor-binding domain
0.0870.180.17 319-541X-ray2.24hetero-1-1-1-mer3 x NAGHHblits0.51
7wp2.1.C
Spike protein S1
Cryo-EM structure of SARS-CoV-2 C.1.2 S6P trimer in complex with neutralizing antibody VacW-209 (local refinement)
0.1098.410.15 333-521EM0.00hetero-1-1-1-mer1 x NAG-NAGBLAST0.62
8gzz.1.B
Spike protein S1
Local refinement of SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab
0.0992.270.15 334-527EM0.00hetero-2-2-2-merBLAST0.60
7xj9.1.A
Spike glycoprotein
Local refinement of the SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab
0.1092.270.15 334-527EM0.00hetero-2-2-2-1-1-merBLAST0.60
7xj9.1.B
Spike glycoprotein
Local refinement of the SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab
0.0892.270.15 334-527EM0.00hetero-2-2-2-1-1-merBLAST0.60
7zf3.1.E
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with Omi-3 and EY6A Fabs
0.0992.270.15 333-526X-ray3.15hetero-1-1-1-1-1-merBLAST0.60
7zf5.1.C
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with Omi-12 and Beta-54 Fabs
0.0892.270.15 333-526X-ray5.32hetero-1-1-1-1-1-merBLAST0.60
7zfb.1.B
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs
0.0892.270.15 333-526X-ray3.08hetero-1-1-1-1-1-1-…1 x NAGBLAST0.60
7zfe.1.B
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with Omi-32 Fab and nanobody C1
0.0792.270.15 333-526X-ray3.25hetero-1-1-1-1-merBLAST0.60
7won.1.A
Spike protein S1
Cryo-EM structure of SARS-CoV-2 S2P trimer in complex with neutralizing antibody VacW-209 (local refinement)
0.09100.000.15 335-521EM0.00hetero-1-1-1-mer1 x NAG-NAGHHblits0.63
7wp6.1.D
Spike protein S1
Cryo-EM structure of SARS-CoV-2 recombinant spike protein STFK in complex with three neutralizing antibodies
0.10100.000.15 335-521EM0.00hetero-1-1-1-1-1-1-…1 x NAG, 1 x NAG-NAGHHblits0.63
7k8m.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment, C102
0.08100.000.15 331-517X-ray3.20hetero-1-1-1-mer1 x NAGBLAST0.63
7xda.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta RBD in complex with BA7208 and BA7125 fab (local refinement)
0.0895.290.15 335-528EM0.00hetero-1-1-1-1-1-merHHblits0.61
7xcz.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Delta RBD in complex with BA7054 and BA7125 fab (local refinement)
0.0995.290.15 335-528EM0.00hetero-1-1-1-1-1-merHHblits0.61
7xb0.1.B
Spike protein S1
Crystal structure of Omicron BA.2 RBD complexed with hACE2
0.0891.710.15 335-527X-ray2.90hetero-1-1-mer1 x ZN, 3 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAGHHblits0.60
7wp1.1.C
Spike protein S1
Cryo-EM structure of SARS-CoV-2 Mu S6P trimer in complex with neutralizing antibody VacW-209 (local refinement)
0.1098.400.15 335-521EM0.00hetero-1-1-1-mer1 x NAG-NAGHHblits0.62
7wk0.1.C
Spike protein S1
Local refine of Omicron spike bitrimer with 6m6 antibody
0.1090.720.15 334-528EM0.00hetero-2-2-2-mer2 x NAGHHblits0.60
7wk0.1.F
Spike protein S1
Local refine of Omicron spike bitrimer with 6m6 antibody
0.0990.720.15 334-528EM0.00hetero-2-2-2-mer2 x NAGHHblits0.60
7wog.1.A
Spike protein S1
SARS-CoV-2 Omicron S monomer complexed with 553-49
0.0890.720.15 334-528EM0.00hetero-1-1-1-merHHblits0.60
7wop.1.A
Spike protein S1
The local refined map of Omicron spike with bispecific antibody FD01
0.0890.720.15 334-528EM0.00hetero-1-1-1-merHHblits0.60
8i5h.3.A
Spike protein S1
Crystal structure of SARS-CoV-2 delta variant spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab
0.0795.260.15 335-527X-ray2.38hetero-1-1-1-mer1 x NAGHHblits0.61
8i5h.1.A
Spike protein S1
Crystal structure of SARS-CoV-2 delta variant spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab
0.0795.260.15 335-527X-ray2.38hetero-1-1-1-mer1 x NAGHHblits0.61
8i5h.2.A
Spike protein S1
Crystal structure of SARS-CoV-2 delta variant spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab
0.0795.260.15 335-527X-ray2.38hetero-1-1-1-mer1 x NAGHHblits0.61
7x7d.1.C
Spike protein S1
SARS-CoV-2 Delta RBD and Nb22
0.0895.260.15 335-527X-ray2.92hetero-3-3-merHHblits0.61
7x7d.1.A
Spike protein S1
SARS-CoV-2 Delta RBD and Nb22
0.0895.260.15 335-527X-ray2.92hetero-3-3-merHHblits0.61
7x7d.1.E
Spike protein S1
SARS-CoV-2 Delta RBD and Nb22
0.0895.260.15 335-527X-ray2.92hetero-3-3-merHHblits0.61
7wp2.1.C
Spike protein S1
Cryo-EM structure of SARS-CoV-2 C.1.2 S6P trimer in complex with neutralizing antibody VacW-209 (local refinement)
0.1098.400.15 335-521EM0.00hetero-1-1-1-mer1 x NAG-NAGHHblits0.62
7fjc.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 Beta RBD complexed with P36-5D2 Fab
0.0898.400.15 333-519X-ray2.96hetero-1-1-1-mer1 x NAG-FUCBLAST0.62
7ya1.1.B
Spike protein S1
Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutations (local refinement)
0.0892.190.15 335-527EM0.00hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.60
7mkm.1.A
Spike protein S1
SARS-CoV-2 Spike RBD in complex with neutralizing Fab SARS2-38 (local refinement)
0.07100.000.15 335-519EM0.00hetero-1-1-1-mer1 x NAGHHblits0.63
7zf8.1.C
Spike protein S1
SARS-CoV-2 Omicron BA.2 RBD in complex with COVOX-150 Fab
0.0891.670.15 335-526X-ray2.95hetero-1-1-1-merHHblits0.60
7zf9.2.C
Spike protein S1
SARS-CoV-2 Omicron BA.2 RBD in complex with COVOX-150 Fab (P21)
0.0891.670.15 335-526X-ray3.25hetero-1-1-1-mer1 x NAGHHblits0.60
7zf9.1.C
Spike protein S1
SARS-CoV-2 Omicron BA.2 RBD in complex with COVOX-150 Fab (P21)
0.0891.670.15 335-526X-ray3.25hetero-1-1-1-mer1 x NAGHHblits0.60
7wrz.1.C
Spike protein S1
Local resolution of BD55-5840 Fab and SARS-COV2 Omicron RBD
0.0991.670.15 336-527EM0.00hetero-1-1-1-mer1 x NAG-NAGHHblits0.60
7y0w.1.E
Spike protein S1
Local structure of BD55-5514 and BD55-5840 Fab and Omicron BA.1 RBD complex
0.1091.670.15 336-527EM0.00hetero-1-1-1-1-1-merHHblits0.60
7y0c.1.C
Spike protein S1
Crystal structure of BD55-1403 and SARS-CoV-2 Omicron RBD
0.0990.670.15 335-528X-ray2.94hetero-1-1-1-merHHblits0.60
7y0c.2.A
Spike protein S1
Crystal structure of BD55-1403 and SARS-CoV-2 Omicron RBD
0.0890.670.15 335-528X-ray2.94hetero-1-1-1-merHHblits0.60
7wry.1.A
Spike protein S1
Local structure of BD55-3546 Fab and SARS-COV2 Delta RBD complex
0.0995.240.15 335-526EM0.00hetero-1-1-1-merHHblits0.61
7w9f.1.C
Spike protein S1
SARS-CoV-2 Delta S-RBD-8D3
0.0895.240.15 335-526EM0.00hetero-1-1-1-merHHblits0.61
7w9i.1.B
Spike protein S1
SARS-CoV-2 Delta S-RBD-ACE2
0.0895.240.15 335-526EM0.00hetero-1-1-merHHblits0.61
7qnw.1.C
Surface glycoprotein
The receptor binding domain of SARS-CoV-2 Omicron variant spike glycoprotein in complex with Beta-55 and EY6A Fabs
0.0890.160.15 335-528X-ray2.40hetero-1-1-1-1-1-mer1 x NAG-NAGHHblits0.59
7k8m.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment, C102
0.08100.000.14 334-517X-ray3.20hetero-1-1-1-mer1 x NAGHHblits0.63
7xb1.1.B
Spike protein S1
Crystal structure of Omicron BA.3 RBD complexed with hACE2
0.0890.630.15 335-527X-ray2.70hetero-1-1-mer1 x ZN, 3 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMAHHblits0.60
8gzz.1.B
Spike protein S1
Local refinement of SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab
0.0890.630.15 335-527EM0.00hetero-2-2-2-merHHblits0.60
8gzz.1.A
Spike protein S1
Local refinement of SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab
0.0890.630.15 335-527EM0.00hetero-2-2-2-merHHblits0.60
7xj9.1.A
Spike glycoprotein
Local refinement of the SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab
0.0990.630.15 335-527EM0.00hetero-2-2-2-1-1-merHHblits0.60
7wwk.1.A
Spike glycoprotein
Local refinement of the SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab
0.0990.630.15 335-527EM0.00hetero-2-2-2-merHHblits0.60
7xj9.1.B
Spike glycoprotein
Local refinement of the SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab
0.0890.630.15 335-527EM0.00hetero-2-2-2-1-1-merHHblits0.60
7wwk.1.B
Spike glycoprotein
Local refinement of the SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab
0.0990.630.15 335-527EM0.00hetero-2-2-2-merHHblits0.60
7wbl.1.B
Spike protein S1
Cryo-EM structure of human ACE2 complexed with SARS-CoV-2 Omicron RBD
0.0890.630.15 335-527EM0.00hetero-1-1-mer4 x NAG, 1 x ZNHHblits0.60
7wi0.1.A
Spike protein S1
SARS-CoV-2 Omicron variant spike in complex with three human neutralizing antibodies
0.0990.630.15 335-527EM0.00hetero-1-1-1-1-1-1-…1 x NAGHHblits0.60
7xcp.1.B
Spike protein S1
Cryo-EM structure of Omicron RBD complexed with ACE2 and 304 Fab
0.0990.630.15 335-527EM0.00hetero-1-1-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.60
7xci.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Omicron RBD in complex with human ACE2 ectodomain (local refinement)
0.0890.630.15 335-527EM0.00hetero-1-1-mer1 x ZN, 6 x NAG, 1 x NAG-NAGHHblits0.60
7zsd.1.A
Spike glycoprotein
cryo-EM structure of omicron spike in complex with de novo designed binder, local
0.0890.630.15 335-527EM0.00hetero-1-1-mer1 x NAG-NAGHHblits0.60
7u0d.1.A
Surface glycoprotein
Local refinement of cryo-EM structure of the interface of the Omicron RBD in complex with antibodies B-182.1 and A19-46.1
0.0990.630.15 334-526EM0.00hetero-1-1-1-1-1-mer1 x NAGHHblits0.60
5kwb.1.A
Spike glycoprotein
Crystal Structure of the Receptor Binding Domain of the Spike Glycoprotein of Human Betacoronavirus HKU1 (HKU1 1A-CTD, 1.9 angstrom, molecular replacement)
0.1121.690.21 316-592X-ray1.91monomer4 x NAG, 6 x MG, 1 x GLC-FRUHHblits0.32
7xaz.1.B
Spike protein S1
Crystal structure of Omicron BA.1.1 RBD complexed with hACE2
0.0990.100.15 335-527X-ray3.00hetero-1-1-mer6 x NAG, 1 x ZNHHblits0.59
7xaz.2.B
Spike protein S1
Crystal structure of Omicron BA.1.1 RBD complexed with hACE2
0.0890.100.15 335-527X-ray3.00hetero-1-1-mer5 x NAG, 1 x ZN, 1 x NAG-NAGHHblits0.59
7yr0.1.A
Spike protein S1
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (interface)
0.0989.580.15 335-527EM0.00hetero-1-1-1-merHHblits0.59
7zf3.1.E
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with Omi-3 and EY6A Fabs
0.0890.580.15 335-526X-ray3.15hetero-1-1-1-1-1-merHHblits0.60
7zfa.2.A
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with Omi-6 and COVOX-150 Fabs
0.0890.580.15 335-526X-ray4.24hetero-1-1-1-1-1-merHHblits0.60
7zfa.4.A
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with Omi-6 and COVOX-150 Fabs
0.0890.580.15 335-526X-ray4.24hetero-1-1-1-1-1-merHHblits0.60
7zfa.3.A
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with Omi-6 and COVOX-150 Fabs
0.0890.580.15 335-526X-ray4.24hetero-1-1-1-1-1-merHHblits0.60
7zfa.1.A
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with Omi-6 and COVOX-150 Fabs
0.0890.580.15 335-526X-ray4.24hetero-1-1-1-1-1-merHHblits0.60
7zf5.1.C
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with Omi-12 and Beta-54 Fabs
0.0890.580.15 335-526X-ray5.32hetero-1-1-1-1-1-merHHblits0.60
7zf5.2.C
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with Omi-12 and Beta-54 Fabs
0.0890.580.15 335-526X-ray5.32hetero-1-1-1-1-1-merHHblits0.60
7zf4.1.D
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with Omi-9 Fab and nanobody F2
0.0890.580.15 335-526X-ray4.18hetero-1-1-1-1-merHHblits0.60
7zfb.1.B
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs
0.0890.580.15 335-526X-ray3.08hetero-1-1-1-1-1-1-…1 x NAGHHblits0.60
7zfb.2.F
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs
0.0890.580.15 335-526X-ray3.08hetero-1-1-1-1-1-1-…1 x NAGHHblits0.60
7zfe.1.B
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with Omi-32 Fab and nanobody C1
0.0790.580.15 335-526X-ray3.25hetero-1-1-1-1-merHHblits0.60
7zfe.2.A
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with Omi-32 Fab and nanobody C1
0.0890.580.15 335-526X-ray3.25hetero-1-1-1-1-merHHblits0.60
7zfe.3.D
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with Omi-32 Fab and nanobody C1
0.0890.580.15 335-526X-ray3.25hetero-1-1-1-1-merHHblits0.60
7zfe.4.D
Spike protein S1
SARS-CoV-2 Omicron RBD in complex with Omi-32 Fab and nanobody C1
0.0790.580.15 335-526X-ray3.25hetero-1-1-1-1-merHHblits0.60
7wr8.1.A
Spike protein S1
Local CryoEM structure of the SARS-CoV-2 S6P(B.1.1.529) in complex with BD55-3152 Fab
0.0990.580.15 335-526EM0.00hetero-1-1-1-merHHblits0.60
7wrl.1.C
Spike protein S1
Local structure of BD55-1239 Fab and SARS-COV2 Omicron RBD complex
0.0890.580.15 335-526EM0.00hetero-1-1-1-merHHblits0.60
7wrj.1.A
Spike protein S1
Local CryoEM structure of the SARS-CoV-2 S6P(B.1.1.529) in complex with BD55-4637 Fab
0.0990.580.15 335-526EM0.00hetero-1-1-1-mer1 x NAG-NAGHHblits0.60
7whh.1.B
Spike glycoprotein
Crystal structure of SARS-CoV-2 omicron RBD and human ACE2
0.0890.580.15 335-526X-ray2.60hetero-1-1-mer1 x ZN, 4 x NAG, 1 x NAG-FUC-NAGHHblits0.60
7tc9.1.A
Spike protein S1
Locally refined region of SARS-CoV-2 spike in complex with antibody A19-46.1
0.1090.580.15 335-526EM0.00hetero-1-1-1-mer1 x NAGHHblits0.60
7f7h.1.C
Spike glycoprotein S1
SARS-CoV-2 S protein RBD in complex with A8-1 Fab
0.08100.000.14 334-515X-ray3.19hetero-1-1-1-merBLAST0.63
7f7h.2.C
Spike glycoprotein S1
SARS-CoV-2 S protein RBD in complex with A8-1 Fab
0.07100.000.14 334-515X-ray3.19hetero-1-1-1-merBLAST0.63
7wro.1.C
Spike protein S1
Local structure of BD55-3372 and delta spike
0.0898.910.14 334-516EM0.00hetero-1-1-1-merBLAST0.63
7fjc.1.C
Spike protein S1
Crystal structure of SARS-CoV-2 Beta RBD complexed with P36-5D2 Fab
0.0798.370.14 335-518X-ray2.96hetero-1-1-1-mer1 x NAG-FUCHHblits0.62
7vib.1.B
Spike glycoprotein
Crystal structure of human ACE2 and GX/P2V RBD
0.0886.980.15 335-526X-ray3.20hetero-1-1-mer1 x ZNHHblits0.59
7vib.2.B
Spike glycoprotein
Crystal structure of human ACE2 and GX/P2V RBD
0.0886.980.15 335-526X-ray3.20hetero-1-1-mer1 x ZNHHblits0.59
7wb5.1.C
Surface glycoprotein
local structure of hu33 and spike
0.0898.360.14 334-516EM0.00hetero-1-1-1-merBLAST0.62
8asy.1.B
Spike protein S1
SARS-CoV-2 Omicron BA.2.75 RBD in complex with ACE2
0.0889.530.15 335-526X-ray2.85hetero-1-1-mer6 x NAGHHblits0.59
7f7h.1.C
Spike glycoprotein S1
SARS-CoV-2 S protein RBD in complex with A8-1 Fab
0.08100.000.14 335-515X-ray3.19hetero-1-1-1-merHHblits0.63
7f7h.2.C
Spike glycoprotein S1
SARS-CoV-2 S protein RBD in complex with A8-1 Fab
0.07100.000.14 335-515X-ray3.19hetero-1-1-1-merHHblits0.63
7vmu.1.B
Spike protein S1
Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody
0.08100.000.14 335-515X-ray2.89hetero-1-1-merBLAST0.63
8dwa.1.A
Spike protein S1
Crystal structure of neutralizing antibody P1D9 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD)
0.08100.000.14 335-515X-ray3.20hetero-1-1-1-mer1 x NAGBLAST0.63
7wb5.1.C
Surface glycoprotein
local structure of hu33 and spike
0.0898.350.14 335-516EM0.00hetero-1-1-1-merHHblits0.62
7vmu.1.B
Spike protein S1
Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody
0.08100.000.14 336-515X-ray2.89hetero-1-1-merHHblits0.63
8dwa.1.A
Spike protein S1
Crystal structure of neutralizing antibody P1D9 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD)
0.08100.000.14 336-515X-ray3.20hetero-1-1-1-mer1 x NAGHHblits0.63
7zxu.1.A
Spike protein S1
SARS-CoV-2 Omicron BA.4/5 RBD in complex with Beta-27 Fab and C1 nanobody
0.0787.430.15 335-528X-ray1.89hetero-1-1-1-1-mer1 x NAGHHblits0.58
7wp0.1.C
Spike protein S1
Cryo-EM structure of SARS-CoV-2 Delta S6P trimer in complex with neutralizing antibody VacW-209 (local refinement)
0.0695.110.14 335-521EM0.00hetero-1-1-1-mer1 x NAGHHblits0.61
8bh5.1.C
Spike protein S1
SARS-CoV-2 BA.2.12.1 RBD in complex with Beta-27 Fab and C1 nanobody
0.0786.910.15 335-528X-ray2.38hetero-1-1-1-1-mer1 x NAG-FUCHHblits0.58
7y7k.1.A
Spike protein S1
SARS-CoV-2 RBD in complex with 1F Fab
0.09100.000.14 336-514EM4.40hetero-1-1-1-merHHblits0.63
5vyh.1.A
S protein
Crystal Structure of MERS-CoV S1 N-terminal Domain
0.0522.010.21 11-305X-ray2.00monomer8 x NAG, 1 x FOL, 1 x IMDHHblits0.31
6j11.1.A
N-terminal domain of Spike glycoprotein
MERS-CoV spike N-terminal domain and 7D10 scFv complex
0.0522.010.21 11-305X-ray3.00hetero-1-1-1-mer3 x NAG, 1 x NAG-NAG-BMA-MAN-MAN-MAN-MAN, 1 x NAG-NAG-BMA-MAN, 2 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.31
7wp5.1.C
Spikeprotein S1
Cryo-EM structure of SARS-CoV-2 Omicron S6P trimer in complex with neutralizing antibody VacW-209 (local refinement)
0.0790.320.15 335-521EM0.00hetero-1-1-1-mer1 x NAG-NAGHHblits0.59
5x4r.1.A
S protein
Structure of the N-terminal domain (NTD) of MERS-CoV spike protein
0.0521.720.21 11-305X-ray1.50monomer2 x NAG-NAGHHblits0.31
7x2j.1.A
Spike protein S1
Crystal structure of nanobody Nb70 with SARS-CoV RBD
0.0772.140.16 319-528X-ray2.40hetero-1-1-mer2 x NAGHHblits0.53
6pxh.1.A
MERS-CoV S1-NTD
Crystal Structure of MERS-CoV S1-NTD bound with G2 Fab
0.0521.800.21 11-303X-ray2.30hetero-1-1-1-mer2 x NAG, 1 x DHF, 3 x NAG-NAG-BMA, 2 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-MAN-MAN-MANHHblits0.31
7x4i.1.A
Spike glycoprotein
Crystal structure of nanobody aSA3 in complex with dimer SARS-CoV-1 RBD
0.0771.720.16 334-537X-ray3.38hetero-4-4-merHHblits0.53
7wro.1.C
Spike protein S1
Local structure of BD55-3372 and delta spike
0.0794.970.14 335-516EM0.00hetero-1-1-1-merHHblits0.61
8gs9.1.A
Spike glycoprotein
SARS-CoV-2 BA.2 spike RBD in complex bound with VacBB-551
0.0791.160.14 337-517EM0.00hetero-1-1-1-merHHblits0.60
8hc8.1.A
Spike protein S1
SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with YB13-292 Fab, focused refinement of Fab region
0.0790.110.14 335-517EM0.00hetero-1-1-1-mer1 x NAGHHblits0.59
7wp8.1.D
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 recombinant spike protein STFK1628x in complex with three neutralizing antibodies
0.0793.300.14 336-517EM0.00hetero-1-1-1-1-1-1-…1 x NAG, 1 x NAG-NAGHHblits0.60
7tty.1.A
Spike protein S1
Crystal structure of potent neutralizing antibody 10-40 in complex with bat WIV1 receptor-binding domain
0.0875.530.15 335-528X-ray3.11hetero-1-1-1-mer1 x NAG-NAGHHblits0.54
2dd8.1.C
Spike glycoprotein
Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody
0.0772.770.15 332-531X-ray2.30hetero-1-1-1-mer1 x NAGHHblits0.53
2ghw.1.A
Spike glycoprotein
Crystal structure of SARS spike protein receptor binding domain in complex with a neutralizing antibody, 80R
0.0672.430.15 331-524X-ray2.30hetero-oligomerHHblits0.53
2ghv.1.A
Spike glycoprotein
Crystal structure of SARS spike protein receptor binding domain
0.0672.430.15 331-524X-ray2.20homo-dimerHHblits0.53
7fc6.1.B
Spike protein S1
Crystal structure of SARS-CoV RBD and horse ACE2
0.0772.130.14 335-526X-ray2.65hetero-1-1-mer2 x NAG, 1 x NAG-NAGHHblits0.53
6qfy.1.A
Spike glycoprotein
CRYSTAL STRUCTURE OF PORCINE HEMAGGLUTINATING ENCEPHALOMYELITIS VIRUS SPIKE PROTEIN LECTIN DOMAIN
0.0922.920.19 30-305X-ray2.97monomer2 x NAG, 2 x NAG-NAGHHblits0.31
6jhy.1.A
Spike protein
Crystal Structure of the S1 subunit N-terminal domain from DcCoV UAE-HKU23 spike protein
0.0922.360.19 31-303X-ray2.50monomer1 x NAG, 2 x NAG-NAGHHblits0.31
3r4d.1.B
Spike glycoprotein
Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor
0.0822.080.19 31-303X-ray3.10hetero-1-1-mer3 x NAG, 1 x NAG-NAGHHblits0.30
3r4d.2.B
Spike glycoprotein
Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor
0.0822.080.19 31-303X-ray3.10hetero-1-1-mer3 x NAG, 1 x NAG-NAGHHblits0.30
3bgf.1.A
Spike protein S1
X-ray crystal structure of the SARS coronavirus spike receptor binding domain in complex with F26G19 Fab
0.0671.670.14 334-524X-ray3.00hetero-1-1-1-merHHblits0.53
4h14.1.A
Spike glycoprotein
Crystal Structure of Bovine Coronavirus Spike Protein Lectin Domain
0.0922.880.19 31-303X-ray1.55monomer1 x NAG, 2 x NAG-NAGHHblits0.31
7rks.1.C
Spike protein S1
Structure of the SARS-CoV receptor binding domain in complex with the human neutralizing antibody Fab fragment, C118
0.0671.510.14 335-524X-ray2.70hetero-1-1-1-mer1 x NAG-NAGHHblits0.52
5x4r.1.A
S protein
Structure of the N-terminal domain (NTD) of MERS-CoV spike protein
0.0012.650.19 890-1258X-ray1.50monomer2 x NAG-NAGHHblits0.27
7x7v.1.G
Spike protein S1
Cryo-EM structure of SARS-CoV spike protein in complex with three nAbs X01, X10 and X17
0.0671.190.14 334-521EM0.00hetero-1-1-1-1-1-1-…2 x NAG-NAGHHblits0.53
3d0i.1.C
Spike glycoprotein
Crystal structure of spike protein receptor-binding domain from the 2005-2006 SARS coronavirus civet strain complexed with human-civet chimeric receptor ACE2
0.0671.260.14 337-516X-ray2.90hetero-2-2-mer4 x NDG, 2 x ZNHHblits0.53
3d0h.1.C
Spike glycoprotein
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus civet strain complexed with human-civet chimeric receptor ACE2
0.0671.260.14 337-516X-ray3.10hetero-2-2-mer5 x NDG, 2 x ZN, 1 x NAGHHblits0.53
3d0g.1.C
Spike glycoprotein
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus human strain complexed with human-civet chimeric receptor ACE2
0.0671.260.14 337-516X-ray2.80hetero-2-2-mer5 x NDG, 2 x ZN, 1 x NAGHHblits0.53
3scl.1.B
Spike glycoprotein
Crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain complexed with human-civet chimeric receptor ACE2
0.0771.260.14 337-516X-ray3.00hetero-1-1-mer1 x ZNHHblits0.53
3sck.1.B
Spike glycoprotein
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet strain complexed with human-civet chimeric receptor ACE2
0.0771.260.14 337-516X-ray3.00hetero-1-1-mer1 x ZNHHblits0.53
6waq.1.B
Spike glycoprotein
Crystal structure of the SARS-CoV-1 RBD bound by the cross-reactive single-domain antibody SARS VHH-72
0.0670.930.14 334-516X-ray2.20hetero-1-1-mer1 x NAGHHblits0.52
6waq.2.A
Spike glycoprotein
Crystal structure of the SARS-CoV-1 RBD bound by the cross-reactive single-domain antibody SARS VHH-72
0.0670.930.14 334-516X-ray2.20hetero-1-1-mer2 x NAGHHblits0.52
7wsf.1.B
Spike protein S1
Cryo-EM structure of SARS-CoV spike receptor-binding domain in complex with minke whale ACE2
0.0670.760.13 335-516EM0.00hetero-1-1-mer1 x ZNHHblits0.52
7wsg.1.B
Spike protein S1
Cryo-EM structure of SARS-CoV spike receptor-binding domain in complex with sea lion ACE2
0.0670.760.13 335-516EM0.00hetero-1-1-mer1 x ZNHHblits0.52
2ajf.1.B
SARS-coronavirus spike protein
Structure of SARS coronavirus spike receptor-binding domain complexed with its receptor
0.0670.590.13 336-516X-ray2.90hetero-1-1-mer4 x NAG, 1 x ZN, 1 x NAG-NAG-BMAHHblits0.52
7wr9.1.C
Spike protein S1
Local CryoEM structure of the SARS-CoV S2P in complex with BD55-3152 Fab
0.0670.590.13 336-516EM0.00hetero-1-1-1-mer1 x NAG, 1 x NAG-NAG-BMA-FUCHHblits0.52
3scj.1.B
Spike glycoprotein
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet strain complexed with human receptor ACE2
0.0670.590.13 336-516X-ray3.00hetero-1-1-mer1 x ZNHHblits0.52
6j11.1.A
N-terminal domain of Spike glycoprotein
MERS-CoV spike N-terminal domain and 7D10 scFv complex
0.0112.020.18 896-1243X-ray3.00hetero-1-1-1-mer3 x NAG, 1 x NAG-NAG-BMA-MAN-MAN-MAN-MAN, 1 x NAG-NAG-BMA-MAN, 2 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.27
6pxh.1.A
MERS-CoV S1-NTD
Crystal Structure of MERS-CoV S1-NTD bound with G2 Fab
0.0012.020.18 896-1243X-ray2.30hetero-1-1-1-mer2 x NAG, 1 x DHF, 3 x NAG-NAG-BMA, 2 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-MAN-MAN-MANHHblits0.27
5vyh.1.A
S protein
Crystal Structure of MERS-CoV S1 N-terminal Domain
0.0112.020.18 896-1243X-ray2.00monomer8 x NAG, 1 x FOL, 1 x IMDHHblits0.27
4qzv.1.B
Spike protein S1
Bat-derived coronavirus HKU4 uses MERS-CoV receptor human CD26 for cell entry
0.0720.910.17 319-541X-ray2.59hetero-1-1-mer3 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.30
4kr0.1.D
S protein
Complex structure of MERS-CoV spike RBD bound to CD26
0.0719.180.17 319-541X-ray2.70hetero-2-2-mer4 x NAG, 8 x NAG-NAG, 2 x NAG-NAG-BMAHHblits0.30
4kqz.1.A
S protein
structure of the receptor binding domain (RBD) of MERS-CoV spike
0.0719.180.17 319-541X-ray2.51monomer1 x NAGHHblits0.30
4kqz.2.A
S protein
structure of the receptor binding domain (RBD) of MERS-CoV spike
0.0719.180.17 319-541X-ray2.51monomer1 x NAGHHblits0.30
5do2.1.A
S protein
Complex structure of MERS-RBD bound with 4C2 antibody
0.0719.180.17 319-541X-ray2.41hetero-1-1-1-mer1 x NAGHHblits0.30
6l8q.1.D
Spike glycoprotein
Complex structure of bat CD26 and MERS-RBD
0.0719.180.17 319-541X-ray3.10hetero-4-4-mer11 x NAG, 13 x NAG-NAG, 4 x NAG-NAG-BMAHHblits0.30
7c02.1.B
Spike glycoprotein
Crystal structure of dimeric MERS-CoV receptor binding domain
0.0719.180.17 319-541X-ray2.91homo-dimer1 x NAGHHblits0.30
7c02.1.A
Spike glycoprotein
Crystal structure of dimeric MERS-CoV receptor binding domain
0.0719.180.17 319-541X-ray2.91homo-dimer1 x NAGHHblits0.30
4xak.1.A
Spike glycoprotein
Crystal structure of potent neutralizing antibody m336 in complex with MERS Co-V RBD
0.0718.690.17 319-536X-ray2.45hetero-1-1-1-mer2 x NAGHHblits0.29
7sb3.1.A
Spike protein
Structure of OC43 spike in complex with polyclonal Fab1 (Donor 269)
0.0730.260.15 242-437EM0.00hetero-3-2-mer27 x NAG, 3 x 8Z9, 13 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.36
7sb3.1.C
Spike protein
Structure of OC43 spike in complex with polyclonal Fab1 (Donor 269)
0.0730.260.15 242-437EM0.00hetero-3-2-mer27 x NAG, 3 x 8Z9, 13 x NAG-NAG, 1 x NAG-NAG-BMABLAST0.36
7sb4.1.A
Spike protein
Structure of OC43 spike in complex with polyclonal Fab2 (Donor 1412)
0.0730.260.15 242-437EM0.00hetero-3-2-mer31 x NAG, 3 x 8Z9, 9 x NAG-NAG, 2 x NAG-NAG-BMABLAST0.36
7sb4.1.B
Spike protein
Structure of OC43 spike in complex with polyclonal Fab2 (Donor 1412)
0.0730.260.15 242-437EM0.00hetero-3-2-mer31 x NAG, 3 x 8Z9, 9 x NAG-NAG, 2 x NAG-NAG-BMABLAST0.36
7sb4.1.C
Spike protein
Structure of OC43 spike in complex with polyclonal Fab2 (Donor 1412)
0.0730.260.15 242-437EM0.00hetero-3-2-mer31 x NAG, 3 x 8Z9, 9 x NAG-NAG, 2 x NAG-NAG-BMABLAST0.36
7sbw.1.C
Spike protein
Structure of OC43 spike in complex with polyclonal Fab5 (Donor 1051)
0.0730.260.15 242-437EM0.00hetero-2-3-mer12 x NAG, 3 x 8Z9, 11 x NAG-NAG-BMA, 20 x NAG-NAGBLAST0.36
5gmq.1.A
S protein
Structure of MERS-CoV RBD in complex with a fully human antibody MCA1
0.0718.840.16 318-528X-ray2.70hetero-1-1-1-merHHblits0.29
6war.1.A
Spike protein
Crystal structure of the MERS-CoV RBD bound by the neutralizing single-domain antibody MERS VHH-55
0.0618.840.16 319-529X-ray3.40hetero-1-1-merHHblits0.29
6c6z.1.A
Spike protein
Crystal structure of potent neutralizing antibody CDC2-C2 in complex with MERS-CoV S1 RBD
0.0618.840.16 319-529X-ray2.10hetero-1-1-1-mer1 x NAGHHblits0.29
6war.4.A
Spike protein
Crystal structure of the MERS-CoV RBD bound by the neutralizing single-domain antibody MERS VHH-55
0.0618.840.16 319-529X-ray3.40hetero-1-1-mer1 x NAGHHblits0.29
6war.5.A
Spike protein
Crystal structure of the MERS-CoV RBD bound by the neutralizing single-domain antibody MERS VHH-55
0.0618.840.16 319-529X-ray3.40hetero-1-1-merHHblits0.29
4zs6.1.C
S protein
Receptor binding domain and Fab complex
0.0618.930.16 319-528X-ray3.17hetero-1-1-1-mer2 x NAGHHblits0.29
7coe.1.C
Spike glycoprotein
Crystal structure of Receptor binding domain of MERS-CoV and KNIH90-F1 Fab complex
0.0718.930.16 319-528X-ray2.05hetero-1-1-1-mer2 x NAGHHblits0.29
5xgr.1.A
Spike protein S1
Structure of the S1 subunit C-terminal domain from bat-derived coronavirus HKU5 spike protein
0.0622.220.15 335-528X-ray2.10monomer2 x NAGHHblits0.31
5xgr.7.A
Spike protein S1
Structure of the S1 subunit C-terminal domain from bat-derived coronavirus HKU5 spike protein
0.0622.220.15 335-528X-ray2.10monomer1 x NAG, 1 x NAG-NAGHHblits0.31
4l3n.1.A
S protein
Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus
0.0618.850.15 335-528X-ray2.13monomer2 x NAG-NAGHHblits0.29
4l3n.2.A
S protein
Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus
0.0618.850.15 335-528X-ray2.13monomer2 x NAG-NAGHHblits0.29
6c6y.1.C
Spike glycoprotein
Crystal structure of Middle-East Respiratory Syndrome (MERS) coronavirus neutralizing antibody JC57-14 isolated from a vaccinated rhesus macaque in complex with MERS Receptor Binding Domain
0.0618.850.15 335-528X-ray3.32hetero-1-1-1-merHHblits0.29
4zpv.1.C
Spike glycoprotein
Structure of MERS-Coronavirus Spike Receptor-binding Domain (England1 Strain) in Complex with Vaccine-Elicited Murine Neutralizing Antibody D12 (Crystal Form 2)
0.0618.850.15 335-528X-ray3.20hetero-1-1-1-mer2 x NAGHHblits0.29
4zpv.2.A
Spike glycoprotein
Structure of MERS-Coronavirus Spike Receptor-binding Domain (England1 Strain) in Complex with Vaccine-Elicited Murine Neutralizing Antibody D12 (Crystal Form 2)
0.0618.850.15 335-528X-ray3.20hetero-1-1-1-merHHblits0.29
4zpw.2.A
Spike glycoprotein
Structure of unbound MERS-CoV spike receptor-binding domain (England1 strain).
0.0618.850.15 335-528X-ray3.02monomer2 x NAGHHblits0.29
4zpw.1.A
Spike glycoprotein
Structure of unbound MERS-CoV spike receptor-binding domain (England1 strain).
0.0618.850.15 335-528X-ray3.02monomer2 x NAGHHblits0.29
5yy5.1.A
MERS-CoV RBD
Structural definition of a unique neutralization epitope on the receptor-binding domain of MERS-CoV spike glycoprotein
0.0618.850.15 335-528X-ray2.80hetero-1-1-1-mer1 x NAGHHblits0.29
5zxv.1.A
MERS-CoV RBD
Structural definition of a unique neutralization epitope on the receptor-binding domain of MERS-CoV spike glycoprotein
0.0618.850.15 335-528X-ray4.48hetero-1-1-1-merHHblits0.29
7x26.1.B
Spike glycoprotein
S41 neutralizing antibody Fab(MERS-CoV)
0.0618.850.15 335-528EM0.00hetero-1-1-1-merHHblits0.29
7wpz.1.B
Spike glycoprotein
Structure of PDF-2180-COV RBD binding to Bat37 ACE2
0.0619.250.15 330-526EM0.00hetero-1-1-mer4 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MANHHblits0.30
4l72.2.A
MERS-CoV RBD
Crystal structure of MERS-CoV complexed with human DPP4
0.0619.150.15 335-525X-ray3.01monomerHHblits0.29
7zr2.1.A
Spike protein S2',Chimeric protein mimic of SARS-CoV-2 Spike HR1
Crystal structure of a chimeric protein mimic of SARS-CoV-2 Spike HR1 in complex with HR2
0.0659.590.11 811-988X-ray1.45hetero-1-1-merHHblits0.43
5gyq.1.A
Spike glycoprotein
Putative receptor-binding domain of bat-derived coronavirus HKU9 spike protein
0.0522.560.13 338-529X-ray2.10monomer1 x NAG-NAGHHblits0.32
1wyy.1.A
E2 Glycoprotein
Post-fusion hairpin conformation of the sars coronavirus spike glycoprotein
0.0270.770.10 903-1036X-ray2.20homo-trimerHHblits0.48
7y9n.1.A
Spike protein S2',5HB-H2
an engineered 5-helix bundle derived from SARS-CoV-2 S2 in complex with HR2P
0.0444.140.11 860-1015X-ray1.88hetero-1-1-merHHblits0.38
8fed.1.D
Virulence factor mce family protein
Structure of Mce1-LucB complex from Mycobacterium smegmatis (Map1)
0.0115.760.13 921-1085EM0.00hetero-1-1-1-1-1-1-…HHblits0.28
7wpo.1.B
Spike glycoprotein
Structure of NeoCOV RBD binding to Bat37 ACE2
0.0518.240.12 330-497EM0.00hetero-1-1-mer5 x NAG, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG, 1 x NAG-NAG-FUCHHblits0.30
6cnv.1.B
Envelope glycoprotein
INFLUENZA B/BRISBANE HEMAGGLUTININ FAB CR9115 SD84H COMPLEX
0.0017.570.12 945-1104X-ray4.10hetero-3-3-3-3-3-mer3 x NAG, 12 x NAG-NAGHHblits0.30
7wxz.1.A
Spike protein S2'
Crystal structure of the recombinant protein HR121 from the S2 protein of SARS-CoV-2
0.0371.050.09 912-1037X-ray2.41homo-dimerHHblits0.48
7wxz.1.B
Spike protein S2'
Crystal structure of the recombinant protein HR121 from the S2 protein of SARS-CoV-2
0.0271.050.09 912-1037X-ray2.41homo-dimerHHblits0.48
7wxz.2.A
Spike protein S2'
Crystal structure of the recombinant protein HR121 from the S2 protein of SARS-CoV-2
0.0271.050.09 912-1037X-ray2.41homo-dimerHHblits0.48
7wxz.2.B
Spike protein S2'
Crystal structure of the recombinant protein HR121 from the S2 protein of SARS-CoV-2
0.0271.050.09 912-1037X-ray2.41homo-dimerHHblits0.48
7cot.1.A
Spike glycoprotein
Structure of post fusion core of SARS-CoV-2 S2 subunit
0.0173.640.09 910-1019X-ray2.16homo-trimerHHblits0.49
7cot.3.A
Spike glycoprotein
Structure of post fusion core of SARS-CoV-2 S2 subunit
0.0173.640.09 910-1019X-ray2.16homo-trimerHHblits0.49
6lxt.1.A
Spike protein S2, Spike protein S2
Structure of post fusion core of 2019-nCoV S2 subunit
0.0173.640.09 910-1019X-ray2.90homo-trimer4 x ZNHHblits0.49
6lxt.1.B
Spike protein S2, Spike protein S2
Structure of post fusion core of 2019-nCoV S2 subunit
0.0173.640.09 910-1019X-ray2.90homo-trimer4 x ZNHHblits0.49
6lxt.1.C
Spike protein S2, Spike protein S2
Structure of post fusion core of 2019-nCoV S2 subunit
0.0173.640.09 910-1019X-ray2.90homo-trimer4 x ZNHHblits0.49
6lxt.2.A
Spike protein S2, Spike protein S2
Structure of post fusion core of 2019-nCoV S2 subunit
0.0173.640.09 910-1019X-ray2.90homo-trimer2 x ZNHHblits0.49
6lxt.2.B
Spike protein S2, Spike protein S2
Structure of post fusion core of 2019-nCoV S2 subunit
0.0173.640.09 910-1019X-ray2.90homo-trimer2 x ZNHHblits0.49
6lxt.2.C
Spike protein S2, Spike protein S2
Structure of post fusion core of 2019-nCoV S2 subunit
0.0173.640.09 910-1019X-ray2.90homo-trimer2 x ZNHHblits0.49
7y9n.1.A
Spike protein S2',5HB-H2
an engineered 5-helix bundle derived from SARS-CoV-2 S2 in complex with HR2P
0.0152.940.09 917-1037X-ray1.88hetero-1-1-merHHblits0.41
7zr2.1.A
Spike protein S2',Chimeric protein mimic of SARS-CoV-2 Spike HR1
Crystal structure of a chimeric protein mimic of SARS-CoV-2 Spike HR1 in complex with HR2
0.0264.290.09 913-1025X-ray1.45hetero-1-1-merHHblits0.46
5evm.1.A
Fusion glycoprotein F0
Crystal Structure of Nipah Virus Fusion Glycoprotein in the Prefusion State
0.0022.560.10 867-1013X-ray3.37homo-trimer1 x NAG-NAG-BMA-MAN-MAN, 3 x NAG-NAG, 3 x NAG-NAG-MAN, 2 x NAG-NAG-MAN-MAN-MANHHblits0.31
5evm.1.C
Fusion glycoprotein F0
Crystal Structure of Nipah Virus Fusion Glycoprotein in the Prefusion State
0.0022.560.10 867-1013X-ray3.37homo-trimer1 x NAG-NAG-BMA-MAN-MAN, 3 x NAG-NAG, 3 x NAG-NAG-MAN, 2 x NAG-NAG-MAN-MAN-MANHHblits0.31
7ki4.1.A
Fusion glycoprotein F0
Structure of the NiV F glycoprotein in complex with the 12B2 neutralizing antibody
0.0022.560.10 867-1013EM0.00hetero-3-3-3-mer6 x NAG-NAG, 3 x NAG-NAG-BMA, 3 x NAG-NAG-BMA-MAN-MAN-FUCHHblits0.31
1x04.1.A
SH3-containing GRB2-like protein 2
Crystal structure of endophilin BAR domain (mutant)
0.0213.770.11 878-1023X-ray2.90homo-dimerHHblits0.27
4mod.1.A
HR1 of S protein, LINKER, HR2 of S protein
Structure of the MERS-CoV fusion core
0.0335.590.09 918-1039X-ray1.90homo-trimerHHblits0.37
6t3f.1.A
Fusion glycoprotein F0
Crystal structure Nipah virus fusion glycoprotein in complex with a neutralising Fab fragment
0.0023.200.10 867-1004X-ray3.20hetero-3-3-3-mer12 x NAG, 3 x NAG-NAGHHblits0.31
6tys.1.A
Fusion glycoprotein F0
A potent cross-neutralizing antibody targeting the fusion glycoprotein inhibits Nipah virus and Hendra virus infection
0.0023.200.10 867-1004EM0.00hetero-3-3-3-mer3 x NAG, 6 x NAG-NAG-MAN, 3 x NAG-NAG, 3 x BMA-MAN-MANHHblits0.31
6v1v.1.A
Vegetative insecticidal protein
VIP3B (VIP3B_2160) adapted for crystallization
0.0222.500.09 910-1032X-ray3.19homo-tetramerHHblits0.32
6v1v.1.C
Vegetative insecticidal protein
VIP3B (VIP3B_2160) adapted for crystallization
0.0122.500.09 910-1032X-ray3.19homo-tetramerHHblits0.32
6v1v.1.D
Vegetative insecticidal protein
VIP3B (VIP3B_2160) adapted for crystallization
0.0222.500.09 910-1032X-ray3.19homo-tetramerHHblits0.32
6yrg.1.A
Vegetative insecticidal protein
Vip3Bc1 tetramer in processed, activated state
0.0122.500.09 910-1032EM7.00homo-tetramerHHblits0.32
6yrf.1.B
Vegetative insecticidal protein
Vip3Bc1 tetramer
0.0122.500.09 910-1032EM0.00homo-tetramerHHblits0.32
6yrf.1.A
Vegetative insecticidal protein
Vip3Bc1 tetramer
0.0122.500.09 910-1032EM0.00homo-tetramerHHblits0.32
6yrg.1.B
Vegetative insecticidal protein
Vip3Bc1 tetramer in processed, activated state
0.0122.500.09 910-1032EM7.00homo-tetramerHHblits0.32
7wkk.1.I
MGC84997 protein
Cryo-EM structure of the IR subunit from X. laevis NPC
0.0114.170.10 911-1037EM4.20hetero-2-2-4-6-4-4-…HHblits0.27
7wkk.1.L
MGC84997 protein
Cryo-EM structure of the IR subunit from X. laevis NPC
0.0114.170.10 911-1037EM4.20hetero-2-2-4-6-4-4-…HHblits0.27
6tfk.1.A
Vegetative insecticidal protein
Vip3Aa toxin structure
0.0019.330.09 911-1032EM0.00homo-tetramer1 x MGHHblits0.32
6tfj.1.B
Vegetative insecticidal protein
Vip3Aa protoxin structure
0.0119.330.09 911-1032EM0.00homo-tetramerHHblits0.32
6tfj.1.A
Vegetative insecticidal protein
Vip3Aa protoxin structure
0.0219.330.09 911-1032EM0.00homo-tetramerHHblits0.32
6wf1.1.B
Hemagglutinin HA2 chain
Crystal Structure of Broadly Neutralizing Antibody 3I14 Bound to the Influenza A H10 Hemagglutinin
0.0020.660.10 949-1070X-ray4.19hetero-3-3-3-3-mer3 x NAGHHblits0.29
7sqc.322.A
FAP76
Ciliary C1 central pair apparatus isolated from Chlamydomonas reinhardtii
0.0114.400.10 912-1039EM0.00monomerHHblits0.27
7wxz.1.A
Spike protein S2'
Crystal structure of the recombinant protein HR121 from the S2 protein of SARS-CoV-2
0.0090.800.07 902-988X-ray2.41homo-dimerHHblits0.55
7wxz.1.B
Spike protein S2'
Crystal structure of the recombinant protein HR121 from the S2 protein of SARS-CoV-2
0.0190.800.07 902-988X-ray2.41homo-dimerHHblits0.55
7wxz.2.A
Spike protein S2'
Crystal structure of the recombinant protein HR121 from the S2 protein of SARS-CoV-2
0.0090.800.07 902-988X-ray2.41homo-dimerHHblits0.55
7wxz.2.B
Spike protein S2'
Crystal structure of the recombinant protein HR121 from the S2 protein of SARS-CoV-2
0.0090.800.07 902-988X-ray2.41homo-dimerHHblits0.55
7rzs.1.A
SARS-CoV-2 HR1 L938F linked to a scaffold,Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with L938F mutation
0.0180.900.07 900-988EM0.00hetero-3-3-merHHblits0.52
7rzs.1.B
SARS-CoV-2 HR1 L938F linked to a scaffold,Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with L938F mutation
0.0180.900.07 900-988EM0.00hetero-3-3-merHHblits0.52
7rzs.1.C
SARS-CoV-2 HR1 L938F linked to a scaffold,Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with L938F mutation
0.0180.900.07 900-988EM0.00hetero-3-3-merHHblits0.52
3rki.1.A
Fusion glycoprotein F0
Structural basis for immunization with post-fusion RSV F to elicit high neutralizing antibody titers
0.0116.530.10 869-1006X-ray3.20homo-trimer1 x NAG, 6 x NAG-NAGHHblits0.28
3rki.1.B
Fusion glycoprotein F0
Structural basis for immunization with post-fusion RSV F to elicit high neutralizing antibody titers
0.0116.530.10 869-1006X-ray3.20homo-trimer1 x NAG, 6 x NAG-NAGHHblits0.28
3rki.1.C
Fusion glycoprotein F0
Structural basis for immunization with post-fusion RSV F to elicit high neutralizing antibody titers
0.0116.530.10 869-1006X-ray3.20homo-trimer1 x NAG, 6 x NAG-NAGHHblits0.28
7rzt.1.A
SARS-CoV-2 HR1 S940F linked to a scaffold,Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with S940F mutation
0.0180.900.07 900-988EM0.00hetero-3-3-merHHblits0.52
7rzt.1.B
SARS-CoV-2 HR1 S940F linked to a scaffold,Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with S940F mutation
0.0180.900.07 900-988EM0.00hetero-3-3-merHHblits0.52
7rzt.1.C
SARS-CoV-2 HR1 S940F linked to a scaffold,Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with S940F mutation
0.0180.900.07 900-988EM0.00hetero-3-3-merHHblits0.52
7rzq.1.A
SARS-CoV-2 HR1 linked to a scaffold,Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex
0.0182.950.07 901-988EM0.00hetero-3-3-merHHblits0.52
7rzq.1.B
SARS-CoV-2 HR1 linked to a scaffold,Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex
0.0182.950.07 901-988EM0.00hetero-3-3-merHHblits0.52
7rzq.1.C
SARS-CoV-2 HR1 linked to a scaffold,Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex
0.0182.950.07 901-988EM0.00hetero-3-3-merHHblits0.52
7rzv.1.A
SARS-CoV-2 HR1 linked to a scaffold,Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with V1176F mutation
0.0182.950.07 901-988EM0.00hetero-3-3-merHHblits0.52
7rzv.1.B
SARS-CoV-2 HR1 linked to a scaffold,Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with V1176F mutation
0.0182.950.07 901-988EM0.00hetero-3-3-merHHblits0.52
7rzv.1.C
SARS-CoV-2 HR1 linked to a scaffold,Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with V1176F mutation
0.0182.950.07 901-988EM0.00hetero-3-3-merHHblits0.52
8czi.1.B
Scaffolded Spike protein S2' HR1
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with extended HR2
0.0182.950.07 901-988EM0.00hetero-3-3-merHHblits0.52
8czi.1.A
Scaffolded Spike protein S2' HR1
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with extended HR2
0.0182.950.07 901-988EM0.00hetero-3-3-merHHblits0.52
8czi.1.C
Scaffolded Spike protein S2' HR1
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with extended HR2
0.0182.950.07 901-988EM0.00hetero-3-3-merHHblits0.52
3u0c.1.A
Invasin ipaB
Crystal structure of N-terminal region of Type III Secretion First Translocator IpaB (residues 74-224)
0.0213.450.09 900-1034X-ray2.05monomerHHblits0.29
3u0c.2.A
Invasin ipaB
Crystal structure of N-terminal region of Type III Secretion First Translocator IpaB (residues 74-224)
0.0213.450.09 900-1034X-ray2.05monomerHHblits0.29
5k6f.1.A
Fusion glycoprotein F0
Crystal structure of prefusion-stabilized RSV F single-chain 9-19 DS-Cav1 variant.
0.0015.830.09 812-955X-ray2.59homo-trimerHHblits0.28
8fa1.1.A
Ferritin, Dps family protein and Spike protein S2' chimera
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with N969K mutation
0.0181.820.07 901-988EM0.00hetero-3-3-merHHblits0.52
8fa1.1.B
Ferritin, Dps family protein and Spike protein S2' chimera
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with N969K mutation
0.0181.820.07 901-988EM0.00hetero-3-3-merHHblits0.52
8fa1.1.C
Ferritin, Dps family protein and Spike protein S2' chimera
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with N969K mutation
0.0181.820.07 901-988EM0.00hetero-3-3-merHHblits0.52
7tik.1.A
Ferritin, Dps family protein and Spike protein S2' chimera
Structure of the SARS-CoV-2 Omicron spike post-fusion bundle
0.0178.650.07 900-988EM0.00hetero-3-3-merHHblits0.51
7tik.1.B
Ferritin, Dps family protein and Spike protein S2' chimera
Structure of the SARS-CoV-2 Omicron spike post-fusion bundle
0.0178.650.07 900-988EM0.00hetero-3-3-merHHblits0.51
7tik.1.C
Ferritin, Dps family protein and Spike protein S2' chimera
Structure of the SARS-CoV-2 Omicron spike post-fusion bundle
0.0178.650.07 900-988EM0.00hetero-3-3-merHHblits0.51
8fa2.1.A
Scaffolded Spike protein S2' HR1
Cryo-EM structure of the SARS-CoV-2 Omicron HR1-42G complex
0.0178.650.07 900-988EM0.00hetero-3-3-merHHblits0.51
8fa2.1.B
Scaffolded Spike protein S2' HR1
Cryo-EM structure of the SARS-CoV-2 Omicron HR1-42G complex
0.0178.650.07 900-988EM0.00hetero-3-3-merHHblits0.51
8fa2.1.C
Scaffolded Spike protein S2' HR1
Cryo-EM structure of the SARS-CoV-2 Omicron HR1-42G complex
0.0178.650.07 900-988EM0.00hetero-3-3-merHHblits0.51
7rzr.1.A
SARS-CoV-2 HR1 D936Y linked to a scaffold,Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with D936Y mutation
0.0181.820.07 901-988EM0.00hetero-3-3-merHHblits0.52
7rzr.1.B
SARS-CoV-2 HR1 D936Y linked to a scaffold,Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with D936Y mutation
0.0181.820.07 901-988EM0.00hetero-3-3-merHHblits0.52
7rzr.1.C
SARS-CoV-2 HR1 D936Y linked to a scaffold,Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with D936Y mutation
0.0181.820.07 901-988EM0.00hetero-3-3-merHHblits0.52
7rzu.1.A
SARS-CoV-2 HR1 A942S linked to a scaffold,Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with A942S mutation
0.0182.760.07 902-988EM0.00hetero-3-3-merHHblits0.52
7rzu.1.B
SARS-CoV-2 HR1 A942S linked to a scaffold,Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with A942S mutation
0.0182.760.07 902-988EM0.00hetero-3-3-merHHblits0.52
7rzu.1.C
SARS-CoV-2 HR1 A942S linked to a scaffold,Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with A942S mutation
0.0182.760.07 902-988EM0.00hetero-3-3-merHHblits0.52
2d1l.1.A
Metastasis suppressor protein 1
Structure of F-actin binding domain IMD of MIM (Missing In Metastasis)
0.0215.380.09 916-1037X-ray1.85homo-dimerHHblits0.28
2d1l.1.B
Metastasis suppressor protein 1
Structure of F-actin binding domain IMD of MIM (Missing In Metastasis)
0.0215.380.09 916-1037X-ray1.85homo-dimerHHblits0.28
5k6b.1.A
Fusion glycoprotein F0
Crystal structure of prefusion-stabilized RSV F single-chain 9 DS-Cav1 variant.
0.0015.520.09 812-955X-ray2.98homo-trimer3 x NAGHHblits0.28
3c98.1.B
Syntaxin-1A
Revised structure of the munc18a-syntaxin1 complex
0.019.320.09 914-1034X-ray2.60hetero-oligomerHHblits0.26
5k6h.1.A
Fusion glycoprotein F0
Crystal structure of prefusion-stabilized RSV F single-chain 9-10 DS-Cav1 A149C-Y458C variant.
0.0016.670.09 812-955X-ray2.65homo-trimerHHblits0.29
5k6i.1.A
Fusion glycoprotein F0
Crystal structure of prefusion-stabilized RSV F single-chain 9-10 DS-Cav1 A149C-Y458C, S46G-E92D-S215P-K465Q variant.
0.0015.790.09 812-955X-ray2.92homo-trimer6 x ZN, 6 x NAGHHblits0.28
5k6c.1.A
Fusion glycoprotein F0,Fusion glycoprotein F0
Crystal structure of prefusion-stabilized RSV F single-chain 9-10 DS-Cav1 variant.
0.0015.790.09 812-955X-ray3.58homo-trimerHHblits0.28
5k6g.1.A
Fusion glycoprotein F0,Fusion glycoprotein F0
Crystal structure of prefusion-stabilized RSV F single-chain 9-24 DS-Cav1 variant.
0.0015.790.09 812-955X-ray2.90homo-trimerHHblits0.28
5zvm.1.A
Spike glycoprotein
Crystal Structure of the Human Coronavirus SARS HR1 motif in complex with pan-CoVs inhibitor EK1
0.0088.610.06 910-988X-ray3.30hetero-3-3-merHHblits0.55
5zvm.1.B
Spike glycoprotein
Crystal Structure of the Human Coronavirus SARS HR1 motif in complex with pan-CoVs inhibitor EK1
0.0088.610.06 910-988X-ray3.30hetero-3-3-merHHblits0.55
4jeu.1.B
Syntaxin-1A
Crystal Structure of Munc18a and Syntaxin1 with native N-terminus complex
0.0110.710.09 920-1034X-ray3.20hetero-oligomerHHblits0.27
1wnc.1.A
E2 glycoprotein
Crystal structure of the SARS-CoV Spike protein fusion core
0.0148.420.07 918-1018X-ray2.80homo-hexamerHHblits0.39
1wnc.1.B
E2 glycoprotein
Crystal structure of the SARS-CoV Spike protein fusion core
0.0148.420.07 918-1018X-ray2.80homo-hexamerHHblits0.39
1wnc.1.C
E2 glycoprotein
Crystal structure of the SARS-CoV Spike protein fusion core
0.0148.420.07 918-1018X-ray2.80homo-hexamerHHblits0.39
1wnc.1.D
E2 glycoprotein
Crystal structure of the SARS-CoV Spike protein fusion core
0.0148.420.07 918-1018X-ray2.80homo-hexamerHHblits0.39
1wnc.1.E
E2 glycoprotein
Crystal structure of the SARS-CoV Spike protein fusion core
0.0048.420.07 918-1018X-ray2.80homo-hexamerHHblits0.39
1wnc.1.F
E2 glycoprotein
Crystal structure of the SARS-CoV Spike protein fusion core
0.0148.420.07 918-1018X-ray2.80homo-hexamerHHblits0.39
2bez.1.A
Spike glycoprotein
Structure of a proteolitically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein
0.0088.310.06 914-990X-ray1.60hetero-3-3-merHHblits0.55
4jeh.1.B
Syntaxin-1A
Crystal Structure of Munc18a and Syntaxin1 lacking N-peptide complex
0.0110.000.09 923-1035X-ray2.50hetero-oligomerHHblits0.27
7xsj.1.B
Syntaxin-1A
The structure of the Mint1/Munc18-1/syntaxin-1 complex
0.0110.190.08 924-1034X-ray3.20hetero-1-1-1-merHHblits0.27
3ghg.1.B
Fibrinogen beta chain
Crystal Structure of Human Fibrinogen
0.0111.320.08 915-1025X-ray2.90hetero-2-2-2-mer4 x CA, 2 x GLY-PRO-ARG-PRO, 2 x GLY-HIS-ARG-PRO, 2 x NAG-NAG-BMA-MAN-NAG-GAL-SIA-MAN-NAG-GAL-SIAHHblits0.27
3ghg.1.E
Fibrinogen beta chain
Crystal Structure of Human Fibrinogen
0.0111.320.08 915-1025X-ray2.90hetero-2-2-2-mer4 x CA, 2 x GLY-PRO-ARG-PRO, 2 x GLY-HIS-ARG-PRO, 2 x NAG-NAG-BMA-MAN-NAG-GAL-SIA-MAN-NAG-GAL-SIAHHblits0.27
3ghg.2.B
Fibrinogen beta chain
Crystal Structure of Human Fibrinogen
0.0111.320.08 915-1025X-ray2.90hetero-2-2-2-mer4 x CA, 2 x GLY-PRO-ARG-PRO, 2 x GLY-HIS-ARG-PRO, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-MAN-NAG-GAL-SIA-MAN-NAG-GAL-SIA, 1 x NAG-NAGHHblits0.27
3ghg.2.E
Fibrinogen beta chain
Crystal Structure of Human Fibrinogen
0.0111.320.08 915-1025X-ray2.90hetero-2-2-2-mer4 x CA, 2 x GLY-PRO-ARG-PRO, 2 x GLY-HIS-ARG-PRO, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-MAN-NAG-GAL-SIA-MAN-NAG-GAL-SIA, 1 x NAG-NAGHHblits0.27
7tdz.1.2
Nup88A protein
Cryo-EM model of protomer of the cytoplasmic ring of the nuclear pore complex from Xenopus laevis
0.028.570.08 900-1011EM0.00hetero-2-2-2-2-2-2-…HHblits0.27
7vop.1.3
Nup88A protein
Cryo-EM structure of Xenopus laevis nuclear pore complex cytoplasmic ring subunit
0.018.570.08 900-1011EM0.00hetero-2-2-2-2-2-2-…HHblits0.27
7vop.1.1
Nup88A protein
Cryo-EM structure of Xenopus laevis nuclear pore complex cytoplasmic ring subunit
0.018.570.08 900-1011EM0.00hetero-2-2-2-2-2-2-…HHblits0.27
3h32.1.B
Fibrinogen beta chain
Crystal structure of D-dimer from human fibrin complexed with Gly-His-Arg-Pro-Tyr-amide
0.0011.650.08 916-1023X-ray3.60hetero-2-2-2-mer4 x CA, 2 x GLY-HIS-ARG-PRO-TYR, 2 x NAG-NAG-MAN-MAN-NAG-GAL-SIA-MANHHblits0.27
7tbi.24.A
Nup49
Composite structure of the S. cerevisiae nuclear pore complex (NPC)
0.0116.160.08 900-1010EM0.00monomerHHblits0.29
5cws.1.E
Nucleoporin NUP57
Crystal structure of the intact Chaetomium thermophilum Nsp1-Nup49-Nup57 channel nucleoporin heterotrimer bound to its Nic96 nuclear pore complex attachment site
0.0116.160.08 900-1010X-ray3.77hetero-1-1-1-1-1-1-…1 x OSHHblits0.29
5cws.2.E
Nucleoporin NUP57
Crystal structure of the intact Chaetomium thermophilum Nsp1-Nup49-Nup57 channel nucleoporin heterotrimer bound to its Nic96 nuclear pore complex attachment site
0.0116.160.08 900-1010X-ray3.77hetero-1-1-1-1-1-1-…1 x OSHHblits0.29
7c53.1.A
Spike protein S2',pan-CoVs inhibitor EK1
Crystal Structure of SARS-CoV-2 HR1 motif in complex with pan-CoVs inhibitor EK1
0.0092.960.06 910-980X-ray2.28homo-trimerHHblits0.55
7c53.1.B
Spike protein S2',pan-CoVs inhibitor EK1
Crystal Structure of SARS-CoV-2 HR1 motif in complex with pan-CoVs inhibitor EK1
0.0092.960.06 910-980X-ray2.28homo-trimerHHblits0.55
7c53.1.C
Spike protein S2',pan-CoVs inhibitor EK1
Crystal Structure of SARS-CoV-2 HR1 motif in complex with pan-CoVs inhibitor EK1
0.0092.960.06 910-980X-ray2.28homo-trimerHHblits0.55
7c53.2.A
Spike protein S2',pan-CoVs inhibitor EK1
Crystal Structure of SARS-CoV-2 HR1 motif in complex with pan-CoVs inhibitor EK1
0.0092.960.06 910-980X-ray2.28homo-trimer2 x CAHHblits0.55
7c53.2.B
Spike protein S2',pan-CoVs inhibitor EK1
Crystal Structure of SARS-CoV-2 HR1 motif in complex with pan-CoVs inhibitor EK1
0.0092.960.06 910-980X-ray2.28homo-trimer2 x CAHHblits0.55
7c53.2.C
Spike protein S2',pan-CoVs inhibitor EK1
Crystal Structure of SARS-CoV-2 HR1 motif in complex with pan-CoVs inhibitor EK1
0.0092.960.06 910-980X-ray2.28homo-trimer2 x CAHHblits0.55
5cws.1.C
Nucleoporin NSP1
Crystal structure of the intact Chaetomium thermophilum Nsp1-Nup49-Nup57 channel nucleoporin heterotrimer bound to its Nic96 nuclear pore complex attachment site
0.0115.310.08 909-1006X-ray3.77hetero-1-1-1-1-1-1-…1 x OSHHblits0.30
5cws.2.C
Nucleoporin NSP1
Crystal structure of the intact Chaetomium thermophilum Nsp1-Nup49-Nup57 channel nucleoporin heterotrimer bound to its Nic96 nuclear pore complex attachment site
0.0115.310.08 909-1006X-ray3.77hetero-1-1-1-1-1-1-…1 x OSHHblits0.30
4njl.1.A
S protein
Crystal structure of middle east respiratory syndrome coronavirus S2 protein fusion core
0.0155.000.06 910-987X-ray2.30homo-trimerHHblits0.45
5ijn.1.H
Nuclear pore glycoprotein p62
Composite structure of the inner ring of the human nuclear pore complex (32 copies of Nup205)
0.0020.210.07 911-1005EM0.00hetero-6-4-4-4-4-4-…HHblits0.32
7r5k.53.A
Nuclear pore glycoprotein p62
Human nuclear pore complex (constricted)
0.0120.210.07 911-1005EM0.00monomerHHblits0.32
7r5k.54.A
Nuclear pore glycoprotein p62
Human nuclear pore complex (constricted)
0.0120.210.07 911-1005EM0.00monomerHHblits0.32
5zvk.1.A
Human Coronavirus MERS HR1 motif
Crystal Structure of the Human Coronavirus MERS HR1 motif in complex with pan-CoVs inhibitor EK1
0.0155.700.06 910-988X-ray3.31hetero-3-3-merHHblits0.45
5zvk.1.B
Human Coronavirus MERS HR1 motif
Crystal Structure of the Human Coronavirus MERS HR1 motif in complex with pan-CoVs inhibitor EK1
0.0155.700.06 910-988X-ray3.31hetero-3-3-merHHblits0.45
5zvk.1.C
Human Coronavirus MERS HR1 motif
Crystal Structure of the Human Coronavirus MERS HR1 motif in complex with pan-CoVs inhibitor EK1
0.0055.700.06 910-988X-ray3.31hetero-3-3-merHHblits0.45
4j2c.1.A
Syntaxin-6
GARP-SNARE Interaction
0.0114.580.08 926-1021X-ray1.80hetero-oligomerHHblits0.29
4dnd.1.A
Syntaxin-10
Crystal structure of syntaxin 10 from Homo sapiens
0.0117.890.07 926-1020X-ray1.40monomerHHblits0.30
5zuv.1.A
Spike glycoprotein,Spike glycoprotein,inhibitor EK1
Crystal Structure of the Human Coronavirus 229E HR1 motif in complex with pan-CoVs inhibitor EK1
0.0245.780.07 914-996X-ray2.21homo-trimerHHblits0.41
5zuv.1.B
Spike glycoprotein,Spike glycoprotein,inhibitor EK1
Crystal Structure of the Human Coronavirus 229E HR1 motif in complex with pan-CoVs inhibitor EK1
0.0245.780.07 914-996X-ray2.21homo-trimerHHblits0.41
5zuv.1.C
Spike glycoprotein,Spike glycoprotein,inhibitor EK1
Crystal Structure of the Human Coronavirus 229E HR1 motif in complex with pan-CoVs inhibitor EK1
0.0145.780.07 914-996X-ray2.21homo-trimerHHblits0.41
7wkk.1.U
IL4I1 protein
Cryo-EM structure of the IR subunit from X. laevis NPC
0.0115.960.07 913-1006EM4.20hetero-2-2-4-6-4-4-…HHblits0.31
7wkk.1.X
IL4I1 protein
Cryo-EM structure of the IR subunit from X. laevis NPC
0.0115.960.07 913-1006EM4.20hetero-2-2-4-6-4-4-…HHblits0.31
7tdz.1.5
Nup62
Cryo-EM model of protomer of the cytoplasmic ring of the nuclear pore complex from Xenopus laevis
0.0115.960.07 913-1006EM0.00hetero-2-2-2-2-2-2-…HHblits0.31
7vop.1.5
IL4I1 protein
Cryo-EM structure of Xenopus laevis nuclear pore complex cytoplasmic ring subunit
0.0015.960.07 913-1006EM0.00hetero-2-2-2-2-2-2-…HHblits0.31
7vop.1.2
IL4I1 protein
Cryo-EM structure of Xenopus laevis nuclear pore complex cytoplasmic ring subunit
0.0115.960.07 913-1006EM0.00hetero-2-2-2-2-2-2-…HHblits0.31
7wot.1.S
Nucleoporin NUP57
Cryo-EM structure of the inner ring monomer of the Saccharomyces cerevisiae nuclear pore complex
0.0112.120.08 920-1019EM0.00hetero-4-2-2-2-2-4-…HHblits0.26
7n85.1.L
Nucleoporin NUP57
Inner ring spoke from the isolated yeast NPC
0.0012.120.08 920-1019EM0.00hetero-2-2-2-4-4-4-…HHblits0.26
7n85.1.O
Nucleoporin NUP57
Inner ring spoke from the isolated yeast NPC
0.0012.120.08 920-1019EM0.00hetero-2-2-2-4-4-4-…HHblits0.26
7n9f.1.F
Nucleoporin NUP57
Structure of the in situ yeast NPC
0.0012.120.08 920-1019EM0.00hetero-2-2-2-6-4-4-…HHblits0.26
7n9f.1.I
Nucleoporin NUP57
Structure of the in situ yeast NPC
0.0012.120.08 920-1019EM0.00hetero-2-2-2-6-4-4-…HHblits0.26
7n9f.1.L
Nucleoporin NUP57
Structure of the in situ yeast NPC
0.0012.120.08 920-1019EM0.00hetero-2-2-2-6-4-4-…HHblits0.26
7n9f.1.O
Nucleoporin NUP57
Structure of the in situ yeast NPC
0.0012.120.08 920-1019EM0.00hetero-2-2-2-6-4-4-…HHblits0.26
7n85.1.F
Nucleoporin NUP57
Inner ring spoke from the isolated yeast NPC
0.0012.120.08 920-1019EM0.00hetero-2-2-2-4-4-4-…HHblits0.26
7wot.1.J
Nucleoporin NUP57
Cryo-EM structure of the inner ring monomer of the Saccharomyces cerevisiae nuclear pore complex
0.0112.120.08 920-1019EM0.00hetero-4-2-2-2-2-4-…HHblits0.26
7n85.1.I
Nucleoporin NUP57
Inner ring spoke from the isolated yeast NPC
0.0012.120.08 920-1019EM0.00hetero-2-2-2-4-4-4-…HHblits0.26
7wot.1.V
Nucleoporin NUP57
Cryo-EM structure of the inner ring monomer of the Saccharomyces cerevisiae nuclear pore complex
0.0112.120.08 920-1019EM0.00hetero-4-2-2-2-2-4-…HHblits0.26
1eq1.1.A
APOLIPOPHORIN-III
NMR STRUCTURE OF AN EXCHANGEABLE APOLIPOPROTEIN-MANDUCA SEXTA APOLIPOPHORIN-III
0.0117.890.07 914-1013NMR0.00monomerHHblits0.30
7ki6.1.A
Fusion glycoprotein F0
Structure of the HeV F glycoprotein in complex with the 1F5 neutralizing antibody
0.0022.580.07 867-972EM0.00hetero-3-3-3-mer6 x NAG, 6 x NAG-NAGHHblits0.31
5ejb.1.A
Fusion glycoprotein F0
Crystal structure of prefusion Hendra virus F protein
0.0022.580.07 867-972X-ray3.20homo-trimer3 x NAG, 2 x NAG-NAGHHblits0.31
1lvf.1.A
syntaxin 6
syntaxin 6
0.0114.890.07 927-1020X-ray2.10monomerHHblits0.29
1lvf.2.A
syntaxin 6
syntaxin 6
0.0114.890.07 927-1020X-ray2.10monomerHHblits0.29
7lze.1.A
Fusion glycoprotein F0
Cryo-EM Structure of disulfide stabilized HMPV F v4-B
0.0014.430.08 869-978EM0.00homo-trimer3 x NAG, 3 x NAG-NAGHHblits0.27
2ykt.1.A
BRAIN-SPECIFIC ANGIOGENESIS INHIBITOR 1-ASSOCIATED PROTEIN 2
Crystal structure of the I-BAR domain of IRSp53 (BAIAP2) in complex with an EHEC derived Tir peptide
0.0113.830.07 918-1017X-ray2.11hetero-oligomerHHblits0.29
1y2o.1.A
BAI1-associated protein 2 isoform 1
Structure of N-terminal domain IRSp53/BAIAP2
0.0113.830.07 918-1017X-ray2.20homo-dimerHHblits0.29
1y2o.1.B
BAI1-associated protein 2 isoform 1
Structure of N-terminal domain IRSp53/BAIAP2
0.0113.830.07 918-1017X-ray2.20homo-dimerHHblits0.29
6o3e.1.A
Catenin alpha-1
mouse aE-catenin 82-883
0.0118.090.07 936-1036X-ray4.00homo-dimerHHblits0.29
6o3e.1.B
Catenin alpha-1
mouse aE-catenin 82-883
0.0118.090.07 936-1036X-ray4.00homo-dimerHHblits0.29
5xa5.1.A
Alpha-catenin-like protein hmp-1
Crystal structure of HMP-1-HMP-2 complex
0.0117.390.07 936-1034X-ray1.60hetero-1-1-merHHblits0.29
3ghg.1.A
Fibrinogen alpha chain
Crystal Structure of Human Fibrinogen
0.0117.580.07 926-1019X-ray2.90hetero-2-2-2-mer4 x CA, 2 x GLY-PRO-ARG-PRO, 2 x GLY-HIS-ARG-PRO, 2 x NAG-NAG-BMA-MAN-NAG-GAL-SIA-MAN-NAG-GAL-SIAHHblits0.30
3ghg.1.D
Fibrinogen alpha chain
Crystal Structure of Human Fibrinogen
0.0017.580.07 926-1019X-ray2.90hetero-2-2-2-mer4 x CA, 2 x GLY-PRO-ARG-PRO, 2 x GLY-HIS-ARG-PRO, 2 x NAG-NAG-BMA-MAN-NAG-GAL-SIA-MAN-NAG-GAL-SIAHHblits0.30
3ghg.2.A
Fibrinogen alpha chain
Crystal Structure of Human Fibrinogen
0.0117.580.07 926-1019X-ray2.90hetero-2-2-2-mer4 x CA, 2 x GLY-PRO-ARG-PRO, 2 x GLY-HIS-ARG-PRO, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-MAN-NAG-GAL-SIA-MAN-NAG-GAL-SIA, 1 x NAG-NAGHHblits0.30
3ghg.2.D
Fibrinogen alpha chain
Crystal Structure of Human Fibrinogen
0.0117.580.07 926-1019X-ray2.90hetero-2-2-2-mer4 x CA, 2 x GLY-PRO-ARG-PRO, 2 x GLY-HIS-ARG-PRO, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-MAN-NAG-GAL-SIA-MAN-NAG-GAL-SIA, 1 x NAG-NAGHHblits0.30
2ieq.1.A
Spike glycoprotein
Core Structure of S2 from the Human Coronavirus NL63 Spike Glycoprotein
0.0135.710.07 921-1004X-ray1.75homo-trimerHHblits0.35
5jst.1.A
Maltose-binding periplasmic protein,Mitochondrial division protein 1
MBP fused MDV1 coiled coil
0.0118.480.07 924-1018X-ray2.20homo-dimer2 x GLC-GLCHHblits0.28
7uyi.1.B
COBRA P1 HA
Crystal structure of the computationally optimized broadly reactive H1 influenza hemagglutinin P1
0.0014.610.07 945-1033X-ray3.00homo-trimer9 x NAG, 1 x NAG-NAG-BMA-MAN, 3 x NAG-NAG, 1 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-MANHHblits0.30
7uyi.1.A
COBRA P1 HA
Crystal structure of the computationally optimized broadly reactive H1 influenza hemagglutinin P1
0.0014.610.07 945-1033X-ray3.00homo-trimer9 x NAG, 1 x NAG-NAG-BMA-MAN, 3 x NAG-NAG, 1 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-MANHHblits0.30
8ct6.1.A
COBRA P1 HA
1F8 mAb in complex with the computationally optimized broadly reactive H1 influenza hemagglutinin P1
0.0014.610.07 946-1034EM0.00hetero-3-2-2-mer10 x NAG, 1 x NAG-NAG-BMA, 1 x NAG-NAG, 2 x NAG-NAG-BMA-MANHHblits0.30
8ct6.1.B
COBRA P1 HA
1F8 mAb in complex with the computationally optimized broadly reactive H1 influenza hemagglutinin P1
0.0014.610.07 946-1034EM0.00hetero-3-2-2-mer10 x NAG, 1 x NAG-NAG-BMA, 1 x NAG-NAG, 2 x NAG-NAG-BMA-MANHHblits0.30
8ct6.1.C
COBRA P1 HA
1F8 mAb in complex with the computationally optimized broadly reactive H1 influenza hemagglutinin P1
0.0014.610.07 946-1034EM0.00hetero-3-2-2-mer10 x NAG, 1 x NAG-NAG-BMA, 1 x NAG-NAG, 2 x NAG-NAG-BMA-MANHHblits0.30
5xjk.1.A
Spike protein S2
NMR Structure and Localization of a Large Fragment of the SARS-CoV Fusion Protein: Implications in Viral Cell Fusion
0.0084.130.05 777-839NMR0.00monomerHHblits0.56
6osr.1.A
Hemagglutinin
Crystal structure of Influenza hemagglutinin from strain A/Melbourne/1/1946(H1N1)
0.0014.610.07 947-1035X-ray2.55homo-trimer10 x NAG, 1 x K, 1 x NAG-NAG-BMA-MANHHblits0.29
8dim.1.A
hemagglutinin
CryoEM structure of Influenza A virus A/Ohio/09/2015 hemagglutinin bound to CR6261 Fab
0.0012.220.07 946-1035EM0.00hetero-3-3-3-mer9 x NAG, 3 x NAG-NAG-BMAHHblits0.28
7mfg.1.B
Hemagglutinin HA2 chain
Cryo-EM structure of the VRC310 clinical trial, vaccine-elicited, human antibody 310-030-1D06 Fab in complex with an H1 NC99 HA trimer
0.0014.610.07 947-1035EM0.00hetero-3-3-3-3-mer21 x NAG, 3 x NAG-NAG-BMAHHblits0.29
8d21.1.A
Hemagglutinin HA2 chain
Cryo-EM structure of the VRC321 clinical trial, vaccine-elicited, human antibody 1B06 in complex with a stabilized NC99 HA trimer
0.0014.610.07 947-1035EM0.00hetero-3-3-3-3-mer21 x NAG, 3 x NAG-NAG-BMAHHblits0.29
5yl9.1.A
Spike glycoprotein
1.86 Angstrom crystal structure of human Coronavirus 229E fusion core
0.0149.330.06 913-987X-ray1.86hetero-3-3-merHHblits0.42
4f15.2.A
Hemagglutinin
Molecular basis of infectivity of 2009 pandemic H1N1 influenza A viruses
0.0013.640.07 946-1033X-ray2.81hetero-oligomerHHblits0.30
4f15.4.A
Hemagglutinin
Molecular basis of infectivity of 2009 pandemic H1N1 influenza A viruses
0.0013.640.07 946-1033X-ray2.81hetero-oligomerHHblits0.30
5k9o.1.C
Hemagglutinin
Crystal structure of multidonor HV1-18+HD3-9 class broadly neutralizing Influenza A antibody 31.b.09 in complex with Hemagglutinin H1 A/California/04/2009
0.0013.640.07 946-1033X-ray3.39hetero-2-2-2-merHHblits0.30
5k9o.1.E
Hemagglutinin
Crystal structure of multidonor HV1-18+HD3-9 class broadly neutralizing Influenza A antibody 31.b.09 in complex with Hemagglutinin H1 A/California/04/2009
0.0013.640.07 946-1033X-ray3.39hetero-2-2-2-merHHblits0.30
6in5.1.A
Hemagglutinin
Crystal structure of H5N2 hemagglutinin G228S Q226L mutant with 3SLN from A/chicken/Taiwan/0502/2012
0.0014.770.07 948-1035X-ray2.92homo-trimer3 x GAL-SIAHHblits0.30
6kcj.1.A
Hemagglutinin
Crystal structure of H5N2 hemagglutinin Apo-Q226L mutant from A/chicken/Taiwan/0502/2012
0.0014.770.07 948-1035X-ray2.46homo-trimer3 x NAGHHblits0.30
5ykc.1.A
Hemagglutinin
crystal structure of H5 hemagglutinin from A/chicken/Taiwan/0502/2012
0.0014.770.07 948-1035X-ray2.82homo-trimer12 x NAG, 1 x NAG-NAGHHblits0.30
5ykc.1.B
Hemagglutinin
crystal structure of H5 hemagglutinin from A/chicken/Taiwan/0502/2012
0.0014.770.07 948-1035X-ray2.82homo-trimer12 x NAG, 1 x NAG-NAGHHblits0.30
5ykc.1.C
Hemagglutinin
crystal structure of H5 hemagglutinin from A/chicken/Taiwan/0502/2012
0.0014.770.07 948-1035X-ray2.82homo-trimer12 x NAG, 1 x NAG-NAGHHblits0.30
6iig.1.B
Hemagglutinin
crystal structure of H5N2 hemagglutinin G228S mutant With 6SLN from A/chicken/Taiwan/0502/2012
0.0014.770.07 948-1035X-ray3.21homo-trimer3 x GAL-SIAHHblits0.30
5z88.1.B
Hemagglutinin
Crystal structure of H5 hemagglutinin G228S mutant with 3SLN from A/chicken/Taiwan/0502/2012
0.0014.770.07 948-1035X-ray3.00homo-trimer3 x GAL-SIAHHblits0.30
6ona.1.A
Hemagglutinin
Crystal structure of Influenza hemagglutinin from strain A/Hickox/JY2/1940
0.0014.770.07 948-1035X-ray1.95homo-trimer11 x NAG, 2 x NAG-NAG-BMA, 2 x NAG-NAGHHblits0.29
8diu.1.A
hemagglutinin
Cryo-EM structure of influenza A virus A/Bayern/7/1995 hemagglutinin bound to CR6261 Fab
0.0014.770.07 948-1035EM0.00hetero-3-3-3-mer21 x NAG, 3 x NAG-NAG-BMA, 3 x NAG-NAGHHblits0.29
6xsk.1.D
Hemagglutinin HA2 chain
Cryo-EM Structure of Vaccine-Elicited Rhesus Antibody 789-203-3C12 in Complex with Stabilized SI06 (A/Solomon Islands/3/06) Influenza Hemagglutinin Trimer
0.0014.770.07 948-1035EM0.00hetero-3-3-3-3-mer15 x NAG, 3 x NAG-NAG-BMA, 6 x NAG-NAGHHblits0.29
6xsk.1.F
Hemagglutinin HA2 chain
Cryo-EM Structure of Vaccine-Elicited Rhesus Antibody 789-203-3C12 in Complex with Stabilized SI06 (A/Solomon Islands/3/06) Influenza Hemagglutinin Trimer
0.0014.770.07 948-1035EM0.00hetero-3-3-3-3-mer15 x NAG, 3 x NAG-NAG-BMA, 6 x NAG-NAGHHblits0.29
6xsk.1.H
Hemagglutinin HA2 chain
Cryo-EM Structure of Vaccine-Elicited Rhesus Antibody 789-203-3C12 in Complex with Stabilized SI06 (A/Solomon Islands/3/06) Influenza Hemagglutinin Trimer
0.0014.770.07 948-1035EM0.00hetero-3-3-3-3-mer15 x NAG, 3 x NAG-NAG-BMA, 6 x NAG-NAGHHblits0.29
1dov.1.A
ALPHA-CATENIN
CRYSTAL STRUCTURE OF THE ALPHA-CATENIN DIMERIZATION DOMAIN
0.0016.090.07 937-1034X-ray3.00homo-dimerHHblits0.30
6xgc.1.B
Hemagglutinin HA2 chain
CryoEM structure of influenza hemagglutinin A/Michigan/45/2015 in complex with cyno antibody 1C4
0.0013.790.07 948-1034EM0.00hetero-3-3-3-3-mer15 x NAG, 3 x NAG-NAGHHblits0.30
6s7o.1.E
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1
Cryo-EM structure of human oligosaccharyltransferase complex OST-A
0.0021.180.07 940-1033EM0.00hetero-1-1-1-1-1-1-…9 x KZB, 7 x EGY, 2 x MG, 1 x KZE, 1 x NAG-NAG-BMA, 2 x NAG-NAG-BMA-MAN-MAN-MAN-MAN-MANHHblits0.32
8b6l.1.O
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1
Subtomogram average of the human Sec61-TRAP-OSTA-translocon
0.0121.180.07 940-1033EM0.00hetero-1-1-1-1-1-1-…HHblits0.32
6ntf.1.A
Hemagglutinin
Crystal structure of a computationally optimized H5 influenza hemagglutinin
0.0011.240.07 947-1035X-ray2.80homo-trimer9 x NAG, 12 x MG, 6 x NAG-NAGHHblits0.28
1wdf.1.A
E2 glycoprotein
crystal structure of MHV spike protein fusion core
0.0051.350.06 919-992X-ray2.50homo-hexamerHHblits0.42
1wdf.1.B
E2 glycoprotein
crystal structure of MHV spike protein fusion core
0.0151.350.06 919-992X-ray2.50homo-hexamerHHblits0.42
6mya.1.A
Hemagglutinin
Crystal structure of InvbP.18715.a.KN11: Influenza hemagglutinin from strain A/Almaty/32/1998
0.0013.790.07 947-1033X-ray2.05homo-trimer11 x NAG, 1 x NAG-NAGHHblits0.30
7zj6.1.A
Hemagglutinin,Fibritin
X-31 Hemagglutinin Precursor HA0 at pH 7.5
0.0017.050.07 948-1035EM0.00homo-trimer6 x NAG, 3 x NAG-NAG, 3 x NAG-NAG-BMA-FUC, 3 x NAG-NAG-BMA-MAN-MAN, 3 x NAG-NAG-BMAHHblits0.28
7zj7.1.A
Hemagglutinin,Fibritin
X-31 Hemagglutinin Precursor HA0 at pH 4.8
0.0017.050.07 948-1035EM0.00homo-trimer3 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMA-FUC, 3 x NAG-NAG-BMAHHblits0.28
7zj8.1.A
Hemagglutinin,Fibritin
X-31 Hemagglutinin Precursor HA0 at pH 7.5 after reneutralization
0.0017.050.07 948-1035EM0.00homo-trimer6 x NAG, 3 x BOG, 3 x NAG-NAG, 3 x NAG-NAG-BMA-FUC, 3 x NAG-NAG-BMA-MAN-MAN, 3 x NAG-NAG-BMAHHblits0.28
6m1v.1.A
Spike protein S2,Spike protein S2
Crystal structure of post fusion core of 2019-nCoV S2 subunit
0.0077.940.05 918-985X-ray1.50homo-trimerHHblits0.48
6pdx.1.A
Hemagglutinin
Crystal structure of C585 Fab in complex with influenza virus hemagglutinin from A/Switzerland/9715293/2013 (H3N2)
0.0018.390.07 946-1032X-ray3.99hetero-3-3-3-mer1 x NAG, 13 x NAG-NAG-BMA, 5 x NAG-NAGHHblits0.29
7umm.1.A
Hemagglutinin
H1 Solomon Islands 2006 hemagglutinin in complex with Ab109
0.0015.120.07 948-1033EM0.00hetero-3-3-3-mer6 x NAG, 3 x NAG-NAGHHblits0.30
7umn.1.A
Hemagglutinin
H1 Solomon Islands 2006 hemagglutinin in complex with Ab36
0.0015.120.07 948-1033EM0.00hetero-3-3-3-merHHblits0.30
6fyt.1.E
Hemagglutinin
Structure of H1 (A/solomon Islands/3/06) Influenza Hemagglutinin in complex with SD38
0.0015.120.07 948-1033X-ray2.80hetero-3-3-3-mer9 x NAG, 6 x NAG-FUC-NAG-FUC, 6 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.30
6cf7.1.D
Hemagglutinin
Crystal structure of the A/Solomon Islands/3/2006(H1N1) influenza virus hemagglutinin in complex with small molecule JNJ4796
0.0015.120.07 948-1033X-ray2.72hetero-3-3-mer3 x NAG, 3 x EZ7, 3 x NAG-NAG-BMA-MAN, 3 x NAG-NAG-BMA, 6 x NAG-NAGHHblits0.30
7yhk.1.C
Hemagglutinin
Cryo-EM structure of the HA trimer of A/Beijing/262/1995(H1N1) in complex with neutralizing antibody 12H5
0.0015.120.07 948-1033EM0.00hetero-3-3-3-mer12 x NAG, 3 x NAG-NAGHHblits0.30
7scn.1.B
Hemagglutinin HA2 chain
Structure of H1 NC99 influenza hemagglutinin bound to Fab 310-63E6
0.0015.120.07 949-1034EM0.00hetero-3-3-3-3-mer15 x NAGHHblits0.30
7sco.1.B
Hemagglutinin HA2 chain
Structure of H1 influenza hemagglutinin bound to Fab 310-39G10
0.0015.120.07 949-1034EM0.00hetero-3-3-3-3-mer12 x NAG, 3 x NAG-NAGHHblits0.30
2yp7.1.A
HEMAGGLUTININ
Haemagglutinin of 2005 Human H3N2 Virus
0.0019.770.07 947-1032X-ray1.85homo-trimer18 x NAG, 3 x TAM, 3 x NAG-NAG-MAN, 3 x NAG-NAGHHblits0.30
6hjp.1.B
Hemagglutinin
Structure of Influenza Hemagglutinin ectodomain (A/duck/Alberta/35/76) in complex with FISW84 Fab Fragment
0.0013.950.07 948-1033EM0.00hetero-3-3-3-3-mer3 x UPL, 6 x NAG-NAG, 3 x NAG-NAG-BMA-FUC, 3 x NAG-NAG-BMA-MAN-MAN, 3 x NAG-NAG-BMAHHblits0.30
4dj7.1.F
Hemagglutinin
Structure of the hemagglutinin complexed with 3SLN from a highly pathogenic H7N7 influenza virus
0.0017.440.07 948-1033X-ray2.81hetero-3-3-mer11 x NAG, 1 x NAG-NAG, 3 x NAG-GAL-SIAHHblits0.30
6pcx.1.A
Hemagglutinin
Crystal Structure of a H5N1 influenza virus hemagglutinin at pH 6.0
0.0011.490.07 947-1033X-ray2.11homo-trimer12 x NAGHHblits0.29
6pd5.1.A
Hemagglutinin
Crystal Structure of a H5N1 influenza virus hemagglutinin at pH 6.5
0.0011.490.07 947-1033X-ray2.39homo-trimer12 x NAGHHblits0.29
7deb.1.A
Hemagglutinin
Structure of an avian influenza H5 hemagglutinin from the influenza virus A/duck/Eastern China/L0230/2010 (H5N2)
0.0011.490.07 947-1033X-ray2.60homo-trimer3 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAGHHblits0.29
7deb.1.B
Hemagglutinin
Structure of an avian influenza H5 hemagglutinin from the influenza virus A/duck/Eastern China/L0230/2010 (H5N2)
0.0011.490.07 947-1033X-ray2.60homo-trimer3 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAGHHblits0.29
7deb.1.C
Hemagglutinin
Structure of an avian influenza H5 hemagglutinin from the influenza virus A/duck/Eastern China/L0230/2010 (H5N2)
0.0011.490.07 947-1033X-ray2.60homo-trimer3 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAGHHblits0.29
1ha0.1.A
PROTEIN (HEMAGGLUTININ PRECURSOR)
HEMAGGLUTININ PRECURSOR HA0
0.0018.600.07 948-1033X-ray2.80homo-trimer6 x NAG, 6 x NAG-NAG-BMA, 3 x NAG-NAG-MANHHblits0.29
7rdh.1.B
Hemagglutinin HA2 chain
Crystal structure of the de novo designed binding protein H3mb in complex with the 1968 influenza A virus hemagglutinin
0.0018.600.07 949-1034X-ray2.75hetero-3-3-2-mer5 x NAG, 5 x NAG-NAG, 2 x NAG-NAG-BMAHHblits0.29
2wre.1.A
HEMAGGLUTININ
structure of H2 japan hemagglutinin with human receptor
0.0010.340.07 948-1034X-ray3.00homo-trimer3 x GAL-SIAHHblits0.28
2wrf.1.A
HEMAGGLUTININ
structure of H2 avian jena hemagglutinin with human receptor
0.0010.340.07 948-1034X-ray3.10homo-trimer1 x SIA, 1 x GAL-SIAHHblits0.28
2wrf.3.A
HEMAGGLUTININ
structure of H2 avian jena hemagglutinin with human receptor
0.0010.340.07 948-1034X-ray3.10homo-trimerHHblits0.28
6wzt.1.A
Hemagglutinin
CryoEM structure of influenza hemagglutinin A/Victoria/361/2011 in complex with cyno antibody 3B10
0.0018.600.07 947-1032EM4.40hetero-3-3-3-mer3 x NAG, 6 x NAG-NAG, 12 x NAG-NAG-BMAHHblits0.29
7tz5.1.G
Hemagglutinin
Cryo-EM structure of antibody TJ5-5 bound to H3 COBRA TJ5 hemagglutinin
0.0018.600.07 948-1033EM0.00hetero-3-3-3-merHHblits0.29
6gap.1.A
Outer capsid protein sigma-1
Crystal structure of the T3D reovirus sigma1 coiled coil tail and body
0.0126.830.06 931-1015X-ray2.15homo-trimerHHblits0.33
6gap.1.B
Outer capsid protein sigma-1
Crystal structure of the T3D reovirus sigma1 coiled coil tail and body
0.0126.830.06 931-1015X-ray2.15homo-trimerHHblits0.33
6gap.1.C
Outer capsid protein sigma-1
Crystal structure of the T3D reovirus sigma1 coiled coil tail and body
0.0126.830.06 931-1015X-ray2.15homo-trimerHHblits0.33
2wrd.1.A
HEMAGGLUTININ
STRUCTURE OF H2 JAPAN HEMAGGLUTININ
0.0010.340.07 947-1033X-ray3.00homo-trimerHHblits0.28
7l0l.1.C
Hemagglutinin HA2 chain
Cryo-EM structure of the VRC316 clinical trial, vaccine-elicited, human antibody 316-310-1B11 in complex with an H2 CAN05 HA trimer
0.0010.470.07 949-1034EM0.00hetero-3-3-3-3-mer15 x NAGHHblits0.28
2wr0.1.A
HEMAGGLUTININ
Structures of influenza H2 Hemagglutinins
0.0010.470.07 948-1033X-ray2.45homo-trimer3 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-BMA, 1 x NAG-NAG-BMA-MANHHblits0.28
2wr0.1.B
HEMAGGLUTININ
Structures of influenza H2 Hemagglutinins
0.0010.470.07 948-1033X-ray2.45homo-trimer3 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-BMA, 1 x NAG-NAG-BMA-MANHHblits0.28
2wr0.1.C
HEMAGGLUTININ
Structures of influenza H2 Hemagglutinins
0.0010.470.07 948-1033X-ray2.45homo-trimer3 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA-BMA, 1 x NAG-NAG-BMA-MANHHblits0.28
2wrc.1.A
HEMAGGLUTININ
THE STRUCTURE OF INFLUENZA H2 HUMAN SINGAPORE HEMAGGLUTININ
0.0010.470.07 948-1033X-ray2.71homo-trimerHHblits0.28
2wr5.1.A
HEMAGGLUTININ
STRUCTURE OF INFLUENZA H2 DUCK ONTARIO HEMAGGLUTININ
0.0010.470.07 948-1033X-ray2.65homo-trimerHHblits0.28
2wr5.1.B
HEMAGGLUTININ
STRUCTURE OF INFLUENZA H2 DUCK ONTARIO HEMAGGLUTININ
0.0010.470.07 948-1033X-ray2.65homo-trimerHHblits0.28
7n9f.1.4
Nucleoporin NUP82
Structure of the in situ yeast NPC
0.0011.360.07 898-989EM0.00hetero-2-2-2-6-4-4-…HHblits0.25
7n9f.1.5
Nucleoporin NUP82
Structure of the in situ yeast NPC
0.0011.360.07 898-989EM0.00hetero-2-2-2-6-4-4-…HHblits0.25
7tbi.51.A
Nup82
Composite structure of the S. cerevisiae nuclear pore complex (NPC)
0.0011.360.07 898-989EM0.00monomerHHblits0.25
7tbi.50.A
Nup82
Composite structure of the S. cerevisiae nuclear pore complex (NPC)
0.0011.360.07 898-989EM0.00monomerHHblits0.25
2dnx.1.A
Syntaxin-12
Solution structure of RSGI RUH-063, an N-terminal domain of Syntaxin 12 from human cDNA
0.0015.660.07 925-1007NMR0.00monomerHHblits0.29
7c53.1.A
Spike protein S2',pan-CoVs inhibitor EK1
Crystal Structure of SARS-CoV-2 HR1 motif in complex with pan-CoVs inhibitor EK1
0.0025.320.06 1123-1203X-ray2.28homo-trimerHHblits0.33
7c53.1.B
Spike protein S2',pan-CoVs inhibitor EK1
Crystal Structure of SARS-CoV-2 HR1 motif in complex with pan-CoVs inhibitor EK1
0.0025.320.06 1123-1203X-ray2.28homo-trimerHHblits0.33
7c53.1.C
Spike protein S2',pan-CoVs inhibitor EK1
Crystal Structure of SARS-CoV-2 HR1 motif in complex with pan-CoVs inhibitor EK1
0.0025.320.06 1123-1203X-ray2.28homo-trimerHHblits0.33
7c53.2.A
Spike protein S2',pan-CoVs inhibitor EK1
Crystal Structure of SARS-CoV-2 HR1 motif in complex with pan-CoVs inhibitor EK1
0.0025.320.06 1123-1203X-ray2.28homo-trimer2 x CAHHblits0.33
7c53.2.B
Spike protein S2',pan-CoVs inhibitor EK1
Crystal Structure of SARS-CoV-2 HR1 motif in complex with pan-CoVs inhibitor EK1
0.0025.320.06 1123-1203X-ray2.28homo-trimer2 x CAHHblits0.33
7c53.2.C
Spike protein S2',pan-CoVs inhibitor EK1
Crystal Structure of SARS-CoV-2 HR1 motif in complex with pan-CoVs inhibitor EK1
0.0025.320.06 1123-1203X-ray2.28homo-trimer2 x CAHHblits0.33
3lay.1.B
Zinc resistance-associated protein
Alpha-Helical barrel formed by the decamer of the zinc resistance-associated protein (STM4172) from Salmonella enterica subsp. enterica serovar Typhimurium str. LT2
0.005.750.07 953-1045X-ray2.70homo-10-merHHblits0.25
3lay.1.A
Zinc resistance-associated protein
Alpha-Helical barrel formed by the decamer of the zinc resistance-associated protein (STM4172) from Salmonella enterica subsp. enterica serovar Typhimurium str. LT2
0.005.750.07 953-1045X-ray2.70homo-10-merHHblits0.25
7y9n.1.A
Spike protein S2',5HB-H2
an engineered 5-helix bundle derived from SARS-CoV-2 S2 in complex with HR2P
0.0061.760.05 1138-1207X-ray1.88hetero-1-1-merHHblits0.44
7uja.1.A
RSV variant (construct pXCS847A) F1
Cryo-EM structure of Human respiratory syncytial virus F variant (construct pXCS847A)
0.0016.870.07 918-1004EM0.00hetero-3-3-3-3-3-3-…3 x NAGHHblits0.28
7uj3.1.B
RSV variant (construct pXCS847A) F1
Crystal structure of Human respiratory syncytial virus F variant (construct pXCS847A)
0.0016.870.07 918-1004X-ray3.50hetero-1-1-mer1 x NAGHHblits0.28
1wdg.1.B
E2 glycoprotein
crystal structure of MHV spike protein fusion core
0.0047.220.06 919-990X-ray2.06homo-hexamerHHblits0.39
1wdg.1.A
E2 glycoprotein
crystal structure of MHV spike protein fusion core
0.0047.220.06 919-990X-ray2.06homo-hexamerHHblits0.39
4mmq.1.B
Fusion glycoprotein F1 fused with Fibritin trimerization domain
Crystal Structure of Prefusion-stabilized RSV F Variant DS
0.0018.290.06 919-1004X-ray3.25hetero-3-3-merHHblits0.29
4ut1.1.A
FLAGELLAR HOOK-ASSOCIATED PROTEIN
The structure of the flagellar hook junction protein FlgK from Burkholderia pseudomallei
0.0013.410.06 966-1052X-ray1.80monomerHHblits0.29
6x45.1.C
Spike protein S2'
SARS-CoV2 spike glycoprotein N-terminal heptad repeat domain + SARS-CoV2(QEYKKEKE)
0.0096.490.04 911-967X-ray2.20hetero-3-3-merHHblits0.56
6x45.1.E
Spike protein S2'
SARS-CoV2 spike glycoprotein N-terminal heptad repeat domain + SARS-CoV2(QEYKKEKE)
0.0096.490.04 911-967X-ray2.20hetero-3-3-merHHblits0.56
6x45.1.F
Spike protein S2'
SARS-CoV2 spike glycoprotein N-terminal heptad repeat domain + SARS-CoV2(QEYKKEKE)
0.0096.490.04 911-967X-ray2.20hetero-3-3-merHHblits0.56
6lxt.1.A
Spike protein S2, Spike protein S2
Structure of post fusion core of 2019-nCoV S2 subunit
0.0077.050.05 1146-1206X-ray2.90homo-trimer4 x ZNHHblits0.51
6lxt.1.B
Spike protein S2, Spike protein S2
Structure of post fusion core of 2019-nCoV S2 subunit
0.0077.050.05 1146-1206X-ray2.90homo-trimer4 x ZNHHblits0.51
6lxt.1.C
Spike protein S2, Spike protein S2
Structure of post fusion core of 2019-nCoV S2 subunit
0.0077.050.05 1146-1206X-ray2.90homo-trimer4 x ZNHHblits0.51
6lxt.2.A
Spike protein S2, Spike protein S2
Structure of post fusion core of 2019-nCoV S2 subunit
0.0077.050.05 1146-1206X-ray2.90homo-trimer2 x ZNHHblits0.51
6lxt.2.B
Spike protein S2, Spike protein S2
Structure of post fusion core of 2019-nCoV S2 subunit
0.0077.050.05 1146-1206X-ray2.90homo-trimer2 x ZNHHblits0.51
6lxt.2.C
Spike protein S2, Spike protein S2
Structure of post fusion core of 2019-nCoV S2 subunit
0.0077.050.05 1146-1206X-ray2.90homo-trimer2 x ZNHHblits0.51
7cot.1.A
Spike glycoprotein
Structure of post fusion core of SARS-CoV-2 S2 subunit
0.0077.050.05 1146-1206X-ray2.16homo-trimerHHblits0.51
7cot.3.A
Spike glycoprotein
Structure of post fusion core of SARS-CoV-2 S2 subunit
0.0077.050.05 1146-1206X-ray2.16homo-trimerHHblits0.51
2ch7.1.A
METHYL-ACCEPTING CHEMOTAXIS PROTEIN
CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF A BACTERIAL CHEMORECEPTOR FROM THERMOTOGA MARITIMA
0.0011.390.06 910-988X-ray2.50hetero-oligomer2 x PBHHblits0.29
3ja6.1.Q
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0011.390.06 910-988EM0.00hetero-oligomerHHblits0.29
3ja6.1.G
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0011.390.06 910-988EM0.00hetero-oligomerHHblits0.29
3ja6.1.K
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0011.390.06 910-988EM0.00hetero-oligomerHHblits0.29
3ja6.1.I
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0011.390.06 910-988EM0.00hetero-oligomerHHblits0.29
3ja6.1.O
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0011.390.06 910-988EM0.00hetero-oligomerHHblits0.29
3ja6.1.M
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0011.390.06 910-988EM0.00hetero-oligomerHHblits0.29
7r5k.94.A
Nuclear pore complex protein Nup214
Human nuclear pore complex (constricted)
0.0020.780.06 937-1013EM0.00monomerHHblits0.31
2fxp.1.A
Spike glycoprotein
Solution Structure of the SARS-Coronavirus HR2 Domain
0.00100.000.04 1159-1211NMR0.00homo-trimerHHblits0.60
5wk5.1.A
B-type flagellin
Cryo-EM structure of P. aeruginosa flagellar filaments A443V
0.008.540.06 927-1008EM0.00homo-41-merHHblits0.26
6qp4.1.A
UspA1
Structure of 299-452 fragment of the UspA1 protein from Moraxella catarrhalis
0.0115.190.06 938-1019X-ray2.50homo-trimer12 x HEZ, 2 x ZNHHblits0.28
6qp4.1.B
UspA1
Structure of 299-452 fragment of the UspA1 protein from Moraxella catarrhalis
0.0115.190.06 938-1019X-ray2.50homo-trimer12 x HEZ, 2 x ZNHHblits0.28
6qp4.1.C
UspA1
Structure of 299-452 fragment of the UspA1 protein from Moraxella catarrhalis
0.0115.190.06 938-1019X-ray2.50homo-trimer12 x HEZ, 2 x ZNHHblits0.28
3maw.1.A
Fusion glycoprotein F0
Structure of the Newcastle disease virus F protein in the post-fusion conformation
0.0021.050.06 867-955X-ray3.50homo-trimer3 x NDG, 6 x NAG-NAGHHblits0.31
7y9n.1.A
Spike protein S2',5HB-H2
an engineered 5-helix bundle derived from SARS-CoV-2 S2 in complex with HR2P
0.0084.480.05 910-967X-ray1.88hetero-1-1-merHHblits0.52
1g5g.1.A
Fusion glycoprotein F0
FRAGMENT OF FUSION PROTEIN FROM NEWCASTLE DISEASE VIRUS
0.0021.050.06 867-955X-ray3.30homo-trimer1 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.30
5ijn.1.G
NUCLEAR PORE COMPLEX PROTEIN NUP58
Composite structure of the inner ring of the human nuclear pore complex (32 copies of Nup205)
0.0011.540.06 915-992EM0.00hetero-6-4-4-4-4-4-…HHblits0.28
7r5k.49.A
Nucleoporin p58/p45
Human nuclear pore complex (constricted)
0.0011.540.06 915-992EM0.00monomerHHblits0.28
7uop.1.A
Fusion glycoprotein F0
Prefusion-stabilized Nipah virus fusion protein complexed with Fab 4H3
0.0019.740.06 867-955EM0.00hetero-3-3-3-mer12 x NAGHHblits0.30
7up9.1.A
Fusion glycoprotein F0
Prefusion-stabilized Nipah virus fusion protein complexed with Fab 2D3
0.0019.740.06 867-955EM0.00hetero-3-1-1-mer11 x NAG, 1 x NAG-NAG-NAGHHblits0.30
7up9.1.C
Fusion glycoprotein F0
Prefusion-stabilized Nipah virus fusion protein complexed with Fab 2D3
0.0019.740.06 867-955EM0.00hetero-3-1-1-mer11 x NAG, 1 x NAG-NAG-NAGHHblits0.30
7upb.1.A
Fusion glycoprotein F0
Prefusion-stabilized Nipah virus fusion protein complexed with Fab 1H1
0.0019.740.06 867-955EM0.00hetero-3-3-3-mer3 x NAGHHblits0.30
7upa.1.C
Fusion glycoprotein F0
Prefusion-stabilized Nipah virus fusion protein complexed with Fab 1H8
0.0019.740.06 867-955EM0.00hetero-3-3-3-mer12 x NAGHHblits0.30
7upk.1.A
Fusion glycoprotein F0
Prefusion-stabilized Nipah virus fusion protein complexed with Fab 1A9
0.0019.740.06 867-955EM0.00hetero-3-3-3-merHHblits0.30
3ja6.1.H
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0013.160.06 917-992EM0.00hetero-oligomerHHblits0.30
3ja6.1.J
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0013.160.06 917-992EM0.00hetero-oligomerHHblits0.30
3ja6.1.L
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0013.160.06 917-992EM0.00hetero-oligomerHHblits0.30
3ja6.1.N
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0013.160.06 917-992EM0.00hetero-oligomerHHblits0.30
3ja6.1.P
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0013.160.06 917-992EM0.00hetero-oligomerHHblits0.30
3ja6.1.R
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0013.160.06 917-992EM0.00hetero-oligomerHHblits0.30
2ch7.1.B
METHYL-ACCEPTING CHEMOTAXIS PROTEIN
CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF A BACTERIAL CHEMORECEPTOR FROM THERMOTOGA MARITIMA
0.0013.160.06 917-992X-ray2.50hetero-oligomer2 x PBHHblits0.30
2d4c.1.A
SH3-containing GRB2-like protein 2
Crystal structure of the endophilin BAR domain mutant
0.0015.580.06 953-1030X-ray2.40homo-dimer1 x CAHHblits0.29
2d4c.1.B
SH3-containing GRB2-like protein 2
Crystal structure of the endophilin BAR domain mutant
0.0015.580.06 953-1030X-ray2.40homo-dimer1 x CAHHblits0.29
2d4c.2.A
SH3-containing GRB2-like protein 2
Crystal structure of the endophilin BAR domain mutant
0.0015.580.06 953-1030X-ray2.40homo-dimerHHblits0.29
2d4c.2.B
SH3-containing GRB2-like protein 2
Crystal structure of the endophilin BAR domain mutant
0.0015.580.06 953-1030X-ray2.40homo-dimerHHblits0.29
1ztm.1.A
Fusion glycoprotein
Structure of the Uncleaved Paramyxovirus (hPIV3) Fusion Protein
0.0014.470.06 867-955X-ray3.05homo-trimer2 x NAGHHblits0.30
1ztm.1.B
Fusion glycoprotein
Structure of the Uncleaved Paramyxovirus (hPIV3) Fusion Protein
0.0014.470.06 867-955X-ray3.05homo-trimer2 x NAGHHblits0.30
1ztm.1.C
Fusion glycoprotein
Structure of the Uncleaved Paramyxovirus (hPIV3) Fusion Protein
0.0014.470.06 867-955X-ray3.05homo-trimer2 x NAGHHblits0.30
7upd.1.A
Fusion glycoprotein F0
Prefusion-stabilized Nipah virus fusion protein complexed with Fab 2B12
0.0018.420.06 867-955EM0.00hetero-3-3-3-mer12 x NAGHHblits0.30
7ek6.1.A
Spike protein S2
Structure of viral peptides IPB19/N52
0.00100.000.04 906-957X-ray1.24hetero-3-3-merHHblits0.59
7ek6.1.C
Spike protein S2
Structure of viral peptides IPB19/N52
0.00100.000.04 906-957X-ray1.24hetero-3-3-merHHblits0.59
7ek6.1.E
Spike protein S2
Structure of viral peptides IPB19/N52
0.00100.000.04 906-957X-ray1.24hetero-3-3-merHHblits0.59
7s94.1.C
Endogenous retrovirus group S71 member 1 Env polyprotein
Structure of the core postfusion porcine endogenous retrovirus fusion protein
0.0022.970.06 917-990X-ray2.00homo-trimerHHblits0.32
7s94.1.B
Endogenous retrovirus group S71 member 1 Env polyprotein
Structure of the core postfusion porcine endogenous retrovirus fusion protein
0.0022.970.06 917-990X-ray2.00homo-trimerHHblits0.32
7s94.1.A
Endogenous retrovirus group S71 member 1 Env polyprotein
Structure of the core postfusion porcine endogenous retrovirus fusion protein
0.0022.970.06 917-990X-ray2.00homo-trimerHHblits0.32
7s94.2.A
Endogenous retrovirus group S71 member 1 Env polyprotein
Structure of the core postfusion porcine endogenous retrovirus fusion protein
0.0022.970.06 917-990X-ray2.00homo-trimerHHblits0.32
7s94.2.B
Endogenous retrovirus group S71 member 1 Env polyprotein
Structure of the core postfusion porcine endogenous retrovirus fusion protein
0.0022.970.06 917-990X-ray2.00homo-trimerHHblits0.32
1m1j.1.B
Fibrinogen beta chain
Crystal structure of native chicken fibrinogen with two different bound ligands
0.0014.100.06 937-1016X-ray2.70hetero-2-2-2-mer4 x NDG, 4 x CA, 2 x GLY-PRO-ARG-PRO, 2 x GLY-HIS-ARG-PROHHblits0.27
1m1j.1.E
Fibrinogen beta chain
Crystal structure of native chicken fibrinogen with two different bound ligands
0.0014.100.06 937-1016X-ray2.70hetero-2-2-2-mer4 x NDG, 4 x CA, 2 x GLY-PRO-ARG-PRO, 2 x GLY-HIS-ARG-PROHHblits0.27
3k8w.1.A
Flagellin homolog
Crysatl structure of a bacterial cell-surface flagellin N20C45
0.0011.690.06 925-1001X-ray1.70monomerHHblits0.28
8fej.1.A
Fusion Protein
Langya Virus Fusion Protein (LayV-F) in Pre-Fusion Conformation
0.0016.000.06 867-955EM0.00homo-trimerHHblits0.30
8fel.1.A
Fusion Protein
Langya Virus Fusion Protein (LayV-F) in Post-Fusion Conformation
0.0016.000.06 867-955EM0.00homo-trimerHHblits0.30
7jpi.1.B
Envelope glycoprotein
Crystal structure of EBOV glycoprotein with modified HR2 stalk at 2.3A resolution
0.0017.110.06 915-990X-ray2.28hetero-3-3-mer3 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MAN-MANHHblits0.28
4nx9.1.A
Flagellin
Crystal structure of Pseudomonas aeruginosa flagellin FliC
0.0014.670.06 928-1002X-ray2.10monomerHHblits0.29
5ijn.1.G
NUCLEAR PORE COMPLEX PROTEIN NUP58
Composite structure of the inner ring of the human nuclear pore complex (32 copies of Nup205)
0.0010.260.06 913-994EM0.00hetero-6-4-4-4-4-4-…HHblits0.26
7r5k.49.A
Nucleoporin p58/p45
Human nuclear pore complex (constricted)
0.0010.260.06 913-994EM0.00monomerHHblits0.26
4whe.1.A
Phage shock protein A
Crystal structure of E. coli phage shock protein A (PspA 1-144)
0.0013.160.06 916-992X-ray1.80monomerHHblits0.27
6mjz.1.A
Fusion glycoprotein F0
Cryo-EM structure of Human Parainfluenza Virus Type 3 (hPIV3) in complex with antibody PIA174
0.0016.220.06 868-955EM4.30hetero-3-1-1-merHHblits0.29
6mjz.1.B
Fusion glycoprotein F0
Cryo-EM structure of Human Parainfluenza Virus Type 3 (hPIV3) in complex with antibody PIA174
0.0016.220.06 868-955EM4.30hetero-3-1-1-merHHblits0.29
6mjz.1.C
Fusion glycoprotein F0
Cryo-EM structure of Human Parainfluenza Virus Type 3 (hPIV3) in complex with antibody PIA174
0.0016.220.06 868-955EM4.30hetero-3-1-1-merHHblits0.29
8dg8.1.A
Fusion glycoprotein F0
Cryo-EM Structure of HPIV3 prefusion F trimer in complex with 3x1 Fab
0.0016.220.06 868-955EM0.00hetero-3-1-1-mer9 x NAGHHblits0.29
8dg8.1.D
Fusion glycoprotein F0
Cryo-EM Structure of HPIV3 prefusion F trimer in complex with 3x1 Fab
0.0016.220.06 868-955EM0.00hetero-3-1-1-mer9 x NAGHHblits0.29
8dg8.1.E
Fusion glycoprotein F0
Cryo-EM Structure of HPIV3 prefusion F trimer in complex with 3x1 Fab
0.0016.220.06 868-955EM0.00hetero-3-1-1-mer9 x NAGHHblits0.29
3rpu.1.D
Chromosome partition protein mukF
Crystal structure of the MukE-MukF complex
0.0025.350.06 898-968X-ray3.60hetero-oligomerHHblits0.33
3rpu.1.A
Chromosome partition protein mukF
Crystal structure of the MukE-MukF complex
0.0025.350.06 898-968X-ray3.60hetero-oligomerHHblits0.33
3euh.1.A
Chromosome partition protein mukF
Crystal Structure of the MukE-MukF Complex
0.0025.350.06 898-968X-ray2.90hetero-2-4-mer4 x GLYHHblits0.33
3euh.1.B
Chromosome partition protein mukF
Crystal Structure of the MukE-MukF Complex
0.0025.350.06 898-968X-ray2.90hetero-2-4-mer4 x GLYHHblits0.33
2oex.1.A
Programmed cell death 6-interacting protein
Structure of ALIX/AIP1 V Domain
0.0018.420.06 957-1032X-ray2.58homo-dimerHHblits0.27
2oex.1.B
Programmed cell death 6-interacting protein
Structure of ALIX/AIP1 V Domain
0.0018.420.06 957-1032X-ray2.58homo-dimerHHblits0.27
7nz0.1.C
Chromosome partition protein MukF
Cryo-EM structure of the MukBEF-MatP-DNA monomer (open conformation)
0.0023.940.06 898-968EM0.00hetero-2-2-2-2-2-mer2 x MG, 2 x ATP, 2 x PNSHHblits0.33
7nyw.1.C
Chromosome partition protein MukF
Cryo-EM structure of the MukBEF-MatP-DNA head module
0.0023.940.06 898-968EM0.00hetero-2-2-2-2-2-mer2 x MG, 2 x ATP, 2 x PNSHHblits0.33
7nyy.1.C
Chromosome partition protein MukF
Cryo-EM structure of the MukBEF monomer
0.0023.940.06 898-968EM0.00hetero-2-2-2-2-mer2 x PNSHHblits0.33
7jph.1.B
Envelope glycoprotein
Crystal structure of EBOV glycoprotein with modified HR1c and HR2 stalk at 3.2 A resolution
0.0017.330.06 916-990X-ray3.19hetero-3-3-mer6 x NAG, 3 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MAN-MANHHblits0.28
2v5d.1.A
O-GLCNACASE NAGJ
STRUCTURE OF A FAMILY 84 GLYCOSIDE HYDROLASE AND A FAMILY 32 CARBOHYDRATE-BINDING MODULE IN TANDEM FROM CLOSTRIDIUM PERFRINGENS.
0.0016.000.06 945-1031X-ray3.30monomer3 x CAHHblits0.28
2zbi.1.A
Flagellin homolog
Crystal structure of a bacterial cell-surface flagellin
0.0018.060.06 926-1001X-ray2.00monomerHHblits0.31
2b9b.1.A
Fusion glycoprotein F0
Structure of the Parainfluenza Virus 5 F Protein in its Metastable, Pre-fusion Conformation
0.0016.440.06 869-955X-ray2.85homo-trimer12 x NAGHHblits0.30
2b9b.1.B
Fusion glycoprotein F0
Structure of the Parainfluenza Virus 5 F Protein in its Metastable, Pre-fusion Conformation
0.0016.440.06 869-955X-ray2.85homo-trimer12 x NAGHHblits0.30
2b9b.1.C
Fusion glycoprotein F0
Structure of the Parainfluenza Virus 5 F Protein in its Metastable, Pre-fusion Conformation
0.0016.440.06 869-955X-ray2.85homo-trimer12 x NAGHHblits0.30
7udb.1.B
Syntaxin-1A
Cryo-EM structure of a synaptobrevin-Munc18-1-syntaxin-1 complex class 2
0.0011.840.06 958-1036EM0.00hetero-1-1-1-merHHblits0.26
7udc.1.B
Syntaxin-1A
cryo-EM structures of a synaptobrevin-Munc18-1-syntaxin-1 complex class1
0.0011.840.06 958-1036EM0.00hetero-1-1-1-merHHblits0.26
1t98.1.A
Chromosome partition protein mukF
Crystal Structure of MukF(1-287)
0.0025.710.05 898-967X-ray2.90homo-dimerHHblits0.33
1t98.1.B
Chromosome partition protein mukF
Crystal Structure of MukF(1-287)
0.0025.710.05 898-967X-ray2.90homo-dimerHHblits0.33
4wsg.1.A
Fusion glycoprotein F0
Crystal Structure of Soluble WR PIV5 F-GCNt
0.0013.510.06 869-955X-ray3.00homo-trimer4 x NAGHHblits0.28
4wsg.1.B
Fusion glycoprotein F0
Crystal Structure of Soluble WR PIV5 F-GCNt
0.0013.510.06 869-955X-ray3.00homo-trimer4 x NAGHHblits0.28
4wsg.1.C
Fusion glycoprotein F0
Crystal Structure of Soluble WR PIV5 F-GCNt
0.0013.510.06 869-955X-ray3.00homo-trimer4 x NAGHHblits0.28
5xbj.1.A
Flagellar hook-associated protein FlgK
The structure of the flagellar hook junction protein HAP1 (FlgK) from Campylobacter jejuni
0.0015.070.06 965-1038X-ray2.45monomerHHblits0.29
5lsj.1.B
Polyamine-modulated factor 1
CRYSTAL STRUCTURE OF THE HUMAN KINETOCHORE MIS12-CENP-C delta-HEAD2 COMPLEX
0.0014.860.06 921-994X-ray3.25hetero-1-1-1-1-1-merHHblits0.28
5lsk.1.B
Polyamine-modulated factor 1
CRYSTAL STRUCTURE OF THE HUMAN KINETOCHORE MIS12-CENP-C COMPLEX
0.0014.860.06 921-994X-ray3.50hetero-1-1-1-1-1-merHHblits0.28
6apb.1.A
Fusion glycoprotein F0,Fusion glycoprotein F0
Crystal Structure of Non-Neutralizing Infant Antibody ADI-14359 in Complex with Postfusion RSV F Glycoprotein
0.0013.510.06 868-955X-ray3.00hetero-3-1-1-mer3 x NAGHHblits0.28
6apb.1.C
Fusion glycoprotein F0,Fusion glycoprotein F0
Crystal Structure of Non-Neutralizing Infant Antibody ADI-14359 in Complex with Postfusion RSV F Glycoprotein
0.0013.510.06 868-955X-ray3.00hetero-3-1-1-mer3 x NAGHHblits0.28
6eay.1.C
Envelope glycoprotein
Structural Basis for Broad Neutralization of Ebolaviruses by an Antibody Targeting the Glycoprotein Fusion Loop
0.0016.670.06 919-990X-ray3.72hetero-1-1-1-1-mer2 x NAG, 1 x NAG-NAG-BMA-MAN-MAN-MAN-MAN-MANHHblits0.28
5ijn.1.H
Nuclear pore glycoprotein p62
Composite structure of the inner ring of the human nuclear pore complex (32 copies of Nup205)
0.0012.500.06 918-989EM0.00hetero-6-4-4-4-4-4-…HHblits0.28
7r5k.53.A
Nuclear pore glycoprotein p62
Human nuclear pore complex (constricted)
0.0012.500.06 918-989EM0.00monomerHHblits0.28
7r5k.54.A
Nuclear pore glycoprotein p62
Human nuclear pore complex (constricted)
0.0012.500.06 918-989EM0.00monomerHHblits0.28
6dzm.1.B
Bundibugyo virus GP2
Bundibugyo virus GP (mucin-deleted) in complex with pan-ebolavirus human antibody ADI-15878 Fab
0.0015.490.06 923-993EM0.00hetero-3-3-3-3-mer6 x NAG, 3 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MANHHblits0.29
5wwl.1.B
Kinetochore protein nnf1
Crystal structure of the Schizogenesis pombe kinetochore Mis12C subcomplex
0.0011.110.06 923-994X-ray2.40hetero-1-1-merHHblits0.28
2ieq.1.A
Spike glycoprotein
Core Structure of S2 from the Human Coronavirus NL63 Spike Glycoprotein
0.0016.900.06 1128-1200X-ray1.75homo-trimerHHblits0.29
4g2k.1.A
General control protein GCN4, Envelope glycoprotein GP2 chimera
Crystal structure of the Marburg Virus GP2 ectodomain in its post-fusion conformation
0.0010.670.06 911-985X-ray1.90homo-trimerHHblits0.25
4g2k.1.B
General control protein GCN4, Envelope glycoprotein GP2 chimera
Crystal structure of the Marburg Virus GP2 ectodomain in its post-fusion conformation
0.0010.670.06 911-985X-ray1.90homo-trimerHHblits0.25
4g2k.1.C
General control protein GCN4, Envelope glycoprotein GP2 chimera
Crystal structure of the Marburg Virus GP2 ectodomain in its post-fusion conformation
0.0010.670.06 911-985X-ray1.90homo-trimerHHblits0.25
7wkk.1.I
MGC84997 protein
Cryo-EM structure of the IR subunit from X. laevis NPC
0.0012.860.05 921-990EM4.20hetero-2-2-4-6-4-4-…HHblits0.30
7wkk.1.L
MGC84997 protein
Cryo-EM structure of the IR subunit from X. laevis NPC
0.0012.860.05 921-990EM4.20hetero-2-2-4-6-4-4-…HHblits0.30
5kel.1.B
Ebola surface glycoprotein, GP2
EBOV GP in complex with variable Fab domains of IgGs c2G4 and c13C6
0.0015.280.06 916-987EM0.00hetero-3-3-3-3-3-3-…3 x NAG, 3 x NAG-NAG, 3 x NAG-NAG-BMA, 3 x NAG-NAG-BMA-MAN, 3 x NAG-NAG-BMA-MAN-MANHHblits0.27
4tql.1.A
Three helix bundle
Computationally designed three helix bundle
0.008.450.06 946-1025X-ray2.80monomerHHblits0.28
6xye.1.B
Fusion glycoprotein F1
Cryo-EM structure of the prefusion state of canine distemper virus fusion protein ectodomain
0.0025.370.05 875-955EM0.00hetero-3-3-merHHblits0.32
5zhy.1.A
Spike glycoprotein, Spike glycoprotein
Structural characterization of the HCoV-229E fusion core
0.0045.000.05 918-977X-ray2.44homo-trimerHHblits0.41
5zhy.1.C
Spike glycoprotein, Spike glycoprotein
Structural characterization of the HCoV-229E fusion core
0.0045.000.05 918-977X-ray2.44homo-trimerHHblits0.41
7o97.1.A
hypothetical protein UY81_C0065G0003 from Candidatus Giovannonibacteria bacterium converted into a canonical coiled coil
hypothetical protein UY81_C0065G0003 from Candidatus Giovannonibacteria bacterium converted into a canonical coiled coil
0.008.570.05 929-1012X-ray2.00homo-trimerHHblits0.29
6txm.1.A
Ferritin
Crystal structure of thermotoga maritima E65R Ferritin
0.0014.290.05 931-1000X-ray2.20homo-24-mer12 x LFAHHblits0.29
6hs4.1.B
Envelope glycoprotein
Crystal structure of Ebolavirus glycoprotein in complex with inhibitor 118
0.0015.490.06 916-983X-ray2.05hetero-3-3-mer15 x NAG, 6 x GON, 3 x NAG-NAG-BMA-MAN-MANHHblits0.28
6hro.1.D
Envelope glycoprotein
Crystal structure of Ebolavirus glycoprotein in complex with inhibitor 118a
0.0015.490.06 916-983X-ray2.30hetero-3-3-mer15 x NAG, 6 x GKZ, 3 x NAG-NAG-BMA-MAN-MANHHblits0.28
6f6s.1.D
Envelope glycoprotein
CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH benztropine
0.0015.490.06 916-983X-ray2.29hetero-3-3-mer15 x NAG, 6 x CXQHHblits0.28
1dow.1.A
ALPHA-CATENIN
CRYSTAL STRUCTURE OF A CHIMERA OF BETA-CATENIN AND ALPHA-CATENIN
0.0014.490.05 964-1034X-ray1.80hetero-oligomerHHblits0.30
5t58.1.B
KLLA0E05809p
Structure of the MIND Complex Shows a Regulatory Focus of Yeast Kinetochore Assembly
0.0014.080.06 922-992X-ray3.21hetero-oligomerHHblits0.27
7nmq.1.A
Hemolysin BL lytic component L1
Bacillus cereus HblL1 toxin component
0.0011.430.05 921-990X-ray1.36monomerHHblits0.28
3tnu.1.A
Keratin, type I cytoskeletal 14
Heterocomplex of coil 2B domains of human intermediate filament proteins, keratin 5 (KRT5) and keratin 14 (KRT14)
0.0010.000.05 917-990X-ray3.01hetero-oligomerHHblits0.28
7xge.1.A
BCL-xL and MCL-1 dual binder 2
Crystal structure of MCL-1 in complex with computationally designed inhibitor protein
0.0032.810.05 910-987X-ray2.38hetero-1-1-merHHblits0.35
7xge.2.A
BCL-xL and MCL-1 dual binder 2
Crystal structure of MCL-1 in complex with computationally designed inhibitor protein
0.0032.810.05 910-987X-ray2.38hetero-1-1-merHHblits0.35
7xge.3.A
BCL-xL and MCL-1 dual binder 2
Crystal structure of MCL-1 in complex with computationally designed inhibitor protein
0.0032.810.05 910-987X-ray2.38hetero-1-1-merHHblits0.35
7xge.4.A
BCL-xL and MCL-1 dual binder 2
Crystal structure of MCL-1 in complex with computationally designed inhibitor protein
0.0032.810.05 910-987X-ray2.38hetero-1-1-merHHblits0.35
2d4x.1.A
Flagellar hook-associated protein 3
Crystal structure of a 26K fragment of HAP3 (FlgL)
0.0011.270.06 917-987X-ray1.90monomerHHblits0.27
4n78.1.E
Abl interactor 2
The WAVE Regulatory Complex Links Diverse Receptors to the Actin Cytoskeleton
0.0017.390.05 941-1011X-ray2.43hetero-oligomerHHblits0.29
7ag9.1.A
Kar9
Structure of the Kar9 protein
0.0014.290.05 927-1004X-ray3.30homo-dimerHHblits0.27
7ag9.1.B
Kar9
Structure of the Kar9 protein
0.0014.290.05 927-1004X-ray3.30homo-dimerHHblits0.27
3jc1.2.A
Charged multivesicular body protein 1b
Electron cryo-microscopy of the IST1-CHMP1B ESCRT-III copolymer
0.0014.930.05 933-1001EM0.00monomerHHblits0.31
1x03.1.A
SH3-containing GRB2-like protein 2
Crystal structure of endophilin BAR domain
0.0015.940.05 953-1022X-ray3.10homo-dimerHHblits0.28
7r95.1.A
Spike protein S2
Membrane bound structure of HR1 domain of SARS-CoV-2 spike protein
0.00100.000.04 919-965NMR0.00monomerHHblits0.58
5yzc.1.B
glycoprotein F1,measles virus fusion protein
Crystal structure of the prefusion form of measles virus fusion protein in complex with a fusion inhibitor compound (AS-48)
0.0022.390.05 875-955X-ray2.33hetero-3-3-mer3 x NAG, 3 x 95C, 3 x NAG-NAGHHblits0.30
5yxw.1.B
glycoprotein F1,measles virus fusion protein
Crystal structure of the prefusion form of measles virus fusion protein
0.0022.390.05 875-955X-ray2.78hetero-3-3-mer3 x NAG, 3 x NAG-NAGHHblits0.30
1zv8.1.A
E2 glycoprotein
A structure-based mechanism of SARS virus membrane fusion
0.0082.000.04 919-968X-ray1.94hetero-oligomerHHblits0.53
1zv8.1.E
E2 glycoprotein
A structure-based mechanism of SARS virus membrane fusion
0.0082.000.04 919-968X-ray1.94hetero-oligomerHHblits0.53
3tnu.1.B
Keratin, type II cytoskeletal 5
Heterocomplex of coil 2B domains of human intermediate filament proteins, keratin 5 (KRT5) and keratin 14 (KRT14)
0.005.710.05 917-990X-ray3.01hetero-oligomerHHblits0.27
7a26.1.A
SmhA
Structure of soluble SmhA crystal form 1 of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.
0.0012.860.05 909-987X-ray2.98monomerHHblits0.27
7a26.2.A
SmhA
Structure of soluble SmhA crystal form 1 of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.
0.0012.860.05 909-987X-ray2.98monomer1 x CAHHblits0.27
7a26.3.A
SmhA
Structure of soluble SmhA crystal form 1 of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.
0.0012.860.05 909-987X-ray2.98monomer2 x CAHHblits0.27
7a26.8.A
SmhA
Structure of soluble SmhA crystal form 1 of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.
0.0012.860.05 909-987X-ray2.98monomerHHblits0.27
7a27.1.A
SmhA
Structure of soluble SmhA crystal form 2 of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.
0.0012.860.05 909-987X-ray2.57monomerHHblits0.27
7a27.2.A
SmhA
Structure of soluble SmhA crystal form 2 of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.
0.0012.860.05 909-987X-ray2.57monomerHHblits0.27
1quu.1.A
HUMAN SKELETAL MUSCLE ALPHA-ACTININ 2
CRYSTAL STRUCTURE OF TWO CENTRAL SPECTRIN-LIKE REPEATS FROM ALPHA-ACTININ
0.0014.930.05 925-991X-ray2.50homo-dimerHHblits0.30
4gip.1.B
Fusion glycoprotein F1
Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 (PIV5) fusion protein
0.0017.910.05 875-955X-ray2.00hetero-3-3-mer11 x NAGHHblits0.30
4gip.1.D
Fusion glycoprotein F1
Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 (PIV5) fusion protein
0.0017.910.05 875-955X-ray2.00hetero-3-3-mer11 x NAGHHblits0.30
4gip.1.F
Fusion glycoprotein F1
Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 (PIV5) fusion protein
0.0017.910.05 875-955X-ray2.00hetero-3-3-mer11 x NAGHHblits0.30
7tn9.1.O
GP2
Structure of the Inmazeb cocktail and resistance to escape against Ebola virus
0.0014.490.05 918-986EM0.00hetero-3-3-3-3-3-3-…8 x NAG, 3 x NAG-NAG-BMA-MAN-MAN-MANHHblits0.27
7tn9.1.H
GP2
Structure of the Inmazeb cocktail and resistance to escape against Ebola virus
0.0014.490.05 918-986EM0.00hetero-3-3-3-3-3-3-…8 x NAG, 3 x NAG-NAG-BMA-MAN-MAN-MANHHblits0.27
7kfe.1.H
Envelope glycoprotein 2
Bundibugyo virus GP (mucin deleted) bound to antibody Fab BDBV-329
0.0014.710.05 923-990EM0.00hetero-2-2-3-3-mer2 x NAG, 3 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAGHHblits0.28
7kfe.1.J
Envelope glycoprotein 2
Bundibugyo virus GP (mucin deleted) bound to antibody Fab BDBV-329
0.0014.710.05 923-990EM0.00hetero-2-2-3-3-mer2 x NAG, 3 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAGHHblits0.28
7kew.1.D
Envelope glycoprotein 2
Bundibugyo virus GP (mucin deleted) bound to antibody Fab BDBV-43
0.0014.710.05 923-990EM4.16hetero-3-3-3-3-mer3 x NAG, 3 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MANHHblits0.28
7kfe.1.F
Envelope glycoprotein 2
Bundibugyo virus GP (mucin deleted) bound to antibody Fab BDBV-329
0.0014.710.05 923-990EM0.00hetero-2-2-3-3-mer2 x NAG, 3 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAGHHblits0.28
6gy6.1.A
XaxA
XaxAB pore complex from Xenorhabdus nematophila
0.0010.140.05 965-1041EM0.00hetero-13-13-merHHblits0.27
6bp2.1.B
Envelope glycoprotein GP2
Therapeutic human monoclonal antibody MR191 bound to a marburgvirus glycoprotein
0.0015.940.05 920-988X-ray3.17hetero-3-3-3-3-mer3 x NAG-NAG-BMA, 6 x NAG-NAG, 3 x BMA-MAN-MANHHblits0.27
4iyh.1.A
Secreted protein EsxB
The crystal structure of a secreted protein EsxB (SeMet-labeled, C-term. His-Tagged) from Bacillus anthracis str. Sterne
0.0016.420.05 923-989X-ray1.88homo-dimerHHblits0.29
4iyh.1.B
Secreted protein EsxB
The crystal structure of a secreted protein EsxB (SeMet-labeled, C-term. His-Tagged) from Bacillus anthracis str. Sterne
0.0016.420.05 923-989X-ray1.88homo-dimerHHblits0.29
1wyy.1.A
E2 Glycoprotein
Post-fusion hairpin conformation of the sars coronavirus spike glycoprotein
0.0097.830.04 1162-1207X-ray2.20homo-trimerHHblits0.58
2gd5.1.A
Charged multivesicular body protein 3
Structural basis for budding by the ESCRTIII factor CHMP3
0.0025.810.05 936-999X-ray2.80homo-dimerHHblits0.35
2gd5.1.B
Charged multivesicular body protein 3
Structural basis for budding by the ESCRTIII factor CHMP3
0.0025.810.05 936-999X-ray2.80homo-dimerHHblits0.35
2gd5.2.A
Charged multivesicular body protein 3
Structural basis for budding by the ESCRTIII factor CHMP3
0.0025.810.05 936-999X-ray2.80homo-dimerHHblits0.35
2gd5.2.B
Charged multivesicular body protein 3
Structural basis for budding by the ESCRTIII factor CHMP3
0.0025.810.05 936-999X-ray2.80homo-dimerHHblits0.35
1wdz.1.A
insulin receptor substrate p53
Crystal structure of RCB domain of IRSp53
0.0015.150.05 917-987X-ray2.63homo-dimerHHblits0.30
1wdz.1.B
insulin receptor substrate p53
Crystal structure of RCB domain of IRSp53
0.0015.150.05 917-987X-ray2.63homo-dimerHHblits0.30
7tik.1.F
Spike protein S2'
Structure of the SARS-CoV-2 Omicron spike post-fusion bundle
0.00100.000.04 1157-1201EM0.00hetero-3-3-merHHblits0.60
8fa1.1.D
Spike protein S2' HR2
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with N969K mutation
0.00100.000.04 1157-1201EM0.00hetero-3-3-merHHblits0.60
8fa1.1.F
Spike protein S2' HR2
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with N969K mutation
0.00100.000.04 1157-1201EM0.00hetero-3-3-merHHblits0.60
7tik.1.D
Spike protein S2'
Structure of the SARS-CoV-2 Omicron spike post-fusion bundle
0.00100.000.04 1157-1201EM0.00hetero-3-3-merHHblits0.60
8fa1.1.E
Spike protein S2' HR2
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with N969K mutation
0.00100.000.04 1157-1201EM0.00hetero-3-3-merHHblits0.60
7tik.1.E
Spike protein S2'
Structure of the SARS-CoV-2 Omicron spike post-fusion bundle
0.00100.000.04 1157-1201EM0.00hetero-3-3-merHHblits0.60
8czi.1.E
Spike protein S2' HR2
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with extended HR2
0.00100.000.04 1157-1201EM0.00hetero-3-3-merHHblits0.60
8czi.1.D
Spike protein S2' HR2
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with extended HR2
0.00100.000.04 1157-1201EM0.00hetero-3-3-merHHblits0.60
8czi.1.F
Spike protein S2' HR2
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with extended HR2
0.00100.000.04 1157-1201EM0.00hetero-3-3-merHHblits0.60
8fa2.1.D
Spike protein S2' 42G
Cryo-EM structure of the SARS-CoV-2 Omicron HR1-42G complex
0.00100.000.04 1157-1201EM0.00hetero-3-3-merHHblits0.60
8fa2.1.E
Spike protein S2' 42G
Cryo-EM structure of the SARS-CoV-2 Omicron HR1-42G complex
0.00100.000.04 1157-1201EM0.00hetero-3-3-merHHblits0.60
8fa2.1.F
Spike protein S2' 42G
Cryo-EM structure of the SARS-CoV-2 Omicron HR1-42G complex
0.00100.000.04 1157-1201EM0.00hetero-3-3-merHHblits0.60
2beq.1.D
Spike glycoprotein
Structure of a Proteolytically Resistant Core from the Severe Acute Respiratory Syndrome Coronavirus S2 Fusion Protein
0.00100.000.04 1167-1211X-ray1.60hetero-6-6-merHHblits0.59
2beq.1.E
Spike glycoprotein
Structure of a Proteolytically Resistant Core from the Severe Acute Respiratory Syndrome Coronavirus S2 Fusion Protein
0.00100.000.04 1167-1211X-ray1.60hetero-6-6-merHHblits0.59
2beq.1.F
Spike glycoprotein
Structure of a Proteolytically Resistant Core from the Severe Acute Respiratory Syndrome Coronavirus S2 Fusion Protein
0.00100.000.04 1167-1211X-ray1.60hetero-6-6-merHHblits0.59
7rzv.1.D
Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with V1176F mutation
0.0097.780.04 1157-1201EM0.00hetero-3-3-merHHblits0.59
7rzv.1.E
Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with V1176F mutation
0.0097.780.04 1157-1201EM0.00hetero-3-3-merHHblits0.59
7rzv.1.F
Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with V1176F mutation
0.0097.780.04 1157-1201EM0.00hetero-3-3-merHHblits0.59
5yfp.1.E
Exocyst complex component SEC10
Cryo-EM Structure of the Exocyst Complex
0.0016.420.05 921-987EM4.40hetero-1-1-1-1-1-1-…HHblits0.28
4uxv.1.A
SEPTATION RING FORMATION REGULATOR EZRA
Cytoplasmic domain of bacterial cell division protein EzrA
0.007.350.05 959-1029X-ray3.96monomerHHblits0.26
4l0r.1.A
Centrosomal protein of 57 kDa
Crystal structure of FGF2-interacting protein from Homo sapiens. Northeast Structural Genomics Consortium Target HR9027A.
0.0013.640.05 954-1020X-ray2.49homo-dimerHHblits0.29
4l0r.1.B
Centrosomal protein of 57 kDa
Crystal structure of FGF2-interacting protein from Homo sapiens. Northeast Structural Genomics Consortium Target HR9027A.
0.0013.640.05 954-1020X-ray2.49homo-dimerHHblits0.29
2gts.1.A
hypothetical protein HP0062
Structure of Protein of Unknown Function HP0062 from Helicobacter pylori
0.008.960.05 921-987X-ray2.10monomerHHblits0.27
4i3m.1.A
Aerotaxis transducer Aer2
Aer2 poly-HAMP domains: L44H HAMP1 CW-lock mutant
0.0016.670.05 915-987X-ray1.95homo-dimer2 x MGHHblits0.28
5jnx.2.A
Envelope glycoprotein
The 6.6 A cryo-EM structure of the full-length human NPC1 in complex with the cleaved glycoprotein of Ebola virus
0.0015.150.05 919-984EM0.00homo-trimer3 x NAG-NAGHHblits0.28
6nb0.1.A
Histidine kinase
Crystal structure of Histidine kinase from Burkholderia phymatum STM815
0.007.250.05 921-989X-ray1.90homo-dimerHHblits0.24
3g67.1.A
Methyl-accepting chemotaxis protein
Crystal Structure of a Soluble Chemoreceptor from Thermotoga maritima
0.0012.310.05 920-988X-ray2.17homo-dimerHHblits0.29
3g67.1.B
Methyl-accepting chemotaxis protein
Crystal Structure of a Soluble Chemoreceptor from Thermotoga maritima
0.0012.310.05 920-988X-ray2.17homo-dimerHHblits0.29
1ux4.1.A
BNI1 PROTEIN
Crystal structures of a Formin Homology-2 domain reveal a tethered-dimer architecture
0.0012.120.05 968-1033X-ray3.30homo-dimerHHblits0.27
4fzs.1.A
Sorting nexin-1
Structure of human SNX1 BAR domain
0.0013.640.05 905-970X-ray2.80homo-dimerHHblits0.27
4fzs.1.B
Sorting nexin-1
Structure of human SNX1 BAR domain
0.0013.640.05 905-970X-ray2.80homo-dimerHHblits0.27
1y64.1.B
BNI1 protein
Bni1p Formin Homology 2 Domain complexed with ATP-actin
0.0012.120.05 968-1033X-ray3.05hetero-oligomer1 x CA, 1 x ATPHHblits0.27
7my8.1.A
Spike protein S2
Fusion Peptide of SARS-CoV-2 Spike Rearranges into a Wedge Inserted in Bilayered Micelles
0.0097.620.03 816-857NMR0.00monomerHHblits0.61
1zv7.1.A
spike glycoprotein
A structure-based mechanism of SARS virus membrane fusion
0.00100.000.03 1169-1211X-ray1.70homo-tetramerHHblits0.59
1zv7.1.B
spike glycoprotein
A structure-based mechanism of SARS virus membrane fusion
0.00100.000.03 1169-1211X-ray1.70homo-tetramerHHblits0.59
6eup.1.A
Adhesin A
Crystal structure of Neisseria meningitidis NadA variant 3 double mutant A33I-I38L
0.0020.970.05 925-986X-ray2.65homo-trimerHHblits0.30
6eun.1.A
Adhesin
Crystal structure of Neisseria meningitidis vaccine antigen NadA variant 3
0.0020.970.05 925-986X-ray2.45homo-trimer1 x 2PE, 2 x P4GHHblits0.30
6h2e.1.A
AhlC
Structure of the soluble AhlC of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.009.230.05 902-967X-ray2.35homo-tetramerHHblits0.27
6h2d.1.B
AhlC
Structure of the soluble AhlC of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.009.230.05 902-967X-ray2.62homo-tetramerHHblits0.27
6h2d.1.C
AhlC
Structure of the soluble AhlC of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.009.230.05 902-967X-ray2.62homo-tetramerHHblits0.27
6h2d.1.D
AhlC
Structure of the soluble AhlC of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.009.230.05 902-967X-ray2.62homo-tetramerHHblits0.27
6h2d.1.A
AhlC
Structure of the soluble AhlC of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.009.230.05 902-967X-ray2.62homo-tetramerHHblits0.27
6h2e.1.B
AhlC
Structure of the soluble AhlC of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.009.230.05 902-967X-ray2.35homo-tetramerHHblits0.27
4lws.1.A
Uncharacterized protein
EsxA : EsxB (SeMet) hetero-dimer from Thermomonospora curvata
0.0013.850.05 923-987X-ray2.00monomerHHblits0.26
1wnc.1.A
E2 glycoprotein
Crystal structure of the SARS-CoV Spike protein fusion core
0.0095.350.03 1161-1203X-ray2.80homo-hexamerHHblits0.58
1wnc.1.B
E2 glycoprotein
Crystal structure of the SARS-CoV Spike protein fusion core
0.0095.350.03 1161-1203X-ray2.80homo-hexamerHHblits0.58
1wnc.1.C
E2 glycoprotein
Crystal structure of the SARS-CoV Spike protein fusion core
0.0095.350.03 1161-1203X-ray2.80homo-hexamerHHblits0.58
1wnc.1.D
E2 glycoprotein
Crystal structure of the SARS-CoV Spike protein fusion core
0.0095.350.03 1161-1203X-ray2.80homo-hexamerHHblits0.58
1wnc.1.E
E2 glycoprotein
Crystal structure of the SARS-CoV Spike protein fusion core
0.0095.350.03 1161-1203X-ray2.80homo-hexamerHHblits0.58
1wnc.1.F
E2 glycoprotein
Crystal structure of the SARS-CoV Spike protein fusion core
0.0095.350.03 1161-1203X-ray2.80homo-hexamerHHblits0.58
1m1j.1.C
Fibrinogen gamma chain
Crystal structure of native chicken fibrinogen with two different bound ligands
0.009.520.05 927-989X-ray2.70hetero-2-2-2-mer4 x NDG, 4 x CA, 2 x GLY-PRO-ARG-PRO, 2 x GLY-HIS-ARG-PROHHblits0.28
1m1j.1.F
Fibrinogen gamma chain
Crystal structure of native chicken fibrinogen with two different bound ligands
0.009.520.05 927-989X-ray2.70hetero-2-2-2-mer4 x NDG, 4 x CA, 2 x GLY-PRO-ARG-PRO, 2 x GLY-HIS-ARG-PROHHblits0.28
6grj.1.A
AhlB
Structure of the AhlB pore of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.0021.310.05 932-992X-ray2.94homo-10-merHHblits0.30
6grj.1.B
AhlB
Structure of the AhlB pore of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.0021.310.05 932-992X-ray2.94homo-10-merHHblits0.30
3lg7.1.A
4E10_S0_1EZ3A_002_C (T246)
Crystal structure of HIV epitope-scaffold 4E10_S0_1EZ3A_002_C
0.009.380.05 956-1019X-ray2.50homo-trimerHHblits0.26
3p8c.1.E
Abl interactor 2
Structure and Control of the Actin Regulatory WAVE Complex
0.0019.670.05 941-1003X-ray2.29hetero-oligomerHHblits0.30
7usc.1.E
Abl interactor 2
Cryo-EM structure of WAVE Regulatory Complex
0.0019.670.05 941-1003EM0.00hetero-1-1-1-1-1-merHHblits0.30
7usd.1.E
Abl interactor 2
Cryo-EM structure of D-site Rac1-bound WAVE Regulatory Complex
0.0019.670.05 941-1003EM0.00hetero-1-1-1-1-1-1-…1 x GTP, 1 x MGHHblits0.30
7use.1.E
Abl interactor 2
Cryo-EM structure of WAVE regulatory complex with Rac1 bound on both A and D site
0.0019.670.05 941-1003EM0.00hetero-1-1-1-1-1-1-…1 x GNP, 2 x MG, 1 x GTPHHblits0.30
2bez.1.B
Spike glycoprotein
Structure of a proteolitically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein
0.00100.000.03 1160-1201X-ray1.60hetero-3-3-merHHblits0.59
1mg1.1.A
PROTEIN (HTLV-1 GP21 ECTODOMAIN/MALTOSE-BINDING PROTEIN CHIMERA)
HTLV-1 GP21 ECTODOMAIN/MALTOSE-BINDING PROTEIN CHIMERA
0.0011.110.05 925-987X-ray2.50homo-trimer3 x GLC-GLCHHblits0.27
4hpq.1.C
Atg17
Crystal Structure of the Atg17-Atg31-Atg29 Complex
0.0018.330.05 945-1005X-ray3.06hetero-2-2-2-merHHblits0.31
4p1w.1.F
Atg17
Crystal structure of Atg13(17BR)-Atg17-Atg29-Atg31 complex
0.0018.330.05 945-1005X-ray3.20hetero-2-2-2-1-merHHblits0.31
4p1w.1.C
Atg17
Crystal structure of Atg13(17BR)-Atg17-Atg29-Atg31 complex
0.0018.330.05 945-1005X-ray3.20hetero-2-2-2-1-merHHblits0.31
5jhf.1.F
KLTH0D15642p
Crystal structure of Atg13(17BR)-Atg13(17LR)-Atg17-Atg29-Atg31 complex
0.0018.330.05 945-1005X-ray3.21hetero-2-2-2-2-2-merHHblits0.31
5jhf.2.C
KLTH0D15642p
Crystal structure of Atg13(17BR)-Atg13(17LR)-Atg17-Atg29-Atg31 complex
0.0018.330.05 945-1005X-ray3.21hetero-1-1-1-1-1-merHHblits0.31
5z7q.1.A
Flagellin
Crystal structure of Bacillus cereus flagellin
0.007.940.05 927-989X-ray1.85monomerHHblits0.27
6upn.1.A
Endophilin-B1
Endophilin B1 helical scaffold
0.0012.900.05 954-1016EM0.00homo-48-merHHblits0.27
6up6.1.A
Endophilin-B1
Endophilin B1 helical scaffold
0.0012.900.05 954-1016EM0.00homo-44-merHHblits0.27
6znl.1.M
Dynactin subunit 2
Cryo-EM structure of the dynactin complex
0.0016.130.05 968-1029EM0.00hetero-8-1-1-1-1-4-…9 x ADP, 1 x ATP, 3 x ZNHHblits0.27
6znl.1.N
Dynactin subunit 2
Cryo-EM structure of the dynactin complex
0.0016.130.05 968-1029EM0.00hetero-8-1-1-1-1-4-…9 x ADP, 1 x ATP, 3 x ZNHHblits0.27
6znl.1.T
Dynactin subunit 2
Cryo-EM structure of the dynactin complex
0.0016.130.05 968-1029EM0.00hetero-8-1-1-1-1-4-…9 x ADP, 1 x ATP, 3 x ZNHHblits0.27
6znl.1.U
Dynactin subunit 2
Cryo-EM structure of the dynactin complex
0.0016.130.05 968-1029EM0.00hetero-8-1-1-1-1-4-…9 x ADP, 1 x ATP, 3 x ZNHHblits0.27
7zr2.1.B
Spike protein S2'
Crystal structure of a chimeric protein mimic of SARS-CoV-2 Spike HR1 in complex with HR2
0.0095.240.03 1165-1206X-ray1.45hetero-1-1-merHHblits0.57
2nps.1.D
Syntaxin-6
Crystal Structure of the Early Endosomal SNARE Complex
0.0013.560.05 927-989X-ray2.50hetero-1-1-1-1-merHHblits0.30
8dyu.1.A
Cytoplasmic dynein 1 heavy chain 1
Structure of human cytoplasmic dynein-1 bound to two Lis1 proteins
0.0013.330.05 933-992EM0.00hetero-1-2-mer3 x ADP, 1 x ATPHHblits0.28
8dyv.1.A
Cytoplasmic dynein 1 heavy chain 1
Structure of human cytoplasmic dynein-1 bound to one Lis1
0.0013.330.05 933-992EM0.00hetero-1-1-mer3 x ADP, 1 x ATPHHblits0.28
7kzm.1.6
Outer dynein arm-docking complex subunit 1
Outer dynein arm bound to doublet microtubules from C. reinhardtii
0.009.840.05 970-1030EM0.00hetero-8-6-1-1-1-1-…7 x GTP, 7 x MG, 8 x GDPHHblits0.27
6u42.439.A
DC1
Natively decorated ciliary doublet microtubule
0.009.840.05 970-1030EM0.00monomerHHblits0.27
6u42.440.A
DC1
Natively decorated ciliary doublet microtubule
0.009.840.05 970-1030EM0.00monomerHHblits0.27
7kzo.1.P
Outer dynein arm-docking complex subunit 1
Outer dynein arm docking complex bound to doublet microtubules from C. reinhardtii
0.009.840.05 970-1030EM0.00hetero-8-6-1-2-2-1-…7 x GTP, 7 x MG, 8 x GDPHHblits0.27
3oa7.1.A
Head morphogenesis protein, Chaotic nuclear migration protein 67 fusion protein
Structure of the C-terminal domain of Cnm67, a core component of the spindle pole body of Saccharomyces cerevisiae
0.0016.950.05 919-977X-ray2.30homo-dimerHHblits0.29
7rzq.1.D
Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex
0.00100.000.03 1162-1201EM0.00hetero-3-3-merHHblits0.59
7rzq.1.E
Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex
0.00100.000.03 1162-1201EM0.00hetero-3-3-merHHblits0.59
7rzq.1.F
Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex
0.00100.000.03 1162-1201EM0.00hetero-3-3-merHHblits0.59
7rzr.1.D
Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with D936Y mutation
0.00100.000.03 1162-1201EM0.00hetero-3-3-merHHblits0.59
7rzr.1.E
Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with D936Y mutation
0.00100.000.03 1162-1201EM0.00hetero-3-3-merHHblits0.59
7rzr.1.F
Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with D936Y mutation
0.00100.000.03 1162-1201EM0.00hetero-3-3-merHHblits0.59
7rzs.1.D
Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with L938F mutation
0.00100.000.03 1162-1201EM0.00hetero-3-3-merHHblits0.59
7rzs.1.E
Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with L938F mutation
0.00100.000.03 1162-1201EM0.00hetero-3-3-merHHblits0.59
7rzs.1.F
Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with L938F mutation
0.00100.000.03 1162-1201EM0.00hetero-3-3-merHHblits0.59
7rzt.1.D
Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with S940F mutation
0.00100.000.03 1162-1201EM0.00hetero-3-3-merHHblits0.59
7rzt.1.E
Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with S940F mutation
0.00100.000.03 1162-1201EM0.00hetero-3-3-merHHblits0.59
7rzt.1.F
Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with S940F mutation
0.00100.000.03 1162-1201EM0.00hetero-3-3-merHHblits0.59
7rzu.1.D
Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with A942S mutation
0.00100.000.03 1162-1201EM0.00hetero-3-3-merHHblits0.59
7rzu.1.E
Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with A942S mutation
0.00100.000.03 1162-1201EM0.00hetero-3-3-merHHblits0.59
7rzu.1.F
Spike protein S2'
Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with A942S mutation
0.00100.000.03 1162-1201EM0.00hetero-3-3-merHHblits0.59
7s5u.1.A
Kinesin-like protein Klp61F
Extended bipolar assembly domain of kinesin-5 minifilament
0.0014.040.04 918-974X-ray4.41homo-tetramerHHblits0.31
7s5u.1.B
Kinesin-like protein Klp61F
Extended bipolar assembly domain of kinesin-5 minifilament
0.0014.040.04 918-974X-ray4.41homo-tetramerHHblits0.31
7s5u.1.C
Kinesin-like protein Klp61F
Extended bipolar assembly domain of kinesin-5 minifilament
0.0014.040.04 918-974X-ray4.41homo-tetramerHHblits0.31
7s5u.1.D
Kinesin-like protein Klp61F
Extended bipolar assembly domain of kinesin-5 minifilament
0.0014.040.04 918-974X-ray4.41homo-tetramerHHblits0.31
1br0.1.A
PROTEIN (SYNTAXIN 1-A)
THREE DIMENSIONAL STRUCTURE OF THE N-TERMINAL DOMAIN OF SYNTAXIN 1A
0.0013.560.05 962-1020NMR0.00monomerHHblits0.29
3a5x.1.A
Flagellin
L-type straight flagellar filament made of full-length flagellin
0.0015.790.04 938-994EM4.00monomerHHblits0.31
1ucu.1.A
phase 1 Flagellin
R-type straight flagellar filament made of full-length flagellin
0.0015.790.04 938-994EM4.00monomerHHblits0.31
2w4u.1.K
TROPOMYOSIN ALPHA-1 CHAIN
Isometrically contracting insect asynchronous flight muscle quick frozen after a length step
0.0022.410.05 975-1035EM35.00hetero-oligomerHHblits0.30
2w4u.1.L
TROPOMYOSIN ALPHA-1 CHAIN
Isometrically contracting insect asynchronous flight muscle quick frozen after a length step
0.0022.410.05 975-1035EM35.00hetero-oligomerHHblits0.30
7fcs.1.A
Apolipoprotein E
Crystal structure of the N-terminal domain of mutants of Human Apolipoprotein-E (ApoE)
0.008.330.05 957-1016X-ray1.60monomerHHblits0.27
7fcr.1.A
Apolipoprotein E
Crystal structure of the N-terminal domain of mutants of Human Apolipoprotein-E (ApoE)
0.008.330.05 957-1016X-ray1.40monomerHHblits0.27
1zva.1.A
E2 glycoprotein
A structure-based mechanism of SARS virus membrane fusion
0.0086.050.03 944-986X-ray1.50homo-dimerHHblits0.52
1wdf.1.A
E2 glycoprotein
crystal structure of MHV spike protein fusion core
0.0025.930.04 1146-1202X-ray2.50homo-hexamerHHblits0.34
1wdf.1.B
E2 glycoprotein
crystal structure of MHV spike protein fusion core
0.0025.930.04 1146-1202X-ray2.50homo-hexamerHHblits0.34
7ung.56.A
Tektin-3
48-nm repeat of the human respiratory doublet microtubule
0.0016.950.05 813-878EM0.00monomerHHblits0.27
7ung.57.A
Tektin-3
48-nm repeat of the human respiratory doublet microtubule
0.0016.950.05 813-878EM0.00monomerHHblits0.27
7ung.58.A
Tektin-3
48-nm repeat of the human respiratory doublet microtubule
0.0016.950.05 813-878EM0.00monomerHHblits0.27
2lem.1.A
Apolipoprotein A-I
Monomeric Mouse ApoAI(1-216)
0.0013.560.05 958-1016NMR0.00monomerHHblits0.27
7rro.56.A
Tektin-3
Structure of the 48-nm repeat doublet microtubule from bovine tracheal cilia
0.0015.250.05 813-878EM0.00monomerHHblits0.27
7rro.57.A
Tektin-3
Structure of the 48-nm repeat doublet microtubule from bovine tracheal cilia
0.0015.250.05 813-878EM0.00monomerHHblits0.27
7rro.58.A
Tektin-3
Structure of the 48-nm repeat doublet microtubule from bovine tracheal cilia
0.0015.250.05 813-878EM0.00monomerHHblits0.27
7rro.61.A
Tektin-3
Structure of the 48-nm repeat doublet microtubule from bovine tracheal cilia
0.0015.250.05 813-878EM0.00monomerHHblits0.27
7rro.62.A
Tektin-3
Structure of the 48-nm repeat doublet microtubule from bovine tracheal cilia
0.0015.250.05 813-878EM0.00monomerHHblits0.27
7rro.63.A
Tektin-3
Structure of the 48-nm repeat doublet microtubule from bovine tracheal cilia
0.0015.250.05 813-878EM0.00monomerHHblits0.27
7rro.64.A
Tektin-3
Structure of the 48-nm repeat doublet microtubule from bovine tracheal cilia
0.0015.250.05 813-878EM0.00monomerHHblits0.27
7rro.120.A
Tektin-3
Structure of the 48-nm repeat doublet microtubule from bovine tracheal cilia
0.0015.250.05 813-878EM0.00monomerHHblits0.27
7rro.121.A
Tektin-3
Structure of the 48-nm repeat doublet microtubule from bovine tracheal cilia
0.0015.250.05 813-878EM0.00monomerHHblits0.27
7rro.122.A
Tektin-3
Structure of the 48-nm repeat doublet microtubule from bovine tracheal cilia
0.0015.250.05 813-878EM0.00monomerHHblits0.27
7rro.123.A
Tektin-3
Structure of the 48-nm repeat doublet microtubule from bovine tracheal cilia
0.0015.250.05 813-878EM0.00monomerHHblits0.27
2kbb.1.A
Talin-1
Solution Structure of the R9 Domain of Talin
0.0011.860.05 930-988NMR0.00monomerHHblits0.27
7wxz.1.A
Spike protein S2'
Crystal structure of the recombinant protein HR121 from the S2 protein of SARS-CoV-2
0.0095.000.03 1169-1208X-ray2.41homo-dimerHHblits0.57
7wxz.1.B
Spike protein S2'
Crystal structure of the recombinant protein HR121 from the S2 protein of SARS-CoV-2
0.0095.000.03 1169-1208X-ray2.41homo-dimerHHblits0.57
7wxz.2.A
Spike protein S2'
Crystal structure of the recombinant protein HR121 from the S2 protein of SARS-CoV-2
0.0095.000.03 1169-1208X-ray2.41homo-dimerHHblits0.57
7wxz.2.B
Spike protein S2'
Crystal structure of the recombinant protein HR121 from the S2 protein of SARS-CoV-2
0.0095.000.03 1169-1208X-ray2.41homo-dimerHHblits0.57
6iwb.1.A
Apolipoprotein E
Crystal structure of a computationally designed protein (LD3) in complex with BCL-2
0.0010.340.05 957-1014X-ray2.50hetero-1-1-merHHblits0.28
6iwb.2.A
Apolipoprotein E
Crystal structure of a computationally designed protein (LD3) in complex with BCL-2
0.0010.340.05 957-1014X-ray2.50hetero-1-1-merHHblits0.28
3r2p.1.A
Apolipoprotein A-I
2.2 Angstrom Crystal Structure of C Terminal Truncated Human Apolipoprotein A-I Reveals the Assembly of HDL by Dimerization.
0.006.670.05 957-1016X-ray2.20homo-dimerHHblits0.25
4f7g.1.B
Talin-1
Crystal structure of talin autoinhibition complex
0.0012.070.05 934-991X-ray2.05hetero-oligomerHHblits0.28
7uvj.1.A
Apolipoprotein E
Rationally Designed ED1 Epitope-Scaffold Immunogen for SARS-CoV-2
0.006.780.05 958-1016X-ray1.99monomerHHblits0.26
7uvj.2.A
Apolipoprotein E
Rationally Designed ED1 Epitope-Scaffold Immunogen for SARS-CoV-2
0.006.780.05 958-1016X-ray1.99monomerHHblits0.26
1lpe.1.A
APOLIPOPROTEIN E3
THREE-DIMENSIONAL STRUCTURE OF THE LDL RECEPTOR-BINDING DOMAIN OF HUMAN APOLIPOPROTEIN E
0.006.780.05 958-1016X-ray2.25monomerHHblits0.26
1ea8.1.A
APOLIPOPROTEIN E
APOLIPOPROTEIN E3 22KD FRAGMENT LYS146GLU MUTANT
0.006.780.05 958-1016X-ray1.95monomerHHblits0.26
1b68.1.A
APOLIPOPROTEIN E
APOLIPOPROTEIN E4 (APOE4), 22K FRAGMENT
0.006.780.05 958-1016X-ray2.00monomerHHblits0.26
1nfo.1.A
APOLIPOPROTEIN E2
APOLIPOPROTEIN E2 (APOE2, D154A MUTATION)
0.006.780.05 958-1016X-ray2.00monomerHHblits0.26
4ilo.1.A
CT398
2.12A resolution structure of CT398 from Chlamydia trachomatis
0.0010.530.04 933-989X-ray2.12monomer1 x ZNHHblits0.28
4ilo.2.A
CT398
2.12A resolution structure of CT398 from Chlamydia trachomatis
0.0010.530.04 933-989X-ray2.12monomer1 x ZNHHblits0.28
6q0x.1.A
Sorting nexin MVP1
The cryo-EM structure of the SNX-BAR Mvp1 tetramer
0.0015.790.04 932-988EM0.00homo-tetramerHHblits0.28
1or2.1.A
APOLIPOPROTEIN E
APOLIPOPROTEIN E3 (APOE3) TRUNCATION MUTANT 165
0.006.900.05 958-1015X-ray2.50monomerHHblits0.26
1or3.1.A
PROTEIN (APOLIPOPROTEIN E)
APOLIPOPROTEIN E3 (APOE3), TRIGONAL TRUNCATION MUTANT 165
0.006.900.05 958-1015X-ray1.73monomerHHblits0.26
7wot.1.W
Nucleoporin NSP1
Cryo-EM structure of the inner ring monomer of the Saccharomyces cerevisiae nuclear pore complex
0.0018.870.04 953-1005EM0.00hetero-4-2-2-2-2-4-…HHblits0.33
7n85.1.K
Nucleoporin NSP1
Inner ring spoke from the isolated yeast NPC
0.0018.870.04 953-1005EM0.00hetero-2-2-2-4-4-4-…HHblits0.33
7n85.1.N
Nucleoporin NSP1
Inner ring spoke from the isolated yeast NPC
0.0018.870.04 953-1005EM0.00hetero-2-2-2-4-4-4-…HHblits0.33
7n9f.1.E
Nucleoporin NSP1
Structure of the in situ yeast NPC
0.0018.870.04 953-1005EM0.00hetero-2-2-2-6-4-4-…HHblits0.33
7n9f.1.H
Nucleoporin NSP1
Structure of the in situ yeast NPC
0.0018.870.04 953-1005EM0.00hetero-2-2-2-6-4-4-…HHblits0.33
7n9f.1.K
Nucleoporin NSP1
Structure of the in situ yeast NPC
0.0018.870.04 953-1005EM0.00hetero-2-2-2-6-4-4-…HHblits0.33
7n9f.1.N
Nucleoporin NSP1
Structure of the in situ yeast NPC
0.0018.870.04 953-1005EM0.00hetero-2-2-2-6-4-4-…HHblits0.33
7n9f.1.8
Nucleoporin NSP1
Structure of the in situ yeast NPC
0.0018.870.04 953-1005EM0.00hetero-2-2-2-6-4-4-…HHblits0.33
7n9f.1.9
Nucleoporin NSP1
Structure of the in situ yeast NPC
0.0018.870.04 953-1005EM0.00hetero-2-2-2-6-4-4-…HHblits0.33
7n85.1.E
Nucleoporin NSP1
Inner ring spoke from the isolated yeast NPC
0.0018.870.04 953-1005EM0.00hetero-2-2-2-4-4-4-…HHblits0.33
7n85.1.H
Nucleoporin NSP1
Inner ring spoke from the isolated yeast NPC
0.0018.870.04 953-1005EM0.00hetero-2-2-2-4-4-4-…HHblits0.33
7woo.1.H
Nucleoporin NSP1
Cryo-EM structure of the inner ring protomer of the Saccharomyces cerevisiae nuclear pore complex
0.0018.870.04 953-1005EM0.00hetero-2-1-1-1-1-2-…HHblits0.33
6mam.1.H
Envelope glycoprotein
Cleaved Ebola GP in complex with a broadly neutralizing human antibody, ADI-15946
0.0017.860.04 910-965X-ray4.10hetero-3-3-3-3-merHHblits0.29
4phq.1.A
Hemolysin E, chromosomal
ClyA CC6/264 ox (6-303)
0.0020.000.04 917-975X-ray1.94monomerHHblits0.30
4phq.2.A
Hemolysin E, chromosomal
ClyA CC6/264 ox (6-303)
0.0020.000.04 917-975X-ray1.94monomerHHblits0.30
4phq.3.A
Hemolysin E, chromosomal
ClyA CC6/264 ox (6-303)
0.0020.000.04 917-975X-ray1.94monomerHHblits0.30
4phq.4.A
Hemolysin E, chromosomal
ClyA CC6/264 ox (6-303)
0.0020.000.04 917-975X-ray1.94monomerHHblits0.30
4pho.1.A
Hemolysin E, chromosomal
ClyA CC6/264 ox (2-303)
0.0020.000.04 917-975X-ray2.12monomerHHblits0.30
4pho.2.A
Hemolysin E, chromosomal
ClyA CC6/264 ox (2-303)
0.0020.000.04 917-975X-ray2.12monomerHHblits0.30
2kvp.1.A
Talin-1
Solution Structure of the R10 Domain of Talin
0.0018.180.04 926-980NMR0.00monomerHHblits0.30
6mrt.1.A
Hemolysin E, chromosomal
12-meric ClyA pore complex
0.0020.000.04 917-975EM0.00homo-12-merHHblits0.30
6mrw.1.A
Hemolysin E, chromosomal
14-meric ClyA pore complex
0.0020.000.04 917-975EM0.00homo-14-merHHblits0.30
2b0h.1.A
Talin-1
Solution structure of VBS3 fragment of talin
0.0018.180.04 927-981NMR0.00monomerHHblits0.30
3n27.1.A
Fusion glycoprotein F0, linker, Fusion glycoprotein F0
Molecular Basis of the Inhibition of Henipa Viruses
0.0022.220.04 927-986X-ray1.80homo-trimerHHblits0.31
3n27.1.B
Fusion glycoprotein F0, linker, Fusion glycoprotein F0
Molecular Basis of the Inhibition of Henipa Viruses
0.0022.220.04 927-986X-ray1.80homo-trimerHHblits0.31
4k1p.1.A
NheA
Structure of the NheA component of the Nhe toxin from Bacillus cereus
0.0012.730.04 979-1033X-ray2.05monomerHHblits0.29
8auc.1.A
Cell wall-associated hydrolases (Invasion-associated proteins)
Structure of peptidoglycan hydrolase Cg1735 from Corynebacterium glutamicum, trigonal crystal form
0.0012.500.04 940-995X-ray3.50monomer1 x PC4HHblits0.28
8auc.2.A
Cell wall-associated hydrolases (Invasion-associated proteins)
Structure of peptidoglycan hydrolase Cg1735 from Corynebacterium glutamicum, trigonal crystal form
0.0012.500.04 940-995X-ray3.50monomer1 x PC4HHblits0.28
6cfe.1.A
Mutant of Apolipoprotein E3 (APO-E3)
Crystal structure of C2S5: A computationally designed immunogen to target Carbohydrate-Occluded Epitopes on the HIV envelope
0.008.930.04 958-1013X-ray1.99monomerHHblits0.28
6ncn.1.A
Apolipoprotein E
Fragment-based Discovery of an apoE4 Stabilizer
0.007.020.04 958-1014X-ray1.82monomer1 x KJMHHblits0.26
5j1i.1.A
Plectin
Structure of the spectrin repeats 7, 8, and 9 of the plakin domain of plectin
0.0014.040.04 957-1016X-ray2.80monomerHHblits0.26
6v7m.1.A
Apolipoprotein E
Crystal structure of a proteolytically cleaved, amino terminal domain of apolipoprotein E3
0.008.930.04 957-1012X-ray2.00hetero-1-1-merHHblits0.27
7ek6.1.B
Spike protein S2
Structure of viral peptides IPB19/N52
0.00100.000.03 1175-1211X-ray1.24hetero-3-3-merHHblits0.59
7ek6.1.D
Spike protein S2
Structure of viral peptides IPB19/N52
0.00100.000.03 1175-1211X-ray1.24hetero-3-3-merHHblits0.59
7ek6.1.F
Spike protein S2
Structure of viral peptides IPB19/N52
0.00100.000.03 1175-1211X-ray1.24hetero-3-3-merHHblits0.59
1qoy.1.A
HEMOLYSIN E
E.coli Hemolysin E (HlyE, ClyA, SheA)
0.0018.520.04 917-974X-ray2.00monomerHHblits0.30
2wcd.1.A
HEMOLYSIN E, CHROMOSOMAL
CRYSTAL STRUCTURE OF THE ASSEMBLED CYTOLYSIN A PORE
0.0018.520.04 917-974X-ray3.29homo-24-mer48 x EMCHHblits0.30
1bz4.1.A
PROTEIN (APOLIPOPROTEIN E)
APOLIPOPROTEIN E3 (APO-E3), TRUNCATION MUTANT 165
0.007.140.04 959-1014X-ray1.85monomerHHblits0.26
1m1j.1.A
Fibrinogen alpha subunit
Crystal structure of native chicken fibrinogen with two different bound ligands
0.0022.000.04 963-1018X-ray2.70hetero-2-2-2-mer4 x NDG, 4 x CA, 2 x GLY-PRO-ARG-PRO, 2 x GLY-HIS-ARG-PROHHblits0.35
1m1j.1.D
Fibrinogen alpha subunit
Crystal structure of native chicken fibrinogen with two different bound ligands
0.0022.000.04 963-1018X-ray2.70hetero-2-2-2-mer4 x NDG, 4 x CA, 2 x GLY-PRO-ARG-PRO, 2 x GLY-HIS-ARG-PROHHblits0.35
6f0k.1.G
ActH
Alternative complex III
0.0020.750.04 968-1020EM0.00hetero-1-1-1-1-1-1-…6 x HEC, 1 x F3S, 3 x SF4HHblits0.30
3efg.1.A
Protein slyX homolog
Structure of SlyX protein from Xanthomonas campestris pv. campestris str. ATCC 33913
0.0012.730.04 973-1031X-ray2.00homo-trimerHHblits0.27
6fln.1.B
E3 ubiquitin/ISG15 ligase TRIM25
Crystal structure of the human TRIM25 coiled-coil and PRYSPRY domains
0.0012.960.04 928-981X-ray3.60homo-dimerHHblits0.29
6fln.1.A
E3 ubiquitin/ISG15 ligase TRIM25
Crystal structure of the human TRIM25 coiled-coil and PRYSPRY domains
0.0012.960.04 928-981X-ray3.60homo-dimerHHblits0.29
6gaj.1.A
Outer capsid protein sigma-1
Crystal structure of the T1L reovirus sigma1 coiled coil tail (iodide)
0.0012.960.04 932-989X-ray1.35homo-trimerHHblits0.28
6gaj.1.B
Outer capsid protein sigma-1
Crystal structure of the T1L reovirus sigma1 coiled coil tail (iodide)
0.0012.960.04 932-989X-ray1.35homo-trimerHHblits0.28
6gaj.1.C
Outer capsid protein sigma-1
Crystal structure of the T1L reovirus sigma1 coiled coil tail (iodide)
0.0012.960.04 932-989X-ray1.35homo-trimerHHblits0.28
6ea5.1.B
Glycoprotein
Structure of BDBV GPcl in complex with the pan-ebolavirus mAb ADI-15878
0.0014.810.04 911-964X-ray4.75hetero-3-3-3-3-mer2 x NAG, 1 x NAG-NAG-BMA-MAN-NAG-MAN, 1 x NAG-NAG-BMA-MAN-MANHHblits0.28
6ea5.1.D
Glycoprotein
Structure of BDBV GPcl in complex with the pan-ebolavirus mAb ADI-15878
0.0014.810.04 911-964X-ray4.75hetero-3-3-3-3-mer2 x NAG, 1 x NAG-NAG-BMA-MAN-NAG-MAN, 1 x NAG-NAG-BMA-MAN-MANHHblits0.28
4nkj.1.A
Hemagglutinin HA2
Structure of influenza B virus hemagglutinin at membrane fusion pH
0.0019.610.04 945-997X-ray2.45homo-trimerHHblits0.33
6ea7.1.B
Envelope glycoprotein
Structure of EBOV GPcl in complex with the pan-ebolavirus mAb ADI-15878
0.0016.670.04 912-965X-ray4.25hetero-3-3-3-3-mer2 x NAG, 1 x NAG-NAG-FUC, 2 x NAG-NAG-BMA-MAN-NAG-GAL-MAN-NAG, 1 x NAG-NAG-BMA-MAN-NAG-MAN-NAGHHblits0.28
6ea7.1.D
Envelope glycoprotein
Structure of EBOV GPcl in complex with the pan-ebolavirus mAb ADI-15878
0.0016.670.04 912-965X-ray4.25hetero-3-3-3-3-mer2 x NAG, 1 x NAG-NAG-FUC, 2 x NAG-NAG-BMA-MAN-NAG-GAL-MAN-NAG, 1 x NAG-NAG-BMA-MAN-NAG-MAN-NAGHHblits0.28
7zgx.1.A
S-layer protein SlpA
S-layer Deinoxanthin Binding Complex, C1 symmetry
0.0028.000.04 972-1022EM0.00homo-trimerHHblits0.34
8ae1.1.A
S-layer protein SlpA
Structure of trimeric SlpA outer membrane protein
0.0028.000.04 972-1022EM0.00homo-trimer18 x CAHHblits0.34
6w16.1.A
Fusion glycoprotein F0,Envelope glycoprotein fusion
Crystal structure of a human metapneumovirus monomeric fusion protein complexed with 458 Fab
0.0017.310.04 928-979X-ray3.10hetero-1-1-1-mer1 x NAG, 1 x NAG-NAG-BMA-MAN-MANHHblits0.30
1gs9.1.A
APOLIPOPROTEIN E
APOLIPOPROTEIN E4, 22K DOMAIN
0.007.410.04 958-1011X-ray1.70monomerHHblits0.27
4pxt.1.A
Bipolar kinesin KRP-130
Structural basis for the assembly of the mitotic motor kinesin-5 into bipolar tetramers
0.0013.730.04 922-972X-ray2.90homo-tetramerHHblits0.31
4pxt.1.B
Bipolar kinesin KRP-130
Structural basis for the assembly of the mitotic motor kinesin-5 into bipolar tetramers
0.0013.730.04 922-972X-ray2.90homo-tetramerHHblits0.31
4pxu.1.A
Bipolar kinesin KRP-130
Structural basis for the assembly of the mitotic motor kinesin-5 into bipolar tetramers
0.0013.730.04 922-972X-ray2.60homo-tetramerHHblits0.31
4pxu.1.B
Bipolar kinesin KRP-130
Structural basis for the assembly of the mitotic motor kinesin-5 into bipolar tetramers
0.0013.730.04 922-972X-ray2.60homo-tetramerHHblits0.31
3h32.1.A
Fibrinogen alpha chain
Crystal structure of D-dimer from human fibrin complexed with Gly-His-Arg-Pro-Tyr-amide
0.0020.000.04 964-1019X-ray3.60hetero-2-2-2-mer4 x CA, 2 x GLY-HIS-ARG-PRO-TYR, 2 x NAG-NAG-MAN-MAN-NAG-GAL-SIA-MANHHblits0.32
5maw.1.A
Flagellin
Crystal structure of the flagellin-FliS complex from Bacillus subtilis
0.007.550.04 935-987X-ray1.50hetero-1-1-merHHblits0.28
7whm.1.A
PPPDE domain-containing protein
Closed spike of Bombyx mori cytoplasmic polyhedrosis virus
0.0024.490.04 948-998EM0.00monomerHHblits0.33
7whn.1.A
PPPDE domain-containing protein
Opened spike of Bombyx mori cytoplasmic polyhedrosis virus
0.0024.490.04 948-998EM0.00monomerHHblits0.33
6znl.1.M
Dynactin subunit 2
Cryo-EM structure of the dynactin complex
0.0015.380.04 937-988EM0.00hetero-8-1-1-1-1-4-…9 x ADP, 1 x ATP, 3 x ZNHHblits0.29
6znl.1.N
Dynactin subunit 2
Cryo-EM structure of the dynactin complex
0.0015.380.04 937-988EM0.00hetero-8-1-1-1-1-4-…9 x ADP, 1 x ATP, 3 x ZNHHblits0.29
6znl.1.T
Dynactin subunit 2
Cryo-EM structure of the dynactin complex
0.0015.380.04 937-988EM0.00hetero-8-1-1-1-1-4-…9 x ADP, 1 x ATP, 3 x ZNHHblits0.29
6znl.1.U
Dynactin subunit 2
Cryo-EM structure of the dynactin complex
0.0015.380.04 937-988EM0.00hetero-8-1-1-1-1-4-…9 x ADP, 1 x ATP, 3 x ZNHHblits0.29
5xbj.1.A
Flagellar hook-associated protein FlgK
The structure of the flagellar hook junction protein HAP1 (FlgK) from Campylobacter jejuni
0.0013.730.04 916-966X-ray2.45monomerHHblits0.30
4zxl.1.A
O-GlcNAcase NagJ
CpOGA D298N in complex with Drosophila HCF -derived Thr-O-GlcNAc peptide
0.0019.610.04 977-1033X-ray2.60monomer1 x NAG, 15 x CD, 1 x PRO-SER-THR-ALAHHblits0.30
8fed.1.B
Virulence factor Mce family protein
Structure of Mce1-LucB complex from Mycobacterium smegmatis (Map1)
0.0020.000.04 918-967EM0.00hetero-1-1-1-1-1-1-…HHblits0.31
6n9h.1.A
amantadine-binding protein
De novo designed homo-trimeric amantadine-binding protein
0.0026.530.04 958-1006X-ray1.04homo-trimer3 x 308HHblits0.33
6naf.1.A
amantadine-binding protein
De novo designed homo-trimeric amantadine-binding protein
0.0026.530.04 958-1006neutron diff.2.50homo-trimer3 x 308HHblits0.33
2oev.1.A
Programmed cell death 6-interacting protein
Crystal structure of ALIX/AIP1
0.0029.170.04 945-992X-ray3.30monomerHHblits0.34
8e15.1.B
F1 protein with Fibritin peptide
A computationally stabilized hMPV F protein
0.0018.000.04 928-977X-ray2.41hetero-3-3-mer6 x NAG, 3 x NAG-NAG-BMAHHblits0.31
6fpd.1.A
Protein AB21
AB21 protein from Agaricus bisporus
0.0020.410.04 914-967X-ray2.50homo-dimerHHblits0.32
7tl0.1.B
Fusion glycoprotein F0
Cryo-EM structure of hMPV preF bound by Fabs MPE8 and SAN32-2
0.0018.000.04 928-977EM0.00hetero-3-3-3-3-3-mer6 x NAG, 3 x NAG-NAGHHblits0.30
7tjq.1.F
Fusion glycoprotein F0
SAN27-14 bound to a antigenic site V on prefusion-stabilized hMPV F
0.0018.000.04 928-977EM0.00hetero-3-3-3-3-3-mer6 x NAG-NAGHHblits0.30
8cw9.1.A
Fusion glycoprotein F0
Prefusion-stabilized hMPV fusion protein bound to ADI-61026 and MPE8 Fabs
0.0018.000.04 928-977EM0.00hetero-3-3-3-3-3-mer3 x NAGHHblits0.30
1zv8.1.B
E2 glycoprotein
A structure-based mechanism of SARS virus membrane fusion
0.00100.000.03 1169-1203X-ray1.94hetero-oligomerHHblits0.58
1zv8.1.D
E2 glycoprotein
A structure-based mechanism of SARS virus membrane fusion
0.00100.000.03 1169-1203X-ray1.94hetero-oligomerHHblits0.58
1zv8.2.D
E2 glycoprotein
A structure-based mechanism of SARS virus membrane fusion
0.00100.000.03 1169-1203X-ray1.94hetero-oligomer1 x CAC, 2 x ZNHHblits0.58
6lvn.1.D
Spike protein S2'
Structure of the 2019-nCoV HR2 Domain
0.00100.000.03 1169-1203X-ray2.47homo-tetramerHHblits0.58
6lvn.1.B
Spike protein S2'
Structure of the 2019-nCoV HR2 Domain
0.00100.000.03 1169-1203X-ray2.47homo-tetramerHHblits0.58
6lvn.1.A
Spike protein S2'
Structure of the 2019-nCoV HR2 Domain
0.00100.000.03 1169-1203X-ray2.47homo-tetramerHHblits0.58
6lvn.1.C
Spike protein S2'
Structure of the 2019-nCoV HR2 Domain
0.00100.000.03 1169-1203X-ray2.47homo-tetramerHHblits0.58
7y9n.1.B
SARS-coV-2 S2 subunit
an engineered 5-helix bundle derived from SARS-CoV-2 S2 in complex with HR2P
0.00100.000.03 1169-1203X-ray1.88hetero-1-1-merHHblits0.58
5ijn.1.G
NUCLEAR PORE COMPLEX PROTEIN NUP58
Composite structure of the inner ring of the human nuclear pore complex (32 copies of Nup205)
0.0020.830.04 1139-1188EM0.00hetero-6-4-4-4-4-4-…HHblits0.33
7r5k.49.A
Nucleoporin p58/p45
Human nuclear pore complex (constricted)
0.0020.830.04 1139-1188EM0.00monomerHHblits0.33
1le2.1.A
APOLIPOPROTEIN E2
STRUCTURAL BASIS FOR ALTERED FUNCTION IN THE COMMON MUTANTS OF HUMAN APOLIPOPROTEIN-E
0.007.690.04 961-1012X-ray3.00monomerHHblits0.27
4cfg.1.A
E3 UBIQUITIN/ISG15 LIGASE TRIM25
Structure of the TRIM25 coiled-coil
0.0014.000.04 929-978X-ray2.80homo-dimerHHblits0.30
4cfg.1.B
E3 UBIQUITIN/ISG15 LIGASE TRIM25
Structure of the TRIM25 coiled-coil
0.0014.000.04 929-978X-ray2.80homo-dimerHHblits0.30
7tbi.46.A
Nsp1
Composite structure of the S. cerevisiae nuclear pore complex (NPC)
0.0016.670.04 959-1006EM0.00monomerHHblits0.33
7tbi.47.A
Nsp1
Composite structure of the S. cerevisiae nuclear pore complex (NPC)
0.0016.670.04 959-1006EM0.00monomerHHblits0.33
7ur4.1.A
Fusion glycoprotein F0
Cryo-EM Structure of the Neutralizing Antibody MPV467 in Complex with Prefusion Human Metapneumovirus F Glycoprotein
0.0018.370.04 928-976EM0.00hetero-3-3-3-mer6 x NAG, 3 x NAG-NAG-BMAHHblits0.31
7ur4.1.B
Fusion glycoprotein F0
Cryo-EM Structure of the Neutralizing Antibody MPV467 in Complex with Prefusion Human Metapneumovirus F Glycoprotein
0.0018.370.04 928-976EM0.00hetero-3-3-3-mer6 x NAG, 3 x NAG-NAG-BMAHHblits0.31
7sej.1.B
Fusion glycoprotein F1 subunit
Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins
0.0018.370.04 928-976X-ray2.51hetero-1-1-mer2 x NAGHHblits0.31
7sej.2.B
Fusion glycoprotein F1 subunit
Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins
0.0018.370.04 928-976X-ray2.51hetero-1-1-mer2 x NAGHHblits0.31
7kna.1.A
Hemagglutinin,I53_dn5
Localized reconstruction of the H1 A/Michigan/45/2015 ectodomain displayed at the surface of I53_dn5 nanoparticle
0.0018.750.04 941-988EM0.00homo-trimer12 x NAG, 6 x NAG-NAGHHblits0.32
6tao.1.A
Non-hemolytic enterotoxin lytic component L1
The cytotoxin MakE from Vibrio cholerae
0.0010.000.04 939-988X-ray1.98monomer2 x NIHHblits0.29
6tao.2.A
Non-hemolytic enterotoxin lytic component L1
The cytotoxin MakE from Vibrio cholerae
0.0010.000.04 939-988X-ray1.98monomer2 x NIHHblits0.29
2raj.1.A
Sorting nexin-9
SO4 bound PX-BAR membrane remodeling unit of Sorting Nexin 9
0.008.000.04 934-983X-ray2.45homo-dimerHHblits0.29
2rai.1.A
Sorting nexin-9
The PX-BAR membrane remodeling unit of Sorting Nexin 9
0.008.000.04 934-983X-ray3.20homo-dimerHHblits0.29
2rak.1.A
Sorting nexin-9
PI(3)P bound PX-BAR membrane remodeling unit of Sorting Nexin 9
0.008.000.04 934-983X-ray3.00homo-dimer2 x PIBHHblits0.29
5wju.1.A
Flagellin
Cryo-EM structure of B. subtilis flagellar filaments A39V, N133H
0.008.000.04 938-987EM4.30homo-46-merHHblits0.29
7tbi.16.A
Nsp1
Composite structure of the S. cerevisiae nuclear pore complex (NPC)
0.0020.830.04 959-1006EM0.00monomerHHblits0.32
1zva.1.A
E2 glycoprotein
A structure-based mechanism of SARS virus membrane fusion
0.00100.000.03 1168-1201X-ray1.50homo-dimerHHblits0.58
2nt8.1.A
Cobalamin adenosyltransferase
ATP bound at the active site of a PduO type ATP:co(I)rrinoid adenosyltransferase from Lactobacillus reuteri
0.0013.730.04 941-991X-ray1.68homo-trimer3 x MG, 3 x ATPHHblits0.27
5cjq.1.D
Designed influenza hemagglutinin stem #4900, HA2
Crystal structure of a trimeric influenza hemagglutinin stem in complex with an broadly neutralizing antibody CR9114
0.0016.670.04 938-985X-ray3.60hetero-oligomerHHblits0.31
7wkk.1.U
IL4I1 protein
Cryo-EM structure of the IR subunit from X. laevis NPC
0.0012.240.04 918-966EM4.20hetero-2-2-4-6-4-4-…HHblits0.29
7wkk.1.X
IL4I1 protein
Cryo-EM structure of the IR subunit from X. laevis NPC
0.0012.240.04 918-966EM4.20hetero-2-2-4-6-4-4-…HHblits0.29
7tdz.1.5
Nup62
Cryo-EM model of protomer of the cytoplasmic ring of the nuclear pore complex from Xenopus laevis
0.0012.240.04 918-966EM0.00hetero-2-2-2-2-2-2-…HHblits0.29
7vop.1.5
IL4I1 protein
Cryo-EM structure of Xenopus laevis nuclear pore complex cytoplasmic ring subunit
0.0012.240.04 918-966EM0.00hetero-2-2-2-2-2-2-…HHblits0.29
7vop.1.2
IL4I1 protein
Cryo-EM structure of Xenopus laevis nuclear pore complex cytoplasmic ring subunit
0.0012.240.04 918-966EM0.00hetero-2-2-2-2-2-2-…HHblits0.29
5c3l.1.C
Nucleoporin Nup62
Structure of the metazoan Nup62.Nup58.Nup54 nucleoporin complex.
0.0012.240.04 918-966X-ray2.90hetero-oligomerHHblits0.29
1zvb.1.A
E2 glycoprotein
A structure-based mechanism of SARS virus membrane fusion
0.00100.000.03 958-991X-ray1.70homo-trimerHHblits0.57
2beq.1.A
Spike glycoprotein
Structure of a Proteolytically Resistant Core from the Severe Acute Respiratory Syndrome Coronavirus S2 Fusion Protein
0.0080.560.03 932-967X-ray1.60hetero-6-6-merHHblits0.53
6v8i.10.A
Fiber Lower, gp62
Composite atomic model of the Staphylococcus aureus phage 80alpha baseplate
0.0016.330.04 916-964EM0.00monomerHHblits0.29
6v8i.11.A
Fiber Lower, gp62
Composite atomic model of the Staphylococcus aureus phage 80alpha baseplate
0.0016.330.04 916-964EM0.00monomerHHblits0.29
6v8i.12.A
Fiber Lower, gp62
Composite atomic model of the Staphylococcus aureus phage 80alpha baseplate
0.0016.330.04 916-964EM0.00monomerHHblits0.29
5cjs.1.D
Designed influenza hemagglutinin stem #4454, HA2
Crystal structure of a monomeric influenza hemagglutinin stem in complex with an broadly neutralizing antibody CR9114
0.0017.020.04 939-986X-ray4.30hetero-1-1-1-1-mer1 x NAGHHblits0.32
6r1j.1.A
Uncharacterized protein
Structure of the soluble AhlC triple head mutant of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.0010.000.04 918-967X-ray1.92homo-tetramerHHblits0.27
6r1j.1.B
Uncharacterized protein
Structure of the soluble AhlC triple head mutant of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.0010.000.04 918-967X-ray1.92homo-tetramerHHblits0.27
5zuv.1.A
Spike glycoprotein,Spike glycoprotein,inhibitor EK1
Crystal Structure of the Human Coronavirus 229E HR1 motif in complex with pan-CoVs inhibitor EK1
0.0037.210.03 1162-1204X-ray2.21homo-trimerHHblits0.38
5zuv.1.B
Spike glycoprotein,Spike glycoprotein,inhibitor EK1
Crystal Structure of the Human Coronavirus 229E HR1 motif in complex with pan-CoVs inhibitor EK1
0.0037.210.03 1162-1204X-ray2.21homo-trimerHHblits0.38
5zuv.1.C
Spike glycoprotein,Spike glycoprotein,inhibitor EK1
Crystal Structure of the Human Coronavirus 229E HR1 motif in complex with pan-CoVs inhibitor EK1
0.0037.210.03 1162-1204X-ray2.21homo-trimerHHblits0.38
3g67.1.A
Methyl-accepting chemotaxis protein
Crystal Structure of a Soluble Chemoreceptor from Thermotoga maritima
0.0010.200.04 905-953X-ray2.17homo-dimerHHblits0.27
3g67.1.B
Methyl-accepting chemotaxis protein
Crystal Structure of a Soluble Chemoreceptor from Thermotoga maritima
0.0010.200.04 905-953X-ray2.17homo-dimerHHblits0.27
5hj3.1.B
Envelope glycoprotein
Crystal structure of host-primed Ebola virus GP, GPcl.
0.0016.670.04 918-965X-ray3.30hetero-3-3-3-3-merHHblits0.29
7tbm.101.A
NUP62 CCS1
Composite structure of the dilated human nuclear pore complex (NPC) generated with a 37A in situ cryo-ET map of CD4+ T cell NPC
0.0012.770.04 922-968EM0.00monomerHHblits0.30
6x45.1.A
Spike protein S2'
SARS-CoV2 spike glycoprotein N-terminal heptad repeat domain + SARS-CoV2(QEYKKEKE)
0.0075.680.03 1168-1204X-ray2.20hetero-3-3-merHHblits0.48
6x45.1.B
Spike protein S2'
SARS-CoV2 spike glycoprotein N-terminal heptad repeat domain + SARS-CoV2(QEYKKEKE)
0.0075.680.03 1168-1204X-ray2.20hetero-3-3-merHHblits0.48
6x45.1.D
Spike protein S2'
SARS-CoV2 spike glycoprotein N-terminal heptad repeat domain + SARS-CoV2(QEYKKEKE)
0.0075.680.03 1168-1204X-ray2.20hetero-3-3-merHHblits0.48
6uyn.1.B
Hemagglutinin HA1 chain
Crystal structure of influenza A virus hemagglutinin from A/Ohio/09/2015 bound to the stalk-binding CR6261 antibody Fab
0.0013.330.04 945-989X-ray2.85hetero-6-3-3-mer6 x NAG, 3 x NAG-NAGHHblits0.32
7nmq.1.A
Hemolysin BL lytic component L1
Bacillus cereus HblL1 toxin component
0.0017.780.04 940-988X-ray1.36monomerHHblits0.32
3bt6.1.B
Influenza B hemagglutinin (HA)
Crystal Structure of Influenza B Virus Hemagglutinin
0.0017.780.04 945-989X-ray2.80hetero-3-3-mer9 x NAG, 6 x NAG-NAG, 6 x NAG-NDGHHblits0.32
2rft.1.B
Influenza B hemagglutinin (HA)
Crystal structure of influenza B virus hemagglutinin in complex with LSTa receptor analog
0.0017.780.04 945-989X-ray2.80hetero-3-3-mer9 x NAG, 12 x NAG-NAG, 3 x BGC-GAL-NDG-GAL-SIAHHblits0.32
6h2e.1.A
AhlC
Structure of the soluble AhlC of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.008.160.04 926-974X-ray2.35homo-tetramerHHblits0.25
6h2d.1.B
AhlC
Structure of the soluble AhlC of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.008.160.04 926-974X-ray2.62homo-tetramerHHblits0.25
6h2d.1.C
AhlC
Structure of the soluble AhlC of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.008.160.04 926-974X-ray2.62homo-tetramerHHblits0.25
6h2d.1.D
AhlC
Structure of the soluble AhlC of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.008.160.04 926-974X-ray2.62homo-tetramerHHblits0.25
6h2d.1.A
AhlC
Structure of the soluble AhlC of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.008.160.04 926-974X-ray2.62homo-tetramerHHblits0.25
6h2e.1.B
AhlC
Structure of the soluble AhlC of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.008.160.04 926-974X-ray2.35homo-tetramerHHblits0.25
6r1j.1.A
Uncharacterized protein
Structure of the soluble AhlC triple head mutant of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.008.160.04 926-974X-ray1.92homo-tetramerHHblits0.25
6r1j.1.B
Uncharacterized protein
Structure of the soluble AhlC triple head mutant of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.008.160.04 926-974X-ray1.92homo-tetramerHHblits0.25
6z6o.1.C
HDA1 complex subunit 2
HDAC-TC
0.0017.020.04 927-973EM0.00hetero-4-4-4-4-mer8 x ZNHHblits0.28
6z6f.1.D
HDA1 complex subunit 2
HDAC-PC
0.0017.020.04 927-973EM0.00hetero-1-1-1-1-mer2 x ZNHHblits0.28
6z6h.1.C
HDA1 complex subunit 2
HDAC-DC
0.0017.020.04 927-973EM0.00hetero-2-2-2-2-mer4 x ZNHHblits0.28
6z6p.1.D
HDA1 complex subunit 2
HDAC-PC-Nuc
0.0017.020.04 927-973EM0.00hetero-1-1-1-1-1-1-…2 x ZNHHblits0.28
5zvm.1.D
pan-CoV inhibitory peptide EK1
Crystal Structure of the Human Coronavirus SARS HR1 motif in complex with pan-CoVs inhibitor EK1
0.0040.000.03 1166-1205X-ray3.30hetero-3-3-merHHblits0.39
5zvm.1.F
pan-CoV inhibitory peptide EK1
Crystal Structure of the Human Coronavirus SARS HR1 motif in complex with pan-CoVs inhibitor EK1
0.0040.000.03 1166-1205X-ray3.30hetero-3-3-merHHblits0.39
5zvk.1.E
pan-CoV inhibitory peptide EK1
Crystal Structure of the Human Coronavirus MERS HR1 motif in complex with pan-CoVs inhibitor EK1
0.0040.000.03 1166-1205X-ray3.31hetero-3-3-merHHblits0.39
5zvk.1.D
pan-CoV inhibitory peptide EK1
Crystal Structure of the Human Coronavirus MERS HR1 motif in complex with pan-CoVs inhibitor EK1
0.0040.000.03 1166-1205X-ray3.31hetero-3-3-merHHblits0.39
5zvk.1.F
pan-CoV inhibitory peptide EK1
Crystal Structure of the Human Coronavirus MERS HR1 motif in complex with pan-CoVs inhibitor EK1
0.0040.000.03 1166-1205X-ray3.31hetero-3-3-merHHblits0.39
7q83.1.B
Protein SSO2
Crystal structure of S. cerevisiae Sso2 in complex with the pleckstrin homology domain of Sec3
0.006.520.04 918-964X-ray2.19hetero-1-1-merHHblits0.28
7q83.2.B
Protein SSO2
Crystal structure of S. cerevisiae Sso2 in complex with the pleckstrin homology domain of Sec3
0.006.520.04 918-964X-ray2.19hetero-1-1-merHHblits0.28
7a26.1.A
SmhA
Structure of soluble SmhA crystal form 1 of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.
0.0020.000.04 923-967X-ray2.98monomerHHblits0.30
7a26.2.A
SmhA
Structure of soluble SmhA crystal form 1 of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.
0.0020.000.04 923-967X-ray2.98monomer1 x CAHHblits0.30
7a26.3.A
SmhA
Structure of soluble SmhA crystal form 1 of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.
0.0020.000.04 923-967X-ray2.98monomer2 x CAHHblits0.30
7a26.8.A
SmhA
Structure of soluble SmhA crystal form 1 of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.
0.0020.000.04 923-967X-ray2.98monomerHHblits0.30
7a27.1.A
SmhA
Structure of soluble SmhA crystal form 2 of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.
0.0020.000.04 923-967X-ray2.57monomerHHblits0.30
7a27.2.A
SmhA
Structure of soluble SmhA crystal form 2 of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.
0.0020.000.04 923-967X-ray2.57monomerHHblits0.30
4fqk.1.J
Hemagglutinin HA2
Influenza B/Brisbane/60/2008 hemagglutinin Fab CR8059 complex
0.0015.910.03 946-989X-ray5.65hetero-3-3-3-3-mer3 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.32
6fyw.1.H
Hemagglutinin
Structure of B/Brisbane/60/2008 Influenza Hemagglutinin in complex with SD83
0.0015.910.03 946-989X-ray2.20hetero-3-3-3-mer3 x NAG, 3 x NAG-NAG-BMA-MAN, 3 x NAG-NAG-BMA-MAN-MAN-MAN-MAN, 6 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MANHHblits0.32
4fqm.2.D
Hemagglutinin HA2
Structure of B/Brisbane/60/2008 Influenza Hemagglutinin
0.0015.910.03 946-989X-ray3.45hetero-3-3-mer7 x NAG, 7 x NAG-NAG-BMA, 8 x NAG-NAGHHblits0.32
4m40.1.B
Hemagglutinin HA2
Crystal structure of hemagglutinin of influenza virus B/Yamanashi/166/1998
0.0015.910.03 946-989X-ray3.54hetero-3-3-mer12 x NAG, 9 x NAG-NAGHHblits0.32
4n5k.1.B
Hemagglutinin HA2
Crystal structure of hemagglutinin from an H7N9 influenza virus in complex with LSTa
0.0020.930.03 945-987X-ray2.71hetero-3-3-mer6 x NAG, 3 x NAG-NAG-BMA, 3 x GAL-SIAHHblits0.33
4k1p.1.A
NheA
Structure of the NheA component of the Nhe toxin from Bacillus cereus
0.006.380.04 965-1013X-ray2.05monomerHHblits0.26
5ghe.1.A
Pesticidal crystal protein Cry6Aa
Crystal Structure of Bacillus thuringiensis Cry6Aa2 Protoxin
0.0023.260.03 973-1015X-ray1.90monomerHHblits0.33
3jcf.1.E
Magnesium transport protein CorA
Cryo-EM structure of the magnesium channel CorA in the closed symmetric magnesium-bound state
0.0010.870.04 942-987EM0.00homo-pentamer11 x MGHHblits0.27
4i0u.1.D
Magnesium transport protein CorA
Improved structure of Thermotoga maritima CorA at 2.7 A resolution
0.0010.870.04 942-987X-ray2.70homo-pentamer11 x MG, 3 x LMTHHblits0.27
4i0u.1.E
Magnesium transport protein CorA
Improved structure of Thermotoga maritima CorA at 2.7 A resolution
0.0010.870.04 942-987X-ray2.70homo-pentamer11 x MG, 3 x LMTHHblits0.27
4i0u.2.A
Magnesium transport protein CorA
Improved structure of Thermotoga maritima CorA at 2.7 A resolution
0.0010.870.04 942-987X-ray2.70homo-pentamer13 x MGHHblits0.27
4i0u.2.B
Magnesium transport protein CorA
Improved structure of Thermotoga maritima CorA at 2.7 A resolution
0.0010.870.04 942-987X-ray2.70homo-pentamer13 x MGHHblits0.27
4i0u.2.C
Magnesium transport protein CorA
Improved structure of Thermotoga maritima CorA at 2.7 A resolution
0.0010.870.04 942-987X-ray2.70homo-pentamer13 x MGHHblits0.27
4i0u.2.D
Magnesium transport protein CorA
Improved structure of Thermotoga maritima CorA at 2.7 A resolution
0.0010.870.04 942-987X-ray2.70homo-pentamer13 x MGHHblits0.27
4i0u.2.E
Magnesium transport protein CorA
Improved structure of Thermotoga maritima CorA at 2.7 A resolution
0.0010.870.04 942-987X-ray2.70homo-pentamer13 x MGHHblits0.27
4i0u.1.A
Magnesium transport protein CorA
Improved structure of Thermotoga maritima CorA at 2.7 A resolution
0.0010.870.04 942-987X-ray2.70homo-pentamer11 x MG, 3 x LMTHHblits0.27
4i0u.1.B
Magnesium transport protein CorA
Improved structure of Thermotoga maritima CorA at 2.7 A resolution
0.0010.870.04 942-987X-ray2.70homo-pentamer11 x MG, 3 x LMTHHblits0.27
3jcg.1.D
Magnesium transport protein CorA
Cryo-EM structure of the magnesium channel CorA in the magnesium-free, asymmetric open state I
0.0010.870.04 942-987EM0.00homo-pentamerHHblits0.27
3jcg.1.E
Magnesium transport protein CorA
Cryo-EM structure of the magnesium channel CorA in the magnesium-free, asymmetric open state I
0.0010.870.04 942-987EM0.00homo-pentamerHHblits0.27
3jcg.1.A
Magnesium transport protein CorA
Cryo-EM structure of the magnesium channel CorA in the magnesium-free, asymmetric open state I
0.0010.870.04 942-987EM0.00homo-pentamerHHblits0.27
3jcg.1.B
Magnesium transport protein CorA
Cryo-EM structure of the magnesium channel CorA in the magnesium-free, asymmetric open state I
0.0010.870.04 942-987EM0.00homo-pentamerHHblits0.27
3jcg.1.C
Magnesium transport protein CorA
Cryo-EM structure of the magnesium channel CorA in the magnesium-free, asymmetric open state I
0.0010.870.04 942-987EM0.00homo-pentamerHHblits0.27
4i0u.1.C
Magnesium transport protein CorA
Improved structure of Thermotoga maritima CorA at 2.7 A resolution
0.0010.870.04 942-987X-ray2.70homo-pentamer11 x MG, 3 x LMTHHblits0.27
3jch.1.C
Magnesium transport protein CorA
Cryo-EM structure of the magnesium channel CorA in the magnesium-free, asymmetric open state II
0.0010.870.04 942-987EM0.00homo-pentamerHHblits0.27
3jch.1.B
Magnesium transport protein CorA
Cryo-EM structure of the magnesium channel CorA in the magnesium-free, asymmetric open state II
0.0010.870.04 942-987EM0.00homo-pentamerHHblits0.27
3jch.1.A
Magnesium transport protein CorA
Cryo-EM structure of the magnesium channel CorA in the magnesium-free, asymmetric open state II
0.0010.870.04 942-987EM0.00homo-pentamerHHblits0.27
3jch.1.D
Magnesium transport protein CorA
Cryo-EM structure of the magnesium channel CorA in the magnesium-free, asymmetric open state II
0.0010.870.04 942-987EM0.00homo-pentamerHHblits0.27
3m6s.1.B
Hemagglutinin
Crystal structure of H1N1pdm Hemagglutinin
0.0014.290.03 947-988X-ray2.80hetero-3-3-mer2 x NAG, 1 x NAG-NAGHHblits0.34
6w08.1.A
Motility Associated Killing Factor E
Crystal Structure of Motility Associated Killing Factor E from Vibrio cholerae
0.0011.110.04 940-984X-ray1.75homo-dimer1 x KHHblits0.29
6w08.1.B
Motility Associated Killing Factor E
Crystal Structure of Motility Associated Killing Factor E from Vibrio cholerae
0.0011.110.04 940-984X-ray1.75homo-dimer1 x KHHblits0.29
6gbq.1.A
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Reston virus
0.0010.870.04 972-1017X-ray2.43homo-tetramerHHblits0.27
6gbq.1.B
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Reston virus
0.0010.870.04 972-1017X-ray2.43homo-tetramerHHblits0.27
6gbq.1.C
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Reston virus
0.0010.870.04 972-1017X-ray2.43homo-tetramerHHblits0.27
6gbq.1.D
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Reston virus
0.0010.870.04 972-1017X-ray2.43homo-tetramerHHblits0.27
6gbq.2.A
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Reston virus
0.0010.870.04 972-1017X-ray2.43homo-tetramerHHblits0.27
6gbq.2.B
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Reston virus
0.0010.870.04 972-1017X-ray2.43homo-tetramerHHblits0.27
6gbq.2.C
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Reston virus
0.0010.870.04 972-1017X-ray2.43homo-tetramerHHblits0.27
6gbq.2.D
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Reston virus
0.0010.870.04 972-1017X-ray2.43homo-tetramerHHblits0.27
6gbr.1.A
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of VP35 from Reston virus, mercury derivative
0.0010.870.04 972-1017X-ray3.15homo-tetramer2 x MBOHHblits0.27
6gbr.1.B
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of VP35 from Reston virus, mercury derivative
0.0010.870.04 972-1017X-ray3.15homo-tetramer2 x MBOHHblits0.27
6gbr.1.C
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of VP35 from Reston virus, mercury derivative
0.0010.870.04 972-1017X-ray3.15homo-tetramer2 x MBOHHblits0.27
6gbr.1.D
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of VP35 from Reston virus, mercury derivative
0.0010.870.04 972-1017X-ray3.15homo-tetramer2 x MBOHHblits0.27
3q4h.1.B
Low molecular weight protein antigen 7
Crystal structure of the Mycobacterium smegmatis EsxGH complex (MSMEG_0620-MSMEG_0621)
0.008.700.04 925-970X-ray2.70hetero-oligomerHHblits0.27
3q4h.1.D
Low molecular weight protein antigen 7
Crystal structure of the Mycobacterium smegmatis EsxGH complex (MSMEG_0620-MSMEG_0621)
0.008.700.04 925-970X-ray2.70hetero-oligomerHHblits0.27
3swf.1.A
cGMP-gated cation channel alpha-1
CNGA1 621-690 containing CLZ domain
0.0018.180.03 949-992X-ray2.14homo-trimer2 x ZNHHblits0.30
3swf.1.B
cGMP-gated cation channel alpha-1
CNGA1 621-690 containing CLZ domain
0.0018.180.03 949-992X-ray2.14homo-trimer2 x ZNHHblits0.30
3swf.1.C
cGMP-gated cation channel alpha-1
CNGA1 621-690 containing CLZ domain
0.0018.180.03 949-992X-ray2.14homo-trimer2 x ZNHHblits0.30
6wf0.1.B
Hemagglutinin
Crystal Structure of Broadly Neutralizing Antibody 3I14 Bound to the Influenza A H3 Hemagglutinin
0.0020.930.03 946-988X-ray3.46hetero-3-3-3-3-mer12 x NAG-NAG-BMA, 6 x NAG-NAGHHblits0.32
1qu1.1.A
PROTEIN (INFLUENZA RECOMBINANT HA2 CHAIN)
CRYSTAL STRUCTURE OF EHA2 (23-185)
0.0018.600.03 946-988X-ray1.90homo-trimerHHblits0.32
1qu1.1.B
PROTEIN (INFLUENZA RECOMBINANT HA2 CHAIN)
CRYSTAL STRUCTURE OF EHA2 (23-185)
0.0018.600.03 946-988X-ray1.90homo-trimerHHblits0.32
1qu1.1.C
PROTEIN (INFLUENZA RECOMBINANT HA2 CHAIN)
CRYSTAL STRUCTURE OF EHA2 (23-185)
0.0018.600.03 946-988X-ray1.90homo-trimerHHblits0.32
1qu1.2.A
PROTEIN (INFLUENZA RECOMBINANT HA2 CHAIN)
CRYSTAL STRUCTURE OF EHA2 (23-185)
0.0018.600.03 946-988X-ray1.90homo-trimerHHblits0.32
1qu1.2.B
PROTEIN (INFLUENZA RECOMBINANT HA2 CHAIN)
CRYSTAL STRUCTURE OF EHA2 (23-185)
0.0018.600.03 946-988X-ray1.90homo-trimerHHblits0.32
1qu1.2.C
PROTEIN (INFLUENZA RECOMBINANT HA2 CHAIN)
CRYSTAL STRUCTURE OF EHA2 (23-185)
0.0018.600.03 946-988X-ray1.90homo-trimerHHblits0.32
6hjr.1.B
Hemagglutinin
Structure of full-length Influenza Hemagglutinin with tilted transmembrane (A/duck/Alberta/35/76[H1N1])
0.0014.290.03 947-988EM0.00hetero-3-3-mer5 x NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-BMA, 4 x NAG-NAGHHblits0.34
6hjr.1.D
Hemagglutinin
Structure of full-length Influenza Hemagglutinin with tilted transmembrane (A/duck/Alberta/35/76[H1N1])
0.0014.290.03 947-988EM0.00hetero-3-3-mer5 x NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-BMA, 4 x NAG-NAGHHblits0.34
6hjr.1.F
Hemagglutinin
Structure of full-length Influenza Hemagglutinin with tilted transmembrane (A/duck/Alberta/35/76[H1N1])
0.0014.290.03 947-988EM0.00hetero-3-3-mer5 x NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-BMA, 4 x NAG-NAGHHblits0.34
4ln3.1.B
Hemagglutinin
The crystal structure of hemagglutinin from a H7N9 influenza virus (A/Shanghai/1/2013)
0.0018.600.03 946-988X-ray2.65hetero-3-3-mer5 x NAG, 3 x NAG-NAG-BMAHHblits0.32
5yl9.1.B
Spike glycoprotein
1.86 Angstrom crystal structure of human Coronavirus 229E fusion core
0.0030.000.03 1160-1202X-ray1.86hetero-3-3-merHHblits0.38
6s1k.1.E
Methyl-accepting chemotaxis protein I
E. coli Core Signaling Unit, carrying QQQQ receptor mutation
0.0010.870.04 912-957EM0.00hetero-2-2-12-merHHblits0.27
6s1k.1.F
Methyl-accepting chemotaxis protein I
E. coli Core Signaling Unit, carrying QQQQ receptor mutation
0.0010.870.04 912-957EM0.00hetero-2-2-12-merHHblits0.27
6s1k.1.G
Methyl-accepting chemotaxis protein I
E. coli Core Signaling Unit, carrying QQQQ receptor mutation
0.0010.870.04 912-957EM0.00hetero-2-2-12-merHHblits0.27
6s1k.1.H
Methyl-accepting chemotaxis protein I
E. coli Core Signaling Unit, carrying QQQQ receptor mutation
0.0010.870.04 912-957EM0.00hetero-2-2-12-merHHblits0.27
6s1k.1.I
Methyl-accepting chemotaxis protein I
E. coli Core Signaling Unit, carrying QQQQ receptor mutation
0.0010.870.04 912-957EM0.00hetero-2-2-12-merHHblits0.27
6s1k.1.J
Methyl-accepting chemotaxis protein I
E. coli Core Signaling Unit, carrying QQQQ receptor mutation
0.0010.870.04 912-957EM0.00hetero-2-2-12-merHHblits0.27
6s1k.1.L
Methyl-accepting chemotaxis protein I
E. coli Core Signaling Unit, carrying QQQQ receptor mutation
0.0010.870.04 912-957EM0.00hetero-2-2-12-merHHblits0.27
6s1k.1.M
Methyl-accepting chemotaxis protein I
E. coli Core Signaling Unit, carrying QQQQ receptor mutation
0.0010.870.04 912-957EM0.00hetero-2-2-12-merHHblits0.27
6s1k.1.N
Methyl-accepting chemotaxis protein I
E. coli Core Signaling Unit, carrying QQQQ receptor mutation
0.0010.870.04 912-957EM0.00hetero-2-2-12-merHHblits0.27
6s1k.1.O
Methyl-accepting chemotaxis protein I
E. coli Core Signaling Unit, carrying QQQQ receptor mutation
0.0010.870.04 912-957EM0.00hetero-2-2-12-merHHblits0.27
6s1k.1.P
Methyl-accepting chemotaxis protein I
E. coli Core Signaling Unit, carrying QQQQ receptor mutation
0.0010.870.04 912-957EM0.00hetero-2-2-12-merHHblits0.27
4lkk.1.B
hemagglutinin
The structure of hemagglutinin L226Q mutant (H3 numbering) from a avian-origin H7N9 influenza virus (A/Anhui/1/2013) in complex with human receptor analog 6'SLNLN
0.0021.430.03 946-987X-ray2.49hetero-3-3-mer9 x NAG, 3 x GAL-SIAHHblits0.33
6id2.2.F
Hemagglutinin HA2 chain
Crystal structure of H7 hemagglutinin mutant H7-AVTL (P221T) from the influenza virus A/Anhui/1/2013 (H7N9)
0.0021.430.03 946-987X-ray2.71hetero-3-3-merHHblits0.33
4bsf.1.D
HAEMAGGLUTININ HA2
Human H7N9 Influenza Virus Haemagglutinin in Complex with Avian Receptor Analogue 3'-SLN
0.0021.430.03 946-987X-ray2.76hetero-3-3-mer9 x NAG, 3 x NAG-GAL-SIA, 3 x NAG-NAGHHblits0.33
4bsb.1.D
HEMAGGLUTININ
Human H7N9 Influenza Virus Haemagglutinin (with Asn-133 Glycosylation) in Complex with Human Receptor Analogue LSTc
0.0021.430.03 946-987X-ray2.35hetero-3-3-mer12 x NAG, 3 x NAG-GAL-SIA, 3 x NAG-NAGHHblits0.33
6idz.1.B
Hemagglutinin HA2 chain
Crystal structure of H7 hemagglutinin mutant H7-SVTQ ( A138S, P221T, L226Q) with 3'SLN
0.0021.430.03 946-987X-ray2.71hetero-3-3-mer6 x NAG, 3 x NAG-GAL-SIAHHblits0.33
6icy.1.F
Hemagglutinin HA2 chain
Crystal structure of H7 hemagglutinin mutant H7-AGTL ( V186G, P221T) from the influenza virus A/Anhui/1/2013 (H7N9)
0.0021.430.03 946-987X-ray2.40hetero-3-3-mer9 x NAGHHblits0.33
4r8w.1.B
Hemagglutinin
Crystal structure of H7 hemagglutinin from A/Anhui/1/2013 in complex with a neutralizing antibody CT149
0.0021.430.03 946-987X-ray2.80hetero-3-3-3-3-mer9 x NAGHHblits0.33
4ln6.1.B
Hemagglutinin
The crystal structure of hemagglutinin from a h7n9 influenza virus (a/shanghai/2/2013)
0.0021.430.03 946-987X-ray2.12hetero-3-3-mer3 x CA, 3 x NAG, 1 x NAG-NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-FUCHHblits0.33
6ii4.1.B
Hemagglutinin
Crystal structure of H7 hemagglutinin from A/Anhui/1/2013 in complex with a human neutralizing antibody L4A-14
0.0021.430.03 946-987X-ray3.30hetero-3-3-3-3-merHHblits0.33
5gox.1.A
DNA repair protein RAD50
Eukaryotic Rad50 Functions as A Rod-shaped Dimer
0.0022.730.03 930-973X-ray2.41homo-dimer1 x ZNHHblits0.30
5gox.1.B
DNA repair protein RAD50
Eukaryotic Rad50 Functions as A Rod-shaped Dimer
0.0022.730.03 930-973X-ray2.41homo-dimer1 x ZNHHblits0.30
5tg8.1.B
Hemagglutinin HA2 chain
Crystal structure of H15 hemagglutinin from A/shearwater/WA/2576/1979 H15N9 influenza virus
0.0018.600.03 946-988X-ray3.10hetero-3-3-mer3 x NAG, 3 x NAG-NAGHHblits0.32
6wcr.1.B
Hemagglutinin
Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with small molecule F0045(S)
0.0019.510.03 948-988X-ray2.68hetero-3-3-mer6 x NAG, 3 x TU7, 3 x NAG-NAG-BMA, 3 x NAG-NAGHHblits0.35
4we8.1.A
Hemagglutinin
The crystal structure of hemagglutinin of influenza virus A/Victoria/361/2011
0.0021.430.03 947-988X-ray2.10homo-trimer21 x NAG, 3 x NAG-NAGHHblits0.33
6lks.1.B
Hemagglutinin HA2 chain
Effects of zinc ion on oligomerization and pH stability of influenza virus hemagglutinin
0.0017.070.03 948-988X-ray3.24hetero-3-3-mer10 x NAG, 2 x ZN, 3 x NAG-NAG-BMA-MAN-NAG-MAN, 1 x NAG-NAG-BMA-MAN-NAG, 2 x NAG-NAG-BMA-MANHHblits0.34
6lks.1.D
Hemagglutinin HA2 chain
Effects of zinc ion on oligomerization and pH stability of influenza virus hemagglutinin
0.0017.070.03 948-988X-ray3.24hetero-3-3-mer10 x NAG, 2 x ZN, 3 x NAG-NAG-BMA-MAN-NAG-MAN, 1 x NAG-NAG-BMA-MAN-NAG, 2 x NAG-NAG-BMA-MANHHblits0.34
6lks.2.B
Hemagglutinin HA2 chain
Effects of zinc ion on oligomerization and pH stability of influenza virus hemagglutinin
0.0017.070.03 948-988X-ray3.24hetero-3-3-mer9 x NAG, 1 x ZN, 4 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMA-MAN-NAG, 1 x NAG-NAG-BMAHHblits0.34
6lks.2.D
Hemagglutinin HA2 chain
Effects of zinc ion on oligomerization and pH stability of influenza virus hemagglutinin
0.0017.070.03 948-988X-ray3.24hetero-3-3-mer9 x NAG, 1 x ZN, 4 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMA-MAN-NAG, 1 x NAG-NAG-BMAHHblits0.34
6lks.2.F
Hemagglutinin HA2 chain
Effects of zinc ion on oligomerization and pH stability of influenza virus hemagglutinin
0.0017.070.03 948-988X-ray3.24hetero-3-3-mer9 x NAG, 1 x ZN, 4 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMA-MAN-NAG, 1 x NAG-NAG-BMAHHblits0.34
4eda.1.B
Hemagglutinin
Structures of monomeric hemagglutinin and its complex with an Fab fragment of a neutralizing antibody that binds to H1 subtype influenza viruses: molecular basis of infectivity of 2009 pandemic H1N1 influenza A viruses
0.0014.630.03 948-988X-ray2.70hetero-1-1-mer2 x NAG, 1 x NAG-NAGHHblits0.34
4eda.2.B
Hemagglutinin
Structures of monomeric hemagglutinin and its complex with an Fab fragment of a neutralizing antibody that binds to H1 subtype influenza viruses: molecular basis of infectivity of 2009 pandemic H1N1 influenza A viruses
0.0014.630.03 948-988X-ray2.70hetero-1-1-mer2 x NAG, 1 x NAG-NAGHHblits0.34
5uk1.1.B
Hemagglutinin HA2
CryoEM structure of an influenza virus receptor-binding site antibody-antigen interface - Class 3
0.0017.070.03 948-988EM0.00hetero-3-3-3-mer18 x NAG, 3 x NAG-NAG-BMA, 3 x NAG-NAGHHblits0.34
5ugy.1.F
Hemagglutinin HA2
Influenza hemagglutinin in complex with a neutralizing antibody
0.0017.070.03 948-988X-ray2.80hetero-3-3-3-3-mer6 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.34
5gjs.1.B
Hemagglutinin
Crystal structure of H1 hemagglutinin from A/California/04/2009 in complex with a neutralizing antibody 3E1
0.0014.630.03 948-988X-ray2.90hetero-3-3-3-3-mer3 x NAG, 3 x NAG-NAGHHblits0.34
7jix.1.B
Hemagglutinin HA2 chain
Murine antibody that engages the influenza hemagglutinin receptor binding site
0.0017.070.03 948-988X-ray3.90hetero-1-1-1-1-merHHblits0.34
3pwx.1.A
Putative flagellar hook-associated protein
Structure of putative flagellar hook-associated protein from Vibrio parahaemolyticus
0.0018.600.03 918-960X-ray2.50homo-dimer1 x MGHHblits0.31
3pwx.1.B
Putative flagellar hook-associated protein
Structure of putative flagellar hook-associated protein from Vibrio parahaemolyticus
0.0018.600.03 918-960X-ray2.50homo-dimer1 x MGHHblits0.31
4i0x.1.A
ESAT-6-like protein MAB_3112
Crystal structure of the Mycobacterum abscessus EsxEF (Mab_3112-Mab_3113) complex
0.0015.560.04 958-1002X-ray1.96hetero-oligomerHHblits0.27
4i0x.2.A
ESAT-6-like protein MAB_3112
Crystal structure of the Mycobacterum abscessus EsxEF (Mab_3112-Mab_3113) complex
0.0015.560.04 958-1002X-ray1.96hetero-oligomerHHblits0.27
4i0x.3.A
ESAT-6-like protein MAB_3112
Crystal structure of the Mycobacterum abscessus EsxEF (Mab_3112-Mab_3113) complex
0.0015.560.04 958-1002X-ray1.96hetero-oligomerHHblits0.27
4i0x.6.A
ESAT-6-like protein MAB_3112
Crystal structure of the Mycobacterum abscessus EsxEF (Mab_3112-Mab_3113) complex
0.0015.560.04 958-1002X-ray1.96hetero-oligomerHHblits0.27
7t3d.1.B
Hemagglutinin HA2 chain
CryoEM map of anchor 222-1C06 Fab and lateral patch 2B05 Fab binding H1 HA
0.0014.630.03 948-988EM0.00hetero-3-3-3-3-3-3-…15 x NAG, 3 x NAG-NAGHHblits0.34
7x6o.1.B
Hemagglutinin
Cryo-EM structure of H1 hemagglutinin from A/Washington/05/2011 in complex with a neutralizing antibody 28-12
0.0014.630.03 948-988EM0.00hetero-3-3-3-3-merHHblits0.34
4lxv.1.B
Hemagglutinin
Crystal Structure of the Hemagglutinin from a H1N1pdm A/WASHINGTON/5/2011 virus
0.0014.630.03 948-988X-ray3.00hetero-3-3-mer5 x NAG, 3 x NAG-NAGHHblits0.34
3tul.1.A
Cell invasion protein sipB
Crystal structure of N-terminal region of Type III Secretion Major Translocator SipB (residues 82-226)
0.0015.910.03 901-944X-ray2.79monomerHHblits0.29
3tul.2.A
Cell invasion protein sipB
Crystal structure of N-terminal region of Type III Secretion Major Translocator SipB (residues 82-226)
0.0015.910.03 901-944X-ray2.79monomerHHblits0.29
3tul.3.A
Cell invasion protein sipB
Crystal structure of N-terminal region of Type III Secretion Major Translocator SipB (residues 82-226)
0.0015.910.03 901-944X-ray2.79monomerHHblits0.29
3tul.4.A
Cell invasion protein sipB
Crystal structure of N-terminal region of Type III Secretion Major Translocator SipB (residues 82-226)
0.0015.910.03 901-944X-ray2.79monomerHHblits0.29
6idd.1.A
Hemagglutinin
Crystal structure of H7 hemagglutinin mutant SH1-AVPL ( S138A, G186V, T221P, Q226L) from the influenza virus A/Shanghai/1/2013 (H7N9)
0.0019.050.03 947-988X-ray2.38homo-trimer5 x NAGHHblits0.32
6idd.2.A
Hemagglutinin
Crystal structure of H7 hemagglutinin mutant SH1-AVPL ( S138A, G186V, T221P, Q226L) from the influenza virus A/Shanghai/1/2013 (H7N9)
0.0019.050.03 947-988X-ray2.38homo-trimer4 x NAGHHblits0.32
3hto.1.B
Hemagglutinin HA2 chain
the hemagglutinin structure of an avian H1N1 influenza A virus
0.0014.630.03 948-988X-ray2.95hetero-3-3-mer6 x NAG, 3 x NAG-NDGHHblits0.34
1jsd.1.B
HAEMAGGLUTININ (HA2 CHAIN)
CRYSTAL STRUCTURE OF SWINE H9 HAEMAGGLUTININ
0.0019.510.03 948-988X-ray1.80hetero-1-1-mer1 x NAG, 4 x NAG-NAGHHblits0.34
1ru7.2.F
hemagglutinin
1934 Human H1 Hemagglutinin
0.0017.070.03 948-988X-ray2.30hetero-oligomerHHblits0.34
1rvx.1.D
Hemagglutinin
1934 H1 Hemagglutinin in complex with LSTA
0.0017.070.03 948-988X-ray2.20hetero-3-3-mer4 x NAG, 3 x NAG-GAL-SIAHHblits0.34
6fyu.1.E
Hemagglutinin
Structure of H7(A/Shanghai/2/2013) Influenza Hemagglutinin in complex SD36
0.0021.950.03 947-987X-ray2.64hetero-3-3-3-mer9 x NAG, 3 x NAG-NAGHHblits0.34
5vjk.1.F
Hemagglutinin HA2
Crystal structure of H7 hemagglutinin mutant (V186K, K193T, G228S) from the influenza virus A/Shanghai/2/2013 (H7N9)
0.0021.950.03 947-987X-ray2.59hetero-3-3-mer6 x NAG, 3 x NAG-NAG-BMAHHblits0.34
4n5j.2.B
Hemagglutinin HA2
Crystal structure of hemagglutinin from an H7N9 influenza virus
0.0021.950.03 947-987X-ray2.70hetero-3-3-merHHblits0.34
5v2a.1.B
Hemagglutinin
Crystal structure of Fab H7.167 in complex with influenza virus hemagglutinin from A/Shanghai/02/2013 (H7N9)
0.0021.950.03 947-987X-ray4.66hetero-3-3-3-3-mer6 x NAG, 3 x NAG-NAG-BMAHHblits0.34
5t6s.1.B
Hemagglutinin HA2
Crystal structure of the A/Shanghai/2/2013 (H7N9) influenza virus hemagglutinin in complex with the antiviral drug arbidol
0.0021.950.03 947-987X-ray2.36hetero-3-3-mer9 x NAG, 3 x 75U, 2 x NAG-NAG-BMA, 1 x NAG-NAGHHblits0.34
5vjl.1.B
Hemagglutinin HA2
Crystal structure of H7 hemagglutinin mutant (V186K, K193T, G228S) from the influenza virus A/Shanghai/2/2013 (H7N9) with LSTc
0.0021.950.03 947-987X-ray2.60hetero-3-3-mer3 x SIA, 9 x NAGHHblits0.34
4kom.1.F
Hemagglutinin HA2
The structure of hemagglutinin from avian-origin H7N9 influenza virus in complex with avian receptor analog 3'SLNLN (NeuAcα2-3Galβ1-4GlcNAcβ1-3Galβ1-4Glc)
0.0021.950.03 947-987X-ray2.60hetero-3-3-mer9 x NAG, 3 x GAL-NAG-GAL-SIAHHblits0.34
1jsm.1.B
HAEMAGGLUTININ (HA2 CHAIN)
STRUCTURE OF H5 AVIAN HAEMAGGLUTININ
0.0014.630.03 948-988X-ray1.90hetero-1-1-mer3 x NAG, 2 x NAG-NAGHHblits0.34
2wrg.1.B
HEMAGGLUTININ HA2 CHAIN
structure of H1 1918 hemagglutinin with human receptor
0.0014.630.03 948-988X-ray3.00hetero-3-3-mer10 x NAG, 1 x GAL-NAG-GAL-SIAHHblits0.34
6hjq.1.B
Hemagglutinin
Structure of Full-length Influenza Hemagglutinin (A/duck/Alberta/35/76) in complex with FISW84 Fab Fragment
0.0014.630.03 948-988EM0.00hetero-3-3-3-3-mer6 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-BMA-MAN, 3 x NAG-NAG-BMAHHblits0.34
2wrh.1.B
HEMAGGLUTININ HA2 CHAIN
structure of H1 duck albert hemagglutinin with human receptor
0.0014.630.03 948-988X-ray3.00hetero-3-3-mer3 x SIAHHblits0.34
6v49.1.B
Hemagglutinin HA2 chain
The crystal structure of hemagglutinin from A/wedge-tailed shearwater/Western Australia/2576/1979 (H15N9)
0.0019.050.03 947-988X-ray2.50hetero-3-3-mer3 x NAG, 3 x NAG-NAGHHblits0.32
7mem.1.D
Hemagglutinin HA2 chain
CryoEM structure of monoclonal Fab 045-09 2B05 binding the lateral patch of influenza virus H1 HA
0.0014.630.03 948-988EM0.00hetero-3-3-3-3-mer6 x NAG, 3 x NAG-FUC, 3 x NAG-NAGHHblits0.34
5tgo.1.B
Hemagglutinin HA2 chain
Crystal structure of H10 hemagglutinin mutant (K158aA-D193T-Q226L-G228S) from Jiangxi-Donghu (2013) H10N8 influenza virus
0.0026.830.03 948-988X-ray2.35hetero-3-3-mer4 x NAG, 1 x NAG-BMA-MAN, 1 x NAG-NAGHHblits0.33
5tgo.1.F
Hemagglutinin HA2 chain
Crystal structure of H10 hemagglutinin mutant (K158aA-D193T-Q226L-G228S) from Jiangxi-Donghu (2013) H10N8 influenza virus
0.0026.830.03 948-988X-ray2.35hetero-3-3-mer4 x NAG, 1 x NAG-BMA-MAN, 1 x NAG-NAGHHblits0.33
5e34.1.B
Hemagglutinin
Crystal structure of H5 hemagglutinin mutant (N224K, Q226L, N158D and L133a deletion) from the influenza virus A/chicken/Vietnam/NCVD-093/2008 (H5N1) with LSTa
0.0014.630.03 948-988X-ray2.70hetero-3-3-mer6 x NAG, 3 x NAG-GAL-SIAHHblits0.33
5e35.1.F
Hemagglutinin
Crystal structure of H5 hemagglutinin mutant (N224K, Q226L, N158D and L133a deletion) from the influenza virus A/chicken/Vietnam/NCVD-093/2008 (H5N1) with LSTc
0.0014.630.03 948-988X-ray2.70hetero-3-3-mer6 x NAG, 3 x NAG-GAL-SIAHHblits0.33
4f3z.1.B
Hemagglutinin
Crystal structure of a swine H1N2 influenza virus hemagglutinin
0.0014.630.03 948-988X-ray3.20hetero-3-3-mer1 x NAGHHblits0.33
4f3z.1.D
Hemagglutinin
Crystal structure of a swine H1N2 influenza virus hemagglutinin
0.0014.630.03 948-988X-ray3.20hetero-3-3-mer1 x NAGHHblits0.33
4f3z.1.F
Hemagglutinin
Crystal structure of a swine H1N2 influenza virus hemagglutinin
0.0014.630.03 948-988X-ray3.20hetero-3-3-mer1 x NAGHHblits0.33
1mqn.3.J
Hemagglutinin HA2 chain
BHA/LSTc
0.0019.510.03 948-988X-ray3.20hetero-6-6-mer18 x NAG, 4 x NAG-NAG, 6 x NAG-NAG-BMA-MAN, 4 x GAL-SIAHHblits0.33
5huf.1.B
hemagglutinin HA2
The crystal structure of hemagglutinin from A/gyrfalcon/Washington/41088-6/2014 influenza virus
0.0014.630.03 948-988X-ray2.81hetero-3-3-mer6 x NAG, 3 x NAG-NAG-MAN, 3 x NAG-NAGHHblits0.33
5hu8.1.D
hemagglutinin HA2
The crystal structure of hemagglutinin from A/Sichuan/26221/2014 (H5N6) influenza virus
0.0014.630.03 948-988X-ray2.45hetero-3-3-mer3 x NAG, 3 x NAG-FUC, 3 x NAG-NAG-FUCHHblits0.33
4kw1.1.B
Hemagglutinin
Structure of a/egypt/n03072/2010 h5 ha
0.0014.630.03 948-988X-ray2.50hetero-3-3-mer3 x NAG, 3 x NAG-NAG-MAN-MAN-MAN, 3 x NAG-NAGHHblits0.33
4kw1.2.B
Hemagglutinin
Structure of a/egypt/n03072/2010 h5 ha
0.0014.630.03 948-988X-ray2.50hetero-3-3-mer3 x NAG, 3 x NAG-NAG-MAN-MAN-MAN, 3 x NAG-NAGHHblits0.33
4kw1.3.B
Hemagglutinin
Structure of a/egypt/n03072/2010 h5 ha
0.0014.630.03 948-988X-ray2.50hetero-3-3-mer3 x NAG, 6 x NAG-NAGHHblits0.33
4n5y.2.F
Hemagglutinin HA2 chain
Crystal structure of H5 hemagglutinin mutant (N158D, N224K and Q226L) from the influenza virus A/Viet Nam/1203/2004 (H5N1)
0.0014.630.03 948-988X-ray3.16hetero-3-3-mer1 x NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAGHHblits0.33
2fk0.3.D
hemagglutinin
Crystal Structure of a H5N1 influenza virus hemagglutinin.
0.0014.630.03 948-988X-ray2.95hetero-3-3-mer6 x NAG-NAGHHblits0.33
2fk0.5.D
hemagglutinin
Crystal Structure of a H5N1 influenza virus hemagglutinin.
0.0014.630.03 948-988X-ray2.95hetero-3-3-merHHblits0.33
2fk0.4.D
hemagglutinin
Crystal Structure of a H5N1 influenza virus hemagglutinin.
0.0014.630.03 948-988X-ray2.95hetero-3-3-mer6 x NAG-NAGHHblits0.33
2fk0.2.B
hemagglutinin
Crystal Structure of a H5N1 influenza virus hemagglutinin.
0.0014.630.03 948-988X-ray2.95hetero-3-3-mer5 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.33
4mhh.2.E
Hemagglutinin HA2 chain
Crystal structure of Fab H5M9 in complex with influenza virus hemagglutinin from A/Viet Nam/1203/2004 (H5N1)
0.0014.630.03 948-988X-ray3.56hetero-3-3-mer1 x NAG, 3 x NAG-NAG-MAN-MAN-MAN, 10 x NAG-NAG, 3 x NAG-NAG-MAN, 1 x NAG-NAG-MAN-MANHHblits0.33
5e2y.1.B
Hemagglutinin
Crystal structure of H5 hemagglutinin Q226L mutant from the influenza virus A/duck/Egypt/10185SS/2010 (H5N1)
0.0014.630.03 948-988X-ray2.60hetero-3-3-mer3 x NAG, 2 x NAG-FUL-NAG, 1 x NAG-FUL-NAG-FUCHHblits0.33
5e2z.1.B
Hemagglutinin
Crystal structure of H5 hemagglutinin Q226L mutant from the influenza virus A/duck/Egypt/10185SS/2010 (H5N1) with LSTa
0.0014.630.03 948-988X-ray2.62hetero-3-3-mer3 x NAG, 2 x NAG-FUL-NAG, 2 x GAL-SIA, 1 x NAG-FUL-NAG-FUC, 1 x NAG-GAL-SIAHHblits0.33
5e2z.1.D
Hemagglutinin
Crystal structure of H5 hemagglutinin Q226L mutant from the influenza virus A/duck/Egypt/10185SS/2010 (H5N1) with LSTa
0.0014.630.03 948-988X-ray2.62hetero-3-3-mer3 x NAG, 2 x NAG-FUL-NAG, 2 x GAL-SIA, 1 x NAG-FUL-NAG-FUC, 1 x NAG-GAL-SIAHHblits0.33
5e30.1.B
Hemagglutinin
Crystal structure of H5 hemagglutinin Q226L mutant from the influenza virus A/duck/Egypt/10185SS/2010 (H5N1) with LSTc
0.0014.630.03 948-988X-ray2.70hetero-3-3-mer2 x NAG, 1 x NAG-FUL-NAG-FUC, 3 x GAL-NAG-GAL-SIA, 2 x NAG-FUL-NAGHHblits0.33
5e30.1.D
Hemagglutinin
Crystal structure of H5 hemagglutinin Q226L mutant from the influenza virus A/duck/Egypt/10185SS/2010 (H5N1) with LSTc
0.0014.630.03 948-988X-ray2.70hetero-3-3-mer2 x NAG, 1 x NAG-FUL-NAG-FUC, 3 x GAL-NAG-GAL-SIA, 2 x NAG-FUL-NAGHHblits0.33
6vmz.1.D
Hemagglutinin
Crystal Structure of a H5N1 influenza virus hemagglutinin with CBS1117
0.0014.630.03 948-988X-ray2.20hetero-3-3-mer8 x NAG, 3 x R3PHHblits0.33
6vmz.1.E
Hemagglutinin
Crystal Structure of a H5N1 influenza virus hemagglutinin with CBS1117
0.0014.630.03 948-988X-ray2.20hetero-3-3-mer8 x NAG, 3 x R3PHHblits0.33
3fku.2.F
Hemagglutinin
Crystal structure of influenza hemagglutinin (H5) in complex with a broadly neutralizing antibody F10
0.0014.630.03 948-988X-ray3.20hetero-3-3-3-mer3 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.33
4jul.2.F
Hemagglutinin HA2
Crystal structure of H5N1 influenza virus hemagglutinin, clade 2.3.4
0.0014.630.03 948-988X-ray2.79hetero-3-3-mer4 x NAG, 2 x NAG-NAGHHblits0.33
4jul.1.F
Hemagglutinin HA2
Crystal structure of H5N1 influenza virus hemagglutinin, clade 2.3.4
0.0014.630.03 948-988X-ray2.79hetero-3-3-mer4 x NAG, 2 x NAG-NAGHHblits0.33
4jul.1.B
Hemagglutinin HA2
Crystal structure of H5N1 influenza virus hemagglutinin, clade 2.3.4
0.0014.630.03 948-988X-ray2.79hetero-3-3-mer4 x NAG, 2 x NAG-NAGHHblits0.33
4jul.2.B
Hemagglutinin HA2
Crystal structure of H5N1 influenza virus hemagglutinin, clade 2.3.4
0.0014.630.03 948-988X-ray2.79hetero-3-3-mer4 x NAG, 2 x NAG-NAGHHblits0.33
4jul.1.D
Hemagglutinin HA2
Crystal structure of H5N1 influenza virus hemagglutinin, clade 2.3.4
0.0014.630.03 948-988X-ray2.79hetero-3-3-mer4 x NAG, 2 x NAG-NAGHHblits0.33
4jul.2.D
Hemagglutinin HA2
Crystal structure of H5N1 influenza virus hemagglutinin, clade 2.3.4
0.0014.630.03 948-988X-ray2.79hetero-3-3-mer4 x NAG, 2 x NAG-NAGHHblits0.33
4juk.1.B
Hemagglutinin HA2
Crystal structure of H5N1 influenza virus hemagglutinin, clade 2.3.2.1
0.0014.630.03 948-988X-ray2.75hetero-3-3-mer9 x NAGHHblits0.33
4jun.1.B
Hemagglutinin HA2
Crystal structure of H5N1 influenza virus hemagglutinin, clade 5
0.0014.630.03 948-988X-ray2.34hetero-3-3-mer3 x NAG, 3 x NAG-NAGHHblits0.33
4jun.1.F
Hemagglutinin HA2
Crystal structure of H5N1 influenza virus hemagglutinin, clade 5
0.0014.630.03 948-988X-ray2.34hetero-3-3-mer3 x NAG, 3 x NAG-NAGHHblits0.33
4kdm.1.B
Hemagglutinin
Crystal structure of the hemagglutinin of ferret-transmissible H5N1 virus
0.0014.630.03 948-988X-ray2.50hetero-3-3-mer3 x NAG, 3 x NAG-NAGHHblits0.33
4mhi.1.B
Hemagglutinin HA2 chain
Crystal structure of a H5N1 influenza virus hemagglutinin from A/goose/Guangdong/1/96
0.0014.630.03 948-988X-ray2.60hetero-3-3-mer4 x NAG, 3 x NAG-NAGHHblits0.33
4kwm.1.B
Hemagglutinin
Structure of a/anhui/5/2005 h5 ha
0.0014.630.03 948-988X-ray2.70hetero-3-3-mer6 x NAGHHblits0.33
4kwm.3.B
Hemagglutinin
Structure of a/anhui/5/2005 h5 ha
0.0014.630.03 948-988X-ray2.70hetero-3-3-mer3 x NAGHHblits0.33
6gbo.1.A
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Ebola virus
0.008.890.04 972-1016X-ray2.10homo-hexamerHHblits0.26
6gbo.1.B
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Ebola virus
0.008.890.04 972-1016X-ray2.10homo-hexamerHHblits0.26
6gbo.1.C
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Ebola virus
0.008.890.04 972-1016X-ray2.10homo-hexamerHHblits0.26
6gbo.1.D
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Ebola virus
0.008.890.04 972-1016X-ray2.10homo-hexamerHHblits0.26
6gbo.1.E
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Ebola virus
0.008.890.04 972-1016X-ray2.10homo-hexamerHHblits0.26
6gbo.1.F
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Ebola virus
0.008.890.04 972-1016X-ray2.10homo-hexamerHHblits0.26
6gbo.2.B
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Ebola virus
0.008.890.04 972-1016X-ray2.10homo-hexamerHHblits0.26
6gbo.2.C
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Ebola virus
0.008.890.04 972-1016X-ray2.10homo-hexamerHHblits0.26
6gbo.2.D
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Ebola virus
0.008.890.04 972-1016X-ray2.10homo-hexamerHHblits0.26
6gbo.2.E
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Ebola virus
0.008.890.04 972-1016X-ray2.10homo-hexamerHHblits0.26
6gbo.2.F
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of Vp35 from Ebola virus
0.008.890.04 972-1016X-ray2.10homo-hexamerHHblits0.26
6gbp.1.A
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of VP35 from Ebola virus, mercury derivative
0.008.890.04 972-1016X-ray3.49homo-trimer4 x HGHHblits0.26
6gbp.1.B
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of VP35 from Ebola virus, mercury derivative
0.008.890.04 972-1016X-ray3.49homo-trimer4 x HGHHblits0.26
6gbp.1.C
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of VP35 from Ebola virus, mercury derivative
0.008.890.04 972-1016X-ray3.49homo-trimer4 x HGHHblits0.26
6gbp.2.A
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of VP35 from Ebola virus, mercury derivative
0.008.890.04 972-1016X-ray3.49homo-trimer1 x HGHHblits0.26
6gbp.3.A
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of VP35 from Ebola virus, mercury derivative
0.008.890.04 972-1016X-ray3.49homo-trimer2 x HGHHblits0.26
6gbp.3.C
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of VP35 from Ebola virus, mercury derivative
0.008.890.04 972-1016X-ray3.49homo-trimer2 x HGHHblits0.26
6gbp.4.A
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of VP35 from Ebola virus, mercury derivative
0.008.890.04 972-1016X-ray3.49homo-trimer4 x HGHHblits0.26
6gbp.4.B
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of VP35 from Ebola virus, mercury derivative
0.008.890.04 972-1016X-ray3.49homo-trimer4 x HGHHblits0.26
6gbp.4.C
Polymerase cofactor VP35
Crystal Structure of the oligomerization domain of VP35 from Ebola virus, mercury derivative
0.008.890.04 972-1016X-ray3.49homo-trimer4 x HGHHblits0.26
7t1v.3.F
Hemagglutinin HA2 chain
Crystal structure of an equine H7 hemagglutinin from A/equine/NY/49/73 (H7N7) in complex with 3'-GcLN
0.0027.500.03 949-988X-ray2.05hetero-3-3-mer3 x NAG, 3 x GAL-NGC, 3 x NAG-NAGHHblits0.35
6n5a.1.B
HEMAGGLUTININ HA2 SUBUNIT
Crystal structure of an equine H7 hemagglutinin from A/equine/NY/49/73 (H7N7)
0.0027.500.03 949-988X-ray3.30hetero-3-3-mer6 x NAGHHblits0.35
1htm.1.B
HEMAGGLUTININ HA2 CHAIN
STRUCTURE OF INFLUENZA HAEMAGGLUTININ AT THE PH OF MEMBRANE FUSION
0.0019.510.03 948-988X-ray2.50hetero-oligomerHHblits0.33
1htm.1.D
HEMAGGLUTININ HA2 CHAIN
STRUCTURE OF INFLUENZA HAEMAGGLUTININ AT THE PH OF MEMBRANE FUSION
0.0019.510.03 948-988X-ray2.50hetero-oligomerHHblits0.33
1htm.1.F
HEMAGGLUTININ HA2 CHAIN
STRUCTURE OF INFLUENZA HAEMAGGLUTININ AT THE PH OF MEMBRANE FUSION
0.0019.510.03 948-988X-ray2.50hetero-oligomerHHblits0.33
7qa4.1.A
Hemagglutinin
Crystal structure of stabilized H3N2 A/Hong Kong/1/1968 Hemagglutinin at 2.2 Angstrom
0.0019.510.03 948-988X-ray2.19homo-trimer3 x NAG, 3 x NAG-NAG-BMA, 3 x NAG-NAG-BMA-MAN-MAN, 6 x NAG-NAGHHblits0.33
7k37.1.B
Hemagglutinin
Structure of full-length influenza HA with a head-binding antibody at pH 7.8
0.0019.510.03 948-988EM0.00hetero-3-3-3-3-mer9 x NAG, 3 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MAN, 3 x NAG-NAG-BMA-MAN-MAN-MAN-MAN-MANHHblits0.33
7k3b.1.B
Hemagglutinin
Structure of full-length influenza HA with a head-binding antibody at pH 5.2, conformation C, central helices splay
0.0019.510.03 948-988EM0.00hetero-3-3-3-3-mer6 x NAG, 3 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MAN, 3 x NAG-NAG-BMA-MAN-MAN-MAN-MAN-MANHHblits0.33
5kaq.1.A
Hemagglutinin
Crystal structure of broadly neutralizing Influenza A antibody 31.a.83 in complex with Hemagglutinin Hong Kong 1968.
0.0019.510.03 948-988X-ray3.51hetero-3-3-3-mer18 x NAGHHblits0.33
6ch3.1.B
Flagellar secretion chaperone FliS,Flagellin
Crystal structure of the cytoplasmic domain of FlhA and FliS-FliC complex
0.0019.050.03 938-985X-ray2.68hetero-1-1-merHHblits0.31
3haj.1.A
human PACSIN2 F-BAR
Crystal structure of human PACSIN2 F-BAR domain (p212121 lattice)
0.0013.330.04 941-989X-ray2.78homo-dimer2 x CAHHblits0.25
3haj.1.B
human PACSIN2 F-BAR
Crystal structure of human PACSIN2 F-BAR domain (p212121 lattice)
0.0013.330.04 941-989X-ray2.78homo-dimer2 x CAHHblits0.25
4jtx.1.B
Hemagglutinin
Crystal structure of 2009 pandemic influenza virus hemagglutinin mutant D225E
0.0015.000.03 948-987X-ray3.00hetero-3-3-mer3 x NAG, 2 x NAG-NAGHHblits0.35
4jtx.1.F
Hemagglutinin
Crystal structure of 2009 pandemic influenza virus hemagglutinin mutant D225E
0.0015.000.03 948-987X-ray3.00hetero-3-3-mer3 x NAG, 2 x NAG-NAGHHblits0.35
3lzg.2.F
Hemagglutinin, HA2 SUBUNIT
Crystal structure of a 2009 H1N1 influenza virus hemagglutinin
0.0015.000.03 948-987X-ray2.60hetero-3-3-mer1 x NAG, 1 x NAG-NAG-BMA-MAN-MANHHblits0.35
3lzg.1.D
Hemagglutinin, HA2 SUBUNIT
Crystal structure of a 2009 H1N1 influenza virus hemagglutinin
0.0015.000.03 948-987X-ray2.60hetero-3-3-mer1 x NAG, 1 x NAG-NAG-BMA, 2 x NAG-NAGHHblits0.35
3ubj.2.D
Hemagglutinin HA2
Influenza hemagglutinin from the 2009 pandemic in complex with ligand LSTa
0.0015.000.03 948-987X-ray2.25hetero-3-3-mer9 x NAG, 3 x GAL-SIA, 1 x NAG-NAGHHblits0.35
3ubj.1.F
Hemagglutinin HA2
Influenza hemagglutinin from the 2009 pandemic in complex with ligand LSTa
0.0015.000.03 948-987X-ray2.25hetero-3-3-mer3 x NAG, 2 x NAG-NAG, 1 x GAL-SIAHHblits0.35
4ju0.1.B
Hemagglutinin
Crystal structure of 2009 pandemic influenza virus hemagglutinin mutant D225E complexed with human receptor analogue LSTc
0.0015.000.03 948-987X-ray2.91hetero-3-3-mer2 x NAG, 3 x GAL-NAG-GAL-SIA, 1 x NAG-NAGHHblits0.35
4ju0.1.F
Hemagglutinin
Crystal structure of 2009 pandemic influenza virus hemagglutinin mutant D225E complexed with human receptor analogue LSTc
0.0015.000.03 948-987X-ray2.91hetero-3-3-mer2 x NAG, 3 x GAL-NAG-GAL-SIA, 1 x NAG-NAGHHblits0.35
5w6g.1.B
Hemagglutinin HA2
Human antibody 6649 in complex with influenza hemagglutinin H1 Solomon Islands
0.0017.500.03 948-987X-ray2.79hetero-3-3-3-3-mer12 x NAG, 3 x NAG-NAGHHblits0.35
5ug0.1.F
Hemagglutinin HA2
Human antibody H2897 in complex with influenza hemagglutinin H1 Solomon Islands/03/2006
0.0017.500.03 948-987X-ray3.40hetero-3-3-3-3-mer12 x NAG, 6 x NAG-NAG-BMA, 3 x NAG-NAGHHblits0.35
4edb.1.F
Hemagglutinin
Structures of monomeric hemagglutinin and its complex with an Fab fragment of a neutralizing antibody that binds to H1 subtype influenza viruses: molecular basis of infectivity of 2009 pandemic H1N1 influenza A viruses
0.0017.500.03 948-987X-ray2.50hetero-oligomerHHblits0.35
4edb.1.D
Hemagglutinin
Structures of monomeric hemagglutinin and its complex with an Fab fragment of a neutralizing antibody that binds to H1 subtype influenza viruses: molecular basis of infectivity of 2009 pandemic H1N1 influenza A viruses
0.0017.500.03 948-987X-ray2.50hetero-oligomerHHblits0.35
4edb.1.B
Hemagglutinin
Structures of monomeric hemagglutinin and its complex with an Fab fragment of a neutralizing antibody that binds to H1 subtype influenza viruses: molecular basis of infectivity of 2009 pandemic H1N1 influenza A viruses
0.0017.500.03 948-987X-ray2.50hetero-oligomerHHblits0.35
4jum.1.B
Hemagglutinin HA2
Crystal structure of H5N1 influenza virus hemagglutinin, clade 4
0.0012.200.03 948-988X-ray2.00hetero-3-3-mer3 x NAG, 3 x NAG-NAGHHblits0.33
4kps.1.B
Hemagglutinin
Structure and receptor binding specificity of the hemagglutinin H13 from avian influenza A virus H13N6
0.0017.500.03 949-988X-ray2.59hetero-3-3-mer1 x NAG, 1 x GAL-SIA, 1 x NAG-GAL-SIAHHblits0.34
4kpq.1.B
Hemagglutinin
Structure and receptor binding specificity of the hemagglutinin H13 from avian influenza A virus H13N6
0.0017.500.03 949-988X-ray2.50hetero-3-3-mer1 x NAGHHblits0.34
4bsg.1.B
HEMAGGLUTININ
Crystal Structure of an H7N3 Avian Influenza Virus Haemagglutinin
0.0019.510.03 948-988X-ray2.10hetero-3-3-mer6 x NAG, 3 x NAG-NAGHHblits0.33
5jw3.1.B
Hemagglutinin
Structure of MEDI8852 Fab Fragment in Complex with H7 HA
0.0019.510.03 948-988X-ray3.75hetero-3-3-3-3-mer3 x NAG, 3 x NAG-NAG-BMA-MAN, 3 x NAG-NAGHHblits0.33
6wxl.1.B
Hemagglutinin HA2 chain
Cryo-EM structure of the VRC315 clinical trial, vaccine-elicited, human antibody 1D12 in complex with an H7 SH13 HA trimer
0.0019.510.03 948-988EM0.00hetero-3-3-3-3-mer9 x NAGHHblits0.33
4w8n.1.B
Hemagglutinin
The crystal structure of hemagglutinin from a swine influenza virus (A/swine/Missouri/2124514/2006)
0.0017.500.03 949-988X-ray2.90hetero-3-3-mer11 x NAGHHblits0.34
4fqv.1.B
Hemagglutinin HA2
Crystal structure of broadly neutralizing antibody CR9114 bound to H7 influenza hemagglutinin
0.0019.510.03 948-988X-ray5.75hetero-3-3-3-3-merHHblits0.32
4wss.1.A
Hemagglutinin
The crystal structure of hemagglutinin form A/chicken/New York/14677-13/1998 in complex with LSTa
0.0012.200.03 948-988X-ray2.80homo-trimer4 x NAG, 1 x NAG-NAG, 1 x NAG-GAL-SIAHHblits0.32
4wss.2.C
Hemagglutinin
The crystal structure of hemagglutinin form A/chicken/New York/14677-13/1998 in complex with LSTa
0.0012.200.03 948-988X-ray2.80homo-trimer3 x NAG, 2 x NAG-GAL-SIA, 1 x NAG-NAGHHblits0.32
4wsr.1.A
Hemagglutinin
The crystal structure of hemagglutinin form A/chicken/New York/14677-13/1998
0.0012.200.03 948-988X-ray2.50homo-trimer5 x NAG, 3 x NAG-NAGHHblits0.32
4wsr.1.C
Hemagglutinin
The crystal structure of hemagglutinin form A/chicken/New York/14677-13/1998
0.0012.200.03 948-988X-ray2.50homo-trimer5 x NAG, 3 x NAG-NAGHHblits0.32
4wsr.2.C
Hemagglutinin
The crystal structure of hemagglutinin form A/chicken/New York/14677-13/1998
0.0012.200.03 948-988X-ray2.50homo-trimer4 x NAG, 1 x NAG-NAGHHblits0.32
7zjr.1.A
Protein PilJ
X-ray structure of the periplasmic region of PilJ from P. aeruginosa
0.0016.280.03 918-963X-ray2.50monomerHHblits0.29
6ii8.1.B
Hemagglutinin
Crystal structure of H7 hemagglutinin from A/Anhui/1/2013 in complex with a human neutralizing antibody L4B-18
0.0022.500.03 948-987X-ray3.32hetero-3-3-3-3-mer9 x NAGHHblits0.34
6ii9.1.B
Hemagglutinin
Crystal structure of H7 hemagglutinin from A/Anhui/1/2013 in complex with a human neutralizing antibody L3A-44
0.0022.500.03 948-987X-ray3.50hetero-3-3-3-3-mer3 x NAGHHblits0.34
6d7c.1.B
Hemagglutinin HA2 chain
The crystal structure of hemagglutinin from A/Hong Kong/61/2016 H7N9 influenza virus
0.0022.500.03 948-987X-ray2.95hetero-3-3-mer6 x NAGHHblits0.34
4n60.1.B
Hemagglutinin HA2
Crystal structure of hemagglutinin from an H7N9 influenza virus in complex with LSTc
0.0022.500.03 948-987X-ray2.90hetero-3-3-mer6 x NAG, 3 x NAG-NAG-BMA, 3 x GAL-SIAHHblits0.34
5t0b.1.D
Hemagglutinin HA2 chain
Crystal structure of H6 hemagglutinin G225D mutant from Taiwan (2013) H6N1 influenza virus in complex with 6'-SLN
0.0012.200.03 948-988X-ray2.00hetero-3-3-mer5 x NAG, 1 x NAG-GAL-SIAHHblits0.32
5t08.1.F
Hemagglutinin HA2 chain
Crystal structure of H6 hemagglutinin G225D mutant from Taiwan (2013) H6N1 influenza virus
0.0012.200.03 948-988X-ray2.19hetero-3-3-mer4 x NAGHHblits0.32
4wsu.1.D
Hemagglutinin HA2 chain
The crystal structure of hemagglutinin from A/Taiwan/1/2013 in complex with 3'SLN
0.0012.200.03 948-988X-ray2.70hetero-3-3-mer9 x NAG, 2 x SIA, 1 x NAG-GALHHblits0.32
4wst.1.D
Hemagglutinin HA2 chain
The crystal structure of hemagglutinin from A/Taiwan/1/2013 influenza virus
0.0012.200.03 948-988X-ray2.40hetero-3-3-mer9 x NAGHHblits0.32
4wsv.1.E
Hemagglutinin HA2 chain
The crystal structure of hemagglutinin from A/Taiwan/1/2013 in complex with 6'SLN
0.0012.200.03 948-988X-ray3.10hetero-3-3-mer9 x NAG, 2 x SIAHHblits0.32
3m5g.1.B
Hemagglutinin
Crystal structure of a H7 influenza virus hemagglutinin
0.0025.000.03 948-987X-ray2.60hetero-3-3-mer3 x NAG, 3 x NAG-NAGHHblits0.34
3m5g.1.D
Hemagglutinin
Crystal structure of a H7 influenza virus hemagglutinin
0.0025.000.03 948-987X-ray2.60hetero-3-3-mer3 x NAG, 3 x NAG-NAGHHblits0.34
6d7u.1.B
Hemagglutinin HA2 chain
The crystal structure of hemagglutinin from A/Guangdong/17SF003/2016 H7N9 influenza virus
0.0022.500.03 948-987X-ray2.70hetero-3-3-mer9 x NAGHHblits0.34
6mlm.1.B
Hemagglutinin HA2 chain
H7 HA0 in complex with Fv from H7.5 IgG
0.0025.000.03 948-987EM0.00hetero-3-3-3-3-mer9 x NAGHHblits0.34
4qy1.2.D
hemagglutinin
Structure of H10 from human-infecting H10N8 in complex with avian receptor
0.0027.500.03 949-988X-ray2.59hetero-3-3-mer6 x NAG, 2 x NAG-GAL-SIAHHblits0.34
4wsx.3.B
Hemagglutinin HA2 chain
The crystal structure of hemagglutinin from A/Jiangxi-Donghu/346/2013 influenza virus
0.0027.500.03 949-988X-ray2.70hetero-3-3-mer6 x NAGHHblits0.34
6tvb.1.B
Hemagglutinin HA2
Crystal structure of the haemagglutinin from a transmissible H10N7 seal influenza virus isolated in Netherland in complex with human receptor analogue 6'-SLN
0.0025.000.03 949-988X-ray1.65hetero-3-3-mer3 x NAG, 3 x NAG-GAL-SIAHHblits0.34
6tvb.1.D
Hemagglutinin HA2
Crystal structure of the haemagglutinin from a transmissible H10N7 seal influenza virus isolated in Netherland in complex with human receptor analogue 6'-SLN
0.0025.000.03 949-988X-ray1.65hetero-3-3-mer3 x NAG, 3 x NAG-GAL-SIAHHblits0.34
6tjw.1.B
Hemagglutinin HA2
Crystal structure of the haemagglutinin mutant (Gln226Leu, Del228) from an H10N7 seal influenza virus isolated in Germany
0.0025.000.03 949-988X-ray2.31hetero-3-3-mer5 x NAG, 1 x CA, 1 x NAG-NAGHHblits0.34
4xqo.1.B
Hemagglutinin HA2 chain
Crystal structure of hemagglutinin from Jiangxi-Donghu (2013) H10N8 influenza virus in complex with 6'-SLN
0.0027.500.03 949-988X-ray2.85hetero-3-3-mer2 x NAG, 2 x NAG-NAG, 1 x NAG-GAL-SIA, 1 x GAL-SIAHHblits0.34
4xqo.1.D
Hemagglutinin HA2 chain
Crystal structure of hemagglutinin from Jiangxi-Donghu (2013) H10N8 influenza virus in complex with 6'-SLN
0.0027.500.03 949-988X-ray2.85hetero-3-3-mer2 x NAG, 2 x NAG-NAG, 1 x NAG-GAL-SIA, 1 x GAL-SIAHHblits0.34
4xqo.1.F
Hemagglutinin HA2 chain
Crystal structure of hemagglutinin from Jiangxi-Donghu (2013) H10N8 influenza virus in complex with 6'-SLN
0.0027.500.03 949-988X-ray2.85hetero-3-3-mer2 x NAG, 2 x NAG-NAG, 1 x NAG-GAL-SIA, 1 x GAL-SIAHHblits0.34
4xqu.1.B
Hemagglutinin HA2
Crystal structure of hemagglutinin from Jiangxi-Donghu (2013) H10N8 influenza virus in complex with 3'-SLN
0.0027.500.03 949-988X-ray3.25hetero-3-3-mer3 x NAG, 2 x NAG-GAL-SIA, 2 x NAG-NAG, 1 x GAL-SIAHHblits0.34
4xqu.1.D
Hemagglutinin HA2
Crystal structure of hemagglutinin from Jiangxi-Donghu (2013) H10N8 influenza virus in complex with 3'-SLN
0.0027.500.03 949-988X-ray3.25hetero-3-3-mer3 x NAG, 2 x NAG-GAL-SIA, 2 x NAG-NAG, 1 x GAL-SIAHHblits0.34
4xqu.1.F
Hemagglutinin HA2
Crystal structure of hemagglutinin from Jiangxi-Donghu (2013) H10N8 influenza virus in complex with 3'-SLN
0.0027.500.03 949-988X-ray3.25hetero-3-3-mer3 x NAG, 2 x NAG-GAL-SIA, 2 x NAG-NAG, 1 x GAL-SIAHHblits0.34
6rh7.1.A
Sensor histidine kinase
Revisiting pH-gated conformational switch. Complex HK853 mutant H260A -RR468 mutant D53A pH 7.5
0.0016.670.03 945-986X-ray2.00hetero-2-2-mer2 x ADPHHblits0.30
6rh8.1.A
Sensor histidine kinase
Revisiting pH-gated conformational switch. Complex HK853 mutant H260A -RR468 mutant D53A pH 5.3
0.0016.670.03 945-986X-ray1.90hetero-2-2-mer2 x ADPHHblits0.30
4k3x.1.D
Hemagglutinin HA2
Crystal structure of a subtype H18 hemagglutinin homologue from A/flat-faced bat/Peru/033/2010 (H18N11)
0.0017.070.03 948-988X-ray2.15hetero-3-3-mer12 x P4G, 2 x NAG, 3 x NAG-NAG-BMA-MAN-MAN-FUL-FUC, 1 x NAG-FUL-NAG-FUL, 5 x NAG-NAG, 1 x NAG-NAG-BMA-BMA-FUL, 1 x NAG-FUL-NAG-FUC, 1 x NAG-FUL-NAGHHblits0.32
8gv7.1.B
Hemagglutinin H18-HA2
Crystal structure of PN-SIA28 in complex with influenza hemagglutinin H18 A/flat-faced bat/Peru/033/2010
0.0017.070.03 948-988X-ray2.60hetero-3-3-3-3-mer6 x NAG, 3 x NAG-FUC, 3 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MANHHblits0.32
6kos.1.A
SUWA (Super WA20)
Crystal structure of SUWA (Super WA20), a hyper-stable de novo protein with a dimeric bisecting topology
0.0025.640.03 952-990X-ray2.00homo-dimerHHblits0.36
6kos.1.B
SUWA (Super WA20)
Crystal structure of SUWA (Super WA20), a hyper-stable de novo protein with a dimeric bisecting topology
0.0025.640.03 952-990X-ray2.00homo-dimerHHblits0.36
6kos.2.A
SUWA (Super WA20)
Crystal structure of SUWA (Super WA20), a hyper-stable de novo protein with a dimeric bisecting topology
0.0025.640.03 952-990X-ray2.00homo-dimerHHblits0.36
6kos.2.B
SUWA (Super WA20)
Crystal structure of SUWA (Super WA20), a hyper-stable de novo protein with a dimeric bisecting topology
0.0025.640.03 952-990X-ray2.00homo-dimerHHblits0.36
5a3i.2.B
HEMAGGLUTININ
Crystal Structure of a Complex formed between FLD194 Fab and Transmissible Mutant H5 Haemagglutinin
0.0015.000.03 948-987X-ray2.89hetero-1-1-1-1-mer1 x NAGHHblits0.34
5wkq.1.A
Invasin IpaB
2.10 A resolution structure of IpaB (residues 74-242) from Shigella flexneri
0.004.550.03 901-944X-ray2.10monomerHHblits0.26
5wkq.2.A
Invasin IpaB
2.10 A resolution structure of IpaB (residues 74-242) from Shigella flexneri
0.004.550.03 901-944X-ray2.10monomerHHblits0.26
5jw4.1.B
Hemagglutinin
Structure of MEDI8852 Fab Fragment in Complex with H5 HA
0.0015.000.03 948-987X-ray3.70hetero-3-3-2-2-1-1-…9 x NAG, 3 x NAG-NAGHHblits0.33
4bh2.1.B
HEMAGGLUTININ
Crystal Structure of the Haemagglutinin from a Transmissible Mutant H5 Influenza Virus
0.0015.000.03 948-987X-ray2.12hetero-3-3-mer6 x NAG, 3 x NAG-NAG-BMA-BMA-MANHHblits0.33
4kdq.1.D
Hemagglutinin
Crystal structure of the hemagglutinin of A/Xinjiang/1/2006 virus
0.0015.000.03 948-987X-ray2.60hetero-3-3-mer7 x NAGHHblits0.33
3znk.1.B
HAEMAGGLUTININ
H5 Haemagglutinin in Complex with 6-O-Sulfo-2,3-Sialyllactosamine (Sulfated 3'SLN)
0.0015.000.03 948-987X-ray2.71hetero-3-3-mer9 x NAG, 3 x NGS-GLA-SIAHHblits0.33
5a3i.1.B
HEMAGGLUTININ
Crystal Structure of a Complex formed between FLD194 Fab and Transmissible Mutant H5 Haemagglutinin
0.0015.000.03 948-987X-ray2.89hetero-1-1-1-1-mer2 x NAG-NAGHHblits0.33
4cqx.1.D
HAEMAGGLUTININ HA2
H5 (tyTy) Del133/Ile155Thr Mutant Haemagglutinin in Complex with Human Receptor Analogue 6'SLN
0.0015.000.03 948-987X-ray2.30hetero-3-3-mer9 x NAG, 3 x NAG-GAL-SIAHHblits0.33
4bh1.1.D
HEMAGGLUTININ
H5 (tyTy) Influenza Virus Haemagglutinin in Complex with Avian Receptor Analogue 3'-SLN
0.0015.000.03 948-987X-ray2.15hetero-3-3-mer3 x NAG, 3 x NAG-GAL-SIAHHblits0.33
4bgz.1.F
HAEMAGGLUTININ HA1
Crystal Structure of H5 (tyTy) Influenza Virus Haemagglutinin
0.0015.000.03 948-987X-ray2.68hetero-3-3-mer4 x NAGHHblits0.33
7dea.1.C
Hemagglutinin
Structure of an avian influenza H5 hemagglutinin from the influenza virus A/duck Northern China/22/2017 (H5N6)
0.0015.000.03 948-987X-ray2.84hetero-3-3-mer6 x NAG, 3 x NAG-NAGHHblits0.33
6zrk.1.B
Hemagglutinin
Crystal structure of H8 haemagglutinin
0.0012.500.03 949-988X-ray2.00hetero-3-3-mer3 x NAG, 3 x NAG-NAG-BMA-MAN-MAN-FUC, 9 x NAG-NAGHHblits0.33
6v46.1.B
Hemagglutinin HA2 chain
The crystal structure of hemagglutinin from A/turkey/Ontario/6118/1968 (H8N4)
0.0012.500.03 949-988X-ray2.25hetero-3-3-mer3 x NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAGHHblits0.33
6v47.1.B
Hemagglutinin HA2 chain
The crystal structure of hemagglutinin from A/duck/Memphis/546/1974 (H11N9)
0.0020.510.03 949-987X-ray2.80hetero-3-3-mer3 x NAG-NAGHHblits0.35
2d4y.1.A
Flagellar hook-associated protein 1
Crystal structure of a 49K fragment of HAP1 (FlgK)
0.004.550.03 997-1040X-ray2.10monomerHHblits0.26
2d4y.2.A
Flagellar hook-associated protein 1
Crystal structure of a 49K fragment of HAP1 (FlgK)
0.004.550.03 997-1040X-ray2.10monomerHHblits0.26
6ml8.1.B
Hemagglutinin
Crystal structure of hemagglutinin from H1N1 Influenza A virus A/Denver/57 bound to the C05 antibody
0.0017.950.03 949-987X-ray2.92hetero-3-3-3-3-mer3 x NAG-NAG-BMA-MAN, 3 x NAG-NAG-BMA, 3 x NAG-NAGHHblits0.35
7jpd.1.B
Hemagglutinin HA2 chain
Crystal structure of the trimeric full length mature hemagglutinin from influenza A virus A/Fort Monmouth/1/1947
0.0017.950.03 949-987X-ray2.95hetero-3-3-mer4 x NAG, 1 x NAG-NAG-BMA, 3 x NAG-NAG, 2 x NAG-NAG-BMA-MAN-MANHHblits0.35
4lkg.3.F
hemagglutinin
The structure of hemagglutinin from a avian-origin H7N9 influenza virus (A/Shanghai/1/2013) in complex with avian receptor analog 3'SLNLN
0.0020.000.03 948-987X-ray2.99hetero-3-3-mer3 x NAG, 3 x GAL-SIAHHblits0.33
5thf.1.B
Hemagglutinin HA2 chain
Crystal structure of H3 hemagglutinin with insertion of two amino acids in the 150-loop from the A/Hong Kong/1/1968 (H3N2) influenza virus
0.0020.000.03 949-988X-ray2.59hetero-3-3-mer4 x NAG, 3 x NAG-NAG-BMA, 3 x NAG-NAGHHblits0.33
4i78.1.B
Hemagglutinin HA2
Crystal structure of a subtype H17 hemagglutinin homologue from A/little yellow-shouldered bat/Guatemala/060/2010 (H17N10)
0.0017.070.03 948-988X-ray3.18hetero-3-3-mer3 x NAG-FUCHHblits0.31
4jtv.1.B
Hemagglutinin
Crystal structure of 2009 pandemic influenza virus hemagglutinin complexed with human receptor analogue LSTc
0.0015.380.03 949-987X-ray3.00hetero-3-3-mer5 x NAG, 1 x NAG-GAL-SIA, 2 x GAL-NAG-GAL-SIA, 1 x NAG-NAGHHblits0.35
4jtv.2.F
Hemagglutinin
Crystal structure of 2009 pandemic influenza virus hemagglutinin complexed with human receptor analogue LSTc
0.0015.380.03 949-987X-ray3.00hetero-3-3-mer2 x NAG, 1 x SIA, 2 x NAG-GAL-SIAHHblits0.35
3ztn.1.B
HAEMAGGLUTININ
STRUCTURE OF INFLUENZA A NEUTRALIZING ANTIBODY SELECTED FROM CULTURES OF SINGLE HUMAN PLASMA CELLS IN COMPLEX WITH HUMAN H1 INFLUENZA HAEMAGGLUTININ.
0.0015.380.03 949-987X-ray3.00hetero-3-3-3-3-mer6 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.35
5ibl.2.C
Hemagglutinin
Human antibody 6639 in complex with influenza hemagglutinin H1 X-181
0.0015.380.03 949-987X-ray3.39hetero-1-1-1-1-mer5 x NAGHHblits0.35
5ibl.1.A
Hemagglutinin
Human antibody 6639 in complex with influenza hemagglutinin H1 X-181
0.0015.380.03 949-987X-ray3.39hetero-1-1-1-1-mer2 x NAGHHblits0.35
3al4.1.B
Hemagglutinin
Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus
0.0015.380.03 949-987X-ray2.87hetero-1-1-mer2 x NAG, 2 x NAG-NAGHHblits0.35
3al4.3.B
Hemagglutinin
Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus
0.0015.380.03 949-987X-ray2.87hetero-1-1-mer4 x NAG, 1 x NAG-NAGHHblits0.35
5nen.1.A
Lipase C
Crystal structure of the soluble domain of LipC, a membrane fusion protein of a type I secretion system
0.0019.510.03 991-1031X-ray2.90homo-dimerHHblits0.31
5nen.1.B
Lipase C
Crystal structure of the soluble domain of LipC, a membrane fusion protein of a type I secretion system
0.0019.510.03 991-1031X-ray2.90homo-dimerHHblits0.31
5gjt.1.B
Hemagglutinin
Crystal structure of H1 hemagglutinin from A/Washington/05/2011 in complex with a neutralizing antibody 3E1
0.0015.380.03 949-987X-ray3.10hetero-3-3-3-3-mer3 x NAG-NAGHHblits0.35
1ruz.1.B
hemagglutinin
1918 H1 Hemagglutinin
0.0015.380.03 949-987X-ray2.90hetero-3-3-mer8 x NDG, 2 x NAGHHblits0.35
4jug.1.B
Hemagglutinin
Crystal structure of 1918 pandemic influenza virus hemagglutinin mutant D225G
0.0015.380.03 949-987X-ray2.70hetero-3-3-mer3 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.35
4jug.1.D
Hemagglutinin
Crystal structure of 1918 pandemic influenza virus hemagglutinin mutant D225G
0.0015.380.03 949-987X-ray2.70hetero-3-3-mer3 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.35
4jug.2.F
Hemagglutinin
Crystal structure of 1918 pandemic influenza virus hemagglutinin mutant D225G
0.0015.380.03 949-987X-ray2.70hetero-3-3-mer3 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.35
4gxx.1.B
Hemagglutinin HA2 chain
Crystal structure of the "avianized" 1918 influenza virus hemagglutinin
0.0015.380.03 949-987X-ray1.80hetero-3-3-mer5 x NAG, 1 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMAHHblits0.35
6hjn.1.B
Hemagglutinin
Structure of Influenza Hemagglutinin ectodomain (A/duck/Alberta/35/76)
0.0015.380.03 949-987EM0.00hetero-3-3-mer3 x UPL, 6 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-BMA-MAN-MAN, 3 x NAG-NAG-BMAHHblits0.35
6tva.1.B
Haemagglutinin HA2
Crystal structure of the haemagglutinin from a transmissible H10N7 seal influenza virus isolated in Netherland in complex with avian receptor analogue, 3'-SLN
0.0025.640.03 949-987X-ray1.74hetero-3-3-mer5 x NAG, 3 x NAG-GAL-SIA, 1 x NAG-NAG-BMA-MAN-MANHHblits0.35
1rd8.1.B
hemagglutinin
Crystal Structure of the 1918 Human H1 Hemagglutinin Precursor (HA0)
0.0015.380.03 949-987X-ray3.00hetero-3-3-mer6 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MANHHblits0.35
3lzf.2.D
Hemagglutinin, HA2 Subunit
Crystal Structure of Fab 2D1 in Complex with the 1918 Influenza Virus Hemagglutinin
0.0015.380.03 949-987X-ray2.80hetero-3-3-mer3 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMA-MANHHblits0.35
4eef.1.B
Hemagglutinin HA2 chain
Crystal structure of the designed inhibitor protein F-HB80.4 in complex with the 1918 influenza virus hemagglutinin.
0.0015.380.03 949-987X-ray2.70hetero-1-1-1-merHHblits0.35
4py8.1.J
Hemagglutinin HA2 chain
Crystal structure of Fab 3.1 in complex with the 1918 influenza virus hemagglutinin
0.0015.380.03 949-987X-ray2.91hetero-3-3-3-3-mer6 x NAG, 3 x NAG-NAGHHblits0.35
4eef.4.F
Hemagglutinin HA2 chain
Crystal structure of the designed inhibitor protein F-HB80.4 in complex with the 1918 influenza virus hemagglutinin.
0.0015.380.03 949-987X-ray2.70hetero-3-3-3-merHHblits0.35
4eef.2.B
Hemagglutinin HA2 chain
Crystal structure of the designed inhibitor protein F-HB80.4 in complex with the 1918 influenza virus hemagglutinin.
0.0015.380.03 949-987X-ray2.70hetero-1-1-1-merHHblits0.35
4d00.1.B
HAEMAGGLUTININ HA1
Haemagglutinin of H10N8 Influenza Virus Isolated from Humans in Complex with Human Receptor Analogue 6'SLN
0.0028.210.03 949-987X-ray2.50hetero-3-3-mer6 x NAG, 3 x NI, 3 x NAG-GAL-SIA, 3 x NAG-NAGHHblits0.35
4d00.1.D
HAEMAGGLUTININ HA1
Haemagglutinin of H10N8 Influenza Virus Isolated from Humans in Complex with Human Receptor Analogue 6'SLN
0.0028.210.03 949-987X-ray2.50hetero-3-3-mer6 x NAG, 3 x NI, 3 x NAG-GAL-SIA, 3 x NAG-NAGHHblits0.35
1ruy.1.B
hemagglutinin
1930 Swine H1 Hemagglutinin
0.0015.380.03 949-987X-ray2.70hetero-3-3-mer4 x NDG, 4 x NAGHHblits0.34
5wko.2.L
Hemagglutinin
Crystal structure of antibody 27F3 recognizing the HA from A/California/04/2009 (H1N1) influenza virus
0.0015.380.03 949-987X-ray3.49hetero-3-3-3-3-merHHblits0.34
6wj1.1.D
Hemagglutinin HA2 chain
Crystal structure of Fab 54-4H03 bound to H1 influenza hemagglutinin
0.0015.380.03 949-987X-ray3.50hetero-3-3-3-3-mer10 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA-MAN, 1 x NAG-FUC, 1 x NAG-NAG-BMAHHblits0.34
4cyw.1.B
HEMAGGLUTININ
Structure of the A_mallard_Sweden_51_2002 H10 Avian Haemmaglutinin in complex with human receptor analog 6-SLN
0.0025.640.03 949-987X-ray2.60hetero-3-3-mer6 x NAG, 3 x NAG-GAL-SIA, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-BMA-MAN, 1 x NAG-NAG-BMA-MANHHblits0.34
4cyv.1.B
HEMAGGLUTININ
Structure of the A_mallard_Sweden_51_2002 H10 Avian Haemmaglutinin
0.0025.640.03 949-987X-ray2.30hetero-3-3-mer6 x NAG, 3 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA, 1 x NAG-NAGHHblits0.34
4cz0.1.D
HAEMAGGLUTININ
Structure of the A_mallard_Sweden_51_2002 H10 Avian Haemmaglutinin in complex with avian receptor analog Su-3SLN
0.0025.640.03 949-987X-ray3.20hetero-3-3-mer7 x NAG, 3 x NGS-GAL-SIA, 3 x NAG-NAG-BMA-MAN-MANHHblits0.34
5w42.1.B
Hemagglutinin
Crystal structure of human monoclonal antibody H3v-47 in complex with influenza virus hemagglutinin from A/Minnesota/11/2010 (H3N2)
0.0023.080.03 949-987X-ray3.57hetero-3-3-3-3-mer6 x NAG, 3 x ZN, 6 x NAG-NAG-BMA-MAN-MAN, 3 x NAG-NAG-BMA-MAN, 3 x NAG-NAG-MAN-MAN-MAN-MAN, 3 x NAG-NAG-BMA, 3 x NAG-NAGHHblits0.34
5xrs.2.F
Hemagglutinin
Crystal structure of A/Minnesota/11/2010 (H3N2) influenza virus hemagglutinin in complex with LSTc
0.0023.080.03 949-987X-ray2.91hetero-3-3-mer3 x NAG, 6 x NAG-NAG-BMA, 3 x NAG-NAG-BMA-MAN, 3 x NAG-NAG-MAN-MAN-MAN, 3 x NAG-NAG, 3 x BGC-GAL-NAG-GAL-SIAHHblits0.34
5xrt.2.B
Hemagglutinin
Crystal structure of A/Minnesota/11/2010 (H3N2) influenza virus hemagglutinin
0.0023.080.03 949-987X-ray3.15hetero-3-3-mer6 x NAG, 3 x NAG-NAG-BMA-MAN-FUC, 3 x NAG-NAG, 3 x NAG-NAG-MAN-MAN-MAN-MAN-MAN, 3 x NAG-NAG-BMA-MAN, 3 x NAG-NAG-BMA-MAN-MANHHblits0.34
5xrt.1.B
Hemagglutinin
Crystal structure of A/Minnesota/11/2010 (H3N2) influenza virus hemagglutinin
0.0023.080.03 949-987X-ray3.15hetero-3-3-mer5 x NAG, 1 x CAC, 1 x NAG-NAG-BMA-FUL-FUC, 3 x NAG-NAG-BMA-MAN, 3 x NAG-NAG-MAN-MAN-MAN-MAN, 4 x NAG-NAG-BMA-MAN-MAN, 3 x NAG-NAG, 2 x NAG-NAG-BMA, 1 x NAG-FUL-FUC, 1 x NAG-NAG-FUCHHblits0.34
6d8d.1.B
Hemagglutinin HA2 chain
The crystal structure of hemagglutinin from A/Hong Kong/125/2017 influenza virus in complex with LSTb
0.0023.080.03 949-987X-ray3.55hetero-3-3-mer6 x NAG, 2 x GAL, 1 x SIA, 2 x NAG-GAL-SIA, 1 x NAG-GALHHblits0.34
4wsw.1.B
Hemagglutinin HA2 chain
The crystal structure of hemagglutinin from A/green-winged teal/Texas/Y171/2006 influenza virus
0.0023.080.03 949-987X-ray2.80hetero-3-3-mer12 x NAGHHblits0.34
4wsw.1.F
Hemagglutinin HA2 chain
The crystal structure of hemagglutinin from A/green-winged teal/Texas/Y171/2006 influenza virus
0.0023.080.03 949-987X-ray2.80hetero-3-3-mer12 x NAGHHblits0.34
3ci9.1.A
Heat shock factor-binding protein 1
Crystal Structure of the human HSBP1
0.0028.950.03 953-990X-ray1.80homo-hexamerHHblits0.36
3ci9.1.B
Heat shock factor-binding protein 1
Crystal Structure of the human HSBP1
0.0028.950.03 953-990X-ray1.80homo-hexamerHHblits0.36
1rvt.1.B
hemagglutinin
1930 H1 Hemagglutinin in complex with LSTC
0.0015.380.03 949-987X-ray2.50hetero-3-3-mer3 x NDG, 2 x GAL-SIA, 1 x BGC-GAL-NAG-GAL-SIAHHblits0.34
3zp6.1.D
HAEMAGGLUTININ
INFLUENZA VIRUS (VN1194) H5 E190D mutant HA with LSTc
0.0015.380.03 949-987X-ray2.60hetero-3-3-mer6 x NAG, 3 x GAL-SIAHHblits0.34
7a9d.1.B
Hemagglutinin
Crystal structure of H12 Haemagglutinin
0.0015.380.03 949-987X-ray2.70hetero-3-3-mer6 x NAG, 3 x NAG-NAGHHblits0.34
4k62.1.B
Hemagglutinin
Structure of an avian influenza H5 hemagglutinin from the influenza virus A/Indonesia/5/2005
0.0015.380.03 949-987X-ray2.50hetero-3-3-mer3 x NAGHHblits0.34
4k62.3.B
Hemagglutinin
Structure of an avian influenza H5 hemagglutinin from the influenza virus A/Indonesia/5/2005
0.0015.380.03 949-987X-ray2.50hetero-3-3-merHHblits0.34
4k65.3.B
Hemagglutinin
Structure of an airborne transmissible avian influenza H5 hemagglutinin mutant from the influenza virus A/Indonesia/5/2005
0.0015.380.03 949-987X-ray2.90hetero-3-3-merHHblits0.34
4cr0.1.B
Hemagglutinin HA2
Crystal Structure of H5 (VN1194) Asn186Lys/Gly143Arg Mutant Haemagglutinin
0.0015.380.03 949-987X-ray2.65hetero-3-3-mer12 x NAGHHblits0.34
6e3h.1.B
Hemagglutinin HA2
Crystal structure of S9-3-37 bound to H5 influenza hemagglutinin
0.0015.380.03 949-987X-ray2.90hetero-3-3-3-3-mer9 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMA-FUCHHblits0.34
3s11.1.B
Hemagglutinin HA2 chain
Crystal structure of H5N1 influenza virus hemagglutinin, strain 437-10
0.0015.380.03 949-987X-ray2.50hetero-3-3-mer3 x NAG, 1 x TAM, 2 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.34
3s12.1.B
Hemagglutinin HA2 chain
Crystal structure of H5N1 influenza virus hemagglutinin, strain YU562 crystal form 1
0.0015.380.03 949-987X-ray3.10hetero-3-3-mer3 x NAG, 3 x NAG-NAGHHblits0.34
3gbm.1.J
Hemagglutinin
Crystal Structure of Fab CR6261 in Complex with a H5N1 influenza virus hemagglutinin.
0.0015.380.03 949-987X-ray2.70hetero-3-3-3-3-mer9 x NAG, 3 x NAG-NAGHHblits0.34
3gbm.2.B
Hemagglutinin
Crystal Structure of Fab CR6261 in Complex with a H5N1 influenza virus hemagglutinin.
0.0015.380.03 949-987X-ray2.70hetero-3-3-3-3-mer6 x NAG, 3 x NAG-NAGHHblits0.34
6e7g.1.B
Hemagglutinin HA2 chain
Crystal structure of H5 hemagglutinin mutant Y161A from A/Viet Nam/1203/2004 H5N1 influenza virus
0.0015.380.03 949-987X-ray3.09hetero-3-3-mer2 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.34
6e7h.1.F
Hemagglutinin HA2 chain
Crystal structure of H5 hemagglutinin mutant Y161A from A/Viet Nam/1203/2004 H5N1 influenza virus in complex with 3'-GcLN
0.0015.380.03 949-987X-ray3.30hetero-3-3-mer2 x NAG, 2 x NAG-NAG, 1 x NAG-NAG-BMA, 1 x GAL-NGCHHblits0.34
4kth.1.A
Hemagglutinin
Structure of A/Hubei/1/2010 H5 HA
0.0015.380.03 949-987X-ray2.60homo-trimer1 x NAG, 1 x NAG-NAGHHblits0.34
4kth.1.B
Hemagglutinin
Structure of A/Hubei/1/2010 H5 HA
0.0015.380.03 949-987X-ray2.60homo-trimer1 x NAG, 1 x NAG-NAGHHblits0.34
7wl5.1.D
Hemagglutinin
Structure of an avian influenza H5 hemagglutinin from the influenza virus A/Equine/Guangxi/25/2010(H5N1) and A/Equine/Guangxi/68/2010(H5N1)
0.0015.380.03 949-987X-ray2.80hetero-3-3-mer3 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.34
7wl5.1.E
Hemagglutinin
Structure of an avian influenza H5 hemagglutinin from the influenza virus A/Equine/Guangxi/25/2010(H5N1) and A/Equine/Guangxi/68/2010(H5N1)
0.0015.380.03 949-987X-ray2.80hetero-3-3-mer3 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.34
7wl5.1.F
Hemagglutinin
Structure of an avian influenza H5 hemagglutinin from the influenza virus A/Equine/Guangxi/25/2010(H5N1) and A/Equine/Guangxi/68/2010(H5N1)
0.0015.380.03 949-987X-ray2.80hetero-3-3-mer3 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.34
2yo3.1.A
GENERAL CONTROL PROTEIN GCN4, PUTATIVE INNER MEMBRANE PROTEIN, GENERAL CONTROL PROTEIN GCN4
Salmonella enterica SadA 1185-1386 fused to GCN4 adaptors (SadAK14)
0.0023.080.03 958-998X-ray2.00homo-trimerHHblits0.34
2yo3.1.B
GENERAL CONTROL PROTEIN GCN4, PUTATIVE INNER MEMBRANE PROTEIN, GENERAL CONTROL PROTEIN GCN4
Salmonella enterica SadA 1185-1386 fused to GCN4 adaptors (SadAK14)
0.0023.080.03 958-998X-ray2.00homo-trimerHHblits0.34
2yo3.1.C
GENERAL CONTROL PROTEIN GCN4, PUTATIVE INNER MEMBRANE PROTEIN, GENERAL CONTROL PROTEIN GCN4
Salmonella enterica SadA 1185-1386 fused to GCN4 adaptors (SadAK14)
0.0023.080.03 958-998X-ray2.00homo-trimerHHblits0.34
5bny.1.B
Hemagglutinin
Crystal structure of hemagglutinin of A/Chicken/Guangdong/S1311/2010 (H6N6)
0.0015.380.03 949-987X-ray2.66hetero-3-3-mer8 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-NAGHHblits0.34
3c98.1.B
Syntaxin-1A
Revised structure of the munc18a-syntaxin1 complex
0.0011.900.03 922-963X-ray2.60hetero-oligomerHHblits0.28
7xsj.1.B
Syntaxin-1A
The structure of the Mint1/Munc18-1/syntaxin-1 complex
0.0011.900.03 923-964X-ray3.20hetero-1-1-1-merHHblits0.28
1ti8.1.B
hemagglutinin
H7 Haemagglutinin
0.0020.510.03 949-987X-ray3.00hetero-3-3-mer3 x NDG, 3 x MAN, 6 x NAGHHblits0.34
4h32.1.F
Hemagglutinin
The crystal structure of the hemagglutinin H17 derived the bat influenza A virus
0.0017.500.03 948-987X-ray2.70hetero-3-3-mer4 x NAGHHblits0.31
4h32.1.D
Hemagglutinin
The crystal structure of the hemagglutinin H17 derived the bat influenza A virus
0.0017.500.03 948-987X-ray2.70hetero-3-3-mer4 x NAGHHblits0.31
4h32.1.B
Hemagglutinin
The crystal structure of the hemagglutinin H17 derived the bat influenza A virus
0.0017.500.03 948-987X-ray2.70hetero-3-3-mer4 x NAGHHblits0.31
4uo0.1.B
HEMAGGLUTININ
Structure of the A_Equine_Richmond_07 H3 haemagglutinin
0.0017.950.03 949-987X-ray1.90hetero-3-3-mer2 x NAG, 9 x NAG-NAG, 4 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-FUC, 3 x NAG-NAG-BMA, 1 x NAG-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 3 x NAG-NAG-FUCHHblits0.33
4uo3.1.B
H3 HAEMAGGLUTININ HA2 CHAIN
Structure of the A_Equine_Richmond_07 H3 haemagglutinin mutant Ser30Thr
0.0017.950.03 949-987X-ray2.87hetero-3-3-mer6 x NAG, 1 x NAG-NAG-BMA-FUC, 3 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 2 x NAG-FUC, 1 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.33
6bkn.2.A
Hemagglutinin
Crystal structure of the A/Wyoming/3/2003 (H3N2) influenza virus hemagglutinin apo form
0.0023.080.03 949-987X-ray1.85homo-trimer3 x NAGHHblits0.33
6ftj.1.o
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1,RPN1
Cryo-EM Structure of the Mammalian Oligosaccharyltransferase Bound to Sec61 and the Non-programmed 80S Ribosome
0.0011.900.03 938-979EM0.00hetero-1-1-1-1-1-1-…20 x MG, 5 x ZN, 1 x 9UB, 1 x NAG-NAG-BMA-MAN-MAN-MAN-MAN-MANHHblits0.27
4mod.1.A
HR1 of S protein, LINKER, HR2 of S protein
Structure of the MERS-CoV fusion core
0.0041.670.03 1168-1203X-ray1.90homo-trimerHHblits0.39
5lqx.1.Z
ATP synthase subunit b
Structure of F-ATPase from Pichia angusta, state3
0.0014.630.03 914-954EM0.00hetero-1-1-1-1-3-3-…1 x ATP, 5 x MG, 5 x ADPHHblits0.29
4nrj.1.B
HEMAGGLUTININ HA2 CHAIN
Structure of hemagglutinin with F95Y mutation of influenza virus B/Lee/40
0.0020.510.03 949-987X-ray2.53hetero-3-3-mer6 x NAG, 12 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.33
3swy.1.A
Cyclic nucleotide-gated cation channel alpha-3
CNGA3 626-672 containing CLZ domain
0.0020.000.03 950-989X-ray1.90homo-trimerHHblits0.31
3swy.1.B
Cyclic nucleotide-gated cation channel alpha-3
CNGA3 626-672 containing CLZ domain
0.0020.000.03 950-989X-ray1.90homo-trimerHHblits0.31
3swy.1.C
Cyclic nucleotide-gated cation channel alpha-3
CNGA3 626-672 containing CLZ domain
0.0020.000.03 950-989X-ray1.90homo-trimerHHblits0.31
5yev.1.A
TNFRSF25 death domain
Murine DR3 death domain
0.0014.290.03 925-966X-ray2.50monomerHHblits0.27
5yev.3.A
TNFRSF25 death domain
Murine DR3 death domain
0.0014.290.03 925-966X-ray2.50monomerHHblits0.27
3qqe.1.B
Hemagglutinin
Crystal structure of HA2 R106H mutant of H2 hemagglutinin, re-neutralized form
0.0015.380.03 949-987X-ray2.10hetero-3-3-mer6 x NAG, 3 x NAG-NAGHHblits0.33
3qqo.1.D
Hemagglutinin
Crystal structure of HA2 R106H mutant of H2 hemagglutinin, acidic pH form
0.0015.380.03 949-987X-ray2.90hetero-3-3-mer3 x NAGHHblits0.33
3ku3.1.B
Hemagglutinin HA2 chain
Crystal structure of a H2N2 influenza virus hemagglutinin, avian like
0.0015.380.03 949-987X-ray1.60hetero-3-3-mer3 x NAG, 6 x NAG-NAGHHblits0.33
4hfu.2.J
Hemagglutinin HA2
Crystal structure of Fab 8M2 in complex with a H2N2 influenza virus hemagglutinin
0.0015.380.03 949-987X-ray3.11hetero-6-6-6-6-mer6 x NAG-NAGHHblits0.33
4hf5.1.F
Hemagglutinin HA2
Crystal structure of Fab 8F8 in complex a H2N2 influenza virus hemagglutinin
0.0015.380.03 949-987X-ray3.00hetero-3-3-3-3-mer3 x NAG-NAG-BMA-MAN, 3 x NAG-NAGHHblits0.33
4hg4.1.F
Hemagglutinin HA2
Crystal structure of Fab 2G1 in complex with a H2N2 influenza virus hemagglutinin
0.0015.380.03 949-987X-ray3.20hetero-3-3-3-3-mer2 x NAG, 2 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.33
4hg4.3.F
Hemagglutinin HA2
Crystal structure of Fab 2G1 in complex with a H2N2 influenza virus hemagglutinin
0.0015.380.03 949-987X-ray3.20hetero-3-3-3-3-mer1 x NAG-NAG-BMA, 4 x NAG-NAGHHblits0.33
4yy0.1.B
HA2
The structure of hemagglutinin from a H6N1 influenza virus (A/chicken/Taiwan/A2837/2013)
0.0012.820.03 949-987X-ray2.59hetero-3-3-mer7 x NAGHHblits0.33
4yy0.1.D
HA2
The structure of hemagglutinin from a H6N1 influenza virus (A/chicken/Taiwan/A2837/2013)
0.0012.820.03 949-987X-ray2.59hetero-3-3-mer7 x NAGHHblits0.33
4yy0.1.F
HA2
The structure of hemagglutinin from a H6N1 influenza virus (A/chicken/Taiwan/A2837/2013)
0.0012.820.03 949-987X-ray2.59hetero-3-3-mer7 x NAGHHblits0.33
4yy1.1.B
HA2
The structure of hemagglutinin from a H6N1 influenza virus (A/chicken/Taiwan/A2837/2013) in complex with human receptor analog 6'SLNLN
0.0012.820.03 949-987X-ray3.10hetero-3-3-mer6 x NAG, 3 x NAG-NAG, 3 x GAL-SIAHHblits0.33
4yy9.1.B
HA2
The structure of hemagglutinin from a H6N1 influenza virus (A/Taiwan/2/2013)
0.0012.820.03 949-987X-ray2.60hetero-3-3-mer6 x NAG, 3 x NAG-NAG-BMAHHblits0.33
4yya.1.B
HA2
The structure of hemagglutinin from a H6N1 influenza virus (A/Taiwan/2/2013) in complex with avian receptor analog 3'SLNLN
0.0012.820.03 949-987X-ray2.60hetero-3-3-mer6 x NAG, 3 x GAL-NAG-GAL-SIA, 3 x NAG-NAG-BMAHHblits0.33
8gv5.1.B
Hemagglutinin HA2 chain
Crystal structure of PN-SIA28 in complex with influenza hemagglutinin A/swine/Guangdong/104/2013 (H1N1)
0.0012.820.03 949-987X-ray3.20hetero-1-1-1-1-mer1 x NAGHHblits0.33
5wb0.1.A
Fusion glycoprotein F0
Crystal structure of human metapneumovirus fusion glycoprotein stabilized in the prefusion state
0.0026.320.03 918-955X-ray2.60homo-trimer3 x NAG, 3 x NAG-NAG, 3 x NAG-NAG-BMA-MANHHblits0.35
5l1x.1.B
hMPV F1 subunit
Structure of the Human Metapneumovirus Fusion Protein in the Postfusion Conformation
0.0026.320.03 918-955X-ray3.30hetero-3-3-mer3 x NAG, 2 x NAG-NAG-FUC, 1 x NAG-FUCHHblits0.35
5l1x.1.D
hMPV F1 subunit
Structure of the Human Metapneumovirus Fusion Protein in the Postfusion Conformation
0.0026.320.03 918-955X-ray3.30hetero-3-3-mer3 x NAG, 2 x NAG-NAG-FUC, 1 x NAG-FUCHHblits0.35
5l1x.1.F
hMPV F1 subunit
Structure of the Human Metapneumovirus Fusion Protein in the Postfusion Conformation
0.0026.320.03 918-955X-ray3.30hetero-3-3-mer3 x NAG, 2 x NAG-NAG-FUC, 1 x NAG-FUCHHblits0.35
7r5k.43.A
Nucleoporin p54
Human nuclear pore complex (constricted)
0.0023.080.03 971-1009EM0.00monomerHHblits0.32
5ijn.1.F
NUCLEAR PORE COMPLEX PROTEIN NUP54
Composite structure of the inner ring of the human nuclear pore complex (32 copies of Nup205)
0.0023.080.03 971-1009EM0.00hetero-6-4-4-4-4-4-…HHblits0.32
5ijn.1.R
NUCLEAR PORE COMPLEX PROTEIN NUP54
Composite structure of the inner ring of the human nuclear pore complex (32 copies of Nup205)
0.0023.080.03 971-1009EM0.00hetero-6-4-4-4-4-4-…HHblits0.32
7per.1.G
Nucleoporin p54
Model of the inner ring of the human nuclear pore complex
0.0023.080.03 971-1009EM0.00hetero-4-4-4-4-4-4-…HHblits0.32
7per.1.J
Nucleoporin p54
Model of the inner ring of the human nuclear pore complex
0.0023.080.03 971-1009EM0.00hetero-4-4-4-4-4-4-…HHblits0.32
5ijn.1.L
NUCLEAR PORE COMPLEX PROTEIN NUP54
Composite structure of the inner ring of the human nuclear pore complex (32 copies of Nup205)
0.0023.080.03 971-1009EM0.00hetero-6-4-4-4-4-4-…HHblits0.32
5k9q.1.B
Hemagglutinin HA2
Crystal structure of multidonor HV1-18-class broadly neutralizing Influenza A antibody 16.a.26 in complex with A/Hong Kong/1-4-MA21-1/1968 (H3N2) Hemagglutinin
0.0017.950.03 949-987X-ray2.50hetero-3-3-3-3-mer18 x NAGHHblits0.32
4uo4.1.B
H3 HAEMAGGLUTININ HA2 CHAIN
Structure of the A_Canine_Colorado_17864_06 H3 haemagglutinin
0.0017.950.03 949-987X-ray2.60hetero-3-3-mer3 x NAG, 6 x NAG-NAG, 3 x NAG-NAG-BMA-MAN, 3 x NAG-NAG-BMA-MAN-MANHHblits0.32
4uo9.1.B
HA2
Structure of the A_Canine_Colorado_17864_06 H3 haemagglutinin Ser30Thr mutant
0.0017.950.03 949-987X-ray3.20hetero-3-3-mer3 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.32
5kan.1.B
Hemagglutinin HA2
Crystal structure of multidonor HV1-18-class broadly neutralizing Influenza A antibody 16.g.07 in complex with A/Hong Kong/1-4-MA21-1/1968 (H3N2) Hemagglutinin
0.0017.950.03 949-987X-ray2.79hetero-3-3-3-3-mer17 x NAGHHblits0.32
5kan.1.D
Hemagglutinin HA2
Crystal structure of multidonor HV1-18-class broadly neutralizing Influenza A antibody 16.g.07 in complex with A/Hong Kong/1-4-MA21-1/1968 (H3N2) Hemagglutinin
0.0017.950.03 949-987X-ray2.79hetero-3-3-3-3-mer17 x NAGHHblits0.32
6nz7.1.B
Hemagglutinin HA2 chain
Crystal structure of broadly neutralizing Influenza A antibody 429 B01 in complex with Hemagglutinin Hong Kong 1968
0.0017.950.03 949-987X-ray2.95hetero-1-1-1-1-mer6 x NAGHHblits0.32
6nz7.2.B
Hemagglutinin HA2 chain
Crystal structure of broadly neutralizing Influenza A antibody 429 B01 in complex with Hemagglutinin Hong Kong 1968
0.0017.950.03 949-987X-ray2.95hetero-1-1-1-1-mer5 x NAGHHblits0.32
4we4.1.B
Hemagglutinin HA2 chain
The crystal structure of hemagglutinin from 1968 H3N2 influenza virus
0.0017.950.03 949-987X-ray2.35hetero-3-3-mer6 x NAG, 3 x PE5, 3 x NAG-NAG-BMA-MAN-NAG-MAN, 3 x NAG-NAG-BMA-MAN-MAN, 3 x NAG-NAG-BMA, 3 x NAG-NAGHHblits0.32
6y5h.1.F
X-31 Influenza Haemagglutinin HA2
Ectodomain of X-31 Haemagglutinin at pH 5 (State I)
0.0017.950.03 949-987EM0.00hetero-3-3-mer6 x NAG, 3 x NAG-NAG-BMA-MAN-MAN, 6 x NAG-NAGHHblits0.32
3eym.1.B
Hemagglutinin HA2 chain
Structure of Influenza Haemagglutinin in complex with an inhibitor of membrane fusion
0.0017.950.03 949-987X-ray2.80hetero-oligomer3 x EYKHHblits0.32
6y5j.1.B
X-31 Influenza Haemagglutinin HA2
Dilated form 2 of X-31 Influenza Haemagglutinin at pH 5 (State III)
0.0017.950.03 949-987EM0.00hetero-3-3-mer6 x NAG, 3 x NAG-NAG-BMA, 3 x NAG-NAGHHblits0.32
6y5l.1.B
X-31 Influenza Haemagglutinin HA2
Signal Subtracted Extended Intermediate form of X-31 Influenza Haemagglutinin at pH 5 (State IV)
0.0017.950.03 949-987EM0.00hetero-3-3-mer3 x NAGHHblits0.32
6y5k.1.B
X-31 Influenza Haemagglutinin HA2
Extended Intermediate form of X-31 Influenza Haemagglutinin at pH 5 (State IV)
0.0017.950.03 949-987EM0.00hetero-3-3-mer6 x NAGHHblits0.32
4unw.1.D
H3 HAEMAGGLUTININ HA2 CHAIN
Structure of the A_Equine_Newmarket_2_93 H3 haemagglutinin
0.0017.950.03 949-987X-ray2.60hetero-3-3-mer6 x NAG, 6 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 4 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-FUL, 1 x NAG-NAG-BMA-MAN-NAG-MANHHblits0.32
4unw.1.B
H3 HAEMAGGLUTININ HA2 CHAIN
Structure of the A_Equine_Newmarket_2_93 H3 haemagglutinin
0.0017.950.03 949-987X-ray2.60hetero-3-3-mer6 x NAG, 6 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 4 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-FUL, 1 x NAG-NAG-BMA-MAN-NAG-MANHHblits0.32
6n4f.1.B
Hemagglutinin HA2
The crystal structure of hemagglutinin from A/canine/IL/11613/2015 (H3N2) influenza virus.
0.0017.950.03 949-987X-ray3.01hetero-3-3-merHHblits0.32
4fqy.1.B
Hemagglutinin HA2
Crystal structure of broadly neutralizing antibody CR9114 bound to H3 influenza hemagglutinin
0.0017.950.03 949-987X-ray5.25hetero-3-3-3-3-merHHblits0.32
5t6n.1.F
Hemagglutinin HA2
Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin in complex with the antiviral drug arbidol
0.0017.950.03 949-987X-ray2.54hetero-3-3-mer7 x NAG, 3 x 75U, 1 x NAG-NAG-BMA-MAN, 6 x NAG-NAG, 1 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-MANHHblits0.32
4uoa.1.B
HA2
Structure of the A_Canine_Colorado_17864_06 H3 haemagglutinin Met29Ile mutant
0.0017.950.03 949-987X-ray2.50hetero-3-3-mer3 x NAG, 3 x NAG-NAG, 6 x NAG-NAG-BMA, 6 x NAG-NAG-BMA-MANHHblits0.32
5hmg.1.B
Hemagglutinin HA2 chain
REFINEMENT OF THE INFLUENZA VIRUS HEMAGGLUTININ BY SIMULATED ANNEALING
0.0017.950.03 949-987X-ray3.20hetero-3-3-mer3 x SIA, 12 x NAG, 3 x NAG-NAG-MANHHblits0.32
4gms.1.B
Hemagglutinin HA2 chain
Crystal structure of heterosubtypic Fab S139/1 in complex with influenza A H3 hemagglutinin
0.0017.950.03 949-987X-ray2.95hetero-3-3-3-3-mer9 x NAG, 5 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MAN, 2 x NAG-NAG-BMA, 2 x NAG-NAG-BMA-MANHHblits0.32
7u8j.1.B
Hemagglutinin HA2 subunit
Crystal structure of chimeric hemagglutinin cH4/3 in complex with broad protective antibody 31.a.83
0.0020.510.03 949-987X-ray4.90hetero-1-1-1-1-merHHblits0.32
1hgj.1.B
HEMAGGLUTININ, CHAIN HA1
BINDING OF INFLUENZA VIRUS HEMAGGLUTININ TO ANALOGS OF ITS CELL-SURFACE RECEPTOR, SIALIC ACID: ANALYSIS BY PROTON NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND X-RAY CRYSTALLOGRAPHY
0.0017.950.03 949-987X-ray2.70hetero-3-3-mer12 x NAG, 3 x AMN, 3 x NAG-NAG-BMAHHblits0.32
2ypg.1.B
HEMAGGLUTININ HA2 CHAIN
Haemagglutinin of 1968 Human H3N2 Virus in Complex with Human Receptor Analogue LSTc
0.0017.950.03 949-987X-ray2.85hetero-3-3-mer5 x NAG, 13 x FLC, 1 x NAG-NAG-FUL, 3 x NAG-NAG-BMA, 5 x NAG-NAG, 2 x BGC-GAL-NAG-GAL-SIA, 1 x GAL-NAG-GAL-SIAHHblits0.32
4hmg.1.F
HEMAGGLUTININ, CHAIN HA1
REFINEMENT OF THE INFLUENZA VIRUS HEMAGGLUTININ BY SIMULATED ANNEALING
0.0017.950.03 949-987X-ray3.00hetero-3-3-mer3 x SIA, 12 x NAG, 3 x NAG-NAG-MANHHblits0.32
3ztj.1.B
HEMAGGLUTININ HA2 CHAIN
Structure of influenza A neutralizing antibody selected from cultures of single human plasma cells in complex with human H3 Influenza haemagglutinin.
0.0017.950.03 949-987X-ray3.41hetero-3-3-3-3-mer1 x NAG, 4 x NAG-NAG-BMA, 10 x NAG-NAGHHblits0.32
1qfu.1.F
PROTEIN (HEMAGGLUTININ (HA2 CHAIN))
INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
0.0017.950.03 949-987X-ray2.80hetero-3-3-3-3-mer9 x NAG, 3 x NAG-NDG, 3 x NAG-NAG-BMAHHblits0.32
1ken.1.F
hemagglutinin HA2
INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH AN ANTIBODY THAT PREVENTS THE HEMAGGLUTININ LOW PH FUSOGENIC TRANSITION
0.0017.950.03 949-987X-ray3.50hetero-3-3-2-2-merHHblits0.32
6bkp.2.A
Hemagglutinin
Crystal structure of the A/Michigan/15/2014 (H3N2) influenza virus hemagglutinin apo form
0.0020.510.03 949-987X-ray2.05homo-trimerHHblits0.32
5y2l.1.B
Hemagglutinin
Crystal structure of a group 2 HA binding antibody AF4H1K1 Fab in complex with the 1968 H3N2 pandemic (H3-AC/68) hemagglutinin
0.0017.950.03 949-987X-ray2.90hetero-1-1-1-1-mer2 x NAG, 2 x NAG-NAGHHblits0.32
7x6l.1.D
Hemagglutinin
Cryo-EM structure of H3 hemagglutinin from A/HongKong/01/1968 in complex with a neutralizing antibody 28-12
0.0017.950.03 949-987EM0.00hetero-3-3-3-3-merHHblits0.32
6aop.1.B
Hemagglutinin HA2 chain
Crystal structure of the A/Brisbane/10/2007 (H3N2) influenza virus hemagglutinin L194P mutant apo form
0.0020.510.03 949-987X-ray2.30hetero-3-3-mer12 x NAG, 6 x NAG-NAG-BMA-MAN, 3 x NAG-NAGHHblits0.32
4we5.1.B
Hemagglutinin HA2 chain
The crystal structure of hemagglutinin from A/Port Chalmers/1/1973 influenza virus
0.0017.950.03 949-987X-ray2.10hetero-3-3-mer6 x NAG, 6 x NAG-NAG-BMA, 3 x NAG-NAGHHblits0.32
4ubd.2.E
Hemagglutinin HA2 chain
Crystal structure of a neutralizing human monoclonal antibody with 1968 H3 HA
0.0017.950.03 949-987X-ray3.50hetero-3-3-3-3-mer4 x NAG, 3 x NAG-NAG-BMA-MAN, 1 x NAG-NAGHHblits0.32
3vun.1.B
Hemagglutinin HA2 chain
Crystal structure of a influenza A virus (A/Aichi/2/1968 H3N2) hemagglutinin in C2 space group.
0.0017.950.03 949-987X-ray3.00hetero-3-3-mer6 x NAG, 3 x NAG-NAG-BMA-MAN-NAG-GAL-MAN-NAG-FUC, 3 x NAG-NAG, 3 x NAG-NAG-BMA-MANHHblits0.32
4nm8.1.F
Hemagglutinin HA2 Chain
Crystal structure of broadly neutralizing antibody CR8043 bound to H3 influenza hemagglutinin
0.0017.950.03 949-987X-ray4.00hetero-3-3-3-3-mer8 x NAG, 6 x NAG-NAGHHblits0.32
3sdy.1.J
Hemagglutinin HA2 chain
Crystal Structure of Broadly Neutralizing Antibody CR8020 Bound to the Influenza A H3 Hemagglutinin
0.0017.950.03 949-987X-ray2.85hetero-3-3-3-3-mer6 x NAG-NAG-BMA-MAN, 3 x NAG-NAG-BMA-MAN-MAN-FUC, 3 x NAG-NAG, 3 x NAG-NAG-BMA-FUCHHblits0.32
5kuy.1.B
Hemagglutinin HA2
Influenza hemagglutinin H3 A/Hong Kong/1/1968 in complex with designed inhibitor protein HSB.2A
0.0017.950.03 949-987X-ray2.60hetero-3-3-3-mer6 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-BMAHHblits0.32
7wvg.1.B
Hemagglutinin
Crystal structure of H18 complexed with SIA28
0.0017.950.03 949-987X-ray2.60hetero-3-3-3-3-mer6 x NAG, 3 x NAG-FUC, 3 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MANHHblits0.32
6ikn.1.A
Growth arrest-specific protein 7
Crystal structure of the GAS7 F-BAR domain
0.0012.200.03 993-1033X-ray3.00homo-dimerHHblits0.28
6ikn.1.B
Growth arrest-specific protein 7
Crystal structure of the GAS7 F-BAR domain
0.0012.200.03 993-1033X-ray3.00homo-dimerHHblits0.28
6ikn.2.A
Growth arrest-specific protein 7
Crystal structure of the GAS7 F-BAR domain
0.0012.200.03 993-1033X-ray3.00homo-dimerHHblits0.28
6ikn.2.B
Growth arrest-specific protein 7
Crystal structure of the GAS7 F-BAR domain
0.0012.200.03 993-1033X-ray3.00homo-dimerHHblits0.28
6v44.1.B
Hemagglutinin HA2 chain
The crystal structure of hemagglutinin from swine influenza virus A/swine/Missouri/A01727926/2015
0.0017.950.03 949-987X-ray2.20hetero-3-3-mer3 x NAG, 3 x NAG-NAG-BMA-MAN-MAN-MANHHblits0.32
6nhq.1.B
Hemagglutinin HA2 chain
Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin HA2 I45M mutant
0.0017.950.03 949-987X-ray2.50hetero-3-3-mer6 x NAG, 2 x NAG-NAG-BMA, 2 x NAG-NAG, 2 x NAG-NAG-BMA-MANHHblits0.32
7qcd.1.B
Structural maintenance of chromosomes protein 6
CryoEM structure of the Smc5/6-holocomplex (composite structure)
0.007.320.03 926-966EM0.00hetero-1-1-1-1-1-1-…3 x ZNHHblits0.28
5xld.2.B
Hemagglutinin
The structure of hemagglutinin Q226L-G228S mutant from an avian-origin H4N6 influenza virus in complex with human receptor analog LSTc
0.0017.950.03 949-987X-ray2.30hetero-1-1-mer2 x NAG, 1 x NAG-GAL-SIAHHblits0.32
6v48.1.B
Hemagglutinin HA2 chain
The crystal structure of hemagglutinin from A/mallard/Gurjev/263/1982 (H14N5)
0.0017.950.03 949-987X-ray3.00hetero-3-3-mer3 x NAG, 6 x NAG-NAGHHblits0.32
8gv6.1.B
Hemagglutinin H14-HA2
Crystal structure of PN-SIA28 in complex with influenza hemagglutinin H14 (A/long-tailed duck/Wisconsin/10OS3912/2010)
0.0017.950.03 949-987X-ray3.40hetero-3-3-2-2-mer1 x NAG, 4 x NAG-NAGHHblits0.32
6nhp.1.B
Hemagglutinin HA2 chain
Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin HA2 I45T mutant
0.0017.950.03 949-987X-ray2.25hetero-3-3-mer7 x NAG, 2 x NAG-NAG-BMA, 2 x NAG-NAG, 2 x NAG-NAG-BMA-MANHHblits0.32
3eyk.1.B
Hemagglutinin HA2 chain
Structure of Influenza Haemagglutinin in complex with an inhibitor of membrane fusion
0.0017.950.03 949-987X-ray2.50hetero-oligomer3 x EYKHHblits0.32
7sem.1.B
Fusion glycoprotein F0
Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins
0.0026.320.03 918-955X-ray2.20hetero-1-1-1-mer3 x NAGHHblits0.34
6nhr.1.B
Hemagglutinin HA2 chain
Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin HA2 I45F mutant
0.0017.950.03 949-987X-ray2.10hetero-3-3-mer7 x NAG, 2 x NAG-NAG-BMA, 2 x NAG-NAG, 2 x NAG-NAG-BMA-MANHHblits0.32
4zcj.1.B
Hemagglutinin
Crystal structure of the A/Hong Kong/1/1968 (H3N2) influenza virus hemagglutinin HA1 Cys30, HA2 Cys47 mutant
0.0015.380.03 949-987X-ray3.00hetero-3-3-mer5 x NAG, 1 x NAG-NAG-BMA, 1 x NAG-NAGHHblits0.31
1wdg.1.B
E2 glycoprotein
crystal structure of MHV spike protein fusion core
0.0034.290.03 1168-1202X-ray2.06homo-hexamerHHblits0.39
1wdg.1.A
E2 glycoprotein
crystal structure of MHV spike protein fusion core
0.0034.290.03 1168-1202X-ray2.06homo-hexamerHHblits0.39
4dag.1.A
Fusion glycoprotein F0
Structure of the Human Metapneumovirus Fusion Protein with Neutralizing Antibody Identifies a Pneumovirus Antigenic Site
0.0021.050.03 918-955X-ray3.39hetero-1-1-1-merHHblits0.33
6qaj.1.A
Endolysin,Transcription intermediary factor 1-beta
Structure of the tripartite motif of KAP1/TRIM28
0.004.880.03 931-971X-ray2.90homo-dimer8 x ZNHHblits0.27
6qaj.1.B
Endolysin,Transcription intermediary factor 1-beta
Structure of the tripartite motif of KAP1/TRIM28
0.004.880.03 931-971X-ray2.90homo-dimer8 x ZNHHblits0.27
2fyz.1.A
Fusion glycoprotein F0
Structural of Mumps virus fusion protein core
0.0021.050.03 918-955X-ray2.20hetero-3-3-merHHblits0.32
2fyz.1.E
Fusion glycoprotein F0
Structural of Mumps virus fusion protein core
0.0021.050.03 918-955X-ray2.20hetero-3-3-merHHblits0.32
5c3l.1.A
Nup54
Structure of the metazoan Nup62.Nup58.Nup54 nucleoporin complex.
0.0024.320.03 972-1008X-ray2.90hetero-oligomerHHblits0.34
4o5n.1.B
Hemagglutinin HA2 chain
Crystal structure of A/Victoria/361/2011 (H3N2) influenza virus hemagglutinin
0.0018.420.03 950-987X-ray1.75hetero-3-3-mer12 x NAG, 3 x NAG-NAG, 3 x NAG-NAG-BMAHHblits0.32
6nsa.1.F
Hemagglutinin HA2 chain
Crystal structure of the IVR-165 (H3N2) influenza virus hemagglutinin in complex with 3'-SLNLN
0.0018.420.03 950-987X-ray1.95hetero-3-3-mer9 x NAG, 6 x NAG-NAG-BMA-MAN, 6 x NAG-NAG, 3 x NAG-NAG-BMA-MAN-MAN, 3 x GAL-NAG-GAL-SIAHHblits0.32
6wez.1.J
Hemagglutinin
Crystal Structure of Broadly Neutralizing Antibody 3I14-D93N Mutant Bound to the Influenza A H3 Hemagglutinin
0.0018.420.03 950-987X-ray3.21hetero-3-3-3-3-mer9 x NAG-NAG-BMA, 9 x NAG-NAGHHblits0.32
6nsc.1.B
Hemagglutinin HA2 chain
Crystal structure of the A/Brisbane/10/2007 (H3N2) influenza virus hemagglutinin G186V/L194P mutant apo form
0.0018.420.03 950-987X-ray2.25hetero-3-3-mer6 x NAG, 3 x NAG-NAG-BMA-MAN-MAN, 3 x NAG-NAG-FUL, 6 x NAG-NAGHHblits0.32
7u8l.1.B
Hemagglutinin HA2 subunit
Crystal structure of chimeric hemagglutinin cH15/3 in complex with broad protective antibody 31.a.83
0.0018.420.03 950-987X-ray4.56hetero-1-1-1-1-merHHblits0.32
5yfp.1.D
Exocyst complex component SEC8
Cryo-EM Structure of the Exocyst Complex
0.0030.560.03 949-988EM4.40hetero-1-1-1-1-1-1-…HHblits0.36
7tdz.1.2
Nup88A protein
Cryo-EM model of protomer of the cytoplasmic ring of the nuclear pore complex from Xenopus laevis
0.005.000.03 966-1008EM0.00hetero-2-2-2-2-2-2-…HHblits0.27
7vop.1.3
Nup88A protein
Cryo-EM structure of Xenopus laevis nuclear pore complex cytoplasmic ring subunit
0.005.000.03 966-1008EM0.00hetero-2-2-2-2-2-2-…HHblits0.27
7vop.1.1
Nup88A protein
Cryo-EM structure of Xenopus laevis nuclear pore complex cytoplasmic ring subunit
0.005.000.03 966-1008EM0.00hetero-2-2-2-2-2-2-…HHblits0.27
7yer.1.C
Polymerase cofactor VP35
The structure of EBOV L-VP35 complex
0.0010.000.03 976-1015EM0.00hetero-1-4-mer1 x ZNHHblits0.27
7yer.1.B
Polymerase cofactor VP35
The structure of EBOV L-VP35 complex
0.0010.000.03 976-1015EM0.00hetero-1-4-mer1 x ZNHHblits0.27
7yer.1.D
Polymerase cofactor VP35
The structure of EBOV L-VP35 complex
0.0010.000.03 976-1015EM0.00hetero-1-4-mer1 x ZNHHblits0.27
7yer.1.E
Polymerase cofactor VP35
The structure of EBOV L-VP35 complex
0.0010.000.03 976-1015EM0.00hetero-1-4-mer1 x ZNHHblits0.27
7yet.1.B
Polymerase cofactor VP35
The structure of EBOV L-VP35 in complex with suramin
0.0010.000.03 976-1015EM0.00hetero-1-4-mer1 x SVRHHblits0.27
4biz.1.A
SENSOR PROTEIN CPXA
Crystal structure of CpxAHDC (orthorhombic form 2)
0.0010.000.03 947-986X-ray2.65homo-dimer2 x ADPHHblits0.27
4biz.1.B
SENSOR PROTEIN CPXA
Crystal structure of CpxAHDC (orthorhombic form 2)
0.0010.000.03 947-986X-ray2.65homo-dimer2 x ADPHHblits0.27
4biz.2.A
SENSOR PROTEIN CPXA
Crystal structure of CpxAHDC (orthorhombic form 2)
0.0010.000.03 947-986X-ray2.65homo-dimer1 x ADPHHblits0.27
4biz.2.B
SENSOR PROTEIN CPXA
Crystal structure of CpxAHDC (orthorhombic form 2)
0.0010.000.03 947-986X-ray2.65homo-dimer1 x ADPHHblits0.27
4biz.3.A
SENSOR PROTEIN CPXA
Crystal structure of CpxAHDC (orthorhombic form 2)
0.0010.000.03 947-986X-ray2.65homo-dimer1 x ADPHHblits0.27
4biz.3.B
SENSOR PROTEIN CPXA
Crystal structure of CpxAHDC (orthorhombic form 2)
0.0010.000.03 947-986X-ray2.65homo-dimer1 x ADPHHblits0.27
6q0s.1.A
Fusion glycoprotein F0
Crystal Structure of RSV strain B18537 Prefusion-stabilized glycoprotein F Variant DS-Cav1
0.0018.420.03 918-955X-ray1.94homo-trimer6 x NAGHHblits0.31
4jhw.1.C
Fusion glycoprotein F0
Crystal Structure of Respiratory Syncytial Virus Fusion Glycoprotein Stabilized in the Prefusion Conformation by Human Antibody D25
0.0015.790.03 918-955X-ray3.60hetero-oligomerHHblits0.30
1cun.1.B
PROTEIN (ALPHA SPECTRIN)
CRYSTAL STRUCTURE OF REPEATS 16 AND 17 OF CHICKEN BRAIN ALPHA SPECTRIN
0.0010.000.03 955-994X-ray2.00homo-trimerHHblits0.26
1cun.1.A
PROTEIN (ALPHA SPECTRIN)
CRYSTAL STRUCTURE OF REPEATS 16 AND 17 OF CHICKEN BRAIN ALPHA SPECTRIN
0.0010.000.03 955-994X-ray2.00homo-trimerHHblits0.26
5iea.2.B
Tripartite motif-containing protein 5, Serine--tRNA ligase Chimera
TRIM5 B-box2 and coiled-coil chimera
0.0018.420.03 953-990X-ray3.26homo-trimer6 x ZNHHblits0.30
5f7t.2.A
Tripartite motif-containing protein 5,Serine--tRNA ligase,Tripartite motif-containing protein 5
TRIM5 B-box2 and coiled-coil chimera
0.0018.420.03 953-990X-ray2.29monomer2 x ZNHHblits0.30
5f7t.3.A
Tripartite motif-containing protein 5,Serine--tRNA ligase,Tripartite motif-containing protein 5
TRIM5 B-box2 and coiled-coil chimera
0.0018.420.03 953-990X-ray2.29monomer2 x ZNHHblits0.30
5f7t.1.A
Tripartite motif-containing protein 5,Serine--tRNA ligase,Tripartite motif-containing protein 5
TRIM5 B-box2 and coiled-coil chimera
0.0018.420.03 953-990X-ray2.29monomer2 x ZNHHblits0.30
5eiu.2.A
TRIM protein-E3 ligase Chimera
Mini TRIM5 B-box 2 dimer C2 crystal form
0.0018.420.03 953-990X-ray1.91monomer2 x ZNHHblits0.30
5eiu.3.A
TRIM protein-E3 ligase Chimera
Mini TRIM5 B-box 2 dimer C2 crystal form
0.0018.420.03 953-990X-ray1.91monomer2 x ZNHHblits0.30
3o0z.1.A
Rho-associated protein kinase 1
Crystal structure of a coiled-coil domain from human ROCK I
0.0015.380.03 998-1036X-ray2.33homo-dimerHHblits0.28
3o0z.1.B
Rho-associated protein kinase 1
Crystal structure of a coiled-coil domain from human ROCK I
0.0015.380.03 998-1036X-ray2.33homo-dimerHHblits0.28
3o0z.2.A
Rho-associated protein kinase 1
Crystal structure of a coiled-coil domain from human ROCK I
0.0015.380.03 998-1036X-ray2.33homo-dimerHHblits0.28
3o0z.2.B
Rho-associated protein kinase 1
Crystal structure of a coiled-coil domain from human ROCK I
0.0015.380.03 998-1036X-ray2.33homo-dimerHHblits0.28
2ba2.1.A
Hypothetical UPF0134 protein MPN010
Crystal structure of the DUF16 domain of MPN010 from Mycoplasma pneumoniae
0.0021.620.03 952-988X-ray1.80homo-trimerHHblits0.32
2ba2.1.B
Hypothetical UPF0134 protein MPN010
Crystal structure of the DUF16 domain of MPN010 from Mycoplasma pneumoniae
0.0021.620.03 952-988X-ray1.80homo-trimerHHblits0.32
2ba2.1.C
Hypothetical UPF0134 protein MPN010
Crystal structure of the DUF16 domain of MPN010 from Mycoplasma pneumoniae
0.0021.620.03 952-988X-ray1.80homo-trimerHHblits0.32
4mmr.1.B
Fusion glycoprotein F1 fused with Fibritin trimerization domain
Crystal Structure of Prefusion-stabilized RSV F Variant Cav1 at pH 9.5
0.0013.160.03 918-955X-ray3.10hetero-3-3-merHHblits0.29
4mms.1.B
Fusion glycoprotein F1 fused with Fibritin trimerization domain
Crystal Structure of Prefusion-stabilized RSV F Variant Cav1 at pH 5.5
0.0013.160.03 918-955X-ray2.40hetero-3-3-merHHblits0.29
7mpg.1.A
Fusion glycoprotein F0,Envelope glycoprotein
Cryo-EM structure of Prefusion-stabilized RSV F (DS-Cav1) in complex with Fab AM14
0.0013.160.03 918-955EM0.00hetero-3-3-3-mer3 x NAGHHblits0.29
2ojq.1.A
Programmed cell death 6-interacting protein
Crystal structure of Alix V domain
0.0027.780.03 957-992X-ray2.87monomerHHblits0.33
7wkk.1.G
Nup54
Cryo-EM structure of the IR subunit from X. laevis NPC
0.0022.220.03 973-1008EM4.20hetero-2-2-4-6-4-4-…HHblits0.33
7owx.1.A
Spike protein S2
Structure of coiled-coil tetramer from SARS-CoV-2 spike stalk region
0.00100.000.02 1178-1203X-ray1.93homo-tetramer2 x ZNHHblits0.59
7owx.1.B
Spike protein S2
Structure of coiled-coil tetramer from SARS-CoV-2 spike stalk region
0.00100.000.02 1178-1203X-ray1.93homo-tetramer2 x ZNHHblits0.59
7owx.1.C
Spike protein S2
Structure of coiled-coil tetramer from SARS-CoV-2 spike stalk region
0.00100.000.02 1178-1203X-ray1.93homo-tetramer2 x ZNHHblits0.59
7owx.1.D
Spike protein S2
Structure of coiled-coil tetramer from SARS-CoV-2 spike stalk region
0.00100.000.02 1178-1203X-ray1.93homo-tetramer2 x ZNHHblits0.59
1svf.1.A
PROTEIN (FUSION GLYCOPROTEIN)
PARAMYXOVIRUS SV5 FUSION PROTEIN CORE
0.0022.220.03 920-955X-ray1.40hetero-3-3-merHHblits0.33
4jq5.1.B
Nucleoporin p58/p45
Crystal structure of the human Nup49CCS2+3* coiled-coil segment
0.0016.220.03 954-990X-ray2.19homo-tetramerHHblits0.30
4jq5.1.A
Nucleoporin p58/p45
Crystal structure of the human Nup49CCS2+3* coiled-coil segment
0.0016.220.03 954-990X-ray2.19homo-tetramerHHblits0.30
4jq5.1.C
Nucleoporin p58/p45
Crystal structure of the human Nup49CCS2+3* coiled-coil segment
0.0016.220.03 954-990X-ray2.19homo-tetramerHHblits0.30
4jq5.2.A
Nucleoporin p58/p45
Crystal structure of the human Nup49CCS2+3* coiled-coil segment
0.0016.220.03 954-990X-ray2.19homo-tetramerHHblits0.30
4jq5.2.B
Nucleoporin p58/p45
Crystal structure of the human Nup49CCS2+3* coiled-coil segment
0.0016.220.03 954-990X-ray2.19homo-tetramerHHblits0.30
4jq5.2.C
Nucleoporin p58/p45
Crystal structure of the human Nup49CCS2+3* coiled-coil segment
0.0016.220.03 954-990X-ray2.19homo-tetramerHHblits0.30
4jq5.3.A
Nucleoporin p58/p45
Crystal structure of the human Nup49CCS2+3* coiled-coil segment
0.0016.220.03 954-990X-ray2.19homo-tetramerHHblits0.30
4oxm.1.A
HA2-Del
CRYSTAL STRUCTURE OF Central Coiled-Coil from Influenza Hemagglutinin HA2 without Heptad Repeat Stutter
0.0019.440.03 949-988X-ray1.90homo-trimerHHblits0.32
4oxm.1.B
HA2-Del
CRYSTAL STRUCTURE OF Central Coiled-Coil from Influenza Hemagglutinin HA2 without Heptad Repeat Stutter
0.0019.440.03 949-988X-ray1.90homo-trimerHHblits0.32
4oxm.1.C
HA2-Del
CRYSTAL STRUCTURE OF Central Coiled-Coil from Influenza Hemagglutinin HA2 without Heptad Repeat Stutter
0.0019.440.03 949-988X-ray1.90homo-trimerHHblits0.32
1ory.1.A
flagellar protein FliS
FLAGELLAR EXPORT CHAPERONE IN COMPLEX WITH ITS COGNATE BINDING PARTNER
0.0016.220.03 941-984X-ray2.45hetero-1-1-merHHblits0.30
3fhn.1.A
Protein transport protein TIP20
Structure of Tip20p
0.0016.220.03 964-1000X-ray3.00monomerHHblits0.30
3fhn.2.A
Protein transport protein TIP20
Structure of Tip20p
0.0016.220.03 964-1000X-ray3.00monomerHHblits0.30
3fhn.3.A
Protein transport protein TIP20
Structure of Tip20p
0.0016.220.03 964-1000X-ray3.00monomerHHblits0.30
3fhn.4.A
Protein transport protein TIP20
Structure of Tip20p
0.0016.220.03 964-1000X-ray3.00monomerHHblits0.30
6eag.1.A
Fusion glycoprotein F0
CRYSTAL STRUCTURE OF FUSION INHIBITOR JNJ-2408068 IN COMPLEX WITH HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN ESCAPE VARIANT G143S STABILIZED IN THE PREFUSION STATE
0.0013.510.03 919-955X-ray3.30homo-trimer3 x NHE, 3 x TAR, 3 x 5NKHHblits0.29
6eaf.1.A
Fusion glycoprotein F0
CRYSTAL STRUCTURE OF HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN INHIBITOR ESCAPE VARIANT G143S STABILIZED IN THE PREFUSION STATE
0.0013.510.03 919-955X-ray3.00homo-trimer1 x NAG, 6 x NHEHHblits0.29
4zyp.1.A
Fusion glycoprotein F0,Fibritin
Crystal Structure of Motavizumab and Quaternary-Specific RSV-Neutralizing Human Antibody AM14 in Complex with Prefusion RSV F Glycoprotein
0.0013.510.03 919-955X-ray5.50hetero-oligomerHHblits0.29
4zyp.1.C
Fusion glycoprotein F0,Fibritin
Crystal Structure of Motavizumab and Quaternary-Specific RSV-Neutralizing Human Antibody AM14 in Complex with Prefusion RSV F Glycoprotein
0.0013.510.03 919-955X-ray5.50hetero-oligomerHHblits0.29
5va4.1.A
TRIM5/cyclophilin A V4 fusion protein
TRIM-Cyclophilin A B-box 2 and coiled-coil chimera
0.0013.510.03 955-991X-ray2.31homo-trimer9 x ZNHHblits0.29
1gl2.1.B
SYNTAXIN 7
Crystal structure of an endosomal SNARE core complex
0.008.110.03 928-964X-ray1.90hetero-1-1-1-1-merHHblits0.29
2osz.1.C
Nucleoporin p58/p45
Structure of Nup58/45 suggests flexible nuclear pore diameter by intermolecular sliding
0.0016.670.03 955-990X-ray2.85homo-tetramerHHblits0.31
3t98.1.B
Nucleoporin Nup58/Nup45
Molecular Architecture of the Transport Channel of the Nuclear Pore Complex: Nup54/Nup58
0.0016.670.03 955-990X-ray2.50hetero-oligomerHHblits0.31
2osz.1.D
Nucleoporin p58/p45
Structure of Nup58/45 suggests flexible nuclear pore diameter by intermolecular sliding
0.0016.670.03 955-990X-ray2.85homo-tetramerHHblits0.31
4jo7.1.C
Nucleoporin p58/p45
Crystal structure of the human Nup49CCS2+3* Nup57CCS3* complex with 2:2 stoichiometry
0.0016.670.03 955-990X-ray1.75hetero-oligomerHHblits0.31
4jo7.1.D
Nucleoporin p58/p45
Crystal structure of the human Nup49CCS2+3* Nup57CCS3* complex with 2:2 stoichiometry
0.0016.670.03 955-990X-ray1.75hetero-oligomerHHblits0.31
4jo7.2.A
Nucleoporin p58/p45
Crystal structure of the human Nup49CCS2+3* Nup57CCS3* complex with 2:2 stoichiometry
0.0016.670.03 955-990X-ray1.75hetero-oligomerHHblits0.31
4jo7.2.C
Nucleoporin p58/p45
Crystal structure of the human Nup49CCS2+3* Nup57CCS3* complex with 2:2 stoichiometry
0.0016.670.03 955-990X-ray1.75hetero-oligomerHHblits0.31
4jo9.1.B
Nucleoporin p58/p45
Crystal structure of the human Nup49CCS2+3* Nup57CCS3* complex 1:2 stoichiometry
0.0016.670.03 955-990X-ray2.50hetero-oligomerHHblits0.31
7nab.1.C
Spike protein S2
Crystal structure of human neutralizing mAb CV3-25 binding to SARS-CoV-2 S MPER peptide 1140-1165
0.00100.000.02 1141-1164X-ray2.15hetero-1-1-1-merHHblits0.63
7nab.2.C
Spike protein S2
Crystal structure of human neutralizing mAb CV3-25 binding to SARS-CoV-2 S MPER peptide 1140-1165
0.00100.000.02 1141-1164X-ray2.15hetero-1-1-1-merHHblits0.63
6j9r.1.A
Brain tumor protein
Coiled-coil Domain of Drosophila TRIM Protein Brat
0.0010.530.03 940-977X-ray2.50homo-dimerHHblits0.26
6j9r.1.B
Brain tumor protein
Coiled-coil Domain of Drosophila TRIM Protein Brat
0.0010.530.03 940-977X-ray2.50homo-dimerHHblits0.26
7abk.1.A
Chloroplast membrane-associated 30 kD protein
Helical structure of PspA
0.0010.530.03 927-964EM0.00monomerHHblits0.26
6gao.1.A
Outer capsid protein sigma-1
Crystal structure of the T1L reovirus sigma1 coiled coil tail and body
0.0016.670.03 928-963X-ray2.10homo-trimerHHblits0.30
6gao.1.B
Outer capsid protein sigma-1
Crystal structure of the T1L reovirus sigma1 coiled coil tail and body
0.0016.670.03 928-963X-ray2.10homo-trimerHHblits0.30
6gao.1.C
Outer capsid protein sigma-1
Crystal structure of the T1L reovirus sigma1 coiled coil tail and body
0.0016.670.03 928-963X-ray2.10homo-trimerHHblits0.30
5ghe.1.A
Pesticidal crystal protein Cry6Aa
Crystal Structure of Bacillus thuringiensis Cry6Aa2 Protoxin
0.007.890.03 930-967X-ray1.90monomerHHblits0.25
8bd7.1.J
Intraflagellar transport protein 57
IFTB1 subcomplex of anterograde Intraflagellar transport trains (Chlamydomonas reinhardtii)
0.0013.890.03 915-950EM0.00hetero-2-2-2-2-2-2-…HHblits0.29
3ogi.1.B
Putative ESAT-6-like protein 7
Crystal structure of the Mycobacterium tuberculosis H37Rv EsxOP complex (Rv2346c-Rv2347c)
0.008.110.03 924-960X-ray2.55hetero-oligomerHHblits0.27
3ogi.2.B
Putative ESAT-6-like protein 7
Crystal structure of the Mycobacterium tuberculosis H37Rv EsxOP complex (Rv2346c-Rv2347c)
0.008.110.03 924-960X-ray2.55hetero-oligomerHHblits0.27
4gzr.1.B
ESAT-6-like protein 7
Crystal structure of the Mycobacterium tuberculosis H37Rv EsxOP (Rv2346c-Rv2347c) complex in space group C2221
0.008.110.03 924-960X-ray2.55hetero-oligomerHHblits0.27
4gzr.2.B
ESAT-6-like protein 7
Crystal structure of the Mycobacterium tuberculosis H37Rv EsxOP (Rv2346c-Rv2347c) complex in space group C2221
0.008.110.03 924-960X-ray2.55hetero-oligomerHHblits0.27
2nps.1.B
Syntaxin 13
Crystal Structure of the Early Endosomal SNARE Complex
0.008.330.03 929-964X-ray2.50hetero-1-1-1-1-merHHblits0.29
2ch7.1.A
METHYL-ACCEPTING CHEMOTAXIS PROTEIN
CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF A BACTERIAL CHEMORECEPTOR FROM THERMOTOGA MARITIMA
0.0011.110.03 918-953X-ray2.50hetero-oligomer2 x PBHHblits0.28
3ja6.1.Q
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0011.110.03 918-953EM0.00hetero-oligomerHHblits0.28
3ja6.1.G
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0011.110.03 918-953EM0.00hetero-oligomerHHblits0.28
3ja6.1.K
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0011.110.03 918-953EM0.00hetero-oligomerHHblits0.28
3ja6.1.I
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0011.110.03 918-953EM0.00hetero-oligomerHHblits0.28
3ja6.1.O
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0011.110.03 918-953EM0.00hetero-oligomerHHblits0.28
3ja6.1.M
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0011.110.03 918-953EM0.00hetero-oligomerHHblits0.28
5kuc.1.A
Pesticidal crystal protein Cry6Aa
Crystal structure of trypsin activated Cry6Aa
0.0014.290.03 960-996X-ray2.00monomerHHblits0.30
7x9e.2.C
Spike peptide
Crystal structure of the 76E1 Fab in complex with a SARS-CoV-2 spike peptide
0.00100.000.02 810-833X-ray2.60hetero-1-1-1-merHHblits0.60
7tow.1.C
Spike protein S2
Antibody DH1058 Fab fragment bound to SARS-CoV-2 fusion peptide
0.00100.000.02 810-833X-ray2.15hetero-1-1-1-mer2 x CAHHblits0.60
7tow.2.C
Spike protein S2
Antibody DH1058 Fab fragment bound to SARS-CoV-2 fusion peptide
0.00100.000.02 810-833X-ray2.15hetero-1-1-1-mer1 x CAHHblits0.60
7sjs.1.C
stem helix peptide of Spike protein S2'
Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CC40.8
0.00100.000.02 1141-1163X-ray1.61hetero-1-1-1-merHHblits0.63
7usw.1.D
Transmembrane inner ear expressed protein
Structure of Expanded C. elegans TMC-1 complex
0.0014.710.03 1203-1236EM0.00hetero-2-2-2-mer8 x CA, 2 x PEE, 2 x 3PE, 34 x ZFC, 12 x D12, 2 x CLR, 4 x R16, 2 x NAG, 2 x PLMHHblits0.32
7usy.1.D
Transmembrane inner ear expressed protein
Structure of C. elegans TMC-1 complex with ARRD-6
0.0014.710.03 1203-1236EM0.00hetero-2-2-2-1-mer8 x CA, 2 x PEE, 2 x 3PE, 2 x NAG, 2 x PLMHHblits0.32
7usy.1.F
Transmembrane inner ear expressed protein
Structure of C. elegans TMC-1 complex with ARRD-6
0.0014.710.03 1203-1236EM0.00hetero-2-2-2-1-mer8 x CA, 2 x PEE, 2 x 3PE, 2 x NAG, 2 x PLMHHblits0.32
1jth.1.B
syntaxin 1a
Crystal structure and biophysical properties of a complex between the N-terminal region of SNAP25 and the SNARE region of syntaxin 1a
0.0014.290.03 929-963X-ray2.00hetero-oligomerHHblits0.30
1jth.1.D
syntaxin 1a
Crystal structure and biophysical properties of a complex between the N-terminal region of SNAP25 and the SNARE region of syntaxin 1a
0.0014.290.03 929-963X-ray2.00hetero-oligomerHHblits0.30
4abx.1.A
DNA REPAIR PROTEIN RECN
Crystal structure of Deinococcus radiodurans RecN coiled-coil domain
0.0013.890.03 995-1030X-ray2.04homo-dimerHHblits0.27
4abx.1.B
DNA REPAIR PROTEIN RECN
Crystal structure of Deinococcus radiodurans RecN coiled-coil domain
0.0013.890.03 995-1030X-ray2.04homo-dimerHHblits0.27
1u4q.1.A
Spectrin alpha chain, brain
Crystal Structure of Repeats 15, 16 and 17 of Chicken Brain Alpha Spectrin
0.0011.430.03 954-988X-ray2.50monomerHHblits0.29
1u4q.2.A
Spectrin alpha chain, brain
Crystal Structure of Repeats 15, 16 and 17 of Chicken Brain Alpha Spectrin
0.0011.430.03 954-988X-ray2.50monomerHHblits0.29
5ziy.1.A
Flagellar hook-associated protein 3
Crystal structure of Bacillus cereus FlgL
0.0017.140.03 925-959X-ray2.20monomer6 x ZNHHblits0.29
7o3x.1.B
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamer1 x ADPHHblits0.31
7o3w.1.B
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamer1 x ADPHHblits0.31
7o3w.1.C
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamer1 x ADPHHblits0.31
7o3w.1.D
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamer1 x ADPHHblits0.31
7o3w.1.E
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamer1 x ADPHHblits0.31
7o3w.1.F
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamer1 x ADPHHblits0.31
7o3x.1.A
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamer1 x ADPHHblits0.31
7o3w.1.A
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamer1 x ADPHHblits0.31
7o3x.1.C
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamer1 x ADPHHblits0.31
7o3x.1.D
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamer1 x ADPHHblits0.31
7o3x.1.E
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamer1 x ADPHHblits0.31
7o3x.1.F
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamer1 x ADPHHblits0.31
7o3y.1.A
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamer1 x ADPHHblits0.31
7o3y.1.B
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamer1 x ADPHHblits0.31
7o3y.1.C
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamer1 x ADPHHblits0.31
7o3y.1.E
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamer1 x ADPHHblits0.31
7o3y.1.F
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamer1 x ADPHHblits0.31
7o3z.1.A
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamerHHblits0.31
7o3z.1.B
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamerHHblits0.31
7o3z.1.C
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamerHHblits0.31
7o3z.1.D
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamerHHblits0.31
7o3z.1.E
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamerHHblits0.31
7o3z.1.F
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamerHHblits0.31
7o40.1.A
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamerHHblits0.31
7o40.1.B
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamerHHblits0.31
7o40.1.C
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamerHHblits0.31
7o40.1.D
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamerHHblits0.31
7o40.1.E
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamerHHblits0.31
7o40.1.F
Protein sll0617
Structural basis for VIPP1 oligomerization and maintenance of thylakoid membrane integrity
0.0020.590.03 927-960EM0.00homo-hexamerHHblits0.31
6gy6.1.A
XaxA
XaxAB pore complex from Xenorhabdus nematophila
0.0017.650.03 1179-1214EM0.00hetero-13-13-merHHblits0.31
8fed.1.F
Mce-family protein mce1f
Structure of Mce1-LucB complex from Mycobacterium smegmatis (Map1)
0.0017.650.03 933-966EM0.00hetero-1-1-1-1-1-1-…HHblits0.30
7aej.1.A
Envelope glycoprotein gp160,Envelope glycoprotein gp160
Crystal structure of asymmetric HIV-1 gp41 containing all membrane anchors
0.0025.810.02 1205-1235X-ray3.80hetero-3-1-merHHblits0.37
7aej.1.B
Envelope glycoprotein gp160,Envelope glycoprotein gp160
Crystal structure of asymmetric HIV-1 gp41 containing all membrane anchors
0.0025.810.02 1205-1235X-ray3.80hetero-3-1-merHHblits0.37
7aej.1.C
Envelope glycoprotein gp160,Envelope glycoprotein gp160
Crystal structure of asymmetric HIV-1 gp41 containing all membrane anchors
0.0025.810.02 1205-1235X-ray3.80hetero-3-1-merHHblits0.37
1wp7.1.A
fusion protein
crystal structure of Nipah Virus fusion core
0.0028.130.03 927-958X-ray2.20homo-trimerHHblits0.34
1wp7.1.C
fusion protein
crystal structure of Nipah Virus fusion core
0.0028.130.03 927-958X-ray2.20homo-trimerHHblits0.34
2xhe.1.B
SYNTAXIN1
Crystal structure of the Unc18-syntaxin 1 complex from Monosiga brevicollis
0.0011.760.03 920-953X-ray2.80hetero-oligomerHHblits0.30
7ns4.1.B
Protein FYV10
Catalytic module of yeast Chelator-GID SR4 E3 ubiquitin ligase
0.0017.650.03 958-991EM0.00hetero-1-1-mer2 x ZNHHblits0.30
6tao.1.A
Non-hemolytic enterotoxin lytic component L1
The cytotoxin MakE from Vibrio cholerae
0.0017.650.03 977-1010X-ray1.98monomer2 x NIHHblits0.29
6tao.2.A
Non-hemolytic enterotoxin lytic component L1
The cytotoxin MakE from Vibrio cholerae
0.0017.650.03 977-1010X-ray1.98monomer2 x NIHHblits0.29
6el1.1.S
YaxA
YaxAB pore complex
0.0021.880.03 1179-1212EM0.00hetero-10-10-merHHblits0.34
6ek7.1.A
YaxA
YaxA from Yersinia enterocolitica
0.0021.880.03 1179-1212X-ray1.80monomerHHblits0.34
3g6b.1.A
Methyl-accepting chemotaxis protein
Crystal structure of a Soluble Chemoreceptor from Thermotoga maritima Asn217Ile mutant
0.0014.710.03 905-938X-ray3.00homo-dimerHHblits0.29
3g6b.1.B
Methyl-accepting chemotaxis protein
Crystal structure of a Soluble Chemoreceptor from Thermotoga maritima Asn217Ile mutant
0.0014.710.03 905-938X-ray3.00homo-dimerHHblits0.29
3ajw.1.A
Flagellar fliJ protein
Structure of FliJ, a soluble component of flagellar type III export apparatus
0.0011.430.03 998-1032X-ray2.10homo-dimer2 x HGHHblits0.26
4wy4.1.B
Syntaxin-17
Crystal structure of autophagic SNARE complex
0.008.820.03 931-964X-ray1.40hetero-1-1-1-1-merHHblits0.28
7nhr.1.A
Putative transmembrane protein Wzc
Putative transmembrane protein Wzc K540M C1
0.0027.270.03 1198-1230EM0.00homo-octamerHHblits0.30
7nhr.1.B
Putative transmembrane protein Wzc
Putative transmembrane protein Wzc K540M C1
0.0027.270.03 1198-1230EM0.00homo-octamerHHblits0.30
7nhr.1.C
Putative transmembrane protein Wzc
Putative transmembrane protein Wzc K540M C1
0.0027.270.03 1198-1230EM0.00homo-octamerHHblits0.30
1wp8.1.A
Fusion glycoprotein F0,Fusion glycoprotein F0
crystal structure of Hendra Virus fusion core
0.0029.030.02 927-957X-ray2.20homo-trimerHHblits0.35
3o9o.1.A
Uncharacterized protein gbs1074
Crystal Structure of GBS1074, an Esat-6 homologue from Group B Streptococcus
0.0025.000.03 956-987X-ray2.00homo-dimerHHblits0.32
3o9o.1.B
Uncharacterized protein gbs1074
Crystal Structure of GBS1074, an Esat-6 homologue from Group B Streptococcus
0.0025.000.03 956-987X-ray2.00homo-dimerHHblits0.32
6tpi.1.A
Murein hydrolase activator EnvC
EnvC bound to the FtsX periplasmic domain
0.008.820.03 1000-1033X-ray2.10hetero-1-2-merHHblits0.27
2elb.1.A
Adapter protein containing PH domain, PTB domain and leucine zipper motif 1
Crystal Structure of the BAR-PH domain of human APPL1
0.008.820.03 996-1029X-ray2.60homo-dimerHHblits0.27
6grj.1.A
AhlB
Structure of the AhlB pore of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.0012.120.03 936-968X-ray2.94homo-10-merHHblits0.29
6grj.1.B
AhlB
Structure of the AhlB pore of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.0012.120.03 936-968X-ray2.94homo-10-merHHblits0.29
1s4b.1.A
Thimet oligopeptidase
Crystal structure of human thimet oligopeptidase.
0.009.090.03 958-990X-ray2.00monomer1 x ZNHHblits0.29
6tao.1.A
Non-hemolytic enterotoxin lytic component L1
The cytotoxin MakE from Vibrio cholerae
0.0021.880.03 936-967X-ray1.98monomer2 x NIHHblits0.31
6tao.2.A
Non-hemolytic enterotoxin lytic component L1
The cytotoxin MakE from Vibrio cholerae
0.0021.880.03 936-967X-ray1.98monomer2 x NIHHblits0.31
4tn3.1.A
TRIM5/cyclophilin A fusion protein/T4 Lysozyme chimera
Structure of the BBox-Coiled-coil region of Rhesus Trim5alpha
0.008.820.03 944-977X-ray3.20homo-dimer4 x ZNHHblits0.26
4tn3.1.B
TRIM5/cyclophilin A fusion protein/T4 Lysozyme chimera
Structure of the BBox-Coiled-coil region of Rhesus Trim5alpha
0.008.820.03 944-977X-ray3.20homo-dimer4 x ZNHHblits0.26
2ch7.1.B
METHYL-ACCEPTING CHEMOTAXIS PROTEIN
CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF A BACTERIAL CHEMORECEPTOR FROM THERMOTOGA MARITIMA
0.0015.150.03 905-937X-ray2.50hetero-oligomer2 x PBHHblits0.27
3ja6.1.H
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.009.090.03 921-953EM0.00hetero-oligomerHHblits0.27
3ja6.1.J
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.009.090.03 921-953EM0.00hetero-oligomerHHblits0.27
3ja6.1.L
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.009.090.03 921-953EM0.00hetero-oligomerHHblits0.27
3ja6.1.N
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.009.090.03 921-953EM0.00hetero-oligomerHHblits0.27
3ja6.1.P
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.009.090.03 921-953EM0.00hetero-oligomerHHblits0.27
3ja6.1.R
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.009.090.03 921-953EM0.00hetero-oligomerHHblits0.27
4nqi.1.A
SH3 domain-containing protein
Structure of the N-terminal I-BAR domain (1-259) of D.Discoideum IBARa
0.0015.150.03 918-950X-ray2.21homo-dimerHHblits0.27
4nqi.1.B
SH3 domain-containing protein
Structure of the N-terminal I-BAR domain (1-259) of D.Discoideum IBARa
0.0015.150.03 918-950X-ray2.21homo-dimerHHblits0.27
4nqi.2.A
SH3 domain-containing protein
Structure of the N-terminal I-BAR domain (1-259) of D.Discoideum IBARa
0.0015.150.03 918-950X-ray2.21homo-dimerHHblits0.27
4nqi.2.B
SH3 domain-containing protein
Structure of the N-terminal I-BAR domain (1-259) of D.Discoideum IBARa
0.0015.150.03 918-950X-ray2.21homo-dimerHHblits0.27
1wa8.1.B
6 KDA EARLY SECRETORY ANTIGENIC TARGET (ESAT-6)
Solution Structure of the CFP-10.ESAT-6 Complex. Major Virulence Determinants of Pathogenic Mycobacteria
0.006.250.03 956-987NMR0.00hetero-1-1-merHHblits0.29
5ijn.1.H
Nuclear pore glycoprotein p62
Composite structure of the inner ring of the human nuclear pore complex (32 copies of Nup205)
0.0012.500.03 915-946EM0.00hetero-6-4-4-4-4-4-…HHblits0.28
7r5k.53.A
Nuclear pore glycoprotein p62
Human nuclear pore complex (constricted)
0.0012.500.03 915-946EM0.00monomerHHblits0.28
7r5k.54.A
Nuclear pore glycoprotein p62
Human nuclear pore complex (constricted)
0.0012.500.03 915-946EM0.00monomerHHblits0.28
7p3r.1.A
MakA tetramer
Helical structure of the toxin MakA from Vibrio cholera
0.009.380.03 937-968EM0.00homo-tetramerHHblits0.28
7p3r.1.B
MakA tetramer
Helical structure of the toxin MakA from Vibrio cholera
0.009.380.03 937-968EM0.00homo-tetramerHHblits0.28
7p3r.1.C
MakA tetramer
Helical structure of the toxin MakA from Vibrio cholera
0.009.380.03 937-968EM0.00homo-tetramerHHblits0.28
7p3r.1.D
MakA tetramer
Helical structure of the toxin MakA from Vibrio cholera
0.009.380.03 937-968EM0.00homo-tetramerHHblits0.28
6nyx.1.A
Fusion glycoprotein F0
Human parainfluenza virus type 3 fusion protein N-terminal heptad repeat domain+VI
0.0032.140.02 928-955X-ray1.85hetero-3-3-merHHblits0.38
6nro.1.A
Human parainfluenza virus type 3 fusion glycoprotein N-terminal heptad repeat domain
Human parainfluenza virus type 3 fusion protein N-terminal heptad repeat domain+VIQKI
0.0032.140.02 928-955X-ray1.75hetero-3-3-mer1 x CAHHblits0.38
6nyx.5.B
Fusion glycoprotein F0
Human parainfluenza virus type 3 fusion protein N-terminal heptad repeat domain+VI
0.0032.140.02 928-955X-ray1.85hetero-3-3-merHHblits0.38
6pyq.1.E
Fusion glycoprotein F1
Assembly of VIQKI D455(beta-L-homoaspartic acid)with human parainfluenza virus type 3 (HPIV3) fusion glycoprotein N-terminal heptad repeat domain
0.0032.140.02 928-955X-ray1.79hetero-3-3-merHHblits0.38
6prl.1.C
Fusion glycoprotein F0
Assembly of VIQKI P5(beta-L-homoproline) with human parainfluenza virus type 3 (HPIV3) fusion glycoprotein N-terminal heptad repeat domain
0.0032.140.02 928-955X-ray1.87hetero-3-3-merHHblits0.38
6pyq.1.A
Fusion glycoprotein F1
Assembly of VIQKI D455(beta-L-homoaspartic acid)with human parainfluenza virus type 3 (HPIV3) fusion glycoprotein N-terminal heptad repeat domain
0.0032.140.02 928-955X-ray1.79hetero-3-3-merHHblits0.38
6prl.1.A
Fusion glycoprotein F0
Assembly of VIQKI P5(beta-L-homoproline) with human parainfluenza virus type 3 (HPIV3) fusion glycoprotein N-terminal heptad repeat domain
0.0032.140.02 928-955X-ray1.87hetero-3-3-merHHblits0.38
6o40.1.C
Fusion glycoprotein F0
Human parainfluenza virus type 3 fusion protein N-terminal heptad repeat domain+VIQKI I454F I456F
0.0032.140.02 928-955X-ray1.20hetero-3-3-merHHblits0.38
7wot.1.F
Nucleoporin NUP49/NSP49
Cryo-EM structure of the inner ring monomer of the Saccharomyces cerevisiae nuclear pore complex
0.009.090.03 921-953EM0.00hetero-4-2-2-2-2-4-…HHblits0.25
7n85.1.M
Nucleoporin NUP49/NSP49
Inner ring spoke from the isolated yeast NPC
0.009.090.03 921-953EM0.00hetero-2-2-2-4-4-4-…HHblits0.25
7n85.1.P
Nucleoporin NUP49/NSP49
Inner ring spoke from the isolated yeast NPC
0.009.090.03 921-953EM0.00hetero-2-2-2-4-4-4-…HHblits0.25
7n9f.1.G
Nucleoporin NUP49/NSP49
Structure of the in situ yeast NPC
0.009.090.03 921-953EM0.00hetero-2-2-2-6-4-4-…HHblits0.25
7n9f.1.J
Nucleoporin NUP49/NSP49
Structure of the in situ yeast NPC
0.009.090.03 921-953EM0.00hetero-2-2-2-6-4-4-…HHblits0.25
7n9f.1.M
Nucleoporin NUP49/NSP49
Structure of the in situ yeast NPC
0.009.090.03 921-953EM0.00hetero-2-2-2-6-4-4-…HHblits0.25
7n9f.1.P
Nucleoporin NUP49/NSP49
Structure of the in situ yeast NPC
0.009.090.03 921-953EM0.00hetero-2-2-2-6-4-4-…HHblits0.25
7n85.1.G
Nucleoporin NUP49/NSP49
Inner ring spoke from the isolated yeast NPC
0.009.090.03 921-953EM0.00hetero-2-2-2-4-4-4-…HHblits0.25
7n85.1.J
Nucleoporin NUP49/NSP49
Inner ring spoke from the isolated yeast NPC
0.009.090.03 921-953EM0.00hetero-2-2-2-4-4-4-…HHblits0.25
7wot.1.I
Nucleoporin NUP49/NSP49
Cryo-EM structure of the inner ring monomer of the Saccharomyces cerevisiae nuclear pore complex
0.009.090.03 921-953EM0.00hetero-4-2-2-2-2-4-…HHblits0.25
2ch7.1.B
METHYL-ACCEPTING CHEMOTAXIS PROTEIN
CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF A BACTERIAL CHEMORECEPTOR FROM THERMOTOGA MARITIMA
0.009.380.03 921-952X-ray2.50hetero-oligomer2 x PBHHblits0.28
2lfs.1.A
HAMP domain-containing protein, Osmolarity sensor protein EnzV chimera
Solution structure of the chimeric Af1503 HAMP- EnvZ DHp homodimer; A219F variant
0.006.060.03 951-983NMR0.00homo-dimerHHblits0.25
2lfs.1.B
HAMP domain-containing protein, Osmolarity sensor protein EnzV chimera
Solution structure of the chimeric Af1503 HAMP- EnvZ DHp homodimer; A219F variant
0.006.060.03 951-983NMR0.00homo-dimerHHblits0.25
3zbh.1.A
ESXA
Geobacillus thermodenitrificans EsxA crystal form I
0.0020.000.02 957-986X-ray1.94homo-dimerHHblits0.32
3zbh.1.B
ESXA
Geobacillus thermodenitrificans EsxA crystal form I
0.0020.000.02 957-986X-ray1.94homo-dimerHHblits0.32
3zbh.2.A
ESXA
Geobacillus thermodenitrificans EsxA crystal form I
0.0020.000.02 957-986X-ray1.94homo-dimerHHblits0.32
3zbh.2.B
ESXA
Geobacillus thermodenitrificans EsxA crystal form I
0.0020.000.02 957-986X-ray1.94homo-dimerHHblits0.32
3zbh.3.A
ESXA
Geobacillus thermodenitrificans EsxA crystal form I
0.0020.000.02 957-986X-ray1.94homo-dimerHHblits0.32
3zbh.3.B
ESXA
Geobacillus thermodenitrificans EsxA crystal form I
0.0020.000.02 957-986X-ray1.94homo-dimerHHblits0.32
3zbh.4.A
ESXA
Geobacillus thermodenitrificans EsxA crystal form I
0.0020.000.02 957-986X-ray1.94homo-dimerHHblits0.32
3zbh.4.B
ESXA
Geobacillus thermodenitrificans EsxA crystal form I
0.0020.000.02 957-986X-ray1.94homo-dimerHHblits0.32
3kpe.1.A
Fusion glycoprotein F0
Solution structure of the respiratory syncytial virus (RSV)six-helix bundle complexed with TMC353121, a small-moleucule inhibitor of RSV
0.0016.670.02 926-955X-ray1.47hetero-oligomer3 x TM3HHblits0.32
1g2c.1.A
FUSION PROTEIN (F)
HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN CORE
0.0016.670.02 926-955X-ray2.30hetero-oligomerHHblits0.32
1g2c.4.C
FUSION PROTEIN (F)
HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN CORE
0.0016.670.02 926-955X-ray2.30hetero-oligomerHHblits0.32
6ntx.1.A
Fusion glycoprotein F0
Respiratory syncytial virus fusion protein N-terminal heptad repeat domain+VIQKI
0.0016.670.02 926-955X-ray2.20hetero-3-3-merHHblits0.32
6oj7.1.E
Fusion glycoprotein F0
Respiratory syncytial virus fusion glycoprotein N-terminal heptad repeat domain+VIQKI I456F
0.0016.670.02 926-955X-ray1.45hetero-3-3-merHHblits0.32
5j3d.1.F
Fusion glycoprotein F0
Crystal structure of human Fab 14N4 in complex with post-fusion RSV F
0.0016.670.02 926-955X-ray4.08hetero-oligomerHHblits0.32
3rrr.2.F
Fusion glycoprotein F0
Structure of the RSV F protein in the post-fusion conformation
0.0016.670.02 926-955X-ray2.82hetero-3-3-mer6 x NAGHHblits0.32
3rrr.2.D
Fusion glycoprotein F0
Structure of the RSV F protein in the post-fusion conformation
0.0016.670.02 926-955X-ray2.82hetero-3-3-mer6 x NAGHHblits0.32
3rrr.2.B
Fusion glycoprotein F0
Structure of the RSV F protein in the post-fusion conformation
0.0016.670.02 926-955X-ray2.82hetero-3-3-mer6 x NAGHHblits0.32
3rrr.1.B
Fusion glycoprotein F0
Structure of the RSV F protein in the post-fusion conformation
0.0016.670.02 926-955X-ray2.82hetero-3-3-mer6 x NAGHHblits0.32
3rrr.1.D
Fusion glycoprotein F0
Structure of the RSV F protein in the post-fusion conformation
0.0016.670.02 926-955X-ray2.82hetero-3-3-mer6 x NAGHHblits0.32
3rrt.1.D
Fusion glycoprotein F0
Structure of the RSV F protein in the post-fusion conformation
0.0016.670.02 926-955X-ray3.20hetero-3-3-merHHblits0.32
1s94.1.A
s-syntaxin
Crystal structure of the Habc domain of neuronal syntaxin from the squid Loligo pealei
0.0016.670.02 962-991X-ray3.34monomerHHblits0.32
1s94.2.A
s-syntaxin
Crystal structure of the Habc domain of neuronal syntaxin from the squid Loligo pealei
0.0016.670.02 962-991X-ray3.34monomerHHblits0.32
2vs0.1.A
VIRULENCE FACTOR ESXA
STRUCTURAL ANALYSIS OF HOMODIMERIC STAPHYLOCOCCAL AUREUS VIRULENCE FACTOR ESXA
0.0020.000.02 957-986X-ray1.40homo-dimer5 x ZN, 1 x CACHHblits0.31
4ckh.1.8
ARF-GAP WITH COILED-COIL, ANK REPEAT AND PH DOMAIN-CONTAINING PROTEIN 1
Helical reconstruction of ACAP1(BAR-PH domain) decorated membrane tubules by cryo-electron microscopy
0.0026.670.02 1000-1029EM14.00homo-40-merHHblits0.30
4ckh.1.9
ARF-GAP WITH COILED-COIL, ANK REPEAT AND PH DOMAIN-CONTAINING PROTEIN 1
Helical reconstruction of ACAP1(BAR-PH domain) decorated membrane tubules by cryo-electron microscopy
0.0026.670.02 1000-1029EM14.00homo-40-merHHblits0.30
4nsw.1.A
Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1
Crystal structure of the BAR-PH domain of ACAP1
0.0026.670.02 1000-1029X-ray2.20homo-dimerHHblits0.30
4nsw.1.B
Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1
Crystal structure of the BAR-PH domain of ACAP1
0.0026.670.02 1000-1029X-ray2.20homo-dimerHHblits0.30
5h3d.2.D
Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1
Helical structure of membrane tubules decorated by ACAP1 (BARPH doamin) protein by cryo-electron microscopy and MD simulation
0.0026.670.02 1000-1029EM0.00homo-tetramerHHblits0.30
5h3d.3.A
Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1
Helical structure of membrane tubules decorated by ACAP1 (BARPH doamin) protein by cryo-electron microscopy and MD simulation
0.0026.670.02 1000-1029EM0.00homo-tetramerHHblits0.30
5h3d.3.C
Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1
Helical structure of membrane tubules decorated by ACAP1 (BARPH doamin) protein by cryo-electron microscopy and MD simulation
0.0026.670.02 1000-1029EM0.00homo-tetramerHHblits0.30
5h3d.3.B
Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1
Helical structure of membrane tubules decorated by ACAP1 (BARPH doamin) protein by cryo-electron microscopy and MD simulation
0.0026.670.02 1000-1029EM0.00homo-tetramerHHblits0.30
3gvm.2.A
Putative uncharacterized protein SAG1039
Structure of the homodimeric WXG-100 family protein from Streptococcus agalactiae
0.0024.140.02 958-986X-ray2.15homo-dimerHHblits0.32
3gwk.1.A
Putative uncharacterized protein SAG1039
Structure of the homodimeric WXG-100 family protein from Streptococcus agalactiae
0.0024.140.02 958-986X-ray1.30homo-dimerHHblits0.32
3gwk.1.B
Putative uncharacterized protein SAG1039
Structure of the homodimeric WXG-100 family protein from Streptococcus agalactiae
0.0024.140.02 958-986X-ray1.30homo-dimerHHblits0.32
5c69.1.A
Fusion glycoprotein F0,Fibritin
Crystal Structure of Prefusion-stabilized RSV F variant PR-DM
0.0017.240.02 927-955X-ray2.30homo-hexamer12 x NHEHHblits0.32
7lvw.1.A
Fusion glycoprotein F0
Structure of RSV F in Complex with VHH Cl184
0.0017.240.02 927-955X-ray2.10hetero-3-3-mer2 x NAG, 1 x NAG-NAG-BMAHHblits0.32
7lvw.1.C
Fusion glycoprotein F0
Structure of RSV F in Complex with VHH Cl184
0.0017.240.02 927-955X-ray2.10hetero-3-3-mer2 x NAG, 1 x NAG-NAG-BMAHHblits0.32
7lvw.1.D
Fusion glycoprotein F0
Structure of RSV F in Complex with VHH Cl184
0.0017.240.02 927-955X-ray2.10hetero-3-3-mer2 x NAG, 1 x NAG-NAG-BMAHHblits0.32
7lvw.2.A
Fusion glycoprotein F0
Structure of RSV F in Complex with VHH Cl184
0.0017.240.02 927-955X-ray2.10hetero-3-3-mer1 x NAGHHblits0.32
7lvw.2.C
Fusion glycoprotein F0
Structure of RSV F in Complex with VHH Cl184
0.0017.240.02 927-955X-ray2.10hetero-3-3-mer1 x NAGHHblits0.32
5nl6.1.A
Calponin domain family protein
The crystal structure of the two spectrin repeat domains from Entamoeba histolytica
0.003.130.03 916-947X-ray2.05homo-dimerHHblits0.24
5nl6.1.B
Calponin domain family protein
The crystal structure of the two spectrin repeat domains from Entamoeba histolytica
0.003.130.03 916-947X-ray2.05homo-dimerHHblits0.24
7x5d.1.A
Lamin-A/C
Crystal Structure of the K316C mutant of Human Lamin A/C Coil 2 (residues 244-340)
0.006.670.02 915-944X-ray1.82homo-tetramerHHblits0.28
7x5d.1.B
Lamin-A/C
Crystal Structure of the K316C mutant of Human Lamin A/C Coil 2 (residues 244-340)
0.006.670.02 915-944X-ray1.82homo-tetramerHHblits0.28
7rtu.1.B
Protein tweety homolog 2
Cryo-EM structure of a TTYH2 trans-dimer
0.0025.000.02 1197-1224EM0.00homo-dimerHHblits0.34
7rtt.1.B
Protein tweety homolog 2
Cryo-EM structure of a TTYH2 cis-dimer
0.0025.000.02 1197-1224EM0.00homo-dimer2 x CA, 4 x NAG-NAG-BMAHHblits0.34
7rtt.1.A
Protein tweety homolog 2
Cryo-EM structure of a TTYH2 cis-dimer
0.0025.000.02 1197-1224EM0.00homo-dimer2 x CA, 4 x NAG-NAG-BMAHHblits0.34
7rtu.1.A
Protein tweety homolog 2
Cryo-EM structure of a TTYH2 trans-dimer
0.0025.000.02 1197-1224EM0.00homo-dimerHHblits0.34
7rtv.1.A
Protein tweety homolog 2
Cryo-EM structure of monomeric TTYH2
0.0025.000.02 1197-1224EM0.00monomerHHblits0.34
7rtw.1.A
Protein tweety homolog 3
Cryo-EM structure of a TTYH3 cis-dimer
0.0017.240.02 1196-1224EM0.00homo-dimer1 x NAG, 2 x CA, 4 x NAG-NAG-BMA, 1 x NAG-NAGHHblits0.31
7rtw.1.B
Protein tweety homolog 3
Cryo-EM structure of a TTYH3 cis-dimer
0.0017.240.02 1196-1224EM0.00homo-dimer1 x NAG, 2 x CA, 4 x NAG-NAG-BMA, 1 x NAG-NAGHHblits0.31
1wa8.1.A
ESAT-6 LIKE PROTEIN ESXB
Solution Structure of the CFP-10.ESAT-6 Complex. Major Virulence Determinants of Pathogenic Mycobacteria
0.0013.330.02 957-986NMR0.00hetero-1-1-merHHblits0.28
3fav.1.A
ESAT-6-like protein esxB
Structure of the CFP10-ESAT6 complex from Mycobacterium tuberculosis
0.0013.330.02 957-986X-ray2.15hetero-oligomer4 x ZN, 1 x IMDHHblits0.28
3fav.2.A
ESAT-6-like protein esxB
Structure of the CFP10-ESAT6 complex from Mycobacterium tuberculosis
0.0013.330.02 957-986X-ray2.15hetero-oligomer3 x ZNHHblits0.28
5tdg.1.A
Fusion glycoprotein F0,Fibritin
Crystal structure of prefusion-stabilized bovine RSV F (DS-Cav1 variant: strain ATue51908)
0.0013.790.02 927-955X-ray2.65homo-trimer3 x NAGHHblits0.30
5tdg.1.B
Fusion glycoprotein F0,Fibritin
Crystal structure of prefusion-stabilized bovine RSV F (DS-Cav1 variant: strain ATue51908)
0.0013.790.02 927-955X-ray2.65homo-trimer3 x NAGHHblits0.30
5tdg.1.C
Fusion glycoprotein F0,Fibritin
Crystal structure of prefusion-stabilized bovine RSV F (DS-Cav1 variant: strain ATue51908)
0.0013.790.02 927-955X-ray2.65homo-trimer3 x NAGHHblits0.30
6xm1.1.B
Tlg2 Qa SNARE
SM Protein Vps45 in Complex with Qa SNARE Tlg2
0.0010.000.02 955-984X-ray2.80hetero-1-1-merHHblits0.28
7dl2.1.A
Hamartin
Cryo-EM structure of human TSC complex
0.0032.140.02 942-969EM0.00hetero-2-2-1-1-merHHblits0.33
7dl2.1.D
Hamartin
Cryo-EM structure of human TSC complex
0.0032.140.02 942-969EM0.00hetero-2-2-1-1-merHHblits0.33
6cxc.1.H
Fusion glycoprotein F0, Envelope glycoprotein chimera
3.9A Cryo-EM structure of murine antibody bound at a novel epitope of respiratory syncytial virus fusion protein
0.0017.860.02 928-955EM0.00hetero-3-3-6-mer6 x NAGHHblits0.32
5tpn.1.A
Fusion glycoprotein F0,Fibritin
Crystal structure of RSV F in complex with human antibody hRSV90
0.0017.860.02 928-955X-ray3.14hetero-oligomerHHblits0.32
5c6b.1.A
Fusion glycoprotein F0,Fibritin
Crystal Structure of Prefusion-stabilized RSV F variant SC-TM
0.0017.860.02 928-955X-ray2.40homo-hexamer6 x NHEHHblits0.32
7lue.1.A
Fusion glycoprotein F0
Prefusion RSV F glycoprotein bound by neutralizing site V-directed antibody ADI-14442
0.0017.860.02 928-955EM0.00hetero-3-3-3-merHHblits0.32
6ead.1.A
Fusion glycoprotein F0
CRYSTAL STRUCTURE OF HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN INHIBITOR ESCAPE VARIANT F140I STABILIZED IN THE PREFUSION STATE
0.0017.860.02 928-955X-ray2.80homo-trimer6 x NAG, 3 x NHEHHblits0.32
6eae.1.A
Fusion glycoprotein F0
CRYSTAL STRUCTURE OF HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN INHIBITOR ESCAPE VARIANT L141W STABILIZED IN THE PREFUSION STATE
0.0017.860.02 928-955X-ray2.90homo-trimer6 x NHEHHblits0.32
6apd.1.A
Fusion glycoprotein F0,Envelope glycoprotein
Crystal structure of RSV F bound by AM22 and the infant antibody ADI-19425
0.0017.860.02 928-955X-ray4.10hetero-3-3-3-3-3-merHHblits0.32
6apd.1.C
Fusion glycoprotein F0,Envelope glycoprotein
Crystal structure of RSV F bound by AM22 and the infant antibody ADI-19425
0.0017.860.02 928-955X-ray4.10hetero-3-3-3-3-3-merHHblits0.32
5w23.1.B
Fusion glycoprotein F0
Crystal Structure of RSV F in complex with 5C4 Fab
0.0017.860.02 928-955X-ray3.40hetero-3-3-3-mer7 x ZNHHblits0.32
5w23.1.A
Fusion glycoprotein F0
Crystal Structure of RSV F in complex with 5C4 Fab
0.0017.860.02 928-955X-ray3.40hetero-3-3-3-mer7 x ZNHHblits0.32
7luc.1.A
Fusion glycoprotein F0
Cryo-EM structure of RSV preF bound by Fabs 32.4K and 01.4B
0.0017.860.02 928-955EM0.00hetero-3-3-3-3-3-merHHblits0.32
6oe5.1.A
Fusion glycoprotein F0,Fibritin
Splayed open prefusion RSV F captured by CR9501 and motavizumab Fabs
0.0017.860.02 928-955X-ray4.10hetero-1-1-1-1-1-merHHblits0.32
3hd7.1.B
Syntaxin-1A
HELICAL EXTENSION OF THE NEURONAL SNARE COMPLEX INTO THE MEMBRANE, spacegroup C 1 2 1
0.0013.330.02 1195-1224X-ray3.40hetero-oligomer2 x GGGHHblits0.27
3ipd.1.B
Syntaxin-1A
Helical extension of the neuronal SNARE complex into the membrane, spacegroup I 21 21 21
0.0013.330.02 1195-1224X-ray4.80hetero-oligomerHHblits0.27
2m8r.1.A
Syntaxin-1A
Pre-Fusion Solution NMR Structure of Neuronal SNARE Syntaxin 1A
0.0013.330.02 1195-1224NMR0.00monomerHHblits0.27
7wot.1.F
Nucleoporin NUP49/NSP49
Cryo-EM structure of the inner ring monomer of the Saccharomyces cerevisiae nuclear pore complex
0.0010.340.02 962-990EM0.00hetero-4-2-2-2-2-4-…HHblits0.29
7n85.1.M
Nucleoporin NUP49/NSP49
Inner ring spoke from the isolated yeast NPC
0.0010.340.02 962-990EM0.00hetero-2-2-2-4-4-4-…HHblits0.29
7n85.1.P
Nucleoporin NUP49/NSP49
Inner ring spoke from the isolated yeast NPC
0.0010.340.02 962-990EM0.00hetero-2-2-2-4-4-4-…HHblits0.29
7n9f.1.G
Nucleoporin NUP49/NSP49
Structure of the in situ yeast NPC
0.0010.340.02 962-990EM0.00hetero-2-2-2-6-4-4-…HHblits0.29
7n9f.1.J
Nucleoporin NUP49/NSP49
Structure of the in situ yeast NPC
0.0010.340.02 962-990EM0.00hetero-2-2-2-6-4-4-…HHblits0.29
7n9f.1.M
Nucleoporin NUP49/NSP49
Structure of the in situ yeast NPC
0.0010.340.02 962-990EM0.00hetero-2-2-2-6-4-4-…HHblits0.29
7n9f.1.P
Nucleoporin NUP49/NSP49
Structure of the in situ yeast NPC
0.0010.340.02 962-990EM0.00hetero-2-2-2-6-4-4-…HHblits0.29
7n85.1.G
Nucleoporin NUP49/NSP49
Inner ring spoke from the isolated yeast NPC
0.0010.340.02 962-990EM0.00hetero-2-2-2-4-4-4-…HHblits0.29
7n85.1.J
Nucleoporin NUP49/NSP49
Inner ring spoke from the isolated yeast NPC
0.0010.340.02 962-990EM0.00hetero-2-2-2-4-4-4-…HHblits0.29
7wot.1.I
Nucleoporin NUP49/NSP49
Cryo-EM structure of the inner ring monomer of the Saccharomyces cerevisiae nuclear pore complex
0.0010.340.02 962-990EM0.00hetero-4-2-2-2-2-4-…HHblits0.29
7p5j.1.A
Protein tweety homolog 1
Cryo-EM structure of human TTYH1 in GDN
0.0010.340.02 927-955EM0.00homo-dimer4 x NAG, 2 x NAG-NAGHHblits0.29
7xgf.1.A
BCL-xL and MCL-1 dual inhibitor 2
Crystal structure of BCL-xL in complex with computationally designed inhibitor protein
0.0025.000.02 910-937X-ray1.90hetero-1-2-merHHblits0.32
7xgf.2.A
BCL-xL and MCL-1 dual inhibitor 2
Crystal structure of BCL-xL in complex with computationally designed inhibitor protein
0.0025.000.02 910-937X-ray1.90hetero-1-2-merHHblits0.32
7p54.1.A
Protein tweety homolog 2
Cryo-EM structure of human TTYH2 in GDN
0.0025.930.02 1197-1223EM0.00homo-dimer4 x NAG, 4 x NAG-NAGHHblits0.35
7p5m.1.A
Protein tweety homolog 2
Cryo-EM structure of human TTYH2 in lipid nanodiscs
0.0025.930.02 1197-1223EM0.00homo-dimer4 x NAG, 4 x NAG-NAGHHblits0.35
2vrz.1.A
VIRULENCE FACTOR ESXA
STRUCTURAL ANALYSIS OF HOMODIMERIC STAPHYLOCOCCAL AUREUS ESXA
0.0021.430.02 959-986X-ray1.90homo-dimer7 x ZNHHblits0.32
2vrz.1.B
VIRULENCE FACTOR ESXA
STRUCTURAL ANALYSIS OF HOMODIMERIC STAPHYLOCOCCAL AUREUS ESXA
0.0021.430.02 959-986X-ray1.90homo-dimer7 x ZNHHblits0.32
6zvt.6.A
Vipp1
C13 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zvr.1.B
Vipp1
C11 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00homo-55-merHHblits0.32
6zvr.1.C
Vipp1
C11 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00homo-55-merHHblits0.32
6zvr.1.D
Vipp1
C11 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00homo-55-merHHblits0.32
6zvr.1.A
Vipp1
C11 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00homo-55-merHHblits0.32
6zvr.1.E
Vipp1
C11 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00homo-55-merHHblits0.32
6zvs.2.A
Vipp1
C12 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zvs.3.A
Vipp1
C12 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zvs.4.A
Vipp1
C12 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zvs.5.A
Vipp1
C12 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zvt.3.A
Vipp1
C13 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zvt.4.A
Vipp1
C13 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zvs.1.A
Vipp1
C12 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zw4.2.A
vipp1
C14 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zw4.3.A
vipp1
C14 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zw4.4.A
vipp1
C14 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zw4.5.A
vipp1
C14 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zw6.1.A
vipp1
C16 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zw6.2.A
vipp1
C16 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zw6.3.A
vipp1
C16 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zw6.4.A
vipp1
C16 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zw6.5.A
vipp1
C16 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zw6.6.A
vipp1
C16 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zw7.2.A
vipp1
C17 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zw7.5.A
vipp1
C17 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zw7.6.A
vipp1
C17 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
6zw7.7.A
vipp1
C17 symmetry: Bacterial Vipp1 and PspA are members of the ancient ESCRT-III membrane-remodeling superfamily.
0.0014.290.02 964-991EM0.00monomerHHblits0.32
7p54.1.A
Protein tweety homolog 2
Cryo-EM structure of human TTYH2 in GDN
0.0013.790.02 926-954EM0.00homo-dimer4 x NAG, 4 x NAG-NAGHHblits0.29
7p5m.1.A
Protein tweety homolog 2
Cryo-EM structure of human TTYH2 in lipid nanodiscs
0.0013.790.02 926-954EM0.00homo-dimer4 x NAG, 4 x NAG-NAGHHblits0.29
3zx6.1.A
HAMP, METHYL-ACCEPTING CHEMOTAXIS PROTEIN I
Structure of Hamp(AF1503)-Tsr fusion - Hamp (A291V) mutant
0.003.330.02 920-949X-ray2.65homo-dimerHHblits0.26
3zx6.1.B
HAMP, METHYL-ACCEPTING CHEMOTAXIS PROTEIN I
Structure of Hamp(AF1503)-Tsr fusion - Hamp (A291V) mutant
0.003.330.02 920-949X-ray2.65homo-dimerHHblits0.26
7p5c.1.A
Protein tweety homolog 3
Cryo-EM structure of human TTYH3 in Ca2+ and GDN
0.0022.220.02 1196-1223EM0.00homo-dimer4 x NAG, 2 x NAG-NAGHHblits0.34
3fav.1.B
6 kDa early secretory antigenic target
Structure of the CFP10-ESAT6 complex from Mycobacterium tuberculosis
0.006.900.02 958-986X-ray2.15hetero-oligomer4 x ZN, 1 x IMDHHblits0.28
5ea3.1.A
Fusion glycoprotein F0
Crystal Structure of Inhibitor JNJ-2408068 in Complex with Prefusion RSV F Glycoprotein
0.0014.290.02 928-955X-ray2.75homo-trimer3 x NHE, 3 x 5NKHHblits0.31
5ea4.1.A
Fusion glycoprotein F0
Crystal Structure of Inhibitor JNJ-49153390 in Complex with Prefusion RSV F Glycoprotein
0.0014.290.02 928-955X-ray2.30homo-trimer3 x NHE, 3 x 5NMHHblits0.31
5udc.1.F
Fusion glycoprotein F0
Crystal Structure of RSV F A2 Bound to MEDI8897
0.0014.290.02 928-955X-ray3.45hetero-3-3-3-merHHblits0.31
6dc3.1.C
RSV fusion glycoprotein
RSV prefusion F bound to RSD5 Fab
0.0014.290.02 928-955X-ray3.50hetero-1-1-1-mer2 x NAGHHblits0.31
6dc5.2.A
RSV fusion glycoprotein
RSV prefusion F in complex with AM22 Fab
0.0014.290.02 928-955X-ray3.50hetero-1-1-1-mer1 x NAG, 1 x CDHHblits0.31
6dc5.3.A
RSV fusion glycoprotein
RSV prefusion F in complex with AM22 Fab
0.0014.290.02 928-955X-ray3.50hetero-1-1-1-mer1 x NAG, 1 x CDHHblits0.31
6dc5.1.A
RSV fusion glycoprotein
RSV prefusion F in complex with AM22 Fab
0.0014.290.02 928-955X-ray3.50hetero-1-1-1-mer1 x NAG, 1 x CDHHblits0.31
6ean.1.A
Fusion glycoprotein F0
CRYSTAL STRUCTURE OF HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN INHIBITOR ESCAPE VARIANT F488I STABILIZED IN THE PREFUSION STATE
0.0014.290.02 928-955X-ray2.90homo-trimer3 x NAG, 6 x NHEHHblits0.31
6eam.1.A
Fusion glycoprotein F0
CRYSTAL STRUCTURE OF HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN INHIBITOR ESCAPE VARIANT E487D STABILIZED IN THE PREFUSION STATE
0.0014.290.02 928-955X-ray2.74homo-trimer3 x NAG, 6 x NHE, 3 x TARHHblits0.31
6eal.1.A
Fusion glycoprotein F0
CRYSTAL STRUCTURE OF HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN INHIBITOR ESCAPE VARIANT D486N STABILIZED IN THE PREFUSION STATE
0.0014.290.02 928-955X-ray2.75homo-trimer9 x TAR, 3 x NHEHHblits0.31
5u68.1.A
Chimera protein of Fusion glycoprotein F0 and Envelope glycoprotein
Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus
0.0014.290.02 928-955X-ray3.08hetero-3-3-merHHblits0.31
5u68.1.B
Chimera protein of Fusion glycoprotein F0 and Envelope glycoprotein
Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus
0.0014.290.02 928-955X-ray3.08hetero-3-3-merHHblits0.31
5u68.1.C
Chimera protein of Fusion glycoprotein F0 and Envelope glycoprotein
Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus
0.0014.290.02 928-955X-ray3.08hetero-3-3-merHHblits0.31
6eai.1.A
Fusion glycoprotein F0
CRYSTAL STRUCTURE OF HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN INHIBITOR ESCAPE VARIANT S398L STABILIZED IN THE PREFUSION STATE
0.0014.290.02 928-955X-ray2.80homo-trimer3 x NAG, 6 x NHE, 2 x TARHHblits0.31
6eaj.1.A
Fusion glycoprotein F0
CRYSTAL STRUCTURE OF HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN INHIBITOR ESCAPE VARIANT T400A STABILIZED IN THE PREFUSION STATE
0.0014.290.02 928-955X-ray2.85homo-trimer3 x NHE, 3 x TARHHblits0.31
6eah.1.A
Fusion glycoprotein F0
CRYSTAL STRUCTURE OF HUMAN RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN INHIBITOR ESCAPE VARIANT K394R-S398L STABILIZED IN THE PREFUSION STATE
0.0014.290.02 928-955X-ray3.00homo-trimer1 x NHE, 1 x NAG-NAG-FUCHHblits0.31
8dg9.1.A
Fusion glycoprotein F0
Cryo-EM Structure of RSV prefusion F trimer in complex with three MxR Fabs
0.0014.290.02 928-955EM0.00hetero-3-3-3-mer6 x NAGHHblits0.31
5ea8.1.A
Fusion glycoprotein F0
Crystal Structure of Prefusion RSV F Glycoprotein Fusion Inhibitor Resistance Mutant D489Y
0.0014.290.02 928-955X-ray2.60homo-trimer3 x NHE, 3 x TARHHblits0.31
5tok.1.A
Fusion glycoprotein F0, Fibritin chimera
Crystal structure of the RSV F glycoprotein in complex with the neutralizing single-domain antibody F-VHH-L66
0.0014.290.02 928-955X-ray3.80hetero-3-3-mer3 x NAGHHblits0.31
5tok.1.B
Fusion glycoprotein F0, Fibritin chimera
Crystal structure of the RSV F glycoprotein in complex with the neutralizing single-domain antibody F-VHH-L66
0.0014.290.02 928-955X-ray3.80hetero-3-3-mer3 x NAGHHblits0.31
5tok.1.C
Fusion glycoprotein F0, Fibritin chimera
Crystal structure of the RSV F glycoprotein in complex with the neutralizing single-domain antibody F-VHH-L66
0.0014.290.02 928-955X-ray3.80hetero-3-3-mer3 x NAGHHblits0.31
5toj.1.C
Fusion glycoprotein F0, Fibritin chimera
Crystal structure of the RSV F glycoprotein in complex with the neutralizing single-domain antibody F-VHH-4
0.0014.290.02 928-955X-ray3.30hetero-3-3-mer3 x NAGHHblits0.31
6oe4.1.A
Fusion glycoprotein F0
Prefusion RSV F monomer bound by neutralizing antibody CR9501
0.0014.290.02 928-955X-ray3.30hetero-1-1-1-merHHblits0.31
4mmt.1.D
Fusion glycoprotein F1 fused with Fibritin trimerization domain
Crystal Structure of Prefusion-stabilized RSV F Variant DS-Cav1 at pH 9.5
0.0014.290.02 928-955X-ray3.05hetero-3-3-merHHblits0.31
6ous.1.D
Fusion glycoprotein F1 fused with Fibritin trimerization domain
Structure of fusion glycoprotein from human respiratory syncytial virus
0.0014.290.02 928-955X-ray3.40hetero-3-3-3-3-mer2 x NAG, 3 x NAG-NAG-BMA-MANHHblits0.31
6ous.2.D
Fusion glycoprotein F1 fused with Fibritin trimerization domain
Structure of fusion glycoprotein from human respiratory syncytial virus
0.0014.290.02 928-955X-ray3.40hetero-3-3-3-3-mer2 x NAG, 3 x NAG-NAG-BMA-MANHHblits0.31
6ous.1.F
Fusion glycoprotein F1 fused with Fibritin trimerization domain
Structure of fusion glycoprotein from human respiratory syncytial virus
0.0014.290.02 928-955X-ray3.40hetero-3-3-3-3-mer2 x NAG, 3 x NAG-NAG-BMA-MANHHblits0.31
6ous.2.F
Fusion glycoprotein F1 fused with Fibritin trimerization domain
Structure of fusion glycoprotein from human respiratory syncytial virus
0.0014.290.02 928-955X-ray3.40hetero-3-3-3-3-mer2 x NAG, 3 x NAG-NAG-BMA-MANHHblits0.31
6ous.1.B
Fusion glycoprotein F1 fused with Fibritin trimerization domain
Structure of fusion glycoprotein from human respiratory syncytial virus
0.0014.290.02 928-955X-ray3.40hetero-3-3-3-3-mer2 x NAG, 3 x NAG-NAG-BMA-MANHHblits0.31
6w52.1.B
Fusion glycoprotein F1 fused with Fibritin trimerization domain
Prefusion RSV F bound by neutralizing antibody RSB1
0.0014.290.02 928-955X-ray3.74hetero-1-1-1-1-merHHblits0.31
6ous.2.B
Fusion glycoprotein F1 fused with Fibritin trimerization domain
Structure of fusion glycoprotein from human respiratory syncytial virus
0.0014.290.02 928-955X-ray3.40hetero-3-3-3-3-mer2 x NAG, 3 x NAG-NAG-BMA-MANHHblits0.31
4mmu.1.B
Fusion glycoprotein F1 fused with Fibritin trimerization domain
Crystal Structure of Prefusion-stabilized RSV F Variant DS-Cav1 at pH 5.5
0.0014.290.02 928-955X-ray3.00hetero-3-3-mer3 x NAGHHblits0.31
7mmn.1.I
Fusion glycoprotein F1,Fibritin
Crystal Structure of the Prefusion RSV F Glycoprotein bound by human antibody AM14
0.0014.290.02 928-955X-ray3.57hetero-3-3-3-3-mer1 x NAGHHblits0.31
4mmv.1.B
Fusion glycoprotein F1 fused with Fibritin trimerization domain
Crystal Structure of Prefusion-stabilized RSV F Variant DS-Cav1-TriC at pH 9.5
0.0014.290.02 928-955X-ray2.81hetero-3-3-merHHblits0.31
3fzh.2.A
BAG family molecular chaperone regulator 1
Crystal Structures of Hsc70/Bag1 in Complex with Small Molecule Inhibitors
0.0017.240.02 963-991X-ray2.00monomerHHblits0.28
1hx1.1.B
BAG family molecular chaperone regulator 1
CRYSTAL STRUCTURE OF A BAG DOMAIN IN COMPLEX WITH THE HSC70 ATPASE DOMAIN
0.0017.240.02 963-991X-ray1.90hetero-1-1-merHHblits0.28
5aqf.1.B
BAG FAMILY MOLECULAR CHAPERONE REGULATOR 1
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues
0.0017.240.02 963-991X-ray1.88hetero-oligomer1 x ADNHHblits0.28
5aqf.2.B
BAG FAMILY MOLECULAR CHAPERONE REGULATOR 1
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues
0.0017.240.02 963-991X-ray1.88hetero-oligomer1 x ADNHHblits0.28
5aqg.2.B
BAG FAMILY MOLECULAR CHAPERONE REGULATOR 1
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues
0.0017.240.02 963-991X-ray2.24hetero-oligomer1 x ZJBHHblits0.28
5aqt.1.B
BAG FAMILY MOLECULAR CHAPERONE REGULATOR 1
Fragment-based screening of HSP70 sheds light on the functional role of ATP-binding site residues
0.0017.240.02 963-991X-ray1.90hetero-oligomer1 x 5P7HHblits0.28
4i0x.1.B
ESAT-6-like protein MAB_3113
Crystal structure of the Mycobacterum abscessus EsxEF (Mab_3112-Mab_3113) complex
0.0010.000.02 957-986X-ray1.96hetero-oligomerHHblits0.24
4i0x.2.B
ESAT-6-like protein MAB_3113
Crystal structure of the Mycobacterum abscessus EsxEF (Mab_3112-Mab_3113) complex
0.0010.000.02 957-986X-ray1.96hetero-oligomerHHblits0.24
4i0x.3.B
ESAT-6-like protein MAB_3113
Crystal structure of the Mycobacterum abscessus EsxEF (Mab_3112-Mab_3113) complex
0.0010.000.02 957-986X-ray1.96hetero-oligomerHHblits0.24
4i0x.4.B
ESAT-6-like protein MAB_3113
Crystal structure of the Mycobacterum abscessus EsxEF (Mab_3112-Mab_3113) complex
0.0010.000.02 957-986X-ray1.96hetero-oligomerHHblits0.24
4i0x.5.B
ESAT-6-like protein MAB_3113
Crystal structure of the Mycobacterum abscessus EsxEF (Mab_3112-Mab_3113) complex
0.0010.000.02 957-986X-ray1.96hetero-oligomerHHblits0.24
4i0x.6.B
ESAT-6-like protein MAB_3113
Crystal structure of the Mycobacterum abscessus EsxEF (Mab_3112-Mab_3113) complex
0.0010.000.02 957-986X-ray1.96hetero-oligomerHHblits0.24
7xgg.1.B
BCL-xL and MCL-1 dual inhibitor
Crystal structure of BCL-xL in complex with computationally designed inhibitor protein
0.0025.930.02 911-937X-ray1.90hetero-2-1-merHHblits0.32
7xgg.2.B
BCL-xL and MCL-1 dual inhibitor
Crystal structure of BCL-xL in complex with computationally designed inhibitor protein
0.0025.930.02 911-937X-ray1.90hetero-2-1-merHHblits0.32
8aud.1.A
Cell wall-associated hydrolases (Invasion-associated proteins)
Structure of peptidoglycan hydrolase Cg1735 from Corynebacterium glutamicum, orthorhombic crystal form
0.0010.340.02 940-968X-ray4.50monomerHHblits0.27
3hd7.1.B
Syntaxin-1A
HELICAL EXTENSION OF THE NEURONAL SNARE COMPLEX INTO THE MEMBRANE, spacegroup C 1 2 1
0.0014.290.02 931-958X-ray3.40hetero-oligomer2 x GGGHHblits0.29
3ipd.1.B
Syntaxin-1A
Helical extension of the neuronal SNARE complex into the membrane, spacegroup I 21 21 21
0.0014.290.02 931-958X-ray4.80hetero-oligomerHHblits0.29
2m8r.1.A
Syntaxin-1A
Pre-Fusion Solution NMR Structure of Neuronal SNARE Syntaxin 1A
0.0014.290.02 931-958NMR0.00monomerHHblits0.29
3lnr.1.A
Aerotaxis transducer Aer2
Crystal structure of poly-HAMP domains from the P. aeruginosa soluble receptor Aer2
0.0017.240.02 916-944X-ray2.64homo-dimerHHblits0.26
4j41.2.B
secreted protein EsxB
The crystal structure of a secreted protein EsxB (Mutant P67A) from Bacillus anthracis str. Sterne
0.0013.790.02 958-986X-ray1.52homo-dimerHHblits0.26
4j41.1.B
secreted protein EsxB
The crystal structure of a secreted protein EsxB (Mutant P67A) from Bacillus anthracis str. Sterne
0.0013.790.02 958-986X-ray1.52homo-dimerHHblits0.26
4j41.2.A
secreted protein EsxB
The crystal structure of a secreted protein EsxB (Mutant P67A) from Bacillus anthracis str. Sterne
0.0013.790.02 958-986X-ray1.52homo-dimerHHblits0.26
4j41.1.A
secreted protein EsxB
The crystal structure of a secreted protein EsxB (Mutant P67A) from Bacillus anthracis str. Sterne
0.0013.790.02 958-986X-ray1.52homo-dimerHHblits0.26
4j41.3.A
secreted protein EsxB
The crystal structure of a secreted protein EsxB (Mutant P67A) from Bacillus anthracis str. Sterne
0.0013.790.02 958-986X-ray1.52homo-dimerHHblits0.26
4wpe.1.A
Cytokinesis protein 2
Crystal Structure of Hof1p F-BAR domain
0.0013.790.02 939-967X-ray2.70homo-dimerHHblits0.26
5c1f.1.A
Septation protein imp2
Structure of the Imp2 F-BAR domain
0.003.330.02 1004-1033X-ray2.36homo-dimerHHblits0.23
5c1f.1.B
Septation protein imp2
Structure of the Imp2 F-BAR domain
0.003.330.02 1004-1033X-ray2.36homo-dimerHHblits0.23
8d47.1.C
SARS-CoV-2 fusion peptide
fp.006 Fab in complex with SARS-CoV-2 Fusion Peptide
0.00100.000.01 813-831X-ray2.00hetero-1-1-1-merHHblits0.59
7nsu.1.D
Colicin-E9
ColicinE9 intact translocation complex
0.0014.290.02 936-963EM0.00hetero-3-1-1-1-merHHblits0.28
3f57.1.A
Spectrin beta chain, erythrocyte
Crystal structure of human erythroid beta spectrin repeats 14 and 15 (ankyrin binding domain)
0.0014.290.02 958-985X-ray2.90monomerHHblits0.28
3mq9.1.A
Bone marrow stromal antigen 2 fused to Maltose-binding periplasmic protein
Crystal Structure of Ectodomain Mutant of BST-2/Tetherin/CD317 Fused to MBP
0.0014.290.02 926-953X-ray2.80homo-tetramerHHblits0.28
3mq9.1.C
Bone marrow stromal antigen 2 fused to Maltose-binding periplasmic protein
Crystal Structure of Ectodomain Mutant of BST-2/Tetherin/CD317 Fused to MBP
0.0014.290.02 926-953X-ray2.80homo-tetramerHHblits0.28
3mq9.1.D
Bone marrow stromal antigen 2 fused to Maltose-binding periplasmic protein
Crystal Structure of Ectodomain Mutant of BST-2/Tetherin/CD317 Fused to MBP
0.0014.290.02 926-953X-ray2.80homo-tetramerHHblits0.28
3jc8.45.A
PilO
Architectural model of the type IVa pilus machine in a piliated state
0.0023.080.02 1206-1231EM0.00monomerHHblits0.33
3jc9.9.A
PilO
Architectural model of the type IVa pilus machine in a non-piliated state
0.0023.080.02 1206-1231EM0.00monomerHHblits0.33
4lws.2.A
Uncharacterized protein
EsxA : EsxB (SeMet) hetero-dimer from Thermomonospora curvata
0.0011.110.02 959-985X-ray2.00monomerHHblits0.29
6gap.1.A
Outer capsid protein sigma-1
Crystal structure of the T3D reovirus sigma1 coiled coil tail and body
0.0011.110.02 963-989X-ray2.15homo-trimerHHblits0.29
6gap.1.B
Outer capsid protein sigma-1
Crystal structure of the T3D reovirus sigma1 coiled coil tail and body
0.0011.110.02 963-989X-ray2.15homo-trimerHHblits0.29
6gap.1.C
Outer capsid protein sigma-1
Crystal structure of the T3D reovirus sigma1 coiled coil tail and body
0.0011.110.02 963-989X-ray2.15homo-trimerHHblits0.29
6f1t.1.h
BICD family-like cargo adapter 1,BICD family-like cargo adapter 1,BICD family-like cargo adapter 1
Cryo-EM structure of two dynein tail domains bound to dynactin and BICDR1
0.0013.330.02 1006-1035EM0.00hetero-8-1-1-1-1-1-…9 x ADP, 1 x ATPHHblits0.21
4j7k.1.A
secreted protein EsxB
The crystal structure of a secreted protein EsxB (Mutant E54Q) from Bacillus anthracis str. Sterne
0.0014.290.02 959-986X-ray1.66homo-dimerHHblits0.26
4j7k.1.B
secreted protein EsxB
The crystal structure of a secreted protein EsxB (Mutant E54Q) from Bacillus anthracis str. Sterne
0.0014.290.02 959-986X-ray1.66homo-dimerHHblits0.26
4j7k.2.A
secreted protein EsxB
The crystal structure of a secreted protein EsxB (Mutant E54Q) from Bacillus anthracis str. Sterne
0.0014.290.02 959-986X-ray1.66homo-dimerHHblits0.26
4j7k.2.B
secreted protein EsxB
The crystal structure of a secreted protein EsxB (Mutant E54Q) from Bacillus anthracis str. Sterne
0.0014.290.02 959-986X-ray1.66homo-dimerHHblits0.26
4j42.1.A
secreted protein EsxB
The crystal structure of a secreted protein EsxB (Mutant Y65F) from Bacillus anthracis str. Sterne
0.0014.290.02 959-986X-ray1.28homo-dimer1 x FLCHHblits0.26
4j42.1.B
secreted protein EsxB
The crystal structure of a secreted protein EsxB (Mutant Y65F) from Bacillus anthracis str. Sterne
0.0014.290.02 959-986X-ray1.28homo-dimer1 x FLCHHblits0.26
1kmi.1.B
Chemotaxis protein cheZ
CRYSTAL STRUCTURE OF AN E.COLI CHEMOTAXIS PROTEIN, CHEZ
0.0011.110.02 1007-1033X-ray2.90hetero-2-2-mer2 x MG, 2 x BEF, 2 x BCNHHblits0.29
3ogi.1.A
Putative ESAT-6-like protein 6
Crystal structure of the Mycobacterium tuberculosis H37Rv EsxOP complex (Rv2346c-Rv2347c)
0.0010.710.02 941-968X-ray2.55hetero-oligomerHHblits0.26
3ogi.2.A
Putative ESAT-6-like protein 6
Crystal structure of the Mycobacterium tuberculosis H37Rv EsxOP complex (Rv2346c-Rv2347c)
0.0010.710.02 941-968X-ray2.55hetero-oligomerHHblits0.26
4gzr.1.A
ESAT-6-like protein 6
Crystal structure of the Mycobacterium tuberculosis H37Rv EsxOP (Rv2346c-Rv2347c) complex in space group C2221
0.0010.710.02 941-968X-ray2.55hetero-oligomerHHblits0.26
4gzr.2.A
ESAT-6-like protein 6
Crystal structure of the Mycobacterium tuberculosis H37Rv EsxOP (Rv2346c-Rv2347c) complex in space group C2221
0.0010.710.02 941-968X-ray2.55hetero-oligomerHHblits0.26
5ew5.1.A
Colicin-E9
Crystal Structure of Colicin E9 In Complex with Its Immunity Protein Im9
0.0014.810.02 937-963X-ray3.20hetero-oligomerHHblits0.29
5ew5.3.A
Colicin-E9
Crystal Structure of Colicin E9 In Complex with Its Immunity Protein Im9
0.0014.810.02 937-963X-ray3.20hetero-oligomerHHblits0.29
6el1.1.S
YaxA
YaxAB pore complex
0.003.570.02 964-991EM0.00hetero-10-10-merHHblits0.25
6ek7.1.A
YaxA
YaxA from Yersinia enterocolitica
0.003.570.02 964-991X-ray1.80monomerHHblits0.25
5y05.1.A
msmeg_4306
Structural characterization of msmeg_4306 from Mycobacterium smegmatis
0.0017.860.02 993-1020X-ray2.80monomer1 x ZNHHblits0.25
6f1t.1.U
BICD family-like cargo adapter 1,BICD family-like cargo adapter 1,BICD family-like cargo adapter 1,BICDR-1
Cryo-EM structure of two dynein tail domains bound to dynactin and BICDR1
0.009.380.03 1011-1042EM0.00hetero-8-1-1-1-1-1-…9 x ADP, 1 x ATPHHblits0.15
2ch7.1.A
METHYL-ACCEPTING CHEMOTAXIS PROTEIN
CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF A BACTERIAL CHEMORECEPTOR FROM THERMOTOGA MARITIMA
0.0014.810.02 910-936X-ray2.50hetero-oligomer2 x PBHHblits0.28
3ja6.1.Q
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0014.810.02 910-936EM0.00hetero-oligomerHHblits0.28
3ja6.1.G
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0014.810.02 910-936EM0.00hetero-oligomerHHblits0.28
3ja6.1.K
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0014.810.02 910-936EM0.00hetero-oligomerHHblits0.28
3ja6.1.I
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0014.810.02 910-936EM0.00hetero-oligomerHHblits0.28
3ja6.1.O
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0014.810.02 910-936EM0.00hetero-oligomerHHblits0.28
3ja6.1.M
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0014.810.02 910-936EM0.00hetero-oligomerHHblits0.28
6ulc.1.B
Envelope glycoprotein gp41
Structure of full-length, fully glycosylated, non-modified HIV-1 gp160 bound to PG16 Fab at a nominal resolution of 4.6 Angstrom
0.007.140.02 878-905EM0.00hetero-3-3-1-1-mer44 x NAG, 1 x NAG-NAG-BMA-MAN-NAG-GAL, 2 x NAG-NAG-BMA-MAN-MAN, 16 x NAG-NAG-BMA, 10 x NAG-NAG, 1 x NAG-NAG-FUC, 1 x NAG-NAG-BMA-MAN-MAN-MAN-MAN, 1 x NAG-NAG-BMA-FUCHHblits0.25
6ulc.1.D
Envelope glycoprotein gp41
Structure of full-length, fully glycosylated, non-modified HIV-1 gp160 bound to PG16 Fab at a nominal resolution of 4.6 Angstrom
0.007.140.02 878-905EM0.00hetero-3-3-1-1-mer44 x NAG, 1 x NAG-NAG-BMA-MAN-NAG-GAL, 2 x NAG-NAG-BMA-MAN-MAN, 16 x NAG-NAG-BMA, 10 x NAG-NAG, 1 x NAG-NAG-FUC, 1 x NAG-NAG-BMA-MAN-MAN-MAN-MAN, 1 x NAG-NAG-BMA-FUCHHblits0.25
6ulc.1.F
Envelope glycoprotein gp41
Structure of full-length, fully glycosylated, non-modified HIV-1 gp160 bound to PG16 Fab at a nominal resolution of 4.6 Angstrom
0.007.140.02 878-905EM0.00hetero-3-3-1-1-mer44 x NAG, 1 x NAG-NAG-BMA-MAN-NAG-GAL, 2 x NAG-NAG-BMA-MAN-MAN, 16 x NAG-NAG-BMA, 10 x NAG-NAG, 1 x NAG-NAG-FUC, 1 x NAG-NAG-BMA-MAN-MAN-MAN-MAN, 1 x NAG-NAG-BMA-FUCHHblits0.25
2etd.1.A
lemA protein
Crystal structure of a lema protein (tm0961) from thermotoga maritima msb8 at 2.28 A resolution
0.0018.520.02 1010-1036X-ray2.28monomerHHblits0.27
6yvu.1.A
Structural maintenance of chromosomes protein 2,Structural maintenance of chromosomes protein 2,Smc2
Condensin complex from S.cerevisiae ATP-free apo non-engaged state
0.0011.110.02 956-982EM0.00hetero-1-1-1-1-merHHblits0.27
4j7j.1.A
secreted protein EsxB
The crystal structure of a secreted protein EsxB (Mutant G53A) from Bacillus anthracis str. Sterne
0.0014.810.02 959-985X-ray1.46homo-dimerHHblits0.26
4j7j.1.B
secreted protein EsxB
The crystal structure of a secreted protein EsxB (Mutant G53A) from Bacillus anthracis str. Sterne
0.0014.810.02 959-985X-ray1.46homo-dimerHHblits0.26
1qu7.1.A
METHYL-ACCEPTING CHEMOTAXIS PROTEIN I
FOUR HELICAL-BUNDLE STRUCTURE OF THE CYTOPLASMIC DOMAIN OF A SERINE CHEMOTAXIS RECEPTOR
0.0015.380.02 914-939X-ray2.60homo-dimerHHblits0.28
1qu7.1.B
METHYL-ACCEPTING CHEMOTAXIS PROTEIN I
FOUR HELICAL-BUNDLE STRUCTURE OF THE CYTOPLASMIC DOMAIN OF A SERINE CHEMOTAXIS RECEPTOR
0.0015.380.02 914-939X-ray2.60homo-dimerHHblits0.28
8dgw.1.C
Spike protein S2'
Crystal structure of HCoV-HKU1 spike stem helix peptide in complex with Fab of broadly neutralizing antibody CC95.108 isolated from a vaccinated COVID-19 convalescent
0.0045.450.02 1141-1162X-ray2.81hetero-1-1-1-merHHblits0.41
8dgw.2.C
Spike protein S2'
Crystal structure of HCoV-HKU1 spike stem helix peptide in complex with Fab of broadly neutralizing antibody CC95.108 isolated from a vaccinated COVID-19 convalescent
0.0045.450.02 1141-1162X-ray2.81hetero-1-1-1-merHHblits0.41
8dgw.4.C
Spike protein S2'
Crystal structure of HCoV-HKU1 spike stem helix peptide in complex with Fab of broadly neutralizing antibody CC95.108 isolated from a vaccinated COVID-19 convalescent
0.0045.450.02 1141-1162X-ray2.81hetero-1-1-1-merHHblits0.41
1fio.1.A
SSO1 PROTEIN
CRYSTAL STRUCTURE OF YEAST T-SNARE PROTEIN SSO1
0.0025.000.02 1180-1203X-ray2.10monomer2 x ZNHHblits0.34
8cxm.1.A
Flagellin
Cryo-EM structure of the supercoiled E. coli K12 flagellar filament core, Normal waveform
0.0020.000.02 929-953EM0.00homo-55-merHHblits0.31
2q13.1.A
DCC-interacting protein 13 alpha
Crystal structure of BAR-PH domain of APPL1
0.007.690.02 1001-1026X-ray2.05homo-dimerHHblits0.27
2kg7.1.B
ESAT-6-like protein esxH
Structure and features of the complex formed by the tuberculosis virulence factors Rv0287 and Rv0288
0.007.410.02 959-985NMR0.00hetero-oligomerHHblits0.24
7wot.1.F
Nucleoporin NUP49/NSP49
Cryo-EM structure of the inner ring monomer of the Saccharomyces cerevisiae nuclear pore complex
0.0016.000.02 974-998EM0.00hetero-4-2-2-2-2-4-…HHblits0.29
7n85.1.M
Nucleoporin NUP49/NSP49
Inner ring spoke from the isolated yeast NPC
0.0016.000.02 974-998EM0.00hetero-2-2-2-4-4-4-…HHblits0.29
7n85.1.P
Nucleoporin NUP49/NSP49
Inner ring spoke from the isolated yeast NPC
0.0016.000.02 974-998EM0.00hetero-2-2-2-4-4-4-…HHblits0.29
7n9f.1.G
Nucleoporin NUP49/NSP49
Structure of the in situ yeast NPC
0.0016.000.02 974-998EM0.00hetero-2-2-2-6-4-4-…HHblits0.29
7n9f.1.J
Nucleoporin NUP49/NSP49
Structure of the in situ yeast NPC
0.0016.000.02 974-998EM0.00hetero-2-2-2-6-4-4-…HHblits0.29
7n9f.1.M
Nucleoporin NUP49/NSP49
Structure of the in situ yeast NPC
0.0016.000.02 974-998EM0.00hetero-2-2-2-6-4-4-…HHblits0.29
7n9f.1.P
Nucleoporin NUP49/NSP49
Structure of the in situ yeast NPC
0.0016.000.02 974-998EM0.00hetero-2-2-2-6-4-4-…HHblits0.29
7n85.1.G
Nucleoporin NUP49/NSP49
Inner ring spoke from the isolated yeast NPC
0.0016.000.02 974-998EM0.00hetero-2-2-2-4-4-4-…HHblits0.29
7n85.1.J
Nucleoporin NUP49/NSP49
Inner ring spoke from the isolated yeast NPC
0.0016.000.02 974-998EM0.00hetero-2-2-2-4-4-4-…HHblits0.29
7wot.1.I
Nucleoporin NUP49/NSP49
Cryo-EM structure of the inner ring monomer of the Saccharomyces cerevisiae nuclear pore complex
0.0016.000.02 974-998EM0.00hetero-4-2-2-2-2-4-…HHblits0.29
6w1s.1.P
Mediator of RNA polymerase II transcription subunit 21
Atomic model of the mammalian Mediator complex
0.0034.780.02 915-937EM0.00hetero-1-1-1-1-1-1-…HHblits0.36
5wjy.1.A
Flagellin
Cryo-EM structure of B. subtilis flagellar filaments S285P
0.008.000.02 900-924EM4.50homo-41-merHHblits0.28
3zx6.1.A
HAMP, METHYL-ACCEPTING CHEMOTAXIS PROTEIN I
Structure of Hamp(AF1503)-Tsr fusion - Hamp (A291V) mutant
0.0016.000.02 914-938X-ray2.65homo-dimerHHblits0.28
3zx6.1.B
HAMP, METHYL-ACCEPTING CHEMOTAXIS PROTEIN I
Structure of Hamp(AF1503)-Tsr fusion - Hamp (A291V) mutant
0.0016.000.02 914-938X-ray2.65homo-dimerHHblits0.28
4clv.1.A
NICKEL-COBALT-CADMIUM RESISTANCE PROTEIN NCCX
Crystal Structure of dodecylphosphocholine-solubilized NccX from Cupriavidus metallidurans 31A
0.0020.830.02 977-1001X-ray3.12homo-dimer10 x ZN, 2 x PCHHblits0.31
4clv.1.B
NICKEL-COBALT-CADMIUM RESISTANCE PROTEIN NCCX
Crystal Structure of dodecylphosphocholine-solubilized NccX from Cupriavidus metallidurans 31A
0.0020.830.02 977-1001X-ray3.12homo-dimer10 x ZN, 2 x PCHHblits0.31
2b5u.1.A
Colicin E3
Crystal Structure Of Colicin E3 V206C Mutant In Complex With Its Immunity Protein
0.0012.000.02 938-962X-ray2.30hetero-1-1-merHHblits0.27
1jch.1.A
COLICIN E3
Crystal Structure of Colicin E3 in Complex with its Immunity Protein
0.0012.000.02 938-962X-ray3.02hetero-oligomerHHblits0.27
3zrw.1.B
AF1503 PROTEIN, OSMOLARITY SENSOR PROTEIN ENVZ
The structure of the dimeric Hamp-Dhp fusion A291V mutant
0.007.690.02 958-983X-ray2.25hetero-oligomerHHblits0.24
5c5b.1.A
DCC-interacting protein 13-alpha
Crystal Structure of Human APPL BAR-PH Heterodimer
0.008.000.02 994-1018X-ray2.90hetero-oligomerHHblits0.27
7emf.1.Q
Mediator of RNA polymerase II transcription subunit 21
Human Mediator (deletion of MED1-IDR) in a Tail-extended conformation
0.0036.360.02 915-936EM0.00hetero-1-1-1-1-1-1-…2 x ZNHHblits0.36
7lbm.1.r
Mediator of RNA polymerase II transcription subunit 21
Structure of the human Mediator-bound transcription pre-initiation complex
0.0036.360.02 915-936EM0.00hetero-1-1-1-1-1-1-…2 x MG, 16 x ZN, 1 x SF4HHblits0.36
7enc.14.A
Mediator of RNA polymerase II transcription subunit 21
TFIID-based PIC-Mediator holo-complex in fully-assembled state (hPIC-MED)
0.0036.360.02 915-936EM0.00monomerHHblits0.36
7ena.69.A
Mediator of RNA polymerase II transcription subunit 21
TFIID-based PIC-Mediator holo-complex in pre-assembled state (pre-hPIC-MED)
0.0036.360.02 915-936EM0.00monomerHHblits0.36
7nvr.1.k
Mediator of RNA polymerase II transcription subunit 21
Human Mediator with RNA Polymerase II Pre-initiation complex
0.0036.360.02 915-936EM0.00hetero-1-1-1-1-1-1-…1 x SF4, 18 x ZN, 1 x MG, 1 x UNK-UNK-UNK-UNK-UNK-UNK-UNK-UNKHHblits0.36
8gxs.55.A
Mediator of RNA polymerase II transcription subunit 21
PIC-Mediator in complex with +1 nucleosome (T40N) in H-binding state
0.0036.360.02 915-936EM0.00monomerHHblits0.36
6h7w.1.C
Putative vacuolar protein sorting-associated protein
Model of retromer-Vps5 complex assembled on membrane.
0.0020.830.02 937-960EM0.00hetero-2-8-4-2-2-2-…HHblits0.29
6h7w.1.D
Putative vacuolar protein sorting-associated protein
Model of retromer-Vps5 complex assembled on membrane.
0.0020.830.02 937-960EM0.00hetero-2-8-4-2-2-2-…HHblits0.29
6h7w.1.J
Putative vacuolar protein sorting-associated protein
Model of retromer-Vps5 complex assembled on membrane.
0.0020.830.02 937-960EM0.00hetero-2-8-4-2-2-2-…HHblits0.29
8aud.1.A
Cell wall-associated hydrolases (Invasion-associated proteins)
Structure of peptidoglycan hydrolase Cg1735 from Corynebacterium glutamicum, orthorhombic crystal form
0.0012.000.02 1012-1036X-ray4.50monomerHHblits0.26
1ez3.1.A
SYNTAXIN-1A
CRYSTAL STRUCTURE OF THE NEURONAL T-SNARE SYNTAXIN-1A
0.008.000.02 995-1019X-ray1.90monomerHHblits0.25
1ez3.2.A
SYNTAXIN-1A
CRYSTAL STRUCTURE OF THE NEURONAL T-SNARE SYNTAXIN-1A
0.008.000.02 995-1019X-ray1.90monomerHHblits0.25
1ez3.3.A
SYNTAXIN-1A
CRYSTAL STRUCTURE OF THE NEURONAL T-SNARE SYNTAXIN-1A
0.008.000.02 995-1019X-ray1.90monomerHHblits0.25
1i84.1.A
SMOOTH MUSCLE MYOSIN HEAVY CHAIN
CRYO-EM STRUCTURE OF THE HEAVY MEROMYOSIN SUBFRAGMENT OF CHICKEN GIZZARD SMOOTH MUSCLE MYOSIN WITH REGULATORY LIGHT CHAIN IN THE DEPHOSPHORYLATED STATE. ONLY C ALPHAS PROVIDED FOR REGULATORY LIGHT CHAIN. ONLY BACKBONE ATOMS PROVIDED FOR S2 FRAGMENT.
0.0012.000.02 112-1362DX20.00hetero-2-2-2-merHHblits0.25
1i84.1.D
SMOOTH MUSCLE MYOSIN HEAVY CHAIN
CRYO-EM STRUCTURE OF THE HEAVY MEROMYOSIN SUBFRAGMENT OF CHICKEN GIZZARD SMOOTH MUSCLE MYOSIN WITH REGULATORY LIGHT CHAIN IN THE DEPHOSPHORYLATED STATE. ONLY C ALPHAS PROVIDED FOR REGULATORY LIGHT CHAIN. ONLY BACKBONE ATOMS PROVIDED FOR S2 FRAGMENT.
0.0012.000.02 112-1362DX20.00hetero-2-2-2-merHHblits0.25
6dm8.1.A
Induced myeloid leukemia cell differentiation protein Mcl-1 homolog - MBP chimera
Understanding the Species Selectivity of Myeloid cell leukemia-1 (Mcl-1) inhibitors
0.0016.670.02 994-1017X-ray2.70monomer3 x 6AK, 1 x GLC-GLCHHblits0.28
6dm8.4.A
Induced myeloid leukemia cell differentiation protein Mcl-1 homolog - MBP chimera
Understanding the Species Selectivity of Myeloid cell leukemia-1 (Mcl-1) inhibitors
0.0016.670.02 994-1017X-ray2.70monomer2 x 6AK, 1 x GLC-GLCHHblits0.28
6dm8.7.A
Induced myeloid leukemia cell differentiation protein Mcl-1 homolog - MBP chimera
Understanding the Species Selectivity of Myeloid cell leukemia-1 (Mcl-1) inhibitors
0.0016.670.02 994-1017X-ray2.70monomer3 x 6AK, 1 x GLC-GLCHHblits0.28
6dm8.8.A
Induced myeloid leukemia cell differentiation protein Mcl-1 homolog - MBP chimera
Understanding the Species Selectivity of Myeloid cell leukemia-1 (Mcl-1) inhibitors
0.0016.670.02 994-1017X-ray2.70monomer4 x 6AK, 1 x GLC-GLCHHblits0.28
1flc.1.B
HAEMAGGLUTININ-ESTERASE-FUSION GLYCOPROTEIN
X-RAY STRUCTURE OF THE HAEMAGGLUTININ-ESTERASE-FUSION GLYCOPROTEIN OF INFLUENZA C VIRUS
0.008.700.02 969-991X-ray3.20hetero-3-3-merHHblits0.30
6yi5.1.D
Hemagglutinin-esterase-fusion glycoprotein
In-situ structure of the trimeric HEF from influenza C by flexible fitting into a cryo-ET map.
0.008.700.02 969-991EM0.00hetero-3-3-merHHblits0.30
6h7w.1.I
Putative vacuolar protein sorting-associated protein
Model of retromer-Vps5 complex assembled on membrane.
0.008.330.02 905-928EM0.00hetero-2-8-4-2-2-2-…HHblits0.27
8fed.1.A
Virulence factor Mce family protein
Structure of Mce1-LucB complex from Mycobacterium smegmatis (Map1)
0.0012.500.02 944-967EM0.00hetero-1-1-1-1-1-1-…HHblits0.26
2nrj.1.A
Hbl B protein
Crystal Structure of Hemolysin binding component from Bacillus cereus
0.0013.640.02 966-987X-ray2.03monomerHHblits0.32
6gy8.1.A
XaxA
Crystal structure of XaxA from Xenorhabdus nematophila
0.008.700.02 965-987X-ray2.50monomerHHblits0.28
6gy8.2.A
XaxA
Crystal structure of XaxA from Xenorhabdus nematophila
0.008.700.02 965-987X-ray2.50monomerHHblits0.28
7wrg.1.A
Kinesin-like protein
Crystal structure of full-length kinesin-3 KLP-6
0.004.170.02 1104-1127X-ray3.16monomer1 x ADP, 1 x MGHHblits0.25
7wrg.2.A
Kinesin-like protein
Crystal structure of full-length kinesin-3 KLP-6
0.004.170.02 1104-1127X-ray3.16monomer1 x ADP, 1 x MGHHblits0.25
1ykh.1.B
RNA polymerase II holoenzyme component SRB7
Structure of the mediator MED7/MED21 (Med7/Srb7) subcomplex
0.0017.390.02 915-937X-ray3.00hetero-1-1-merHHblits0.28
4rsi.1.B
Structural maintenance of chromosomes protein 4
Yeast Smc2-Smc4 hinge domain with extended coiled coils
0.0013.040.02 969-991X-ray2.90hetero-oligomerHHblits0.28
3zg1.1.A
NICKEL AND COBALT RESISTANCE PROTEIN CNRR
NI-BOUND FORM OF M123A MUTANT OF CUPRIAVIDUS METALLIDURANS CH34 CNRXS
0.0022.730.02 979-1001X-ray1.85homo-dimer2 x NIHHblits0.31
3zg1.1.B
NICKEL AND COBALT RESISTANCE PROTEIN CNRR
NI-BOUND FORM OF M123A MUTANT OF CUPRIAVIDUS METALLIDURANS CH34 CNRXS
0.0022.730.02 979-1001X-ray1.85homo-dimer2 x NIHHblits0.31
3zg1.2.A
NICKEL AND COBALT RESISTANCE PROTEIN CNRR
NI-BOUND FORM OF M123A MUTANT OF CUPRIAVIDUS METALLIDURANS CH34 CNRXS
0.0022.730.02 979-1001X-ray1.85homo-dimer2 x NIHHblits0.31
3zg1.2.B
NICKEL AND COBALT RESISTANCE PROTEIN CNRR
NI-BOUND FORM OF M123A MUTANT OF CUPRIAVIDUS METALLIDURANS CH34 CNRXS
0.0022.730.02 979-1001X-ray1.85homo-dimer2 x NIHHblits0.31
3zcc.1.A
HAMP, OSMOLARITY SENSOR PROTEIN ENVZ
High resolution structure of the asymmetric R333G Hamp-Dhp mutant
0.008.330.02 957-980X-ray1.25homo-dimerHHblits0.24
3zcc.1.B
HAMP, OSMOLARITY SENSOR PROTEIN ENVZ
High resolution structure of the asymmetric R333G Hamp-Dhp mutant
0.008.330.02 957-980X-ray1.25homo-dimerHHblits0.24
3n4x.1.A
Monopolin complex subunit CSM1
Structure of Csm1 full-length
0.008.330.02 1045-1068X-ray3.41homo-dimerHHblits0.23
3n4x.1.B
Monopolin complex subunit CSM1
Structure of Csm1 full-length
0.008.330.02 1045-1068X-ray3.41homo-dimerHHblits0.23
3n4x.2.A
Monopolin complex subunit CSM1
Structure of Csm1 full-length
0.008.330.02 1045-1068X-ray3.41homo-dimerHHblits0.23
3n4x.2.B
Monopolin complex subunit CSM1
Structure of Csm1 full-length
0.008.330.02 1045-1068X-ray3.41homo-dimerHHblits0.23
3n7n.1.D
Monopolin complex subunit CSM1
Structure of Csm1/Lrs4 complex
0.008.330.02 1045-1068X-ray3.90hetero-4-2-merHHblits0.23
3n7n.1.C
Monopolin complex subunit CSM1
Structure of Csm1/Lrs4 complex
0.008.330.02 1045-1068X-ray3.90hetero-4-2-merHHblits0.23
3n7n.1.B
Monopolin complex subunit CSM1
Structure of Csm1/Lrs4 complex
0.008.330.02 1045-1068X-ray3.90hetero-4-2-merHHblits0.23
5ktb.1.B
Monopolin complex subunit CSM1
Structure of a complex between S. cerevisiae Csm1 and Mam1
0.008.330.02 1045-1068X-ray3.05hetero-2-1-merHHblits0.23
5ktb.1.A
Monopolin complex subunit CSM1
Structure of a complex between S. cerevisiae Csm1 and Mam1
0.008.330.02 1045-1068X-ray3.05hetero-2-1-merHHblits0.23
8aud.1.A
Cell wall-associated hydrolases (Invasion-associated proteins)
Structure of peptidoglycan hydrolase Cg1735 from Corynebacterium glutamicum, orthorhombic crystal form
0.008.700.02 915-937X-ray4.50monomerHHblits0.26
5n9j.1.D
Mediator of RNA polymerase II transcription subunit 21
Core Mediator of transcriptional regulation
0.0028.570.02 916-936X-ray3.40hetero-oligomerHHblits0.33
5u0p.1.K
Mediator complex subunit 21
Cryo-EM structure of the transcriptional Mediator
0.0028.570.02 916-936EM0.00hetero-1-1-1-1-1-1-…HHblits0.33
5u0s.1.K
Mediator complex subunit 21
Cryo-EM structure of the Mediator-RNAPII complex
0.0028.570.02 916-936EM0.00hetero-1-1-1-1-1-1-…HHblits0.33
7a0g.1.A
SmhB
Structure of the SmhB pore of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.
0.0018.180.02 967-988X-ray6.98homo-10-merHHblits0.30
6zz5.2.A
SmhB
Structure of soluble SmhB of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.
0.0018.180.02 967-988X-ray1.84monomerHHblits0.30
6zzh.1.A
SmhB
Structure of soluble SmhB crystal form 2 of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.
0.0018.180.02 967-988X-ray1.86monomerHHblits0.30
6zzh.2.A
SmhB
Structure of soluble SmhB crystal form 2 of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.
0.0018.180.02 967-988X-ray1.86monomerHHblits0.30
6zz5.1.A
SmhB
Structure of soluble SmhB of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.
0.0018.180.02 967-988X-ray1.84monomerHHblits0.30
7a0g.1.B
SmhB
Structure of the SmhB pore of the tripartite alpha-pore forming toxin, Smh, from Serratia marcescens.
0.0018.180.02 967-988X-ray6.98homo-10-merHHblits0.30
7q83.1.B
Protein SSO2
Crystal structure of S. cerevisiae Sso2 in complex with the pleckstrin homology domain of Sec3
0.004.170.02 993-1016X-ray2.19hetero-1-1-merHHblits0.23
7q83.2.B
Protein SSO2
Crystal structure of S. cerevisiae Sso2 in complex with the pleckstrin homology domain of Sec3
0.004.170.02 993-1016X-ray2.19hetero-1-1-merHHblits0.23
6xp5.1.A
Mediator of RNA polymerase II transcription subunit 21
Head-Middle module of Mediator
0.0022.730.02 915-936EM0.00hetero-1-1-1-1-1-1-…HHblits0.29
5m4y.1.A
Protein SSO2
Crystal structure of the Sec3/Sso2 complex at 2.20 angstrom resolution
0.0019.050.02 1181-1201X-ray2.20hetero-1-1-merHHblits0.33
5m4y.2.A
Protein SSO2
Crystal structure of the Sec3/Sso2 complex at 2.20 angstrom resolution
0.0019.050.02 1181-1201X-ray2.20hetero-1-1-merHHblits0.33
5m4y.3.A
Protein SSO2
Crystal structure of the Sec3/Sso2 complex at 2.20 angstrom resolution
0.0019.050.02 1181-1201X-ray2.20hetero-1-1-merHHblits0.33
6n2d.1.B
ATP synthase subunit b
Bacillus PS3 ATP synthase membrane region
0.0025.000.02 912-931EM0.00hetero-2-1-10-merHHblits0.36
4i44.1.A
Aerotaxis transducer Aer2
Aer2 poly-HAMP domains: V33G HAMP1 inverted signaling mutant
0.0013.040.02 917-939X-ray2.88homo-dimerHHblits0.24
2iub.1.A
DIVALENT CATION TRANSPORT-RELATED PROTEIN
CRYSTAL STRUCTURE OF A DIVALENT METAL ION TRANSPORTER CORA AT 2.9 A RESOLUTION.
0.0019.050.02 944-964X-ray2.90homo-pentamer10 x MGHHblits0.30
2iub.1.C
DIVALENT CATION TRANSPORT-RELATED PROTEIN
CRYSTAL STRUCTURE OF A DIVALENT METAL ION TRANSPORTER CORA AT 2.9 A RESOLUTION.
0.0019.050.02 944-964X-ray2.90homo-pentamer10 x MGHHblits0.30
8fck.1.A
HAUS augmin-like complex subunit 1
Structure of the vertebrate augmin complex
0.004.550.02 968-989EM0.00hetero-1-1-1-1-1-1-…HHblits0.26
4bne.1.A
PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS PROTEIN 2
Pacsin2 Interacts with Membranes and Actin-Filaments
0.009.090.02 940-961X-ray2.57homo-dimerHHblits0.26
4bne.1.B
PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS PROTEIN 2
Pacsin2 Interacts with Membranes and Actin-Filaments
0.009.090.02 940-961X-ray2.57homo-dimerHHblits0.26
6tpi.1.A
Murein hydrolase activator EnvC
EnvC bound to the FtsX periplasmic domain
0.009.090.02 916-937X-ray2.10hetero-1-2-merHHblits0.26
4uxv.1.A
SEPTATION RING FORMATION REGULATOR EZRA
Cytoplasmic domain of bacterial cell division protein EzrA
0.009.520.02 969-989X-ray3.96monomerHHblits0.29
7p3r.1.A
MakA tetramer
Helical structure of the toxin MakA from Vibrio cholera
0.0015.000.02 968-987EM0.00homo-tetramerHHblits0.33
7p3r.1.B
MakA tetramer
Helical structure of the toxin MakA from Vibrio cholera
0.0015.000.02 968-987EM0.00homo-tetramerHHblits0.33
7p3r.1.C
MakA tetramer
Helical structure of the toxin MakA from Vibrio cholera
0.0015.000.02 968-987EM0.00homo-tetramerHHblits0.33
7p3r.1.D
MakA tetramer
Helical structure of the toxin MakA from Vibrio cholera
0.0015.000.02 968-987EM0.00homo-tetramerHHblits0.33
3dyu.1.A
Sorting nexin-9
Crystal structure of Snx9PX-BAR (230-595), H32
0.0014.290.02 964-984X-ray4.10homo-dimerHHblits0.28
3dyu.2.A
Sorting nexin-9
Crystal structure of Snx9PX-BAR (230-595), H32
0.0014.290.02 964-984X-ray4.10homo-dimerHHblits0.28
3dyt.1.A
Sorting nexin-9
Crystal structure of Snx9PX-BAR (230-595), C2221
0.0014.290.02 964-984X-ray2.08homo-dimerHHblits0.28
1qu7.1.A
METHYL-ACCEPTING CHEMOTAXIS PROTEIN I
FOUR HELICAL-BUNDLE STRUCTURE OF THE CYTOPLASMIC DOMAIN OF A SERINE CHEMOTAXIS RECEPTOR
0.0019.050.02 1180-1200X-ray2.60homo-dimerHHblits0.28
1qu7.1.B
METHYL-ACCEPTING CHEMOTAXIS PROTEIN I
FOUR HELICAL-BUNDLE STRUCTURE OF THE CYTOPLASMIC DOMAIN OF A SERINE CHEMOTAXIS RECEPTOR
0.0019.050.02 1180-1200X-ray2.60homo-dimerHHblits0.28
5ip0.1.A
PHA granule-associated protein
PHA Binding Protein PhaP (Phasin)
0.0014.290.02 969-989X-ray3.00homo-tetramer10 x CDHHblits0.28
5ip0.1.D
PHA granule-associated protein
PHA Binding Protein PhaP (Phasin)
0.0014.290.02 969-989X-ray3.00homo-tetramer10 x CDHHblits0.28
6tt7.1.K
ATP synthase subunit b
Ovine ATP synthase 1a state
0.0025.000.02 976-995EM0.00hetero-3-3-1-1-1-1-…3 x MG, 5 x ADP, 6 x LHG, 1 x P5S, 3 x CDL, 1 x S12HHblits0.31
6gap.1.A
Outer capsid protein sigma-1
Crystal structure of the T3D reovirus sigma1 coiled coil tail and body
0.004.760.02 999-1019X-ray2.15homo-trimerHHblits0.27
6gap.1.B
Outer capsid protein sigma-1
Crystal structure of the T3D reovirus sigma1 coiled coil tail and body
0.004.760.02 999-1019X-ray2.15homo-trimerHHblits0.27
6gap.1.C
Outer capsid protein sigma-1
Crystal structure of the T3D reovirus sigma1 coiled coil tail and body
0.004.760.02 999-1019X-ray2.15homo-trimerHHblits0.27
6gaj.1.A
Outer capsid protein sigma-1
Crystal structure of the T1L reovirus sigma1 coiled coil tail (iodide)
0.0015.000.02 969-988X-ray1.35homo-trimerHHblits0.31
6gaj.1.B
Outer capsid protein sigma-1
Crystal structure of the T1L reovirus sigma1 coiled coil tail (iodide)
0.0015.000.02 969-988X-ray1.35homo-trimerHHblits0.31
6gaj.1.C
Outer capsid protein sigma-1
Crystal structure of the T1L reovirus sigma1 coiled coil tail (iodide)
0.0015.000.02 969-988X-ray1.35homo-trimerHHblits0.31
8fed.1.C
MCE-family protein MCE1c
Structure of Mce1-LucB complex from Mycobacterium smegmatis (Map1)
0.000.000.02 915-935EM0.00hetero-1-1-1-1-1-1-…HHblits0.27
3ja6.1.H
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0015.000.02 915-934EM0.00hetero-oligomerHHblits0.30
3ja6.1.J
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0015.000.02 915-934EM0.00hetero-oligomerHHblits0.30
3ja6.1.L
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0015.000.02 915-934EM0.00hetero-oligomerHHblits0.30
3ja6.1.N
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0015.000.02 915-934EM0.00hetero-oligomerHHblits0.30
3ja6.1.P
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0015.000.02 915-934EM0.00hetero-oligomerHHblits0.30
3ja6.1.R
Methyl-accepting chemotaxis protein 2
Cryo-electron Tomography and All-atom Molecular Dynamics Simulations Reveal a Novel Kinase Conformational Switch in Bacterial Chemotaxis Signaling
0.0015.000.02 915-934EM0.00hetero-oligomerHHblits0.30
2z0n.1.A
DCC-interacting protein 13-alpha
Crystal structure of APPL1-BAR domain
0.009.520.02 996-1016X-ray1.95homo-dimerHHblits0.26
7aal.1.A
Proline-serine-threonine phosphatase-interacting protein 1
Crystal structure of the F-BAR domain of PSTIPIP1, G258A mutant
0.009.520.02 1012-1032X-ray1.97homo-dimerHHblits0.26
7aal.1.B
Proline-serine-threonine phosphatase-interacting protein 1
Crystal structure of the F-BAR domain of PSTIPIP1, G258A mutant
0.009.520.02 1012-1032X-ray1.97homo-dimerHHblits0.26
5wjv.1.A
Flagellin
Cryo-EM structure of B. subtilis flagellar filaments A233V
0.0010.000.02 938-957EM5.50homo-46-merHHblits0.30
1sg2.1.A
Seventeen Kilodalton Protein
Crystal structure of the periplasmic chaperone Skp
0.0015.000.02 1023-1042X-ray2.35homo-trimerHHblits0.29
1sg2.1.B
Seventeen Kilodalton Protein
Crystal structure of the periplasmic chaperone Skp
0.0015.000.02 1023-1042X-ray2.35homo-trimerHHblits0.29
1sg2.1.C
Seventeen Kilodalton Protein
Crystal structure of the periplasmic chaperone Skp
0.0015.000.02 1023-1042X-ray2.35homo-trimerHHblits0.29
7d6e.1.A
Sorting nexin-1
Structural insights into membrane remodeling by SNX1
0.0026.320.01 938-956EM0.00homo-18-merHHblits0.33
7d6d.1.A
Sorting nexin-1
Structural insights into membrane remodeling by SNX1
0.0026.320.01 938-956EM0.00homo-16-merHHblits0.33
8dk2.1.C
JetC
CryoEM structure of Pseudomonas aeruginosa PA14 JetABC in an unclamped state trapped in ATP dependent dimeric form
0.0021.050.01 1182-1200EM0.00hetero-2-2-4-mer2 x AGS, 2 x MGHHblits0.33
8dk2.1.D
JetC
CryoEM structure of Pseudomonas aeruginosa PA14 JetABC in an unclamped state trapped in ATP dependent dimeric form
0.0021.050.01 1182-1200EM0.00hetero-2-2-4-mer2 x AGS, 2 x MGHHblits0.33
8dk3.1.B
JetC
CryoEM structure of Pseudomonas aeruginosa PA14 JetC ATPase domain bound to DNA and cWHD domain of JetA
0.0021.050.01 1182-1200EM0.00hetero-2-1-mer2 x AGS, 2 x MGHHblits0.33
6dfp.1.A
VCA0883
Crystal Structure of a Tripartite Toxin Component VCA0883 from Vibrio cholerae
0.0015.790.01 969-987X-ray1.50monomerHHblits0.33
6w08.1.A
Motility Associated Killing Factor E
Crystal Structure of Motility Associated Killing Factor E from Vibrio cholerae
0.0021.050.01 968-986X-ray1.75homo-dimer1 x KHHblits0.33
6w08.1.B
Motility Associated Killing Factor E
Crystal Structure of Motility Associated Killing Factor E from Vibrio cholerae
0.0021.050.01 968-986X-ray1.75homo-dimer1 x KHHblits0.33
5krw.1.A
Flagellar protein FliT,Flagellar hook-associated protein 2 fusion
Recognition and targeting mechanisms by chaperones in flagella assembly and operation
0.009.520.02 915-935NMR0.00monomerHHblits0.25
1eq1.1.A
APOLIPOPHORIN-III
NMR STRUCTURE OF AN EXCHANGEABLE APOLIPOPROTEIN-MANDUCA SEXTA APOLIPOPHORIN-III
0.0026.320.01 943-961NMR0.00monomerHHblits0.33
6w08.1.A
Motility Associated Killing Factor E
Crystal Structure of Motility Associated Killing Factor E from Vibrio cholerae
0.0010.000.02 976-995X-ray1.75homo-dimer1 x KHHblits0.28
6w08.1.B
Motility Associated Killing Factor E
Crystal Structure of Motility Associated Killing Factor E from Vibrio cholerae
0.0010.000.02 976-995X-ray1.75homo-dimer1 x KHHblits0.28
6h2f.1.A
AhlB
Structure of the pre-pore AhlB of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.0027.780.01 969-986X-ray2.55homo-10-merHHblits0.36
6grk.3.A
AhlB
Structure of the soluble AhlB of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.0027.780.01 969-986X-ray2.33monomerHHblits0.36
6grk.1.A
AhlB
Structure of the soluble AhlB of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.0027.780.01 969-986X-ray2.33monomerHHblits0.36
6h2f.1.B
AhlB
Structure of the pre-pore AhlB of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.0027.780.01 969-986X-ray2.55homo-10-merHHblits0.36
6h2f.1.F
AhlB
Structure of the pre-pore AhlB of the tripartite alpha-pore forming toxin, AHL, from Aeromonas hydrophila.
0.0027.780.01 969-986X-ray2.55homo-10-merHHblits0.36
7aam.1.A
Proline-serine-threonine phosphatase-interacting protein 1
Crystal structure of the F-BAR domain of PSTIPIP1 bound to the CTH domain of the phosphatase LYP
0.004.760.02 911-931X-ray2.15hetero-2-1-merHHblits0.24
7aam.1.B
Proline-serine-threonine phosphatase-interacting protein 1
Crystal structure of the F-BAR domain of PSTIPIP1 bound to the CTH domain of the phosphatase LYP
0.004.760.02 911-931X-ray2.15hetero-2-1-merHHblits0.24
7jg6.1.K
ATP synthase subunit b-delta
Cryo-EM structure of bedaquiline-free Mycobacterium smegmatis ATP synthase rotational state 2 (backbone model)
0.005.000.02 913-932EM0.00hetero-2-1-3-1-1-1-…HHblits0.27
7jg5.1.K
ATP synthase subunit b-delta
Cryo-EM structure of bedaquiline-free Mycobacterium smegmatis ATP synthase rotational state 1
0.005.000.02 913-932EM0.00hetero-2-1-3-1-1-1-…3 x ATP, 4 x MG, 1 x ADPHHblits0.27
7jg7.1.K
ATP synthase subunit b-delta
Cryo-EM structure of bedaquiline-free Mycobacterium smegmatis ATP synthase rotational state 3 (backbone model)
0.005.000.02 913-932EM0.00hetero-2-1-3-1-1-1-…HHblits0.27
7jg8.1.K
ATP synthase subunit b-delta
Cryo-EM structure of bedaquiline-saturated Mycobacterium smegmatis ATP synthase rotational state 1 (backbone model)
0.005.000.02 913-932EM0.00hetero-3-3-1-1-1-1-…7 x BQ1HHblits0.27
7jg9.1.K
ATP synthase subunit b-delta
Cryo-EM structure of bedaquiline-saturated mycobacterium smegmatis ATP synthase rotational state 2 (backbone model)
0.005.000.02 913-932EM0.00hetero-3-3-1-1-1-1-…7 x BQ1HHblits0.27
7jga.1.K
ATP synthase subunit b-delta
Cryo-EM structure of bedaquiline-saturated Mycobacterium smegmatis ATP synthase rotational state 3
0.005.000.02 913-932EM0.00hetero-3-3-1-1-1-1-…3 x ATP, 4 x MG, 1 x ADP, 7 x BQ1HHblits0.27
7njo.1.T
ATP synthase subunit b-delta
Mycobacterium smegmatis ATP synthase state 1e
0.005.000.02 913-932EM0.00hetero-3-3-1-1-9-1-…4 x ATP, 5 x MG, 2 x ADPHHblits0.27
7njn.1.T
ATP synthase subunit b-delta
Mycobacterium smegmatis ATP synthase state 1d
0.005.000.02 913-932EM0.00hetero-3-3-1-1-9-1-…4 x ATP, 5 x MG, 2 x ADPHHblits0.27
7njk.1.T
ATP synthase subunit b-delta
Mycobacterium smegmatis ATP synthase state 1a
0.005.000.02 913-932EM0.00hetero-3-3-1-1-9-1-…4 x ATP, 5 x MG, 2 x ADPHHblits0.27
7njs.1.T
ATP synthase subunit b-delta
Mycobacterium smegmatis ATP synthase state 3c
0.005.000.02 913-932EM0.00hetero-3-3-1-1-9-1-…4 x ATP, 5 x MG, 2 x ADPHHblits0.27
7njq.1.T
ATP synthase subunit b-delta
Mycobacterium smegmatis ATP synthase state 3a
0.005.000.02 913-932EM0.00hetero-3-3-1-1-9-1-…4 x ATP, 5 x MG, 2 x ADPHHblits0.27
7njm.1.T
ATP synthase subunit b-delta
Mycobacterium smegmatis ATP synthase state 1c
0.005.000.02 913-932EM0.00hetero-3-3-1-1-9-1-…4 x ATP, 5 x MG, 2 x ADPHHblits0.27
7njr.1.T
ATP synthase subunit b-delta
Mycobacterium smegmatis ATP synthase state 3b
0.005.000.02 913-932EM0.00hetero-3-3-1-1-9-1-…4 x ATP, 5 x MG, 2 x ADPHHblits0.27
7njl.1.T
ATP synthase subunit b-delta
Mycobacterium smegmatis ATP synthase state 1b
0.005.000.02 913-932EM0.00hetero-3-3-1-1-9-1-…4 x ATP, 5 x MG, 2 x ADPHHblits0.27
7y5d.1.C
ATP synthase subunit b-delta
Cryo-EM structure of F-ATP synthase from Mycolicibacterium smegmatis (rotational state 3) (backbone)
0.005.000.02 913-932EM0.00hetero-1-1-1-9-1-2-…HHblits0.27
8g0e.1.J
ATP synthase subunit b-delta
Cryo-EM structure of TBAJ-876-bound Mycobacterium smegmatis ATP synthase rotational state 3
0.005.000.02 913-932EM0.00hetero-3-3-1-1-1-1-…4 x ATP, 4 x MG, 7 x YGRHHblits0.27
8g0a.1.J
ATP synthase subunit b-delta
Cryo-EM structure of SQ31f-bound Mycobacterium smegmatis ATP synthase rotational state 3
0.005.000.02 913-932EM0.00hetero-3-3-1-1-1-1-…4 x ATP, 4 x MG, 1 x SQCHHblits0.27
5w9a.1.A
Tripartite motif-containing protein 5
The structure of the Trim5alpha Bbox- coiled coil in complex LC3B
0.0015.790.01 959-977X-ray2.74hetero-2-2-mer4 x ZNHHblits0.31
5w9a.1.D
Tripartite motif-containing protein 5
The structure of the Trim5alpha Bbox- coiled coil in complex LC3B
0.0015.790.01 959-977X-ray2.74hetero-2-2-mer4 x ZNHHblits0.31
6fki.1.D
ATP synthase subunit b', chloroplastic
Chloroplast F1Fo conformation 3
0.0010.000.02 913-932EM0.00hetero-1-1-1-1-1-1-…3 x ATP, 5 x MG, 2 x ADPHHblits0.27
6fkf.1.I
ATP synthase subunit b', chloroplastic
Chloroplast F1Fo conformation 1
0.0010.000.02 913-932EM3.10hetero-3-3-1-1-1-1-…3 x ATP, 5 x MG, 2 x ADPHHblits0.27
6von.1.K
ATP synthase subunit b', chloroplastic
Chloroplast ATP synthase (R1, CF1FO)
0.0010.000.02 913-932EM0.00hetero-3-3-1-1-1-1-…4 x ATP, 1 x TTX, 2 x ADPHHblits0.27
6vm4.1.H
ATP synthase subunit b', chloroplastic
Chloroplast ATP synthase (C2, CF1FO)
0.0010.000.02 913-932EM0.00hetero-3-3-1-1-1-1-…HHblits0.27
6vmb.1.H
ATP synthase subunit b', chloroplastic
Chloroplast ATP synthase (C1, CF1FO)
0.0010.000.02 913-932EM0.00hetero-3-3-1-1-1-1-…3 x ATP, 2 x ADPHHblits0.27
6vmg.1.D
ATP synthase subunit b', chloroplastic
Chloroplast ATP synthase (O3, CF1FO)
0.0010.000.02 913-932EM0.00hetero-1-1-1-1-1-1-…HHblits0.27
6vof.1.K
ATP synthase subunit b', chloroplastic
Chloroplast ATP synthase (O2, CF1FO)
0.0010.000.02 913-932EM0.00hetero-3-3-1-1-1-1-…4 x ATP, 1 x ADPHHblits0.27
6vol.1.K
ATP synthase subunit b', chloroplastic
Chloroplast ATP synthase (R2, CF1FO)
0.0010.000.02 913-932EM0.00hetero-3-3-1-1-1-1-…4 x ATP, 2 x ADP, 1 x TTXHHblits0.27
4nqj.1.A
E3 ubiquitin-protein ligase TRIM69
Structure of coiled-coil domain
0.0021.050.01 961-979X-ray2.15homo-hexamer10 x LMTHHblits0.31
4nqj.1.B
E3 ubiquitin-protein ligase TRIM69
Structure of coiled-coil domain
0.0021.050.01 961-979X-ray2.15homo-hexamer10 x LMTHHblits0.31
4nqj.1.C
E3 ubiquitin-protein ligase TRIM69
Structure of coiled-coil domain
0.0021.050.01 961-979X-ray2.15homo-hexamer10 x LMTHHblits0.31
5wjw.1.A
Flagellin
Cryo-EM structure of B. subtilis flagellar filaments H84R
0.0010.530.01 906-924EM4.40homo-41-merHHblits0.31
5wjt.1.A
Flagellin
Cryo-EM structure of B. subtilis flagellar filaments N226Y
0.0010.530.01 906-924EM3.80homo-41-merHHblits0.31
7p5j.1.A
Protein tweety homolog 1
Cryo-EM structure of human TTYH1 in GDN
0.0029.410.01 1201-1218EM0.00homo-dimer4 x NAG, 2 x NAG-NAGHHblits0.39
6ezv.1.A
Non-hemolytic enterotoxin lytic component L1
The cytotoxin MakA from Vibrio cholerae
0.0016.670.01 969-986X-ray1.90monomer1 x CACHHblits0.34
7wkk.1.U
IL4I1 protein
Cryo-EM structure of the IR subunit from X. laevis NPC
0.0010.530.01 921-939EM4.20hetero-2-2-4-6-4-4-…HHblits0.30
7wkk.1.X
IL4I1 protein
Cryo-EM structure of the IR subunit from X. laevis NPC
0.0010.530.01 921-939EM4.20hetero-2-2-4-6-4-4-…HHblits0.30
7tdz.1.5
Nup62
Cryo-EM model of protomer of the cytoplasmic ring of the nuclear pore complex from Xenopus laevis
0.0010.530.01 921-939EM0.00hetero-2-2-2-2-2-2-…HHblits0.30
7vop.1.5
IL4I1 protein
Cryo-EM structure of Xenopus laevis nuclear pore complex cytoplasmic ring subunit
0.0010.530.01 921-939EM0.00hetero-2-2-2-2-2-2-…HHblits0.30
7vop.1.2
IL4I1 protein
Cryo-EM structure of Xenopus laevis nuclear pore complex cytoplasmic ring subunit
0.0010.530.01 921-939EM0.00hetero-2-2-2-2-2-2-…HHblits0.30
2j69.1.A
BACTERIAL DYNAMIN-LIKE PROTEIN
BACTERIAL DYNAMIN-LIKE PROTEIN BDLP
0.0010.530.01 967-985X-ray3.00monomerHHblits0.29
2w6d.1.B
DYNAMIN FAMILY PROTEIN
BACTERIAL DYNAMIN-LIKE PROTEIN LIPID TUBE BOUND
0.0010.530.01 967-985EM9.00homo-dimer2 x GDP, 23 x CPLHHblits0.29
2w6d.1.A
DYNAMIN FAMILY PROTEIN
BACTERIAL DYNAMIN-LIKE PROTEIN LIPID TUBE BOUND
0.0010.530.01 967-985EM9.00homo-dimer2 x GDP, 23 x CPLHHblits0.29
2j68.1.A
BACTERIAL DYNAMIN-LIKE PROTEIN
BACTERIAL DYNAMIN-LIKE PROTEIN BDLP, GDP BOUND
0.0010.530.01 967-985X-ray3.10homo-dimer2 x GDPHHblits0.29
4lin.1.A
Tail needle protein gp26
Exploring the atomic structure and conformational flexibility of a 320 angstrom long engineered viral fiber using X-ray crystallography
0.0022.220.01 858-876X-ray2.70homo-trimer1 x CAHHblits0.33
4lin.1.B
Tail needle protein gp26
Exploring the atomic structure and conformational flexibility of a 320 angstrom long engineered viral fiber using X-ray crystallography
0.0022.220.01 858-876X-ray2.70homo-trimer1 x CAHHblits0.33
4lin.1.C
Tail needle protein gp26
Exploring the atomic structure and conformational flexibility of a 320 angstrom long engineered viral fiber using X-ray crystallography
0.0022.220.01 858-876X-ray2.70homo-trimer1 x CAHHblits0.33
4lin.2.A
Tail needle protein gp26
Exploring the atomic structure and conformational flexibility of a 320 angstrom long engineered viral fiber using X-ray crystallography
0.0022.220.01 858-876X-ray2.70homo-trimer1 x CAHHblits0.33
4lin.2.B
Tail needle protein gp26
Exploring the atomic structure and conformational flexibility of a 320 angstrom long engineered viral fiber using X-ray crystallography
0.0022.220.01 858-876X-ray2.70homo-trimer1 x CAHHblits0.33
4lin.2.C
Tail needle protein gp26
Exploring the atomic structure and conformational flexibility of a 320 angstrom long engineered viral fiber using X-ray crystallography
0.0022.220.01 858-876X-ray2.70homo-trimer1 x CAHHblits0.33
4lin.3.A
Tail needle protein gp26
Exploring the atomic structure and conformational flexibility of a 320 angstrom long engineered viral fiber using X-ray crystallography
0.0022.220.01 858-876X-ray2.70homo-trimer1 x CAHHblits0.33
4lin.3.B
Tail needle protein gp26
Exploring the atomic structure and conformational flexibility of a 320 angstrom long engineered viral fiber using X-ray crystallography
0.0022.220.01 858-876X-ray2.70homo-trimer1 x CAHHblits0.33
4lin.3.C
Tail needle protein gp26
Exploring the atomic structure and conformational flexibility of a 320 angstrom long engineered viral fiber using X-ray crystallography
0.0022.220.01 858-876X-ray2.70homo-trimer1 x CAHHblits0.33
4lin.4.A
Tail needle protein gp26
Exploring the atomic structure and conformational flexibility of a 320 angstrom long engineered viral fiber using X-ray crystallography
0.0022.220.01 858-876X-ray2.70homo-trimer1 x CAHHblits0.33
4lin.4.B
Tail needle protein gp26
Exploring the atomic structure and conformational flexibility of a 320 angstrom long engineered viral fiber using X-ray crystallography
0.0022.220.01 858-876X-ray2.70homo-trimer1 x CAHHblits0.33
4lin.4.C
Tail needle protein gp26
Exploring the atomic structure and conformational flexibility of a 320 angstrom long engineered viral fiber using X-ray crystallography
0.0022.220.01 858-876X-ray2.70homo-trimer1 x CAHHblits0.33
5jsb.1.B
Mcl-1 inhibitor
Crystal structure of Mcl1-inhibitor complex
0.0037.500.01 976-991X-ray2.74hetero-1-1-merHHblits0.40
5xei.1.A
Chromosome partition protein Smc
Crystal structure of the Smc head domain with a coiled coil and joint derived from Pyrococcus yayanosii
0.0011.110.01 971-988X-ray2.60monomerHHblits0.30
6gao.1.A
Outer capsid protein sigma-1
Crystal structure of the T1L reovirus sigma1 coiled coil tail and body
0.0029.410.01 1000-1016X-ray2.10homo-trimerHHblits0.34
6gao.1.B
Outer capsid protein sigma-1
Crystal structure of the T1L reovirus sigma1 coiled coil tail and body
0.0029.410.01 1000-1016X-ray2.10homo-trimerHHblits0.34
6gao.1.C
Outer capsid protein sigma-1
Crystal structure of the T1L reovirus sigma1 coiled coil tail and body
0.0029.410.01 1000-1016X-ray2.10homo-trimerHHblits0.34
4hwd.1.A
BAG family molecular chaperone regulator 2
Crystal structure of ATBAG2
0.005.560.01 1017-1034X-ray2.31monomerHHblits0.29
4hwd.2.A
BAG family molecular chaperone regulator 2
Crystal structure of ATBAG2
0.005.560.01 1017-1034X-ray2.31monomerHHblits0.29
4hwd.3.A
BAG family molecular chaperone regulator 2
Crystal structure of ATBAG2
0.005.560.01 1017-1034X-ray2.31monomerHHblits0.29
7sn9.1.A
Flagellin A
Cryo-EM structure of the Sinorhizobium meliloti flagellar filament
0.0011.110.01 970-987EM0.00homo-42-merHHblits0.29
7sn9.1.B
Flagellin A
Cryo-EM structure of the Sinorhizobium meliloti flagellar filament
0.0011.110.01 970-987EM0.00homo-42-merHHblits0.29
8bd7.1.I
Clusterin-associated protein 1
IFTB1 subcomplex of anterograde Intraflagellar transport trains (Chlamydomonas reinhardtii)
0.005.260.01 1013-1031EM0.00hetero-2-2-2-2-2-2-…HHblits0.25
6gcv.1.A
Chemotaxis transducer
Ligand binding domain (LBD) of the p. aeruginosa nitrate receptor McpN
0.0011.760.01 965-981X-ray1.30homo-dimerHHblits0.32
6gcv.1.B
Chemotaxis transducer
Ligand binding domain (LBD) of the p. aeruginosa nitrate receptor McpN
0.0011.760.01 965-981X-ray1.30homo-dimerHHblits0.32
5kuc.1.A
Pesticidal crystal protein Cry6Aa
Crystal structure of trypsin activated Cry6Aa
0.005.560.01 968-985X-ray2.00monomerHHblits0.26
4akv.1.A
SORTING NEXIN-33
Crystal structure of human sorting nexin 33 (SNX33)
0.0025.000.01 959-974X-ray2.65homo-dimerHHblits0.35
4akv.1.B
SORTING NEXIN-33
Crystal structure of human sorting nexin 33 (SNX33)
0.0025.000.01 959-974X-ray2.65homo-dimerHHblits0.35
7ank.1.B
Alpha-actinin-2
Crystal structure of sarcomeric protein FATZ-1 (d91-FATZ-1 construct) in complex with half dimer of alpha-actinin-2
0.0037.500.01 994-1009X-ray3.20hetero-1-1-1-merHHblits0.35
6ek4.1.A
PaxB
PaxB from Photorhabdus luminescens
0.0016.670.01 901-918X-ray2.80monomerHHblits0.25
6ek4.2.A
PaxB
PaxB from Photorhabdus luminescens
0.0016.670.01 901-918X-ray2.80monomerHHblits0.25
6ek4.4.A
PaxB
PaxB from Photorhabdus luminescens
0.0016.670.01 901-918X-ray2.80monomerHHblits0.25
5xau.1.A
Laminin subunit alpha-5
Crystal structure of integrin binding fragment of laminin-511
0.0011.760.01 972-988X-ray1.80hetero-1-1-1-mer1 x CA, 3 x NAG, 1 x NAG-NAGHHblits0.29
5xau.2.A
Laminin subunit alpha-5
Crystal structure of integrin binding fragment of laminin-511
0.0011.760.01 972-988X-ray1.80hetero-1-1-1-mer1 x CA, 4 x NAGHHblits0.29
7cec.1.C
Laminin subunit alpha-5
Structure of alpha6beta1 integrin in complex with laminin-511
0.0011.760.01 972-988EM0.00hetero-1-1-1-1-1-1-…4 x CA, 6 x NAG, 3 x MN, 1 x NAG-NAGHHblits0.29
3zrw.2.A
AF1503 PROTEIN, OSMOLARITY SENSOR PROTEIN ENVZ
The structure of the dimeric Hamp-Dhp fusion A291V mutant
0.0011.110.01 962-979X-ray2.25homo-dimerHHblits0.24
3zrw.1.A
AF1503 PROTEIN, OSMOLARITY SENSOR PROTEIN ENVZ
The structure of the dimeric Hamp-Dhp fusion A291V mutant
0.0011.110.01 962-979X-ray2.25hetero-oligomerHHblits0.24
7ogt.1.B
Structural maintenance of chromosomes protein 3
Folded elbow of cohesin
0.005.560.01 918-935EM0.00hetero-1-1-merHHblits0.24
6zz6.1.B
Structural maintenance of chromosomes protein 3,Structural maintenance of chromosomes protein 3,Structural maintenance of chromosomes protein 3
Cryo-EM structure of S.cerevisiae cohesin-Scc2-DNA complex
0.0017.650.01 804-822EM0.00hetero-1-1-1-1-mer2 x ATP, 2 x MGHHblits0.27
7n9f.1.4
Nucleoporin NUP82
Structure of the in situ yeast NPC
0.005.560.01 972-989EM0.00hetero-2-2-2-6-4-4-…HHblits0.23
7n9f.1.5
Nucleoporin NUP82
Structure of the in situ yeast NPC
0.005.560.01 972-989EM0.00hetero-2-2-2-6-4-4-…HHblits0.23
7tbi.51.A
Nup82
Composite structure of the S. cerevisiae nuclear pore complex (NPC)
0.005.560.01 972-989EM0.00monomerHHblits0.23
7tbi.50.A
Nup82
Composite structure of the S. cerevisiae nuclear pore complex (NPC)
0.005.560.01 972-989EM0.00monomerHHblits0.23
4dcn.1.C
Arfaptin-2
Crystal Structure Analysis of the Arfaptin2 BAR domain in Complex with ARL1
0.0018.750.01 915-930X-ray3.01hetero-oligomer2 x MG, 2 x GNPHHblits0.31
4dcn.1.D
Arfaptin-2
Crystal Structure Analysis of the Arfaptin2 BAR domain in Complex with ARL1
0.0018.750.01 915-930X-ray3.01hetero-oligomer2 x MG, 2 x GNPHHblits0.31
4cgk.1.A
SECRETED 45 KDA PROTEIN
Crystal structure of the essential protein PcsB from Streptococcus pneumoniae
0.0012.500.01 975-990X-ray2.55homo-tetramer2 x MGHHblits0.30
4cgk.1.B
SECRETED 45 KDA PROTEIN
Crystal structure of the essential protein PcsB from Streptococcus pneumoniae
0.0012.500.01 975-990X-ray2.55homo-tetramer2 x MGHHblits0.30
4n21.1.A
GP2 Ectodomain
Crystal structure of the GP2 Core Domain from the California Academy of Science Virus
0.0020.000.01 927-941X-ray1.99homo-trimerHHblits0.34
4n21.2.B
GP2 Ectodomain
Crystal structure of the GP2 Core Domain from the California Academy of Science Virus
0.0020.000.01 927-941X-ray1.99homo-trimerHHblits0.34
5ghe.1.A
Pesticidal crystal protein Cry6Aa
Crystal Structure of Bacillus thuringiensis Cry6Aa2 Protoxin
0.006.250.01 969-984X-ray1.90monomerHHblits0.28
7muc.3.A
DotF
Legionella pneumophila Dot/Icm T4SS C1 Reconstruction
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muc.12.A
DotF
Legionella pneumophila Dot/Icm T4SS C1 Reconstruction
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muc.36.A
DotF
Legionella pneumophila Dot/Icm T4SS C1 Reconstruction
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muc.48.A
DotF
Legionella pneumophila Dot/Icm T4SS C1 Reconstruction
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muc.72.A
DotF
Legionella pneumophila Dot/Icm T4SS C1 Reconstruction
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muc.84.A
DotF
Legionella pneumophila Dot/Icm T4SS C1 Reconstruction
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muc.96.A
DotF
Legionella pneumophila Dot/Icm T4SS C1 Reconstruction
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muc.132.A
DotF
Legionella pneumophila Dot/Icm T4SS C1 Reconstruction
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muc.144.A
DotF
Legionella pneumophila Dot/Icm T4SS C1 Reconstruction
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mue.27.A
DotF
Legionella pneumophila Dot/Icm T4SS PR
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.4.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.6.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.15.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.18.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.28.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.31.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.41.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.43.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.53.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.57.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.66.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.68.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.78.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.81.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.92.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.93.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.97.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.103.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.107.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.111.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.114.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.122.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.124.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.127.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.134.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.150.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.152.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.160.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.169.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.171.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muq.191.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 1
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.3.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.12.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.14.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.24.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.28.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.37.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.39.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.48.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.53.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.63.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.65.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.75.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.79.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.84.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.90.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.91.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.95.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.99.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.101.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.105.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.110.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.119.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.121.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.130.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.149.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.151.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.159.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.168.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.170.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.189.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7mus.192.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 2
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.8.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.10.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.18.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.20.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.22.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.31.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.33.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.42.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.45.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.55.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.57.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.65.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.69.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.79.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.81.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.91.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.94.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.104.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.105.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.108.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.110.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.114.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.118.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.124.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.139.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.141.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.148.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.166.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.168.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.188.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muv.191.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 3
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.11.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.22.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.24.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.36.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.48.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.60.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.73.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.83.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.86.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.98.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.108.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.110.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.114.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.118.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.122.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.129.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.140.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.168.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muw.191.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 4
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.3.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.12.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.14.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.24.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.27.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.29.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.38.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.41.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.50.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.54.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.64.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.66.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.75.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.79.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.88.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.90.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.99.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.103.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.112.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.113.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.117.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.125.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.132.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.140.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.142.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.150.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.160.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.169.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.171.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7muy.191.A
DotF
Reconstruction of the Legionella pneumophila Dot/Icm T4SS 3DVA Map 5
0.000.000.01 1057-1073EM0.00monomerHHblits0.23
7r5k.95.A
Nuclear pore complex protein Nup88
Human nuclear pore complex (constricted)
0.0026.670.01 190-205EM0.00monomerHHblits0.32
5c5b.1.B
DCC-interacting protein 13-beta
Crystal Structure of Human APPL BAR-PH Heterodimer
0.006.250.01 914-929X-ray2.90hetero-oligomerHHblits0.26
6ewy.1.A
Peptidoglycan endopeptidase RipA
RipA Peptidoglycan hydrolase (Rv1477, Mycobacterium tuberculosis) N-terminal domain
0.0013.330.01 974-988X-ray2.20monomerHHblits0.31
4rsi.1.A
Structural maintenance of chromosomes protein 2
Yeast Smc2-Smc4 hinge domain with extended coiled coils
0.0033.330.01 1055-1069X-ray2.90hetero-oligomerHHblits0.29
6c14.1.A
Protocadherin-15
CryoEM structure of mouse PCDH15-1EC-LHFPL5 complex
0.0013.330.01 1050-1064EM0.00hetero-2-2-merHHblits0.24
7zcg.1.B
Charged multivesicular body protein 3
CHMP2A-CHMP3 heterodimer (430 Angstrom diameter)
0.006.670.01 902-916EM0.00hetero-1-1-merHHblits0.24
7zch.1.B
Charged multivesicular body protein 3
CHMP2A-CHMP3 heterodimer (410 Angstrom diameter)
0.006.670.01 902-916EM0.00hetero-1-1-merHHblits0.24